Sunteți pe pagina 1din 233

Anexa 2

DCI/DENUMIRE COMERCIALA CONCENTRATIE FORMA FARM. FIRMA PROTOCOL

SUBLISTA A - MEDICAMENTE CU NIVEL DE COMPENSARE 90% DIN PREUL DE REFERIN. 1 A02BA02 RANITIDINUM
A02BA02 RANITIDINUM
ULCORAN

CAPS.
150mg EUROPHARM SA

150mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA02 RANITIDINUM
RANITIDIN RANITIDINA 150 mg

COMPR.
150mg 150mg SLAVIA PHARM SRL MAGISTRA C & C

150mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA02 RANITIDINUM
DIGEN EFF 150 mg ZANTAC

COMPR. EFF.
150mg 150mg OZONE LABORATORIES LTD. GLAXOWELLCOME UK LTD.

150mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA02 RANITIDINUM
ALS-RANITIDINA 150 mg GERTOCALM HISTAC 150 RANITAL RANITIDIN RANITIDIN 150 mg RANITIDINA RANITIDINA 150 mg RANITIDINA ANTIBIOTICE 150 mg RANITIDINA LPH 150 mg ZANTAC 150 mg

COMPR. FILM.
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg ALSIFCOM INTERMED SRL FARAN LABORATORIES S.A. TERAPIA S.A. LEK PHARMACEUTICALS D.D. OZONE LABORATORIES LTD. AC HELCOR SRL LAROPHARM SRL FILDAS TRADING SRL ANTIBIOTICE SA LABORMED PHARMA SA GLAXO WELLCOME UK LTD.

150mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA02 RANITIDINUM
ARNETIN ZANTAC SOLUTIE INJECTABILA

SOL. INJ.
25mg/ml 25mg/ml MEDOCHEMIE LTD. GLAXO WELLCOME UK LTD.

25mg/ml

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA02 RANITIDINUM
RANITIDINA ARENA 300 mg

CAPS.
300mg ARENA GROUP S.A.

300mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA02 RANITIDINUM
HISTAC 300 RANITIDIN 300 mg RANITIDINA 300 mg RANITIDINA LPH 300 mg

COMPR. FILM.
300mg 300mg 300mg 300mg TERAPIA S.A. AC HELCOR SRL FILDAS TRADING SRL LABORMED PHARMA SA

300mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA02 RANITIDINUM
RANITIDINA ARENA 75 mg 75mg

CAPS.
ARENA GROUP S.A.

75mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA02 RANITIDINUM
DIGEN 75 mg HISTAC 75 RANITIDINA LPH 75 mg ZANTAC 75 75mg 75mg 75mg 75mg

COMPR. FILM.
OZONE LABORATORIES LTD. TERAPIA S.A. LABORMED PHARMA SA GLAXOSMITHKLINE CONSUMER HEALTHCARE

75mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

2
FAMODAR ABR

A02BA03

FAMOTIDINUM
COMPR. FILM.
10mg DAR AL DAWA PHARMA S.R.L.

A02BA03 FAMOTIDINUM

10mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA03 FAMOTIDINUM
FAMODAR 20 FAMODIN 20 FAMOTAK FAMOTIDINA ZENTIVA 20mg QUAMATEL 20 mg 20mg 20mg 20mg 20mg 20mg

COMPR. FILM.
DAR AL DAWA PHARMA S.R.L AC HELCOR PHARMA SRL SEDICO IMPEX S.R.L. ZENTIVA S.A GEDEON RICHTER PLC

20mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA03 FAMOTIDINUM
FAMODAR 20 FAMODIN 20 FAMOTAK FAMOTIDINA ZENTIVA 20mg QUAMATEL 20 mg 20mg 20mg 20mg 20mg 20mg

COMPR. FILM.
DAR AL DAWA PHARMA S.R.L AC HELCOR PHARMA SRL SEDICO IMPEX S.R.L. ZENTIVA S.A GEDEON RICHTER PLC

20mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA03 FAMOTIDINUM
QUAMATEL 20 mg 20mg

LIOF. + SOLV. PT. SOL. INJ.


GEDEON RICHTER PLC

20mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA03 FAMOTIDINUM
FAMODAR 40 FAMODIN 40 FAMOTAK FAMOTIDINA ZENTIVA 40 mg GASTROSIDIN QUAMATEL 40 mg 40mg 40mg 40mg 40mg 40mg 40mg

COMPR. FILM.
DAR AL DAWA PHARMA SRL AC HELCOR PHARMA SRL SEDICO IMPEX S.R.L. ZENTIVA S.A ECZACIBASI PHARMACEUTICALS S.R.L. GEDEON RICHTER PLC

40mg

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

A02BA04

NIZATIDINUM
CAPS. 150mg

A02BA04 NIZATIDINUM

1 / 233

DCI/DENUMIRE COMERCIALA
NIZATIDIN 150 mg NIZATIDINA LAROPHARM 150 mg

CONCENTRATIE
150mg 150mg

FORMA FARM.
VIM SPECTRUM SRL LAROPHARM S.R.L.

FIRMA

PROTOCOL

NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie avuta in vedere inaintea initierii tratamentului ulcerului peptic cu acest medicament..

4
HELICID 10 OMERAN 10 ORTANOL S ULTOP ZIMEZAL 10 mg

A02BC01

OMEPRAZOLUM
CAPS. GASTROREZ.
10mg 10mg 10mg 10mg 10mg 10mg ZENTIVA AS EUROPHARM SA LEK PHARMACEUTICALS D.D. KRKA D.D. NOVO MESTO OZONE LABORATORIES LTD.

A02BC01 OMEPRAZOLUM

10mg

A02BC01 OMEPRAZOLUM
LOSEC MUPS 10 mg

COMPR. FILM. GASTROREZ.


ASTRAZENECA AB

10mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:


RISEK

Boala de reflux gastro-esofagian Sclerodermia esofagului. Sindromul Zollinger-Ellison

A02BC01 OMEPRAZOLUM
20mg

CAPS. ENTER.
GULF PHARMACEUTICAL INDUSTRIES S.R.L.

20mg

Prescriere limitata: Tratamentul initial al ulcerului peptic NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie luata in considerare..

A02BC01 OMEPRAZOLUM
HELICID 20 OMEPRAZOL 20 mg OMEPRAZOL AL 20 OMEPRAZOL ARENA 20 mg OMEPRAZOL BIOFARM 20 mg OMEPRAZOL LPH 20 mg OMEPRAZOL TERAPIA 20 mg OMERAN 20 OMEZ ORTANOL 20 mg ULTOP ZIMEZAL 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

CAPS. GASTROREZ.
ZENTIVA AS SLAVIA PHARM SRL ALIUD PHARMA GMBH & CO.KG ARENA GROUP S.A. BIOFARM S.A. LABORMED PHARMA SA TERAPIA S.A. EUROPHARM SA DR. REDDY'S LABORATORIES LEK PHARMACEUTICALS D.D. KRKA D.D. OZONE LABORATORIES LTD.

20mg

Prescriere limitata: Tratamentul initial al ulcerului peptic NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie luata in considerare..

A02BC01 OMEPRAZOLUM
LOSEC MUPS 20 mg OMEDAR 20mg 20mg

COMPR. FILM. GASTROREZ.


ASTRAZENECA AB DAR AL DAWA PHARMA S.R.L

20mg

Prescriere limitata: Tratamentul initial al ulcerului peptic NOTA: Terapia de eradicare a infectiei cu Helicobacter pylori trebuie luata in considerare..

A02BC01 OMEPRAZOLUM
OMERAN 40 ORTANOL ULTOP 40mg 40mg 40mg 40mg 40mg 40mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

CAPS. GASTROREZ.
EUROPHARM SA LEK PHARMACEUTICALS D.D. KRKA D.D. NOVO MESTO

40mg

A02BC01 OMEPRAZOLUM
LOSEC 40 mg ULTOP

LIOF. PT. SOL. PERF.


ASTRAZENECA AB KRKA D.D.

40mg

A02BC01 OMEPRAZOLUM
OMEZ PULBERE PENTRU SOLUTIE PERFUZABILA

PULB. PT. SOL. PERF.


DR. REDDY'S LABORATORIES

40mg 20mg

A02BC01 OMEPRAZOLUM
HELICID 20 OMEPRAZOL 20 mg OMEPRAZOL AL 20 OMEPRAZOL ARENA 20 mg OMEPRAZOL BIOFARM 20 mg OMEPRAZOL LPH 20 mg OMEPRAZOL TERAPIA 20 mg OMERAN 20 OMEZ ORTANOL 20 mg ULTOP ZIMEZAL 20 mg

CAPS. GASTROREZ.
ZENTIVA AS GEDEON RICHTER ROMANIA SA ALIUD PHARMA GMBH & CO.KG ARENA GROUP S.A. BIOFARM S.A. LABORMED PHARMA SA TERAPIA S.A. EUROPHARM SA DR. REDDY'S LABORATORIES LEK PHARMACEUTICALS D.D. KRKA D.D. OZONE LABORATORIES LTD.

Prescriere limitata: Prescriere limitata: Prescriere limitata:


LOSEC MUPS 20 mg OMEDAR

Boala de reflux gastro-esofagian Sclerodermia esofagului. Sindromul Zollinger-Ellison

A02BC01 OMEPRAZOLUM
20mg 20mg

COMPR. FILM. GASTROREZ.


ASTRAZENECA AB DAR AL DAWA PHARMA S.R.L

20mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:


HELICID 40 INF

Boala de reflux gastro-esofagian Sclerodermia esofagului. Sindromul Zollinger-Ellison

A02BC01 OMEPRAZOLUM

LIOF. PT. SOL. PERF.


ZENTIVA A.S.

A02BC03

LANSOPRAZOLUM
CAPS. GASTROREZ.
15mg 15mg 15mg 15mg 15mg SANDOZ S.R.L. LINCOSA S.A. REAL PHARMA SRL LABORATORIOS BELMAC S.A. RANBAXY UK LTD.

A02BC03 LANSOPRAZOLUM
LANOL 15 mg LANSOPRAZOL LINCOSA 15 mg LANSOPRAZOL MF 15 LANZOL 15 LEVANT 15 mg

15mg

Prescriere limitata: Prescriere limitata:


LANOL 30 mg LANSOPRAZOL LINCOSA 30 mg

Boala de reflux gastro-esofagian Sclerodermia esofagului.

A02BC03 LANSOPRAZOLUM
30mg 30mg

CAPS. GASTROREZ.
SANDOZ S.R.L. LINCOSA S.A.

30mg

2 / 233

DCI/DENUMIRE COMERCIALA
LANSOPRAZOL MF 30 LANZAP 30mg LANZOGASTRO LANZOL 30 LANZUL LEVANT 30 mg

CONCENTRATIE
30mg 30mg 30mg 30mg 30mg 30mg

FORMA FARM.

FIRMA

PROTOCOL

REAL PHARMA SRL DR. REDDY'S LABORATORIES BIOSAUDE PRODUTOS FARMACEUTICOS LDA. LABORATORIOS BELMAC S.A. KRKA D.D. NOVO MESTO RANBAXY UK LTD.

Prescriere limitata:
LANOL 30 mg LANSOPRAZOL LINCOSA 30 mg LANSOPRAZOL MF 30 LANZAP 30mg LANZOGASTRO LANZOL 30 LANZUL LEVANT 30 mg

Tratamentul initial al ulcerului peptic

A02BC03 LANSOPRAZOLUM
30mg 30mg 30mg 30mg 30mg 30mg 30mg 30mg

CAPS. GASTROREZ.
SANDOZ S.R.L. LINCOSA S.A. REAL PHARMA SRL DR. REDDY'S LABORATORIES BIOSAUDE PRODUTOS FARMACEUTICOS LDA. LABORATORIOS BELMAC S.A. KRKA D.D. NOVO MESTO RANBAXY UK LTD.

30mg

Prescriere limitata: Prescriere limitata:

Boala de reflux gastro-esofagian Sclerodermia esofagului.

6
COLOSPASMIN

A03AA04

MEBEVERINUM
DRAJ.
100mg 200mg E.I.P.I.CO. MED SRL

A03AA04 MEBEVERINUM A03AA04 MEBEVERINUM


DUSPATALIN 200 mg

100mg 200mg

CAPS. ELIB. PREL.


SOLVAY PHARMACEUTICALS BV

A03AA05

TRIMEBUTINUM
COMPR.
100mg 100mg 100mg 100mg 100mg 24mg/5ml 300mg LAB. FOURNIER SA GEDEON RICHTER ROMANIA S.A. TERAPIA SA MAGISTRA C & C

A03AA05 TRIMEBUTINUM
COLOBUTINE COLPERIN 100 mg PROMEBUTIN 100 mg TRIMEBUTIN 100

100mg

A03AA05 TRIMEBUTINUM
DEBRIDAT 100 mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

100mg 24mg/5ml 300mg

A03AA05 TRIMEBUTINUM
DEBRIDAT

GRAN. PT. SUSP. ORALA


PFIZER EUROPE MA EEIG ZENTIVA SA

A03AA05 TRIMEBUTINUM
IBUTIN 300 mg

COMPR. FILM. ELIB. PREL.

A03AD01

PAPAVERINI HYDROCHLORIDUM
COMPR.
100mg 100mg 100mg FABIOL SA SINTOFARM SA LAROPHARM SRL

A03AD01 PAPAVERINI HYDROCHLORIDUM


CLORHIDRAT DE PAPAVERINA PAPAVERINA 100 mg PAPAVERINA LAROPHARM 100 mg

100mg

A03AD01 PAPAVERINI HYDROCHLORIDUM


PAPAVERINA

COMPR.
200mg FARMACOM SA

200mg 50mg
ARENA GROUP SA

A03AD01 PAPAVERINI HYDROCHLORIDUM


PAPAVERINA 50 mg 50mg

COMPR.

A03FA01

METOCLOPRAMIDUM
COMPR.
10mg 10mg 10mg 10mg SLAVIA PHARM SRL FARMEX COMPANY SRL LAROPHARM S.R.L. MEDUMAN SA

A03FA01 METOCLOPRAMIDUM
METOCLOPRAMID METOCLOPRAMID 10 mg METOCLOPRAMID LAROPHARM N - METOCLOPRAMID

10mg

A03FA01 METOCLOPRAMIDUM
METOCLOPRAMID BIOFARM 1mg/5ml

SIROP
1mg/5ml BIOFARM S.A.

1mg/5ml 5mg/ml
TERAPIA SA

A03FA01 METOCLOPRAMIDUM
METOCLOPRAMID 10 mg

SOL. INJ.
5mg/ml 7mg/ml

A03FA01 METOCLOPRAMIDUM
METOCLOPRAMID

PIC. ORALE-SOL.
BIOFARM SA

7mg/ml

10
MOTILIUM MOTILIUM 10 mg

A03FA03

DOMPERIDONUM
COMPR. FILM.
10mg 10mg JANSSEN PHARMACEUTICA NV TERAPIA SA

A03FA03 DOMPERIDONUM

10mg

A03FA03 DOMPERIDONUM
MOTILIUM LINGUAL 10mg

LIOF. ORAL
JANSSEN PHARMACEUTICA NV

10mg

11
URSOCHOL 150 mg

A05AA02

ACIDUM URSODEOXYCHOLICUM *
COMPR.
150mg ZAMBON S.P.A.

A05AA02 ACIDUM URSODEOXYCHOLICUM


NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

150mg

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOFALK URSOSAN

CAPS.
250mg 250mg DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

250mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOCHOL 300 mg

COMPR.
300mg ZAMBON S.P.A.

300mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

12
EPALFEN 12 g

A06AD11

LACTULOSUM
GRAN. PT. SOL. ORALA
12g 66.7% ZAMBON S.P.A.

A06AD11 LACTULOSUM A06AD11 LACTULOSUM


DUPHALAC

12g 66.7%

LICHID ORAL
SOLVAY PHARMACEUTICALS BV

Prescriere limitata: Prescriere limitata:

Coma sau precoma hepatica (encefalopatie cronica porto-sistemica) Constipatie la pacientii neoplazici.

A06AD11 LACTULOSUM

SIROP

66.7%

3 / 233

DCI/DENUMIRE COMERCIALA
LACTULOSE AL SIROP

CONCENTRATIE
66.7%

FORMA FARM.
ALIUD PHARMA GMBH & CO.KG

FIRMA

PROTOCOL

Prescriere limitata: Prescriere limitata:


LAEVOLAC 670mg/ml

Coma sau precoma hepatica (encefalopatie cronica porto-sistemica) Constipatie la pacientii neoplazici.

A06AD11 LACTULOSUM
Prescriere limitata: Prescriere limitata:
EPALFEN 6 g

SOL. ORALA
670mg/ml FRESENIUS KABI AUSTRIA GMBH

670mg/ml

Coma sau precoma hepatica (encefalopatie cronica porto-sistemica) Constipatie la pacientii neoplazici.

A06AD11 LACTULOSUM
6g

GRAN. PT. SOL. ORALA


ZAMBON S.P.A.

6g 66.7%

A06AD11 LACTULOSUM
LACTULOSE AL SIROP 66.7%

SIROP
ALIUD PHARMA GMBH & CO.KG

Prescriere limitata:
LAEVOLAC 670mg/ml

Coma sau precoma hepatica (encefalopatie cronica porto-sistemica)

A06AD11 LACTULOSUM
Prescriere limitata:
LACTULOSE AL SIROP

SOL. ORALA
670mg/ml FRESENIUS KABI AUSTRIA GMBH

670mg/ml

Coma sau precoma hepatica (encefalopatie cronica porto-sistemica)

A06AD11 LACTULOSUM
66.7%

SIROP
ALIUD PHARMA GMBH & CO.KG

66.7% 670mg/ml 66.7% 65%


E.I.P.I.CO. MED S.R.L.

A06AD11 LACTULOSUM
LAEVOLAC 670mg/ml

SOL. ORALA
670mg/ml 66.7% FRESENIUS KABI AUSTRIA GMBH SOLVAY PHARMACEUTICALS BV

A06AD11 LACTULOSUM
DUPHALAC

LICHID ORAL SIROP


65%

A06AD11 LACTULOSUM
LACTULOSE

13
NISTATINA

A07AA02

NYSTATINUM
COMPR. FILM.
500.000ui 500000ui ANTIBIOTICE SA

A07AA02 NYSTATINUM A07AA02 NYSTATINUM


STAMICIN 500000 U.I.

500.000ui 500000ui

COMPR. FILM.
ZENTIVA SA

14
SALAZIDIN

A07EC01

SULFASALAZINUM
COMPR. FILM.
500mg 500mg 500mg AC HELCOR SRL

A07EC01 SULFASALAZINUM A07EC01 SULFASALAZINUM


SALAZOPYRIN EN SULFASALAZIN EN

500mg 500mg

COMPR. FILM. GASTROREZ.


PFIZER EUROPE MA EEIG KRKA D.D. NOVO MESTO

15
PENTASA

A07EC02

MESALAZINUM **
SUPOZ.
1g FERRING A/S

A07EC02 MESALAZINUM

1g

Prescriere limitata: Episod acut de proctita ulcerativa forma moderata NOTA: Terapie de linia a doua in boala Crohn.

A07EC02 MESALAZINUM
SALOFALK FOAM

SPUMA RECTALA
1g/doza DR. FALK PHARMA GMBH

1g/doza

Cod restrictie 1707:

Episod acut de colita ulcerativa forma moderata

A07EC02 MESALAZINUM
SALOFALK 250 mg COMPRIMATE GASTROREZISTENTE

COMPR. GASTROREZ.
250mg DR. FALK PHARMA GMBH

250mg

Cod restrictie 1708: Cod restrictie 1709: Cod restrictie 2268: Cod restrictie 2269:

Colita ulcerativa asociata cu hipersensibilitate la sulfonamide Colita ulcerativa asociata cu intoleranta la sulfasalazinum Boala Crohn in cazul in care exista hipersensibilitate la sulfonamide Boala Crohn in cazul in care exista intoleranta la sulfasalazinum

A07EC02 MESALAZINUM
SALOFALK 250 mg

SUPOZ.
250mg 400mg 4g/60ml DR. FALK PHARMA GMBH

250mg 400mg 4g/60ml

A07EC02 MESALAZINUM
ASACOL 400 mg

COMPR.FILM.GASTROREZ
LEK PHARMACEUTICALS D.D. DR. FALK PHARMA GMBH

A07EC02 MESALAZINUM
SALOFALK 4 g/ 60 ml

SUSP. RECTALA
Episod acut de colita ulcerativa forma moderata

Cod restrictie 1707:

A07EC02 MESALAZINUM
PENTASA

COMPR. ELIB. PREL.


500mg FERRING A/S

500mg

Cod restrictie 1708: Cod restrictie 1709: Cod restrictie 2268: Cod restrictie 2269:

Colita ulcerativa asociata cu hipersensibilitate la sulfonamide Colita ulcerativa asociata cu intoleranta la sulfasalazinum Boala Crohn in cazul in care exista hipersensibilitate la sulfonamide Boala Crohn in cazul in care exista intoleranta la sulfasalazinum

A07EC02 MESALAZINUM
SALOFALK 500 mg COMPRIMATE GASTROREZISTENTE

COMPR. GASTROREZ.
500mg DR. FALK PHARMA GMBH

500mg

Cod restrictie 1708: Cod restrictie 1709: Cod restrictie 2268: Cod restrictie 2269:

Colita ulcerativa asociata cu hipersensibilitate la sulfonamide Colita ulcerativa asociata cu intoleranta la sulfasalazinum Boala Crohn in cazul in care exista hipersensibilitate la sulfonamide Boala Crohn in cazul in care exista intoleranta la sulfasalazinum

A07EC02 MESALAZINUM
SALOFALK 500 mg

SUPOZ.
500mg 800mg DR. FALK PHARMA GMBH

500mg 800mg

A07EC02 MESALAZINUM
ASACOL 800 mg

COMPR.FILM.GASTROREZ
LEK PHARMACEUTICALS D.D.

16

B01AA07

ACENOCUMAROLUM
COMPR.
2mg 2mg LAROPHARM SRL TERAPIA SA

B01AA07 ACENOCUMAROLUM
ACENOCUMAROL 2 mg TROMBOSTOP 2 mg

2mg

B01AA07 ACENOCUMAROLUM
SINTROM 4mg

COMPR.
NOVARTIS PHARMA GMBH

4mg

17

B01AC05

TICLOPIDINUM (1)
COMPR. FILM. 250mg

B01AC05 TICLOPIDINUM

4 / 233

DCI/DENUMIRE COMERCIALA
IPATON TICLID 250 mg TICLODIN TICLOPIDIN 250 mg TICLOPIDIN SANDOZ

CONCENTRATIE
250mg 250mg 250mg 250mg 250mg

FORMA FARM.
EGIS PHARMACEUTICALS PLC SANOFI-SYNTHELABO FRANCE AC HELCOR SRL LAROPHARM S.R.L. HEXAL AG

FIRMA

PROTOCOL

Cod restrictie 1719:

Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de episoade ischiemice cererbrovasculare in timpul terapiei cu doze reduse de aspirina Cod restrictie 1720: Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii la care terapia cu doze reduse de aspirina prezinta un risc major (inacceptabil) de sangerare gastrointestinala; Cod restrictie 1721: Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de reactie anafilactica , urticarie sau astm bronsic in decurs de 4 ore de la administrarea de aspirina, ali salicilati sau AINS Neutropenia severa este un efect advers comun in primele luni de terapie. Monitorizarea hematologica se impune la inceputul tratamentului si apoi la fiecare doua saptamani in primele patru luni de tratament.

18

B02BA01

PHYTOMENADIONUM
SOL. INJ.
10mg/ml TERAPIA SA

B02BA01 PHYTOMENADIONUM
FITOMENADION 10 mg/ml

10mg/ml

19
FERROGRADUMET

B03AA07

FERROSI SULFAS
COMPR. ELIB. PREL.
105mg 80mg TEOFARMA SRL

B03AA07 FERROSI SULFAS B03AA07 FERROSI SULFAS


TARDYFERON 80 mg

105mg 80mg

DRAJ. ELIB. PREL.


LAB. PIERRE FABRE

B03AA07 FERROSI SULFAS


FERRO-GRADUMET

COMPR.FILM.ELIB.PREL
POLIPHARMA INDUSTRIES S.R.L.

20

B03AB05

COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT


COMPR. MAST.
100mg VIFOR FRANCE S.A.

B03AB05 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT


MALTOFER

100mg

B03AB05 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT


FERRUM HAUSMANN

SIROP
10mg/ml VIFOR FRANCE S.A.

10mg/ml

B03AB05 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT


FERGLUROM 50mg/5ml

SIROP
50mg/5ml BIOFARM S.A.

50mg/5ml

B03AB05 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT


PHARMA-FERRUM 5%

PICATURI ORALE-SOL.
TERAPIA SA

5%

B03AB05 COMPLEX DE HIDROXID DE FER (III) POLIMALTOZAT


FERRUM HAUSMANN

PICATURI ORALE-SOL.
50mg/ml VIFOR FRANCE S.A.

50mg/ml

21

B03AEN1

COMBINATII (FERROSI SULFAS+ACIDUM ASCORBICUM)


COMPR. FILM.
EGIS PHARMACEUTICALS LTD.

B03AEN1 COMBINATII (FERROSI SULFAS+ACIDUM ASCORBICUM)


SORBIFER DURULES

22
ACIFOL 5 mg

B03BB01

ACIDUM FOLICUM
COMPR. FILM.
5mg ZENTIVA S.A.

B03BB01 ACIDUM FOLICUM

5mg

23

C01AA05

DIGOXINUM
SOL. ORALA
0.05mg/ml THE WELLCOME FOUNDATION LTD.

C01AA05 DIGOXINUM
LANOXIN SOLUTIE ORALA

0.05mg/ml 0.25mg

C01AA05 DIGOXINUM
DIGOXIN 0,25 mg

COMPR.
0.25mg ZENTIVA S.A.

C01AA05 DIGOXINUM
LANOXIN

SOL. INJ.
0.25mg/ml THE WELLCOME FOUNDATION LTD.

0.25mg/ml 0.5mg/ml
ZENTIVA S.A.

C01AA05 DIGOXINUM
DIGOXIN 0,5 mg/2 ml

SOL. INJ.
0.5mg/ml

24

C01BA01

CHINIDINI SULFAS
COMPR.
200mg 200mg LAROPHARM SRL ARENA GROUP SA

C01BA01 CHINIDINI SULFAS


CHINIDINA LAROPHARM 200 mg CHINIDINA SULFAT 200 mg

200mg

25

C01BC03

PROPAFENONUM
COMPR.
150mg 150mg 150mg 150mg 150mg 300mg 300mg TAD PHARMA GMBH ARENA GROUP SA

C01BC03 PROPAFENONUM
PROPAFE TAD 150 PROPAFENONA 150 mg

150mg

C01BC03 PROPAFENONUM
PROPAFENON AL 150 PROPAFENON SANDOZ 150 mg RYTMONORM

COMPR. FILM.
ALIUD PHARMA GMBH & CO.KG HEXAL AG ABBOTT GMBH&CO.KG

150mg

C01BC03 PROPAFENONUM
PROPAFENON SANDOZ 300 mg PROPANORM 300 mg

COMPR. FILM.
HEXAL AG PRO. MED. CS PRAHA

300mg

C01BC03 PROPAFENONUM
RYTMONORM

SOL. INJ.
70mg/20ml ABBOTT GMBH&CO.KG

70mg/20ml

26

C01BD01

AMIODARONUM
COMPR.
200mg 200mg 200mg 200mg 200mg TAD PHARMA GMBH ARENA GROUP SA LABORMED PHARMA SA GEDEON RICHTER ROMANIA SA EBEWE PHARMA GMBH NFG. KG

C01BD01 AMIODARONUM
AMIO TAD 200 AMIODARONA 200 mg AMIODARONA LPH 200 mg DARITMIN 200 mg SEDACORON

200mg

Prescriere limitata:

Aritmii cardiace severe.

5 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Exista dovezi ca amiodarona poate produce toxicitate frecvent i potenial sever. Se recomand monitorizarea periodic a funciilor hepatice i tiroidiene.

C01BD01 AMIODARONUM
CORDARONE 200 mg

COMPR. DIVIZ.
200mg SANOFI-AVENTIS FRANCE

200mg

Prescriere limitata: Aritmii cardiace severe. Exista dovezi ca amiodarona poate produce toxicitate frecvent i potenial sever. Se recomand monitorizarea periodic a funciilor hepatice i tiroidiene.

C01BD01 AMIODARONUM
SEDACORON

CONC. PT. SOL. PERF.


50mg/ml EBEWE PHARMA GMBH NFG. KG

50mg/ml 50mg/ml

C01BD01 AMIODARONUM
CORDARONE 150 mg/3 ml

SOL. INJ.
50mg/ml SANOFI-AVENTIS FRANCE

27
NITROMINT

C01DA02
NOTA: Sprayul nu trebuie inhalat..

NITROGLYCERINUM
SPRAY SUBLINGUAL
0.4mg/doza EGIS PHARMACEUTICALS P.L.C.

C01DA02 NITROGLYCERINUM

0.4mg/doza

C01DA02 NITROGLYCERINUM
NITROGLICERINA 0,5 mg 0.5mg

COMPR. SUBLING.
ZENTIVA SA

0.5mg 10mg/24 ore 2.6mg 25mg 5mg/ml

C01DA02 NITROGLYCERINUM
DEPONIT NT 10

SIST. TRANSDERMIC
10mg/24 ore 2.6mg 25mg 5mg/ml SCHWARZ PHARMA AG EGIS PHARMACEUTICALS LTD.

C01DA02 NITROGLYCERINUM
NITROMINT 2,6 mg

COMPR. ELIB. PREL. SIST. TERAP. TRANSDERM.


NOVARTIS PHARMA GMBH

C01DA02 NITROGLYCERINUM
NITRODERM TTS 5

C01DA02 NITROGLYCERINUM
TRINITROSAN

CONC. PT. SOL. PERF.


MERCK KGAA

28
ISOKET

C01DA08

ISOSORBIDI DINITRAS
SPRAY BUCOFARINGIAN,SOL
1,25mg/doza SCHWARZ PHARMA AG

C01DA08 ISOSORBIDI DINITRAS C01DA08 ISOSORBIDI DINITRAS


ISODINIT ISOSORBID DINITRAT 10 mg ISOSORBIDE DINITRATE 10 mg 10mg 10mg 10mg

1,25mg/doza 10mg

COMPR.
BALKAN PHARMA DUPNITZA AD ARENA GROUP SA E.I.P.I.CO. MED S.R.L.

C01DA08 ISOSORBIDI DINITRAS


ISOKET

CONC. PT. SOL. PERF.


1mg/ml 20mg 20mg 40mg 50mg SCHWARZ PHARMA AG

1mg/ml 20mg 20mg 40mg 50mg

C01DA08 ISOSORBIDI DINITRAS


DINITER SR 20 mg

CAPS. ELIB. PREL.


TERAPIA SA

C01DA08 ISOSORBIDI DINITRAS


ISODINIT RETARD

COMPR. ELIB. PREL.


BALKAN PHARMA DUPNITZA AD

C01DA08 ISOSORBIDI DINITRAS


DINITER SR 40 mg

CAPS. ELIB. PREL.


TERAPIA SA

C01DA08 ISOSORBIDI DINITRAS


ELANTAN LONG

CAPS. ELIB. PREL.


SCHWARZ PHARMA AG

29

C01DA14

ISOSORBIDI MONONITRAS
CAPS. ELIB. PREL.
40mg 60mg 60mg SOLVAY PHARMACEUTICALS GMBH

C01DA14 ISOSORBIDI MONONITRAS


OLICARD 40 mg RETARD

40mg 60mg 60mg

C01DA14 ISOSORBIDI MONONITRAS


OLICARD 60 mg RETARD

CAPS. ELIB. PREL.


SOLVAY PHARMACEUTICALS GMBH

C01DA14 ISOSORBIDI MONONITRAS


MONONITRON EP 60 mg

COMPR. FILM. ELIB. PREL.


ZENTIVA S.A

30

C01EA01

ALPROSTADILUM ***
CONC. PT. SOL. PERF.
20g 20g PINT-PHARMA GMBH

Protocol: C002I
20g 20g

C01EA01 ALPROSTADILUM
ALPROSTADIL "PINT" 20 g

C01EA01 ALPROSTADILUM
VASAPROSTAN 20

LIOF. PT. SOL. PERF.


SCHWARZ PHARMA AG

31
TRIMETAZIDIN 20 mg

C01EB15

TRIMETAZIDINUM
CAPS.
20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg VIM SPECTRUM SRL

C01EB15 TRIMETAZIDINUM C01EB15 TRIMETAZIDINUM


ADEXOR DILATAN 20 mg MEDIZIDIN MODUXIN 20 mg PREDOZONE 20 mg PREDUCTAL TRIMETAZIDINA LPH 20 mg TRIVEDON 20

20mg 20mg

COMPR. FILM.
EGIS PHARMACEUTICALS LTD. TERAPIA SA STD CHEMICALS LIMITED GEDEON RICHTER ROMANIA SA OZONE LABORATORIES LTD. LES LAB. SERVIER IND. LABORMED PHARMA SA CIPLA (UK) LIMITED

C01EB15 TRIMETAZIDINUM
TRIMETAZIDINA 20 mg 20mg 35mg 35mg 35mg 35mg

DRAJ.
TERAPIA SA

20mg 35mg

C01EB15 TRIMETAZIDINUM
DILATAN MR 35 mg PREDUCTAL MR 35 mg TRIMETAZIDINA LPH 35 mg TRIMETAZIDINE 35 mg SERVIER

COMPR. FILM. ELIB. MODIF.


TERAPIA SA LES LAB. SERVIER IND. LABORMED PHARMA SA ANPHARM SA

32
DOPEGYT

C02AB01

METHYLDOPUM
COMPR.
250mg EGIS PHARMACEUTICALS PLC

C02AB01 METHYLDOPUM

250mg

33

C02AC01

CLONIDINUM
COMPR.
0.15mg 0.15mg ARENA GROUP SA SINTOFARM SA

C02AC01 CLONIDINUM
CLONIDINA 0,15 mg CLONIDINA SINTOFARM 0,15 mg

0.15mg

34

C02CA04

DOXAZOSINUM
COMPR. 1mg

C02CA04 DOXAZOSINUM

6 / 233

DCI/DENUMIRE COMERCIALA
ALS-DOXAZOSIN 1 mg DOXAZOSIN 1 MEDOCHEMIE DOXAZOSIN AL 1 DOXAZOSIN ARENA 1 mg KAMIREN MAGUROL ZOXON 1

CONCENTRATIE
1mg 1mg 1mg 1mg 1mg 1mg 1mg

FORMA FARM.
ALSIFCOM INTERMED SRL MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG ARENA GROUP S.A. KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

FIRMA

PROTOCOL

C02CA04 DOXAZOSINUM
ALS-DOXAZOSIN 2 mg ANIPROSIN 2 mg DOXAZOSIN 2 MEDOCHEMIE DOXAZOSIN AL 2 DOXAZOSIN SANDOZ 2 mg KAMIREN MAGUROL ZOXON 2 2mg 2 mg 2mg 2mg 2mg 2mg 2mg 2mg

COMPR.
ALSIFCOM INTERMED SRL OZONE LABORATORIES BV MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG HEXAL AG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

2mg

C02CA04 DOXAZOSINUM
ANIPROSIN 4 mg DOXAZOSIN 4 MEDOCHEMIE DOXAZOSIN AL 4 KAMIREN MAGUROL ZOXON 4 4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg

COMPR.
OZONE LABORATORIES BV MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

4mg

C02CA04 DOXAZOSINUM
CARDURA XL 4 mg

COMPR. ELIB. MODIF.


PFIZER H.C.P. CORPORATION

4mg 4mg 1mg

C02CA04 DOXAZOSINUM
KAMIREN XL 4 mg

COMPR. FILM. ELIB. PREL.


KRKA D.D. NOVO MESTO

C02CA04 DOXAZOSINUM
ALS-DOXAZOSIN 1 mg DOXAZOSIN 1 MEDOCHEMIE DOXAZOSIN AL 1 KAMIREN MAGUROL ZOXON 1 1mg 1mg 1mg 1mg 1mg 1mg

COMPR.
ALSIFCOM INTERMED SRL MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

C02CA04 DOXAZOSINUM
ANIPROSIN 2 mg 2 mg

COMPR.
OZONE LABORATORIES BV

2 mg 2mg
ALSIFCOM INTERMED SRL MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG HEXAL AG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

C02CA04 DOXAZOSINUM
ALS-DOXAZOSIN 2 mg DOXAZOSIN 2 MEDOCHEMIE DOXAZOSIN AL 2 DOXAZOSIN SANDOZ 2 mg KAMIREN MAGUROL ZOXON 2 2mg 2mg 2mg 2mg 2mg 2mg 2mg

COMPR.

C02CA04 DOXAZOSINUM
ANIPROSIN 4 mg DOXAZOSIN 4 MEDOCHEMIE DOXAZOSIN AL 4 KAMIREN MAGUROL ZOXON 4 4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg

COMPR.
OZONE LABORATORIES BV MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

4mg

C02CA04 DOXAZOSINUM
CARDURA XL 4 mg

COMPR. ELIB. MODIF.


PFIZER H.C.P. CORPORATION

4mg 4mg

C02CA04 DOXAZOSINUM
KAMIREN XL 4 mg

COMPR. FILM. ELIB. PREL.


KRKA D.D. NOVO MESTO

35
NEFRIX 25 mg

C03AA03

HYDROCHLOROTHIAZIDUM
COMPR.
25mg ZENTIVA SA

C03AA03 HYDROCHLOROTHIAZIDUM

25mg

36

C03BA11

INDAPAMIDUM
COMPR. FILM. ELIB. PREL.
1,5mg 1,5mg 1,5mg 1.5 mg 1.5mg 1.5mg 1.5mg 1.5mg 1.5mg 1.5mg 1.5mg GEDEON RICHTER ROMANIA S.A. STADA ARZNEIMITTEL AG TERAPIA SA

C03BA11 INDAPAMIDUM
IMPAMID SR 1,5 mg INDAPAMID STADA 1,5mg INDATER SR 1,5 mg

1,5mg

C03BA11 INDAPAMIDUM
INDAPAMID SR 1,5 mg LAROPHARM

COMPR. FILM. ELIB. PREL.


LAROPHARM SRL

1.5 mg 1.5mg 1.5mg

C03BA11 INDAPAMIDUM
INDAPAMID MCC 1,5 mg

COMPR. ELIB. PREL.


MAGISTRA C & C SRL

C03BA11 INDAPAMIDUM
INDAPAMID LPH 1,5 mg INDAPAMID SR OZONE 1,5mg INDAPAMIDE 1,5 mg SERVIER RAWEL SR 1,5 mg TERTENSIF SR

COMPR. FILM. ELIB. PREL.


LABORMED PHARMA SA OZONE LABORATORIES BV ANPHARM SA KRKA D.D. NOVO MESTO LES LAB. SERVIER IND.

C03BA11 INDAPAMIDUM
INDAPAMIDA SR TERAPIA 1,5 mg

DRAJ. ELIB. PREL.


TERAPIA S.A.

1.5mg 2.5mg

C03BA11 INDAPAMIDUM
IMPAMID 2,5 mg 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg

COMPR.
GEDEON RICHTER ROMANIA SA

C03BA11 INDAPAMIDUM
INDAPAMID 2,5 mg INDAPAMID LPH 2,5 mg INDAPAMIDE 2,5 mg INDATER 2,5 mg VALUTENS 2,5

COMPR. FILM.
LAROPHARM SRL LABORMED PHARMA SA HEMOFARM S.R.L. TERAPIA SA ANTIBIOTICE S.A.

2.5mg

37

C03CA01

FUROSEMIDUM

7 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
ZENTIVA SA

FIRMA

PROTOCOL

C03CA01 FUROSEMIDUM
FUROSEMID 20 mg/2 ml

SOL. INJ.
10mg/ml

10mg/ml

Electroliii serici trebuie s fie verificai periodic.

C03CA01 FUROSEMIDUM
FUROSEMID 40 mg FUROSEMID ARENA 40 mg FUROSEMID EEL FUROSEMID LPH 40 mg FUROSEMID MCC 40 mg FUROSEMID SLAVIA FUROSEMID ZENTIVA 40mg 40mg 40mg 40mg 40mg 40mg 40mg

COMPR.
LAROPHARM SRL ARENA GROUP S.A. BIO EEL SRL LABORMED PHARMA SA MAGISTRA C & C SRL SLAVIA PHARM SRL ZENTIVA SA

40mg

Electroliii serici trebuie s fie verificai periodic.

38
VEROSPIRON

C03DA01

SPIRONOLACTONUM
CAPS.
100mg GEDEON RICHTER LTD.

C03DA01 SPIRONOLACTONUM

100mg

Electroliii serici trebuie s fie verificai periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

C03DA01 SPIRONOLACTONUM
SPIRONOLACTONA 25 mg 25mg

COMPR.
OZONE LABORATORIES LTD.

25mg

Electroliii serici trebuie s fie verificai periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

C03DA01 SPIRONOLACTONUM
ALSPIRON 25 mg SPIRONOLACTONA 25 mg 25mg 25mg

COMPR. FILM.
AC HELCOR PHARMA SRL TERAPIA SA

25mg

Electroliii serici trebuie s fie verificai periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

C03DA01 SPIRONOLACTONUM
SPIRONOLACTONA 50 mg VEROSPIRON 50mg 50mg 50mg

CAPS.
LAROPHARM SRL GEDEON RICHTER LTD.

50mg

C03DA01 SPIRONOLACTONUM
ALSPIRON 50 mg

COMPR. FILM.
AC HELCOR PHARMA SRL

50mg

39

C03EB01

COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM) **
CAPS.
TERAPIA SA

C03EB01 COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM)


DIUREX 50

40

C04AD03

PENTOXIFYLLINUM
COMPR. ELIB. PREL.
400mg 400mg 400mg 400mg 400mg 400mg 600mg ZENTIVA AS

C04AD03 PENTOXIFYLLINUM
PENTOXIFILINA SR ZENTIVA 400 mg

400mg 400mg

C04AD03 PENTOXIFYLLINUM
ALS-PENTOXIFILINA RETARD ANGIOPENT 400 mg PENTOXI RETARD 400 mg PENTOXIFILINA LPH 400 mg

COMPR. FILM. ELIB. PREL.


ALSIFCOM INTERMED SRL AC HELCOR PHARMA SRL TERAPIA SA LABORMED PHARMA S.A.

C04AD03 PENTOXIFYLLINUM
TRENTAL

DRAJ. ELIB. PREL.


AVENTIS PHARMA DEUTSCHLAND GMBH

400mg 600mg 100mg

C04AD03 PENTOXIFYLLINUM
ANGIOPENT 600 mg

COMPR. FILM. ELIB. PREL.


AC HELCOR PHARMA SRL TERAPIA SA

C04AD03 PENTOXIFYLLINUM
PENTOXIFILIN 100 mg

DRAJ.
100mg 100mg/5ml 200mg

C04AD03 PENTOXIFYLLINUM
PENTOXIFILIN 100 mg

CONC. PT. SOL. PERF.


TERAPIA SA

100mg/5ml 200mg

C04AD03 PENTOXIFYLLINUM
ANGIOPENT 200 mg

COMPR. FILM.
AC HELCOR SRL

41

C07AA05

PROPRANOLOLUM
COMPR.
10mg 10mg 10mg SC MEDUMAN SA BIO EEL SRL SINTOFARM SA

C07AA05 PROPRANOLOLUM
N - PROPRANOLOL 10 mg PROPRANOLOL PROPRANOLOL 10 mg

10mg

C07AA05 PROPRANOLOLUM
PROPRANOLOL 40 mg PROPRANOLOL EEL 40 mg 40mg 40mg

COMPR.
SINTOFARM SA BIO EEL SRL

40mg

42
ALS-SOTALOL 160 mg DAROB 160 mg SOTAGAMMA 160 SOTALOL AL 160

C07AA07

SOTALOLUM
COMPR.
160mg 160mg 160mg 160mg ALSIFCOM INTERMED SRL ABBOTT GMBH&CO.KG WORWAG PHARMA GMBH & CO. KG ALIUD PHARMA GMBH & CO.KG

C07AA07 SOTALOLUM

160mg

Prescriere limitata:

Aritmii cardiace severe.

C07AA07 SOTALOLUM
ALS-SOTALOL 80 mg DAROB 80 mg SOTAGAMMA 80 SOTALOL AL 80 80mg 80mg 80mg 80mg

COMPR.
ALSIFCOM INTERMED SRL ABBOTT GMBH&CO.KG WORWAG PHARMA GMBH & CO. KG ALIUD PHARMA GMBH & CO.KG

80mg

Prescriere limitata:

Aritmii cardiace severe.

43
BETAPROL 100 mg BLOXAN CORVITOL 100 EGILOK 100 mg METOPRO TAD 100

C07AB02

METOPROLOLUM
COMPR.
100mg 100mg 100mg 100mg 100mg AC HELCOR PHARMA SRL KRKA D.D. NOVO MESTO BERLIN - CHEMIE AG EGIS PHARMACEUTICALS P.L.C. TAD PHARMA GMBH

C07AB02 METOPROLOLUM

100mg

8 / 233

DCI/DENUMIRE COMERCIALA
METOPROLOL 100 mg METOPROLOL AL 100 METOPROLOL LAROPHARM 100 mg METOPROLOL LPH 100 mg METOPROLOL MEDICO UNO 100 mg METOPROLOL TARTRAT SANDOZ 100 mg METOPROLOL TERAPIA 100 mg VASOCARDIN 100

CONCENTRATIE
100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 190mg

FORMA FARM.

FIRMA

PROTOCOL

ARENA GROUP SA ALIUD PHARMA GMBH & CO.KG LAROPHARM SRL LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L. HEXAL AG TERAPIA SA SLOVAKOFARMA

C07AB02 METOPROLOLUM
METOPROLOL RETARD 100 mg

COMPR. ELIB. PREL.


TERAPIA S.A.

100mg 100mg

C07AB02 METOPROLOLUM
BETALOC ZOC 100 mg EGILOK R 100 EMZOK 100 mg

COMPR. FILM. ELIB. PREL.


ASTRAZENECA AB EGIS PHARMACEUTICALS P.L.C. IVAX PHARMCEUTICALS S.R.O.

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 190 mg

COMPR.FILM.ELIB.MOD.
HEXAL AG

190mg

Cod restrictie 1734:


BETALOC

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

C07AB02 METOPROLOLUM C07AB02 METOPROLOLUM


VASOCARDIN SR 200

SOL. INJ.
1mg/ml 200mg 200mg ASTRAZENECA AB

1mg/ml 200mg 200mg 25mg


EGIS PHARMACEUTICALS P.L.C. ARENA GROUP S.A. LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L.

COMPR. ELIB. PREL.


ZENTIVA AS IVAX PHARMCEUTICALS S.R.O.

C07AB02 METOPROLOLUM
EMZOK 200 mg

COMPR. FILM. ELIB. PREL. COMPR.


25mg 25mg 25mg 25mg 25mg 47.5mg

C07AB02 METOPROLOLUM
EGILOK 25 mg METOPROLOL 25 mg METOPROLOL LPH 25 mg METOPROLOL MEDICO UNO 25 mg

C07AB02 METOPROLOLUM
BETALOC ZOC 25 mg

COMPR. FILM. ELIB. PREL.


ASTRAZENECA AB

25mg 47.5mg

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 47,5 mg

COMPR.FILM.ELIB.MOD.
HEXAL AG

Cod restrictie 1734:

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

C07AB02 METOPROLOLUM
BETAPROL 50 mg CORVITOL 50 EGILOK 50 mg METOPRO TAD 50 METOPROLOL 50 mg METOPROLOL AL 50 METOPROLOL FABIOL 50 mg METOPROLOL LAROPHARM 50 mg METOPROLOL LPH 50 mg METOPROLOL MEDICO UNO 50 mg METOPROLOL TARTRAT SANDOZ 50 mg METOPROLOL TERAPIA 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 95mg

COMPR.
AC HELCOR PHARMA SRL BERLIN - CHEMIE AG EGIS PHARMACEUTICALS P.L.C. TAD PHARMA GMBH MAGISTRA C & C SRL ALIUD PHARMA GMBH & CO.KG FABIOL S.A. LAROPHARM SRL LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L. HEXAL AG TERAPIA SA

50mg

C07AB02 METOPROLOLUM
BETALOC ZOC 50 mg EGILOK R 50 EMZOK 50 mg

COMPR. FILM. ELIB. PREL.


ASTRAZENECA AB EGIS PHARMACEUTICALS P.L.C. IVAX PHARMCEUTICALS S.R.O.

50mg

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 95 mg

COMPR.FILM.ELIB.MOD.
HEXAL AG

95mg

Cod restrictie 1734:

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

44

C07AB03

ATENOLOLUM
COMPR.
100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 25mg WIN - MEDICARE LTD. AC HELCOR SRL SLAVIA PHARM SRL LABORMED PHARMA SA

C07AB03 ATENOLOLUM
ATECOR ATENOCOR 100 mg ATENOLOL 100 mg ATENOLOL LPH 100 mg

100mg

C07AB03 ATENOLOLUM
ATENOLOL 100 mg ATENOLOL 100 mg MEDO ATENOLOL OZONE 100 mg VASCOTEN

COMPR. FILM.
TERAPIA SA MEDOCHEMIE ROMANIA SRL OZONE LABORATORIES LTD. MEDOCHEMIE LTD.

100mg

C07AB03 ATENOLOLUM
ATENOLOL OZONE 25 mg

COMPR. FILM.
OZONE LABORATORIES LTD.

25mg 50 mg

C07AB03 ATENOLOLUM
ATENOLOL 50 mg 50 mg

COMPR.
LAROPHARM SRL

C07AB03 ATENOLOLUM
ATENOCOR 50 mg ATENOLOL 50 mg ATENOLOL ANTIBIOTICE 50 mg ATENOLOL LPH 50 mg ATENOLOL MEDUMAN 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

COMPR.
AC HELCOR SRL SLAVIA PHARM SRL ANTIBIOTICE SA LABORMED PHARMA SA MEDUMAN SA

50mg

C07AB03 ATENOLOLUM
ATENOLOL 50 mg ATENOLOL OZONE 50 mg

COMPR. FILM.
TERAPIA SA OZONE LABORATORIES LTD.

50mg

45
BETAC BETAXA LOKREN 20 mg

C07AB05

BETAXOLOLUM
COMPR. FILM.
20mg 20mg 20mg MEDOCHEMIE LTD. ZENTIVA AS SANOFI-AVENTIS FRANCE

C07AB05 BETAXOLOLUM

20mg

46

C07AB07

BISOPROLOLUM

9 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
KERI PHARMA GENERICS LTD.

FIRMA

PROTOCOL

C07AB07 BISOPROLOLUM
BISOBLOCK 10 mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 2.5mg

COMPR. COMPR. FILM.


WORWAG PHARMA GMBH & CO. KG MERCK KGAA STADA ARZNEIMITTEL AG ANTIBIOTICE S.A. SANDOZ SRL MERCK KGAA MERCK KGAA ZENTIVA AS

10mg 10mg

C07AB07 BISOPROLOLUM
BISOGAMMA 10 BISOMERCK 10 mg BISOSTAD 10 mg BISOTENS 10 mg BYOL 10 mg CONCOR 10 mg CONCOR COR 10 mg CORONAL 10

C07AB07 BISOPROLOLUM
CONCOR COR 2,5 mg

COMPR. FILM.
MERCK KGAA

2.5mg

Cod restrictie 1734:


BISOBLOCK 5 mg

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

C07AB07 BISOPROLOLUM
5mg

COMPR.
KERI PHARMA GENERICS LTD.

5mg

Cod restrictie 1734:


BISOGAMMA 5 BISOMERCK 5 mg BISOSTAD 5 mg BISOTENS 5 mg BYOL 5 mg CONCOR 5 mg CONCOR COR 5 mg CORONAL 5

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

C07AB07 BISOPROLOLUM
5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG MERCK KGAA STADA ARZNEIMITTEL AG ANTIBIOTICE S.A. SANDOZ SRL MERCK KGAA MERCK KGAA ZENTIVA AS

5mg

Cod restrictie 1734:

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

47

C07AG02

CARVEDILOLUM
COMPR.
12,5 mg HEXAL AG

C07AG02 CARVEDILOLUM
CARVEDILOL SANDOZ

12,5 mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
ATRAM 12,5 CARVEDILOL 12,5 mg CARVEDILOL HELCOR 12,5 mg CARVEDILOL LPH 12,5 mg CARVEDILOL STADA 12,5 mg CARVEDILOL TEVA 12,5 mg CORYOL DILATREND 12,5 mg KALLIDOL 12,5 mg TALLITON 12,5 mg

COMPR.
12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg ZENTIVA AS VIM SPECTRUM SRL AC HELCOR PHARMA SRL LABORMED PHARMA SA STADA ARZNEIMITTEL AG TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. GEDEON RICHTER ROMANIA S.A. EGIS PHARMACEUTICALS LTD.

12.5mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 12,5 mg CARVEDILOL POLPHARMA 12,5 mg CARVEDILOL POLPHARMA 6,25 mg

COMPR. FILM.
12.5mg 12.5mg 6.25mg WORWAG PHARMA GMBH & CO. KG PHARMACEUTICAL WORKS POLPHARMA SA PHARMACEUTICAL WORKS POLPHARMA SA

12.5mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
ATRAM 25 CARVEDILOL HELCOR 25 mg CARVEDILOL LPH 25 mg CARVEDILOL SANDOZ CARVEDILOL STADA 25 mg CARVEDILOL TEVA 25 mg CORYOL DILATREND 25 mg KALLIDOL 25 mg TALLITON 25 mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg

COMPR.
ZENTIVA AS AC HELCOR PHARMA SRL LABORMED PHARMA SA HEXAL AG STADA ARZNEIMITTEL AG TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. GEDEON RICHTER ROMANIA S.A. EGIS PHARMACEUTICALS LTD.

25mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 25 mg CARVEDILOL POLPHARMA 25 mg 25mg 25mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG PHARMACEUTICAL WORKS POLPHARMA SA

25mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
CARVEDILOL STADA 3,125 mg CORYOL 3,125 mg KALLIDOL 3,125 mg

COMPR.
3.125mg 3.125mg 3.125mg STADA ARZNEIMITTEL AG KRKA D.D. GEDEON RICHTER ROMANIA S.A.

3.125mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 3,125 mg CARVEDILOL POLPHARMA 3,125 mg

COMPR. FILM.
3.125mg 3.125mg WORWAG PHARMA GMBH & CO. KG PHARMACEUTICAL WORKS POLPHARMA SA

3.125mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
ATRAM 6,25 CARVEDILOL 6,25 mg CARVEDILOL LPH 6,25 mg CARVEDILOL SANDOZ CARVEDILOL STADA 6,25 mg CARVEDILOL TEVA 6,25 mg CORYOL DILATREND 6,25 mg KALLIDOL 6,25 mg TALLITON 6,25 mg

COMPR.
6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg ZENTIVA AS VIM SPECTRUM SRL LABORMED PHARMA SA HEXAL AG STADA ARZNEIMITTEL AG TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. GEDEON RICHTER ROMANIA S.A. EGIS PHARMACEUTICALS LTD.

6.25mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

10 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 6,25 mg CARVEDILOL POLPHARMA 12,5 mg CARVEDILOL POLPHARMA 6,25 mg

COMPR. FILM.
6.25mg 12.5mg 6.25mg WORWAG PHARMA GMBH & CO. KG PHARMACEUTICAL WORKS POLPHARMA SA PHARMACEUTICAL WORKS POLPHARMA SA

6.25mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

48

C08CA01

AMLODIPINUM
COMPR.
10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg ZENTIVA A.S. OZONE LABORATORIES BV TAD PHARMA GMBH VIM SPECTRUM SRL ALIUD-PHARMA GMBH & CO.KG MEDOCHEMIE LTD. SPECIFAR S.A. TEVA PHARMACEUTICAL S.R.L. HEXAL AG EGIS PHARMACEUTICALS PLC LEK PHARMACEUTICALS D.D. PFIZER EUROPE MA EEIG SPECIFAR S.A. DR. REDDY'S LABORATORIES KRKA D.D. LABORMED PHARMA S.A.

C08CA01 AMLODIPINUM
AGEN 10 ALOZUR 10 mg AMLO TAD 10 mg AMLODIPIN 10 mg AMLODIPIN AL 10 mg AMLODIPINE MEDOCHEMIE 10 mg AMLODIPINE SPECIFAR 10 mg AMLODIPINE-TEVA 10 mg AMLOHEXAL 10 mg CARDILOPIN 10 mg CRISTACOR NORVASC 10 mg NORVATENS 10 mg STAMLO M 10 mg TENOX 10 VASOREX 10 mg

10mg

C08CA01 AMLODIPINUM
CARDILOPIN 2,5 mg 2.5mg

COMPR.
EGIS PHARMACEUTICALS PLC

2.5mg 5mg
ZENTIVA A.S. OZONE LABORATORIES BV TAD PHARMA GMBH VIM SPECTRUM SRL ALIUD-PHARMA GMBH & CO.KG MEDOCHEMIE LTD. SPECIFAR S.A. TEVA PHARMACEUTICAL S.R.L. HEXAL AG EGIS PHARMACEUTICALS PLC LEK PHARMACEUTICALS D.D. PFIZER EUROPE MA EEIG SPECIFAR S.A. DR. REDDY'S LABORATORIES KRKA D.D. LABORMED PHARMA S.A.

C08CA01 AMLODIPINUM
AGEN 5 ALOZUR 5 mg AMLO TAD 5 mg AMLODIPIN 5 mg AMLODIPIN AL 5 mg AMLODIPINE MEDOCHEMIE 5 mg AMLODIPINE SPECIFAR 5 mg AMLODIPINE-TEVA 5 mg AMLOHEXAL 5 mg CARDILOPIN 5 mg CRISTACOR NORVASC 5 mg NORVATENS 5 mg STAMLO M 5 mg TENOX 5 VASOREX 5 mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.

49

C08CA02

FELODIPINUM
COMPR. ELIB. MODIF.
10mg 10mg 10mg 10mg 10mg 10mg 10mg 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg ALIUD PHARMA GMBH & CO.KG

C08CA02 FELODIPINUM
FELODIPIN AL 10 RETARD

10mg 10mg 10mg 10mg

C08CA02 FELODIPINUM
PLENDIL

COMPR. ELIB. PREL.


ASTRAZENECA AB

C08CA02 FELODIPINUM
SISTAR 10 mg

COMPR. FILM. ELIB. MODIF.


GEDEON RICHTER ROMANIA SA

C08CA02 FELODIPINUM
AURONAL 10 mg FELODIPIN SANDOZ 10 mg MIVARA 10 mg PRESID 10 mg

COMPR. FILM. ELIB. PREL.


EGIS PHARMACEUTICALS PLC HEXAL AG STADA ARZNEIMITTEL AG IVAX - PHARMACEUTICALS S.R.O.

C08CA02 FELODIPINUM
FELODIPIN AL 2,5 RETARD

COMPR. ELIB. MODIF.


ALIUD PHARMA GMBH & CO.KG

2.5mg 2.5mg 2.5mg 2.5mg

C08CA02 FELODIPINUM
PLENDIL

COMPR. ELIB. PREL.


ASTRAZENECA AB

C08CA02 FELODIPINUM
SISTAR 2,5 mg

COMPR. FILM. ELIB. MODIF.


GEDEON RICHTER ROMANIA SA

C08CA02 FELODIPINUM
AURONAL 2,5 mg PRESID 2,5 mg

COMPR. FILM. ELIB. PREL.


EGIS PHARMACEUTICALS PLC IVAX - PHARMACEUTICALS S.R.O.

C08CA02 FELODIPINUM
FELODIPIN AL 5 RETARD

COMPR. ELIB. MODIF.


ALIUD PHARMA GMBH & CO.KG

5mg 5mg 5mg 5mg

C08CA02 FELODIPINUM
PLENDIL

COMPR. ELIB. PREL.


ASTRAZENECA AB

C08CA02 FELODIPINUM
SISTAR 5 mg

COMPR. FILM. ELIB. MODIF.


GEDEON RICHTER ROMANIA SA

C08CA02 FELODIPINUM
AURONAL 5 mg FELODIPIN SANDOZ 5 mg MIVARA 5 mg PRESID 5 mg

COMPR. FILM. ELIB. PREL.


EGIS PHARMACEUTICALS PLC HEXAL AG STADA ARZNEIMITTEL AG IVAX - PHARMACEUTICALS S.R.O.

50
ADALAT CR 20

C08CA05

NIFEDIPINUM
COMPR. ELIB. MODIF.
20mg 20mg 20mg BAYER HEALTHCARE AG

C08CA05 NIFEDIPINUM C08CA05 NIFEDIPINUM


ADALAT RETARD NIFEDIPIN RETARD TERAPIA 20 mg

20mg 20mg

COMPR. FILM. ELIB. PREL.


BAYER HEALTHCARE AG TERAPIA SA

C08CA05 NIFEDIPINUM
EPILAT RETARD 20mg

DRAJ.
E.I.P.I.CO. MED S.R.L.

20mg 30mg

C08CA05 NIFEDIPINUM

COMPR. ELIB. MODIF.

11 / 233

DCI/DENUMIRE COMERCIALA
ADALAT CR 30

CONCENTRATIE
30mg 60mg 60mg 20mg 20mg 20mg

FORMA FARM.
BAYER HEALTHCARE AG

FIRMA

PROTOCOL

C08CA05 NIFEDIPINUM
ADALAT CR 60

COMPR. ELIB. MODIF.


BAYER HEALTHCARE AG

60mg 60mg 20mg 20mg

C08CA05 NIFEDIPINUM
NIFECARD XL 60 mg

COMPR. FILM. ELIB. PREL.


LEK PHARMACEUTICALS D.D.

C08CA05 NIFEDIPINUM
ADALAT CR 20

COMPR. ELIB. MODIF.


BAYER HEALTHCARE AG

C08CA05 NIFEDIPINUM
ADALAT RETARD NIFEDIPIN RETARD TERAPIA 20 mg

COMPR. FILM. ELIB. PREL.


BAYER HEALTHCARE AG TERAPIA SA

C08CA05 NIFEDIPINUM
NIFEDIPIN NIFEDIPIN 10 mg 10mg 10mg

DRAJ.
TERAPIA SA LAROPHARM SRL

10mg

51

C08DA01

VERAPAMILUM
COMPR. FILM. ELIB. PREL.
240mg 240mg ABBOTT GMBH&CO.KG IVAX - PHARMACEUTICALS S.R.O.

C08DA01 VERAPAMILUM
ISOPTIN RR VEROGALID ER 240 mg

240mg

Efectele de inhibare a funciei miocardice ale acestui medicament se cumuleaz cu cele ale beta-blocantelor

C08DA01 VERAPAMILUM
CORDAMIL 40 ISOPTIN 40 mg VERAPAMIL AL 40 40mg 40mg 40mg

COMPR. FILM.
AC HELCOR SRL ABBOTT GMBH&CO.KG ALIUD PHARMA GMBH & CO.KG

40mg

Efectele de inhibare a funciei miocardice ale acestui medicament se cumuleaz cu cele ale beta-blocantelor

C08DA01 VERAPAMILUM
VERAPAMIL 40 mg 40mg

DRAJ.
SANOFI-AVENTIS ROMANIA S.R.L.

40mg

Efectele de inhibare a funciei miocardice ale acestui medicament se cumuleaz cu cele ale beta-blocantelor

C08DA01 VERAPAMILUM
VERAPAMIL 80mg

CAPS.
ARENA GROUP SA

80mg

Efectele de inhibare a funciei miocardice ale acestui medicament se cumuleaz cu cele ale beta-blocantelor

C08DA01 VERAPAMILUM
CORDAMIL 80 ISOPTIN 80 mg VERAPAMIL AL 80 80mg 80mg 80mg

COMPR. FILM.
AC HELCOR SRL ABBOTT GMBH&CO.KG ALIUD PHARMA GMBH & CO.KG

80mg

Efectele de inhibare a funciei miocardice ale acestui medicament se cumuleaz cu cele ale beta-blocantelor

C08DA01 VERAPAMILUM
VERAPAMIL 80 mg 80mg

DRAJ.
SANOFI-AVENTIS ROMANIA S.R.L.

80mg

Efectele de inhibare a funciei miocardice ale acestui medicament se cumuleaz cu cele ale beta-blocantelor

52
DILTIAZEM SR 120 mg

C08DB01

DILTIAZEMUM
CAPS. ELIB. PREL.
120mg 120mg 180mg TERAPIA SA

C08DB01 DILTIAZEMUM C08DB01 DILTIAZEMUM


CORZEM 120

120mg 120mg 180mg

COMPR. FILM.
AC HELCOR SRL TERAPIA SA

C08DB01 DILTIAZEMUM
DILTIAZEM SR 180 mg

CAPS. ELIB. PREL.

Efectele de inhibare a funciei miocardice ale acestui medicament se cumuleaz cu cele ale beta-blocantelor

C08DB01 DILTIAZEMUM
DILTIAZEM 60 mg DILTIAZEM ALKALOID 60 mg DILTIAZEM EIPICO 60 mg DILTIAZEM LPH 60 mg DILZEM 60 mg 60mg 60mg 60mg 60mg 60mg

COMPR.
ARENA GROUP SA ALKALOID DOO E.I.P.I.CO. MED S.R.L. LABORMED PHARMA SA PFIZER EUROPE MA EEIG

60mg

Efectele de inhibare a funciei miocardice ale acestui medicament se cumuleaz cu cele ale beta-blocantelor

C08DB01 DILTIAZEMUM
CORZEM 60 60mg

COMPR. FILM.
AC HELCOR SRL

60mg

Efectele de inhibare a funciei miocardice ale acestui medicament se cumuleaz cu cele ale beta-blocantelor

C08DB01 DILTIAZEMUM
DILTIAZEM SR 90 mg 90mg

CAPS. ELIB. PREL.


TERAPIA SA

90mg 90mg

C08DB01 DILTIAZEMUM
DILTIAZEM ALKALOID 90 mg 90mg 90mg

COMPR.
ALKALOID DOO

C08DB01 DILTIAZEMUM
DILZEM 90 mg RETARD

COMPR. FILM. ELIB. PREL.


PFIZER EUROPE MA EEIG

90mg

53

C09AA01

CAPTOPRILUM
COMPR.
12,5mg MAGISTRA C & C

C09AA01 CAPTOPRILUM
CAPTOPRIL MCC 12,5 mg

12,5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA01 CAPTOPRILUM
CAPTOPRIL 12,5 mg

COMPR.
12.5mg EGIS PHARMACEUTICALS LTD.

12.5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA01 CAPTOPRILUM
CAPTOPRIL - AC 25 mg CAPTOPRIL LAROPHARM 25 mg CAPTOPRIL SINTOFARM 25 mg CAPTOPRIL 25 EEL CAPTOPRIL 25 mg CAPTOPRIL FARMEX 25 mg CAPTOPRIL LPH 25 mg CAPTOPRIL MCC 25 mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg

COMPR.
AC HELCOR PHARMA SRL LAROPHARM SRL SINTOFARM SA BIO EEL SRL EGIS PHARMACEUTICALS LTD. FARMEX COMPANY SRL LABORMED PHARMA SA MAGISTRA C & C

25mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

12 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
ARENA GROUP SA

FIRMA

PROTOCOL

C09AA01 CAPTOPRILUM
CAPTOPRIL 50 mg 50 mg

COMPR.

50 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA01 CAPTOPRILUM
CAPTOPRIL - AC 50 mg CAPTOPRIL 50 EEL CAPTOPRIL 50 mg CAPTOPRIL LPH 50 mg CAPTOPRIL MCC 50 mg 50mg 50mg 50mg 50mg 50mg

COMPR.
AC HELCOR PHARMA SRL BIO EEL SRL EGIS PHARMACEUTICALS LTD. LABORMED PHARMA SA MAGISTRA C & C

50mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

54
ENAP

C09AA02

ENALAPRILUM
SOL. INJ.
1.25mg/ml KRKA D.D.

C09AA02 ENALAPRILUM C09AA02 ENALAPRILUM


BERLIPRIL 10 EDNYT 10 mg ENAHEXAL 10 mg ENALA TAD 10 ENALAP ENALAPRIL 10 mg ENALAPRIL AL 10 ENALAPRIL FABIOL 10 mg ENALAPRIL LPH 10 mg ENALAPRIL MEDICO UNO 10 mg ENALAPRIL SANDOZ 10 mg ENALAPRIL TERAPIA 10 mg ENAM 10 mg ENAP 10 mg INVORIL 10 mg OLINAPRIL 10 mg RENITEC 10 mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg

1.25mg/ml 10mg
BERLIN CHEMIE AG (MENARINI GROUP) GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH E.I.P.I.CO. MED S.R.L. OZONE LABORATORIES LTD. ALIUD PHARMA GMBH & CO.KG FABIOL SA LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL SRL SANDOZ SRL TERAPIA SA REPREZENTANTA DR. REDDY'S LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. LEK PHARMACEUTICALS D.D. MERCK SHARP & DOHME ROMANIA S.R.L.

COMPR.

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA02 ENALAPRILUM
EDNYT 2,5 mg ENAP 2,5 mg 2.5mg 2.5mg

COMPR.
GEDEON RICHTER LTD. KRKA D.D. NOVO MESTO

2.5mg

C09AA02 ENALAPRILUM
BERLIPRIL 20 EDNYT 20 mg ENAHEXAL 20 mg ENALA TAD 20 ENALAPRIL ENALAPRIL 20 mg ENALAPRIL AL 20 ENALAPRIL FABIOL 20 mg ENALAPRIL LPH 20 mg ENALAPRIL MEDICO UNO 20 mg ENALAPRIL OZONE 20 mg ENALAPRIL SANDOZ 20 mg ENALAPRIL TERAPIA 20 mg ENAP 20 mg INVORIL 20 mg OLINAPRIL 20 mg RENITEC 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR.
BERLIN CHEMIE AG (MENARINI GROUP) GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH OZONE LABORATORIES LTD. LAROPHARM SRL ALIUD PHARMA GMBH & CO.KG FABIOL SA LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL SRL OZONE LABORATORIES BV SANDOZ SRL TERAPIA SA KRKA D.D. NOVO MESTO TERAPIA S.A. LEK PHARMACEUTICALS D.D. MERCK SHARP & DOHME ROMANIA S.R.L.

20mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA02 ENALAPRILUM
BERLIPRIL 5 EDNYT 5 mg ENAHEXAL 5 mg ENALA TAD 5 ENALAPRIL 5 mg ENALAPRIL AL 5 ENALAPRIL LPH 5 mg ENALAPRIL MEDICO UNO 5 mg ENALAPRIL SANDOZ 5 mg ENALAPRIL TERAPIA 5 mg ENAP 5 mg INVORIL 5 mg OLINAPRIL 5 mg RENITEC 5 mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.
BERLIN CHEMIE AG (MENARINI GROUP) GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH VIM SPECTRUM SRL ALIUD PHARMA GMBH & CO.KG LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL SRL SANDOZ SRL TERAPIA SA KRKA D.D. NOVO MESTO TERAPIA S.A. LEK PHARMACEUTICALS D.D. MERCK SHARP & DOHME ROMANIA S.R.L.

5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

55

C09AA03

LISINOPRILUM
COMPR.
10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg SANDOZ GMBH WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL ANTIBIOTICE SA HEXAL AG AC HELCOR SRL MEDOCHEMIE LTD. RANBAXY U.K. LIMITED ANTIBIOTICE SA

C09AA03 LISINOPRILUM
LISDENE 10 mg LISIGAMMA 10 mg LISINOPRIL 10 MEDO LISINOPRIL ANTIBIOTICE 10 mg LISINOPRIL SANDOZ 10 mg LISIREN 10 mg MEDAPRIL 10 RANOLIP SINOPRYL 10

10mg

13 / 233

DCI/DENUMIRE COMERCIALA
TONOLYSIN 10 mg

CONCENTRATIE
10mg

FORMA FARM.
GEDEON RICHTER LTD.

FIRMA

PROTOCOL

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA03 LISINOPRILUM
TONOLYSIN 2,5 mg 2.5mg

COMPR.
GEDEON RICHTER LTD.

2.5mg 20mg
SANDOZ GMBH WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL ANTIBIOTICE SA HEXAL AG AC HELCOR SRL MEDOCHEMIE LTD. RANBAXY U.K. LIMITED GEDEON RICHTER LTD.

C09AA03 LISINOPRILUM
LISDENE 20 mg LISIGAMMA 20 mg LISINOPRIL 20 MEDO LISINOPRIL ANTIBIOTICE 20 mg LISINOPRIL SANDOZ 20 mg LISIREN 20 mg MEDAPRIL 20 RANOLIP TONOLYSIN 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR.

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA03 LISINOPRILUM
LISINOPRIL ANTIBIOTICE 40 mg 40mg

COMPR.
ANTIBIOTICE SA

40mg 5mg
SANDOZ GMBH WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL HEXAL AG MEDOCHEMIE LTD. RANBAXY U.K. LIMITED GEDEON RICHTER LTD.

C09AA03 LISINOPRILUM
LISDENE 5 mg LISIGAMMA 5 mg LISINOPRIL 5 MEDO LISINOPRIL SANDOZ 5 mg MEDAPRIL 5 RANOLIP TONOLYSIN 5 mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

56
EMREN 1,25 mg

C09AA05

RAMIPRILUM
COMPR.
1,25 mg GEDEON RICHTER ROMANIA S.A.

C09AA05 RAMIPRILUM

1,25 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
AMPRIL 1,25 mg HARTIL 1,25 mg PIRAMIL 1,25 mg RAMIPRIL SANDOZ 1,25 mg

COMPR.
1.25mg 1.25mg 1.25mg 1.25mg KRKA D.D. NOVO MESTO EGIS PHARMACEUTICALS PLC SANDOZ SRL HEXAL AG

1.25mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIRAN 1,25 mg

COMPR. FILM.
1.25mg RANBAXY U.K. LIMITED

1.25mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
EMREN 10 mg VIVACE 10 mg 10 mg 10 mg

COMPR.
GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

10 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIPRIL STADA 10 mg 10mg

CAPS.
STADA ARZNEIMITTEL AG

10mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
AMPRIL 10 mg HARTIL 10 mg PIRAMIL 10 mg RAMIGAMMA 10 mg RAMIPRIL SANDOZ 10 mg RAMIPRIL STADA 10 mg RAMIPRIL-AC 10 mg TRITACE 10 ZENRA 10 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg

COMPR.
KRKA D.D. NOVO MESTO EGIS PHARMACEUTICALS PLC SANDOZ SRL WORWAG PHARMA GMBH & CO. KG HEXAL AG STADA ARZNEIMITTEL AG AC HELCOR PHARMA SRL SANOFI - AVENTIS DEUTSCHLAND GMBH ZENTIVA S.A.

10mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIRAN 10 mg 10mg

COMPR. FILM.
RANBAXY U.K. LIMITED

10mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
EMREN 2,5 mg VIVACE 2,5 mg

COMPR.
2,5 mg 2,5 mg GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

2,5 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIPRIL STADA 2,5 mg 2.5mg

CAPS.
STADA ARZNEIMITTEL AG

2.5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
AMPRIL 2,5 mg HARTIL 2,5 mg PIRAMIL 2,5 mg 2.5mg 2.5mg 2.5mg

COMPR.
KRKA D.D. NOVO MESTO EGIS PHARMACEUTICALS PLC SANDOZ SRL

2.5mg

14 / 233

DCI/DENUMIRE COMERCIALA
RAMIGAMMA 2,5 mg RAMIPRIL SANDOZ 2,5 mg RAMIPRIL STADA 2,5 mg RAMIPRIL-AC 2,5 mg TRITACE 2,5 ZENRA 2,5

CONCENTRATIE
2.5mg 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg

FORMA FARM.

FIRMA

PROTOCOL

WORWAG PHARMA GMBH & CO. KG HEXAL AG STADA ARZNEIMITTEL AG AC HELCOR PHARMA SRL AVENTIS PHARMA DEUTSCHLAND GMBH ZENTIVA S.A.

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIRAN 2,5 mg 2.5mg

COMPR. FILM.
RANBAXY U.K. LIMITED

2.5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
EMREN 5 mg VIVACE 5 mg 5 mg 5 mg

COMPR.
GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

5 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIPRIL STADA 5 mg 5mg

CAPS.
STADA ARZNEIMITTEL AG

5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
AMPRIL 5 mg HARTIL 5 mg PIRAMIL 5 mg RAMIGAMMA 5 mg RAMIPRIL SANDOZ 5 mg RAMIPRIL STADA 5 mg RAMIPRIL-AC 5 mg TRITACE 5 ZENRA 5 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.
KRKA D.D. NOVO MESTO EGIS PHARMACEUTICALS PLC SANDOZ SRL WORWAG PHARMA GMBH & CO. KG HEXAL AG STADA ARZNEIMITTEL AG AC HELCOR PHARMA SRL AVENTIS PHARMA DEUTSCHLAND GMBH ZENTIVA S.A.

5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIRAN 5 mg 5mg

COMPR. FILM.
RANBAXY U.K. LIMITED

5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIPRIL SANDOZ 7,5 mg 7.5mg

COMPR.
HEXAL AG

7.5mg

57

C09AA06

QUINAPRILUM
COMPR. FILM.
10 mg HEXAL AG

C09AA06 QUINAPRILUM
QUINAPRIL SANDOZ 10 mg

10 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA06 QUINAPRILUM
ACCUPRO 10 mg AQUIRIL 10 mg QUINAPRIL AL 10 QUINARAN 10 mg 10mg 10mg 10mg 10mg

COMPR. FILM.
PFIZER EUROPE MA EEIG LABORMED PHARMA SA ALIUD PHARMA GMBH & CO.KG RANBAXY UK LIMITED

10mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA06 QUINAPRILUM
QUINAPRIL SANDOZ 20 mg 20 mg

COMPR. FILM.
HEXAL AG

20 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA06 QUINAPRILUM
ACCUPRO 20 QUINARAN 20 mg 20mg 20mg

COMPR. FILM.
PFIZER EUROPE MA EEIG RANBAXY UK LIMITED

20mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA06 QUINAPRILUM
QUINAPRIL SANDOZ 40 mg 40 mg 40mg 5 mg

COMPR. FILM.
HEXAL AG

40 mg 40mg 5 mg

C09AA06 QUINAPRILUM
QUINARAN 40 mg

COMPR. FILM.
RANBAXY UK LIMITED

C09AA06 QUINAPRILUM
QUINAPRIL SANDOZ 5 mg

COMPR. FILM.
HEXAL AG

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA06 QUINAPRILUM
ACCUPRO 5 QUINAPRIL AL 5 QUINARAN 5 mg 5mg 5mg 5mg

COMPR. FILM.
PFIZER EUROPE MA EEIG ALIUD PHARMA GMBH & CO.KG RANBAXY UK LIMITED

5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

58

C09AA09

FOSINOPRILUM
COMPR.
10mg 10mg 10mg TERAPIA SA TERAPIA S.A. BRISTOL MYERS SQUIBB KFT

C09AA09 FOSINOPRILUM
FOSINOPRIL TERAPIA 10 mg FOSYPRIL 10 mg MONOPRIL 10 mg

10mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA09 FOSINOPRILUM

COMPR.

20mg

15 / 233

DCI/DENUMIRE COMERCIALA
FOSINOPRIL TERAPIA 20 mg FOSINOPRIL TEVA 20 mg FOSYPRIL 20 mg MONOPRIL 20 mg

CONCENTRATIE
20mg 20mg 20mg 20mg

FORMA FARM.
TERAPIA SA TEVA PHARMACEUTICAL S.R.L. TERAPIA S.A. BRISTOL-MYERS SQUIBB KFT

FIRMA

PROTOCOL

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA09 FOSINOPRILUM
FOSIPRIL 5 mg 5mg

COMPR.
TERAPIA S.A.

5mg

59

C09BA02

COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR. 10mg/25mg

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDU M)


ENALAPRIL HCT SANDOZ 10 mg/25 mg

10mg/25mg

HEXAL AG

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDU M)


ENAP HL

COMPR.

10mg+12.5mg

10mg+12.5mg

KRKA D.D. NOVO MESTO

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDU M)


ENAP H

COMPR.

10mg+25mg

10mg+25mg

KRKA D.D. NOVO MESTO

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDU M)


ENAP HL 20 mg/12,5 mg

COMPR.

20 mg/12.5mg

20 mg/12.5mg

KRKA D.D. NOVO MESTO

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDU M)


ENALAPRIL HCT SANDOZ 20 mg/12,5 mg OLINAPRIL HCT SANDOZ 20mg/12,5mg

COMPR.

20mg/12.5mg

20mg/12.5mg 20mg/12.5mg

HEXAL AG SANDOZ SRL

C09BA02 COMBINATII (ENALAPRILUM+HYDROCHLOROTHIAZIDU M)


VIMAPRIL H VIMAPRIL HL

COMPR.

VIM SPECTRUM SRL VIM SPECTRUM SRL

60

C09BA05

COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR. 2.5mg/12.5mg

C09BA05 COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM )


EMREN HCT 2,5mg/12,5mg HARTIL HCT 2,5 mg/12,5mg PIRAMIL HCT 2,5 mg/12,5 mg RAMIPRIL HCT-MEDOCHEMIE TENSIL 2,5mg/12,5mg TRITACE 2,5 PLUS

2.5mg/12.5mg 2.5mg/12.5mg 2.5mg/12.5mg 2.5mg/12.5mg 2.5mg/12.5mg 2.5mg/12.5mg

GEDEON RICHTER ROMANIA S.A. EGIS PHARMACEUTICALS PLC HEXAL AG MEDOCHEMIE LTD. TEVA PHARMACEUTICALS S.R.L. AVENTIS PHARMA DEUTSCHLAND GMBH

C09BA05 COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM )


AMPRIL HL

COMPR.

2.5mg+12.5mg

2.5mg+12.5mg

KRKA D.D. NOVO MESTO

C09BA05 COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM )


EMREN HCT 5mg/25mg HARTIL HCT 5 mg/25mg PIRAMIL HCT 5 mg/25 mg RAMIPRIL HCT-MEDOCHEMIE TENSIL 5mg/25mg TRITACE 5 PLUS

COMPR.

5mg/25mg

5mg/25mg 5mg/25mg 5mg/25mg 5mg/25mg 5mg/25mg 5mg/25mg

GEDEON RICHTER ROMANIA S.A. EGIS PHARMACEUTICALS PLC HEXAL AG MEDOCHEMIE LTD. TEVA PHARMACEUTICALS S.R.L. AVENTIS PHARMA DEUTSCHLAND GMBH

C09BA05 COMBINATII (RAMIPRILUM+HYDROCHLOROTHIAZIDUM )


AMPRIL HD

COMPR.

5mg+25mg

5mg+25mg

KRKA D.D. NOVO MESTO

61
LOZAP 100

C09CA01

LOSARTANUM
COMPR. FILM.
100mg 12,5mg 12,5mg 25mg 50mg 50mg 50mg 50mg ZENTIVA A.S.

C09CA01 LOSARTANUM C09CA01 LOSARTANUM


LOZAP 12,5 SARTENS 12,5 mg

100mg 12,5mg

COMPR. FILM.
ZENTIVA A.S. LANNACHER HEILMITTEL GES.M.B.H.

C09CA01 LOSARTANUM
LOZAP 25

COMPR. FILM.
ZENTIVA A.S.

25mg 50mg

C09CA01 LOSARTANUM
COZAAR LORISTA LOZAP 50 SARTENS 50 mg

COMPR. FILM.
MERCK SHARP & DOHME ROMANIA S.R.L. KRKA D.D. NOVO MESTO ZENTIVA A.S. LANNACHER HEILMITTEL GES.M.B.H.

62

C10AA01

SIMVASTATINUM
COMPR. FILM.
10 mg 10 mg TERAPIA S.A. LABORATOARELE PROF.DR.MORAIT S.R.L.

C10AA01 SIMVASTATINUM
SIMVASTATIN 10 mg SIMVASTATINA BIOGALENICA 10 mg

10 mg

Prescriere limitata:

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

16 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

C10AA01 SIMVASTATINUM
CLERIVAS 10 mg SIMGAL 10 mg SIMVA TAD 10 mg SIMVACARD 10 SIMVAGAMMA 10 mg SIMVAHEXAL 10 mg SIMVASTATIN 10 mg SIMVASTATIN AL 10 mg SIMVASTATIN LPH 10 mg SIMVASTATINA ACTAVIS 10 mg SIMVOR 10 mg SINTENAL 10 mg VABADIN 10 mg VASILIP 10 mg ZAREDIL 10 mg ZEPLAN 10 mg ZOCOR 10 mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg

COMPR. FILM.

10mg

TEVA PHARMACEUTICAL S.R.L. IVAX - PHARMACEUTICALS S.R.O. TAD PHARMA GMBH ZENTIVA AS WORWAG PHARMA GMBH & CO. KG HEXAL AG LAROPHARM SRL ALIUD PHARMA GMBH LABORMED PHARMA SA ACTAVIS GROUP PTC EHF. RANBAXY U.K. LIMITED AC HELCOR PHARMA SRL MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A. KRKA D.D. OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SA MERCK SHARP & DOHME ROMANIA S.R.L.

Prescriere limitata:

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA01 SIMVASTATINUM
SIMVASTATIN 20 mg SIMVASTATINA BIOGALENICA 20 mg 20 mg 20 mg

COMPR. FILM.
TERAPIA S.A. LABORATOARELE PROF.DR.MORAIT S.R.L.

20 mg

Prescriere limitata:
CLERIVAS 20 mg SIMCOR 20 mg SIMGAL 20 mg SIMVA TAD 20 mg SIMVACARD 20 SIMVAGAMMA 20 mg SIMVAHEXAL 20 mg SIMVASTATIN AL 20 mg SIMVASTATIN LPH 20 mg SIMVASTATINA ACTAVIS 20 mg SIMVOR 20 mg SINTENAL 20 mg VABADIN 20 mg VASILIP 20 mg ZAREDIL 20 mg ZEPLAN 20 mg ZOCOR 20 mg

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA01 SIMVASTATINUM
20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR. FILM.

20mg

TEVA PHARMACEUTICALS S.R.L. ANTIBIOTICE SA IVAX - PHARMACEUTICALS S.R.O. TAD PHARMA GMBH ZENTIVA AS WORWAG PHARMA GMBH & CO. KG HEXAL AG ALIUD PHARMA GMBH LABORMED PHARMA SA ACTAVIS GROUP PTC EHF. RANBAXY U.K. LIMITED AC HELCOR PHARMA SRL MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A. KRKA D.D. OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SA MERCK SHARP & DOHME ROMANIA S.R.L.

Prescriere limitata:
SIMVAHEXAL 30 mg

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA01 SIMVASTATINUM
30mg 40 mg 40 mg

COMPR. FILM.
HEXAL AG

30mg 40 mg

C10AA01 SIMVASTATINUM
SIMVASTATIN 40 mg SIMVASTATINA BIOGALENICA 40 mg

COMPR. FILM.
TERAPIA S.A. LABORATOARELE PROF.DR.MORAIT S.R.L.

Prescriere limitata:
CLERIVAS 40 mg SIMCOR 40 mg SIMGAL 40 mg SIMVA TAD 40 mg SIMVACARD 40 SIMVAGAMMA 40 mg SIMVAHEXAL 40 mg SIMVASTATIN AL 40 mg SIMVASTATIN LPH 40 mg SIMVASTATINA ACTAVIS 40 mg SIMVOR 40 mg SINTENAL 40 mg VABADIN 40 mg VASILIP 40 mg ZAREDIL 40 mg ZEPLAN 40 mg ZOCOR FORTE

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA01 SIMVASTATINUM
40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg 40mg

COMPR. FILM.

40mg

TEVA PHARMACEUTICAL S.R.L. ANTIBIOTICE S.A. IVAX - PHARMACEUTICALS S.R.O. TAD PHARMA GMBH ZENTIVA AS WORWAG PHARMA GMBH & CO. KG HEXAL AG ALIUD PHARMA GMBH LABORMED PHARMA S.A. ACTAVIS GROUP PTC EHF. RANBAXY U.K. LIMITED AC HELCOR PHARMA SRL MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A. KRKA D.D. OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SA MERCK SHARP & DOHME ROMANIA S.R.L.

Prescriere limitata:
CLERIVAS 5 mg SIMVAGAMMA 5 mg SIMVOR 5 mg

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA01 SIMVASTATINUM
5mg 5mg 5mg

COMPR. FILM.
TEVA PHARMACEUTICAL S.R.L. WORWAG PHARMA GMBH & CO. KG RANBAXY U.K. LIMITED

5mg

Prescriere limitata:
CLERIVAS 80 mg SIMVASANDOZ 80 SIMVASTATIN LPH 80 mg SIMVOR 80mg

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA01 SIMVASTATINUM
80mg 80mg 80mg 80mg

COMPR. FILM.
TEVA PHARMACEUTICAL S.R.L. SANDOZ S.R.L. LABORMED PHARMA S.A. RANBAXY UK LIMITED

80mg

Prescriere limitata:

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

63

C10AA02

LOVASTATINUM
COMPR.
20mg 20mg 20mg LAROPHARM SRL LABORATOARELE PROF.DR.MORAIT S.R.L. MEDOCHEMIE LTD.

C10AA02 LOVASTATINUM
LOVASTATIN 20 mg LOVASTATINA BIOGALENICA 20 mg MEDOSTATIN

20mg

C10AA02 LOVASTATINUM
LOVASTATIN UNIVERSAL ESPANA MEDOSTATIN 40 mg 40mg 40mg

COMPR.
UNIVERSAL FARMA S.L. MEDOCHEMIE LTD.

40mg

17 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

64

C10AA03

PRAVASTATINUM
COMPR.
10mg 10mg 10mg 10mg APOTEX EUROPE LTD. SANDOZ SRL HEXAL AG RANBAXY U.K. LIMITED

C10AA03 PRAVASTATINUM
APO-PRAVASTATIN 10 mg PRALIP 10 mg PRAVASTATIN SANDOZ PRAVATOR 10 mg

10mg

Prescriere limitata:
APO-PRAVASTATIN 20 mg PRALIP 20 mg PRAVASTATIN SANDOZ PRAVATOR 20 mg

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA03 PRAVASTATINUM
20mg 20mg 20mg 20mg

COMPR.
APOTEX EUROPE LTD. SANDOZ SRL HEXAL AG RANBAXY U.K. LIMITED

20mg

Prescriere limitata:
PRAVASTATIN SANDOZ

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA03 PRAVASTATINUM
30mg

COMPR.
HEXAL AG

30mg 40mg
APOTEX EUROPE LTD. SANDOZ SRL HEXAL AG RANBAXY U.K. LIMITED

C10AA03 PRAVASTATINUM
APO-PRAVASTATIN 40 mg PRALIP 40 mg PRAVASTATIN SANDOZ PRAVATOR 40 mg 40mg 40mg 40mg 40mg

COMPR.

Prescriere limitata:

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

65
LIPANTHYL 100

C10AB05

FENOFIBRATUM
CAPS.
100mg 145mg 145mg 145mg LAB. FOURNIER SA

C10AB05 FENOFIBRATUM C10AB05 FENOFIBRATUM


LIPANTHYL PENTA 145mg LIPANTIL NANO 145 mg TRICOR 145 mg

100mg 145mg

COMPR. FILM.
LABORATOIRES FOURNIER SA LAB. FOURNIER S.A. LABORATOIRES FOURNIER SA

Prescriere limitata: Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante. NOTA: Riscul de toxicitate muscular sever creste dac fenofibratum este utilizat simultan cu inhibitori de HMG CoA reductaza sau ali fibrai. Terapia combinata trebuie folosit cu precautie la pacienii cu dislipidemie mixta sever combinat cu risc cardiovascular nalt, in absenta antecedentelor de afectiune muscular. Pacienii vor fi monitorizai regulat pentru semne cronice de toxicitate muscular..

C10AB05 FENOFIBRATUM
LIPOFIB 160 mg

CAPS.
160mg 160mg 160mg TERAPIA S.A.

160mg 160mg

C10AB05 FENOFIBRATUM
FENOX 160 mg LIPANTHYL SUPRA 160 mg

COMPR. FILM. ELIB. MODIF.


LAB. FOURNIER SA LAB. FOURNIER SA

C10AB05 FENOFIBRATUM
FENOFIBRAT TERAPIA 200 mg LIPOFIB 200 mg

CAPS.
200mg 200mg 200mg 200mg 200mg TERAPIA S.A. TERAPIA S.A.

200mg

C10AB05 FENOFIBRATUM
FENOFIBRAT LPH 200 mg LIPANTHYL 200 M LIPIVIM

CAPS. PULB. MICRONIZATA


LABORMED PHARMA SA LAB. FOURNIER SA VIM SPECTRUM SRL

200mg

C10AB05 FENOFIBRATUM
LIPANTHYL 267 M LIPOFIB 267 mg

CAPS.
267mg 267mg LAB. FOURNIER S.A. TERAPIA S.A.

267mg

C10AB05 FENOFIBRATUM
LIPANTHYL 67M LIPOFIB 67 mg 67mg 67mg

CAPS.
LAB. FOURNIER S.A. TERAPIA S.A.

67mg

66
MICONAL ECOBI

D01AC02

MICONAZOLUM
CREMA
20mg/g FARMACEUTICI ECOBI S.A.S

D01AC02 MICONAZOLUM D01AC02 MICONAZOLUM


MEDACTER MICONAZOL NITRAT 2% 2% 2%

20mg/g 2%
FARAN LABORATORIES S.A. SLAVIA PHARM SRL

CREMA

D01AC02 MICONAZOLUM
DERMOZOL 2%

GEL
PHARCO IMPEX 93 S.R.L.

2%

67
MYCOSPOR

D01AC10

BIFONAZOLUM
SOL. CUT.
0,01g/ml BAYER HEALTHCARE AG

D01AC10 BIFONAZOLUM D01AC10 BIFONAZOLUM


MYCO - FLUSEMIDON 100g

0,01g/ml 100g
ANFARM HELLAS S.A. PHARMACEUTICALS

CREMA CREMA
10mg/g GEDEON RICHTER ROMANIA SA

D01AC10 BIFONAZOLUM
BIAZOL 10 mg/g

10mg/g 1%
BAYER HEALTHCARE AG

D01AC10 BIFONAZOLUM
MYCOSPOR 1%

CREMA

68

D06BB03

ACICLOVIRUM
CREMA
50mg/g 50mg/g 50mg/g HYPERION S.A. TIS FARMACEUTIC SA A & G MED TRADING S.R.L.

D06BB03 ACICLOVIRUM
ACICLOVIR HYPERION ACICLOVIR TIS 50mg/g ACIKLOVIR CREMA

50mg/g

D06BB03 ACICLOVIRUM
ACICLOVIR ACICLOVIR 5% ACICLOVIR MK CLOVIRAL 5% LOVIR ZOVIRAX 5% 5% 5% 5% 5% 5%

CREMA
OZONE LABORATORIES LTD. EGIS PHARMACEUTICALS PLC FITERMAN PHARMA S.R.L. ANTIBIOTICE SA RANBAXY U.K. LIMITED THE WELLCOME FOUNDATION LTD.

5%

69

D07AA02

HYDROCORTISONUM
UNGUENT 1,00%

Protocol: D001L

D07AA02 HYDROCORTISONUM

18 / 233

DCI/DENUMIRE COMERCIALA
HIDROCORTIZON 1%

CONCENTRATIE
1%

FORMA FARM.
ANTIBIOTICE SA

FIRMA

PROTOCOL

Prescriere limitata:

Tratamentul dermatozelor sensibile la administrarea de corticosteroizi topici.

70
BELODERM CREMA

D07AC01
Prescriere limitata:

BETAMETHASONUM
CREMA
0,5mg/g A & G MED TRADING S.R.L.

Protocol: D001L
0,5mg/g

D07AC01 BETAMETHASONUM

Tratamentul dermatozelor sensibile la administrarea de corticosteroizi topici.

D07AC01 BETAMETHASONUM
BELODERM UNGUENT

UNGUENT
0,5mg/g A & G MED TRADING S.R.L.

0,5mg/g

Prescriere limitata:
BETADERM

Tratamentul dermatozelor sensibile la administrarea de corticosteroizi topici.

D07AC01 BETAMETHASONUM
0.1%

CREMA
E.I.P.I.CO. MED S.R.L.

0.1% 0.1%
E.I.P.I.CO. MED S.R.L.

D07AC01 BETAMETHASONUM
BETADERM 0.1%

UNGUENT CREMA
0.5mg ANTIBIOTICE S.A.

D07AC01 BETAMETHASONUM
BETAMETAZONA ANTIBIOTICE 0,5mg/g

0.5mg

Prescriere limitata:

Tratamentul dermatozelor sensibile la administrarea de corticosteroizi topici.

71
MICONAL ECOBI

G01AF04

MICONAZOLUM
CAPS. MOI VAG.
1.2g 200mg 200mg 20mg/g 2mg/ml 400mg FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM G01AF04 MICONAZOLUM


GYNOZOL 200

1.2g 200mg 200mg 20mg/g 2mg/ml 400mg 50mg

CAPS. VAG.
PHARCO IMPEX 93 S.R.L. DAR AL DAWA PHARMA S.R.L FARMACEUTICI ECOBI S.A.S FARMACEUTICI ECOBI S.A.S PHARCO IMPEX 93 S.R.L. FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM
MYCOHEAL 200

SUPOZ. VAG. CREMA VAG. SOL. VAGINALA CAPS. VAG. OVULE


50mg 2% 2%

G01AF04 MICONAZOLUM
MICONAL ECOBI

G01AF04 MICONAZOLUM
MICONAL ECOBI

G01AF04 MICONAZOLUM
GYNOZOL 400

G01AF04 MICONAZOLUM
MICONAL ECOBI

G01AF04 MICONAZOLUM
MEDACTER MYCOHEAL

CREMA VAG.
FARAN LABORATORIES S.A. DAR AL DAWA PHARMA S.R.L.

2%

72

G02AB03

ERGOMETRINUM
SOL. INJ.
0.2mg/ml ZENTIVA S.A.

G02AB03 ERGOMETRINUM
MALEAT DE ERGOMETRINA 0,2 mg/ml

0.2mg/ml

73
NEBIDO 1000 mg/4 ml

G03BA03

TESTOSTERONUM *
SOL. INJ.
1000mg/4ml 300g/24h 300g/24h 300g/24h 300g/24h SCHERING AG

G03BA03 TESTOSTERONUM G03BA03 TESTOSTERONUM


INTRINSA LIVENSA 300g/24h

1000mg/4ml 300g/24h

PLASTURE TRANSDERMIC
PROCTER & GAMBLE PHARMACEUTICALS UK LTD PROCTER & GAMBLE PHARMACEUTICALS GMBH

G03BA03 TESTOSTERONUM
INTRINSA LIVENSA 300g/24h

PLASTURE TRANSDERMIC
PROCTER & GAMBLE PHARMACEUTICALS UK LTD PROCTER & GAMBLE PHARMACEUTICALS GMBH

300g/24h

G03BA03 TESTOSTERONUM
UNDESTOR TESTOCAPS 40mg

CAPS. MOI
ORGANON NV

40mg

Prescriere limitata: Prescriere limitata:

Deficit androgenic la barbatii cu disfunctii hipofizare sau testiculare; Deficit androgenic la barbatii de 40 de ani si peste care nu sunt diagnosticai cu insuficienta hipofizara sau testiculara alta dect cea apruta ca urmare a vrstei, confirmata prin cel puin doua probe de laborator din sngele recoltat in doua dimineti diferite. Deficitul androgenic este confirmat prin nivelul testosteronului mai mic de 8 mmol/l sau cu valori de 8-15 mmol/l si LH crescut ( mai mare de 1,5 ori limita superioara a valorii la brbatul tanar cu funcie normal a gonadelor) Micropenis, inducerea pubertatii sau intarzierea constitutionala a cresterii sau a pubertatii la barbatii sub 18 ani.

Prescriere limitata:
ANDROGEL 50 mg

G03BA03 TESTOSTERONUM
50mg

GEL
LAB. BESINS INTERNATIONAL

50mg

74
OESTROGEL

G03CA03

ESTRADIOLUM *
GEL
0.06% LAB. BESINS INTERNATIONAL

G03CA03 ESTRADIOLUM G03CA03 ESTRADIOLUM


ESTREVA 0.1%

0.06% 0.1%
LAB. THERAMEX

GEL SIST. TERAP. TRANSDERM.


100g/24 ore NOVARTIS PHARMA GMBH

G03CA03 ESTRADIOLUM
ESTRADOT 100

100g/24 ore

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. NOTA: Estradiol trebuie folosit mpreuna cu un progestativ oral la femeile nehisterectomizate..

G03CA03 ESTRADIOLUM
ESTROFEM 1 mg 1mg 25g

COMPR. FILM.
NOVO NORDISK A/S

1mg 25g 25mg

G03CA03 ESTRADIOLUM
VAGIFEM

COMPR. VAG.
NOVO NORDISK A/S

G03CA03 ESTRADIOLUM
RISELLE 25 mg 25mg

IMPLANT
ORGANON NV

G03CA03 ESTRADIOLUM
ESTRADOT 37,5

SIST. TERAP. TRANSDERM.


37.5g/24 ore NOVARTIS PHARMA GMBH

37.5g/24 ore

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. NOTA: Estradiol trebuie folosit mpreuna cu un progestativ oral la femeile nehisterectomizate..

G03CA03 ESTRADIOLUM
ESTRADOT 50

SIST. TERAP. TRANSDERM.


50g/24 ore NOVARTIS PHARMA GMBH

50g/24 ore

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. NOTA: Estradiol trebuie folosit mpreuna cu un progestativ oral la femeile nehisterectomizate..

G03CA03 ESTRADIOLUM

PLASTURE TRANSDERM.

50g/24ore

19 / 233

DCI/DENUMIRE COMERCIALA
CLIMARA

CONCENTRATIE
50g/24ore

FORMA FARM.
SCHERING AG

FIRMA

PROTOCOL

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. NOTA: Estradiol trebuie folosit mpreuna cu un progestativ oral la femeile nehisterectomizate..

G03CA03 ESTRADIOLUM
ESTRADOT 75

SIST. TERAP. TRANSDERM.


75g/24 ore NOVARTIS PHARMA GMBH

75g/24 ore

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. NOTA: Estradiol trebuie folosit mpreuna cu un progestativ oral la femeile nehisterectomizate..

75

G04CAN1

DOXAZOSINUM
COMPR.
1mg 1mg 1mg 1mg 1mg 1mg ALSIFCOM INTERMED SRL MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

G04CAN1 DOXAZOSINUM
ALS-DOXAZOSIN 1 mg DOXAZOSIN 1 MEDOCHEMIE DOXAZOSIN AL 1 KAMIREN MAGUROL ZOXON 1

1mg

G04CAN1 DOXAZOSINUM
ALS-DOXAZOSIN 2 mg ANIPROSIN 2 mg DOXAZOSIN 2 MEDOCHEMIE DOXAZOSIN AL 2 DOXAZOSIN SANDOZ 2 mg KAMIREN MAGUROL ZOXON 2 2mg 2 mg 2mg 2mg 2mg 2mg 2mg 2mg

COMPR.
ALSIFCOM INTERMED SRL OZONE LABORATORIES BV MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG HEXAL AG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

2mg

G04CAN1 DOXAZOSINUM
ANIPROSIN 4 mg DOXAZOSIN 4 MEDOCHEMIE DOXAZOSIN AL 4 KAMIREN MAGUROL ZOXON 4 4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg

COMPR.
OZONE LABORATORIES BV MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

4mg

G04CAN1 DOXAZOSINUM
CARDURA XL 4 mg

COMPR. ELIB. MODIF.


PFIZER H.C.P. CORPORATION

4mg 4mg 1mg

G04CAN1 DOXAZOSINUM
KAMIREN XL 4 mg

COMPR. FILM. ELIB. PREL.


KRKA D.D. NOVO MESTO

G04CAN1 DOXAZOSINUM
ALS-DOXAZOSIN 1 mg DOXAZOSIN 1 MEDOCHEMIE DOXAZOSIN AL 1 DOXAZOSIN ARENA 1 mg KAMIREN MAGUROL ZOXON 1 1mg 1mg 1mg 1mg 1mg 1mg 1mg

COMPR.
ALSIFCOM INTERMED SRL MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG ARENA GROUP S.A. KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

G04CAN1 DOXAZOSINUM
ANIPROSIN 2 mg 2 mg

COMPR.
OZONE LABORATORIES BV

2 mg 2mg
ALSIFCOM INTERMED SRL MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG HEXAL AG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

G04CAN1 DOXAZOSINUM
ALS-DOXAZOSIN 2 mg DOXAZOSIN 2 MEDOCHEMIE DOXAZOSIN AL 2 DOXAZOSIN SANDOZ 2 mg KAMIREN MAGUROL ZOXON 2 2mg 2mg 2mg 2mg 2mg 2mg 2mg

COMPR.

G04CAN1 DOXAZOSINUM
ANIPROSIN 4 mg DOXAZOSIN 4 MEDOCHEMIE DOXAZOSIN AL 4 DOXAZOSIN SANDOZ 4 mg KAMIREN MAGUROL ZOXON 4 4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg

COMPR.
OZONE LABORATORIES BV MEDOCHEMIE ROMANIA SRL ALIUD PHARMA GMBH & CO.KG HEXAL AG KRKA D.D. NOVO MESTO MEDOCHEMIE LTD. ZENTIVA AS

4mg

G04CAN1 DOXAZOSINUM
CARDURA XL 4 mg

COMPR. ELIB. MODIF.


PFIZER H.C.P. CORPORATION

4mg 4mg

G04CAN1 DOXAZOSINUM
KAMIREN XL 4 mg

COMPR. FILM. ELIB. PREL.


KRKA D.D. NOVO MESTO

76
LEMOD SOLU 125 mg

H02AB04

METHYLPREDNISOLONUM
LIOF. PT. SOL. INJ.
125mg 125mg/2ml 20mg 250mg/4ml 40mg 40mg/1ml 500mg 500mg/7.8ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM H02AB04 METHYLPREDNISOLONUM


SOLU - MEDROL ACT-O-VIAL

125mg 125mg/2ml 20mg 250mg/4ml 40mg 40mg/1ml 500mg 500mg/7.8ml

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 20 mg

LIOF. PT. SOL. INJ. LIOF. SI SOLV.PT.SOL.INJ


PFIZER EUROPE MA EEIG HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 40 mg

LIOF. PT. SOL. INJ. LIOF. SI SOLV.PT.SOL.INJ


PFIZER EUROPE MA EEIG HEMOFARM S.R.L. PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 500 mg

LIOF. PT. SOL. INJ. LIOF. + SOLV. PT. SOL. INJ.

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL 500 mg/7,8 ml

77

H02AB07

PREDNISONUM

20 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

FIRMA

PROTOCOL

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg 5mg 5mg 5mg 5mg 5mg

COMPR.

5mg

78

H02AB09

HYDROCORTISONUM *
LIOF. + SOLV. PT. SOL. INJ.
100mg 100mg 25mg/5ml 500mg HEMOFARM S.R.L. E.I.P.I.CO. MED S.R.L.

H02AB09 HYDROCORTISONUM
HYDROCORTISONE 100 mg HYDROCORTISONE SUCCINAT SODIC

100mg

H02AB09 HYDROCORTISONUM
HIDROCORTIZON HEMISUCCINAT

SOL. INJ. I.V.


ZENTIVA S.A.

25mg/5ml 500mg

H02AB09 HYDROCORTISONUM
HYDROCORTISONE 500 mg

LIOF. PT. SOL. INJ. + SOLV.


HEMOFARM S.R.L.

79
J01AA02

J01AA02
DOXYCYCLINUM

DOXYCYCLINUM
CAPS.
100mg 100mg 100mg 100mg 100mg EUROPHARM SA ANTIBIOTICE SA SANDOZ SRL

100mg

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02

DOXYCYCLINUM

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V. PFIZER EUROPE MA EEIG

100mg

UNIDOX SOLUTAB VIBRAMYCIN D

J01AA02

DOXYCYCLINUM

CAPS.
100mg 100mg 100mg 100mg 100mg ARENA GROUP SA ANTIBIOTICE SA SANDOZ SRL

100mg

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02

DOXYCYCLINUM

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V. PFIZER EUROPE MA EEIG

100mg

UNIDOX SOLUTAB VIBRAMYCIN D

J01AA02

DOXYCYCLINUM

CAPS.
100mg 100mg 100mg 100mg 100mg ARENA GROUP SA ANTIBIOTICE SA SANDOZ SRL

100mg

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02

DOXYCYCLINUM

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V. PFIZER EUROPE MA EEIG

100mg

UNIDOX SOLUTAB VIBRAMYCIN D

80
OSPAMOX 1000 mg

J01CA04

AMOXICILLINUM
COMPR. FILM.
1000mg 1000mg 125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml SANDOZ GMBH

J01CA04 AMOXICILLINUM J01CA04 AMOXICILLINUM


OSPAMOX DT 1000 mg

1000mg 1000mg 125mg/5ml

COMPR. FILM. DISPERSABILE


SANDOZ GMBH OZONE LABORATORIES LTD. SANDOZ S.R.L. GULF PHARMACEUTICAL INDUSTRIES S.R.L. SANDOZ GMBH TERAPIA S.A.

J01CA04 AMOXICILLINUM
AMOXICILINA 125 mg/5 ml AMOXICILINA SANDOZ 125 mg/5 ml PULBERE PENTRU SUSPENSIE ORALA JULPHAMOX OSPAMOX 125 mg/5 ml RANOXIL 125 mg/5 ml

PULB. PT. SUSP. ORALA

J01CA04 AMOXICILLINUM
MOXILEN

PULB. SUSP.
MEDOCHEMIE LTD.

125mg/5ml 250mg

J01CA04 AMOXICILLINUM
AMOXICILINA AMOXICILINA SANDOZ 250 mg CAPSULE AMOXICILINA 250 mg AMOXICILINA ANTIBIOTICE 250 mg AMOXICILINA ARENA 250 mg AMOXICILINA FARMEX 250 mg AMOXICILINA MEDICO UNO 250 mg OSPAMOX 250 mg RANOXIL 250 mg

CAPS.
250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml EUROPHARM SA SANDOZ SRL OZONE LABORATORIES LTD. ANTIBIOTICE SA ARENA GROUP SA FARMEX COMPANY SRL MEDICO UNO PHARMACEUTICAL S.R.L. SANDOZ GMBH TERAPIA S.A.

J01CA04 AMOXICILLINUM
AMOXICILINA SANDOZ 250 mg/ 5 ml PULBERE PENTRU SUSPENSIE ORALA AMOXICILINA 250 mg/5 ml E - MOX JULPHAMOX OSPAMOX 250 mg/5 ml RANOXIL 250 mg/5 ml

PULB. PT. SUSP. ORALA


SANDOZ S.R.L. OZONE LABORATORIES LTD. E.I.P.I.CO. MED S.R.L. GULF PHARMACEUTICAL INDUSTRIES S.R.L. SANDOZ GMBH TERAPIA S.A.

250mg/5ml

J01CA04 AMOXICILLINUM
MOXILEN FORTE

PULB. SUSP.
MEDOCHEMIE LTD.

250mg/5ml 500mg

J01CA04 AMOXICILLINUM
AMOXICILINA ANTIBIOTICE 500 mg AMOXICILINA ARENA 500 mg AMOXICILINA FORTE 500 mg AMOXICILINA MEDICO UNO 500 mg AMOXICILINA SANDOZ 500 mg CAPSULE E - MOX EPHAMOX MOXILEN RANOXIL 500 mg

CAPS.
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg ANTIBIOTICE SA ARENA GROUP SA OZONE LABORATORIES LTD. MEDICO UNO PHARMACEUTICAL S.R.L. SANDOZ SRL E.I.P.I.CO. MED S.R.L. EUROPHARM SA MEDOCHEMIE LTD. TERAPIA S.A.

J01CA04 AMOXICILLINUM
OSPAMOX 500 mg

COMPR. FILM.
SANDOZ GMBH

500mg 500mg

J01CA04 AMOXICILLINUM
OSPAMOX DT 500 mg

COMPR. FILM. DISPERSABILE


SANDOZ GMBH

21 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
500mg/5ml 750mg 1000mg 1g 250mg 500mg 750mg

FORMA FARM.
SANDOZ GMBH

FIRMA

PROTOCOL

J01CA04 AMOXICILLINUM
OSPAMOX 500 mg/5 ml

PULB. PT. SUSP. ORALA COMPR. FILM. DISPERSABILE


SANDOZ GMBH

500mg/5ml 750mg 1000mg 1g 250mg 500mg 750mg

J01CA04 AMOXICILLINUM
OSPAMOX DT 750 mg

J01CA04 AMOXICILLINUM
DUOMOX 1000 mg

COMPR. PT. DISPERSIE ORALA


ASTELLAS PHARMA EUROPE BV TERAPIA S.A.

J01CA04 AMOXICILLINUM
RANOXIL 1g

COMPR. PT. DISP. ORALA COMPR. PT. DISPERSIE ORALA


ASTELLAS PHARMA EUROPE BV ASTELLAS PHARMA EUROPE BV ASTELLAS PHARMA EUROPE BV

J01CA04 AMOXICILLINUM
DUOMOX 250 mg

J01CA04 AMOXICILLINUM
DUOMOX 500 mg

COMPR. PT. DISPERSIE ORALA COMPR. PT. DISPERSIE ORALA

J01CA04 AMOXICILLINUM
DUOMOX 750 mg

81

J01CE02

PHENOXYMETHYLPENICILLINUM
COMPR.
1000000ui 1000000ui 1500000ui EUROPHARM SA

J01CE02 PHENOXYMETHYLPENICILLINUM
PENICILINA V 1 000 000 U.I.

1000000ui 1000000ui 1500000ui 400000ui/5ml


SANDOZ GMBH

J01CE02 PHENOXYMETHYLPENICILLINUM
OSPEN 1000

COMPR. FILM.
SANDOZ GMBH SANDOZ GMBH

J01CE02 PHENOXYMETHYLPENICILLINUM
OSPEN 1500

COMPR. FILM. SIROP


400000ui/5ml 500000ui

J01CE02 PHENOXYMETHYLPENICILLINUM
OSPEN 400

J01CE02 PHENOXYMETHYLPENICILLINUM
OSPEN 500

COMPR. FILM.
SANDOZ GMBH

500000ui

82
MOLDAMIN

J01CE08

BENZATHINI BENZYLPENICILLINUM
PULB. PT. SUSP. INJ.
1200000ui 2400000ui 600000ui ANTIBIOTICE SA

J01CE08 BENZATHINI BENZYLPENICILLINUM J01CE08 BENZATHINI BENZYLPENICILLINUM


MOLDAMIN

1200000ui 2400000ui 600000ui

PULB. PT. SUSP. INJ.


ANTIBIOTICE SA ANTIBIOTICE SA

J01CE08 BENZATHINI BENZYLPENICILLINUM


MOLDAMIN

PULB. PT. SUSP. INJ.

83
J01CF04

J01CF04
OXACILLINUM

OXACILLINUM
CAPS.
250mg 250mg 250mg 250mg 250mg FARMACOM SA OZONE LABORATORIES LTD. ARENA GROUP SA FARMEX COMPANY SRL SANDOZ SRL

250mg

OXACILINA OXACILINA 250 mg OXACILINA ARENA 250 mg OXACILINA FARMEX 250 mg OXACILINA SANDOZ 250 mg

J01CF04

OXACILLINUM

CAPS.
500mg 500mg 500mg 500mg 500mg 500mg 500mg 1g 250mg ANTIBIOTICE SA ARENA GROUP SA OZONE LABORATORIES LTD. MARK PHARMACEUTICS SRL SANDOZ SRL EUROPHARM SA

500mg

OXACILINA 500 mg OXACILINA ARENA 500 mg OXACILINA FORTE 500 mg OXACILINA MARK 500 mg OXACILINA SANDOZ 500 mg OXALIN 500 mg

J01CF04 J01CF04 J01CF04

OXACILLINUM OXACILLINUM OXACILLINUM

PULB. PT. SOL. INJ./PERF. I.M./I.V.


ANTIBIOTICE SA

500mg 1g 250mg

OXACILINA ANTIBIOTICE 500 mg OXACILINA ANTIBIOTICE 1 g OXACILINA ANTIBIOTICE 250 mg

PULB. PT. SOL. INJ./PERF.I.M./I.V.


ANTIBIOTICE SA

PULB. PT. SOL. INJ./PERF.I.M./I.V.


ANTIBIOTICE SA

84

J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM


COMPR.
1000mg KRKA D.D. NOVO MESTO

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


BETAKLAV DUO 1000 mg

1000mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 2 x 1000 mg MEDOCLAV 1000 mg

COMPR. FILM.
1000mg 1000mg LEK PHARMACEUTICALS D.D. MEDOCHEMIE LTD.

1000mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AUGMENTIN SR

COMPR. FILM. ELIB. PREL.


1062.5mg BEECHAM GROUP PLC

1062.5mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


FORCID SOLUTAB 125/31,25

COMPR. DISP.
125/31,25mg ASTELLAS PHARMA EUROPE BV

125/31,25mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


MEDOCLAV 156,25 mg/5 ml

PULB. PT. SUSP. ORALA


125mg+31.25/5ml MEDOCHEMIE LTD.

125mg+31.25/5ml

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 156,25mg/5ml BIOCLAVID 156.25mg/5ml

PULB. PT. SUSP. ORALA


156.25mg/5ml 156.25mg/5ml LEK PHARMACEUTICALS D.D. SANDOZ GMBH

156.25mg/5ml

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


FORCID SOLUTAB 250/62,5

COMPR. DISP.
250/62,5mg ASTELLAS PHARMA EUROPE BV

250/62,5mg

22 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


MEDOCLAV 375 mg

COMPR. FILM.
250mg+125mg MEDOCHEMIE LTD.

250mg+125mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


MEDOCLAV FORTE 312,5mg/5ml

PULB. PT. SUSP. ORALA


250mg+62.5mg/5 ml MEDOCHEMIE LTD.

250mg+62.5mg/5 ml 312.5mg/5ml

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


BIOCLAVID 312.5mg/5ml

PULB. PT. SUSP. ORALA


312.5mg/5ml SANDOZ GMBH

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 312.5mg/5ml ENHANCIN 312,5 mg/5 ml

PULB. PT.SUSP. ORALA


312.5mg/5ml 312.5mg/5ml LEK PHARMACEUTICALS D.D. RANBAXY UK LIMITED

312.5mg/5ml

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


FORCID SOLUTAB 375/93,75

COMPR. DISP.
375/93,75mg ASTELLAS PHARMA EUROPE BV

375/93,75mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 2x AUGMENTIN BIS CLAVUMOX DUO

PULB. PT. SUSP. ORALA


400mg+57mg/5ml 400mg+57mg/5ml 400mg+57mg/5ml LEK PHARMACEUTICALS D.D. SMITHKLINE BEECHAM PLC GLAXOSMITHKLINE SRL

400mg+57mg/5ml

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


FORCID SOLUTAB 500/125

COMPR. DISP.
500/125mg ASTELLAS PHARMA EUROPE BV

500/125mg

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AUGMENTIN 625 mg CLAVUMOX DUO 625 mg MEDOCLAV 625 mg

COMPR. FILM.
500mg+125mg 500mg+125mg 500mg+125mg BEECHAM GROUP PLC GLAXOSMITHKLINE SRL MEDOCHEMIE LTD.

500mg+125mg

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


BETAKLAV 625 mg

COMPR.
625mg KRKA D.D. NOVO MESTO

625mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 2 x 625 mg AMOKSIKLAV 625 mg BIOCLAVID 625 mg ENHANCIN 625 mg

COMPR. FILM.
625mg 625mg 625mg 625mg LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. SANDOZ GMBH RANBAXY UK LIMITED

625mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AUGMENTIN ES

PULB. PT. SUSP. ORALA


642.90mg/5ml SMITHKLINE BEECHAM PLC

642.90mg/5ml

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


FORCID SOLUTAB 875/125

COMPR. DISP.
875mg+125mg ASTELLAS PHARMA EUROPE BV

875mg+125mg

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AUGMENTIN 1 g BIOCLAVID 1000 mg CLAVUMOX DUO 1 g

COMPR. FILM.
875mg+125mg 875mg+125mg 875mg+125mg BEECHAM GROUP PLC SANDOZ GMBH GLAXOSMITHKLINE SRL

875mg+125mg

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV QUICKTAB 1000 mg

COMPR. PT. DISPERSIE ORALA/ORODISPERSABILE


1000mg BIOMEDIAL PHARMA S.R.L.

1000mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV QUICKTAB 625 mg

COMPR. PT. DISPERSIE ORALA/ORODISPERSABILE


625mg BIOMEDIAL PHARMA S.R.L.

625mg

85

J01DB01

CEFALEXINUM
COMPR. FILM.
1000mg 1000mg 125mg/5ml 125mg/5ml 125mg/5ml SANDOZ SRL SANDOZ GMBH

J01DB01 CEFALEXINUM
CEFALEXIN SANDOZ 1000 mg COMPRIMATE FILMATE OSPEXIN 1000 mg

1000mg

J01DB01 CEFALEXINUM
CEFALEXIN SANDOZ 125 mg/5 ml GRANULE PENTRU SUSPENSIE ORALA KEFLEX 125 mg/5 ml OSPEXIN 125 mg/5 ml

GRAN. PT. SUSP. ORALA


SANDOZ SRL ACTAVIS GROUP HF SANDOZ GMBH

125mg/5ml

J01DB01 CEFALEXINUM

PULB. PT. SUSP. ORALA

125mg/5ml

23 / 233

DCI/DENUMIRE COMERCIALA
CEFALEXIN 125 mg/5 ml

CONCENTRATIE
125mg/5ml

FORMA FARM.
OZONE LABORATORIES LTD.

FIRMA

PROTOCOL

J01DB01 CEFALEXINUM
CEFALEXIN 250 mg CEFALEXIN SANDOZ 250 mg CAPSULE CEFALEXINA 250 mg CEFALEXINA ARENA 250 mg CEFALEXINA MEDICO UNO 250 mg OSPEXIN 250 mg SPORIDEX 250 mg

CAPS.
250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml OZONE LABORATORIES LTD. SANDOZ SRL ANTIBIOTICE SA ARENA GROUP SA MEDICO UNO PHARMACEUTICAL S.R.L. SANDOZ GMBH TERAPIA S.A.

250mg

J01DB01 CEFALEXINUM
CEFALEXIN SANDOZ 250 mg/5 ml GRANULE PENTRU SUSPENSIE ORALA KEFLEX 250 mg/5 ml OSPEXIN 250 mg/5 ml

GRAN. PT. SUSP. ORALA


SANDOZ SRL ACTAVIS GROUP HF SANDOZ GMBH

250mg/5ml

J01DB01 CEFALEXINUM
CEFALEXIN 250 mg/5 ml

PULB. PT. SUSP. ORALA


OZONE LABORATORIES LTD.

250mg/5ml 500mg

J01DB01 CEFALEXINUM
CEFALEXIN 500 mg CEFALEXIN SANDOZ CEFALEXINA 500 mg CEFALEXINA ARENA 500 mg CEFALEXINA MEDICO UNO 500 mg OSPEXIN 500 mg SPORIDEX 500 mg

CAPS.
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg LEK PHARMATECH SRL SANDOZ S.R.L. ANTIBIOTICE SA ARENA GROUP SA MEDICO UNO PHARMACEUTICAL S.R.L. SANDOZ GMBH TERAPIA S.A.

J01DB01 CEFALEXINUM
CEFALEXIN SANDOZ 500 mg COMPRIMATE FILMATE OSPEXIN 500 mg

COMPR. FILM.
SANDOZ SRL SANDOZ GMBH

500mg

86
CEXYL 1000 mg

J01DB05

CEFADROXILUM
COMPR. FILM.
1000mg 125mg/5ml SANDOZ S.R.L.

J01DB05 CEFADROXILUM J01DB05 CEFADROXILUM


CEXYL 125 mg/5 ml

1000mg 125mg/5ml 250mg

GRAN. PT. SUSP. ORALA


SANDOZ S.R.L. SANDOZ S.R.L.

J01DB05 CEFADROXILUM
CEXYL 250 mg

CAPS.
250mg 250mg/5ml

J01DB05 CEFADROXILUM
CEXYL 250 mg/5 ml

GRAN. SUSP. ORALA


SANDOZ S.R.L.

250mg/5ml 500mg

J01DB05 CEFADROXILUM
CEFADROXIL CEFADROXIL TERAPIA CEFORAN 500 mg CEXYL 500 mg

CAPS.
500mg 500mg 500mg 500mg 500mg/5ml OZONE LABORATORIES LTD. TERAPIA S.A. ANTIBIOTICE SA SANDOZ S.R.L.

J01DB05 CEFADROXILUM
CEXYL 500 mg/5 ml

GRAN. SUSP. ORALA


SANDOZ S.R.L.

500mg/5ml

87
AXYCEF 125

J01DC02

CEFUROXIMUM
COMPR. ACOPERITE
125mg 125mg 125mg/5ml 125mg/5ml 125mg/5ml SANDOZ SRL

J01DC02 CEFUROXIMUM J01DC02 CEFUROXIMUM


ZINNAT 125 mg

125mg 125mg 125mg/5ml

COMPR. FILM.
GLAXOWELLCOME UK LTD. RANBAXY UK LIMITED GLAXO WELLCOME UK LTD.

J01DC02 CEFUROXIMUM
CEROXIM 125mg/5ml ZINNAT

GRAN. PT. SUSP. ORALA

J01DC02 CEFUROXIMUM
AXYCEF 125 mg/5 ml

PULB. PT. SUSP. ORALA


SANDOZ SRL

125mg/5ml 250mg

J01DC02 CEFUROXIMUM
CEFUROXIMA

CAPS.
250mg ARENA GROUP SA

J01DC02 CEFUROXIMUM
CEROXIM 250 mg

COMPR.
250mg 250mg 250mg 250mg/5ml RANBAXY U.K. LIMITED

250mg 250mg 250mg 250mg/5ml 500mg


RANBAXY U.K. LIMITED

J01DC02 CEFUROXIMUM
AXYCEF 250

COMPR. ACOPERITE
SANDOZ SRL GLAXOWELLCOME UK LTD. RANBAXY UK LIMITED

J01DC02 CEFUROXIMUM
ZINNAT 250 mg

COMPR. FILM. GRAN. PT. SUSP. ORALA COMPR.


500mg 500mg 500mg 1.5g 1.5g 1.5g 1.5g 1.5mg 1500mg

J01DC02 CEFUROXIMUM
CEROXIM 250mg/5ml

J01DC02 CEFUROXIMUM
CEROXIM 500 mg

J01DC02 CEFUROXIMUM
AXYCEF 500

COMPR. ACOPERITE
SANDOZ SRL

500mg 500mg 1.5g 1.5g 1.5g 1.5g 1.5mg 1500mg

J01DC02 CEFUROXIMUM
ZINNAT 500 mg

COMPR. FILM.
GLAXOWELLCOME UK LTD. GLAXO OPERATIONS UK LTD.

J01DC02 CEFUROXIMUM
ZINACEF 1,5 g

PULB. PT. SOL. INJ. PULB. PT. SOL. INJ. I.V.


TEVA PHARMACEUTICALS SRL

J01DC02 CEFUROXIMUM
CEFUROXIME TEVA 1,5 g

J01DC02 CEFUROXIMUM
AXETINE 1,5 g

PULB. PT. SOL. INJ. I.V./PERF.


MEDOCHEMIE LTD.

J01DC02 CEFUROXIMUM
CEFUROXIME PANPHARMA 1,5 g

PULB. PT. SOL. PERF. I.V.


PANPHARMA

J01DC02 CEFUROXIMUM
CEFUROXIMA ANTIBIOTICE 1,5mg

PULB. PT. SUSP. (I.M)/SOL. INJ. ( I.M.,I.V.)


ANTIBIOTICE S.A.

J01DC02 CEFUROXIMUM
CEFUROXIME SANDOZ 1500 mg

PULB. PT. SOL. INJ. I.V./PERF.


SANDOZ GMBH

24 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
250mg 750mg 750mg 750mg 750mg 750mg 750mg

FORMA FARM.
MEDOCHEMIE LTD.

FIRMA

PROTOCOL

J01DC02 CEFUROXIMUM
AXETINE 250 mg

PULB. PT. SUSP. INJ. SAU SOL. INJ. I.M./I.V. PULB. PT. SOL. INJ.
GLAXO OPERATIONS UK LTD.

250mg 750mg 750mg 750mg

J01DC02 CEFUROXIMUM
ZINACEF 750 mg

J01DC02 CEFUROXIMUM
CEFUROXIME SANDOZ 750 mg

PULB. PT. SOL. INJ. I.M./I.V.


SANDOZ GMBH PANPHARMA TEVA PHARMACEUTICALS SRL

J01DC02 CEFUROXIMUM
CEFUROXIME PANPHARMA 750 mg CEFUROXIME TEVA 750 mg

PULB. PT. SOL./SUSP. INJ. IV/IM

J01DC02 CEFUROXIMUM
CEFUROXIMA ANTIBIOTICE 750mg

PULB. PT. SUSP. (I.M)/SOL. INJ. ( I.M.,I.V.)


ANTIBIOTICE S.A.

750mg 750mg

J01DC02 CEFUROXIMUM
AXETINE 750 mg

PULB. PT. SUSP. INJ. SAU SOL. INJ. I.M./I.V.


MEDOCHEMIE LTD.

88

J01DC04

CEFACLORUM
GRAN. PT. SUSP. ORALA
125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml SANDOZ SRL ACTAVIS GROUP HF OZONE LABORATORIES LTD. TERAPIA S.A.

J01DC04 CEFACLORUM
CECLODYNE 125 mg/5 ml CECLOR 125 mg/5 ml CEFACLOR 125 mg/5ml VERCEF 125 mg/5 ml

125mg/5ml

Reactii asemanatoare bolii serului au fost raportate la utilizarea acestui medicament, in special de catre copii

J01DC04 CEFACLORUM
CEFAKLOR 125 mg/5 ml CLORACEF 125

PULB. PT. SUSP. ORALA


125mg/5ml 125mg/5ml HEMOFARM S.R.L. DAR AL DAWA PHARMA S.R.L

125mg/5ml

Reactii asemanatoare bolii serului au fost raportate la utilizarea acestui medicament, in special de catre copii

J01DC04 CEFACLORUM
VERCEF 250 mg/5 ml

GRAN. PT. SUSP. ORALA


250 mg/5 ml TERAPIA S.A.

250 mg/5 ml

Reactii asemanatoare bolii serului au fost raportate la utilizarea acestui medicament, in special de catre copii

J01DC04 CEFACLORUM
CECLODYNE 250 mg CEFACLOR 250 mg CLORACEF 250 MEDOCLOR 250 VERCEF 250 mg

CAPS.
250mg 250mg 250mg 250mg 250mg 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml 250mg/5ml 375mg 375mg 375mg SANDOZ SRL OZONE LABORATORIES LTD. DAR AL DAWA PHARMA S.R.L MEDOCHEMIE LTD. TERAPIA S.A.

250mg

J01DC04 CEFACLORUM
CECLODYNE 250 mg/ 5 ml CECLOR 250 mg/5 ml CEFACLOR 250 mg/5ml

GRAN. PT. SUSP. ORALA


SANDOZ SRL ACTAVIS GROUP HF OZONE LABORATORIES LTD.

250mg/5ml

J01DC04 CEFACLORUM
CEC HEXAL FORTE 250mg/5ml CEFAKLOR 250 mg/5 ml CLORACEF 250

PULB. PT. SUSP. ORALA


HEXAL AG HEMOFARM S.R.L. DAR AL DAWA PHARMA S.R.L

250mg/5ml

J01DC04 CEFACLORUM
CECLOR MR CECLOZONE MR 375 mg VERCEF MR 375

COMPR. ELIB. PREL.


ACTAVIS GROUP HF OZONE LABORATORIES LTD. TERAPIA S.A.

375mg

Reactii asemanatoare bolii serului au fost raportate la utilizarea acestui medicament, in special de catre copii

J01DC04 CEFACLORUM
CECLODYNE MR 375 mg

COMPR. FILM. ELIB. MODIF.


375mg SANDOZ SRL

375mg

Reactii asemanatoare bolii serului au fost raportate la utilizarea acestui medicament, in special de catre copii

J01DC04 CEFACLORUM
CECLODYNE FORTE 500 mg CEFACLOR 500 mg CLORACEF FORTE 500 MEDOCLOR 500 VERCEF 500 mg

CAPS.
500mg 500mg 500mg 500mg 500mg 500mg 500mg 750mg 750mg 750mg 750mg SANDOZ SRL OZONE LABORATORIES LTD. DAR AL DAWA PHARMA S.R.L MEDOCHEMIE LTD. TERAPIA S.A.

500mg

J01DC04 CEFACLORUM
CECLOR MR

COMPR. ELIB. PREL.


ACTAVIS GROUP HF

500mg 500mg 750mg

J01DC04 CEFACLORUM
CECLODYNE MR 500 mg

COMPR. FILM. ELIB. MODIF.


SANDOZ SRL ACTAVIS GROUP HF OZONE LABORATORIES LTD. TERAPIA S.A.

J01DC04 CEFACLORUM
CECLOR MR CECLOZONE MR 750 mg VERCEF MR 750

COMPR. ELIB. PREL.

J01DC04 CEFACLORUM
CECLODYNE MR 750 mg

COMPR. FILM. ELIB. MODIF.


SANDOZ SRL

750mg

89
SUPRAX

J01DD08

CEFIXIMUM
GRAN. PT. SUSP. ORALA
100mg/5ml GEDEON RICHTER LTD.

J01DD08 CEFIXIMUM J01DD08 CEFIXIMUM


EFICEF 200 mg

100mg/5ml 200mg

CAPS.
200mg 200mg ANTIBIOTICE SA

J01DD08 CEFIXIMUM
SUPRAX

COMPR. FILM.
GEDEON RICHTER LTD.

200mg

90
J01EE01
EPITRIM

J01EE01
SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM
SUSP. ORALA
200mg/40mg /5ml E.I.P.I.CO. MED S.R.L.

200mg/40mg /5ml

Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.

J01EE01
SUMETROLIM

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SIROP
25mg/5mg/ml EGIS PHARMACEUTICALS P.L.C.

25mg/5mg/ml

25 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

J01EE01
BISEPTRIM CO - TRIM ELL SUMETROLIM TAGREMIN

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

COMPR.
400mg/80mg 400mg/80mg 400mg/80mg 400mg/80mg EUROPHARM SA ARENA GROUP S.A. EGIS PHARMACEUTICALS P.L.C. ZENTIVA S.A.

400mg/80mg

Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.

J01EE01
SEPTRIN

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SOL. PERF.
400mg/80mg THE WELLCOME FOUNDATION LTD.

400mg/80mg

91
J01FA01

J01FA01
ERYTHROMYCINUM

ERYTHROMYCINUM
COMPR.
200mg 200mg 200mg 200mg 200mg/5ml ARENA GROUP SA ANTIBIOTICE SA EUROPHARM SA SANDOZ S.R.L.

200mg

ERITROMAGIS 200 mg ERITROMICINA 200 mg ERITROMICINA EUROPHARM 200 mg ERITROMICINA SANDOZ 200 mg COMPRIMATE

J01FA01
ERITRO 200

ERYTHROMYCINUM

PULB. PT. SUSP. ORALA


LEK PHARMATECH SRL

200mg/5ml

92
J01FA09

J01FA09
CLARITHROMYCINUM

CLARITHROMYCINUM
GRAN. PT. SUSP. ORALA
125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg/5ml 250mg/5ml 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg KRKA D.D. TERAPIA S.A. ABBOTT SPA SANDOZ S.R.L.

125mg/5ml

FROMILID 125 mg/5 ml KLABAX 125 mg/5 ml KLACID LEKOKLAR 125 mg/5 ml

J01FA09

CLARITHROMYCINUM

COMPR. FILM.
MEDICAROM GROUP S.R.L. HEXAL AG OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT SPA MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

250mg

CLAR 250 CLARITROMICIN HEXAL 250 CLARITROMICINA 250 mg FROMILID 250 KLABAX 250 mg KLACID KLERIMED 250 LEKOKLAR 250 mg

J01FA09

CLARITHROMYCINUM

GRAN. PT. SUSP. ORALA


TERAPIA S.A. SANDOZ SRL

250mg/5ml

KLABAX 250 mg/5 ml LEKOKLAR 250 mg/5 ml

J01FA09

CLARITHROMYCINUM

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT LABORATORIES LTD. MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

500mg

CLAR 500 CLARITROMICINA 500 mg FROMILID 500 KLABAX 500 mg KLACID 500 mg KLERIMED 500 LEKOKLAR 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. MODIF.


TERAPIA S.A. LEK PHARMACEUTICALS D.D.

500mg

KLABAX MR 500 mg LEKOKLAR XL 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. PREL.


KRKA D.D. ABBOTT LABORATORIES LTD.

500mg

FROMILID UNO KLACID SR

J01FA09
KLACID I.V.

CLARITHROMYCINUM

LIOF. PT. SOL. PERF.


ABBOTT LABORATORIES LTD.

500mg

93
OFLOXACIN 200 mg OFLOXIN 200 ZANOCIN

J01MA01

OFLOXACINUM
COMPR. FILM.
200mg 200mg 200mg 400mg ANTIBIOTICE SA ZENTIVA AS RANBAXY UK LIMITED

J01MA01 OFLOXACINUM

200mg

J01MA01 OFLOXACINUM
ZANOCIN OD 400

COMPR. FILM. ELIB. PREL.


RANBAXY U.K. LIMITED

400mg

94

J01MA02

CIPROFLOXACINUM
COMPR. FILM. ELIB. PREL.
1000 mg BAYER HEALTHCARE AG

J01MA02 CIPROFLOXACINUM
CIPROBAY XR 1000 mg

1000 mg 250mg

J01MA02 CIPROFLOXACINUM
EUCIPRIN

CAPS.
250mg EUROPHARM SA

J01MA02 CIPROFLOXACINUM
LOXACIL 250 mg

COMPR.
250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 500 mg TERAPIA SA

250mg 250mg

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 250 CIPRINOL 250 mg CIPROCIN 250 mg CIPROFLOXACIN 250 mg CIPROFLOXACINA ALKALOID 250 mg CIPROLEN 250 mg CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg SERVIFLOX 250 mg

COMPR. FILM.
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO E.I.P.I.CO. MED S.R.L. LAROPHARM SRL ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SANDOZ GMBH

J01MA02 CIPROFLOXACINUM
CIPROBAY XR 500 mg

COMPR. FILM. ELIB. PREL.


BAYER HEALTHCARE AG

500 mg 500mg

J01MA02 CIPROFLOXACINUM
LOXACIL 500 mg

COMPR.
500mg TERAPIA S.A.

J01MA02 CIPROFLOXACINUM

COMPR. FILM.

500mg

26 / 233

DCI/DENUMIRE COMERCIALA
CIFRAN CIPHIN 500 CIPRINOL 500 mg CIPRO QUIN CIPROBAY 500 CIPROCIN 500 mg CIPRODAR CIPROFLOXACINA ALKALOID 500 mg CIPROLEN 500 mg CIPROLET 500 mg CIPROZONE FORTE 500 mg CUMINOL 500 mg SERVIFLOX 500 mg SIFLOKS

CONCENTRATIE
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 50mg/ml 50mg/ml 750mg

FORMA FARM.

FIRMA

PROTOCOL

RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO ANTIBIOTICE SA BAYER HEALTHCARE AG E.I.P.I.CO. MED S.R.L. DAR AL DAWA PHARMA S.R.L ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SANDOZ GMBH ECZACIBASI ILAC SANAYI VE TICARET AS

J01MA02 CIPROFLOXACINUM
CIPROXIN 10% CIPROXIN 5%

MICROCAPS. + DIL.
BAYER AG PHARMA DEUTSCHLAND BAYER AG PHARMA DEUTSCHLAND

50mg/ml

J01MA02 CIPROFLOXACINUM
CIPRINOL 750 mg

COMPR. FILM.
KRKA D.D. NOVO MESTO

750mg

95

J01MA03

PEFLOXACINUM
COMPR. FILM.
400mg 400mg LEK PHARMACEUTICALS D.D. LAROPHARM S.R.L.

J01MA03 PEFLOXACINUM
ABAKTAL PEFLOXACIN LAROPHARM

400mg

96
NORFLOXACINA - 400

J01MA06
Prescriere limitata: Prescriere limitata:

NORFLOXACINUM
CAPS.
400mg ARENA GROUP SA

J01MA06 NORFLOXACINUM
Enterocolita bacteriana acuta Infectii de tract urinar.

400mg

J01MA06 NORFLOXACINUM
EPINOR H - NORFLOXACIN 400 mg NOLICIN 400 mg NORFLOX - 400 NORFLOXACIN 400 mg NORFLOXACIN OZONE 400 mg NORFLOXACINA LPH 400 mg NORFLOXACINA TERAPIA 400 mg

COMPR. FILM.
400mg 400mg 400mg 400mg 400mg 400mg 400mg 400mg E.I.P.I.CO. MED S.R.L. AC HELCOR SRL KRKA D.D. NOVO MESTO LEK PHARMATECH SRL OZONE LABORATORIES LTD. OZONE LABORATORIES LTD. LABORMED PHARMA SA TERAPIA S.A.

400mg

Prescriere limitata: Prescriere limitata:

Enterocolita bacteriana acuta Infectii de tract urinar.

97
NALIXID 500 mg

J01MB02

ACIDUM NALIDIXICUM
CAPS.
500mg ZENTIVA SA

J01MB02 ACIDUM NALIDIXICUM

500mg

98

J01XD01

METRONIDAZOLUM
COMPR.
250mg 250mg 250mg ARENA GROUP SA ARENA GROUP SA

J01XD01 METRONIDAZOLUM
METRONIDAZOL 250 mg (J01XD01) METRONIDAZOL 250 mg (P01AB1)

250mg

J01XD01 METRONIDAZOLUM
FLAGYL

COMPR. FILM.
LABORATOIRE AVENTIS

250mg 250mg

J01XD01 METRONIDAZOLUM
METRONIDAZOL 250 mg (J01XD01) METRONIDAZOL 250 mg (P01AB1)

COMPR.
250mg 250mg 250mg ARENA GROUP SA ARENA GROUP SA

J01XD01 METRONIDAZOLUM
FLAGYL

COMPR. FILM.
LABORATOIRE AVENTIS

250mg

Prescriere limitata:
FLAGYL 4 % (J01XD01) FLAGYL 4% (P01AB01)

Tratamentul infectiilor cu anaerobi

J01XD01 METRONIDAZOLUM
4% 4%

SUSP. ORALA
LABORATOIRE AVENTIS LABORATOIRE AVENTIS

4%

99

J01XD02

TINIDAZOLUM
COMPR. FILM.
500mg 500mg 500mg 500mg 500mg PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG ZENTIVA S.A. ZENTIVA S.A. AC HELCOR SRL

J01XD02 TINIDAZOLUM
FASIGYN (J01XD02) FASIGYN (P01AB02) TINIZOL 500 mg (J01XD02) TINIZOL 500 mg (P01AB02) TIPROGYN 500

500mg

J01XD02 TINIDAZOLUM
TINIZOL 2 g/l 0.2%

SOL. PERF.
INFOMED FLUIDS SRL

0.2% 500mg

J01XD02 TINIDAZOLUM
FASIGYN (J01XD02) FASIGYN (P01AB02) TINIZOL 500 mg (J01XD02) TINIZOL 500 mg (P01AB02) TIPROGYN 500

COMPR. FILM.
500mg 500mg 500mg 500mg 500mg PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG ZENTIVA S.A. ZENTIVA S.A. AC HELCOR SRL

100
J02AB02

J02AB02
KETOCONAZOLUM

KETOCONAZOLUM
COMPR.
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg ANTIBIOTICE SA MAGISTRA C & C FABIOL S.A. FARMEX COMPANY SRL OZONE LABORATORIES LTD. AC HELCOR SRL MEDUMAN S.A. JANSSEN PHARMACEUTICA NV TERAPIA SA

200mg

KEFUNGIN KETOCONAZOL 200 mg KETOCONAZOL FABIOL 200 mg KETOCONAZOL FARMEX 200 mg KETOCONAZOL OZONE 200 mg KETOSTIN 200 mg N - KETOCONAZOL 200 mg NIZORAL NIZORAL 200 mg

27 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Prescriere limitata: Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade. A fost raportat hepatotoxicitate la ketoconazol.

J02AB02

KETOCONAZOLUM

COMPR.
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg ANTIBIOTICE SA MAGISTRA C & C FABIOL S.A. FARMEX COMPANY SRL OZONE LABORATORIES LTD. AC HELCOR SRL MEDUMAN S.A. JANSSEN PHARMACEUTICA NV TERAPIA SA

200mg

KEFUNGIN KETOCONAZOL 200 mg KETOCONAZOL FABIOL 200 mg KETOCONAZOL FARMEX 200 mg KETOCONAZOL OZONE 200 mg KETOSTIN 200 mg N - KETOCONAZOL 200 mg NIZORAL NIZORAL 200 mg

Prescriere limitata: Candidoza orala la persoanele imunocompromise sever la care tratamentul local nu a avut rezultate Prescriere limitata: Micoze sistemice la care alte forme de terapie antifungica nu au avut efect. A fost raportat hepatotoxicitate la ketoconazol.

101

J02AC01

FLUCONAZOLUM
CAPS.
100mg 100mg 100mg 100mg 100mg 100mg 100mg KRKA D.D. OZONE LABORATORIES LTD. LINCOSA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

J02AC01 FLUCONAZOLUM
DIFLAZON 100 mg FLUCONAZOL 100 mg FLUCONAZOLE LINCOSA 100mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

100mg

J02AC01 FLUCONAZOLUM
DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL BIOGALENICA 150 mg FLUCONAZOL LAROPHARM 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCONIMED 150 mg FLUCORIC 150 mg FLUCOVIM 150 MEDOFLUCON 150 mg MYCOMAX 150

CAPS.
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. LAROPHARM S.R.L. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL MEDOCHEMIE LTD. ZENTIVA AS

150mg

J02AC01 FLUCONAZOLUM
DIFLAZON 200 mg FLUCONAZOLE LINCOSA 200 mg FLUCONAZOLE TEVA 200 mg

CAPS.
200mg 200mg 200mg KRKA D.D. LICONSA S.A. TEVA PHARMACEUTICALS SRL

200mg

J02AC01 FLUCONAZOLUM
DIFLAZON DIFLUCAN FLUCONAZOL BIOGALENICA 2mg/ml MYCOMAX INF

SOL. PERF.
2mg/ml 2mg/ml 2mg/ml 2mg/ml KRKA D.D. PFIZER EUROPE MA EEIG LABORATOARELE PROF.DR.MORAIT S.R.L. ZENTIVA AS

2mg/ml

J02AC01 FLUCONAZOLUM
DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL BIOGALENICA 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCONIMED 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg MEDOFLUCON 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD MEDOCHEMIE LTD

50mg

J02AC01 FLUCONAZOLUM
DIFLUCAN 50 mg/5 ml

PULB. PT. SUSP. ORALA


50mg/5ml PFIZER EUROPE MA EEIG

50mg/5ml

102
J05AB01
ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01
ACICLOVIRUM

ACICLOVIRUM
CAPS.
200mg 200mg ARENA GROUP SA EUROPHARM SA

200mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR.
200mg 200mg 200mg 200mg GEDEON RICHTER ROMANIA SA ALSIFCOM INTERMED SRL ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

200mg

ACICLOVIR 200 mg ALS-ACICLOVIR CLOVIRAL 200 mg ZOVIRAX

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR. DISP.
200mg 200mg OZONE LABORATORIES LTD. RANBAXY UK LIMITED

200mg

ACICLOVIR 200 mg LOVIR 200 mg

28 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01
VIROLEX

ACICLOVIRUM ACICLOVIRUM

PULB. PT. SOL. INJ./PERF.


250mg KRKA D.D. NOVO MESTO

250mg 400mg

J05AB01

CAPS.
400mg ARENA GROUP S.A.

ACICLOVIR 400 mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

J05AB01

ACICLOVIRUM

COMPR.
400mg EGIS PHARMACEUTICALS P.L.C.

400mg

ACICLOVIR 400 mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

J05AB01
ACIKLOVIR

ACICLOVIRUM

COMPR. FILM.
400mg A & G MED TRADING S.R.L.

400mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

103
ROGLUTEN 250 mg

L02BG01

AMINOGLUTETHIMIDUM
COMPR.
250mg ACTAVIS S.R.L.

L02BG01 AMINOGLUTETHIMIDUM

250mg

104
INDOMETACIN 25 mg

M01AB01
Prescriere limitata: Prescriere limitata:

INDOMETACINUM
CAPS.
25mg LAROPHARM SRL

M01AB01 INDOMETACINUM

25mg

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB01 INDOMETACINUM
INDOMETACIN 50 mg 50mg

CAPS.
ARENA GROUP SA

50mg 50mg
MAGISTRA C & C

M01AB01 INDOMETACINUM
INDOMETACIN 50 mg 50mg

SUPOZ.

105
DICLOTARD 100 mg REFEN RETARD VOLTAREN RETARD

M01AB05

DICLOFENACUM
COMPR. FILM. ELIB. PREL.
100mg 100mg 100mg TERAPIA SA HEMOFARM S.R.L. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM

100mg

M01AB05 DICLOFENACUM
CLAFEN 100 mg DICLOFENAC 100 mg DICLOFENAC SODIC 100 mg DICLOGESIC 100 SUPOZITOARE EPIFENAC VOLTAREN

SUPOZ.
100mg 100mg 100mg 100mg 100mg 100mg 12.5mg ANTIBIOTICE SA SINTOFARM SA MAGISTRA C & C DAR AL DAWA PHARMA SRL E.I.P.I.CO. MED S.R.L. NOVARTIS PHARMA GMBH

100mg

M01AB05 DICLOFENACUM
VOLTAREN DOLO

COMPR. FILM.
NOVARTIS CONSUMER HEALTH GMBH

12.5mg 12.5mg

M01AB05 DICLOFENACUM
DICLOGESIC 12,5 SUPOZITOARE

SUPOZ.
12.5mg DAR AL DAWA PHARMA S.R.L

M01AB05 DICLOFENACUM
TRATUL 120

SUPOZ.
120mg 150mg 25mg 25mg GEROT PHARMAZEUTIKA GMBH

120mg 150mg 25mg

M01AB05 DICLOFENACUM
DICLOREUM 150 mg

CAPS. ELIB. PREL.


ALFA WASSERMANN SPA FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
RHEUMAVEK VOLTAREN 25

COMPR. FILM. GASTROREZ.

Prescriere limitata: Prescriere limitata:


EPIFENAC

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
25mg

COMPR. GASTROREZ.
E.I.P.I.CO. MED S.R.L.

25mg

Prescriere limitata: Prescriere limitata:


DICLOFENAC 25 mg

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
25mg

DRAJ. GASTROREZ.
ARENA GROUP SA

25mg

Prescriere limitata: Prescriere limitata:


REFEN RHEUMAVEK VOLTAREN

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM

SOL. INJ.
25mg/ml 25mg/ml 25mg/ml HEMOFARM S.R.L. FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

25mg/ml

M01AB05 DICLOFENACUM
TRATUL

SOL. INJ.
30mg/ml 50mg GEROT PHARMAZEUTIKA GMBH

30mg/ml 50mg

M01AB05 DICLOFENACUM
TRATUL 50

CAPS. GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

Prescriere limitata: Prescriere limitata:


CLAFEN 50 mg DICLOFENAC 50 mg

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
50mg 50mg 50mg 50mg

COMPR. FILM. GASTROREZ.


ANTIBIOTICE SA TERAPIA SA DAR AL DAWA PHARMA S.R.L NOVARTIS PHARMA GMBH

50mg

DICLOGESIC 50 COMPRIMATE FILMATE GASTROREZISTENTE VOLTAREN 50

Prescriere limitata: Prescriere limitata:

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

29 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
NOVARTIS PHARMA GMBH

FIRMA

PROTOCOL

M01AB05 DICLOFENACUM
VOLTAREN RAPID 50mg

DRAJ.

50mg

Prescriere limitata: Prescriere limitata:


DICLOFENAC 50 mg N - DICLOFENAC

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
50mg 50mg

DRAJ. GASTROREZ.
ARENA GROUP SA MEDUMAN SA

50mg

Prescriere limitata: Prescriere limitata:


VOLTAREN

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
50mg

SUPOZ.
NOVARTIS PHARMA GMBH

50mg 60mg
GEROT PHARMAZEUTIKA GMBH

M01AB05 DICLOFENACUM
TRATUL 60 60mg 75mg 75mg

SUPOZ. CAPS. ELIB. PREL.


BRISTOL-MYERS SQUIBB KFT.

M01AB05 DICLOFENACUM
DICLOFENAC DUO BMS 75 mg

75mg 75mg 75mg

M01AB05 DICLOFENACUM
DICLAC 75 ID

COMPR. ELIB. MODIF.


HEXAL AG

M01AB05 DICLOFENACUM
DICLAC VURDON 75mg 75mg

SOL. INJ.
HEXAL AG HELP S.A. PHARMACEUTICALS

M01AB05 DICLOFENACUM
ALMIRAL DICLOFENAC 75 mg DICLOFENAC AL I.M.

SOL. INJ.
75mg/3ml 75mg/3ml 75mg/3ml MEDOCHEMIE LTD. TERAPIA SA ALIUD PHARMA GMBH & CO.KG

75mg/3ml

106
KETANOV 10 mg KETOROL

M01AB15

KETOROLACUM TROMETHAMIN
COMPR. FILM.
10mg 10mg TERAPIA S.A. DR. REDDY'S LABORATORIES

M01AB15 KETOROLACUM TROMETHAMIN

10mg

M01AB15 KETOROLACUM TROMETHAMIN


KETANOV KETOROL

SOL. INJ.
30mg/ml 30mg/ml TERAPIA S.A. DR. REDDY'S LABORATORIES

30mg/ml

107
AFLAMIL

M01AB16
Prescriere limitata: Prescriere limitata:

ACECLOFENACUM
COMPR. FILM.
100mg GEDEON RICHTER PLC.

M01AB16 ACECLOFENACUM

100mg

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

108

M01AC02

TENOXICAMUM
CAPS.
20mg 20mg LAROPHARM SRL LABORMED PHARMA SA

M01AC02 TENOXICAMUM
TENOXICAM 20 mg TENOXICAM LPH 20 mg

20mg

Prescriere limitata:
TENOXICAM 20 mg

Tratamentul simptomatic al osteoartritelor.

M01AC02 TENOXICAMUM
20mg

COMPR.
ARENA GROUP SA

20mg

Prescriere limitata:
NEO - ENDUSIX TILCOTIL

Tratamentul simptomatic al osteoartritelor.

M01AC02 TENOXICAMUM
20mg 20mg

COMPR. FILM.
ANFARM HELLAS S.A. PHARMACEUTICALS ROCHE ROMANIA S.R.L.

20mg

Prescriere limitata:
NEO - ENDUSIX

Tratamentul simptomatic al osteoartritelor.

M01AC02 TENOXICAMUM
20mg 20mg

LIOF. + SOLV. PT. SOL. INJ.


ANFARM HELLAS S.A. PHARMACEUTICALS

20mg 20mg

M01AC02 TENOXICAMUM
TILCOTIL

LIOF. SI SOLV.PT.SOL.INJ
ROCHE ROMANIA S.R.L.

109

M01AC06

MELOXICAMUM
COMPR.
15mg 15mg 15mg 15mg 15mg 15mg 15mg 15mg 15mg 15mg 15mg 15mg ACTAVIS GROUP HF. TERAPIA SA MEDOCHEMIE LTD VIM SPECTRUM SRL LABORMED PHARMA SA MAGISTRA C & C SRL PHARMACEUTICAL WORKS POLPHARMA SA HEXAL AG BOEHRINGER INGELHEIM INT. GMBH RANBAXY UK LTD. ZENTIVA AS GEDEON RICHTER ROMANIA S.A.

M01AC06 MELOXICAMUM
CELOMIX MELARTRIN 15 mg MELOX 15 mg MELOXICAM 15 mg MELOXICAM LPH 15 mg MELOXICAM MCC 15 mg MELOXICAM POLPHARMA 15 mg MELOXICAM SANDOZ 15 mg MOVALIS 15 mg MOXCIPAM 15 mg RECOXA 15 VALZER 15 mg

15mg

Prescriere limitata:
MELOXICAM 15 mg MOVALIS 15 mg

Tratamentul simptomatic al osteoartritelor.

M01AC06 MELOXICAMUM
15mg 15mg

SUPOZ.
MAGISTRA C & C BOEHRINGER INGELHEIM INT. GMBH

15mg

M01AC06 MELOXICAMUM
MOVALIS

SOL. INJ.
15mg/1.5ml BOEHRINGER INGELHEIM INT. GMBH

15mg/1.5ml 7,5mg
GEDEON RICHTER ROMANIA S.A.

M01AC06 MELOXICAMUM
VALZER 7,5mg 7,5mg

COMPR.

Prescriere limitata:
MELOX 7,5 mg

Tratamentul simptomatic al osteoartritelor.

M01AC06 MELOXICAMUM
Prescriere limitata:
MELOXICAM 7,5 mg MELOXICAM LPH 7,5 mg

COMPR.
7.5 mg MEDOCHEMIE LTD

7.5 mg

Tratamentul simptomatic al osteoartritelor.

M01AC06 MELOXICAMUM
7.5mg 7.5mg

COMPR.
VIM SPECTRUM SRL LABORMED PHARMA SA

7.5mg

30 / 233

DCI/DENUMIRE COMERCIALA
MELOXICAM MCC 7,5 mg MELOXICAM POLPHARMA 7,5 mg MELOXICAM SANDOZ 7,5 mg MOVALIS 7,5 mg MOXCIPAM 7,5 mg RECOXA 7,5

CONCENTRATIE
7.5mg 7.5mg 7.5mg 7.5mg 7.5mg 7.5mg

FORMA FARM.

FIRMA

PROTOCOL

MAGISTRA C & C SRL PHARMACEUTICAL WORKS POLPHARMA SA HEXAL AG BOEHRINGER INGELHEIM INT. GMBH RANBAXY UK LTD. ZENTIVA AS

Prescriere limitata:
MELOXICAM 7,5 mg MOVALIS

Tratamentul simptomatic al osteoartritelor.

M01AC06 MELOXICAMUM
7.5mg 7.5mg

SUPOZ.
MAGISTRA C & C BOEHRINGER INGELHEIM INTERNATIONAL GMBH

7.5mg

110
RUBIFEN 100 mg

M01AE03

KETOPROFENUM
COMPR. FILM.
100 mg 100mg 100mg 100mg 100mg 100mg ANTIBIOTICE SA

M01AE03 KETOPROFENUM M01AE03 KETOPROFENUM


KETOPROFEN SR 100 mg

100 mg 100mg 100mg

CAPS. ELIB. PREL.


TERAPIA SA LEK PHARMACEUTICALS D.D. AC HELCOR PHARMA SRL LAB. AVENTIS

M01AE03 KETOPROFENUM
KETONAL FORTE 100 mg KETOPROXIN 100 mg PROFENID 100 mg

COMPR. FILM.

M01AE03 KETOPROFENUM
PROFENID 100 mg

LIOF. + SOLV. PT. SOL. INJ.


LAB. AVENTIS

100mg 100mg

M01AE03 KETOPROFENUM
KETOMAG KETONAL 100 mg RUBIFEN 100 mg

SUPOZ.
100mg 100mg 100mg MAGISTRA C & C LEK PHARMACEUTICALS D.D. ANTIBIOTICE SA

M01AE03 KETOPROFENUM
KETONAL 100 mg/ 2 ml

SOL. INJ.
100mg/2ml 100mg/2ml 150mg 150mg 200mg 200mg 200mg LEK PHARMACEUTICALS D.D.

100mg/2ml 100mg/2ml 150mg 150mg 200mg

M01AE03 KETOPROFENUM
KETOPROFEN 100mg/2ml

SOL. INJ./CONC. SOL. PERF.


TERAPIA SA SANDOZ S.R.L. LEK PHARMACEUTICALS D.D. NOVIA FARM SOLUTIONS SRL SANDOZ S.R.L. TERAPIA SA

M01AE03 KETOPROFENUM
KETONAL DUO 150 mg

CAPS. ELIB. PREL. COMPR. ELIB. PREL. CAPS. ELIB. PREL.

M01AE03 KETOPROFENUM
KETONAL RETARD

M01AE03 KETOPROFENUM
KETALGON 200 mg KETONAL UNO KETOPROFEN SR 200 mg

Prescriere limitata:
PROFENID LP 200 mg

Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AE03 KETOPROFENUM
Prescriere limitata:
KETOPROXIN 50 mg

COMPR. FILM. ELIB. PREL.


200mg LAB. AVENTIS

200mg

Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AE03 KETOPROFENUM
50mg

COMPR. FILM.
AC HELCOR PHARMA SRL

50mg

111
MYOLASTAN 50 mg RELAXAM

M03BX07

TETRAZEPAMUM
COMPR. FILM.
50mg 50mg SANOFI-SYNTHELABO FRANCE AC HELCOR SRL

M03BX07 TETRAZEPAMUM

50mg

112
ALLOPURINOL MILURIT 100 mg

M04AA01

ALLOPURINOLUM *
COMPR.
100mg 100mg ARENA GROUP SA EGIS PHARMACEUTICALS LTD.

M04AA01 ALLOPURINOLUM

100mg

NOTA: Doza trebuie ajustata in concordanta cu functia renala.

M04AA01 ALLOPURINOLUM
MILURIT 300 mg

COMPR.
300mg EGIS PHARMACEUTICALS LTD.

300mg

NOTA: Doza trebuie ajustata in concordanta cu functia renala.

113
COLCHICINA COLCHICINA FABIOL

M04AC01

COLCHICINUM
COMPR.
1mg 1mg BIOFARM SA FABIOL SA

M04AC01 COLCHICINUM

1mg

114
FORTRAL FORTWIN

N02AD01

PENTAZOCINUM
SOL. INJ.
30mg/ml 30mg/ml KRKA D.D. NOVO MESTO TERAPIA S.A.

N02AD01 PENTAZOCINUM

30mg/ml

Prescriere limitata: Prescriere limitata:


FORTRAL 50 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AD01 PENTAZOCINUM
50mg

COMPR.
KRKA D.D. NOVO MESTO

50mg

Prescriere limitata: Prescriere limitata:

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

115

N02AX02
Prescriere limitata: Prescriere limitata:

TRAMADOLUM
COMPR. ELIB. MODIF.
100mg HEXAL AG

N02AX02 TRAMADOLUM
TRAMADOLOR 100 ID

100mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
NOAX UNO 100 mg TRALGIT SR 100 TRAMADOL RETARD

COMPR. ELIB. PREL.


100mg 100mg 100mg LABOPHARM EUROPE LIMITED ZENTIVA AS KRKA D.D.

100mg

Prescriere limitata: Prescriere limitata:

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.

100mg

31 / 233

DCI/DENUMIRE COMERCIALA
TRAMAL RETARD 100 mg TRAMUNDIN RETARD 100 mg

CONCENTRATIE
100mg 100mg

FORMA FARM.
GRUNENTHAL GMBH MUNDIPHARMA GES.M.B.H

FIRMA

PROTOCOL

Prescriere limitata: Prescriere limitata:


MABRON TRADOLAN

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

SOL. INJ.
100mg 100mg MEDOCHEMIE LTD. LANNACHER HEILMITTEL GMBH

100mg

Prescriere limitata:
TRADOLAN TRAMADOL TRAMAG 100 TRAMAL

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM

SUPOZ.
100mg 100mg 100mg 100mg LANNACHER HEILMITTEL GMBH KRKA D.D. MAGISTRA C & C GRUNENTHAL GMBH

100mg

N02AX02 TRAMADOLUM
TRALGIT 100

SOL. INJ.
100mg/2ml ZENTIVA A.S.

100mg/2ml

Prescriere limitata:
TRALGIT

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
TRADOLAN

PIC. ORALE, SOL.


100mg/ml ZENTIVA A.S.

100mg/ml

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
TRALGIT SR 150

SOL. ORALA
100mg/ml LANNACHER HEILMITTEL GMBH

100mg/ml

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
TRAMADOL RETARD 150 mg TRAMAL RETARD 150 mg

COMPR. ELIB. PREL.


150mg ZENTIVA AS

150mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.


150mg 150mg KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

150mg

Prescriere limitata: Prescriere limitata:


NOAX UNO 200 mg TRALGIT SR 200

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. ELIB. PREL.


200mg 200mg LABOPHARM EUROPE LIMITED ZENTIVA AS

200mg

Prescriere limitata: Prescriere limitata:


TRAMADOL RETARD 200 mg TRAMAL RETARD 200 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.


200mg 200mg KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

200mg

Prescriere limitata: Prescriere limitata:


NOAX UNO 300 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
K-ALMA MABRON 50 mg TRALGIT 50 TRAMACALM TRAMADOL TRAMADOL LPH 50 mg TRAMADOL AL 50 TRAMADOL ARENA TRAMADOLOR 50 mg TRAMAL URGENDOL

COMPR. ELIB. PREL.


300mg LABOPHARM EUROPE LIMITED

300mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
ANTIBIOTICE SA MEDOCHEMIE LTD. ZENTIVA A.S. AC HELCOR SRL KRKA D.D. LABORMED PHARMA SA ALIUD PHARMA GMBH & CO.KG ARENA GROUP S.A. HEXAL AG GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg

Prescriere limitata:
TRAMADOL 50 mg TRAMADOL EEL TRAMAG 50

Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg 50mg 50mg

COMPR.
OZONE LABORATORIES LTD. BIO EEL SRL MAGISTRA C & C

50mg

Prescriere limitata: Prescriere limitata:


TRADOLAN 50 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg

COMPR. FILM.
LANNACHER HEILMITTEL GMBH

50mg

Prescriere limitata: Prescriere limitata:


TRADOLAN 50 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg

SOL. INJ.
LANNACHER HEILMITTEL GMBH

50mg

Prescriere limitata:
TRALGIT 50 TRAMADOL TRAMADOL AL 100 Fiole TRAMAL 100 TRAMAL 50 URGENDOL

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM

SOL. INJ.
50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml ZENTIVA A.S. KRKA D.D. ALIUD PHARMA GMBH & CO.KG GRUNENTHAL GMBH GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg/ml

Prescriere limitata:
TRAMADOL AL PICATURI

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM

PIC. ORALE, SOL.


ALIUD PHARMA GMBH & CO.KG

32 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
100mg/ml

FORMA FARM.
GRUNENTHAL GMBH

FIRMA

PROTOCOL

N02AX02 TRAMADOLUM
TRAMAL

PICATURI ORALE-SOL.

100mg/ml

116

N02CC01

SUMATRIPTANUM *
COMPR.
100mg 100mg 100mg 100mg 100mg TERAPIA S.A. SANDOZ S.R.L.

N02CC01 SUMATRIPTANUM
SUMATRIPTAN TERAPIA 100 mg SUMIGRA 100 mg

100mg

N02CC01 SUMATRIPTANUM
IMIGRAN 100 SUMACTA 100 mg SUMATRIPTAN

COMPR. FILM.
GLAXO WELLCOME UK LTD. ACTAVIS GROUP PTC EHF. DR. REDDY'S LABORATORIES

100mg

N02CC01 SUMATRIPTANUM
SUMATRIPTAN TERAPIA 50 mg SUMIGRA 50 mg 50mg 50mg

COMPR.
TERAPIA S.A. SANDOZ S.R.L.

50mg

Prescriere limitata:

Atacurile de migrena la pacientii care primesc sau au primit medicatie profilactica si la care crizele migrenoase nu au raspuns la tratamentul oral cu ergotamina sau alte medicamente antimigrenoase, sau la care aceste medicamente sunt contraindicate

N02CC01 SUMATRIPTANUM
IMIGRAN 50 SUMACTA 50 mg SUMATRIPTAN 50mg 50mg 50mg

COMPR. FILM.
GLAXO WELLCOME UK LTD. ACTAVIS GROUP PTC EHF. DR. REDDY'S LABORATORIES

50mg

Prescriere limitata:

Atacurile de migrena la pacientii care primesc sau au primit medicatie profilactica si la care crizele migrenoase nu au raspuns la tratamentul oral cu ergotamina sau alte medicamente antimigrenoase, sau la care aceste medicamente sunt contraindicate

117
TIMONIL SIROP

N03AF01

CARBAMAZEPINUM
SUSP. ORALA
100mg/5ml 150mg DESITIN ARZNEIMITTEL GMBH

Protocol: N025G
100mg/5ml 150mg 200mg
SLAVIA PHARM SRL BIO EEL SRL OZONE LABORATORIES LTD. LAROPHARM SRL ARENA GROUP SA LABORMED PHARMA SA TEVA PHARMACEUTICALS S.R.L. VIM SPECTRUM SRL AC HELCOR SRL AWD PHARMA GMBH & CO.KG GEROT PHARMAZEUTIKA GMBH MEDOCHEMIE LTD. NOVARTIS PHARMA GMBH

N03AF01 CARBAMAZEPINUM N03AF01 CARBAMAZEPINUM


TIMONIL 150 RETARD

COMPR. RET.
DESITIN

N03AF01 CARBAMAZEPINUM
CARBAMAZEPIN CARBAMAZEPIN EEL CARBAMAZEPINA CARBAMAZEPINA 200 mg CARBAMAZEPINA ARENA 200 mg CARBAMAZEPINA LPH 200 mg CARBAMAZEPINE TEVA 200 CARBAVIM CARBEPSIL 200 FINLEPSIN NEUROTOP TAVER TEGRETOL 200

COMPR.
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 300mg 300mg 300mg

N03AF01 CARBAMAZEPINUM
TEGRETOL CR 200

COMPR. FILM. ELIB. PREL.


NOVARTIS PHARMA GMBH

200mg 300mg

N03AF01 CARBAMAZEPINUM
CARBAMAZEPIN SANDOZ 300 mg NEUROTOP RETARD 300 mg

COMPR. ELIB. PREL.


HEXAL AG GEROT PHARMAZEUTIKA GMBH

N03AF01 CARBAMAZEPINUM
TIMONIL 300 RETARD

COMPR. RET.
DESITIN

300mg 400mg

N03AF01 CARBAMAZEPINUM
CARBEPSIL 400 TEGRETOL 400

COMPR.
400mg 400mg 400mg 400mg 400mg 600mg 600mg 600mg 200mg AC HELCOR SRL NOVARTIS PHARMA GMBH

N03AF01 CARBAMAZEPINUM
CARBAMAZEPIN SANDOZ 400 mg

COMPR. ELIB. PREL.


HEXAL AG

400mg 400mg 400mg 600mg

N03AF01 CARBAMAZEPINUM
TEGRETOL CR 400

COMPR. FILM. ELIB. PREL.


NOVARTIS PHARMA GMBH AWD PHARMA GMBH & CO.KG HEXAL AG GEROT PHARMAZEUTIKA GMBH

N03AF01 CARBAMAZEPINUM
FINLEPSIN 400 RETARD

COMPR. RET. COMPR. ELIB. PREL.

N03AF01 CARBAMAZEPINUM
CARBAMAZEPIN SANDOZ 600 mg NEUROTOP RETARD 600 mg

N03AF01 CARBAMAZEPINUM
TIMONIL 600 RETARD

COMPR. RET.
DESITIN

600mg 200mg

N03AF01 CARBAMAZEPINUM
FINLEPSIN 200 RETARD

COMPR.FILM.ELIB.PREL
AWD PHARMA GMBH & CO.KG

118

N03AX12

GABAPENTINUM
CAPS.
100mg 100mg 100mg 100mg 100mg WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O. STADA ARZNEIMITTEL AG RANBAXY UK LTD. GEDEON RICHTER LTD.

Protocol: N025G
100mg

N03AX12 GABAPENTINUM
GABAGAMMA 100 mg GABALEPT 100 mg GABAPENTIN STADA 100 mg GABARAN 100 mg GORDIUS 100 mg

N03AX12 GABAPENTINUM
GABAGAMMA 300 mg GABALEPT 300 mg GABAPENTIN STADA 300 mg GABARAN 300 mg GABOTON 300 GORDIUS 300 mg

CAPS.
300mg 300mg 300mg 300mg 300mg 300mg WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O. STADA ARZNEIMITTEL AG RANBAXY UK LTD. HEXAL AG GEDEON RICHTER LTD.

300mg

N03AX12 GABAPENTINUM
GABAGAMMA 400 mg GABALEPT 400 mg GABAPENTIN STADA 400 mg GABARAN 400 mg GABOTON 400

CAPS.
400mg 400mg 400mg 400mg 400mg WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O. STADA ARZNEIMITTEL AG RANBAXY UK LTD. HEXAL AG

400mg

33 / 233

DCI/DENUMIRE COMERCIALA
GORDIUS 400 mg

CONCENTRATIE
400mg 600mg 800mg

FORMA FARM.
GEDEON RICHTER LTD.

FIRMA

PROTOCOL

N03AX12 GABAPENTINUM
GABARAN 600 mg

COMPR. FILM.
RANBAXY UK LTD.

600mg 800mg

N03AX12 GABAPENTINUM
GABARAN 800 mg

COMPR. FILM.
RANBAXY UK LTD.

119

N05AD01

HALOPERIDOLUM
COMPR.
0.5mg LAROPHARM S.R.L.

N05AD01 HALOPERIDOLUM
HALOPERIDOL LAROPHARM 0,5 mg

0.5mg 1mg
ARENA GROUP SA

N05AD01 HALOPERIDOLUM
HALOPERIDOL 1 mg 1mg

COMPR. COMPR.
2mg 2mg/ml ARENA GROUP SA

N05AD01 HALOPERIDOLUM
HALOPERIDOL 2 mg

2mg 2mg/ml 50mg/ml


GEDEON RICHTER LTD.

N05AD01 HALOPERIDOLUM
HALOPERIDOL RANBAXY 2mg/ml

PIC. ORALE, SOL.


RANBAXY U.K. LIMITED

N05AD01 HALOPERIDOLUM
HALOPERIDOL DECANOAT

SOL. INJ.
50mg/ml

N05AD01 HALOPERIDOLUM
HALDOL 5mg

COMPR.
JANSSEN PHARMACEUTICA NV

5mg 5mg/ml
GEDEON RICHTER LTD.

N05AD01 HALOPERIDOLUM
HALOPERIDOL 5 mg/ml

SOL. INJ.
5mg/ml 2mg/ml 2mg/ml

N05AD01 HALOPERIDOLUM
HALOPERIDOL 2 mg/ml

PIC. ORALE-SOL.
GEDEON RICHTER ROMANIA SA

2mg/ml 2mg/ml

N05AD01 HALOPERIDOLUM
HALOPERIDOL

PICATURI ORALE-SOL.
TERAPIA SA

120

N05BA01

DIAZEPAMUM
COMPR.
10mg 10mg 10mg 10mg/2.5ml TERAPIA SA GEDEON RICHTER ROMANIA SA LAROPHARM SRL

N05BA01 DIAZEPAMUM
DIAZEPAM DIAZEPAM 10 mg DIAZEPAM LAROPHARM 10 mg

10mg

N05BA01 DIAZEPAMUM
DIAZEPAM DESITIN SOLUTIE RECTALA 10 mg

SOL. RECTALA
DESITIN

10mg/2.5ml 10mg/2ml

N05BA01 DIAZEPAMUM
CALMPOSE DIAZEPAM 10 mg

SOL. INJ.
10mg/2ml 10mg/2ml 5mg/2.5ml TERAPIA S.A. TERAPIA SA

N05BA01 DIAZEPAMUM
DIAZEPAM DESITIN SOLUTIE RECTALA 5 mg

SOL. RECTALA
DESITIN

5mg/2.5ml

121
MEDAZEPAM

N05BA03

MEDAZEPAMUM *
COMPR.
10 mg ARENA GROUP SA

N05BA03 MEDAZEPAMUM N05BA03 MEDAZEPAMUM


ANSILAN 10 mg 10mg

10 mg 10mg
LEK PHARMACEUTICALS D.D.

CAPS. COMPR.
10mg 10mg LAROPHARM SRL AWD PHARMA GMBH & CO.KG

N05BA03 MEDAZEPAMUM
MEDAZEPAM 10 mg RUDOTEL

10mg

122
ANXIAR 1 mg

N05BA06

LORAZEPAMUM *
COMPR.
1 mg GEDEON RICHTER ROMANIA SA

N05BA06 LORAZEPAMUM

1 mg

123

N05BA08

BROMAZEPAMUM *
COMPR.
1.5mg 1.5mg 1.5mg OZONE LABORATORIES S.R.L. LABORMED PHARMA SA GLAXOSMITHKLINE (GSK) SRL

N05BA08 BROMAZEPAMUM
BROMAZEPAM 1,5 mg BROMAZEPAM LPH 1,5 mg CALMEPAM

1.5mg

N05BA08 BROMAZEPAMUM
BROMAZEPAM 3 mg BROMAZEPAM LPH 3 mg BROMAZEPAM SLAVIA 3 mg CALMEPAM LEXOTAN LEXOTANIL 3mg 3mg 3mg 3mg 3mg 3mg

COMPR.
OZONE LABORATORIES S.R.L. LABORMED PHARMA SA SLAVIA PHARM SRL GLAXOSMITHKLINE (GSK) SRL ROCHE ROMANIA S.R.L. TERAPIA S.A.

3mg

Prescriere limitata:

Pacienti cu stari fobice sau anxioase refractare.

124
XANAX 0,25 mg

N05BA12
Prescriere limitata: Prescriere limitata:

ALPRAZOLAMUM *
COMPR.
0,25mg PFIZER EUROPE MA EEIG

N05BA12 ALPRAZOLAMUM

0,25mg

Tulburari de panica, in cazul esecului la tratamente similare. Pentru tratamentul de scurta durata al anxietatii

N05BA12 ALPRAZOLAMUM
XANAX 0,5 mg 0,5mg

COMPR.
PFIZER EUROPE MA EEIG

0,5mg

Prescriere limitata: Prescriere limitata:


ALPRAZOLAM LPH 0,25 mg FRONTIN 0,25 mg PRAZOLEX 0,25 mg

Tulburari de panica, in cazul esecului la tratamente similare. Pentru tratamentul de scurta durata al anxietatii

N05BA12 ALPRAZOLAMUM

COMPR.
0.25mg 0.25mg 0.25mg LABORMED PHARMA SA EGIS PHARMACEUTICALS PLC GEDEON RICHTER ROMANIA SA

0.25mg

Prescriere limitata: Prescriere limitata:


ALPRAZOLAM LPH 0,5 mg FRONTIN 0,5 mg PRAZOLEX 0,5 mg

Tulburari de panica, in cazul esecului la tratamente similare. Pentru tratamentul de scurta durata al anxietatii

N05BA12 ALPRAZOLAMUM
0.5mg 0.5mg 0.5mg

COMPR.
LABORMED PHARMA SA EGIS PHARMACEUTICALS PLC GEDEON RICHTER ROMANIA SA

0.5mg

Prescriere limitata:

Tulburari de panica, in cazul esecului la tratamente similare.

34 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata:


NEUROL SR 0,5 XANAX XR 0,5 mg

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Pentru tratamentul de scurta durata al anxietatii

N05BA12 ALPRAZOLAMUM
0.5mg 0.5mg

COMPR. ELIB. PREL.


ZENTIVA AS PFIZER EUROPE MA EEIG

0.5mg

Prescriere limitata: Prescriere limitata:


ALPRAZOLAM LPH 1 mg FRONTIN PRAZOLEX 1 mg XANAX 1 mg

Tulburari de panica, in cazul esecului la tratamente similare. Pentru tratamentul de scurta durata al anxietatii

N05BA12 ALPRAZOLAMUM
1mg 1mg 1mg 1mg

COMPR.
LABORMED PHARMA SA EGIS PHARMACEUTICALS PLC GEDEON RICHTER ROMANIA SA PFIZER EUROPE MA EEIG

1mg

Prescriere limitata: Prescriere limitata:


NEUROL SR 1 XANAX XR 1 mg

Tulburari de panica, in cazul esecului la tratamente similare. Pentru tratamentul de scurta durata al anxietatii

N05BA12 ALPRAZOLAMUM
1mg 1mg

COMPR. ELIB. PREL.


ZENTIVA AS PFIZER EUROPE MA EEIG

1mg

Prescriere limitata: Prescriere limitata:


XANAX 2 mg

Tulburari de panica, in cazul esecului la tratamente similare. Pentru tratamentul de scurta durata al anxietatii

N05BA12 ALPRAZOLAMUM
2mg

COMPR.
PFIZER EUROPE MA EEIG

2mg

Prescriere limitata: Prescriere limitata:


NEUROL SR 2 XANAX XR 2 mg

Tulburari de panica, in cazul esecului la tratamente similare. Pentru tratamentul de scurta durata al anxietatii

N05BA12 ALPRAZOLAMUM
2mg 2mg

COMPR. ELIB. PREL.


ZENTIVA AS PFIZER EUROPE MA EEIG

2mg

Prescriere limitata: Prescriere limitata:


XANAX XR 3 mg

Tulburari de panica, in cazul esecului la tratamente similare. Pentru tratamentul de scurta durata al anxietatii

N05BA12 ALPRAZOLAMUM
3mg

COMPR. ELIB. PREL.


PFIZER EUROPE MA EEIG

3mg

Prescriere limitata: Prescriere limitata:

Tulburari de panica, in cazul esecului la tratamente similare. Pentru tratamentul de scurta durata al anxietatii

125
EUNOCTIN 10 mg

N05CD02

NITRAZEPAMUM
COMPR.
10mg GEDEON RICHTER ROMANIA S.A.

N05CD02 NITRAZEPAMUM N05CD02 NITRAZEPAMUM


NITRAZEPAM LPH 2,5 mg 2.5mg

10mg 2.5mg
LABORMED PHARMA SA

COMPR. COMPR.
5mg 5mg GEDEON RICHTER ROMANIA SA LABORMED PHARMA SA

N05CD02 NITRAZEPAMUM
NITRAZEPAM 5 mg NITRAZEPAM LPH 5 mg

5mg

N05CD02 NITRAZEPAMUM
NITRAZEPAM 5 mg NITRAZEPAM LPH 5 mg 5mg 5mg

COMPR.
GEDEON RICHTER ROMANIA SA LABORMED PHARMA SA

5mg

126
ZOPIMERCK 3,75 mg

N05CF01

ZOPICLONUM *
COMPR. FILM.
3.75mg 7.5mg 7.5mg 7.5mg GENERICS LTD.

N05CF01 ZOPICLONUM N05CF01 ZOPICLONUM


ALS-ZOPICLON 7,5 mg IMOVANE 7,5 mg ZOPIMERCK 7,5 mg

3.75mg 7.5mg

COMPR. FILM.
ALSIFCOM INTERMED SRL SANOFI AVENTIS GENERICS LTD.

Prescriere limitata:

Pentru tratamentul de scurta durata al insomniei

127

N05CF02

ZOLPIDEMUM *
COMPR. FILM.
10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 5mg 5mg 5mg 5mg BMF PHARM SRL ZENTIVA AS GEDEON RICHTER ROMANIA S.A. LEK PHARMACEUTICALS D.D. SANOFI-AVENTIS FRANCE HEXAL AG LABORMED PHARMA SA ALIUD PHARMA GMBH & CO.KG ANTIBIOTICE S.A. STADA ARZNEIMITTEL AG KRKA D.D. NOVO MESTO

N05CF02 ZOLPIDEMUM
BUNAPTE HYPNOGEN 10 mg LADINOX SANVAL 10 mg STILNOX 10 mg ZOLDEM 10 ZOLPIDEM 10 mg ZOLPIDEM AL 10 mg ZOLPIDEM ANTIBIOTICE 10 mg ZOLPIDEM STADA 10 mg ZOLSANA 10 mg

10mg

N05CF02 ZOLPIDEMUM
SANVAL 5 mg ZOLPIDEM AL 5 mg ZOLPIDEM STADA 5 mg ZOLSANA 5 mg

COMPR. FILM.
LEK PHARMACEUTICALS D.D. ALIUD PHARMA GMBH & CO.KG STADA ARZNEIMITTEL AG KRKA D.D. NOVO MESTO

5mg

128
ANAFRANIL 10 mg

N06AA04

CLOMIPRAMINUM *
DRAJ.
10mg NOVARTIS PHARMA GMBH

N06AA04 CLOMIPRAMINUM N06AA04 CLOMIPRAMINUM


ANAFRANIL 25 mg CLOMIPRAMIN 25 mg 25mg 25mg

10mg 25mg
NOVARTIS PHARMA GMBH TERAPIA SA

DRAJ.

Prescriere limitata: Prescriere limitata:

Tulburari obsesiv-compulsive Tulburari fobice la adulti.

129

N06AA09

AMITRIPTYLINUM *
CAPS. RET.
25mg 25mg DESITIN

N06AA09 AMITRIPTYLINUM
AMITRIPTILIN 25 R. DESITIN

25mg 25mg

N06AA09 AMITRIPTYLINUM
AMITRIPTILINA ARENA 25 mg

COMPR. FILM.
ARENA GROUP S.A.

35 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
DESITIN

FIRMA

PROTOCOL

N06AA09 AMITRIPTYLINUM
AMITRIPTILIN 50 R. DESITIN 50mg

CAPS. RET.

50mg

130
DOXEPIN 25 mg

N06AA12

DOXEPINUM *
DRAJ.
25mg TERAPIA SA

N06AA12 DOXEPINUM

25mg

131
FLOXET 10 mg

N06AB03

FLUOXETINUM *
CAPS.
10mg EGIS PHARMACEUTICALS LTD.

N06AB03 FLUOXETINUM N06AB03 FLUOXETINUM


FLOXET FLUOHEXAL 20 FLUOXETINE 20 mg FLUOXIN FLURAN MAGRILAN 20 mg PORTAL ROFLUXIN 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

10mg 20mg
EGIS PHARMACEUTICALS LTD. HEXAL AG DR. REDDY'S LABORATORIES VIM SPECTRUM SRL RANBAXY U.K. LIMITED MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D. ANTIBIOTICE S.A.

CAPS.

N06AB03 FLUOXETINUM
PROZAC 20 mg

COMPR. DISP.
ELI LILLY SA

20mg

132
CITALEC 10

N06AB04

CITALOPRAMUM **
COMPR. FILM.
10 mg 10mg 10mg 10mg 10mg 10mg 10mg 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 30mg 40 mg 40mg 40mg 40mg 40mg 40mg 60mg ZENTIVA A.S.

Protocol: N008F
10 mg 10mg

N06AB04 CITALOPRAMUM N06AB04 CITALOPRAMUM


CITALOMERCK 10 mg CITALOPRAM SANDOZ 10 mg CITALOPRAM STADA 10 mg CITALORAN 10 mg DALSAN 10 mg LINISAN 10 mg

COMPR. FILM.
GENERICS LTD. HEXAL AG STADA ARZNEIMITTEL AG RANBAXY UK LIMITED EGIS PHARMACEUTICALS P.L.C. GEDEON RICHTER ROMANIA S.A.

N06AB04 CITALOPRAMUM
CITALEC 20

COMPR. FILM.
ZENTIVA A.S.

20 mg 20mg

N06AB04 CITALOPRAMUM
CITALOMERCK 20 mg CITALOPRAM SANDOZ 20 mg CITALOPRAM STADA 20 mg CITALORAN 20mg DALSAN 20 mg LINISAN 20 mg

COMPR. FILM.
GENERICS LTD. HEXAL AG STADA ARZNEIMITTEL AG RANBAXY UK LIMITED EGIS PHARMACEUTICALS P.L.C. GEDEON RICHTER ROMANIA S.A.

N06AB04 CITALOPRAMUM
CITALOPRAM SANDOZ 30 mg

COMPR. FILM.
HEXAL AG

30mg 40 mg 40mg

N06AB04 CITALOPRAMUM
CITALEC 40

COMPR. FILM.
ZENTIVA A.S.

N06AB04 CITALOPRAMUM
CITALOPRAM SANDOZ 40 mg CITALOPRAM STADA 40 mg CITALORAN 40 mg DALSAN 40 mg LINISAN 40 mg

COMPR. FILM.
HEXAL AG STADA ARZNEIMITTEL AG RANBAXY UK LIMITED EGIS PHARMACEUTICALS P.L.C. GEDEON RICHTER ROMANIA S.A.

N06AB04 CITALOPRAMUM
CITALOPRAM SANDOZ 60 mg

COMPR. FILM.
HEXAL AG

60mg

133
ARKETIS 10 mg

N06AB05

PAROXETINUM *
COMPR.
10mg MEDOCHEMIE LTD

N06AB05 PAROXETINUM N06AB05 PAROXETINUM


ARKETIS 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

10mg 20mg
MEDOCHEMIE LTD.

COMPR. COMPR. FILM.


ALSIFCOM INTERMED SRL HEXAL AG GLAXOSMITHKLINE SRL ALIUD PHARMA GMBH & CO.KG STADA ARZNEIMITTEL AG TEVA PHARMACEUTICALS S.R.L. ACTAVIS GROUP HF. GEDEON RICHTER PLC. SMITHKLINE BEECHAM PLC

N06AB05 PAROXETINUM
ALS-PAROXETIN 20 mg PALUXETIL 20 mg PAROXAT PAROXETIN AL 20 PAROXETIN STADA 20 mg PAROXETIN TEVA 20 mg PAXETEN 20 mg REXETIN SEROXAT 20 mg

20mg

N06AB05 PAROXETINUM
ARKETIS 30 mg 30mg 30mg 30mg

COMPR.
MEDOCHEMIE LTD

30mg 30mg

N06AB05 PAROXETINUM
PAROXAT SEROXAT 30 mg

COMPR. FILM.
GLAXOSMITHKLINE SRL SMITHKLINE BEECHAM PLC

N06AB05 PAROXETINUM
ARKETIS 40 mg 40mg 40mg

COMPR.
MEDOCHEMIE LTD

40mg 40mg

N06AB05 PAROXETINUM
PALUXETIL 40 mg

COMPR. FILM.
HEXAL AG

134

N06AB06

SERTRALINUM *
COMPR. FILM.
100mg 100mg 100mg 100mg 100mg 100mg 100mg ALSIFCOM INTERMED SRL KRKA D.D. BIOFARM SP.ZO.O TERAPIA S.A. SANDOZ S.R.L. OZONE LABORATORIES LTD. HEXAL AG

N06AB06 SERTRALINUM
ALS-SERTRALINA 100 mg ASENTRA ASERTIN 100 mg SERLIFT 100 mg SERTIVA 100 mg SERTRALIN 100 mg SERTRALIN SANDOZ 100 mg

100mg

36 / 233

DCI/DENUMIRE COMERCIALA
SERTRALINA 100 mg SERTRALINA DR. REDDY'S 100 mg SETALOFT 100 mg STIMULOTON 100 mg ZOLOFT 100 mg

CONCENTRATIE
100mg 100mg 100mg 100mg 100mg 20mg/ml 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 100mg

FORMA FARM.
ARENA GROUP S.A. DR. REDDY'S LABORATORIES ACTAVIS GROUP PTC EHF. EGIS PHARMACEUTICALS LTD. PFIZER EUROPE MA EEIG

FIRMA

PROTOCOL

N06AB06 SERTRALINUM
ZOLOFT

SOL. ORALA
PFIZER EUROPE MA EEIG

20mg/ml 50mg

N06AB06 SERTRALINUM
ALS-SERTRALINA 50 mg ASENTRA ASERTIN 50 mg SERLIFT 50 mg SERTIVA 50 mg SERTRALIN 50 mg SERTRALIN SANDOZ 50 mg SERTRALINA 50 mg SERTRALINA DR. REDDY'S 50 mg SERTRALINE 50 mg SETALOFT 50 mg STIMULOTON 50 mg ZOLOFT 50 mg

COMPR. FILM.
ALSIFCOM INTERMED SRL KRKA D.D. BIOFARM SP.ZO.O TERAPIA S.A. SANDOZ S.R.L. OZONE LABORATORIES LTD. HEXAL AG ARENA GROUP SA DR. REDDY'S LABORATORIES TORREX PHARMA GMBH ACTAVIS GROUP PTC EHF. EGIS PHARMACEUTICALS LTD. PFIZER EUROPE MA EEIG

N06AB06 SERTRALINUM
SERTRALINE 100 mg

COMPR.FILM
TORREX PHARMA GMBH

100mg

135

N06AB08

FLUVOXAMINUM *
COMPR. FILM.
100mg 100mg 100mg 50mg 50mg 50mg SOLVAY PHARMACEUTICALS BV STADA ARZNEIMITTEL AG TEVA PHARMACEUTICALS SRL

N06AB08 FLUVOXAMINUM
FEVARIN 100 FLUVOXAMIN STADA 100 mg FLUVOXAMINE TEVA 100 mg

100mg

N06AB08 FLUVOXAMINUM
FEVARIN 50 FLUVOXAMIN STADA 50 mg FLUVOXAMINE TEVA 50 mg

COMPR. FILM.
SOLVAY PHARMACEUTICALS BV STADA ARZNEIMITTEL AG TEVA PHARMACEUTICALS SRL

50mg

136
MIANSERIN 10

N06AX03

MIANSERINUM *
COMPR. FILM.
10mg REMEDICA LTD.

N06AX03 MIANSERINUM N06AX03 MIANSERINUM


MIANSERIN 10 mg 10mg 30mg

10mg 10mg

DRAJ.
TERAPIA SA

N06AX03 MIANSERINUM
MIANSERIN 30

COMPR. FILM.
REMEDICA LTD.

30mg 30mg

N06AX03 MIANSERINUM
MIANSERIN 30 mg 30mg

DRAJ.
TERAPIA SA

137

N06AX11

MIRTAZAPINUM *
COMPR. DISP.
15mg 15mg 15mg 15mg 15mg 15mg 15mg 30mg 30mg 30mg 30mg 30mg 30mg 30mg 30mg 30mg 30mg 45mg 45mg 45mg 45mg 45mg 45mg 45mg 45mg ORGANON NV

N06AX11 MIRTAZAPINUM
REMERON SOLTAB 15 mg

15mg 15mg

N06AX11 MIRTAZAPINUM
ESPRITAL 15 MIRZALUX 15 mg MIRZATEN 15 mg

COMPR. FILM.
ZENTIVA AS HEXAL AG KRKA D.D.

N06AX11 MIRTAZAPINUM
MIRTAZAPIN AUROBINDO 15 mg MIRTAZAPINA BLUEFISH 15 mg MIRZATEN Q-TAB 15 mg

COMPR. ORODISPERSABILE
AUROBINDO PHARMA LIMITED BLUEFISH PHARMACEUTICALS AB KRKA D.D. NOVO MESTO

15mg

N06AX11 MIRTAZAPINUM
REMERON SOLTAB 30 mg

COMPR. DISP.
ORGANON NV

30mg 30mg

N06AX11 MIRTAZAPINUM
ESPRITAL 30 MIRTAZAPIN STADA 30 mg MIRTAZAPINE-TEVA 30 mg MIRZALUX 30 mg MIRZATEN 30 mg PHARMATAZ 30 mg

COMPR. FILM.
ZENTIVA AS STADA ARZNEIMITTEL AG TEVA PHARMACEUTICALS SRL HEXAL AG KRKA D.D. ACTAVIS GROUP HF.

N06AX11 MIRTAZAPINUM
MIRTAZAPIN AUROBINDO 30 mg MIRTAZAPINA BLUEFISH 30 mg MIRZATEN Q-TAB 30 mg

COMPR. ORODISPERSABILE
AUROBINDO PHARMA LIMITED BLUEFISH PHARMACEUTICALS AB KRKA D.D. NOVO MESTO

30mg

N06AX11 MIRTAZAPINUM
REMERON SOLTAB 45 mg

COMPR. DISP.
ORGANON NV

45mg 45mg

N06AX11 MIRTAZAPINUM
ESPRITAL 45 MIRTAZAPIN STADA 45 mg MIRZALUX 45 mg MIRZATEN 45 mg

COMPR. FILM.
ZENTIVA AS STADA ARZNEIMITTEL AG HEXAL AG KRKA D.D.

N06AX11 MIRTAZAPINUM
MIRTAZAPIN AUROBINDO 45 mg MIRTAZAPINA BLUEFISH 45 mg MIRZATEN Q-TAB 45 mg

COMPR. ORODISPERSABILE
AUROBINDO PHARMA LIMITED BLUEFISH PHARMACEUTICALS AB KRKA D.D. NOVO MESTO

45mg

138
ALVENTA 150mg EFECTIN ER 150 mg VELAXIN 150 mg

N06AX16

VENLAFAXINUM **
CAPS. ELIB. PREL.
150mg 150mg 150mg 150mg KRKA D.D. NOVO MESTO WYETH LEDERLE PHARMA GMBH EGIS PHARMACEUTICALS P.L.C.

Protocol: N013F
150mg

N06AX16 VENLAFAXINUM

N06AX16 VENLAFAXINUM
ARGOFAN 150 SR

COMPR. ELIB. PREL.


ZENTIVA A.S.

150mg

37 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
EGIS PHARMACEUTICALS P.L.C. TERAPIA S.A.

FIRMA

PROTOCOL

N06AX16 VENLAFAXINUM
VELAXIN 25 mg VENLAFAXINA TERAPIA 25 mg 25mg 25mg

COMPR.

25mg

N06AX16 VENLAFAXINUM
EFECTIN ER 37,5 mg VELAXIN 37,5 mg

CAPS. ELIB. PREL.


37,5mg 37,5mg 37.5mg WYETH LEDERLE PHARMA GMBH EGIS PHARMACEUTICALS P.L.C.

37,5mg

N06AX16 VENLAFAXINUM
ALVENTA 37,5 mg

CAPS. ELIB. PREL.


KRKA D.D. NOVO MESTO

37.5mg 37.5mg

N06AX16 VENLAFAXINUM
VELAXIN 37,5 mg VENLAFAXINA LPH 37,5 mg VENLAFAXINA TERAPIA 37,5 mg

COMPR.
37.5mg 37.5mg 37.5mg EGIS PHARMACEUTICALS PLC LABORMED PHARMA SA TERAPIA S.A.

N06AX16 VENLAFAXINUM
VELAXIN 50 mg VENLAFAXINA TERAPIA 50 mg 50mg 50mg 75mg 75mg 75mg

COMPR.
EGIS PHARMACEUTICALS PLC TERAPIA S.A.

50mg

N06AX16 VENLAFAXINUM
ALVENTA 75 mg EFECTIN ER 75 mg VELAXIN 75 mg

CAPS. ELIB. PREL.


KRKA D.D. NOVO MESTO WYETH LEDERLE PHARMA GMBH EGIS PHARMACEUTICALS P.L.C.

75mg

N06AX16 VENLAFAXINUM
VELAXIN 75 mg VENLAFAXINA LPH 75 mg VENLAFAXINA TERAPIA 75 mg 75mg 75mg 75mg 75mg

COMPR.
EGIS PHARMACEUTICALS PLC LABORMED PHARMA SA TERAPIA S.A.

75mg

N06AX16 VENLAFAXINUM
ARGOFAN 75 SR

COMPR. ELIB. PREL.


ZENTIVA A.S.

75mg

139
MIOSTIN 0,5 mg/ml

N07AA01

NEOSTIGMINI BROMIDUM
SOL. INJ.
0.5mg/ml ZENTIVA S.A.

N07AA01 NEOSTIGMINI BROMIDUM N07AA01 NEOSTIGMINI BROMIDUM


NEOSTIGMINA LPH 15 mg 15mg

0.5mg/ml 15mg
LABORMED PHARMA SA

COMPR.

140

P01AB01

METRONIDAZOLUM
COMPR.
250mg 250mg 250mg 250mg ZENTIVA SA ZENTIVA SA ARENA GROUP SA

P01AB01 METRONIDAZOLUM
METRONIDAZOL 250 mg (J01XD01) METRONIDAZOL 250 mg (P01AB01) METRONIDAZOL 250 mg (P01AB1)

250mg

P01AB01 METRONIDAZOLUM
FLAGYL

COMPR. FILM.
LABORATOIRE AVENTIS

250mg

Prescriere limitata:
FLAGYL 4 % (J01XD01) FLAGYL 4% (P01AB01)

Tratamentul infectiilor cu anaerobi

P01AB01 METRONIDAZOLUM
4% 4%

SUSP. ORALA
LABORATOIRE AVENTIS LABORATOIRE AVENTIS

4%

141
TINIZOL 2 g/l

P01AB02

TINIDAZOLUM
SOL. PERF.
0.2% 500mg 500mg 500mg 500mg 500mg INFOMED FLUIDS SRL

P01AB02 TINIDAZOLUM P01AB02 TINIDAZOLUM


FASIGYN (J01XD02) FASIGYN (P01AB02) TINIZOL 500 mg (J01XD02) TINIZOL 500 mg (P01AB02) TIPROGYN 500

0.2% 500mg

COMPR. FILM.
PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG ZENTIVA S.A. ZENTIVA S.A. AC HELCOR SRL

P01AB02 TINIDAZOLUM
TINIZOL 2 g/l 0.2%

SOL. PERF.
INFOMED FLUIDS SRL

0.2% 500mg

P01AB02 TINIDAZOLUM
FASIGYN (J01XD02) FASIGYN (P01AB02) TINIZOL 500 mg (J01XD02) TINIZOL 500 mg (P01AB02) TIPROGYN 500

COMPR. FILM.
500mg 500mg 500mg 500mg 500mg PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG ZENTIVA S.A. ZENTIVA S.A. AC HELCOR SRL

142

P02CA03

ALBENDAZOLUM
SUSP. ORALA
0.4g/10ml 0.4g/10ml 200mg 200mg 200mg GLAXOSMITHKLINE SRL GLAXOSMITHKLINE EXPORT LTD.

P02CA03 ALBENDAZOLUM
ALBENDOL 0,4 g /10 ml ZENTEL 0,4 g/10 ml

0.4g/10ml

P02CA03 ALBENDAZOLUM
ALBENDOL 200 mg DUADOR 200 mg ZENTEL 200 mg

COMPR. FILM.
GLAXOSMITHKLINE SRL GEDEON RICHTER ROMANIA SA GLAXOSMITHKLINE EXPORT LTD.

200mg

P02CA03 ALBENDAZOLUM
ESKAZOLE

COMPR.
400mg GLAXO SMITHKLINE EXPORT LTD.

400mg

Cod restrictie 1496:

Pentru tratamentul chistului hidatic in combinatie cu tratamentul chirurgical sau atunci cand vindecarea chirurgicala nu a putut fi obtinuta sau tratamentul chirurgical nu poate fi aplicat

P02CA03 ALBENDAZOLUM
ALBENDAZOL BIOFARM 400 mg

SUSP. ORALA
400mg 200mg BIOFARM S.A.

400mg 200mg

P02CA03 ALBENDAZOLUM
ALBENDAZOL

COMPR.FILM
OZONE LABORATORIES LTD.

143
DECARIS 150 mg

P02CE01

LEVAMISOLUM
COMPR.
150mg GEDEON RICHTER ROMANIA SA

P02CE01 LEVAMISOLUM P02CE01 LEVAMISOLUM


DECARIS 50 mg 50mg

150mg 50mg
GEDEON RICHTER ROMANIA SA

COMPR.

144

R03AC02

SALBUTAMOLUM
SUSP. INHAL. PRESURIZATA 100g/doza

R03AC02 SALBUTAMOLUM

38 / 233

DCI/DENUMIRE COMERCIALA
ASTHALIN INHALER ECOSAL Easi-Breath ECOSAL Inhaler VENTOLIN 100 INHALER CFC-FREE

CONCENTRATIE
100g/doza 100g/doza 100g/doza 100g/doza 2.5mg 200g/doza 5mg 5mg/ml

FORMA FARM.
CIPLA (UK) LIMITED IVAX - PHARMACEUTICALS S.R.O. IVAX - PHARMACEUTICALS S.R.O. GLAXOWELLCOME UK LTD.

FIRMA

PROTOCOL

R03AC02 SALBUTAMOLUM
VENTOLIN NEBULES 2,5 mg

SOL. INHAL.
GLAXO WELLCOME LIMITED

2.5mg 200g/doza 5mg 5mg/ml

R03AC02 SALBUTAMOLUM
VENTOLIN DISKUS 200 g

PULB. INHAL.
GLAXO WELLCOME LTD. GLAXO WELLCOME LIMITED

R03AC02 SALBUTAMOLUM
VENTOLIN NEBULES 5 mg

SOL. INHAL. SOL. INHAL.


GLAXOWELLCOME UK LTD.

R03AC02 SALBUTAMOLUM
VENTOLIN

145

R03BA01

BECLOMETASONUM *
AEROSOL SOL. INHAL.
100g/doza 100g/doza 100g/doza 250g/doza 250g/doza 250g/doza 250g/doza 250g/doza 50g/doza IVAX - PHARMACEUTICALS S.R.O. IVAX - PHARMACEUTICALS S.R.O.

R03BA01 BECLOMETASONUM
ECOBEC 100 g CFC FREE ECOBEC EASI - BREATHE 100 g CFC FREE

100g/doza

R03BA01 BECLOMETASONUM
RINOCLENIL 100

SPRAY NAZ.,SUSP.
CHIESI FARMACEUTICI S.P.A.

100g/doza 250g/doza

R03BA01 BECLOMETASONUM
ECOBEC 250 g CFC FREE ECOBEC EASI - BREATHE 250 g CFC FREE

AEROSOL SOL. INHAL.


IVAX - PHARMACEUTICALS S.R.O. IVAX - PHARMACEUTICALS S.R.O.

R03BA01 BECLOMETASONUM
BECLOFORTE CFC-Free CLENIL

SOL. DE INHALAT PRESURIZATA


GLAXO WELLCOME UK LTD. CHIESI FARMACEUTICI SPA

250g/doza

R03BA01 BECLOMETASONUM
CLENIL JET 250 g

SOL. INHALAT PRESURIZATA


CHIESI FARMACEUTICI SPA

250g/doza 50g/doza

R03BA01 BECLOMETASONUM
BECOTIDE CFC-Free

SOL. DE INHALAT PRESURIZATA


GLAXO WELLCOME UK LTD.

146
FRENOLYN 200

R03BA02

BUDESONIDUM *
PULB. INHAL.
200 g/doza 200 mcg/doza 200g/doza 200g/doza 200mcg/doza 400 g/doza MEDOCHEMIE ROMANIA SRL

R03BA02 BUDESONIDUM R03BA02 BUDESONIDUM


BUDIAIR 200 mcg

200 g/doza 200 mcg/doza 200g/doza

SOL. DE INHALAT PRESURIZATA


CHIESI FARMACEUTICI S.P.A. ASTRAZENECA AB SANDOZ SRL

R03BA02 BUDESONIDUM
PULMICORT TURBUHALER 200 g/doza TAFEN NOVOLIZER 200 g

PULB. INHAL.

R03BA02 BUDESONIDUM
BUDIAIR 200 mcg JET

SOL. DE INHALAT PRESURIZATA


CHIESI FARMACEUTICI S.P.A.

200mcg/doza 400 g/doza

R03BA02 BUDESONIDUM
FRENOLYN 400

PULB. INHAL.
MEDOCHEMIE ROMANIA SRL

147

R03BB01

IPRATROPII BROMIDUM *
AEROSOL
20g/doza 20g/doza 250g/ml 500g/2ml CIPLA (UK) LIMITED

R03BB01 IPRATROPII BROMIDUM


IPRAVENT 20 - INHALER

20g/doza 20g/doza 250g/ml 500g/2ml

R03BB01 IPRATROPII BROMIDUM


ATROVENT 20 g

SUSP. INHAL. PRESURIZATA


BOEHRINGER INGELHEIM INT. GMBH TEVA PHARMACEUTICALS S.R.L. TEVA PHARMACEUTICALS S.R.L.

R03BB01 IPRATROPII BROMIDUM


IPRAXA 250g/ml

SOL. DE INHALAT PRIN NEBULIZ. SOL. DE INHALAT PRIN NEBULIZ.

R03BB01 IPRATROPII BROMIDUM


IPRAXA 500g/2ml

148
SALBUTAMOL T

R03CC02

SALBUTAMOLUM
SOL. ORALA
0.04% TIS FARMACEUTIC SA

R03CC02 SALBUTAMOLUM R03CC02 SALBUTAMOLUM


VENTOLIN

0.04% 0.5mg/ml

SOL. INJ.
0.5mg/ml GLAXO WELLCOME UK LTD.

R03CC02 SALBUTAMOLUM
SALBUTAMOL EIPICO 2mg/5ml VENTOLIN

SIROP
2mg/5ml 2mg/5ml 2mg/5ml E.I.P.I.CO. MED S.R.L. GLAXOWELLCOME UK LTD.

2mg/5ml

R03CC02 SALBUTAMOLUM
SALBUTAMOL

SOL. ORALA
TERAPIA S.A.

2mg/5ml 4mg

R03CC02 SALBUTAMOLUM
SALBUTAMOL 4 mg 4mg

COMPR.
MAGISTRA C & C

149
TEOFILINA SR 100 mg THEO SR 100

R03DA04

THEOPHYLLINUM
CAPS. ELIB. PREL.
100mg 100mg TERAPIA SA GLAXOSMITHKLINE (GSK) SRL

R03DA04 THEOPHYLLINUM

100mg

Datorita efectelor variabile ale alimentelor asupra absorbtiei teofilinei, pacientii care folosesc un anumit preparat nu trebuie sa il schimbe cu un altul fara o monitorizare adecvata.

R03DA04 THEOPHYLLINUM
TEOFILINA SR 200 mg TEOTARD 200 THEO SR 200

CAPS. ELIB. PREL.


200mg 200mg 200mg TERAPIA SA KRKA D.D. GLAXOSMITHKLINE (GSK) SRL

200mg

Datorita efectelor variabile ale alimentelor asupra absorbtiei teofilinei, pacientii care folosesc un anumit preparat nu trebuie sa il schimbe cu un altul fara o monitorizare adecvata.

R03DA04 THEOPHYLLINUM
TEOFILINA SR 300 mg THEO SR 300

CAPS. ELIB. PREL.


300mg 300mg TERAPIA SA GLAXOSMITHKLINE (GSK) SRL

300mg

Datorita efectelor variabile ale alimentelor asupra absorbtiei teofilinei, pacientii care folosesc un anumit preparat nu trebuie sa il schimbe cu un altul fara o monitorizare adecvata.

R03DA04 THEOPHYLLINUM
TEOTARD 350

CAPS. ELIB. PREL.


350mg KRKA D.D.

350mg

Datorita efectelor variabile ale alimentelor asupra absorbtiei teofilinei, pacientii care folosesc un anumit preparat nu trebuie sa il schimbe cu un altul fara o monitorizare adecvata.

R03DA04 THEOPHYLLINUM
TEOFILINA SR 50 mg 50mg

CAPS. ELIB. PREL.


TERAPIA SA

50mg

39 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Datorita efectelor variabile ale alimentelor asupra absorbtiei teofilinei, pacientii care folosesc un anumit preparat nu trebuie sa il schimbe cu un altul fara o monitorizare adecvata.

150

R05DA04

CODEINUM
COMPR.
15mg 15mg 15mg 15mg 15mg 15mg 15mg SLAVIA PHARM SRL OZONE LABORATORIES LTD. LABORMED PHARMA SA BIO EEL SRL MAGISTRA C & C FARMACOM SA SINTOFARM SA

R05DA04 CODEINUM
CODEINA FOSFAT CODEINA FOSFAT 15 mg CODEINA FOSFAT LPH 15 mg CODEINA FOSFORICA CODEINA FOSFORICA 15 mg FARMACOD FOSFAT DE CODEINA 15 mg

15mg

R05DA04 CODEINUM
TUSOCALM 7,5mg/120mg

COMPR.
7.5mg/120mg ARENA GROUP SA

7.5mg/120mg

151
CLORFENIRAMIN

R06AB04

CHLORPHENAMINUM
COMPR.
4mg LABORMED PHARMA SA

R06AB04 CHLORPHENAMINUM

4mg

152
ANALERGIN

R06AE07

CETIRIZINUM
COMPR. FILM.
10 mg 10 mg 10mg 10mg 10mg 10mg 10mg 1mg/ml 10mg/ml IVAX PHARMCEUTICALS S.R.O.

R06AE07 CETIRIZINUM R06AE07 CETIRIZINUM


CELERG

10 mg 10 mg 10mg

COMPR. FILM.
AC HELCOR PHARMA SRL

R06AE07 CETIRIZINUM
ALERID ALERID 10 mg CETIRIZIN 10 mg LETIZEN 10 mg ZYRTEC

COMPR. FILM.
CIPLA (UK) LIMITED TERAPIA SA LAROPHARM S.R.L. KRKA D.D. U.C.B. GMBH

R06AE07 CETIRIZINUM
LETIZEN

SOL. ORALA
KRKA D.D.

1mg/ml 10mg/ml

R06AE07 CETIRIZINUM
ZYRTEC

PICATURI ORALE-SOL.
U.C.B. GMBH

153
KETOF 1 mg

R06AX17

KETOTIFENUM
CAPS.
1mg HEXAL AG

R06AX17 KETOTIFENUM R06AX17 KETOTIFENUM


H - KETOTIFEN KETOTIFEN KETOTIFEN LAROPHARM 1 mg KETOTIFEN LPH 1 mg 1mg 1mg 1mg 1mg

1mg 1mg
AC HELCOR SRL MAGISTRA C & C LAROPHARM SRL LABORMED PHARMA SA

COMPR.

R06AX17 KETOTIFENUM
FRENASMA KETOF 1 mg/5 ml

SIROP
1mg/5ml 1mg/5ml FARAN LABORATORIES S.A. HEXAL AG

1mg/5ml

154
ALCON CILOXAN CIPLOX

S01AX13

CIPROFLOXACINUM
UNG. OFT.
0.3% 0.3% ALCON COUVREUR NV CIPLA (UK) LIMITED

S01AX13 CIPROFLOXACINUM

0.3%

155

S01BC03

DICLOFENACUM
PICATURI OFT.-SOL.
0.1% 0.1% 0.1% 1mg/ml 1mg/ml DAR AL DAWA PHARMA S.R.L. UNIMED PHARMA LTD. NOVARTIS PHARMA GMBH

S01BC03 DICLOFENACUM
DICLOGESIC 0,1% PICATURI OFTALMICE, SOLUTIE UNICLOPHEN 0,1% VOLTAREN OPHTHA CD

0.1%

S01BC03 DICLOFENACUM
DICLOFENAC RPH

PIC. OFT.-SOL.
ROMPHARM COMPANY SRL

1mg/ml 1mg/ml

S01BC03 DICLOFENACUM
VURDON

PIC.OFT.-SOL.
HELP S.A. PHARMACEUTICALS

156

S01CA05

COMBINATII (BETHAMETASONUM+ANTIINFECTIOASE)
UNG. OFT.
0,2g+0,5g FARMILA FARMACEUTICI

S01CA05 COMBINATII (BETHAMETASONUM+ANTIINFECTIOASE)


BETABIOPTAL

0,2g+0,5g

S01CA05 COMBINATII (BETHAMETASONUM+ANTIINFECTIOASE)


BETABIOPTAL

PICATURI OFT.SUSP.
0,2g+0,5g FARMILA FARMACEUTICI MILANO SPA

0,2g+0,5g

40 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA B - MEDICAMENTE CU NIVEL DE COMPENSARE 50% DIN PREUL DE REFERIN. 157 A02BC02 PANTOPRAZOLUM
A02BC02 PANTOPRAZOLUM
CONTROLOC 20 mg 20mg

COMPR. FILM. GASTROREZ.


ALTANA PHARMA AG

20mg

Prescriere limitata:
CONTROLOC 40mg

Boala de reflux gastro-esofagian

A02BC02 PANTOPRAZOLUM
40mg

COMPR. FILM. GASTROREZ.


ALTANA PHARMA AG

40mg

Prescriere limitata:

Tratamentul initial al ulcerului peptic

A02BC02 PANTOPRAZOLUM
CONTROLOC 40mg LIOFILIZAT PENTRU SOLUTIE INJECTABILA 40mg

LIOF. PT. SOL. INJ.


ALTANA PHARMA AG

40mg

A02BC02 PANTOPRAZOLUM
CONTROLOC 40mg 40mg

COMPR. FILM. GASTROREZ.


ALTANA PHARMA AG

40mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Boala de reflux gastro-esofagian Sclerodermia esofagului. Sindromul Zollinger-Ellison

158
NEXIUM 20 mg

A02BC05
Prescriere limitata:

ESOMEPRAZOLUM
COMPR. FILM. GASTROREZ.
20mg ASTRAZENECA AB

A02BC05 ESOMEPRAZOLUM
Tratamentul iniial al ulcerului gastric

20mg

A02BC05 ESOMEPRAZOLUM
NEXIUM 40 mg 40mg

COMPR. FILM. GASTROREZ.


ASTRAZENECA AB

40mg

Prescriere limitata:
NEXIUM

Terapia refluxului gastro-esofagian

A02BC05 ESOMEPRAZOLUM
40mg 20mg

LIOF. PT. SOL. INJ./PERF.


ASTRAZENECA AB

40mg 20mg

A02BC05 ESOMEPRAZOLUM
NEXIUM 20 mg

COMPR. FILM. GASTROREZ.


ASTRAZENECA AB

Prescriere limitata:

Mentinerea rezultatelor terapiei refluxului gastro-esofagian

159
GASTROFAIT SUCRALAN VENTER

A02BX02

SUCRALFATUM
COMPR.
1g 1g 1g E.I.P.I.CO. MED S.R.L. LANNACHER HEILMITTEL GMBH KRKA D.D.

A02BX02 SUCRALFATUM

1g

160
DE - NOL

A02BX05

BISMUTHI SUBCITRAS
COMPR. FILM.
120mg ASTELLAS PHARMA EUROPE B.V.

A02BX05 BISMUTHI SUBCITRAS

120mg

161
SPASMOMEN

A03AB06

OTILONIUM BROMIDUM
COMPR. FILM.
40mg A. MENARINI IND. FARM. RIUNITE SRL

A03AB06 OTILONIUM BROMIDUM

40mg

162
FORLAX 10 g

A06AD15

MACROGOLUM *(2)
PULB. PT. SOL. ORALA
10g 4g BEAUFOUR IPSEN PHARMA

A06AD15 MACROGOLUM A06AD15 MACROGOLUM


FORLAX 4 g

10g 4g

PULB. PT. SOL. ORALA


BEAUFOUR IPSEN INT.

A06AD15 MACROGOLUM
FORTRANS

PULB. PT. SOL. ORALA


BEAUFOUR IPSEN INT.

163
NORMIX 100mg/5ml

A07AA11

RIFAXIMINUM
GRAN. PT. SUSP. ORALA
100mg/5ml 200mg 400mg ALFA WASSERMANN SPA

A07AA11 RIFAXIMINUM A07AA11 RIFAXIMINUM


NORMIX 200 mg

100mg/5ml 200mg 400mg

COMPR. FILM.
ALFA WASSERMANN SPA BAMA-GEVE S.L.

A07AA11 RIFAXIMINUM
NORMIX 400 mg

COMPR. FILM.

164
BUDENOFALK

A07EA06

BUDESONIDUM **
CAPS. GASTROREZ.
3mg DR. FALK PHARMA GMBH

A07EA06 BUDESONIDUM

3mg

165
HIDRASEC 100 mg

A07XA04

RACECADOTRILUM
CAPS.
100mg 10mg 30mg LAB. FOURNIER SA

A07XA04 RACECADOTRILUM A07XA04 RACECADOTRILUM


HIDRASEC 10 mg

100mg 10mg 30mg

PULB. PT. SOL. ORALA


LAB. FOURNIER SA

A07XA04 RACECADOTRILUM
HIDRASEC 30 mg

PULB. PT. SOL. ORALA


LAB. FOURNIER SA

166
LINDAXA 10 MINIMACIN 10 mg REDUCTIL 10mg

A08AA10

SIBUTRAMINUM ****
CAPS.
10mg 10mg 10mg ZENTIVA A.S. SANDOZ S.R.L. ABBOTT GMBH&CO.KG

Protocol: A003E
10mg

A08AA10 SIBUTRAMINUM

A08AA10 SIBUTRAMINUM
LINDAXA 15 MINIMACIN 15 mg REDUCTIL 15 mg 15mg 15mg 15mg

CAPS.
ZENTIVA A.S. SANDOZ S.R.L. ABBOTT GMBH&CO.KG

15mg

167
ORLISTAT GSK XENICAL 120mg

A08AB01

ORLISTATUM ****
CAPS.
120mg 120mg GLAXO GROUP LTD. ROCHE REGISTRATION LTD.

Protocol: A001E
120mg

A08AB01 ORLISTATUM

168

A08AX01

RIMONABANTUM ****
COMPR. FILM. 20mg

Protocol: A031E

A08AX01 RIMONABANTUM

41 / 233

DCI/DENUMIRE COMERCIALA
ACOMPLIA 20mg ZIMULTI 20mg

CONCENTRATIE
20mg 20mg

FORMA FARM.
SANOFI AVENTIS SANOFI AVENTIS

FIRMA

PROTOCOL

169
ALPHA D3 0,25 g

A11CC03

ALFACALCIDOLUM
CAPS. MOI
0.25g TEVA PHARMACEUTICALS SRL

A11CC03 ALFACALCIDOLUM A11CC03 ALFACALCIDOLUM


ALPHA D3 0.50 g

0.25g 0.50g
TEVA PHARMACEUTICALS S.R.L.

CAPS. MOI
0.50g

A11CC03 ALFACALCIDOLUM
ALPHA D3 1 g 1g

CAPS. MOI
TEVA PHARMACEUTICALS SRL

1g

170

A16AX01

ACIDUM TIOCTICUM (ALFA-LIPOICUM) **#


SOL. PERF.
12mg/ml 12mg/ml WORWAG PHARMA GMBH & CO. KG WORWAG PHARMA GMBH & CO. KG

Protocol: A021E
12mg/ml

A16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM)


THIOGAMMA TURBO-SE THIOGAMMA TURBO-SET

A16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM)


THIOCTACID 600T

SOL. INJ.
25mg/ml 30mg/ml 600mg 600mg VIATRIS GMBH&CO. KG

25mg/ml 30mg/ml 600mg

A16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM)


THIOGAMMA 600 INJEKT

CONC. PT. SOL. PERF.


WORWAG PHARMA GMBH & CO. KG MEDA PHARMA GMBH & CO. KG WORWAG PHARMA GMBH & CO. KG

A16AX01 ACIDUM TIOCTICUM (ALFA-LIPOICUM)


THIOCTACID 600 HR THIOGAMMA 600 oral

COMPR. FILM.

171

B01AB04

DALTEPARINUM **#
SOL. INJ.
10000UI/0.4ml PFIZER EUROPE MA EEIG

Protocol: B008D
10000UI/0.4ml 10000ui/ml
PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM
FRAGMIN 10000 UI/0,4 ml

B01AB04 DALTEPARINUM
FRAGMIN 10000 UI/ml

SOL. INJ.
10000ui/ml

B01AB04 DALTEPARINUM
FRAGMIN 12500 UI/0,5 ml

SOL. INJ.
12500 UI/0.5ml PFIZER EUROPE MA EEIG

12500 UI/0.5ml 15000ui/0.6ml


PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM
FRAGMIN15000 UI/0,6 ml

SOL. INJ.
15000ui/0.6ml

B01AB04 DALTEPARINUM
FRAGMIN 18000 UI/0,72 ml

SOL. INJ.
18000 UI/0.72ml PFIZER EUROPE MA EEIG

18000 UI/0.72ml 25000 UI/ml


PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM
FRAGMIN 25000 UI/ml

SOL. INJ.
25000 UI/ml

B01AB04 DALTEPARINUM
FRAGMIN 2500 UI/0,2 ml

SOL. INJ.
2500ui/0.2ml PFIZER EUROPE MA EEIG

2500ui/0.2ml 5000ui/0.2ml
PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM
FRAGMIN 5000 UI/0,2 ml

SOL. INJ.
5000ui/0.2ml

B01AB04 DALTEPARINUM
FRAGMIN 7500 UI/0,3 ml

SOL. INJ.
7500ui/0.3ml PFIZER EUROPE MA EEIG

7500ui/0.3ml

172
CLEXANE

B01AB05

ENOXAPARINUM **#
SOL. INJ.
100mg/ml LAB. AVENTIS

Protocol: B008D
100mg/ml 2000ui anti-Xa/0.2ml
LAB. AVENTIS

B01AB05 ENOXAPARINUM B01AB05 ENOXAPARINUM


CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

B01AB05 ENOXAPARINUM
CLEXANE 8000ui anti-Xa/0.8ml

SOL. INJ.
8000ui anti-Xa/0.8ml LAB. AVENTIS

8000ui anti-Xa/0.8ml

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

173

B01AB06

NADROPARINUM **#
SOL. INJ.
11400 uiAXa/0.6ml GLAXO GROUP LTD.

Protocol: B008D
11400 uiAXa/0.6ml 15200 uiAXa/0.8ml
GLAXO GROUP LTD.

B01AB06 NADROPARINUM
FRAXODI 11400 UI anti-factor Xa/0,6ml

B01AB06 NADROPARINUM
FRAXODI 15200 UI anti-factor Xa/0,8ml

SOL. INJ.
15200 uiAXa/0.8ml

B01AB06 NADROPARINUM
FRAXODI 19000 UI anti-factor Xa/1 ml

SOL. INJ.
19000 uiAXa/ml GLAXO GROUP LTD.

19000 uiAXa/ml

42 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

B01AB06 NADROPARINUM
FRAXIPARINE 2850 UI anti-factor Xa/0,3 ml

SOL. INJ.
2850 ui AFXa/0.3ml GLAXO GROUP LTD.

2850 ui AFXa/0.3ml

B01AB06 NADROPARINUM
FRAXIPARINE 3800 UI anti-factor Xa/0,4 ml

SOL. INJ.
3800 ui AFXa/0.4ml GLAXO GROUP LTD.

3800 ui AFXa/0.4ml

B01AB06 NADROPARINUM
FRAXIPARINE 5700 UI anti-factor Xa/0,6 ml

SOL. INJ.
5700 ui AFXa/0.6ml GLAXO GROUP LTD.

5700 ui AFXa/0.6ml 7600 ui AXa/0.8ml


GLAXO GROUP LTD.

B01AB06 NADROPARINUM
FRAXIPARINE 7600 UI anti-factor Xa/0,8 ml

SOL. INJ.
7600 ui AXa/0.8ml

174

B01AB08

REVIPARINUM **#
SOL. INJ.
1432ui/0.25ml 1432ui/0.25ml ABBOTT GMBH&CO.KG ABBOTT GMBH&CO.KG

Protocol: B008D
1432ui/0.25ml

B01AB08 REVIPARINUM
CLIVARIN 1432UI/0,25 ml CLIVARIN -PEN

B01AB08 REVIPARINUM
CLIVARIN 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml ABBOTT GMBH&CO.KG

3436ui/0.6ml 5726ui/ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN - multi

SOL. INJ.
5726ui/ml

175

B01AB10

TINZAPARINUM **#
SOL. INJ.
10000u ANTIF. Xa/ml LEO PHARMACEUTICAL PRODUCTS

Protocol: B008D
10000u ANTIF. Xa/ml

B01AB10 TINZAPARINUM
INNOHEP

B01AB10 TINZAPARINUM
INNOHEP

SOL. INJ.
20000u ANTIF. Xa/ml LEO PHARMACEUTICAL PRODUCTS

20000u ANTIF. Xa/ml

176
VESSEL DUE F

B01AB11

SULODEXIDUM **
CAPS. MOI
250ULS ALFA WASSERMANN SPA

Protocol: B014I
250ULS 600ULS/2ml
ALFA WASSERMANN SPA

B01AB11 SULODEXIDUM B01AB11 SULODEXIDUM


VESSEL DUE F

SOL. INJ.
600ULS/2ml

177
ISCOVER 75mg PLAVIX 75mg

B01AC04

CLOPIDOGRELUM **
COMPR. FILM.
75mg 75mg BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB

Protocol: B009I
75mg

B01AC04 CLOPIDOGRELUM

Cod restrictie 1719:

Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de episoade ischiemice cererbrovasculare in timpul terapiei cu doze reduse de aspirina Cod restrictie 1720: Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii la care terapia cu doze reduse de aspirina prezinta un risc major (inacceptabil) de sangerare gastrointestinala; Cod restrictie 1721: Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de reactie anafilactica , urticarie sau astm bronsic in decurs de 4 ore de la administrarea de aspirina, ali salicilati sau AINS Cod restrictie 1722: Preventia recurentei infarctului de miocard sau a anginei instabile la pacienii cu istoric de evenimente ischiemice cardiace simptomatice in timpul terapiei cu doze reduse de aspirina;. Cod restrictie 1723: Preventia recurentei infarctului de miocard sau a anginei instabile la pacientii la care terapia cu doze reduse de aspirina prezinta un risc major (inacceptabil) de sangerare gastrointestinala; Cod restrictie 1724: Preventia recurentei infarctului de miocard sau a anginei instabile la pacientii cu istoric de reactie anafilactica , urticarie sau astm bronsic in decurs de 4 ore de la administrarea de aspirina, alti salicilati sau AINS. NOTA: Nu se administreaza pentru profilaxia trombozei venoase profunde sau a bolii arteriale periferice..

178

B01AC30

COMBINATII (DIPYRIDAMOLUM+ACIDUM ACETYLSALICYLICUM) **


CAPS. ELIB. MODIF.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

B01AC30 COMBINATII (DIPYRIDAMOLUM+ACIDUM ACETYLSALICYLICUM)


AGGRENOX

Cod restrictie 1719: Cod restrictie 2966:

Preventia recurentei accidentului vascular ischiemic sau a accidentului ischemic tranzitor la pacientii cu istoric de episoade ischiemice cererbrovasculare in timpul terapiei cu doze reduse de aspirina Preventia recurentei accidentului vascular ischiemic sau a accidentului ischiemic tranzitor la pacientii cu istoric de episoade ischiemice cerebrovasculare.

179
ARIXTRA 1.5mg/0.3ml

B01AX05

FONDAPARINUX SODIUM **#


SOL. INJ. IN SERINGA PREUMPLUTA
1.5mg/0.3ml 10mg/0.8ml 2.5mg/0.5ml 2.5mg/0.5ml 5mg/0.4ml 7.5mg/0.6ml GLAXO GROUP LTD.

B01AX05 FONDAPARINUX SODIUM B01AX05 FONDAPARINUX SODIUM


ARIXTRA 10mg/0.8ml

1.5mg/0.3ml 10mg/0.8ml 2.5mg/0.5ml 5mg/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA


GLAXO GROUP LTD. GLAXO GROUP LTD. GLAXO GROUP LTD. GLAXO GROUP LTD.

B01AX05 FONDAPARINUX SODIUM


ARIXTRA 2.5mg/0.5ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B01AX05 FONDAPARINUX SODIUM


ARIXTRA 2.5mg/0.5ml ARIXTRA 5mg/0.4ml

B01AX05 FONDAPARINUX SODIUM


ARIXTRA 7.5mg/0.6ml

SOL. INJ. IN SERINGA PREUMPLUTA


GLAXO GROUP LTD.

7.5mg/0.6ml

180

B03AC02

COMPLEX DE HIDROXID DE FER (III) SUCROZA


SOL. INJ./PERF.
20mg/ml VIFOR FRANCE S.A.

B03AC02 COMPLEX DE HIDROXID DE FER (III) SUCROZA


VENOFER

20mg/ml

Cod restrictie 2070:

Anemie feripriv, la pacieni hemodializai cronic care au prezenta o reacie de hipersensibilitate documentat la fier polimaltozat i la care este indicat administrarea continu intravenoas.

181

B01AC18

TRIFLUSALUM

43 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
ZENTIVA S.A.

FIRMA

PROTOCOL

B01AC18 TRIFLUSALUM
AFLEN

CAPS.
300mg

300mg

182
MEXITIL 200 mg

C01BB02

MEXILETINUM
CAPS.
200mg BOEHRINGER INGELHEIM INT. GMBH

C01BB02 MEXILETINUM

200mg

183
CORLENTOR 5mg PROCORALAN 5 mg

C01EB17

IVABRADINUM **
COMPR. FILM.
5mg 5mg 7,5mg 7.5mg LES LAB. SERVIER LES LAB. SERVIER

Protocol: C003I
5mg

C01EB17 IVABRADINUM

C01EB17 IVABRADINUM
PROCORALAN 7,5 mg

COMPR. FILM.
LES LAB. SERVIER

7,5mg 7.5mg

C01EB17 IVABRADINUM
CORLENTOR 7,5mg

COMPR. FILM.
LES LAB. SERVIER

184
CYNT 0,2 MOXOGAMMA 0,2 mg MOXONIDIN AL 0,2 PHYSIOTENS 0,2

C02AC05

MOXONIDINUM
COMPR. FILM.
0.2mg 0.2mg 0.2mg 0.2mg SOLVAY PHARMACEUTICALS GMBH WORWAG PHARMA GMBH ALIUD PHARMA GMBH & CO.KG SOLVAY PHARMACEUTICALS GMBH

C02AC05 MOXONIDINUM

0.2mg

Prescriere limitata:
CYNT 0,3 MOXOGAMMA 0,3 mg MOXONIDIN AL 0,3 PHYSIOTENS 0,3

Hipertensiune arteriala la pacienii care primesc tratament antihipertensiv concomitent.

C02AC05 MOXONIDINUM
0.3mg 0.3mg 0.3mg 0.3mg

COMPR. FILM.
SOLVAY PHARMACEUTICALS GMBH WORWAG PHARMA GMBH ALIUD PHARMA GMBH & CO.KG SOLVAY PHARMACEUTICALS GMBH

0.3mg

Prescriere limitata:
CYNT 0,4 MOXOGAMMA 0,4 mg MOXONIDIN AL 0,4 PHYSIOTENS 0,4

Hipertensiune arteriala la pacienii care primesc tratament antihipertensiv concomitent.

C02AC05 MOXONIDINUM
0.4mg 0.4mg 0.4mg 0.4mg

COMPR. FILM.
SOLVAY PHARMACEUTICALS GMBH WORWAG PHARMA GMBH ALIUD PHARMA GMBH & CO.KG SOLVAY PHARMACEUTICALS GMBH

0.4mg

Prescriere limitata:

Hipertensiune arteriala la pacienii care primesc tratament antihipertensiv concomitent.

185
TENAXUM

C02AC06

RILMENIDINUM
COMPR.
1mg LES LABORATOIRES SERVIER INDUSTRIE

C02AC06 RILMENIDINUM

1mg

186
MINIPRESS 1 mg

C02CA01

PRAZOSINUM
COMPR.
1mg PFIZER EUROPE MA EEIG

C02CA01 PRAZOSINUM C02CA01 PRAZOSINUM


MINIPRESS 2 mg 2mg

1mg 2mg
PFIZER EUROPE MA EEIG

COMPR.

187
INSPRA 25 mg

C03DA04
Prescriere limitata:

EPLERENONUM *#
COMPR. FILM.
25mg PFIZER EUROPE MA EEIG

C03DA04 EPLERENONUM

25mg

Insuficien cardiac cu o fracie de ejecie a ventriculului stng de 40% sau mai puin, aprut la 3-14 zile de la un infarct miocardic acut. Tratmentul cu eplerenone trebuie nceput nainte de 14 zile de la data aparitiei infarctului miocardic acut. Data infarctului miocardic acut i data iniierii tratamentului cu eplerenone trebuie documentate n fia pacientului. Electroliii serici trebuie s fie verificai periodic.

C03DA04 EPLERENONUM
INSPRA 50 mg 50mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

50mg

Prescriere limitata:

Insuficien cardiac cu o fracie de ejecie a ventriculului stng de 40% sau mai puin, aprut la 3-14 zile de la un infarct miocardic acut. Tratmentul cu eplerenone trebuie nceput nainte de 14 zile de la data aparitiei infarctului miocardic acut. Data infarctului miocardic acut i data iniierii tratamentului cu eplerenone trebuie documentate n fia pacientului. Electroliii serici trebuie s fie verificai periodic.

188

C04AE02

NICERGOLINUM
COMPR. FILM.
10mg 10mg LABORMED PHARMA SA PABIANICKIE ZAKLADY FARMACEUTYCZNE POLFA

C04AE02 NICERGOLINUM
NICERGOLINA LPH 10 mg NILOGRIN 10 mg

10mg

C04AE02 NICERGOLINUM
NICERIUM 10 SINERGOLIN 10 10mg 10mg 15mg 30mg 30mg 30mg 30mg

DRAJ.
HEXAL AG SINTOFARM SA

10mg

C04AE02 NICERGOLINUM
NICERIUM 15

CAPS. ELIB. MODIF.


HEXAL AG

15mg 30mg 30mg

C04AE02 NICERGOLINUM
NICERIUM 30 UNO

CAPS. ELIB. MODIF.


HEXAL AG

C04AE02 NICERGOLINUM
NICERGOLINA LPH 30 mg NILOGRIN 30 mg SERMION

COMPR. FILM.
LABORMED PHARMA SA PABIANICKIE ZAKLADY FARMACEUTYCZNE POLFA PFIZER EUROPE MA EEIG

C04AE02 NICERGOLINUM
SINERGOLIN 30 30mg 5mg

DRAJ.
SINTOFARM SA

30mg 5mg

C04AE02 NICERGOLINUM
NICERGOLINA LPH 5 mg

COMPR. FILM.
LABORMED PHARMA SA

189
VINCAMINA

C04AX07

VINCAMINUM
DRAJ.
10mg BIOFARM SA

C04AX07 VINCAMINUM C04AX07 VINCAMINUM


VINCAMIL 20mg 30mg

10mg 20mg
FARMACEUTICI ECOBI S.A.S

COMPR. CAPS. ELIB. PREL.


GLAXOSMITHKLINE (GSK) SRL

C04AX07 VINCAMINUM
OXYBRAL SR 30 mg

30mg

190

C04AXN1

GINKGO BILOBA **

Protocol: C001I

44 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

C04AXN1 GINKGO BILOBA


GINGIUM 120m TEBOKAN

COMPR. FILM.
120mg 120mg HEXAL AG DR. WILLMAR SCHWABE GMBH & CO KG

120mg

C04AXN1 GINKGO BILOBA


BILOBIL (N06DX02) 40mg 40mg 40mg 40mg 40mg 40mg

CAPS.
KRKA D.D.

40mg 40mg

C04AXN1 GINKGO BILOBA


FLAVOTAN 40 mg (N06DX02) GINGIUM 40mg GINKOFAR 40 mg TANAKAN (EGB 761) (N06DX02) TEBOKAN

COMPR. FILM.
LABORMED PHARMA SA HEXAL AG BIOFARM SP.ZO.O IPSEN BIOTECH DR. WILLMAR SCHWABE GMBH & CO KG

C04AXN1 GINKGO BILOBA


BILOBIL FORTE 80mg 80mg 80mg

CAPS.
KRKA D.D. NOVO MESTO

80mg 80mg

C04AXN1 GINKGO BILOBA


GINGIUM 80mg TEBOKAN

COMPR. FILM.
HEXAL AG DR. WILLMAR SCHWABE GMBH & CO KG

C04AXN1 GINKGO BILOBA


TANAKAN (EGB 761) (N06DX02)

PICATURI ORALE-SOL.
40mg/ml BEAUFOUR IPSEN PHARMA

40mg/ml

191
DETRALEX

C05CA53

DIOSMINUM (COMBINATII) **
COMPR. FILM.
500mg LES LAB. SERVIER IND.

C05CA53 DIOSMINUM (COMBINATII)

500mg

192

C07AB12

NEBIVOLOLUM
COMPR.
5mg 5mg 5mg BIOFARM SP.ZO.O BERLIN CHEMIE AG MENARINI GROUP ACTAVIS S.R.L.

C07AB12 NEBIVOLOLUM
NEBICARD 5 mg NEBILET NEBIVOLOL ACTAVIS 5 mg

5mg

C07AB12 NEBIVOLOLUM
EZOCEM 5 mg 5mg

COMPR
OZONE LABORATORIES BV

5mg

193

C07BB07

COMBINATII (BISOPROLOLUM+HYDROCHLOROTHIAZIDUM)
COMPR. FILM.

C07BB07 COMBINATII (BISOPROLOLUM+HYDROCHLOROTHIAZI DUM)


LODOZ 10 mg LODOZ 2,5 mg LODOZ 5 mg

MERCK KGAA MERCK KGAA MERCK KGAA

194

C07EBN1

COMBINATII (METOPROLOLUM+FELODIPINUM)
COMPR. ELIB. PREL.
50mg+5mg ASTRAZENECA AB

C07EBN1 COMBINATII (METOPROLOLUM+FELODIPINUM)


LOGIMAX

50mg+5mg

195
LACIPIL 2 mg

C08CA09

LACIDIPINUM
COMPR. FILM.
2mg 4mg 6mg GLAXO OPERATIONS UK LTD.

C08CA09 LACIDIPINUM C08CA09 LACIDIPINUM


LACIPIL 4 mg

2mg 4mg 6mg

COMPR. FILM.
GLAXO OPERATIONS UK LTD.

C08CA09 LACIDIPINUM
LACIPIL 6 mg

COMPR. FILM.
GLAXO OPERATIONS UK LTD.

196
LERIDIP

C08CA13

LERCANIDIPINUM
COMPR. FILM.
10mg 20mg BERLIN CHEMIE AG MENARINI GROUP

C08CA13 LERCANIDIPINUM C08CA13 LERCANIDIPINUM


LERIDIP 20

10mg 20mg

COMPR. FILM.
BERLIN CHEMIE AG MENARINI GROUP

197
PRESTARIUM 10 mg

C09AA04

PERINDOPRILUM
COMPR. FILM.
10 mg LES LAB. SERVIER IND.

C09AA04 PERINDOPRILUM

10 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA04 PERINDOPRILUM
PRESTARIUM 2,5 mg 2.5mg

COMPR. FILM.
LES LAB. SERVIER IND.

2.5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA04 PERINDOPRILUM
PRENESSA 2 mg 2mg

COMPR.
KRKA, TOVARNA ZDRAVIL, D.D. NOVO MESTO

2mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA04 PERINDOPRILUM
COVEREX 4 mg PERINDOPRIL TEVA 4 mg PRENESSA 4 mg PRESTARIUM 4 mg VIDOTIN 4 mg 4mg 4mg 4mg 4mg 4mg

COMPR.
EGIS PHARMACEUTICALS LTD. TEVA PHARMACEUTICALS S.R.L. KRKA, TOVARNA ZDRAVIL, D.D. NOVO MESTO LES LAB. SERVIER IND. GEDEON RICHTER ROMANIA S.A.

4mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA04 PERINDOPRILUM
PRESTARIUM 5 mg 5mg

COMPR. FILM.
LES LAB. SERVIER IND.

5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA04 PERINDOPRILUM
PERINDOPRIL TEVA 8 mg PRESTARIUM 8 mg VIDOTIN 8 mg 8mg 8mg 8mg

COMPR.
TEVA PHARMACEUTICALS S.R.L. LES LAB. SERVIER IND. GEDEON RICHTER ROMANIA S.A.

8mg

45 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

198

C09AA07

BENAZEPRILUM
COMPR. FILM.
10mg 10mg 10mg 20mg 20mg 20mg 5mg 5mg 5mg HEXAL AG STADA ARZNEIMITTEL AG NOVARTIS PHARMA GMBH

C09AA07 BENAZEPRILUM
BENAZEPRIL SANDOZ 10 mg BENAZEPRIL STADA 10 mg CIBACEN 10 mg

10mg

C09AA07 BENAZEPRILUM
BENAZEPRIL SANDOZ 20 mg BENAZEPRIL STADA 20 mg CIBACEN 20 mg

COMPR. FILM.
HEXAL AG STADA ARZNEIMITTEL AG NOVARTIS PHARMA GMBH

20mg

C09AA07 BENAZEPRILUM
BENAZEPRIL SANDOZ 5 mg BENAZEPRIL STADA 5 mg CIBACEN 5 mg

COMPR. FILM.
HEXAL AG STADA ARZNEIMITTEL AG NOVARTIS PHARMA GMBH

5mg

199
GOPTEN 0,5 mg

C09AA10

TRANDOLAPRILUM
CAPS.
0.5mg ABBOTT GMBH&CO.KG

C09AA10 TRANDOLAPRILUM

0.5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA10 TRANDOLAPRILUM
GOPTEN 2 mg 2mg

CAPS.
ABBOTT GMBH&CO.KG

2mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA10 TRANDOLAPRILUM
GOPTEN 4 mg 4mg

CAPS.
ABBOTT GMBH&CO.KG

4mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

200
ZOMEN 30 mg

C09AA15

ZOFENOPRILUM
COMPR. FILM.
30mg 7.5mg BERLIN CHEMIE AG

C09AA15 ZOFENOPRILUM C09AA15 ZOFENOPRILUM


ZOMEN 7,5 mg

30mg 7.5mg

COMPR. FILM.
BERLIN CHEMIE AG

201

C09BA04

COMBINATII (PERINDOPRILUM+INDAPAMIDUM)
COMPR. FILM.
2,5mg/0,625mg LES LABORATOIRES SERVIER

C09BA04 COMBINATII (PERINDOPRILUM+INDAPAMIDUM)


NOLIPREL ARG 2,5mg/0,625mg

2,5mg/0,625mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09BA04 COMBINATII (PERINDOPRILUM+INDAPAMIDUM)


CO-PRENESSA 2mg/0,625 mg

COMPR.
2mg/0.625mg KRKA POLSKA SP ZO.O.

2mg/0.625mg

C09BA04 COMBINATII (PERINDOPRILUM+INDAPAMIDUM)


NOLIPREL

COMPR.
2mg+0.625mg LES LAB. SERVIER IND.

2mg+0.625mg

C09BA04 COMBINATII (PERINDOPRILUM+INDAPAMIDUM)


CO-TERTENSIF

COMPR.
4mg/1,25mg SERVIER PHARMA SRL

4mg/1,25mg

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate adecvat cu indapamide si/sau perindopril.

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09BA04 COMBINATII (PERINDOPRILUM+INDAPAMIDUM)


CO-PRENESSA 4mg/1,25 mg

COMPR.
4mg/1.25mg KRKA POLSKA SP ZO.O.

4mg/1.25mg

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate adecvat cu indapamide si/sau perindopril.

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09BA04 COMBINATII (PERINDOPRILUM+INDAPAMIDUM)


NOLIPREL FORTE PRESTARIUM PLUS

COMPR.
4mg+1.25mg 4mg+1.25mg LES LAB. SERVIER IND. LES LAB. SERVIER IND.

4mg+1.25mg

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate adecvat cu indapamide si/sau perindopril.

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09BA04 COMBINATII (PERINDOPRILUM+INDAPAMIDUM)


NOLIPREL ARG FORTE 5mg/1,25mg PRESTARIUM ARG PLUS 5mg/1,25mg

COMPR. FILM.
5mg/1,25mg 5mg/1,25mg LES LABORATOIRES SERVIER LES LABORATOIRES SERVIER

5mg/1,25mg

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate adecvat cu indapamide si/sau perindopril.

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

202

C09BA06

COMBINATII (QUINAPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR. FILM. 10mg/12.5mg

C09BA06 COMBINATII (QUINAPRILUM+HYDROCHLOROTHIAZIDU M)


ACCUZIDE

10mg/12.5mg

PFIZER EUROPE MA EEIG

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau quinapril hydrochloride in monoterapie. Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

46 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

C09BA06 COMBINATII (QUINAPRILUM+HYDROCHLOROTHIAZIDU M)


ACUZIDE FORTE EDOLFIX H 20mg/12,5mg

COMPR. FILM.

20mg/12.5mg

20mg/12.5mg 20mg/12.5mg

PFIZER EUROPE MA EEIG RANBAXY UK LIMITED

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau quinapril hydrochloride in monoterapie. Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09BA06 COMBINATII (QUINAPRILUM+HYDROCHLOROTHIAZIDU M)


ACUZIDE FORTE PLUS

COMPR. FILM.

20mg/25mg

20mg/25mg

PFIZER EUROPE MA EEIG

203

C09BA09

COMBINATII (FOSINOPRILUM+HYDROCHLOROTHIAZIDUM)
COMPR. 10mg/12.5mg

C09BA09 COMBINATII (FOSINOPRILUM+HYDROCHLOROTHIAZID UM)


FOSINOZIDE 10 mg/12,5 mg

10mg/12.5mg

BRISTOL MYERS SQUIBB KFT

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau quinapril hydrochloride in monoterapie. Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09BA09 COMBINATII (FOSINOPRILUM+HYDROCHLOROTHIAZID UM)


FOSINOZIDE 20 mg/12,5 mg

COMPR.

20mg/12.5mg

20mg/12.5mg

BRISTOL MYERS SQUIBB KFT

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau quinapril hydrochloride in monoterapie. Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

204

C09BB02

COMBINATII (NITRENDIPINUM+ENALAPRILUM)
COMPR.
10mg+20mg VITA CIENTIFICA SL

C09BB02 COMBINATII (NITRENDIPINUM+ENALAPRILUM)


ENEAS

10mg+20mg

205

C09BB10

COMBINATII (VERAPAMILUM+TRANDOLAPRILUM)
COMPR.FILM.ELIB.MODIF.
180mg/2mg ABBOTT GMBH&CO.KG

C09BB10 COMBINATII (VERAPAMILUM+TRANDOLAPRILUM)


TARKA

180mg/2mg

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu trandolaprilum in monoterapie.

C09BB10 COMBINATII (VERAPAMILUM+TRANDOLAPRILUM)


TARKA

CAPS. ELIB. MODIF.


180mg+2mg ABBOTT GMBH&CO.KG

180mg+2mg

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu trandolaprilum in monoterapie.

206
DIOVAN 160 mg

C09CA03

VALSARTANUM
COMPR. FILM.
160mg 40mg 80mg NOVARTIS PHARMA GMBH

C09CA03 VALSARTANUM C09CA03 VALSARTANUM


DIOVAN 40 mg

160mg 40mg 80mg

COMPR. FILM.
NOVARTIS PHARMA GMBH

C09CA03 VALSARTANUM
DIOVAN 80 mg

COMPR. FILM.
NOVARTIS PHARMA GMBH

207

C09CA04

IRBESARTANUM
COMPR.
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

C09CA04 IRBESARTANUM
APROVEL 150mg IRBESARTAN BMS 150mg IRBESARTAN WINTHROP 150mg KARVEA 150 mg

150mg

C09CA04 IRBESARTANUM
APROVEL 150mg IRBESARTAN BMS 150mg IRBESARTAN WINTHROP 150mg KARVEA 150 mg

COMPR. FILM.
SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

150mg

C09CA04 IRBESARTANUM
APROVEL 300mg IRBESARTAN BMS 300mg IRBESARTAN WINTHROP 300mg KARVEA 300 mg

COMPR.
300mg 300mg 300mg 300mg 300mg 300mg 300mg 300mg SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

300mg

C09CA04 IRBESARTANUM
APROVEL 300mg IRBESARTAN BMS 300mg IRBESARTAN WINTHROP 300mg KARVEA 300 mg

COMPR. FILM.
SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

300mg

C09CA04 IRBESARTANUM
APROVEL 75mg IRBESARTAN BMS 75mg IRBESARTAN WINTHROP 75mg KARVEA 75 mg 75mg 75mg 75mg 75mg 75mg 75mg 75mg 75mg

COMPR.
SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

75mg

C09CA04 IRBESARTANUM
APROVEL 75mg IRBESARTAN BMS 75mg IRBESARTAN WINTHROP 75mg KARVEA 75 mg

COMPR. FILM.
SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

75mg

47 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

208
ATACAND

C09CA06

CANDESARTANUM CILEXETIL
COMPR.
16mg ASTRAZENECA AB

C09CA06 CANDESARTANUM CILEXETIL C09CA06 CANDESARTANUM CILEXETIL


ATACAND 8mg

16mg 8mg
ASTRAZENECA AB

COMPR.

209
KINZALMONO 20mg MICARDIS 20 mg PRITOR 20 mg

C09CA07

TELMISARTANUM
COMPR.
20mg 20mg 20mg BAYER HEALTHCARE AG BOEHRINGER INGELHEIM BAYER HEALTHCARE AG

C09CA07 TELMISARTANUM

20mg

C09CA07 TELMISARTANUM
KINZALMONO 40mg MICARDIS 40 mg PRITOR 40 mg 40mg 40mg 40mg

COMPR.
BAYER HEALTHCARE AG BOEHRINGER INGELHEIM INT. GMBH BAYER HEALTHCARE AG

40mg

C09CA07 TELMISARTANUM
KINZALMONO 80mg MICARDIS 80 mg PRITOR 80 mg 80mg 80mg 80mg

COMPR.
BAYER HEALTHCARE AG BOEHRINGER INGELHEIM INT. GMBH BAYER HEALTHCARE AG

80mg

210

C09DA01

COMBINATII (LOSARTANUM+HYDROCHLOROTHIAZIDUM)
COMPR. FILM. 100mg/25mg

C09DA01 COMBINATII (LOSARTANUM+HYDROCHLOROTHIAZIDU M)


LORISTA HD 100mg/25mg

100mg/25mg

KRKA D.D. NOVO MESTO

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau losartan in monoterapie.

C09DA01 COMBINATII (LOSARTANUM+HYDROCHLOROTHIAZIDU M)


FORTZAAR 100/25 mg

COMPR. FILM.

100mg+25mg

100mg+25mg

MERCK SHARP & DOHME ROMANIA S.R.L.

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau losartan in monoterapie.

C09DA01 COMBINATII (LOSARTANUM+HYDROCHLOROTHIAZIDU M)


HYZAAR 50 mg/12,5 mg

COMPR. FILM.

50mg+12.5mg

50mg+12.5mg

MERCK SHARP & DOHME ROMANIA S.R.L.

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau losartan in monoterapie.

C09DA01 COMBINATII (LOSARTANUM+HYDROCHLOROTHIAZIDU M)


LORISTA H

COMPR.FILM

50mg+ 12,50mg

50mg+ 12,50mg

KRKA D.D. NOVO MESTO

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau losartan in monoterapie.

211

C09DA03

COMBINATII (VALSARTANUM+HYDROCHLOROTHIAZIDUM)
COMPR. FILM. 160mg/12.5mg

C09DA03 COMBINATII (VALSARTANUM+HYDROCHLOROTHIAZID UM)


CO-DIOVAN 160mg/12,5 mg

160mg/12.5mg

NOVARTIS PHARMA GMBH

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau valsartan in monoterapie.

C09DA03 COMBINATII (VALSARTANUM+HYDROCHLOROTHIAZID UM)


CO-DIOVAN 160 mg/25 mg

COMPR. FILM.

160mg/25mg

160mg/25mg

NOVARTIS PHARMA GMBH

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau valsartan in monoterapie.

C09DA03 COMBINATII (VALSARTANUM+HYDROCHLOROTHIAZID UM)


CO-DIOVAN 80 mg/12,5 mg

COMPR. FILM.

80mg/12.5mg

80mg/12.5mg

NOVARTIS PHARMA GMBH

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau valsartan in monoterapie.

212

C09DA04

COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZIDUM)
COMPR. 150mg/12,5mg

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP 150mg/12,5mg IRBESARTAN HYDROCHLOROTHIAZIDE BMS 150mg/12,5mg KARVEZIDE 150mg/12,5mg

150mg/12,5mg 150mg/12,5mg 150mg/12,5mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG BRISTOL-MYERS SQUIBB PHARMA EEIG

Prescriere limitata:

Hipertensiune arteriala la pacientii ale caror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau irbesartan in monoterapie.

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


IRBESARTAN HYDROCHLOROTHIAZIDE BMS 150mg/12,5mg KARVEZIDE 150mg/12,5mg

COMPR. FILM.

150mg/12,5mg

150mg/12,5mg 150mg/12,5mg

BRISTOL-MYERS SQUIBB PHARMA EEIG BRISTOL-MYERS SQUIBB PHARMA EEIG

Prescriere limitata:

Hipertensiune arteriala la pacientii ale caror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau irbesartan in monoterapie.

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


COAPROVEL 150mg/12.5mg

COMPR.

150mg/12.5mg

150mg/12.5mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC

Prescriere limitata:

Hipertensiune arteriala la pacientii ale caror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau irbesartan in monoterapie.

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


COAPROVEL 150mg/12.5mg

COMPR. FILM.

150mg/12.5mg

150mg/12.5mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC

48 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Hipertensiune arteriala la pacientii ale caror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau irbesartan in monoterapie.

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP 300mg/12,5mg IRBESARTAN HYDROCHLOROTHIAZIDE BMS 300mg/2,5mg KARVEZIDE 300mg/12,5mg

COMPR.

300mg/12,5mg

300mg/12,5mg 300mg/12,5mg 300mg/12,5mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG BRISTOL-MYERS SQUIBB PHARMA EEIG

Prescriere limitata:

Hipertensiune arteriala la pacientii ale caror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau irbesartan in monoterapie.

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


IRBESARTAN HYDROCHLOROTHIAZIDE BMS 300mg/12,5mg KARVEZIDE 300mg/12,5mg

COMPR. FILM.

300mg/12,5mg

300mg/12,5mg 300mg/12,5mg

BRISTOL-MYERS SQUIBB PHARMA EEIG BRISTOL-MYERS SQUIBB PHARMA EEIG

Prescriere limitata:

Hipertensiune arteriala la pacientii ale caror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau irbesartan in monoterapie.

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


COAPROVEL 300mg/12.5mg

COMPR.

300mg/12.5mg

300mg/12.5mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC

Prescriere limitata:

Hipertensiune arteriala la pacientii ale caror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau irbesartan in monoterapie.

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


COAPROVEL 300mg/12.5mg

COMPR. FILM.

300mg/12.5mg

300mg/12.5mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC

Prescriere limitata:

Hipertensiune arteriala la pacientii ale caror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau irbesartan in monoterapie.

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


COAPROVEL 300mg/25mg IRBESARTAN HYDROCHLOROTHIAZIDE BMS 300mg/25mg KARVEZIDE 300mg/25mg

COMPR. FILM.

300mg/25mg

300mg/25mg 300mg/25mg 300mg/25mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG BRISTOL-MYERS SQUIBB PHARMA EEIG

Prescriere limitata:

Hipertensiune arteriala la pacientii ale caror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau irbesartan in monoterapie.

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP 150mg/12,5mg

COMPR. FILM

150mg/12,5mg

150mg/12,5mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP 300mg/12,5mg

COMPR. FILM

300mg/12,5mg

300mg/12,5mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC

C09DA04 COMBINATII (IRBERSARTANUM+HYDROCHLOROTHIAZ IDUM)


IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP 300mg/25mg

COMPR. FILM

300mg/25mg

300mg/25mg

SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC

213

C09DA07

COMBINATII (TELMISARTANUM+HYDROCHLOROTHIAZIDUM)
COMPR. 40/12.5mg

C09DA07 COMBINATII (TELMISARTANUM+HYDROCHLOROTHIAZI DUM)


KINZALKOMB 40/12.5mg MICARDISPLUS 40/12.5mg

40/12.5mg 40/12.5mg

BAYER HEALTHCARE AG BOEHRINGER INGELHEIM INT. GMBH

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau telmisartan in monoterapie.

C09DA07 COMBINATII (TELMISARTANUM+HYDROCHLOROTHIAZI DUM)


PRITOR PLUS 40mg/12,5mg

COMPR.

40mg/12.5mg

40mg/12.5mg

BAYER HEALTHCARE AG

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau telmisartan in monoterapie.

C09DA07 COMBINATII (TELMISARTANUM+HYDROCHLOROTHIAZI DUM)


KINZALKOMB 80/12,5mg

COMPR.

80/12,5mg

80/12,5mg

BAYER HEALTHCARE AG

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau telmisartan in monoterapie.

C09DA07 COMBINATII (TELMISARTANUM+HYDROCHLOROTHIAZI DUM)


MICARDISPLUS 80/12.5mg

COMPR.

80/12.5mg

80/12.5mg

BOEHRINGER INGELHEIM INT. GMBH

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau telmisartan in monoterapie.

C09DA07 COMBINATII (TELMISARTANUM+HYDROCHLOROTHIAZI DUM)


PRITOR PLUS 80mg/12,5mg

COMPR.

80mg/12.5mg

80mg/12.5mg

BAYER HEALTHCARE AG

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau telmisartan in monoterapie.

214

C09DB01

COMBINATII ( VALSARTANUM+AMLODIPINUM)
COMPR. FILM.
10mg/160mg 10mg/160mg NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

C09DB01 COMBINATII ( VALSARTANUM+AMLODIPINUM)


COPALIA 10mg/160mg DAFIRO 10mg/160mg

10mg/160mg

49 / 233

DCI/DENUMIRE COMERCIALA
EXFORGE 10mg/160mg IMPRIDA 10mg/160mg

CONCENTRATIE
10mg/160mg 10mg/160mg

FORMA FARM.
NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

FIRMA

PROTOCOL

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau valsartan in monoterapie.

C09DB01 COMBINATII ( VALSARTANUM+AMLODIPINUM)


COPALIA 5mg/160mg DAFIRO 5mg/160mg EXFORGE 5mg/160mg IMPRIDA 5mg/160mg

COMPR. FILM.
5mg/160mg 5mg/160mg 5mg/160mg 5mg/160mg NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

5mg/160mg

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau valsartan in monoterapie.

C09DB01 COMBINATII ( VALSARTANUM+AMLODIPINUM)


COPALIA 5mg/80mg DAFIRO 5mg/80mg EXFORGE 5mg/80mg IMPRIDA 5mg/80mg

COMPR. FILM.
5mg/80mg 5mg/80mg 5mg/80mg 5mg/80mg NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

5mg/80mg

Prescriere limitata:

Hipertensiune arteriala la pacienii ale cror valori tensionale nu pot fi controlate in mod adecvat cu hydrochlorothiazida sau valsartan in monoterapie.

215
LESCOL 20

C10AA04
Prescriere limitata:

FLUVASTATINUM
CAPS.
20mg NOVARTIS PHARMA GMBH

Protocol: CE01E
20mg

C10AA04 FLUVASTATINUM

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA04 FLUVASTATINUM
LESCOL 40 40mg

CAPS.
NOVARTIS PHARMA GMBH

40mg

Prescriere limitata:
LESCOL XL

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA04 FLUVASTATINUM
80mg

COMPR. ELIB. PREL.


NOVARTIS PHARMA GMBH

80mg

Prescriere limitata:

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

216
SORTIS 10 mg

C10AA05
Prescriere limitata:

ATORVASTATINUM
COMPR. FILM.
10mg PFIZER EUROPE MA EEIG

Protocol: CE01E
10mg

C10AA05 ATORVASTATINUM

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA05 ATORVASTATINUM
SORTIS 20 mg 20mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

20mg

Prescriere limitata:
SORTIS 40 mg

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA05 ATORVASTATINUM
40mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

40mg

Prescriere limitata:
SORTIS 80 mg

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA05 ATORVASTATINUM
80mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

80mg

Prescriere limitata:

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

217
CRESTOR 10 mg

C10AA07
Prescriere limitata:

ROSUVASTATINUM
COMPR. FILM.
10mg ASTRAZENECA UK LTD.

Protocol: CE01E
10mg

C10AA07 ROSUVASTATINUM

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA07 ROSUVASTATINUM
CRESTOR 20 mg 20mg

COMPR. FILM.
ASTRAZENECA UK LTD.

20mg

Prescriere limitata:
CRESTOR 40 mg

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA07 ROSUVASTATINUM
40mg

COMPR. FILM.
ASTRAZENECA UK LTD.

40mg

Prescriere limitata:
CRESTOR 5 mg

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

C10AA07 ROSUVASTATINUM
5mg

COMPR. FILM.
ASTRAZENECA UK LTD.

5mg

Prescriere limitata:

Se utilizeaza pentru pacientii care indeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

218
BEZAFIBRAT 200 mg

C10AB02

BEZAFIBRATUM
COMPR.
200mg SLAVIA PHARM SRL

Protocol: CE01E
200mg 200mg
BERLIN CHEMIE AG MENARINI GROUP

C10AB02 BEZAFIBRATUM C10AB02 BEZAFIBRATUM


REGADRIN B

DRAJ.
200mg

219
LIPANOR 100 mg

C10AB08

CIPROFIBRATUM
CAPS.
100mg SANOFI-AVENTIS FRANCE

Protocol: CE01E
100mg

C10AB08 CIPROFIBRATUM

220
OMACOR

C10AX06

ACID OMEGA-3-ESTERI ETILICI 90 **


CAPS. MOI
1000mg PRONOVA BIOCARE AS

Protocol: C004I
1000mg

C10AX06 ACID OMEGA-3-ESTERI ETILICI 90

221
EZETROL

C10AX09
Cod restrictie 2649:

EZETIMIBUM
COMPR.
10mg MERCK SHARP & DOHME ROMANIA SRL

C10AX09 EZETIMIBUM

10mg

Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(a) boal coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib

50 / 233

DCI/DENUMIRE COMERCIALA Cod restrictie 2650:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Cod restrictie 2651:

Cod restrictie 2652:

Cod restrictie 2652:

Cod restrictie 2667:

Cod restrictie 2668:

Cod resctrictie 1989: Cod resctrictie 2669:

Cod restrictie 1991: Cod restrictie 2438:

Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(b) diabet zaharat. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(c) boala vasculara periferica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(d) hipercolesterolemie familiala heterozigota. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(e) boala cerebrovasculara simptomatica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(f) istoric familial de boala coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(g) HTA. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Pacienti care indeplinesc criteriile de eligibilitate pentru prescrierea de hipolipemiante (in concordanta cu criteriile stabilite in Protocoalele de prescriere in vederea decontarii) atunci cand tratamentul cu un inhibitor de HMG CoA reductaza (statin) este contraindicat Pacienti care indeplinesc criteriile de eligibilitate pentru prescrierea de hipolipemiante (in concordanta cu criteriile stabilite in Protocoalele de prescriere in vederea decontarii) atunci cand tratamentul cu un inhibitor de HMG CoA reductaza (statin) trebuie intrerupt sau redus la mai putin de 20 mg/zi datorita aparitiei efectelor secundare urmatoare: (i) Mialgie severa (simptome mulsculare fara cresterea CK) care survine pe perioada tratamentului cu statine; sau (ii) Miozita (cresterea importanta a CK, cu sau fara simptomatologie musculara) demonstrata prin valori de doua ori mai mari decat limita superioara a normalului la o singura determinare sau o tendinta de crestere la determinari consecutive, neexplicate de alte cauze; sau (iii) Persistenta unor valori crescute ale transaminazelor, neexplicata de alte cauze (mai mult de trei ori decat valoarea limita maxima a normalului) in timpul tratamentului cu o statina Homozygous sitosterolaemia; Pacienti cu hipercolesterolemie familiala (homozigota) care sunt eligibili pentru tratamentul cu hipolipemiante (in concordanta cu Protocolul de prescriere in vederea decontarii), in combinatie cu un inhibitor de HMG CoA reductase (statin)

222

C10BA02

COMBINATII (EZETIMIBUM + SIMVASTATINUM)


COMPR.
10mg/10mg MERCK SHARP & DOHME ROMANIA S.R.L.

C10BA02 COMBINATII (EZETIMIBUM + SIMVASTATINUM)


INEGY 10 mg/10 mg

10mg/10mg

C10BA02 COMBINATII (EZETIMIBUM + SIMVASTATINUM)


INEGY 10 mg/20 mg

COMPR.
10mg/20mg MERCK SHARP & DOHME ROMANIA S.R.L.

10mg/20mg

C10BA02 COMBINATII (EZETIMIBUM + SIMVASTATINUM)


INEGY 10 mg/40 mg

COMPR.
10mg/40mg MERCK SHARP & DOHME ROMANIA S.R.L.

10mg/40mg

51 / 233

DCI/DENUMIRE COMERCIALA Cod restrictie 2654:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Cod restrictie 2655:

Cod restrictie 2656:

Cod restrictie 2657:

Cod restrictie 2657:

Cod restrictie 2678:

Cod restrictie 2679:

Cod resctrictie 2431:

Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(a) boal coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(b) diabet zaharat. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(c) boala vasculara periferica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(d) hipercolesterolemie familiala heterozigota. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(e) boala cerebrovasculara simptomatica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(f) istoric familial de boala coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetimib. Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(g) HTA. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetimib. Pacientii cu hipercolesterolemie familiala (heterozigota) care sunt eligibili pentru tratament cu hipo-lipemiante (in concordanta cu criteriile stabilite prin Protocolul de prescriere in vederea decontarii)

C10BA02 COMBINATII (EZETIMIBUM + SIMVASTATINUM)


INEGY 10 mg/80 mg

COMPR.
10mg/80mg MERCK SHARP & DOHME ROMANIA S.R.L.

10mg/80mg

Cod restrictie 2654:

Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(a) boal coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib.

52 / 233

DCI/DENUMIRE COMERCIALA Cod restrictie 2655:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Cod restrictie 2656:

Cod restrictie 2657:

Cod restrictie 2657:

Cod restrictie 2678:

Cod restrictie 2679:

Cod resctrictie 2431:

Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(b) diabet zaharat. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(c) boala vasculara periferica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(d) hipercolesterolemie familiala heterozigota. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(e) boala cerebrovasculara simptomatica. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetimib. Valoarea colesterolului controlat inadecvat trebuie sa fie mai recenta de doua luni la momentul initierii tratamentului cu ezetimib. Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(f) istoric familial de boala coronariana. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetimib. Tratamentul, n combinatie cu dieta i exerciiu fizic, ce presupune asocierea cu un inhibitor de HMG CoA reductaza (statin) la pacienii al cror nivel de colesterol nu este controlat adecvat cu o statin i care au:(g) HTA. Controlul inadecvat sub tratament cu o statina este definit astfel: (1) nivel al colesterolului peste pragul initial dupa cel putin 3 luni de tratament cu o statina in doza zilnica de 40 mg sau mai mult, concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetinib; SAU (2) Controlul inadecvat al colesterolului cu nivele ale acestuia mai mari decat 4 mmol/litru dupa cel ptuin 3 luni de tratament cu o doza zilnica de cel putin 40 mg statine concomitent cu dieta si exercitii fizice. Doza, durata tratamentului cu statine si nivelul colesterolului controlat inadecvat trebuie sa fie inregistrate in dosarul medical al pacientului la momentul initierii tratamentului cu ezetinimb. Valoarea colesterolului controlat inadcvat trebuie sa fie mai recent de doua luni la momentul initierii tratamentului cu ezetimib. Pacientii cu hipercolesterolemie familiala (heterozigota) care sunt eligibili pentru tratament cu hipo-lipemiante (in concordanta cu criteriile stabilite prin Protocolul de prescriere in vederea decontarii)

223

C10BX03

COMBINATII (ATORVASTATINUM + AMLODIPINUM)


COMPR. FILM.
10mg/10mg PFIZER EUROPE MA EEIG

C10BX03 COMBINATII (ATORVASTATINUM + AMLODIPINUM)


CADUET 10mg/10mg

10mg/10mg

Prescriere limitata: Prescriere limitata:

Prescriere limitata:

Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor hipolipemiante in vederea decontarii, si:(a) care primesc in mod curent tratament cu un blocant de canale de calciu Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor hipolipemiante in vederea decontarii, si:(b) al caror nivel al tensiunii arteriale si/sau angina pectorala sunt insuficient controlate cu alte clase de antihipertensive si/sau medicamente anti-angina si la care terapia adjuvanta cu blocanti ai canalelor de calciu ar fi adecvata; Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor hipolipemiante in vederea decontarii, si (c) care nu tolereaza efectele secundare ale altor clase de antihipertensive si/sau medicamente anti-angina si la care inlocuirea terapiei cu un blocant de canale de calciu ar fi indicata

C10BX03 COMBINATII (ATORVASTATINUM + AMLODIPINUM)


CADUET 5mg/10mg

COMPR. FILM.
5mg/10mg PFIZER EUROPE MA EEIG

5mg/10mg

Prescriere limitata: Prescriere limitata:

Prescriere limitata:

Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor hipolipemiante in vederea decontarii, si:(a) care primesc in mod curent tratament cu un blocant de canale de calciu Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor hipolipemiante in vederea decontarii, si:(b) al caror nivel al tensiunii arteriale si/sau angina pectorala sunt insuficient controlate cu alte clase de antihipertensive si/sau medicamente anti-angina si la care terapia adjuvanta cu blocanti ai canalelor de calciu ar fi adecvata; Pentru utilizarea la pacientii cu hipertensiune arteriala si/sau angina pectorala care indeplinesc criteriile sabilite de Protocolul de prescriere a medicamentelor hipolipemiante in vederea decontarii, si (c) care nu tolereaza efectele secundare ale altor clase de antihipertensive si/sau medicamente anti-angina si la care inlocuirea terapiei cu un blocant de canale de calciu ar fi indicata

224

D01AA02

NATAMYCINUM

53 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
ASTELLAS EUROPE B.V.

FIRMA

PROTOCOL

D01AA02 NATAMYCINUM
PIMAFUCIN

CREMA
20mg/g

20mg/g

226

D01BA02

TERBINAFINUM
COMPR.
125mg 125mg 125mg 125mg MEDIS DANMARK A/S DR. REDDY'S LABORATORIES ZENTIVA AS HEXAL AG

D01BA02 TERBINAFINUM
AMIADA 125 mg EXIFINE 125 mg ONYCHON 125 TERBINAFIN SANDOZ 125 mg

125mg

Prescriere limitata:

Onicomicoza proximala sau extinsa (>80% din suprafata unghiilor) la care tratamentul topic a esuat.

D01BA02 TERBINAFINUM
AMIADA 250 mg EXIFINE 250 mg LAMISIL ONYCHON 250 TERBINAFIN SANDOZ 250 mg TERBINAFINA BIOGALENICA 250 mg TERBINAFINE 250 mg TERBINARAN TERBISIL 250 mg

COMPR.
250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg MEDIS DANMARK A/S DR. REDDY'S LABORATORIES NOVARTIS PHARMA GMBH ZENTIVA AS SANDOZ S.R.L. LABORATOARELE PROF.DR.MORAIT S.R.L. ACTAVIS GROUP HF RANBAXY UK LIMITED GEDEON RICHTER LTD.

250mg

Prescriere limitata:

Onicomicoza proximala sau extinsa (>80% din suprafata unghiilor) la care tratamentul topic a esuat.

227
DAIVONEX

D05AX02

CALCIPOTRIOLUM *
CREMA
50g/g LEO PHARMACEUTICAL PRODUCTS

D05AX02 CALCIPOTRIOLUM D05AX02 CALCIPOTRIOLUM


DAIVONEX UNGUENT

50g/g 50g/g
LEO PHARMACEUTICAL PRODUCTS

UNGUENT
50g/g

D05AX02 CALCIPOTRIOLUM
DAIVONEX SOLUTIE CUTANATA PENTRU SCALP

SOL. CUT.
50g/ml LEO PHARMACEUTICAL PRODUCTS

50g/ml 0.005%
LEK PHARMACEUTICALS D.D.

D05AX02 CALCIPOTRIOLUM
SOREL unguent 0,005%

UNGUENT
0.005%

228

D05AX52

COMBINATII (CALCIPOTRIOLUM+BETAMETHASONUM) *
UNGUENT
LEO PHARMACEUTICAL PRODUCTS

D05AX52 COMBINATII (CALCIPOTRIOLUM+BETAMETHASONUM)


DAIVOBET UNGUENT

229
NEOTIGASON

D05BB02

ACITRETINUM **
CAPS.
10mg ACTAVIS GROUP PTC EHF

D05BB02 ACITRETINUM

10mg

Cod restrictie 1363: Forme severe de psoriasis cu keratinizare intensa. Acest medicament are un mare potential teratogen - sarcina trebuie evitata pentru o perioada de cel puin doi ani dupa intreruperea tratamentului

230
FUCIDIN

D06AX01

ACIDUM FUSIDICUM
CREMA
2% LEO PHARMACEUTICAL PRODUCTS

D06AX01 ACIDUM FUSIDICUM D06AX01 ACIDUM FUSIDICUM


FUCIDIN 2%

2,00% 2,00%
LEO PHARMACEUTICAL PRODUCTS

UNGUENT

231

D06AXN1

COMBINATII (NEOMYCINUM+BACITRACINUM)
PULB. CUT.
SANDOZ GMBH

D06AXN1 COMBINATII (NEOMYCINUM+BACITRACINUM)


BANEOCIN

D06AXN1 COMBINATII (NEOMYCINUM+BACITRACINUM)


BANEOCIN NEOBACIN

UNGUENT
SANDOZ GMBH DAR AL DAWA PHARMA SRL

232
DERMAZIN 1%

D06BA01

SULFADIAZINUM
CREMA
1% LEK PHARMACEUTICALS D.D.

D06BA01 SULFADIAZINUM

1,00%

233
WARTEC 1,5 mg/g

D06BB04

PODOPHYLLOTOXINUM *
CREMA
1,5 mg/g STIEFEL LABORATORIES (UK) LTD.

D06BB04 PODOPHYLLOTOXINUM D06BB04 PODOPHYLLOTOXINUM


CONDYLINE

1,5 mg/g 5mg/ml


ASTELLAS PHARMA EUROPE B.V.

SOL. CUT.
5mg/ml

Prescriere limitata:

Pentru tratamentul verucilor.

234
ALDARA 5%

D06BB10

IMIQUIMODUM *
CREMA
5% MEDA AB

D06BB10 IMIQUIMODUM

5,00%

235

D07AB02

HYDROCORTISONUM BUTYRATUM
CREMA
0.1% 0.1% 0.1% ASTELLAS PHARMA EUROPE BV ASTELLAS PHARMA EUROPE B.V.

Protocol: D001L
0.1%

D07AB02 HYDROCORTISONUM BUTYRATUM


LOCOID crema 0,1% LOCOID LIPOCREAM 0,1%

D07AB02 HYDROCORTISONUM BUTYRATUM


LOCOID CRELO 0,1%

EMULSIE CUT.
ASTELLAS PHARMA EUROPE BV

0.1% 0.1%

D07AB02 HYDROCORTISONUM BUTYRATUM


LOCOID 0.1%

SOL. CUT.
ASTELLAS PHARMA EUROPE B.V.

236
ELOCOM

D07AC13
Prescriere limitata:

MOMETASONUM
CREMA
1mg/g SCHERING PLOUGH EUROPE

Protocol: D001L
1mg/g

D07AC13 MOMETASONUM

Tratamentul dermatozelor sensibile la administrarea de corticosteroizi topici.

D07AC13 MOMETASONUM
ELOCOM 1mg/g

SOL. CUT.
SCHERING PLOUGH EUROPE

1mg/g

Prescriere limitata:

Tratamentul dermatozelor sensibile la administrarea de corticosteroizi topici.

D07AC13 MOMETASONUM

UNGUENT

1mg/g

54 / 233

DCI/DENUMIRE COMERCIALA
ELOCOM

CONCENTRATIE
1mg/g

FORMA FARM.
SCHERING PLOUGH EUROPE

FIRMA

PROTOCOL

Prescriere limitata:

Tratamentul dermatozelor sensibile la administrarea de corticosteroizi topici.

237
ADVANTAN MILK

D07AC14
Prescriere limitata:

METHYLPREDNISOLONUM ACEPONAT
EMULSIE CUT.
0.1% INTENDIS GMBH

Protocol: D001L
0.1%

D07AC14 METHYLPREDNISOLONUM ACEPONAT

Tratamentul dermatozelor sensibile la administrarea de corticosteroizi topici.

D07AC14 METHYLPREDNISOLONUM ACEPONAT


ADVANTAN 1mg/g

CREMA
INTENDIS GmbH

1mg/g

Prescriere limitata:
ADVANTAN

Tratamentul dermatozelor sensibile la administrarea de corticosteroizi topici.

D07AC14 METHYLPREDNISOLONUM ACEPONAT


1mg/g

UNGUENT
INTENDIS GmbH

1mg/g

Prescriere limitata:

Tratamentul dermatozelor sensibile la administrarea de corticosteroizi topici.

238
CUTIVATE

D07AC17

FLUTICASONUM
CREMA
0.05% GLAXO WELLCOME UK LIMITED

Protocol: D001L
0.05% 0.005%
GLAXO WELLCOME UK LIMITED

D07AC17 FLUTICASONUM D07AC17 FLUTICASONUM


CUTIVATE

UNGUENT
0.005%

239
DERMOVATE

D07AD01

CLOBETASOLUM *
CREMA
0.05% GLAXOWELLCOME UK LTD.

Protocol: D001L
0.05% 0.05%
GLAXO WELLCOME UK LTD.

D07AD01 CLOBETASOLUM D07AD01 CLOBETASOLUM


DERMOVATE 0.05%

SOL. CUT. UNGUENT


0.05% 0.05% 0.05% FITERMAN PHARMA S.R.L. OZONE LABORATORIES LTD. GLAXOWELLCOME UK LTD.

D07AD01 CLOBETASOLUM
CLOBETASOL MK DERMIONE DERMOVATE

0.05%

240

D07CA01

COMBINATII (HYDROCORTISONUM+ANTIINFECTIOASE)
CREMA
LEO PHARMACEUTICAL PRODUCTS ASTELLAS PHARMA EUROPE B.V.

Protocol: D001L

D07CA01 COMBINATII (HYDROCORTISONUM+ANTIINFECTIOASE)


FUCIDIN H PIMAFUCORT

D07CA01 COMBINATII (HYDROCORTISONUM+ANTIINFECTIOASE)


OXIMED

SPRAY CUT. - SUSP.


MEBRA SRL

D07CA01 COMBINATII (HYDROCORTISONUM+ANTIINFECTIOASE)


PIMAFUCORT

UNGUENT
ASTELLAS PHARMA EUROPE B.V.

241

D07CC01

COMBINATII (BETAMETHASONUM+ANTIINFECTIOASE)
CREMA
A & G MED TRADING S.R.L. SCHERING PLOUGH EUROPE LEO PHARMACEUTICAL PRODUCTS SCHERING PLOUGH EUROPE

Protocol: D001L

D07CC01 COMBINATII (BETAMETHASONUM+ANTIINFECTIOASE)


BELOGENT DIPROGENTA FUCICORT TRIDERM

D07CC01 COMBINATII (BETAMETHASONUM+ANTIINFECTIOASE)


BELOGENT DIPROGENTA TRIDERM

UNGUENT
A & G MED TRADING S.R.L. SCHERING PLOUGH EUROPE SCHERING PLOUGH EUROPE

242

D07XC03

COMBINATII (MOMETASONUM + AC. SALICILICUM)


UNGUENT
SCHERING PLOUGH EUROPE

Protocol: D001L

D07XC03 COMBINATII (MOMETASONUM + AC. SALICILICUM)


ELOSALIC

243

D10AD54

COMBINATII (ISOTRETINOINUM + ERITROMICINUM)


GEL
0,05%/0,2% STIEFEL LABORATORIES (UK) LTD.

D10AD54 COMBINATII (ISOTRETINOINUM + ERITROMICINUM)


ISOTREXIN GEL

0,05%/0,2%

244
SKINOREN

D10AX03

ACIDUM AZELAICUM
CREMA
200mg/g INTENDIS GmbH

D10AX03 ACIDUM AZELAICUM D10AX03 ACIDUM AZELAICUM


SKINOREN 15% 15%

200mg/g 15%
INTENDIS GMBH

GEL

245
ROACCUTANE 10 mg SOTRET 10 mg

D10BA01

ISOTRETINOINUM **
CAPS. MOI
10mg 10mg ROCHE ROMANIA SRL RANBAXY U.K. LIMITED

D10BA01 ISOTRETINOINUM

10mg

Cod restrictie 1354: Acnee chistica severa care nu raspunde la alte tipuri de tratamente Acest medicament poate cauza defecte la nastere. Isotretinoin a fost incriminat pentru cauzarea frecventa a altor efecte toxice cu potential sever.

D10BA01 ISOTRETINOINUM
ROACCUTANE 20 mg SOTRET 20 mg 20mg 20mg

CAPS. MOI
ROCHE ROMANIA SRL RANBAXY U.K. LIMITED

20mg

Cod restrictie 1354: Acnee chistica severa care nu raspunde la alte tipuri de tratamente Acest medicament poate cauza defecte la nastere. Isotretinoin a fost incriminat pentru cauzarea frecventa a altor efecte toxice cu potential sever.

246
PIMAFUCIN

G01AA02

NATAMYCINUM
OVULE
100mg ASTELLAS PHARMA EUROPE B.V.

G01AA02 NATAMYCINUM

100mg

247

G01AA51

COMBINATII
CREMA VAG.
10g/400000UI POLICHEM SA

G01AA51 COMBINATII
MACMIROR COMPLEX

10g/400000UI

55 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
500mg/200000UI

FORMA FARM.
POLICHEM SA LAB. INNOTECH INT.

FIRMA

PROTOCOL

G01AA51 COMBINATII
MACMIROR COMPLEX

CAPS. MOI VAG. CAPS. MOI VAG.

500mg/200000UI

G01AA51 COMBINATII
POLYGYNAX

248
LOMEXIN 1000 mg

G01AF12

FENTICONAZOLUM
CAPS. MOI VAG.
1000mg 200mg 600mg 2% RECORDATI SPA

G01AF12 FENTICONAZOLUM G01AF12 FENTICONAZOLUM


LOMEXIN 200 mg

1000mg 200mg 600mg 2%

CAPS. MOI VAG.


RECORDATI SPA RECORDATI SPA RECORDATI SPA

G01AF12 FENTICONAZOLUM
LOMEXIN 600 mg

CAPS. MOI VAG. CREMA VAG.

G01AF12 FENTICONAZOLUM
LOMEXIN CREMA VAGINALA

249
GYNOFORT 2%

G01AF15

BUTOCONAZOLUM
CREMA VAG.
GEDEON RICHTER LTD.

G01AF15 BUTOCONAZOLUM

250

G01AF20

COMBINATII (METRONIDAZOLUM+CLOTRIMAZOLUM)
COMPR. VAG.
100mg/100mg GEDEON RICHTER LTD.

G01AF20 COMBINATII (METRONIDAZOLUM+CLOTRIMAZOLUM)


KLION-D 100

100mg/100mg

G01AF20 COMBINATII (METRONIDAZOLUM+CLOTRIMAZOLUM)


MECLODIN

COMPR. VAG.
500mg/200mg ARENA GROUP S.A.

500mg/200mg

251
MACMIROR

G01AX05

NIFURATELUM
DRAJ.
200mg POLICHEM SA

G01AX05 NIFURATELUM

200mg

252
DOSTINEX

G02CB03

CABERGOLINUM *
COMPR.
0.5mg PFIZER EUROPE MA EEG

Protocol: G001C
0.5mg 0.5mg
PFIZER EUROPE MA EEG

G02CB03 CABERGOLINUM G02CB03 CABERGOLINUM


DOSTINEX 0.5mg

COMPR.

Prescriere limitata: Prevenirea aparitiei lactatiei in lauzie din motive medicale Cod restrictie 2659: Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicala Cod restrictie 2660: Hiperprolactinemia patologica pentru care a fost utilizat tratament chirurgical dar cu rezultate incomplete Cod restrictie 2661: Hiperprolactinemia patologica pentru care radioterapia este contraindicata Cod restrictie 2662: Hiperprolactinemia patologica pentru care a fost utilizata radioterapia, dar cu rezultate incomplete

253
EXLUTON

G03AC02

LYNESTRENOLUM *
COMPR.
0.5mg ORGANON NV

G03AC02 LYNESTRENOLUM

0.5mg

254
POSTINOR-2

G03AC03

LEVONORGESTRELUM ***#
COMPR.
0.75mg GEDEON RICHTER PLC

Protocol: G005N
0.75mg 1.5mg

G03AC03 LEVONORGESTRELUM G03AC03 LEVONORGESTRELUM


ESCAPELLE 1,5 mg 1.5mg

COMPR.
GEDEON RICHTER PLC.

G03AC03 LEVONORGESTRELUM
NORLEVO 750g 52mg

COMPR.
LAB. HRA PHARMA

750g 52mg

G03AC03 LEVONORGESTRELUM
MIRENA 20 g/24 h

DISPOZITIV INTRAUTERIN
SCHERING OY (SCHERING AG)

255
OVESTIN

G03CA04

ESTRIOLUM *
CREMA VAG.
0.1% ORGANON NV

G03CA04 ESTRIOLUM G03CA04 ESTRIOLUM


OVESTIN 0.5mg

0.1% 0.5mg

OVULE
ORGANON NV

256
COLPOTROPHINE

G03CA09

PROMESTRIENUM *
CAPS. MOI VAG.
10mg 1% LAB. THERAMEX

G03CA09 PROMESTRIENUM G03CA09 PROMESTRIENUM


COLPOTROPHINE

10mg 1%

CREMA VAG.
LAB. THERAMEX

257

G03DA04

PROGESTERONUM *
CAPS. MOI
100mg 100mg LADEE PHARMA Kft. LAB. BESINS INTERNATIONAL

G03DA04 PROGESTERONUM
AREFAM 100 mg UTROGESTAN 100 mg

100mg

G03DA04 PROGESTERONUM
AREFAM 200 mg UTROGESTAN 200 mg

CAPS. MOI
200mg 200mg LADEE PHARMA Kft. LAB. BESINS INTERNATIONAL

200mg

G03DA04 PROGESTERONUM
MASTOPROFEN 1% PROGESTOGEL 1% 1%

GEL
ANTIBIOTICE SA LAB. BESINS INTERNATIONAL

1%

258
DUPHASTON

G03DB01

DYDROGESTERONUM *
COMPR. FILM.
10mg SOLVAY PHARMACEUTICALS BV

G03DB01 DYDROGESTERONUM

10mg

259
ORGAMETRIL

G03DC03

LYNESTRENOLUM *
COMPR.
5mg ORGANON NV

G03DC03 LYNESTRENOLUM

5mg

260
LADYBON

G03DC05

TIBOLONUM **
COMPR.
2,5mg ZENTIVA A.S.

Protocol: G007N
2,5mg 2.5mg

G03DC05 TIBOLONUM G03DC05 TIBOLONUM

COMPR.

56 / 233

DCI/DENUMIRE COMERCIALA
LIVIAL 2,5 mg

CONCENTRATIE
2.5mg

FORMA FARM.
ORGANON NV

FIRMA

PROTOCOL

261
ACTIVELLE 1mg/0,5mg

G03FA01

COMBINATII **
COMPR. FILM.
1mg/0,5mg NOVO NORDISK A/S

G03FA01 COMBINATII

1mg/0,5mg

262
FEMOSTON conti 1/5

G03FA14

COMBINATII **
COMPR. FILM.
SOLVAY PHARMACEUTICALS BV

G03FA14 COMBINATII

263
KLIMODIEN

G03FA15

ESTRADIOLUMVALERAT+DIENOGEST **
DRAJ.
SCHERING AG

Protocol: G002N

G03FA15 ESTRADIOLUMVALERAT+DIENOGEST

264
ANGELIQ

G03FA17

COMBINATII **
COMPR. FILM.
SCHERING AG

G03FA17 COMBINATII

265
CYCLO PROGINOVA

G03FB01

COMBINATII **
DRAJ.
SCHERING AG

G03FB01 COMBINATII

266
NOVOFEM

G03FB05

COMBINATII **
COMPR. FILM.
NOVO NORDISK A/S

G03FB05 COMBINATII

267
FEMOSTON 2/10 FEMOSTON 1/10

G03FB08

COMBINATII **
COMPR. FILM.
SOLVAY PHARMACEUTICALS BV SOLVAY PHARMACEUTICALS BV

G03FB08 COMBINATII

G03FB08 COMBINATII
FEMOSTON 2/10 FEMOSTON 1/10

COMPR. FILM.
SOLVAY PHARMACEUTICALS BV SOLVAY PHARMACEUTICALS BV

268

G03GA05

FOLITROPINUM ALFA ****#


PULB. + SOLV. PT. SOL. INJ.
150UI 150UI 150UI/75UI 150UI/75UI 300UI/0.5ml SERONO EUROPE LTD. SERONO EUROPE LTD.

Protocol: G003N
150UI

G03GA05 FOLITROPINUM ALFA


GONAL - f 150 UI GONAL - f 150 UI (11 g)

G03GA05 FOLITROPINUM ALFA


PERGOVERIS 150UI/75UI PERGOVERIS 150UI/75UI

PULB.+SOLV. PT. SOL. INJ.


SERONO EUROPE LTD. SERONO EUROPE LTD.

150UI/75UI

G03GA05 FOLITROPINUM ALFA


GONAL-f 300 UI/0,5 ml (22 g/0,5 ml)

PULB. + SOLV. PT. SOL. INJ.


SERONO EUROPE LTD.

300UI/0.5ml

Prescriere limitata: Infertilitate anovulatorie NOTA: Cu excepia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fr efect (sarcina nu a fost obinuta). Femeile care au urmat tratament pentru inducerea ovulaiei cu alte clase de medicamente si nu au obinut o sarcina necesita evaluare laparoscopic pentru a exclude alte cauze care mpiedica apariia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puin dousprezece luni sau amenoreea sa fie prezenta de cel puin sase luni naintea tratamentului. naintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical..

G03GA05 FOLITROPINUM ALFA


GONAL-f 300 UI/0,5 ml ( 22 g/0,5 ml)

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


300UI/0.5ml SERONO EUROPE LTD.

300UI/0.5ml

Prescriere limitata: Infertilitate anovulatorie NOTA: Cu excepia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fr efect (sarcina nu a fost obinuta). Femeile care au urmat tratament pentru inducerea ovulaiei cu alte clase de medicamente si nu au obinut o sarcina necesita evaluare laparoscopic pentru a exclude alte cauze care mpiedica apariia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puin dousprezece luni sau amenoreea sa fie prezenta de cel puin sase luni naintea tratamentului. naintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical..

G03GA05 FOLITROPINUM ALFA


GONAL-f 37,5 UI (2,8 g) 37,5UI

PULB. + SOLV. PT. SOL. INJ.


SERONO EUROPE LTD.

37,5UI 450UI/0.75ml

G03GA05 FOLITROPINUM ALFA


GONAL-f 450 UI/0,75 ml (33 g/0,75 ml)

PULB. + SOLV. PT. SOL. INJ.


450UI/0.75ml SERONO EUROPE LTD.

Prescriere limitata: Infertilitate anovulatorie NOTA: Cu excepia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fr efect (sarcina nu a fost obinuta). Femeile care au urmat tratament pentru inducerea ovulaiei cu alte clase de medicamente si nu au obinut o sarcina necesita evaluare laparoscopic pentru a exclude alte cauze care mpiedica apariia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puin dousprezece luni sau amenoreea sa fie prezenta de cel puin sase luni naintea tratamentului. naintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical..

G03GA05 FOLITROPINUM ALFA


GONAL-f 450 UI/0,75 ml (33 g/0,75 ml)

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


450UI/0.75ml SERONO EUROPE LTD.

450UI/0.75ml

Prescriere limitata: Infertilitate anovulatorie NOTA: Cu excepia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fr efect (sarcina nu a fost obinuta). Femeile care au urmat tratament pentru inducerea ovulaiei cu alte clase de medicamente si nu au obinut o sarcina necesita evaluare laparoscopic pentru a exclude alte cauze care mpiedica apariia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puin dousprezece luni sau amenoreea sa fie prezenta de cel puin sase luni naintea tratamentului. naintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical..

G03GA05 FOLITROPINUM ALFA


GONAL-f 1050 UI/1,75 ml (77 g/1,75 ml)

PULB. + SOLV. PT. SOL. INJ.


600UI/ml 75UI 75UI SERONO EUROPE LTD.

600UI/ml 75UI

G03GA05 FOLITROPINUM ALFA


GONAL - f 75 UI GONAL - f 75 UI (5,5 g)

PULB. + SOLV. PT. SOL. INJ.


SERONO EUROPE LTD. SERONO EUROPE LTD.

Prescriere limitata: Infertilitate anovulatorie NOTA: Cu excepia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fr efect (sarcina nu a fost obinuta). Femeile care au urmat tratament pentru inducerea ovulaiei cu alte clase de medicamente si nu au obinut o sarcina necesita evaluare laparoscopic pentru a exclude alte cauze care mpiedica apariia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puin dousprezece luni sau amenoreea sa fie prezenta de cel puin sase luni naintea tratamentului. naintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical..

G03GA05 FOLITROPINUM ALFA


GONAL-f 900 UI/1,5ml (66 g/1,5 ml)

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


900UI/0.75ml SERONO EUROPE LTD.

900UI/0.75ml

Prescriere limitata:

Infertilitate anovulatorie

57 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

NOTA: Cu excepia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fr efect (sarcina nu a fost obinuta). Femeile care au urmat tratament pentru inducerea ovulaiei cu alte clase de medicamente si nu au obinut o sarcina necesita evaluare laparoscopic pentru a exclude alte cauze care mpiedica apariia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puin dousprezece luni sau amenoreea sa fie prezenta de cel puin sase luni naintea tratamentului. naintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical..

G03GA05 FOLITROPINUM ALFA


PERGOVERIS 150UI/75UI PERGOVERIS 150UI/75UI

PULB.+SOLV. PT. SOL. INJ.


150UI/75UI 150UI/75UI SERONO EUROPE LTD. SERONO EUROPE LTD.

150UI/75UI

269

G03GA06

FOLLITROPINUM BETA ****#


SOL. INJ.
100UI/0.5ml N. V. ORGANON

Protocol: G008N
100UI/0.5ml 150UI/0.18ml

G03GA06 FOLLITROPINUM BETA


PUREGON 100UI/0,5ml

G03GA06 FOLLITROPINUM BETA


PUREGON 150UI/0,18 ml

SOL. INJ.
150UI/0.18ml N. V. ORGANON

G03GA06 FOLLITROPINUM BETA


PUREGON 150UI/0,5ml

SOL. INJ.
150UI/0.5ml N. V. ORGANON

150UI/0.5ml 200UI/0.5ml
N. V. ORGANON

G03GA06 FOLLITROPINUM BETA


PUREGON 200UI/0,5ml

SOL. INJ.
200UI/0.5ml

G03GA06 FOLLITROPINUM BETA


PUREGON 225UI/0,5ml

SOL. INJ.
225UI/0.5ml N. V. ORGANON

225UI/0.5ml 250UI/0.5ml
N. V. ORGANON

G03GA06 FOLLITROPINUM BETA


PUREGON 250UI/0,5ml

SOL. INJ.
250UI/0.5ml

G03GA06 FOLLITROPINUM BETA


PUREGON 300UI/0,36 ml

SOL. INJ.
300UI/0.36ml N. V. ORGANON

300UI/0.36ml

Prescriere limitata: Infertilitate anovulatorie NOTA: Cu excepia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fr efect (sarcina nu a fost obinuta). Femeile care au urmat tratament pentru inducerea ovulaiei cu alte clase de medicamente si nu au obinut o sarcina necesita evaluare laparoscopic pentru a exclude alte cauze care mpiedica apariia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puin dousprezece luni sau amenoreea sa fie prezenta de cel puin sase luni naintea tratamentului. naintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical..

G03GA06 FOLLITROPINUM BETA


PUREGON 50UI/0,5ml

SOL. INJ.
50UI/0.5ml N. V. ORGANON

50UI/0.5ml 600UI/0.72ml
N. V. ORGANON

G03GA06 FOLLITROPINUM BETA


PUREGON 600UI/0,72 ml

SOL. INJ.
600UI/0.72ml

Prescriere limitata: Infertilitate anovulatorie NOTA: Cu excepia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fr efect (sarcina nu a fost obinuta). Femeile care au urmat tratament pentru inducerea ovulaiei cu alte clase de medicamente si nu au obinut o sarcina necesita evaluare laparoscopic pentru a exclude alte cauze care mpiedica apariia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puin dousprezece luni sau amenoreea sa fie prezenta de cel puin sase luni naintea tratamentului. naintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical..

G03GA06 FOLLITROPINUM BETA


PUREGON 75UI/0,5ml

SOL. INJ.
75UI/0.5ml N. V. ORGANON

75UI/0.5ml 900UI/1.08ml
N. V. ORGANON

G03GA06 FOLLITROPINUM BETA


PUREGON 900UI/1,08 ml

SOL. INJ.
900UI/1.08ml

Prescriere limitata: Infertilitate anovulatorie NOTA: Cu excepia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fr efect (sarcina nu a fost obinuta). Femeile care au urmat tratament pentru inducerea ovulaiei cu alte clase de medicamente si nu au obinut o sarcina necesita evaluare laparoscopic pentru a exclude alte cauze care mpiedica apariia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puin dousprezece luni sau amenoreea sa fie prezenta de cel puin sase luni naintea tratamentului. naintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical..

G03GA06 FOLLITROPINUM BETA


PUREGON 100UI

PULB+SOLV. PT. SOL. INJ.


100UI/ml ORGANON NV

100UI/ml

Prescriere limitata:
PUREGON 150UI

Infertilitate anovulatorie

G03GA06 FOLLITROPINUM BETA


Prescriere limitata:
PUREGON 50UI

PULB+SOLV. PT. SOL. INJ.


150UI/ml ORGANON NV

150UI/ml

Infertilitate anovulatorie

G03GA06 FOLLITROPINUM BETA


Prescriere limitata:
PUREGON 75UI

PULB+SOLV. PT. SOL. INJ


50UI/ml ORGANON NV

50UI/ml

Infertilitate anovulatorie

G03GA06 FOLLITROPINUM BETA


Prescriere limitata: Infertilitate anovulatorie

PULB+SOLV. PT. SOL. INJ.


75UI/ml ORGANON NV

75UI/ml

270

G03GA07

LUTROPINA ALFA ****#


PULB.+SOLV. PT. SOL. INJ.
150UI/75UI 150UI/75UI 150UI/75UI 150UI/75UI 75UI SERONO EUROPE LTD. SERONO EUROPE LTD.

Protocol: G006N
150UI/75UI

G03GA07 LUTROPINA ALFA


PERGOVERIS 150UI/75UI PERGOVERIS 150UI/75UI

G03GA07 LUTROPINA ALFA


PERGOVERIS 150UI/75UI PERGOVERIS 150UI/75UI

PULB.+SOLV. PT. SOL. INJ.


SERONO EUROPE LTD. SERONO EUROPE LTD.

150UI/75UI

G03GA07 LUTROPINA ALFA


LUVERIS 75UI

PULB+SOLV.PT.SOL.INJ
SERONO EUROPE LTD.

75UI

271
CLOSTILBEGYT OVA - MIT

G03GB02

CLOMIFENUM
COMPR.
50mg 50mg EGIS PHARMACEUTICALS PLC REMEDICA LTD.

G03GB02 CLOMIFENUM

50mg

Prescriere limitata:

Infertilitate anovulatorie

272
EVISTA 60mg OPTRUMA 60mg

G03XC01

RALOXIFENUM
COMPR. FILM.
60mg 60mg ELI LILLY NEDERLAND BV ELI LILLY NEDERLAND BV

G03XC01 RALOXIFENUM

60mg

Cod restrictie 2647:

Monoterapia cu medicamente anti-resorbtive pentru tratamentul osteoporozei post-menopauza la pacientele cu fracturi consecutive unor traume minore. Ofractura vertebrala se definiste ca fiind o reducere de cel putin 20% a inaltimii pertiunii anterioare raportata la inaltimea zonei posterioare sau o reducere cu cel putin 20% a inaltimii oricarei zone a acorpului vertebral prin compararea cu inltimea corpuirilor vertrbreleor vecine, afectate. NOTA: Agentii anti-resorbtivi utilizati in tratamentul osteoporozei instalate sunt: alendronate sodium, risedronate sodium, disodium etidronate, raloxifene hydrochloride si strontium ranelate..

58 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

273
KENTERA

G04BD04

OXYBUTYNINUM
PLASTURE TRANSDERMIC
3,9mg/24h NICOBRAND LIMITED

G04BD04 OXYBUTYNINUM G04BD04 OXYBUTYNINUM


DRIPTANE 5 mg 5mg

3,9mg/24h 5mg

COMPR.
LAB. FOURNIER SA

Prescriere limitata:

Hipereactivitate a detrusorului

274
UROFLOW 1

G04BD07

TOLTERODINUM **#
COMPR. FILM.
1mg 2mg 2mg 4mg ZENTIVA A.S.

Protocol: G010N
1mg 2mg 2mg 4mg

G04BD07 TOLTERODINUM G04BD07 TOLTERODINUM


DETRUSITOL SR 2 mg

CAPS. ELIB. PREL.


PFIZER EUROPE MA EEIG

G04BD07 TOLTERODINUM
UROFLOW 2

COMPR. FILM.
ZENTIVA A.S.

G04BD07 TOLTERODINUM
DETRUSITOL SR 4 mg

CAPS. ELIB. PREL.


PFIZER EUROPE MA EEIG

275
VESICARE 10 mg

G04BD08

SOLIFENACINUM SUCCINATE **#


COMPR. FILM.
10mg 5mg ASTELLAS PHARMA EUROPE B.V.

Protocol: G009N
10mg 5mg

G04BD08 SOLIFENACINUM SUCCINATE G04BD08 SOLIFENACINUM SUCCINATE


VESICARE 5 mg

COMPR. FILM.
ASTELLAS PHARMA EUROPE B.V.

276
INKONTAN 15 mg

G04BD09

TROSPIUM
COMPR. FILM.
15mg PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H.

G04BD09 TROSPIUM G04BD09 TROSPIUM


SPASMOLYT 20 mg 20mg 30mg

15mg 20mg

DRAJ.
MADAUS GMBH

G04BD09 TROSPIUM
INKONTAN 30 mg

COMPR. FILM.
PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H.

30mg

277
ALFURAN MR 10 mg XATRAL SR 10 mg

G04CA01

ALFUZOSINUM
COMPR. ELIB. PREL.
10mg 10mg 2.5mg 5mg TERAPIA S.A. SANOFI-SYNTHELABO FRANCE

G04CA01 ALFUZOSINUM

10mg

G04CA01 ALFUZOSINUM
XATRAL 2,5 mg

COMPR. FILM.
SANOFI-SYNTHELABO FRANCE

2.5mg 5mg

G04CA01 ALFUZOSINUM
XATRAL LP 5 mg

COMPR. FILM. ELIB. PREL.


SANOFI-SYNTHELABO FRANCE

278

G04CA02

TAMSULOSINUM
CAPS. ELIB. MODIF.
0,4mg 0,4mg GEDEON RICHTER ROMANIA ACTAVIS GROUP HF.

G04CA02 TAMSULOSINUM
TAMSOL 0,4 mg TAMSULOSIN ACTAVIS

0,4mg

Prescriere limitata:

Tratamentul hiperplaziei benigne de prostata, in cazul in care tratamentul chirurgical este contraindicat, sau in care alt tratament medicamentos a esuat sau este contraindicat.

G04CA02 TAMSULOSINUM
TAMSULOSIN STADA 0,4mg

CAPS. ELIB. PREL.


STADA ARZNEIMITTEL AG

0,4mg

Prescriere limitata:

Tratamentul hiperplaziei benigne de prostata, in cazul in care tratamentul chirurgical este contraindicat, sau in care alt tratament medicamentos a esuat sau este contraindicat.

G04CA02 TAMSULOSINUM
FOKUSIN TAFLOSIN 0,4 mg TAMSULOSINI HYDROCHLORIDUM YAMANOUCHI 0.4mg 0.4mg 0.4mg

CAPS. ELIB. MODIF.

0.4mg

ZENTIVA AS MENARINI INTERNATIONAL OPERATIONS LUXEMBURG S.A. ASTELLAS PHARMA EUROPE B.V.

Prescriere limitata:

Tratamentul hiperplaziei benigne de prostata, in cazul in care tratamentul chirurgical este contraindicat, sau in care alt tratament medicamentos a esuat sau este contraindicat.

G04CA02 TAMSULOSINUM
CONTIFLO MR OMNIC 0,4 mg TANYZ 0.4mg 0.4mg 0.4mg

CAPS. ELIB. PREL.


RANBAXY UK LTD. ASTELLAS PHARMA EUROPE B.V. KRKA D.D. NOVO MESTO

0.4mg

Prescriere limitata:

Tratamentul hiperplaziei benigne de prostata, in cazul in care tratamentul chirurgical este contraindicat, sau in care alt tratament medicamentos a esuat sau este contraindicat.

G04CA02 TAMSULOSINUM
OMNIC TOCAS 0,4 0.4mg

COMPR. FILM. ELIB. PREL.


ASTELLAS PHARMA EUROPE B.V.

0.4mg

Prescriere limitata:

Tratamentul hiperplaziei benigne de prostata, in cazul in care tratamentul chirurgical este contraindicat, sau in care alt tratament medicamentos a esuat sau este contraindicat.

279

G04CB01

FINASTERIDUM *
COMPR. FILM.
5mg 5mg 5mg 5mg STADA ARZNEIMITTEL AG PLIVA LJUBLIJANA D.O.O. MERCK SHARP & DOHME ROMANIA S.R.L. DR. REDDY'S LABORATORIES

G04CB01 FINASTERIDUM
FINASTERID STADA 5 mg MOSTRAFIN PROSCAR 5 mg TAREDOX 5 mg

5mg

Prescriere limitata:

Tratamentul hiperplaziei benigne de prostata, in cazul in care tratamentul chirurgical este contraindicat, sau in care alt tratament medicamentos a esuat sau este contraindicat.

G04CB01 FINASTERIDUM
FINASTERID STADA 5 mg MOSTRAFIN PROSCAR 5 mg TAREDOX 5 mg 5mg 5mg 5mg 5mg

COMPR. FILM.
STADA ARZNEIMITTEL AG PLIVA LJUBLIJANA D.O.O. MERCK SHARP & DOHME ROMANIA S.R.L. DR. REDDY'S LABORATORIES

5mg

Prescriere limitata:

Tratamentul hiperplaziei benigne de prostata, in cazul in care tratamentul chirurgical este contraindicat, sau in care alt tratament medicamentos a esuat sau este contraindicat.

G04CB01 FINASTERIDUM
FINASTERID SANDOZ 5 mg 5 mg

COMPR. FILM.
HEXAL AG

5 mg

280

G04CB02

DUTASTERIDUM *
CAPS. MOI 0.5mg

G04CB02 DUTASTERIDUM

59 / 233

DCI/DENUMIRE COMERCIALA
AVODART

CONCENTRATIE
0.5mg

FORMA FARM.
GLAXO GROUP LTD.

FIRMA

PROTOCOL

Prescriere limitata:

Tratamentul hiperplaziei benigne de prostata, in cazul in care tratamentul chirurgical este contraindicat, sau in care alt tratament medicamentos a esuat sau este contraindicat.

281
SYNACHTEN DEPOT

H01AA02

TETRACOSACTIDUM
SUSP. INJ.
1mg/ml NOVARTIS PHARMA GMBH

H01AA02 TETRACOSACTIDUM

1mg/ml

282
OMNITROPE 1,3mg/ml

H01AC01

SOMATROPINUM ***#
PULB+SOLV.PT.SOL.INJ
1,3mg/ml SANDOZ GMBH

Protocol: H009E
1,3mg/ml 10mg/1.5ml
NOVO NORDISK A/S

H01AC01 SOMATROPINUM H01AC01 SOMATROPINUM


NORDITROPIN SIMPLEX x 10mg/1,5ml

SOL. INJ.
10mg/1.5ml

H01AC01 SOMATROPINUM
NUTROPINAq 10 mg/2 ml

SOL. INJ.
10mg/2ml IPSEN LIMITED

10mg/2ml 3,3mg/ml
SANDOZ GMBH

H01AC01 SOMATROPINUM
OMNITROPE 3,3mg/ml

SOL. INJ.
3,3mg/ml 4mg (12ui) 5.3mg/ml (16ui) 5mg/1,5ml

H01AC01 SOMATROPINUM
ZOMACTON

LIOF. + SOLV. PT. SOL. INJ.


FERING GMBH

4mg (12ui) 5.3mg/ml (16ui) 5mg/1,5ml 5mg/1.5ml

H01AC01 SOMATROPINUM
GENOTROPIN 16 ui (5,3 mg)

PULB. + SOLV. PT. SOL. INJ.


PFIZER EUROPE MA EEIG BIOPARTNERS GMBH NOVO NORDISK A/S

H01AC01 SOMATROPINUM
VALTROPIN

PULB. + SOLV. PT. SOL. INJ. SOL. INJ.


5mg/1.5ml 5mg/ml

H01AC01 SOMATROPINUM
NORDITROPIN SIMPLEXx 5 mg/1,5 ml

H01AC01 SOMATROPINUM
OMNITROPE 5mg/ml

PULB+SOLV.PT.SOL.INJ
SANDOZ GMBH

5mg/ml 6,7mg/ml

H01AC01 SOMATROPINUM
OMNITROPE 6,7mg/ml

SOL. INJ.
6,7mg/ml SANDOZ GMBH

283

H01CC01

GANIRELIXUM ***#
SOL. INJ.
0.25mg/0.5ml N. V. ORGANON

Protocol: G004N
0.25mg/0.5ml

H01CC01 GANIRELIXUM
ORGALUTRAN 0.25mg/0.5ml

284
CETROTIDE 0,25 mg

H01CC02

CETRORELIXUM ***#
LIOF. + SOLV. PT. SOL. INJ.
0.25mg 3mg SERONO EUROPE LTD.

Protocol: H004E
0.25mg 3mg

H01CC02 CETRORELIXUM H01CC02 CETRORELIXUM


CETROTIDE 3 mg

LIOF. + SOLV. PT. SOL. INJ.


SERONO EUROPE LTD.

285
ASTONIN H

H02AA02

FLUDROCORTISONUM
COMPR.
0.1mg MERCK KGAA

H02AA02 FLUDROCORTISONUM

0.1mg

286
DIPROPHOS

H02AB01

BETAMETHASONUM
SUSP. INJ. I.M.
7mg/ml SCHERING PLOUGH EUROPE

H02AB01 BETAMETHASONUM

7mg/ml

287
DECORTIN H 20 mg

H02AB06

PREDNISOLONUM
COMPR.
20 mg 250mg MERCK KGAA

H02AB06 PREDNISOLONUM H02AB06 PREDNISOLONUM


SOLU - DECORTIN H 250

20 mg 250mg 5 mg
MERCK KGAA

LIOF. + SOLV. PT. SOL. INJ.


MERCK KGAA

H02AB06 PREDNISOLONUM
DECORTIN H 5 mg 5 mg 50mg

COMPR. LIOF. + SOLV. PT. SOL. INJ.


MERCK KGAA

H02AB06 PREDNISOLONUM
SOLU - DECORTIN H 50

50mg

288
THYROZOL 10 mg

H03BB02

THIAMAZOLUM
COMPR. FILM.
10mg 20mg 5mg MERCK KGAA

H03BB02 THIAMAZOLUM H03BB02 THIAMAZOLUM


THYROZOL 20 mg

10mg 20mg 5mg

COMPR. FILM.
MERCK KGAA

H03BB02 THIAMAZOLUM
THYROZOL 5 mg

COMPR. FILM.
MERCK KGAA

289
FORCALTONIN

H05BA01

CALCITONINUM (SOMON)
SOL. INJ.
100 UI UNIGENE UK LIMITED

H05BA01 CALCITONINUM (SOMON) H05BA01 CALCITONINUM (SOMON)


TONOCALCIN 100 UI 100UI

100 UI 100UI
ALFA WASSERMANN SPA

SOL. INJ. SPRAY NAZ.,SOL.


100UI/doza 100ui/doza PHARMACEUTICAL IND. PROEL EPAM. G.CORONIS SA ALFA WASSERMANN SPA

H05BA01 CALCITONINUM (SOMON)


NYLEX 100 UI/doza TONOCALCIN

100ui/doza

H05BA01 CALCITONINUM (SOMON)


NYLEX

SOL. INJ.
100UI/ml 200ui/doza 200UI/doza PROEL E.P. CORONIS SA

100UI/ml 200UI/doza

H05BA01 CALCITONINUM (SOMON)


MIACALCIC NASAL 200 NYLEX

SPRAY NAZAL - SOL.


NOVARTIS PHARMA GMBH PROEL E.P. CORONIS SA

H05BA01 CALCITONINUM (SOMON)


TONOCALCIN 50 UI 50UI

SOL. INJ.
ALFA WASSERMANN SPA

50UI 50ui/ml
NOVARTIS PHARMA GMBH

H05BA01 CALCITONINUM (SOMON)


MIACALCIC

SOL. INJ.
50ui/ml

290
UNASYN im/iv

J01CR01

AMPICILLINUM + SULBACTAM
PULB. PT. SOL. INJ. IM/IV
1g + 500mg PFIZER EUROPE MA EEIG

J01CR01 AMPICILLINUM + SULBACTAM J01CR01 AMPICILLINUM + SULBACTAM

1g + 500mg 1g+500mg

PULB. PT. SOL. INJ.

60 / 233

DCI/DENUMIRE COMERCIALA
AMPIPLUS 1,5 g

CONCENTRATIE
1g+500mg

FORMA FARM.
ANTIBIOTICE SA

FIRMA

PROTOCOL

291
UNASYN

J01CR04

SULTAMICILLINUM
PULB. PT. SUSP. ORALA
250mg/5ml 375mg PFIZER EUROPE MA EEIG

J01CR04 SULTAMICILLINUM J01CR04 SULTAMICILLINUM


UNASYN

250mg/5ml 375mg

COMPR. FILM.
PFIZER EUROPE MA EEIG

292
CEFZIL 125 mg/5 ml

J01DC10

CEFPROZILUM
PULB. PT. SUSP. ORALA
125mg/5ml 250mg 250mg/5ml 500mg BRISTOL-MYERS SQUIBB KFT.

J01DC10 CEFPROZILUM J01DC10 CEFPROZILUM


CEFZIL 250 mg

125mg/5ml 250mg 250mg/5ml 500mg

COMPR. FILM.
BRISTOL-MYERS SQUIBB KFT. BRISTOL-MYERS SQUIBB KFT. BRISTOL-MYERS SQUIBB KFT.

J01DC10 CEFPROZILUM
CEFZIL 250 mg/5 ml

PULB. PT. SUSP. ORALA COMPR. FILM.

J01DC10 CEFPROZILUM
CEFZIL 500 mg

293
CEDAX

J01DD14

CEFTIBUTENUM
PULB. PT. SUSP. ORALA
36mg/ml SCHERING PLOUGH EUROPE

J01DD14 CEFTIBUTENUM J01DD14 CEFTIBUTENUM


CEDAX

36mg/ml 400mg

CAPS.
400mg SCHERING PLOUGH EUROPE

294
J01FA02 J01FA02

J01FA02
SPIRAMYCINUM SPIRAMYCINUM

SPIRAMYCINUM
COMPR. FILM.
1.5 M ui 3M ui LAB. AVENTIS

1.5 M ui 3M ui

ROVAMYCINE 1,5 Mil. UI ROVAMYCINE 3 Mil. UI

COMPR. FILM.
LAB. AVENTIS

295
J01FA10

J01FA10
AZITHROMYCINUM

AZITHROMYCINUM
PULB. PT. SUSP. ORALA
100mg/5ml 100mg/5ml 125mg 125mg 200 mg/5 ml 200mg/5ml 200mg/5ml SANDOZ SRL PLIVA LJUBLIJANA D.O.O.

100mg/5ml

AZITROMICINA SANDOZ 100 mg/5 ml SUMAMED

J01FA10

AZITHROMYCINUM

COMPR. FILM.
GEDEON RICHTER ROMANIA S.A. PLIVA LJUBLJANA D.O.O.

125mg

ORIGEN 125 mg SUMAMED 125 mg

J01FA10 J01FA10 J01FA10 J01FA10

AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM

PULB. PT. SUSP. ORALA


SANDOZ SRL

200 mg/5 ml 200mg/5ml 200mg/5ml 250mg

AZITROMICINA SANDOZ 200 mg/5 ml AZITROX 200 mg/5 ml SUMAMED FORTE AZATRIL 250 mg SUMAMED

PULB. + SOLV. SUSP. ORALA


ECZACIBASI PHARMACEUTICALS S.R.L. PLIVA LJUBLIJANA D.O.O. BALKANPHARMA RAZGRAD AD PLIVA LJUBLIJANA D.O.O.

PULB. PT. SUSP. ORALA CAPS.


250mg 250mg 250mg 250mg 250mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg

J01FA10

AZITHROMYCINUM

COMPR. FILM.
SANDOZ S.R.L. TERAPIA S.A. ZENTIVA AS

250mg

AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE AZITROMICINA TERAPIA 250 mg AZITROX 250

J01FA10

AZITHROMYCINUM

COMPR. FILM.
KRKA D.D. NOVO MESTO HEXAL AG SANDOZ S.R.L. TERAPIA S.A. ZENTIVA AS ECZACIBASI PHARMACEUTICALS S.R.L. GEDEON RICHTER ROMANIA S.A. PLIVA LJUBLJANA D.O.O. OZONE LABORATORIES LTD.

500mg

AZIBIOT 500 mg AZITROMICIN HEXAL 500 mg AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE AZITROMICINA TERAPIA 500 mg AZITROX 500 AZRO 500 mg ORIGEN 500 mg SUMAMED 500 mg ZITROCIN 500 mg

J01FA10
SUMAMED

AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM


2g

LIOF. PT. SOL. PERF.


PLIVA LJUBLJANA D.O.O.

500mg 600mg 500mg 250mg 2g

J01FA10 J01FA10 J01FA10 J01FA10


ZMAX 2 g

COMPR. FILM.
600mg 500mg 250mg TERAPIA S.A. SANDOZ S.R.L. HEXAL AG PFIZER EUROPE MA EEIG

AZITROMICINA TERAPIA 600 mg AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE AZITROMICIN HEXAL 250 mg

COMPR. FILM. COMPR.FILM GRAN. ELIB. PREL. PT. SUSP. ORALA

296
J01FF01
DALACIN C 150 mg

J01FF01
CLINDAMYCINUM
Prescriere limitata:

CLINDAMYCINUM
CAPS.
150mg PFIZER EUROPE MA EEIG

150mg

Infectii cu coci Gram pozitivi care nu pot fi tratate eficient cu penicilina.

J01FF01 J01FF01
CLINDAMYCIN

CLINDAMYCINUM CLINDAMYCINUM

CAPS.
300mg 300mg/2ml PFIZER EUROPE MA EEIG

300mg 300mg/2ml

DALACIN C 300 mg

SOL. INJ. I.M./I.V.


HEMOFARM S.R.L.

297

J01MA12

LEVOFLOXACINUM
COMPR. FILM.
250mg 250mg 500mg 500mg ACTAVIS GROUP PTC EHF. AVENTIS PHARMA DEUTSCHLAND GMBH

J01MA12 LEVOFLOXACINUM
LEVOFLOXACINA ACTAVIS 250 mg TAVANIC

250mg

J01MA12 LEVOFLOXACINUM
LEVOFLOXACINA ACTAVIS 500 mg TAVANIC

COMPR. FILM.
ACTAVIS GROUP PTC EHF. AVENTIS PHARMA DEUTSCHLAND GMBH

500mg

61 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

298
AVELOX 400 mg

J01MA14

MOXIFLOXACINUM
COMPR. FILM.
400mg BAYER HEALTHCARE AG

J01MA14 MOXIFLOXACINUM

400mg

299

J02AC02

ITRACONAZOLUM *
CAPS.
100mg 100mg 100mg 100mg TERAPIA S.A. MEDICO UNO PHARMACEUTICAL S.R.L. JANSSEN PHARMACEUTICA NV GEDEON RICHTER ROMANIA S.A.

J02AC02 ITRACONAZOLUM
ITRACONAZOL 100 mg OMICRAL 100 mg ORUNGAL SPORILIN 100 mg

100mg

300
J05AB11
VALTREX 500 mg

J05AB11
VALACYCLOVIRUM
Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

VALACYCLOVIRUM *
COMPR. FILM.
500mg THE WELLCOME FOUNDATION LTD.

500mg

Tratamentul pacientilor cu herpes zoster in decurs de 72 de ore de la debutul rash-ului Herpes zoster oftalmic. Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe).

301
BRIVAL

J05ABN1

BRIVUDINUM *#
COMPR.
125mg BERLIN CHEMIE AG MENARINI GROUP

J05ABN1 BRIVUDINUM

125mg

302
ENDOXAN 50 mg

L01AA01

CYCLOPHOSPHAMIDUM *
DRAJ.
50mg BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM

50mg

303

L02AE02
Prescriere limitata:

LEUPRORELINUM ***#
LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.
11.25mg ABBOTT LABORATORIES S.A.

L02AE02 LEUPRORELINUM
LUCRIN DEPOT 11,25mg

11.25mg

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

L02AE02 LEUPRORELINUM
ELIGARD 22,5 mg

LIOF. SI SOLV. PT. SOL. INJ.


22.5mg ASTELLAS PHARMA EUROPE B.V.

22.5mg

Prescriere limitata:
LUCRIN DEPOT 3,75mg

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

L02AE02 LEUPRORELINUM
Prescriere limitata:
ELIGARD 45 mg

LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.


3.75mg ABBOTT LABORATORIES S.A.

3.75mg

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

L02AE02 LEUPRORELINUM
45mg

PULB+SOLV.PT.SOL.INJ
ASTELLAS PHARMA EUROPE B.V.

45mg

Prescriere limitata:
ELIGARD 7,5 mg

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

L02AE02 LEUPRORELINUM
7.5mg

LIOF. SI SOLV. PT. SOL. INJ.


ASTELLAS PHARMA EUROPE B.V.

7.5mg

Prescriere limitata:

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

304
ZOLADEX LA

L02AE03
Prescriere limitata:

GOSERELINUM ***#
CAPS. MOI
10,8mg ASTRAZENECA UK LTD.

L02AE03 GOSERELINUM

50mg

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

L02AE03 GOSERELINUM
ZOLADEX 3.6mg

IMPLANT
ASTRAZENECA UK LTD.

3.6mg

Prescriere limitata:

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

305
DIPHERELINE 0,1 mg

L02AE04
Prescriere limitata:

TRIPTORELINUM ***#
LIOF. + SOLV. PT. SOL. INJ.
0.1mg BEAUFOUR IPSEN PHARMA

Protocol: L013E
0.1mg

L02AE04 TRIPTORELINUM

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

L02AE04 TRIPTORELINUM
DIPHERELINE 11,25 mg

LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.


11.25mg BEAUFOUR IPSEN PHARMA

11.25mg

Prescriere limitata:
DIPHERELINE 3,75 mg

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

L02AE04 TRIPTORELINUM
Prescriere limitata:

LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.


3.75mg BEAUFOUR IPSEN PHARMA

3.75mg

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

306
IMURAN

L04AX01

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

L04AX01 AZATHIOPRINUM

50mg

307

M01AC01

PIROXICAMUM
COMPR.
20mg 20mg 20mg 20mg 20mg 20mg 20mg CHIESI FARMACEUTICI SPA MEDUMAN S.A. LAROPHARM SRL ARENA GROUP SA FABIOL SA LABORMED PHARMA SA SLAVIA PHARM SRL

M01AC01 PIROXICAMUM
FLAMEXIN N - PIROXICAM MEDUMAN 20 mg PIROXICAM PIROXICAM 20 mg PIROXICAM FABIOL 20 mg PIROXICAM LPH 20 mg PIROXSAL

20mg

Prescriere limitata:
FLAMEXIN

Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AC01 PIROXICAMUM
20mg

COMPR. EFF.
CHIESI FARMACEUTICI S.P.A.

20mg

Prescriere limitata:
PIROXICAM 20 mg

Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AC01 PIROXICAMUM
20mg

SUPOZ.
SINTOFARM SA

20mg 20mg/ml
PFIZER EUROPE MA EEIG EGIS PHARMACEUTICALS PLC

M01AC01 PIROXICAMUM
FELDENE 20 mg/ml HOTEMIN

SOL. INJ.
20mg/ml 20mg/ml 20mg/plic

M01AC01 PIROXICAMUM
FLAMEXIN

PULB. PT. SOL. ORALA


CHIESI FARMACEUTICI SPA

20mg/plic 40mg

M01AC01 PIROXICAMUM

SUPOZ.

62 / 233

DCI/DENUMIRE COMERCIALA
PIROXICAM 40 mg

CONCENTRATIE
40mg

FORMA FARM.
ANTIBIOTICE SA

FIRMA

PROTOCOL

308
XEFO 4 mg

M01AC05
Prescriere limitata:

LORNOXICAMUM
COMPR. FILM.
4mg NYCOMED AUSTRIA GMBH

M01AC05 LORNOXICAMUM

4mg

Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AC05 LORNOXICAMUM
XEFO 8 mg 8mg

COMPR. FILM.
NYCOMED AUSTRIA GMBH

8mg

Prescriere limitata:
XEFO 8 mg/ 2 ml

Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AC05 LORNOXICAMUM
Prescriere limitata:

PULB. + SOLV. PT. SOL. INJ.


8mg/2ml NYCOMED AUSTRIA GMBH

8mg/2ml

Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

309
TADOR

M01AE17
Prescriere limitata:

DEXKETOPROFENUM
COMPR. FILM.
25mg BERLIN CHEMIE AG MENARINI GROUP

M01AE17 DEXKETOPROFENUM

25mg

Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AE17 DEXKETOPROFENUM
TADOR INJECT

SOL. INJ./CONC. PT. SOL. PERF.


50mg/2ml MENARINI INTERNATIONAL OPERATIONS S.A.

50mg/2ml

Prescriere limitata:

Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

310
CELEBREX 100 mg

M01AH01
Prescriere limitata: Prescriere limitata:

CELECOXIBUM
CAPS.
100mg PFIZER EUROPE MA EEIG

M01AH01 CELECOXIBUM

100mg

Tratamentul simptomatic al osteoartritelor. Tratamentul simptomatic al poliartritei reumatoide

M01AH01 CELECOXIBUM
CELEBREX 200 mg

CAPS.
200mg PFIZER EUROPE MA EEIG

200mg

Prescriere limitata: Prescriere limitata:

Tratamentul simptomatic al osteoartritelor. Tratamentul simptomatic al poliartritei reumatoide

311
ARCOXIA 120 mg

M01AH05
Prescriere limitata: Prescriere limitata:

ETORICOXIBUM
COMPR. FILM.
120mg MERCK SHARP & DOHME ROMANIA S.R.L.

M01AH05 ETORICOXIBUM

120mg

Tratamentul simptomatic al osteoartritelor. Tratamentul simptomatic al poliartritei reumatoide

M01AH05 ETORICOXIBUM
ARCOXIA 60 mg 60mg

COMPR. FILM.
MERCK SHARP & DOHME ROMANIA S.R.L.

60mg

Prescriere limitata: Prescriere limitata:


ARCOXIA 90 mg

Tratamentul simptomatic al osteoartritelor. Tratamentul simptomatic al poliartritei reumatoide

M01AH05 ETORICOXIBUM
90mg

COMPR. FILM.
MERCK SHARP & DOHME ROMANIA S.R.L.

90mg

Prescriere limitata: Prescriere limitata:

Tratamentul simptomatic al osteoartritelor. Tratamentul simptomatic al poliartritei reumatoide

312
FLEXODON FORTE

M01AX05

GLUCOSAMINUM
PULB. PT. SOL. ORALA
1.5g/plic 150mg/plic CSC PHARMACEUTICALS HANDELS GMBH

M01AX05 GLUCOSAMINUM M01AX05 GLUCOSAMINUM


DONA

1.5g/plic 150mg/plic

PULB. PT. SOL. ORALA


ROTTAPHARM SPA

313

M01AX17

NIMESULIDUM
COMPR.
100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg/plic 100mg/plic MEDOCHEMIE LTD CSC PHARMACEUTICALS HANDELS GMBH ZENTIVA AS ANFARM HELLAS S.A. PHARMACEUTICALS LABORMED PHARMA SA MAGISTRA C & C ARENA GROUP S.A. SLAVIA PHARM SRL DR. REDDY'S LABORATORIES

M01AX17 NIMESULIDUM
APONIL AULIN 100 mg COXTRAL LEMESIL NIMESULID LPH 100 mg NIMESULID 100 mg NIMESULID ARENA 100 mg NIMESULID SLAVIA NISE 100 mg

100mg

M01AX17 NIMESULIDUM
SULIDAMOR

PULB. PT. SUSP. ORALA


FARMACEUTICI DAMOR SPA

100mg 100mg/plic

M01AX17 NIMESULIDUM
AULIN NIMESIL

GRAN. PT. SUSP. ORALA


CSC PHARMACEUTICALS HANDELS GMBH LAB. GUIDOTTI SPA

314
LIORESAL

M03BX01

BACLOFENUM
COMPR.
10mg NOVARTIS PHARMA GMBH

M03BX01 BACLOFENUM M03BX01 BACLOFENUM


LIORESAL 25mg

10mg 25mg
NOVARTIS PHARMA GMBH

COMPR.

315
FOSAMAX 10 mg TEVA NAT 10 mg

M05BA04

ACIDUM ALENDRONICUM *
COMPR.
10mg 10mg MERCK SHARP & DOHME S.R.L. TEVA PHARMACEUTICALS S.R.L.

M05BA04 ACIDUM ALENDRONICUM

10mg

M05BA04 ACIDUM ALENDRONICUM


FOSAMAX 5mg

COMPR.
MERCK SHARP & DOHME ROMANIA S.R.L.

5mg 70 mg
TEVA PHARMACEUTICALS SRL

M05BA04 ACIDUM ALENDRONICUM


TEVA NAT 70 mg

COMPR. COMPR.
70mg 70mg MERCK SHARP & DOHME S.R.L.

M05BA04 ACIDUM ALENDRONICUM


FOSAMAX 70 mg

70mg 70mg

M05BA04 ACIDUM ALENDRONICUM


ALENDRONAT SANDOZ 70 mg

COMPR. FILM.
SANDOZ S.R.L.

316

M05BA06

ACIDUM IBANDRONICUM *

63 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

FIRMA

PROTOCOL

M05BA06 ACIDUM IBANDRONICUM


BONDEZA 150mg BONVIVA 150mg

COMPR. FILM.
150mg 150mg 2.5mg 2.5mg

150mg

M05BA06 ACIDUM IBANDRONICUM


BONDEZA 2.5mg BONVIVA 2.5mg

COMPR. FILM.
ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

2.5mg

317

M05BA07

ACIDUM RISEDRONICUM *
COMPR. FILM.
35mg 35mg 5mg AVENTIS PHARMA AB ZENTIVA A.S.

M05BA07 ACIDUM RISEDRONICUM


ACTONEL SAPTAMANAL RISENDROS 35 mg

35mg

M05BA07 ACIDUM RISEDRONICUM


ACTONEL 5 mg

COMPR. FILM.
AVENTIS PHARMA AB

5mg

318
OSSEOR 2 g PROTELOS 2 g

M05BX03

STRONTIUM RANELATUM *
GRAN. PT. SUSP. ORALA
2g 2g LES LAB. SERVIER LES LAB. SERVIER IND.

M05BX03 STRONTIUM RANELATUM

2g

319

M05BB03

COMBINATII (ACIDUM ALENDRONICUM+COLECALCIFEROLUM) *


COMPR.
70mg/2800UI 70mg/2800UI MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD.

M05BB03 COMBINATII (ACIDUM ALENDRONICUM+COLECALCIFEROLUM)


ADROVANCE 70mg/2800UI FOSAVANCE 70mg/2800UI

70mg/2800UI

M05BB03 COMBINATII (ACIDUM ALENDRONICUM+COLECALCIFEROLUM)


ADROVANCE 70mg/5600UI FOSAVANCE 70mg/5600UI

COMPR.
70mg/5600UI 70mg/5600UI MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD.

70mg/5600UI

320
OXYCONTIN 10 mg

N02AA05

OXYCODONUM *#
COMPR. FILM. ELIB. MODIF.
10 mg MUNDIPHARMA GMBH

N02AA05 OXYCODONUM

10 mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA05 OXYCODONUM
OXYCONTIN 20 mg 20 mg

COMPR. FILM. ELIB. MODIF.


MUNDIPHARMA GMBH

20 mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA05 OXYCODONUM
OXYCONTIN 40 mg 40 mg

COMPR. FILM. ELIB. MODIF.


MUNDIPHARMA GMBH

40 mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA05 OXYCODONUM
OXYCONTIN 80 mg 80mg

COMPR. FILM. ELIB. MODIF.


MUNDIPHARMA GMBH

80mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

321

N02AA08

DIHYDROCODEINUM *
COMPR. ELIB. PREL.
120mg 60mg 90mg MUNDIPHARMA GMBH

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 120 mg

120mg 60mg 90mg

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 60 mg

COMPR. ELIB. PREL.


MUNDIPHARMA GMBH

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 90 mg

COMPR. ELIB. PREL.


MUNDIPHARMA GMBH

322

N02AX52

COMBINATII (TRAMADOLUM+PARACETAMOLUM)
COMPR. FILM.
37,5mg+325mg GRUNENTHAL GMBH

N02AX52 COMBINATII (TRAMADOLUM+PARACETAMOLUM)


ZALDIAR

37,5mg+325mg

323
RIVOTRIL

N03AE01

CLONAZEPAMUM
COMPR.
0.5mg ROCHE ROMANIA S.R.L.

N03AE01 CLONAZEPAMUM N03AE01 CLONAZEPAMUM


RIVOTRIL 2mg

0.5mg 2mg
ROCHE ROMANIA S.R.L.

COMPR.

324
LYRICA 100 mg

N03AX16

PREGABALINUM **#
CAPS.
100mg PFIZER LTD.

Protocol: N025G;N032G
100mg 150mg
PFIZER LTD.

N03AX16 PREGABALINUM N03AX16 PREGABALINUM


LYRICA 150 mg

CAPS.
150mg

N03AX16 PREGABALINUM
LYRICA 200 mg

CAPS.
200mg PFIZER LTD.

200mg 225mg
PFIZER LTD.

N03AX16 PREGABALINUM
LYRICA 225 mg

CAPS.
225mg

N03AX16 PREGABALINUM
LYRICA 25 mg 25mg

CAPS.
PFIZER LTD.

25mg 300mg
PFIZER LTD.

N03AX16 PREGABALINUM
LYRICA 300 mg

CAPS.
300mg

64 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
PFIZER LTD.

FIRMA

PROTOCOL

N03AX16 PREGABALINUM
LYRICA 50 mg 50mg

CAPS. CAPS.
75mg PFIZER LTD.

50mg 75mg

N03AX16 PREGABALINUM
LYRICA 75 mg

325
AKINETON

N04AA02

BIPERIDENUM
COMPR.
2mg DESMA GMBH

N04AA02 BIPERIDENUM

2mg

326
SIFROL 0,088mg

N04BC05

PRAMIPEXOLUM *
COMPR.
0,088mg BOEHRINGER INGELHEIM INT. GMBH

N04BC05 PRAMIPEXOLUM

0,088mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
SIFROL 0,18mg

COMPR.
0,18mg BOEHRINGER INGELHEIM INT. GMBH

0,18mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
SIFROL 0,70mg

COMPR.
0,70mg BOEHRINGER INGELHEIM INT. GMBH

0,70mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 0,088 mg

COMPR.
0.088mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH

0.088mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 0,18 mg

COMPR.
0.18mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH

0.18mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 0,35 mg SIFROL 0.35mg

COMPR.
0.35mg 0.35mg BOEHRINGER INGELHEIM INT. GMBH BOEHRINGER INGELHEIM INT. GMBH

0.35mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 0,7 mg 0.7mg

COMPR.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

0.7mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 1,1mg SIFROL 1,1mg 1,1mg 1,1mg

COMPR.
BOEHRINGER INGELHEIM INT. GMBH BOEHRINGER INGELHEIM INT. GMBH

1,1mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

327

N04BXN1

PIRIBEDILUM **
DRAJ. ELIB. PREL.
50mg LES LAB. SERVIER IND.

N04BXN1 PIRIBEDILUM
PRONORAN 50 mg LP (C04AX13)

50mg

328
TIAPRIDAL 100 mg

N05AL03

TIAPRIDUM
COMPR.
100mg SANOFI-SYNTHELABO FRANCE

N05AL03 TIAPRIDUM N05AL03 TIAPRIDUM


TIAPRIDAL 100 mg/2 ml

100mg 100mg/2ml
SANOFI-AVENTIS FRANCE

SOL. INJ.
100mg/2ml

329
SPITOMIN 10 mg STRESSIGAL

N05BE01

BUSPIRONUM
COMPR.
10mg 10mg EGIS PHARMACEUTICALS PLC ANFARM HELLAS S.A. PHARMACEUTICALS

N05BE01 BUSPIRONUM

10mg

Prescriere limitata:
SPITOMIN 5 mg

Pentru tratamentul de scurta durata al anxietatii

N05BE01 BUSPIRONUM
5mg

COMPR.
EGIS PHARMACEUTICALS PLC

5mg

Prescriere limitata:

Pentru tratamentul de scurta durata al anxietatii

330
LUDIOMIL 10 mg

N06AA21

MAPROTILINUM *
COMPR. FILM.
10mg 25mg NOVARTIS PHARMA GMBH

N06AA21 MAPROTILINUM N06AA21 MAPROTILINUM


LUDIOMIL 25 mg

10mg 25mg

COMPR. FILM.
NOVARTIS PHARMA GMBH

331
CIPRALEX 10 mg

N06AB10

ESCITALOPRAMUM **
COMPR. FILM.
10mg 15mg 20mg 5mg H. LUNDBECK A/S

Protocol: N009F
10mg 15mg 20mg 5mg

N06AB10 ESCITALOPRAMUM N06AB10 ESCITALOPRAMUM


CIPRALEX 15 mg

COMPR. FILM.
H. LUNDBECK A/S

N06AB10 ESCITALOPRAMUM
CIPRALEX 20 mg

COMPR. FILM.
H. LUNDBECK A/S

N06AB10 ESCITALOPRAMUM
CIPRALEX 5 mg

COMPR. FILM.
H. LUNDBECK A/S

332
TRITTICO AC 150 mg

N06AX05

TRAZODONUM **
COMPR. ELIB. PREL.
150mg 75mg ANGELINI FRANCESCO SPA

Protocol: N010F
150mg 75mg

N06AX05 TRAZODONUM N06AX05 TRAZODONUM


TRITTICO AC 75 mg

COMPR. ELIB. PREL.


ANGELINI FRANCESCO SPA

333
COAXIL

N06AX14

TIANEPTINUM **
DRAJ.
12.5mg LES LAB. SERVIER IND.

Protocol: N011F
12.5mg

N06AX14 TIANEPTINUM

334
IXEL

N06AX17

MILNACIPRANUM **
CAPS.
25mg PIERRE FABRE MEDICAMENT

Protocol: N002F
25mg 50mg
PIERRE FABRE MEDICAMENT

N06AX17 MILNACIPRANUM N06AX17 MILNACIPRANUM


IXEL 50mg

CAPS.

335

N06AX21

DULOXETINUM **

Protocol: N014F

65 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
20 mg 20mg 30mg 30mg 30mg 40 mg 40mg

FORMA FARM.
ELI LILLY NEDERLAND BV

FIRMA

PROTOCOL

N06AX21 DULOXETINUM
YENTREVE 20mg

CAPS. GASTROREZ. CAPS. GASTROREZ.


ELI LILLY NEDERLAND BV

20 mg 20mg 30mg

N06AX21 DULOXETINUM
ARICLAIM 20mg

N06AX21 DULOXETINUM
ARICLAIM 30mg CYMBALTA 30mg XERISTAR 30mg

CAPS. GASTROREZ.
ELI LILLY NEDERLAND BV ELI LILLY NEDERLAND BV BOEHRINGER INGELHEIM INTERNATIONAL GMBH

N06AX21 DULOXETINUM
YENTREVE 40mg

COMPR. FILM. ELIB. PREL.


ELI LILLY NEDERLAND BV

1000 mg 100mg/10ml 100mg/50ml

N06AX21 DULOXETINUM
ARICLAIM 40mg

CONC. PT. SOL. PERF.


ELI LILLY NEDERLAND BV

N06AX21 DULOXETINUM
ARICLAIM 60mg CYMBALTA 60mg XERISTAR 60mg 60mg 60mg 60mg

SOL. PERF.
ELI LILLY NEDERLAND BV ELI LILLY NEDERLAND BV BOEHRINGER INGELHEIM INTERNATIONAL GMBH

336

N06AXN1

BUPROPIONUM **#
COMPR. FILM. ELIB. PREL.
150mg 250mg 250mg GLAXO WELLCOME UK LTD.

N06AXN1 BUPROPIONUM
WELLBUTRIN SR 150 mg

150mg 250mg

N06AXN1 BUPROPIONUM
HYPERFORAT 250 mg REMOTIV 250

COMPR. FILM.
DR. GUSTAV KLEIN ARZNEIPFLA EWOPHARMA INTERNATIONAL SRO

N06AXN1 BUPROPIONUM
FELIS

CAPS.
425mg 500mg HEXAL AG

425mg 500mg

N06AXN1 BUPROPIONUM
REMOTIV 500

COMPR. FILM.
EWOPHARMA INTERNATIONAL SRO

337
PRAMISTAR

N06BX16

PRAMIRACETAMUM **#
COMPR. FILM.
600mg F.I.R.M.A. S.p.a. (MENARINI GROUP)

N06BX16 PRAMIRACETAMUM

600mg

338
CAVINTON FORTE

N06BX18

VINPOCETINUM
COMPR.
10mg 10mg/2ml GEDEON RICHTER LTD.

N06BX18 VINPOCETINUM N06BX18 VINPOCETINUM


CAVINTON

10mg 10mg/2ml 5mg


VIM SPECTRUM SRL LAROPHARM SRL

CONC. PT. SOL. PERF.


GEDEON RICHTER LTD.

N06BX18 VINPOCETINUM
VIMPOCETIN 5 mg VINPOCETIN 5 mg 5mg 5mg

CAPS.

N06BX18 VINPOCETINUM
CAVINTON VICEBROL 5mg 5mg

COMPR.
GEDEON RICHTER LTD. BIOFARM SP.ZO.O

5mg

339
MICROSER

N07CA01

BETAHISTINUM
SOL. ORALA IN PICATURI
1.25% PRODOTTI FORMENTI

N07CA01 BETAHISTINUM N07CA01 BETAHISTINUM


BETASERC 16 mg 16mg

1.25% 16mg

COMPR.
SOLVAY PHARMACEUTICALS BV

N07CA01 BETAHISTINUM
BETASERC 24 mg 24mg

COMPR.
SOLVAY PHARMACEUTICALS BV

24mg 80mg
A & G MED TRADING S.R.L.

N07CA01 BETAHISTINUM
URUTAL 8 mg 80mg

COMPR. COMPR.
8mg 8mg 8mg SOLVAY PHARMACEUTICALS BV PRODOTTI FORMENTI ACTAVIS GROUP HF.

N07CA01 BETAHISTINUM
BETASERC 8 mg MICROSER VESTIBO 8 mg

8mg

340

N07CA52

COMBINATII (CINNARIZINUM+DIMENHIDRATUM)
COMPR.
HENNIG ARZNEIMITTEL GMBH & CO.KG

N07CA52 COMBINATII (CINNARIZINUM+DIMENHIDRATUM)


ARLEVERT

341

N07XN01

HIDROLIZAT DE PROTEINA DIN CREIER DE PORCINA **


SOL. INJ./PERF.
215.2mg/ml EBEWE PHARMA GMBH NFG. KG

Protocol: N026F

N07XN01 HIDROLIZAT DE PROTEINA DIN CREIER DE PORCINA


CEREBROLYSIN

215.2mg/ml

342
PLAQUENIL

P01BA02

HYDROXYCHLOROQUINUM
COMPR. FILM.
200mg SANOFI-SYNTHELABO LTD.

P01BA02 HYDROXYCHLOROQUINUM

200mg

343
BEROTEC N - 100 g

R03AC04

FENOTEROLUM
SOL. DE INHALAT PRESURIZATA
100g/doza BOEHRINGER INGELHEIM INT. GMBH

R03AC04 FENOTEROLUM

100g/doza

344
RHINOCORT AQUA

R01AD05

BUDESONIDUM *
SPRAY NAZAL SUSP.
32g/doza 50g/doza ASTRAZENECA AB

R01AD05 BUDESONIDUM R01AD05 BUDESONIDUM


TAFEN NASAL

32g/doza 50g/doza

SPRAY NAZ.,SUSP.
LEK PHARMACEUTICALS D.D.

345
FLIXONASE

R01AD08
Prescriere limitata:

FLUTICASONUM *
SPRAY NAZAL SUSP.
50g/doza GLAXOWELLCOME UK LTD.

R01AD08 FLUTICASONUM

50g/doza

Tratamentul profilactic al crizelor de astm bronsic.

346
NASONEX

R01AD09

MOMETASONUM *
SPRAY NAZAL SUSP.
50g/doza SCHERING PLOUGH EUROPE

R01AD09 MOMETASONUM

50g/doza

66 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul de fond al astmului bronsic persistent.

347

R03AK03

COMBINATII (FENOTEROLUM + IPRATROPIUM) *


AEROSOL SOL. INHAL.
0,020mg+0,050mg BOEHRINGER INGELHEIM INT. GMBH

R03AK03 COMBINATII (FENOTEROLUM + IPRATROPIUM)


BERODUAL N

0,020mg+0,050mg

348

R03AK06

COMBINATII (SALMETEROLUM+FLUTICASONUM) *
AEROSOL SUSP. INHAL.
25mg/125mg GLAXOWELLCOME UK LTD.

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)


SERETIDE 25/125 g INHALER CFC FREE

25mg/125mg

Prescriere limitata:

Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici. Prescriere limitata: Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata. NOTA: Seretide nu este indicat pentru initierea terapiei bronhodilatatoare in cazul bolii pulmonare cronice obstructive..

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)


SERETIDE 25/250 g INHALER CFC FREE

AEROSOL SUSP. INHAL.


25mg/250mg GLAXOWELLCOME UK LTD.

25mg/250mg

Prescriere limitata:

Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici. Prescriere limitata: Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata. NOTA: Seretide nu este indicat pentru initierea terapiei bronhodilatatoare in cazul bolii pulmonare cronice obstructive..

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)


SERETIDE 25/50 g INHALER CFC FREE

AEROSOL SUSP. INHAL.


25mg/50mg GLAXOWELLCOME UK LTD.

25mg/50mg

Prescriere limitata:

Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici. Prescriere limitata: Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata. NOTA: Seretide nu este indicat pentru initierea terapiei bronhodilatatoare in cazul bolii pulmonare cronice obstructive..

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)


SERETIDE DISKUS 50/100

PULB. INHAL.
50mg/100mg GLAXO WELLCOME UK LIMITED

50mg/100mg

Prescriere limitata:

Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici. Prescriere limitata: Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata. NOTA: Seretide nu este indicat pentru initierea terapiei bronhodilatatoare in cazul bolii pulmonare cronice obstructive..

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)


SERETIDE DISKUS 50/250

PULB. INHAL.
50mg/250mg GLAXOWELLCOME UK LTD.

50mg/250mg

Prescriere limitata:

Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici. Prescriere limitata: Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata. NOTA: Seretide nu este indicat pentru initierea terapiei bronhodilatatoare in cazul bolii pulmonare cronice obstructive..

R03AK06 COMBINATII (SALMETEROLUM+FLUTICASONUM)


SERETIDE DISKUS 50/500

PULB. INHAL.
50mg/500mg GLAXOWELLCOME UK LTD.

50mg/500mg

Prescriere limitata:

Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici. Prescriere limitata: Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata. NOTA: Seretide nu este indicat pentru initierea terapiei bronhodilatatoare in cazul bolii pulmonare cronice obstructive..

349

R03AK07

COMBINATII (BUDESONIDUM+FORMOTEROLUM) *
PULB. INHAL.
160/4.5g ASTRAZENECA AB

R03AK07 COMBINATII (BUDESONIDUM+FORMOTEROLUM)


SYMBIOCORT TURBUHALER 160/4,5 g

160/4.5g

Prescriere limitata: Prescriere limitata:

Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici. Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata.

R03AK07 COMBINATII (BUDESONIDUM+FORMOTEROLUM)


SYMBIOCORT TURBUHALER 320/9 g

PULB. INHAL.
320/9g ASTRAZENECA AB

320/9g

Prescriere limitata: Prescriere limitata:

Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici. Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata.

R03AK07 COMBINATII (BUDESONIDUM+FORMOTEROLUM)


SYMBIOCORT TURBUHALER 80/4,5 g

PULB. INHAL.
80/4.5g ASTRAZENECA AB

80/4.5g

Prescriere limitata: Prescriere limitata:

Tratament simptomatic al bolii pulmonare cronice obstructive (BPCO) la pacientii cu FEV1 mai mica decat 50% fata de normal si cu istoric de exacerbari repetate si simptome importante in timpul tratamentului bronhodilatator cu agonisti ai receptorilor beta-2 adrenergici. Tratamentul astmului bronsic care nu este controlat adecvat cu corticosteroizi inhalatori si beta-2-agonisti inhalatori de scurta durata.

350

R03BA05
Prescriere limitata:

FLUTICASONUM *
SUSP. INHAL.
0.5mg/2ml GLAXO WELLCOME UK LTD.

R03BA05 FLUTICASONUM
FLIXOTIDE NEBULES 0,5 mg/2 ml

0.5mg/2ml

Tratamentul profilactic al crizelor de astm bronsic.

R03BA05 FLUTICASONUM
FLIXOTIDE DISKUS 100 g

PULB. INHAL.
100g/doza GLAXO WELLCOME UK LTD.

100g/doza

Prescriere limitata:

Tratamentul profilactic al crizelor de astm bronsic.

R03BA05 FLUTICASONUM
FLIXOTIDE 125 INHALER CFC - Free

SUSP. INHAL. PRESURIZATA


125g/doza GLAXO WELLCOME UK LTD.

125g/doza

Prescriere limitata:
FLIXOTIDE DISKUS 250 g

Tratamentul profilactic al crizelor de astm bronsic.

R03BA05 FLUTICASONUM

PULB. INHAL.
250g/doza GLAXO WELLCOME UK LTD.

250g/doza

67 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul profilactic al crizelor de astm bronsic.

R03BA05 FLUTICASONUM
FLIXOTIDE 250 INHALER CFC - Free

SUSP. INHAL. PRESURIZATA


250g/doza GLAXO WELLCOME UK LTD.

250g/doza

Prescriere limitata:

Tratamentul profilactic al crizelor de astm bronsic.

R03BA05 FLUTICASONUM
FLIXOTIDE NEBULES 2 mg/2 ml

SUSP. INHAL.
2mg/2ml GLAXO WELLCOME UK LTD.

2mg/2ml

Prescriere limitata:
FLIXOTIDE DISKUS 50 g

Tratamentul profilactic al crizelor de astm bronsic.

R03BA05 FLUTICASONUM
Prescriere limitata:

PULB. INHAL.
50g/doza GLAXO WELLCOME UK LTD.

50g/doza

Tratamentul profilactic al crizelor de astm bronsic.

R03BA05 FLUTICASONUM
FLIXOTIDE 50 INHALER CFC - Free

SUSP. INHAL. PRESURIZATA


50g/doza GLAXO WELLCOME UK LTD.

50g/doza

Prescriere limitata:
FLIXOTIDE DISKUS 500 g

Tratamentul profilactic al crizelor de astm bronsic.

R03BA05 FLUTICASONUM
Prescriere limitata:

PULB. INHAL.
500g/doza GLAXO WELLCOME UK LTD.

500g/doza

Tratamentul profilactic al crizelor de astm bronsic.

351

R03BA07
Prescriere limitata:

MOMETASONUM *
PULB. INHAL.
200g/doza SCHERING PLOUGH EUROPE

R03BA07 MOMETASONUM
ASMANEX TWISTHALER 200 g

200g/doza

Tratamentul de fond al astmului bronsic persistent.

R03BA07 MOMETASONUM
ASMANEX TWISTHALER 400 g

PULB. INHAL.
400g/doza SCHERING PLOUGH EUROPE

400g/doza

Prescriere limitata:

Tratamentul de fond al astmului bronsic persistent.

352

R03BA08
Prescriere limitata:

CICLESONIDUM *
SOL. DE INHALAT PRESURIZATA
160g/doza ALTANA PHARMA AG

R03BA08 CICLESONIDUM
ALVESCO 160 INHALER

160g/doza

Tratamentul de fond al astmului bronsic persistent.

R03BA08 CICLESONIDUM
ALVESCO 40 INHALER

SOL. DE INHALAT PRESURIZATA


40g/doza ALTANA PHARMA AG

40g/doza

Prescriere limitata:
ALVESCO 80 INHALER

Tratamentul de fond al astmului bronsic persistent.

R03BA08 CICLESONIDUM
Prescriere limitata:

SOL. DE INHALAT PRESURIZATA


80g/doza ALTANA PHARMA AG

80g/doza

Tratamentul de fond al astmului bronsic persistent.

353
SPIRIVA 18 g

R03BB04
Prescriere limitata:

TIOTROPIUM *
CAPS. CU PULB.INHAL.
18g BOEHRINGER INGELHEIM PHARMA GMBH&CO.KG

R03BB04 TIOTROPIUM

18g

Pentru tratamentul de intretinere pe termen lung al bronhospasmului si dispneei associate bolii pulmonare obstructive cronice

354
MIOFILIN 100 mg

R03DA05

AMINOPHYLLINUM
CAPS.
100mg ZENTIVA SA

R03DA05 AMINOPHYLLINUM R03DA05 AMINOPHYLLINUM


AMINOFILIN 100 mg AMINOFILINA 100 mg AMINOFILINA EEL

100mg 100mg
FARMACOM SA ARENA GROUP SA BIO EEL SRL

COMPR.
100mg 100mg 100mg

R03DA05 AMINOPHYLLINUM
AMINOFILINA 200 mg

COMPR.
200mg ARENA GROUP SA

200mg 24mg/ml
ZENTIVA S.A.

R03DA05 AMINOPHYLLINUM
MIOFILIN

SOL. INJ.
24mg/ml

355
SINGULAIR

R03DC03
Prescriere limitata:

MONTELUKASTUM *
COMPR. FILM.
10mg MERCK SHARP & DOHME ROMANIA S.R.L.

R03DC03 MONTELUKASTUM

10mg

Tratamentul combinat al astmului bronsic la pacientii cu simptomatologie necontrolata corespunzator cu corticoizi inhalatori si beta-2-agonisti de scurta durata.

R03DC03 MONTELUKASTUM
SINGULAIR 4mg

COMPR. MAST.
MERCK SHARP & DOHME S.R.L.

4mg

Prescriere limitata: Tratamentul combinat al astmului bronsic la pacientii cu simptomatologie necontrolata corespunzator cu corticoizi inhalatori si beta-2-agonisti de scurta durata. Cod restrictie 2617: Tratament preventiv de prima linie, ca singur agent pentru copii cu varste cuprinse intre 2 si 5 ani cu episoade de astm intermitente frecvente sau persistente usoare.

R03DC03 MONTELUKASTUM
SINGULAIR

GRANULE
4mg/plic MERCK SHARP & DOHME ROMANIA S.R.L.

4mg/plic

Prescriere limitata:
SINGULAIR

Tratamentul combinat al astmului bronsic la pacientii cu simptomatologie necontrolata corespunzator cu corticoizi inhalatori si beta-2-agonisti de scurta durata.

R03DC03 MONTELUKASTUM
5mg

COMPR. MAST.
MERCK SHARP & DOHME ROMANIA S.R.L.

5mg

Prescriere limitata: Tratamentul combinat al astmului bronsic la pacientii cu simptomatologie necontrolata corespunzator cu corticoizi inhalatori si beta-2-agonisti de scurta durata. Cod restrictie 2618: Tratament preventiv de prima linie, ca singur agent pentru copii cu varste cuprinse intre 6 si 14 ani cu episoade astm intermitente frecvente sau persistente usoare.

356
EURESPAL

R03DX03

FENSPIRIDUM
SIROP
0.2% 80mg LES LAB. SERVIER IND.

R03DX03 FENSPIRIDUM R03DX03 FENSPIRIDUM


EURESPAL 80 mg

0.2% 80mg

COMPR. FILM.
LES LAB. SERVIER IND.

357
ERDOMED 175

R05CB15

ERDOSTEINUM
PULB. PT. SUSP. ORALA
175mg/5ml 225mg 225mg/plic CSC PHARMACEUTICALS HANDELS GMBH

R05CB15 ERDOSTEINUM R05CB15 ERDOSTEINUM


ERDOMED

175mg/5ml 225mg 225mg/plic 300mg

PULB. PT. SOL. INHAL.


CSC PHARMACEUTICALS HANDELS GMBH CSC PHARMACEUTICALS HANDELS GMBH MEDICOM INTERNATIONAL SRO

R05CB15 ERDOSTEINUM
ERDOMED 225

GRAN. PT. SUSP. ORALA CAPS.


300mg

R05CB15 ERDOSTEINUM
ERDOMED

358

R05DA09

DEXTROMETHORPHANUM
SIROP 0.1%

R05DA09 DEXTROMETHORPHANUM

68 / 233

DCI/DENUMIRE COMERCIALA
HUMEX TUSSIN SIROP

CONCENTRATIE
0.1% 0.1%

FORMA FARM.

FIRMA

PROTOCOL

LAB. URGO SA GLOBAL PHARMACEUTICALS S.R.L.

R05DA09 DEXTROMETHORPHANUM
HUMEX 0.13%

SIROP
LAB. URGO SA

0.13% 10mg
EUROPHARM SA

R05DA09 DEXTROMETHORPHANUM
TUSSIN 10mg

COMPR. SIROP
15mg/5ml 15mg/5ml BIOFARM SA PIERRE FABRE MEDICAMENT

R05DA09 DEXTROMETHORPHANUM
ROFEDEX TUSSIDRIL

15mg/5ml

R05DA09 DEXTROMETHORPHANUM
TUSSIN FORTE 20mg

COMPR.
EUROPHARM SA

20mg 3.75mg/5ml 7.5mg/5ml

R05DA09 DEXTROMETHORPHANUM
ROBITUSSIN JUNIOR

SOL. ORALA
3.75mg/5ml 7.5mg/5ml WYETH WHITEHALL EXPORT GMBH WYETH WHITEHALL EXPORT GMBH

R05DA09 DEXTROMETHORPHANUM
ROBITUSSIN ANTITUSSICUM

SOL. ORALA

359
CEZERA 5 mg XYZAL

R06AE09

LEVOCETIRIZINUM
COMPR. FILM.
5mg 5mg 5mg/ml KRKA D.D. NOVO MESTO U.C.B. GMBH

R06AE09 LEVOCETIRIZINUM

5mg

R06AE09 LEVOCETIRIZINUM
XYZAL

PIC. ORALE, SOL.


U.C.B. GMBH

5mg/ml

360
ALTIVA 120 mg EWOFEX 120 mg TELFAST 120 mg

R06AX26

FEXOFENADINUM
COMPR. FILM.
120mg 120mg 120mg 180mg 180mg 180mg 30mg RANBAXY UK LTD. EWOPHARMA INTERNATIONAL S.R.O. AVENTIS PHARMA DEUTSCHLAND GMBH

R06AX26 FEXOFENADINUM

120mg

R06AX26 FEXOFENADINUM
ALTIVA 180 mg EWOFEX 180 mg TELFAST 180 mg

COMPR. FILM.
RANBAXY UK LTD. EWOPHARMA INTERNATIONAL S.R.O. AVENTIS PHARMA DEUTSCHLAND GMBH

180mg

R06AX26 FEXOFENADINUM
TELFAST 30 mg

COMPR. FILM.
AVENTIS PHARMA DEUTSCHLAND GMBH

30mg

361

R06AX27

COMBINATII (DESLORATADINUM+PSEUDOEPHEDRINE)
SIROP
0,5mg/ml 0,5mg/ml SP EUROPE SP EUROPE

R06AX27 COMBINATII (DESLORATADINUM+PSEUDOEPHEDRINE)


AZOMYR 0,5mg/ml NEOCLARITYN 0,5mg/ml

0,5mg/ml

R06AX27 COMBINATII (DESLORATADINUM+PSEUDOEPHEDRINE)


AZOMYR 0,5mg/ml NEOCLARITYN 0,5mg/ml

SOL. ORALA
0,5mg/ml 0,5mg/ml SP EUROPE SP EUROPE

0,5mg/ml

R06AX27 COMBINATII (DESLORATADINUM+PSEUDOEPHEDRINE)


AERIUS 0.5mg/ml

SIROP
0.5mg/ml SP EUROPE

0.5mg/ml

R06AX27 COMBINATII (DESLORATADINUM+PSEUDOEPHEDRINE)


AERIUS 0.5mg/ml

SOL. ORALA
0.5mg/ml SP EUROPE

0.5mg/ml

R06AX27 COMBINATII (DESLORATADINUM+PSEUDOEPHEDRINE)


AERIUS 2,5mg NEOCLARITYN 2,5mg 2,5mg 2,5mg

COMPR. ORODISPERSABILE
SP EUROPE SP EUROPE

2,5mg

R06AX27 COMBINATII (DESLORATADINUM+PSEUDOEPHEDRINE)


AERINAZE 2,5mg/120mg

COMPR. FILM. ELIB. MODIF.


2,5mg/120mg SP EUROPE

2,5mg/120mg

R06AX27 COMBINATII (DESLORATADINUM+PSEUDOEPHEDRINE)


AZOMYR 2,5mg 2.5mg

COMPR. ORODISPERSABILE
SP EUROPE

2.5mg

R06AX27 COMBINATII (DESLORATADINUM+PSEUDOEPHEDRINE)


AERIUS 5mg AZOMYR 5mg NEOCLARITYN 5mg 5mg 5mg 5mg

COMPR. FILM.
SP EUROPE SP EUROPE SP EUROPE

5mg

R06AX27 COMBINATII (DESLORATADINUM+PSEUDOEPHEDRINE)


AERIUS 5mg AZOMYR 5mg NEOCLARITYN 5mg 5mg 5mg 5mg

COMPR. ORODISPERSABILE
SP EUROPE SP EUROPE SP EUROPE

5mg

R06AX27 COMBINATII (DESLORATADINUM+PSEUDOEPHEDRINE)


AERIUS 5mg AZOMYR 5mg NEOCLARITYN 5mg 5mg 5mg 5mg

LIOF. ORAL
SP EUROPE SP EUROPE SP EUROPE

5mg

362
OPHTAGRAM 0,3%

S01AA11
Prescriere limitata: Prescriere limitata: Prescriere limitata:

GENTAMICINUM
PICATURI OFT.-SOL.
0.3% LAB. CHAUVIN

S01AA11 GENTAMICINUM

0.3%

Infectie oculara invaziva Utilizare perioperatorie in chirurgia ochiului Suspiciune de infectie a ochiului cu Pseudomonas

S01AA11 GENTAMICINUM
GENTICOL 0.3%

SOL. OFT.
S.I.F.I. SPA

0.3%

69 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata: Prescriere limitata: Prescriere limitata:


GENTICOL OPHTAGRAM 0,3%

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Infectie oculara invaziva Utilizare perioperatorie in chirurgia ochiului Suspiciune de infectie a ochiului cu Pseudomonas

S01AA11 GENTAMICINUM
0.3% 0.3% 0.3%

UNG. OFT.
S.I.F.I. SPA LAB. CHAUVIN

0.3%

S01AA11 GENTAMICINUM
GENTAMICIN SULPHATE

PIC. OFT., SOL


E.I.P.I.CO. MED S.R.L.

0.3%

363
TOBREX 2 X

S01AA12
Prescriere limitata: Prescriere limitata: Prescriere limitata:

TOBRAMYCINUM
PICATURI OFT.-SOL.
0.3% ALCON COUVREUR NV

S01AA12 TOBRAMYCINUM

0.3%

Infectie oculara invaziva Utilizare perioperatorie in chirurgia ochiului Suspiciune de infectie a ochiului cu Pseudomonas

S01AA12 TOBRAMYCINUM
TOBREX 0.3%

UNG. OFT.
ALCON COUVREUR NV

0.3%

Prescriere limitata: Prescriere limitata: Prescriere limitata:


TOBISOL

Infectie oculara invaziva Utilizare perioperatorie in chirurgia ochiului Suspiciune de infectie a ochiului cu Pseudomonas

S01AA12 TOBRAMYCINUM
0.3%

PIC. OFT., SOL.


E.I.P.I.CO. MED S.R.L.

0.3% 3mg/ml

S01AA12 TOBRAMYCINUM
TOBREX

PIC. OFT.,SOL.
3mg/ml ALCON COUVREUR NV

364
NETTACIN

S01AA23

NETILMICINUM
PICATURI OFT.-SOL.
0.3% S.I.F.I. SPA

S01AA23 NETILMICINUM S01AA23 NETILMICINUM


NETTAVISC 3mg/g 3mg/g 0.3%

0.3% 3mg/g

UNG. OFT.
S.I.F.I. SPA

S01AA23 NETILMICINUM
NETTACIN

PIC. OFT., SOL


S.I.F.I. SPA

0.3%

365
FLOXAL

S01AX11
Prescriere limitata: Keratita bacteriana

OFLOXACINUM
PICATURI OFT.-SOL.
0.3% DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

S01AX11 OFLOXACINUM

0.3%

S01AX11 OFLOXACINUM
FLOXAL 0.3%

UNG. OFT.
DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

0.3%

366
MAXIDEX

S01BA01

DEXAMETHASONUM
PICATURI OFT.-SUSP.
0.1% ALCON COUVREUR NV

S01BA01 DEXAMETHASONUM S01BA01 DEXAMETHASONUM


MAXIDEX 0.1%

0.1% 0.1%

UNG. OFT.
ALCON COUVREUR NV

S01BA01 DEXAMETHASONUM
DEXAGEL

GEL OFT.
0.985mg/g 1mg/ml DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

0.985mg/g 1mg/ml

S01BA01 DEXAMETHASONUM
DEXAMETAZONA RPH 1mg/ml

PIC. OFT. SUSP.


ROMPHARM COMPANY SRL

367
OPHTAMESONE

S01BA06

BETAMETHASONUM
SOL. OFT.
0.1% DAR AL DAWA PHARMA S.R.L

S01BA06 BETAMETHASONUM

0.1%

368

S01CA01

COMBINATII (NETILMICINUM + DEXAMETHASONUM)


PIC. OFT.,SOL.
S.I.F.I. SPA

S01CA01 COMBINATII (NETILMICINUM + DEXAMETHASONUM)


NETILDEX

S01CA01 COMBINATII (NETILMICINUM + DEXAMETHASONUM)


NETILDEX

PIC. OFT.SOL. UNIDOZA


S.I.F.I. SPA

369

S01CA01

COMBINATII (TOBRAMYCINUM + DEXAMETHASONUM)


UNG. OFT.
1mg+3mg ALCON COUVREUR NV

S01CA01 COMBINATII (TOBRAMYCINUM + DEXAMETHASONUM)


TOBRADEX

1mg+3mg

S01CA01 COMBINATII (TOBRAMYCINUM + DEXAMETHASONUM)


TOBRADEX

PICATURI OFT.-SUSP.
1mg+3mg ALCON COUVREUR NV

1mg+3mg

370

S01CA01

COMBINATII (CHLORAMPHENICOLUM + DEXAMETHASONUM)


PICATURI OFT.-SOL.
5mg/ml+1mg/ml NOVARTIS PHARMA GMBH

S01CA01 COMBINATII (CHLORAMPHENICOLUM + DEXAMETHASONUM)


SPERSADEX COMP

5mg/ml+1mg/ml

371
OPATANOL 1mg/ml

S01GX09

OLOPATADINUM
PIC. OFT., SOL.
1mg/ml ALCON LABORATORIES LTD.

S01GX09 OLOPATADINUM

1mg/ml

372
OCULOTECT

S01XA02

RETINOLUM
GEL OFT.
10mg/g NOVARTIS PHARMA GMBH

S01XA02 RETINOLUM

10mg/g

1219
CARBIMAZOLE 5

H03BB01

CARBIMAZOLUM
COMPR. FILM.
5mg REMEDICA LTD.

H03BB01 CARBIMAZOLUM

5mg

70 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G1 INSUFICIENTA CARDIACA CRONICA (CLASA III SAU IV NYHA). 373 B01AA07 ACENOCUMAROLUM
B01AA07 ACENOCUMAROLUM
ACENOCUMAROL 2 mg TROMBOSTOP 2 mg 2mg 2mg

COMPR.
LAROPHARM SRL TERAPIA SA

2mg

B01AA07 ACENOCUMAROLUM
SINTROM 4mg

COMPR.
NOVARTIS PHARMA GMBH

4mg

374

C01AA05

DIGOXINUM
SOL. ORALA
0.05mg/ml THE WELLCOME FOUNDATION LTD.

C01AA05 DIGOXINUM
LANOXIN SOLUTIE ORALA

0.05mg/ml 0.25mg

C01AA05 DIGOXINUM
DIGOXIN 0,25 mg

COMPR.
0.25mg ZENTIVA S.A.

C01AA05 DIGOXINUM
LANOXIN

SOL. INJ.
0.25mg/ml THE WELLCOME FOUNDATION LTD.

0.25mg/ml 0.5mg/ml
ZENTIVA S.A.

C01AA05 DIGOXINUM
DIGOXIN 0,5 mg/2 ml

SOL. INJ.
0.5mg/ml

375
NEFRIX 25 mg

C03AA03

HYDROCHLOROTHIAZIDUM
COMPR.
25mg ZENTIVA SA

C03AA03 HYDROCHLOROTHIAZIDUM

25mg

376

C03CA01

FUROSEMIDUM
SOL. INJ.
10mg/ml ZENTIVA SA

C03CA01 FUROSEMIDUM
FUROSEMID 20 mg/2 ml

10mg/ml

Electroliii serici trebuie s fie verificai periodic.

C03CA01 FUROSEMIDUM
FUROSEMID 40 mg FUROSEMID ARENA 40 mg FUROSEMID EEL FUROSEMID LPH 40 mg FUROSEMID MCC 40 mg FUROSEMID SLAVIA FUROSEMID ZENTIVA 40mg 40mg 40mg 40mg 40mg 40mg 40mg

COMPR.
LAROPHARM SRL ARENA GROUP S.A. BIO EEL SRL LABORMED PHARMA SA MAGISTRA C & C SRL SLAVIA PHARM SRL ZENTIVA SA

40mg

Electroliii serici trebuie s fie verificai periodic.

377
VEROSPIRON

C03DA01

SPIRONOLACTONUM
CAPS.
100mg GEDEON RICHTER LTD.

C03DA01 SPIRONOLACTONUM

100mg

Electroliii serici trebuie s fie verificai periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

C03DA01 SPIRONOLACTONUM
SPIRONOLACTONA 25 mg 25mg

COMPR.
OZONE LABORATORIES LTD.

25mg

Electroliii serici trebuie s fie verificai periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

C03DA01 SPIRONOLACTONUM
ALSPIRON 25 mg SPIRONOLACTONA 25 mg 25mg 25mg

COMPR. FILM.
AC HELCOR PHARMA SRL TERAPIA SA

25mg

Electroliii serici trebuie s fie verificai periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

C03DA01 SPIRONOLACTONUM
SPIRONOLACTONA 50 mg VEROSPIRON 50mg 50mg 50mg

CAPS.
LAROPHARM SRL GEDEON RICHTER LTD.

50mg

C03DA01 SPIRONOLACTONUM
ALSPIRON 50 mg

COMPR. FILM.
AC HELCOR PHARMA SRL

50mg

378

C07AB02

METOPROLOLUM
COMPR.
100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 190mg AC HELCOR PHARMA SRL KRKA D.D. NOVO MESTO BERLIN - CHEMIE AG EGIS PHARMACEUTICALS P.L.C. TAD PHARMA GMBH ARENA GROUP SA ALIUD PHARMA GMBH & CO.KG LAROPHARM SRL LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L. HEXAL AG TERAPIA SA SLOVAKOFARMA

C07AB02 METOPROLOLUM
BETAPROL 100 mg BLOXAN CORVITOL 100 EGILOK 100 mg METOPRO TAD 100 METOPROLOL 100 mg METOPROLOL AL 100 METOPROLOL LAROPHARM 100 mg METOPROLOL LPH 100 mg METOPROLOL MEDICO UNO 100 mg METOPROLOL TARTRAT SANDOZ 100 mg METOPROLOL TERAPIA 100 mg VASOCARDIN 100

100mg

C07AB02 METOPROLOLUM
METOPROLOL RETARD 100 mg

COMPR. ELIB. PREL.


TERAPIA S.A.

100mg 100mg

C07AB02 METOPROLOLUM
BETALOC ZOC 100 mg EGILOK R 100 EMZOK 100 mg

COMPR. FILM. ELIB. PREL.


ASTRAZENECA AB EGIS PHARMACEUTICALS P.L.C. IVAX PHARMCEUTICALS S.R.O.

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 190 mg

COMPR.FILM.ELIB.MOD.
HEXAL AG

190mg

Cod restrictie 1734:


BETALOC

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

C07AB02 METOPROLOLUM C07AB02 METOPROLOLUM


VASOCARDIN SR 200

SOL. INJ.
1mg/ml 200mg 200mg ASTRAZENECA AB

1mg/ml 200mg 200mg

COMPR. ELIB. PREL.


ZENTIVA AS IVAX PHARMCEUTICALS S.R.O.

C07AB02 METOPROLOLUM
EMZOK 200 mg

COMPR. FILM. ELIB. PREL.

71 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

C07AB02 METOPROLOLUM
EGILOK 25 mg METOPROLOL 25 mg METOPROLOL LPH 25 mg METOPROLOL MEDICO UNO 25 mg 25mg 25mg 25mg 25mg 25mg

COMPR.
EGIS PHARMACEUTICALS P.L.C. ARENA GROUP S.A. LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L.

25mg

C07AB02 METOPROLOLUM
BETALOC ZOC 25 mg

COMPR. FILM. ELIB. PREL.


ASTRAZENECA AB

25mg 47.5mg

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 47,5 mg

COMPR.FILM.ELIB.MOD.
47.5mg HEXAL AG

Cod restrictie 1734:

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

C07AB02 METOPROLOLUM
BETAPROL 50 mg CORVITOL 50 EGILOK 50 mg METOPRO TAD 50 METOPROLOL 50 mg METOPROLOL AL 50 METOPROLOL FABIOL 50 mg METOPROLOL LAROPHARM 50 mg METOPROLOL LPH 50 mg METOPROLOL MEDICO UNO 50 mg METOPROLOL TARTRAT SANDOZ 50 mg METOPROLOL TERAPIA 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 95mg

COMPR.
AC HELCOR PHARMA SRL BERLIN - CHEMIE AG EGIS PHARMACEUTICALS P.L.C. TAD PHARMA GMBH OZONE LABORATORIES LTD. ALIUD PHARMA GMBH & CO.KG FABIOL S.A. LAROPHARM SRL LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL S.R.L. HEXAL AG TERAPIA SA

50mg

C07AB02 METOPROLOLUM
BETALOC ZOC 50 mg EGILOK R 50 EMZOK 50 mg

COMPR. FILM. ELIB. PREL.


ASTRAZENECA AB EGIS PHARMACEUTICALS P.L.C. IVAX PHARMCEUTICALS S.R.O.

50mg

C07AB02 METOPROLOLUM
METOSUCCINAT SANDOZ 95 mg

COMPR.FILM.ELIB.MOD.
HEXAL AG

95mg

Cod restrictie 1734:

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

379
BISOBLOCK 10 mg

C07AB07

BISOPROLOLUM
COMPR.
10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 2.5mg KERI PHARMA GENERICS LTD.

C07AB07 BISOPROLOLUM C07AB07 BISOPROLOLUM


BISOGAMMA 10 BISOMERCK 10 mg BISOSTAD 10 mg BISOTENS 10 mg BYOL 10 mg CONCOR 10 mg CONCOR COR 10 mg CORONAL 10

10mg 10mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG MERCK KGAA STADA ARZNEIMITTEL AG ANTIBIOTICE S.A. SANDOZ SRL MERCK KGAA MERCK KGAA ZENTIVA AS

C07AB07 BISOPROLOLUM
CONCOR COR 2,5 mg

COMPR. FILM.
MERCK KGAA

2.5mg

Cod restrictie 1734:


BISOBLOCK 5 mg

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

C07AB07 BISOPROLOLUM
5mg

COMPR.
KERI PHARMA GENERICS LTD.

5mg

Cod restrictie 1734:


BISOGAMMA 5 BISOMERCK 5 mg BISOSTAD 5 mg BISOTENS 5 mg BYOL 5 mg CONCOR 5 mg CONCOR COR 5 mg CORONAL 5

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

C07AB07 BISOPROLOLUM
5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG MERCK KGAA STADA ARZNEIMITTEL AG ANTIBIOTICE S.A. SANDOZ SRL MERCK KGAA MERCK KGAA ZENTIVA AS

5mg

Cod restrictie 1734:

Insuficien cardiac moderat/sever la pacieni stabilizai prin terapie convenional care trebuie s includ un inhibitor de enzim de conversie, dac este tolerat.

380

C07AB12

NEBIVOLOLUM **
COMPR.
5mg 5mg 5mg BIOFARM SP.ZO.O BERLIN CHEMIE AG MENARINI GROUP ACTAVIS S.R.L.

C07AB12 NEBIVOLOLUM
NEBICARD 5 mg NEBILET NEBIVOLOL ACTAVIS 5 mg

5mg

C07AB12 NEBIVOLOLUM
EZOCEM 5 mg 5mg

COMPR
OZONE LABORATORIES BV

5mg

381

C07AG02

CARVEDILOLUM
COMPR.
12,5 mg HEXAL AG

C07AG02 CARVEDILOLUM
CARVEDILOL SANDOZ

12,5 mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
ATRAM 12,5 CARVEDILOL 12,5 mg CARVEDILOL HELCOR 12,5 mg CARVEDILOL LPH 12,5 mg CARVEDILOL STADA 12,5 mg CARVEDILOL TEVA 12,5 mg CORYOL DILATREND 12,5 mg KALLIDOL 12,5 mg TALLITON 12,5 mg

COMPR.
12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg 12.5mg ZENTIVA AS VIM SPECTRUM SRL AC HELCOR PHARMA SRL LABORMED PHARMA SA STADA ARZNEIMITTEL AG TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. GEDEON RICHTER ROMANIA S.A. EGIS PHARMACEUTICALS LTD.

12.5mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 12,5 mg CARVEDILOL POLPHARMA 12,5 mg

COMPR. FILM.
12.5mg 12.5mg WORWAG PHARMA GMBH & CO. KG PHARMACEUTICAL WORKS POLPHARMA SA

12.5mg

72 / 233

DCI/DENUMIRE COMERCIALA
CARVEDILOL POLPHARMA 6,25 mg

CONCENTRATIE
6.25mg

FORMA FARM.

FIRMA

PROTOCOL

PHARMACEUTICAL WORKS POLPHARMA SA

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
ATRAM 25 CARVEDILOL HELCOR 25 mg CARVEDILOL LPH 25 mg CARVEDILOL SANDOZ CARVEDILOL STADA 25 mg CARVEDILOL TEVA 25 mg CORYOL DILATREND 25 mg KALLIDOL 25 mg TALLITON 25 mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg

COMPR.
ZENTIVA AS AC HELCOR PHARMA SRL LABORMED PHARMA SA HEXAL AG STADA ARZNEIMITTEL AG TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. GEDEON RICHTER ROMANIA S.A. EGIS PHARMACEUTICALS LTD.

25mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 25 mg CARVEDILOL POLPHARMA 25 mg 25mg 25mg

COMPR. FILM.
WORWAG PHARMA GMBH & CO. KG PHARMACEUTICAL WORKS POLPHARMA SA

25mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
CARVEDILOL STADA 3,125 mg CORYOL 3,125 mg KALLIDOL 3,125 mg

COMPR.
3.125mg 3.125mg 3.125mg STADA ARZNEIMITTEL AG KRKA D.D. GEDEON RICHTER ROMANIA S.A.

3.125mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 3,125 mg CARVEDILOL POLPHARMA 3,125 mg

COMPR. FILM.
3.125mg 3.125mg WORWAG PHARMA GMBH & CO. KG PHARMACEUTICAL WORKS POLPHARMA SA

3.125mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
ATRAM 6,25 CARVEDILOL 6,25 mg CARVEDILOL LPH 6,25 mg CARVEDILOL SANDOZ CARVEDILOL STADA 6,25 mg CARVEDILOL TEVA 6,25 mg CORYOL DILATREND 6,25 mg KALLIDOL 6,25 mg TALLITON 6,25 mg

COMPR.
6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg 6.25mg ZENTIVA AS VIM SPECTRUM SRL LABORMED PHARMA SA HEXAL AG STADA ARZNEIMITTEL AG TEVA PHARMACEUTICAL S.R.L. KRKA D.D. ROCHE ROMANIA S.R.L. GEDEON RICHTER ROMANIA S.A. EGIS PHARMACEUTICALS LTD.

6.25mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

C07AG02 CARVEDILOLUM
CARVEDIGAMMA 6,25 mg CARVEDILOL POLPHARMA 12,5 mg CARVEDILOL POLPHARMA 6,25 mg

COMPR. FILM.
6.25mg 12.5mg 6.25mg WORWAG PHARMA GMBH & CO. KG PHARMACEUTICAL WORKS POLPHARMA SA PHARMACEUTICAL WORKS POLPHARMA SA

6.25mg

NOTA: Tratamentul se va initia numai dupa o evaluare cardiovasculara completa a pacientului efectuata de medicul cardiolog..

382

C09AA01

CAPTOPRILUM
COMPR.
12,5mg MAGISTRA C & C

C09AA01 CAPTOPRILUM
CAPTOPRIL MCC 12,5 mg

12,5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA01 CAPTOPRILUM
CAPTOPRIL 12,5 mg

COMPR.
12.5mg EGIS PHARMACEUTICALS LTD.

12.5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA01 CAPTOPRILUM
CAPTOPRIL - AC 25 mg CAPTOPRIL LAROPHARM 25 mg CAPTOPRIL SINTOFARM 25 mg CAPTOPRIL 25 EEL CAPTOPRIL 25 mg CAPTOPRIL FARMEX 25 mg CAPTOPRIL LPH 25 mg CAPTOPRIL MCC 25 mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg

COMPR.
AC HELCOR PHARMA SRL LAROPHARM SRL SINTOFARM SA BIO EEL SRL EGIS PHARMACEUTICALS LTD. FARMEX COMPANY SRL LABORMED PHARMA SA MAGISTRA C & C

25mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA01 CAPTOPRILUM
CAPTOPRIL 50 mg 50 mg

COMPR.
ARENA GROUP SA

50 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA01 CAPTOPRILUM
CAPTOPRIL - AC 50 mg CAPTOPRIL 50 EEL CAPTOPRIL 50 mg CAPTOPRIL LPH 50 mg CAPTOPRIL MCC 50 mg 50mg 50mg 50mg 50mg 50mg

COMPR.
AC HELCOR PHARMA SRL BIO EEL SRL EGIS PHARMACEUTICALS LTD. LABORMED PHARMA SA MAGISTRA C & C

50mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

383
ENAP

C09AA02

ENALAPRILUM
SOL. INJ.
1.25mg/ml KRKA D.D.

C09AA02 ENALAPRILUM C09AA02 ENALAPRILUM


BERLIPRIL 10 EDNYT 10 mg ENAHEXAL 10 mg ENALA TAD 10 10mg 10mg 10mg 10mg

1.25mg/ml 10mg
BERLIN CHEMIE AG (MENARINI GROUP) GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH

COMPR.

73 / 233

DCI/DENUMIRE COMERCIALA
ENALAP ENALAPRIL 10 mg ENALAPRIL AL 10 ENALAPRIL FABIOL 10 mg ENALAPRIL LPH 10 mg ENALAPRIL MEDICO UNO 10 mg ENALAPRIL SANDOZ 10 mg ENALAPRIL TERAPIA 10 mg ENAM 10 mg ENAP 10 mg INVORIL 10 mg OLINAPRIL 10 mg RENITEC 10 mg

CONCENTRATIE
10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg

FORMA FARM.

FIRMA

PROTOCOL

E.I.P.I.CO. MED S.R.L. OZONE LABORATORIES LTD. ALIUD PHARMA GMBH & CO.KG FABIOL SA LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL SRL SANDOZ SRL TERAPIA SA REPREZENTANTA DR. REDDY'S LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. LEK PHARMACEUTICALS D.D. MERCK SHARP & DOHME ROMANIA S.R.L.

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA02 ENALAPRILUM
EDNYT 2,5 mg ENAP 2,5 mg 2.5mg 2.5mg

COMPR.
GEDEON RICHTER LTD. KRKA D.D. NOVO MESTO

2.5mg

C09AA02 ENALAPRILUM
BERLIPRIL 20 EDNYT 20 mg ENAHEXAL 20 mg ENALA TAD 20 ENALAPRIL ENALAPRIL 20 mg ENALAPRIL AL 20 ENALAPRIL FABIOL 20 mg ENALAPRIL LPH 20 mg ENALAPRIL MEDICO UNO 20 mg ENALAPRIL OZONE 20 mg ENALAPRIL SANDOZ 20 mg ENALAPRIL TERAPIA 20 mg ENAP 20 mg INVORIL 20 mg OLINAPRIL 20 mg RENITEC 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR.
BERLIN CHEMIE AG (MENARINI GROUP) GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH OZONE LABORATORIES LTD. LAROPHARM SRL ALIUD PHARMA GMBH & CO.KG FABIOL SA LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL SRL OZONE LABORATORIES BV SANDOZ SRL TERAPIA SA KRKA D.D. NOVO MESTO TERAPIA S.A. LEK PHARMACEUTICALS D.D. MERCK SHARP & DOHME ROMANIA S.R.L.

20mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA02 ENALAPRILUM
BERLIPRIL 5 EDNYT 5 mg ENAHEXAL 5 mg ENALA TAD 5 ENALAPRIL 5 mg ENALAPRIL AL 5 ENALAPRIL LPH 5 mg ENALAPRIL MEDICO UNO 5 mg ENALAPRIL SANDOZ 5 mg ENALAPRIL TERAPIA 5 mg ENAP 5 mg INVORIL 5 mg OLINAPRIL 5 mg RENITEC 5 mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.
BERLIN CHEMIE AG (MENARINI GROUP) GEDEON RICHTER LTD. HEXAL AG TAD PHARMA GMBH VIM SPECTRUM SRL ALIUD PHARMA GMBH & CO.KG LABORMED PHARMA SA MEDICO UNO PHARMACEUTICAL SRL SANDOZ SRL TERAPIA SA KRKA D.D. NOVO MESTO TERAPIA S.A. LEK PHARMACEUTICALS D.D. MERCK SHARP & DOHME ROMANIA S.R.L.

5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

384

C09AA03

LISINOPRILUM
COMPR.
10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg SANDOZ GMBH WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL ANTIBIOTICE SA HEXAL AG AC HELCOR SRL MEDOCHEMIE LTD. RANBAXY U.K. LIMITED ANTIBIOTICE SA GEDEON RICHTER LTD.

C09AA03 LISINOPRILUM
LISDENE 10 mg LISIGAMMA 10 mg LISINOPRIL 10 MEDO LISINOPRIL ANTIBIOTICE 10 mg LISINOPRIL SANDOZ 10 mg LISIREN 10 mg MEDAPRIL 10 RANOLIP SINOPRYL 10 TONOLYSIN 10 mg

10mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA03 LISINOPRILUM
TONOLYSIN 2,5 mg 2.5mg

COMPR.
GEDEON RICHTER LTD.

2.5mg 20mg
SANDOZ GMBH WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL ANTIBIOTICE SA HEXAL AG AC HELCOR SRL MEDOCHEMIE LTD. RANBAXY U.K. LIMITED GEDEON RICHTER LTD.

C09AA03 LISINOPRILUM
LISDENE 20 mg LISIGAMMA 20 mg LISINOPRIL 20 MEDO LISINOPRIL ANTIBIOTICE 20 mg LISINOPRIL SANDOZ 20 mg LISIREN 20 mg MEDAPRIL 20 RANOLIP TONOLYSIN 20 mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR.

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA03 LISINOPRILUM
LISINOPRIL ANTIBIOTICE 40 mg 40mg

COMPR.
ANTIBIOTICE SA

40mg 5mg

C09AA03 LISINOPRILUM

COMPR.

74 / 233

DCI/DENUMIRE COMERCIALA
LISDENE 5 mg LISIGAMMA 5 mg LISINOPRIL 5 MEDO LISINOPRIL SANDOZ 5 mg MEDAPRIL 5 RANOLIP TONOLYSIN 5 mg

CONCENTRATIE
5mg 5mg 5mg 5mg 5mg 5mg 5mg

FORMA FARM.

FIRMA

PROTOCOL

SANDOZ GMBH WORWAG PHARMA GMBH & CO. KG MEDOCHEMIE ROMANIA SRL HEXAL AG MEDOCHEMIE LTD. RANBAXY U.K. LIMITED GEDEON RICHTER LTD.

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

385
EMREN 1,25 mg

C09AA05

RAMIPRILUM
COMPR.
1,25 mg GEDEON RICHTER ROMANIA S.A.

C09AA05 RAMIPRILUM

1,25 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
AMPRIL 1,25 mg HARTIL 1,25 mg PIRAMIL 1,25 mg RAMIPRIL SANDOZ 1,25 mg

COMPR.
1.25mg 1.25mg 1.25mg 1.25mg KRKA D.D. NOVO MESTO EGIS PHARMACEUTICALS PLC SANDOZ SRL HEXAL AG

1.25mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIRAN 1,25 mg

COMPR. FILM.
1.25mg RANBAXY U.K. LIMITED

1.25mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
EMREN 10 mg VIVACE 10 mg 10 mg 10 mg

COMPR.
GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

10 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIPRIL STADA 10 mg 10mg

CAPS.
STADA ARZNEIMITTEL AG

10mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
AMPRIL 10 mg HARTIL 10 mg PIRAMIL 10 mg RAMIGAMMA 10 mg RAMIPRIL SANDOZ 10 mg RAMIPRIL STADA 10 mg RAMIPRIL-AC 10 mg TRITACE 10 ZENRA 10 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg

COMPR.
KRKA D.D. NOVO MESTO EGIS PHARMACEUTICALS PLC SANDOZ SRL WORWAG PHARMA GMBH & CO. KG HEXAL AG STADA ARZNEIMITTEL AG AC HELCOR PHARMA SRL SANOFI - AVENTIS DEUTSCHLAND GMBH ZENTIVA S.A.

10mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIRAN 10 mg 10mg

COMPR. FILM.
RANBAXY U.K. LIMITED

10mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
EMREN 2,5 mg VIVACE 2,5 mg

COMPR.
2,5 mg 2,5 mg GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

2,5 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIPRIL STADA 2,5 mg 2.5mg

CAPS.
STADA ARZNEIMITTEL AG

2.5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
AMPRIL 2,5 mg HARTIL 2,5 mg PIRAMIL 2,5 mg RAMIGAMMA 2,5 mg RAMIPRIL SANDOZ 2,5 mg RAMIPRIL STADA 2,5 mg RAMIPRIL-AC 2,5 mg TRITACE 2,5 ZENRA 2,5 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg 2.5mg

COMPR.
KRKA D.D. NOVO MESTO EGIS PHARMACEUTICALS PLC SANDOZ SRL WORWAG PHARMA GMBH & CO. KG HEXAL AG STADA ARZNEIMITTEL AG AC HELCOR PHARMA SRL AVENTIS PHARMA DEUTSCHLAND GMBH ZENTIVA S.A.

2.5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIRAN 2,5 mg 2.5mg

COMPR. FILM.
RANBAXY U.K. LIMITED

2.5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
EMREN 5 mg VIVACE 5 mg 5 mg 5 mg

COMPR.
GEDEON RICHTER ROMANIA S.A. ACTAVIS GROUP HF

5 mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIPRIL STADA 5 mg 5mg

CAPS.
STADA ARZNEIMITTEL AG

5mg

75 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
AMPRIL 5 mg HARTIL 5 mg PIRAMIL 5 mg RAMIGAMMA 5 mg RAMIPRIL SANDOZ 5 mg RAMIPRIL STADA 5 mg RAMIPRIL-AC 5 mg TRITACE 5 ZENRA 5 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg 5mg

COMPR.
KRKA D.D. NOVO MESTO EGIS PHARMACEUTICALS PLC SANDOZ SRL WORWAG PHARMA GMBH & CO. KG HEXAL AG STADA ARZNEIMITTEL AG AC HELCOR PHARMA SRL AVENTIS PHARMA DEUTSCHLAND GMBH ZENTIVA S.A.

5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIRAN 5 mg 5mg

COMPR. FILM.
RANBAXY U.K. LIMITED

5mg

Utilizarea inhibitorilor enzimelor de conversie a angiotensinei in timpul sarcinii este contraindicata deoarece medicamentele din aceasta categorie au fost asociate cu moartea ftului in utero.

C09AA05 RAMIPRILUM
RAMIPRIL SANDOZ 7,5 mg 7.5mg

COMPR.
HEXAL AG

7.5mg

386
DIOVAN 160 mg

C09CA03

VALSARTANUM **
COMPR. FILM.
160mg 40mg 80mg NOVARTIS PHARMA GMBH

Protocol: C005I
160mg 40mg 80mg

C09CA03 VALSARTANUM C09CA03 VALSARTANUM


DIOVAN 40 mg

COMPR. FILM.
NOVARTIS PHARMA GMBH

C09CA03 VALSARTANUM
DIOVAN 80 mg

COMPR. FILM.
NOVARTIS PHARMA GMBH

387
ATACAND

C09CA06

CANDESARTANUM CILEXETIL **
COMPR.
16mg ASTRAZENECA AB

Protocol: C005I
16mg 8mg

C09CA06 CANDESARTANUM CILEXETIL C09CA06 CANDESARTANUM CILEXETIL


ATACAND 8mg

COMPR.
ASTRAZENECA AB

SUBLISTA C1-G2 BOLNAVI CU PROTEZE VALVULARE SI VASCULARE. 388 B01AA07 ACENOCUMAROLUM *


B01AA07 ACENOCUMAROLUM
ACENOCUMAROL 2 mg TROMBOSTOP 2 mg 2mg 2mg

Protocol: BB01I Protocol: B003I


2mg

COMPR.
LAROPHARM SRL TERAPIA SA

B01AA07 ACENOCUMAROLUM
SINTROM 4mg

COMPR.
NOVARTIS PHARMA GMBH

4mg

SUBLISTA C1-G3 BOLNAVI CU PROCEDURI INTERVENTIONALE PERCUTANE, NUMAI DUPA IMPLANTAREA UNEI PROTEZE ENDOVASCULARE (STENT). 389 B01AC04 CLOPIDOGRELUM ***
B01AC04 CLOPIDOGRELUM
ISCOVER 75mg PLAVIX 75mg 75mg 75mg

COMPR. FILM.
BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB

75mg

Prescriere limitata:

Pentru tratamentul pacientilor pre- si post-angioplastie

76 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G4 HEPATITELE CRONICE DE ETIOLOGIE VIRALA B, C SI D. 390 B03XA01 EPOETINUM ALFA **
B03XA01 EPOETINUM ALFA
EPREX 10000 UI

Protocol: LB01B;LB02B Protocol: B013K


10000ui/ml 1000UI/0.5ml

SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O. RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA


EPOKINE 1000 UI/0,5 ml EPREX 1000 UI

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml 1000UI/ml 20000UI/ml

B03XA01 EPOETINUM ALFA


NEORECORMON 500UI

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD.

1000UI/ml 20000UI/ml 2000UI

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 2000 U.I.

SOL. INJ.
2000UI

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/0,5 ml EPREX 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

2000ui/0.5ml

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA


EPREX 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA


EPREX 40 000 UI

SOL. INJ.
40 000UI JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 4000 U.I.

SOL. INJ.
4000UI

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/0,4 ml EPREX 4000 UI

SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

4000ui/0.4ml

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 50000UI/ml 10000UI/1,0ml 10000UI/1,0ml 10000UI/1,0ml 1000UI/0,5ml 1000UI/0,5ml 1000UI/0,5ml 2000UI/1,0ml 2000UI/1,0ml 2000UI/1,0ml 3000UI/0,3ml 3000UI/0,3ml 3000UI/0,3ml 4000UI/0,4ml 4000UI/0,4ml 4000UI/0,4ml 5000UI/0,5ml 5000UI/0,5ml 5000UI/0,5ml 6000UI/0,6ml 6000UI/0,6ml 6000UI/0,6ml 8000UI/0,8ml 8000UI/0,8ml 8000UI/0,8ml RENAMED FARMA S.R.L.

4000UI/1ml 50000UI/ml 10000UI/1,0ml

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

B03XA01 EPOETINUM ALFA


ABSEAMED 10000UI/1,0ml BINOCRIT 10000UI/1,0ml EPOETIN ALFA HEXAL 10000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA


ABSEAMED 1000UI/0,5ml BINOCRIT 1000UI/0,5ml EPOETIN ALFA HEXAL 1000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

1000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 2000UI/1,0ml BINOCRIT 2000UI/1,0ml EPOETIN ALFA HEXAL 2000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

2000UI/1,0ml

B03XA01 EPOETINUM ALFA


ABSEAMED 3000UI/0,3ml BINOCRIT 3000UI/0,3ml EPOETIN ALFA HEXAL 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

3000UI/0,3ml

B03XA01 EPOETINUM ALFA


ABSEAMED 4000UI/0,4ml BINOCRIT 4000UI/0,4ml EPOETIN ALFA HEXAL 4000UI/0,4ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

4000UI/0,4ml

B03XA01 EPOETINUM ALFA


ABSEAMED 5000UI/0,5ml BINOCRIT 5000UI/0,5ml EPOETIN ALFA HEXAL 5000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

5000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 6000UI/0,6ml BINOCRIT 6000UI/0,6ml EPOETIN ALFA HEXAL 6000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

6000UI/0,6ml

B03XA01 EPOETINUM ALFA


ABSEAMED 8000UI/0,8ml BINOCRIT 8000UI/0,8ml EPOETIN ALFA HEXAL 8000UI/0,8ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

8000UI/0,8ml

391

B03XA01

EPOETINUM BETA **
LIOF. + SOLV. PT. SOL. INJ.
1000UI/ml 20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml ROCHE REGISTRATION LTD.

Protocol: B013K
1000UI/ml 20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 500UI

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ. SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 1000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/ml

B03XA01 EPOETINUM BETA

77 / 233

DCI/DENUMIRE COMERCIALA
NEORECORMON 2000UI/0,3ml

CONCENTRATIE
2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

FORMA FARM.
ROCHE REGISTRATION LTD.

FIRMA

PROTOCOL

B03XA01 EPOETINUM BETA


NEORECORMON 30000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD.

30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON 4000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA


NEORECORMON 5000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 500UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 60000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 6000UI/0,3ml

392
J05AB04 J05AB04
COPEGUS REBETOL 200 mg

J05AB04
RIBAVIRINUM RIBAVIRINUM RIBAVIRINUM

RIBAVIRINUM ****
CAPS.
200mg 200mg 40mg/ml SP EUROPE

Protocol: J002N
200mg 200mg 40mg/ml

COMPR. FILM.
ROCHE ROMANIA SRL SP EUROPE

J05AB04

SOL. ORALA

REBETOL 40 mg/ml

393
J05AF05 J05AF05 J05AF05
EPIVIR 150mg ZEFFIX 100 mg

J05AF05
LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM

LAMIVUDINUM ****
COMPR. FILM.
100mg 10mg/ml 150mg 300mg 5mg/ml GLAXO GROUP LTD.

Protocol: J005N
100mg 10mg/ml 150mg 300mg 5mg/ml

SOL. ORALA
GLAXO GROUP LTD. GLAXO GROUP LTD. GLAXO GROUP LTD. GLAXO GROUP LTD.

EPIVIR 10mg/ml

COMPR. FILM. COMPR. FILM. SOL. ORALA

J05AF05
EPIVIR 300mg

J05AF05

ZEFFIX 5 mg/ml

394
J05AF08
HEPSERA

J05AF08
ADEFOVIRUM DIPIVOXILUM

ADEFOVIRUM DIPIVOXILUM ****


COMPR.
10mg GILEAD SCIENCE INTERNATIONAL LIMITED

Protocol: J009N
10mg

395
J05AF10 J05AF10 J05AF10

J05AF10
ENTECAVIRUM ENTECAVIRUM

ENTECAVIRUM ****
SOL. ORALA
0,05mg/ml 0,5mg 1mg BRISTOL-MYERS SQUIBB PHARMA EEIG

Protocol: J008N
0,05mg/ml 0,5mg 1mg

BARACLUDE 0,05mg/ml BARACLUDE 0,5mg

COMPR. FILM.
BRISTOL-MYERS SQUIBB PHARMA EEIG

ENTECAVIRUM

COMPR. FILM.
BRISTOL-MYERS SQUIBB PHARMA EEIG

BARACLUDE 1mg

396
NEUPOGEN

L03AA02

FILGRASTIMUM (G-CSF) **
SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

Protocol: B013K
30MU/0.5ml 48MU/0.5ml

L03AA02 FILGRASTIMUM (G-CSF) L03AA02 FILGRASTIMUM (G-CSF)


NEUPOGEN

SOL. INJ.
48MU/0.5ml AMGEN EUROPE B.V.

397
ROFERON A

L03AB04

INTERFERONUM ALFA 2a ****


SOL. INJ.
18Mui/0.6ml ROCHE ROMANIA S.R.L.

Protocol: J007N
18Mui/0.6ml

L03AB04 INTERFERONUM ALFA 2a

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
3Mui/0.5ml ROCHE ROMANIA S.R.L.

3Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
6Mui/0.5ml ROCHE ROMANIA S.R.L.

6Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
9Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
3Mui/0.5ml ROCHE ROMANIA S.R.L.

3Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
6Mui/0.5ml ROCHE ROMANIA S.R.L.

6Mui/0.5ml

78 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
9Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

398

L03AB05

INTERFERONUM ALFA 2b ****


SOL. INJ./PERF.
10 milioane U.I./ml SP EUROPE

Protocol: J006N
10 milioane U.I./ml

L03AB05 INTERFERONUM ALFA 2b


INTRON A 10 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 10milioane UI/ml

PULB. + SOLV. PT. SOL. INJ.


10milioane UI/ml SCHERING PLOUGH EUROPE

10milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 10milioane UI/ml

SOL. INJ.
10milioane UI/ml SCHERING PLOUGH EUROPE

10milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 18 milioane U.I./0,3ml

SOL. INJ./PERF.
18 milioane U.I./0,3 ml SP EUROPE

18 milioane U.I./0,3 ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 18 milioane UI/3ml

SOL. INJ.
18 milioane UI/3ml SCHERING PLOUGH EUROPE

18 milioane UI/3ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 1milionUI/ml

PULB. + SOLV. PT. SOL. INJ.


1milionUI/ml SCHERING PLOUGH EUROPE

1milionUI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 25 milioane U.I./2,5ml

SOL. INJ./PERF.
25 milioane U.I./2,5 ml SP EUROPE

25 milioane U.I./2,5 ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 25milioane UI/2,5ml

SOL. INJ.
25milioane UI/2,5ml SCHERING PLOUGH EUROPE

25milioane UI/2,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 3 milioane U.I./0,5ml

SOL. INJ./PERF.
3 milioane U.I./0,5ml SP EUROPE

3 milioane U.I./0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 3milioane UI/0,5ml

SOL. INJ.
3milioane UI/0,5ml SCHERING PLOUGH EUROPE

3milioane UI/0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 3milioane UI/ml

PULB. + SOLV. PT. SOL. INJ.


3milioane UI/ml SCHERING PLOUGH EUROPE

3milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 5 milioane U.I./0,5ml

SOL. INJ./PERF.
5 milioane U.I./0,5ml SP EUROPE

5 milioane U.I./0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 5milioane UI/0,5ml

SOL. INJ.
5milioane UI/0,5ml SCHERING PLOUGH EUROPE

5milioane UI/0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 5milioane UI/ml

PULB. + SOLV. PT. SOL. INJ.


5milioane UI/ml SCHERING PLOUGH EUROPE

5milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 1 milion U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


1 milion U.I./ml SP EUROPE

1 milion U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 10 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


10 milioane U.I./ml SP EUROPE

10 milioane U.I./ml

79 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 18 milioane U.I.

SOL. INJ. PEN MULTIDOZA


18 milioane U.I. SP EUROPE

18 milioane U.I.

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 18 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


18 milioane U.I./ml SP EUROPE

18 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 18milioane UI

SOL. INJ. PEN MULTIDOZA


18milioane UI SCHERING PLOUGH EUROPE

18milioane UI

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 3 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


3 milioane U.I./ml SP EUROPE

3 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

SOL. INJ. PEN MULTIDOZA


30 milioane U.I. 60 milioane U.I. SP EUROPE SP EUROPE

30 milioane U.I.

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 30 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


30 milioane U.I./ml SP EUROPE

30 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 30milioane UI

SOL. INJ. PEN MULTIDOZA


30milioane UI SCHERING PLOUGH EUROPE

30milioane UI

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 5 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


5 milioaneU.I./ml SP EUROPE

5 milioaneU.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

SOL. INJ. PEN MULTIDOZA


30 milioane U.I. 60 milioane U.I. SP EUROPE SP EUROPE

60 milioane U.I.

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 60milioane UI

SOL. INJ. PEN MULTIDOZA


60milioane UI SCHERING PLOUGH EUROPE

60milioane UI

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

399

L03AB10

PEGINTERFERON alfa-2b ****


PULB. + SOLV. PT. SOL. INJ. IN STILOU INJECTOR
100 g SP EUROPE

Protocol: J003N
100 g

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 100g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 100 g 100g

PULB. + SOLV. PT. SOL. INJ.


SP EUROPE

100g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 120g

PULB. + SOLV. PT. SOL. INJ. IN STILOU INJECTOR


120 g SP EUROPE

120 g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 120 g 120g

PULB. + SOLV. PT. SOL. INJ.


SP EUROPE

120g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 150g

PULB. + SOLV. PT. SOL. INJ. IN STILOU INJECTOR


150 g SP EUROPE

150 g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 150 g 150g

PULB. + SOLV. PT. SOL. INJ.


SP EUROPE

150g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 50g 50 g

PULB. + SOLV. PT. SOL. INJ. IN STILOU INJECTOR


SP EUROPE

50 g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 50 g 50g

PULB. + SOLV. PT. SOL. INJ.


SP EUROPE

50g

80 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 80g 80 g

PULB. + SOLV. PT. SOL. INJ. IN STILOU INJECTOR


SP EUROPE

80 g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 80 g 80g

PULB. + SOLV. PT. SOL. INJ.


SP EUROPE

80g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 100g

PULB. + SOL. PT. SOL. INJ.


100 g SP EUROPE

100 g 100g/0.5ml

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 100g/0.5ml

PULB.+SOLV. PT. SOL. INJ. IN STILOU INJ. PREUMPLUT


100g/0.5ml 120 g SP EUROPE

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 120g

PULB. + SOL. PT. SOL. INJ.


SP EUROPE

120 g 120g/0.5ml

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 120g/0.5ml

PULB.+SOLV. PT. SOL. INJ. IN STILOU INJ. PREUMPLUT


120g/0.5ml 150 g SP EUROPE

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 150g

PULB. + SOL. PT. SOL. INJ.


SP EUROPE

150 g 150g/0.5ml

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 150g/0.5ml

PULB.+SOLV. PT. SOL. INJ. IN STILOU INJ. PREUMPLUT


150g/0.5ml 50 g SP EUROPE

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 50 g

PULB. + SOL. PT. SOL. INJ.


SP EUROPE

50 g 50g/0.5ml

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 50g/0.5ml

PULB.+SOLV. PT. SOL. INJ. IN STILOU INJ. PREUMPLUT


50g/0.5ml 80 g SP EUROPE

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 80 g

PULB. + SOL. PT. SOL. INJ.


SP EUROPE

80 g 80g/0.5ml

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 80g/0.5ml

PULB.+SOLV. PT. SOL. INJ. IN STILOU INJ. PREUMPLUT


80g/0.5ml SP EUROPE

400
PEGASYS 135 g/ml

L03AB11

PEGINTERFERON alfa-2a ****


SOL. INJ.
135g/ml ROCHE REGISTRATION LTD.

Protocol: J004N
135g/ml

L03AB11 PEGINTERFERON alfa-2a

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB11 PEGINTERFERON alfa-2a


PEGASYS 180 g/ml

SOL. INJ.
180g/ml ROCHE REGISTRATION LTD.

180g/ml

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB11 PEGINTERFERON alfa-2a


PEGASYS 135 g/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


135g/0,5ml 180g/0.5ml ROCHE REGISTRATION LTD.

135g/0,5ml 180g/0.5ml

L03AB11 PEGINTERFERON alfa-2a


PEGASYS 180 g/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD.

401
VIREGYT- K

N04BB01

AMANTADINUM **
CAPS.
100mg EGIS PHARMACEUTICALS LTD.

N04BB01 AMANTADINUM

100mg

81 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G5 HEPATITA AUTOIMUNA. 402 H02AB04 METHYLPREDNISOLONUM


H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 125 mg

LIOF. PT. SOL. INJ.


125mg 125mg/2ml HEMOFARM S.R.L.

125mg 125mg/2ml 16mg

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL A 16 16mg 20mg

COMPR. LIOF. PT. SOL. INJ.


HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 20 mg

20mg 250mg/4ml 32mg

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
250mg/4ml PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 32 32mg 40mg

COMPR. LIOF. PT. SOL. INJ.


HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 40 mg

40mg 40mg/1ml 4mg

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
40mg/1ml PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg 4mg

COMPR. LIOF. PT. SOL. INJ.


500mg 500mg/7.8ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 500 mg

500mg 500mg/7.8ml

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL 500 mg/7,8 ml

LIOF. + SOLV. PT. SOL. INJ.


PFIZER EUROPE MA EEIG

403
DECORTIN H 20 mg

H02AB06

PREDNISOLONUM
COMPR.
20 mg 250mg MERCK KGAA

H02AB06 PREDNISOLONUM H02AB06 PREDNISOLONUM


SOLU - DECORTIN H 250

20 mg 250mg 5 mg
MERCK KGAA

LIOF. + SOLV. PT. SOL. INJ.


MERCK KGAA

H02AB06 PREDNISOLONUM
DECORTIN H 5 mg 5 mg 50mg

COMPR. LIOF. + SOLV. PT. SOL. INJ.


MERCK KGAA

H02AB06 PREDNISOLONUM
SOLU - DECORTIN H 50

50mg

404
IMURAN

L04AX01

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

L04AX01 AZATHIOPRINUM

50mg

SUBLISTA C1-G6 CIROZA BILIARA PRIMARA, COLANGITA SCLEROZANTA PRIMITIVA, HEPATITA CRONICA SI CIROZE DE ALTE ETIOLOGII CU COLESTAZA. 405 A05AA02 ACIDUM URSODEOXYCHOLICUM
A05AA02 ACIDUM URSODEOXYCHOLICUM
URSOCHOL 150 mg

COMPR.
150mg ZAMBON S.P.A.

150mg

Cod restrictie 1700: Ciroza biliara primitiva NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOFALK URSOSAN

CAPS.
250mg 250mg DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

250mg

Cod restrictie 1700: Ciroza biliara primitiva NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOCHOL 300 mg

COMPR.
300mg ZAMBON S.P.A.

300mg

Cod restrictie 1700: Ciroza biliara primitiva NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

82 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G7 CIROZA HEPATICA. 406 A06AD11 LACTULOSUM *


A06AD11 LACTULOSUM
EPALFEN 12 g 12g 66.7%

GRAN. PT. SOL. ORALA


ZAMBON S.P.A.

12g 66.7%

A06AD11 LACTULOSUM
DUPHALAC

LICHID ORAL
SOLVAY PHARMACEUTICALS BV

Prescriere limitata:
LACTULOSE AL SIROP

Coma sau precoma hepatica (encefalopatie cronica porto-sistemica)


66.7% 6g 670mg/ml 6g ALIUD PHARMA GMBH & CO.KG ZAMBON S.P.A. FRESENIUS KABI AUSTRIA GMBH

A06AD11 LACTULOSUM A06AD11 LACTULOSUM


EPALFEN 6 g LAEVOLAC 670mg/ml

A06AD11 LACTULOSUM
EPALFEN 6 g

GRAN. PT. SOL. ORALA


ZAMBON S.P.A.

6g 66.7%

A06AD11 LACTULOSUM
LACTULOSE AL SIROP 66.7%

SIROP
ALIUD PHARMA GMBH & CO.KG

Prescriere limitata:
LAEVOLAC 670mg/ml

Coma sau precoma hepatica (encefalopatie cronica porto-sistemica)

A06AD11 LACTULOSUM
Prescriere limitata:
LACTULOSE AL SIROP

SOL. ORALA
670mg/ml FRESENIUS KABI AUSTRIA GMBH

670mg/ml

Coma sau precoma hepatica (encefalopatie cronica porto-sistemica)

A06AD11 LACTULOSUM
66.7%

SIROP
ALIUD PHARMA GMBH & CO.KG

66.7% 670mg/ml 66.7% 65%


E.I.P.I.CO. MED S.R.L.

A06AD11 LACTULOSUM
LAEVOLAC 670mg/ml

SOL. ORALA
670mg/ml 66.7% FRESENIUS KABI AUSTRIA GMBH SOLVAY PHARMACEUTICALS BV

A06AD11 LACTULOSUM
DUPHALAC

LICHID ORAL SIROP


65%

A06AD11 LACTULOSUM
LACTULOSE

407
NORMIX 100mg/5ml

A07AA11

RIFAXIMINUM *
GRAN. PT. SUSP. ORALA
100mg/5ml 200mg 400mg ALFA WASSERMANN SPA

A07AA11 RIFAXIMINUM A07AA11 RIFAXIMINUM


NORMIX 200 mg

100mg/5ml 200mg 400mg

COMPR. FILM.
ALFA WASSERMANN SPA BAMA-GEVE S.L.

A07AA11 RIFAXIMINUM
NORMIX 400 mg

COMPR. FILM.

408
EPREX 10000 UI

B03XA01

EPOETINUM ALFA **
SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

Protocol: B013K
10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA


EPOKINE 1000 UI/0,5 ml EPREX 1000 UI

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml 1000UI/ml 20000UI/ml

B03XA01 EPOETINUM ALFA


NEORECORMON 500UI

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD.

1000UI/ml 20000UI/ml 2000UI

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 2000 U.I.

SOL. INJ.
2000UI

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/0,5 ml EPREX 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

2000ui/0.5ml

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA


EPREX 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA


EPREX 40 000 UI

SOL. INJ.
40 000UI JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 4000 U.I.

SOL. INJ.
4000UI

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/0,4 ml EPREX 4000 UI

SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

4000ui/0.4ml

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 50000UI/ml 10000UI/1,0ml 10000UI/1,0ml 10000UI/1,0ml 1000UI/0,5ml 1000UI/0,5ml 1000UI/0,5ml 2000UI/1,0ml 2000UI/1,0ml 2000UI/1,0ml 3000UI/0,3ml 3000UI/0,3ml RENAMED FARMA S.R.L.

4000UI/1ml 50000UI/ml 10000UI/1,0ml

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

B03XA01 EPOETINUM ALFA


ABSEAMED 10000UI/1,0ml BINOCRIT 10000UI/1,0ml EPOETIN ALFA HEXAL 10000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA


ABSEAMED 1000UI/0,5ml BINOCRIT 1000UI/0,5ml EPOETIN ALFA HEXAL 1000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

1000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 2000UI/1,0ml BINOCRIT 2000UI/1,0ml EPOETIN ALFA HEXAL 2000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

2000UI/1,0ml

B03XA01 EPOETINUM ALFA


ABSEAMED 3000UI/0,3ml BINOCRIT 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH

3000UI/0,3ml

83 / 233

DCI/DENUMIRE COMERCIALA
EPOETIN ALFA HEXAL 3000UI/0,3ml

CONCENTRATIE
3000UI/0,3ml 4000UI/0,4ml 4000UI/0,4ml 4000UI/0,4ml 5000UI/0,5ml 5000UI/0,5ml 5000UI/0,5ml 6000UI/0,6ml 6000UI/0,6ml 6000UI/0,6ml 8000UI/0,8ml 8000UI/0,8ml 8000UI/0,8ml

FORMA FARM.

FIRMA

PROTOCOL

HEXAL BIOTECH FORSCHUNGS GMBH

B03XA01 EPOETINUM ALFA


ABSEAMED 4000UI/0,4ml BINOCRIT 4000UI/0,4ml EPOETIN ALFA HEXAL 4000UI/0,4ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

4000UI/0,4ml

B03XA01 EPOETINUM ALFA


ABSEAMED 5000UI/0,5ml BINOCRIT 5000UI/0,5ml EPOETIN ALFA HEXAL 5000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

5000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 6000UI/0,6ml BINOCRIT 6000UI/0,6ml EPOETIN ALFA HEXAL 6000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

6000UI/0,6ml

B03XA01 EPOETINUM ALFA


ABSEAMED 8000UI/0,8ml BINOCRIT 8000UI/0,8ml EPOETIN ALFA HEXAL 8000UI/0,8ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

8000UI/0,8ml

409

B03XA01

EPOETINUM BETA **
LIOF. + SOLV. PT. SOL. INJ.
1000UI/ml 20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml ROCHE REGISTRATION LTD.

Protocol: B013K
1000UI/ml 20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 500UI

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ. SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 1000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 2000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 30000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 3000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 4000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 5000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 500UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 60000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 6000UI/0,3ml

410

C03CA01

FUROSEMIDUM
SOL. INJ.
10mg/ml ZENTIVA SA

C03CA01 FUROSEMIDUM
FUROSEMID 20 mg/2 ml

10mg/ml

Electroliii serici trebuie s fie verificai periodic.

C03CA01 FUROSEMIDUM
FUROSEMID 40 mg FUROSEMID ARENA 40 mg FUROSEMID EEL FUROSEMID LPH 40 mg FUROSEMID MCC 40 mg FUROSEMID SLAVIA FUROSEMID ZENTIVA 40mg 40mg 40mg 40mg 40mg 40mg 40mg

COMPR.
LAROPHARM SRL ARENA GROUP S.A. BIO EEL SRL LABORMED PHARMA SA MAGISTRA C & C SRL SLAVIA PHARM SRL ZENTIVA SA

40mg

Electroliii serici trebuie s fie verificai periodic.

411
VEROSPIRON

C03DA01

SPIRONOLACTONUM
CAPS.
100mg GEDEON RICHTER LTD.

C03DA01 SPIRONOLACTONUM

100mg

Electroliii serici trebuie s fie verificai periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

C03DA01 SPIRONOLACTONUM
SPIRONOLACTONA 25 mg 25mg

COMPR.
OZONE LABORATORIES LTD.

25mg

Electroliii serici trebuie s fie verificai periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

C03DA01 SPIRONOLACTONUM
ALSPIRON 25 mg SPIRONOLACTONA 25 mg 25mg 25mg

COMPR. FILM.
AC HELCOR PHARMA SRL TERAPIA SA

25mg

Electroliii serici trebuie s fie verificai periodic. Femeile la varsta fertila la care s-a initiat tratament cu spironolactona trebuie sa ia masuri adecvate de contraceptie.

C03DA01 SPIRONOLACTONUM
SPIRONOLACTONA 50 mg VEROSPIRON 50mg 50mg

CAPS.
LAROPHARM SRL GEDEON RICHTER LTD.

50mg

C03DA01 SPIRONOLACTONUM

COMPR. FILM.

50mg

84 / 233

DCI/DENUMIRE COMERCIALA
ALSPIRON 50 mg

CONCENTRATIE
50mg

FORMA FARM.
AC HELCOR PHARMA SRL

FIRMA

PROTOCOL

412
DECORTIN H 20 mg

H02AB06

PREDNISOLONUM
COMPR.
20 mg 250mg MERCK KGAA

H02AB06 PREDNISOLONUM H02AB06 PREDNISOLONUM


SOLU - DECORTIN H 250

20 mg 250mg 5 mg
MERCK KGAA

LIOF. + SOLV. PT. SOL. INJ.


MERCK KGAA

H02AB06 PREDNISOLONUM
DECORTIN H 5 mg 5 mg 50mg

COMPR. LIOF. + SOLV. PT. SOL. INJ.


MERCK KGAA

H02AB06 PREDNISOLONUM
SOLU - DECORTIN H 50

50mg

413
J05AB04 J05AB04
COPEGUS REBETOL 200 mg

J05AB04
RIBAVIRINUM RIBAVIRINUM RIBAVIRINUM

RIBAVIRINUM ****
CAPS.
200mg 200mg 40mg/ml SP EUROPE

200mg 200mg 40mg/ml

COMPR. FILM.
ROCHE ROMANIA SRL SP EUROPE

J05AB04

SOL. ORALA

REBETOL 40 mg/ml

414
J05AF05 J05AF05 J05AF05
EPIVIR 150mg ZEFFIX 100 mg

J05AF05
LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM

LAMIVUDINUM ****
COMPR. FILM.
100mg 10mg/ml 150mg 300mg 5mg/ml GLAXO GROUP LTD.

100mg 10mg/ml 150mg 300mg 5mg/ml

SOL. ORALA
GLAXO GROUP LTD. GLAXO GROUP LTD. GLAXO GROUP LTD. GLAXO GROUP LTD.

EPIVIR 10mg/ml

COMPR. FILM. COMPR. FILM. SOL. ORALA

J05AF05
EPIVIR 300mg

J05AF05

ZEFFIX 5 mg/ml

415
J05AF08
HEPSERA

J05AF08
ADEFOVIRUM DIPIVOXILUM

ADEFOVIRUM DIPIVOXILUM ****


COMPR.
10mg GILEAD SCIENCE INTERNATIONAL LIMITED

10mg

416
J05AF10 J05AF10 J05AF10

J05AF10
ENTECAVIRUM ENTECAVIRUM

ENTECAVIRUM ****
SOL. ORALA
0,05mg/ml 0,5mg 1mg BRISTOL-MYERS SQUIBB PHARMA EEIG

0,05mg/ml 0,5mg 1mg

BARACLUDE 0,05mg/ml BARACLUDE 0,5mg

COMPR. FILM.
BRISTOL-MYERS SQUIBB PHARMA EEIG

ENTECAVIRUM

COMPR. FILM.
BRISTOL-MYERS SQUIBB PHARMA EEIG

BARACLUDE 1mg

417
NEUPOGEN

L03AA02

FILGRASTIMUM (G-CSF) **
SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

Protocol: B013K
30MU/0.5ml 48MU/0.5ml

L03AA02 FILGRASTIMUM (G-CSF) L03AA02 FILGRASTIMUM (G-CSF)


NEUPOGEN

SOL. INJ.
48MU/0.5ml AMGEN EUROPE B.V.

418
ROFERON A

L03AB04

INTERFERONUM ALFA 2a ****


SOL. INJ.
18Mui/0.6ml ROCHE ROMANIA S.R.L.

L03AB04 INTERFERONUM ALFA 2a

18Mui/0.6ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
3Mui/0.5ml ROCHE ROMANIA S.R.L.

3Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
6Mui/0.5ml ROCHE ROMANIA S.R.L.

6Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
9Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
3Mui/0.5ml ROCHE ROMANIA S.R.L.

3Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
6Mui/0.5ml ROCHE ROMANIA S.R.L.

6Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
9Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5ml

85 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

419

L03AB05

INTERFERONUM ALFA 2b ****


SOL. INJ./PERF.
10 milioane U.I./ml SP EUROPE

L03AB05 INTERFERONUM ALFA 2b


INTRON A 10 milioane U.I./ml

10 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 10milioane UI/ml

PULB. + SOLV. PT. SOL. INJ.


10milioane UI/ml SCHERING PLOUGH EUROPE

10milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 10milioane UI/ml

SOL. INJ.
10milioane UI/ml SCHERING PLOUGH EUROPE

10milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 18 milioane U.I./0,3ml

SOL. INJ./PERF.
18 milioane U.I./0,3 ml SP EUROPE

18 milioane U.I./0,3 ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 18 milioane UI/3ml

SOL. INJ.
18 milioane UI/3ml SCHERING PLOUGH EUROPE

18 milioane UI/3ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 1milionUI/ml

PULB. + SOLV. PT. SOL. INJ.


1milionUI/ml SCHERING PLOUGH EUROPE

1milionUI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 25 milioane U.I./2,5ml

SOL. INJ./PERF.
25 milioane U.I./2,5 ml SP EUROPE

25 milioane U.I./2,5 ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 25milioane UI/2,5ml

SOL. INJ.
25milioane UI/2,5ml SCHERING PLOUGH EUROPE

25milioane UI/2,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 3 milioane U.I./0,5ml

SOL. INJ./PERF.
3 milioane U.I./0,5ml SP EUROPE

3 milioane U.I./0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 3milioane UI/0,5ml

SOL. INJ.
3milioane UI/0,5ml SCHERING PLOUGH EUROPE

3milioane UI/0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 3milioane UI/ml

PULB. + SOLV. PT. SOL. INJ.


3milioane UI/ml SCHERING PLOUGH EUROPE

3milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 5 milioane U.I./0,5ml

SOL. INJ./PERF.
5 milioane U.I./0,5ml SP EUROPE

5 milioane U.I./0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 5milioane UI/0,5ml

SOL. INJ.
5milioane UI/0,5ml SCHERING PLOUGH EUROPE

5milioane UI/0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 5milioane UI/ml

PULB. + SOLV. PT. SOL. INJ.


5milioane UI/ml SCHERING PLOUGH EUROPE

5milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 1 milion U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


1 milion U.I./ml SP EUROPE

1 milion U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 10 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


10 milioane U.I./ml SP EUROPE

10 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 18 milioane U.I.

SOL. INJ. PEN MULTIDOZA


18 milioane U.I. SP EUROPE

18 milioane U.I.

86 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 18 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


18 milioane U.I./ml SP EUROPE

18 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 18milioane UI

SOL. INJ. PEN MULTIDOZA


18milioane UI SCHERING PLOUGH EUROPE

18milioane UI

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 3 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


3 milioane U.I./ml SP EUROPE

3 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

SOL. INJ. PEN MULTIDOZA


30 milioane U.I. 60 milioane U.I. SP EUROPE SP EUROPE

30 milioane U.I.

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 30 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


30 milioane U.I./ml SP EUROPE

30 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 30milioane UI

SOL. INJ. PEN MULTIDOZA


30milioane UI SCHERING PLOUGH EUROPE

30milioane UI

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 5 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


5 milioaneU.I./ml SP EUROPE

5 milioaneU.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

SOL. INJ. PEN MULTIDOZA


30 milioane U.I. 60 milioane U.I. SP EUROPE SP EUROPE

60 milioane U.I.

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 60milioane UI

SOL. INJ. PEN MULTIDOZA


60milioane UI SCHERING PLOUGH EUROPE

60milioane UI

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

420

L03AB10

PEGINTERFERON alfa-2b ****


PULB. + SOLV. PT. SOL. INJ. IN STILOU INJECTOR
100 g SP EUROPE

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 100g

100 g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 100 g 100g

PULB. + SOLV. PT. SOL. INJ.


SP EUROPE

100g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 120g

PULB. + SOLV. PT. SOL. INJ. IN STILOU INJECTOR


120 g SP EUROPE

120 g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 120 g 120g

PULB. + SOLV. PT. SOL. INJ.


SP EUROPE

120g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 150g

PULB. + SOLV. PT. SOL. INJ. IN STILOU INJECTOR


150 g SP EUROPE

150 g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 150 g 150g

PULB. + SOLV. PT. SOL. INJ.


SP EUROPE

150g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 50g 50 g

PULB. + SOLV. PT. SOL. INJ. IN STILOU INJECTOR


SP EUROPE

50 g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 50 g 50g

PULB. + SOLV. PT. SOL. INJ.


SP EUROPE

50g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 80g 80 g

PULB. + SOLV. PT. SOL. INJ. IN STILOU INJECTOR


SP EUROPE

80 g

87 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 80 g 80g

PULB. + SOLV. PT. SOL. INJ.


SP EUROPE

80g

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 100g

PULB. + SOL. PT. SOL. INJ.


100 g SP EUROPE

100 g 100g/0.5ml

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 100g/0.5ml

PULB.+SOLV. PT. SOL. INJ. IN STILOU INJ. PREUMPLUT


100g/0.5ml 120 g SP EUROPE

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 120g

PULB. + SOL. PT. SOL. INJ.


SP EUROPE

120 g 120g/0.5ml

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 120g/0.5ml

PULB.+SOLV. PT. SOL. INJ. IN STILOU INJ. PREUMPLUT


120g/0.5ml 150 g SP EUROPE

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 150g

PULB. + SOL. PT. SOL. INJ.


SP EUROPE

150 g 150g/0.5ml

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 150g/0.5ml

PULB.+SOLV. PT. SOL. INJ. IN STILOU INJ. PREUMPLUT


150g/0.5ml 50 g SP EUROPE

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 50 g

PULB. + SOL. PT. SOL. INJ.


SP EUROPE

50 g 50g/0.5ml

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 50g/0.5ml

PULB.+SOLV. PT. SOL. INJ. IN STILOU INJ. PREUMPLUT


50g/0.5ml 80 g SP EUROPE

L03AB10 PEGINTERFERON alfa-2b


VIRAFERONPEG 80 g

PULB. + SOL. PT. SOL. INJ.


SP EUROPE

80 g 80g/0.5ml

L03AB10 PEGINTERFERON alfa-2b


PEGINTRON 80g/0.5ml

PULB.+SOLV. PT. SOL. INJ. IN STILOU INJ. PREUMPLUT


80g/0.5ml SP EUROPE

421
PEGASYS 135 g/ml

L03AB11

PEGINTERFERON alfa-2a ****


SOL. INJ.
135g/ml ROCHE REGISTRATION LTD.

L03AB11 PEGINTERFERON alfa-2a

135g/ml

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB11 PEGINTERFERON alfa-2a


PEGASYS 180 g/ml

SOL. INJ.
180g/ml ROCHE REGISTRATION LTD.

180g/ml

Tratamentul cu peginterferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB11 PEGINTERFERON alfa-2a


PEGASYS 135 g/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


135g/0,5ml 180g/0.5ml ROCHE REGISTRATION LTD.

135g/0,5ml 180g/0.5ml

L03AB11 PEGINTERFERON alfa-2a


PEGASYS 180 g/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD.

422
VIREGYT- K

N04BB01

AMANTADINUM **
CAPS.
100mg EGIS PHARMACEUTICALS LTD.

N04BB01 AMANTADINUM

100mg

88 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G10 LEUCEMII, LIMFOAME, APLAZIE MEDULARA, GAMAPATII MONOCLONALE MALIGNE, MIELOPROLIFERARI CRONICE SI TUMORI MALIGNE, SINDROAME MIELODISPLAZICE. 423 A04AA01 ONDANSETRONUM **
A04AA01 ONDANSETRONUM
OSETRON 4 mg OSETRON 8 mg

Protocol: N030C
Protocol: A004C

SOL. INJ.
2mg/ml 2mg/ml 2mg/ml 2mg/ml 4mg 4mg 4mg 4mg 4mg DR. REDDY'S LABORATORIES DR. REDDY'S LABORATORIES

2mg/ml

A04AA01 ONDANSETRONUM
EMESET 4 mg/2 ml EMESET 8 mg/4 ml

SOL. INJ./PERF.
CIPLA (UK) LIMITED CIPLA (UK) LIMITED

2mg/ml

A04AA01 ONDANSETRONUM
ONDANSETRON TEVA 4mg ONDANTOR 4 mg OSETRON 4 mg SETRONON 4 mg ZOFRAN 4 mg

COMPR. FILM.
TEVA PHARMACEUTICALS SRL SANDOZ SRL DR. REDDY'S LABORATORIES PLIVA LJUBLJANA D.O.O. GLAXO WELLCOME UK LTD.

4mg

Prescriere limitata:
ONDARAN MD 4mg

Managementul greturilor si varsaturilor in cadrul tratamentului citotoxic chimioterapic utilizat in cancer

A04AA01 ONDANSETRONUM
4mg

COMPR. ORODISPERSABILE
RANBAXY UK LTD.

4mg

Prescriere limitata:
ZOFRAN 4mg/2ml

Managementul greturilor si varsaturilor in cadrul tratamentului citotoxic chimioterapic utilizat in cancer

A04AA01 ONDANSETRONUM
Prescriere limitata:
SETRONON 4 mg/2 ml

SOL. INJ.
4mg/2ml GLAXO WELLCOME UK LIMITED

4mg/2ml

Managementul greturilor si varsaturilor in cadrul tratamentului citotoxic chimioterapic utilizat in cancer

A04AA01 ONDANSETRONUM
Prescriere limitata:
ONDANSETRON TEVA 8 mg ONDANTOR 8 mg OSETRON 8 mg SETRONON 8 mg ZOFRAN 8 mg

SOL. INJ./PERF.
4mg/2ml PLIVA LJUBLJANA D.O.O.

4mg/2ml

Managementul greturilor si varsaturilor in cadrul tratamentului citotoxic chimioterapic utilizat in cancer

A04AA01 ONDANSETRONUM
8mg 8mg 8mg 8mg 8mg

COMPR. FILM.
TEVA PHARMACEUTICALS SRL SANDOZ SRL DR. REDDY'S LABORATORIES (UK) LTD PLIVA LJUBLJANA D.O.O. GLAXO WELLCOME UK LTD.

8mg

Prescriere limitata:
ONDARAN MD 8 mg

Managementul greturilor si varsaturilor in cadrul tratamentului citotoxic chimioterapic utilizat in cancer

A04AA01 ONDANSETRONUM
8mg

COMPR. ORODISPERSABILE
RANBAXY UK LIMITED

8mg

Prescriere limitata:
ZOFRAN 8mg/4ml

Managementul greturilor si varsaturilor in cadrul tratamentului citotoxic chimioterapic utilizat in cancer

A04AA01 ONDANSETRONUM
Prescriere limitata:
ONDANSETRON TEVA 4mg ONDANTOR 4 mg OSETRON 4 mg SETRONON 4 mg ZOFRAN 4 mg

SOL. INJ.
8mg/4ml GLAXO WELLCOME UK LIMITED

8mg/4ml

Managementul greturilor si varsaturilor in cadrul tratamentului citotoxic chimioterapic utilizat in cancer

A04AA01 ONDANSETRONUM
4mg 4mg 4mg 4mg 4mg

COMPR. FILM.
TEVA PHARMACEUTICALS SRL SANDOZ SRL DR. REDDY'S LABORATORIES PLIVA LJUBLJANA D.O.O. GLAXO WELLCOME UK LTD.

4mg

Prescriere limitata:
ONDARAN MD 4mg

Managementul greturilor si varsaturilor in cadrul tratamentului radioterapic utilizat in cancer

A04AA01 ONDANSETRONUM
4mg

COMPR. ORODISPERSABILE
RANBAXY UK LTD.

4mg

Prescriere limitata:
ONDANSETRON TEVA 8 mg ONDANTOR 8 mg OSETRON 8 mg SETRONON 8 mg ZOFRAN 8 mg

Managementul greturilor si varsaturilor in cadrul tratamentului radioterapic utilizat in cancer

A04AA01 ONDANSETRONUM
8mg 8mg 8mg 8mg 8mg

COMPR. FILM.
TEVA PHARMACEUTICALS SRL SANDOZ SRL DR. REDDY'S LABORATORIES (UK) LTD PLIVA LJUBLJANA D.O.O. GLAXO WELLCOME UK LTD.

8mg

Prescriere limitata:
ONDARAN MD 8 mg

Managementul greturilor si varsaturilor in cadrul tratamentului radioterapic utilizat in cancer

A04AA01 ONDANSETRONUM
8mg

COMPR. ORODISPERSABILE
RANBAXY UK LIMITED

8mg

Prescriere limitata:
SETRONON 8 mg/4 ml

Managementul greturilor si varsaturilor in cadrul tratamentului radioterapic utilizat in cancer

A04AA01 ONDANSETRONUM

SOL. INJ./PERF.
8mg/4 ml PLIVA LJUBLJANA D.O.O.

8mg/4 ml

424
KYTRIL 1 mg

A04AA02

GRANISETRONUM **
COMPR. FILM.
1mg 20g/ml 2mg ROCHE ROMANIA S.R.L.

Protocol: A004C
1mg 20g/ml 2mg

A04AA02 GRANISETRONUM A04AA02 GRANISETRONUM


KYTRIL

SOL. ORALA
F. HOFFMANN LA ROCHE LTD. F. HOFFMANN LA ROCHE LTD.

A04AA02 GRANISETRONUM
KYTRIL

COMPR. FILM.

Prescriere limitata:
KYTRIL

Managementul greturilor si varsaturilor in cadrul tratamentului citotoxic chimioterapic utilizat in cancer

A04AA02 GRANISETRONUM
Prescriere limitata: Prescriere limitata:
KYTRIL

SOL. INJ.
3mg/3ml ROCHE ROMANIA SRL

3mg/3ml

Managementul greturilor si varsaturilor in cadrul tratamentului citotoxic chimioterapic utilizat in cancer Managementul greturilor si varsaturilor in cadrul tratamentului radioterapic utilizat in cancer

A04AA02 GRANISETRONUM
2mg

COMPR. FILM.
F. HOFFMANN LA ROCHE LTD.

2mg

Prescriere limitata:

Managementul greturilor si varsaturilor in cadrul tratamentului radioterapic utilizat in cancer

425
ALOXI

A04AA05

PALONOSETRONUM **
SOL. INJ.
250 g/5ml HELSINN BIREX PHARMACEUTICALS LTD.

Protocol: A002C;A004C
250 g/5ml

A04AA05 PALONOSETRONUM

426
EPREX 10000 UI

B03XA01

EPOETINUM ALFA ***


SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

Protocol: L022B
10000ui/ml

B03XA01 EPOETINUM ALFA

89 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

FIRMA

PROTOCOL

B03XA01 EPOETINUM ALFA


EPOKINE 1000 UI/0,5 ml EPREX 1000 UI

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml 1000UI/ml 20000UI/ml

1000UI/0.5ml

B03XA01 EPOETINUM ALFA


NEORECORMON 500UI

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD.

1000UI/ml 20000UI/ml 2000UI

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 2000 U.I.

SOL. INJ.
2000UI

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/0,5 ml EPREX 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

2000ui/0.5ml

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA


EPREX 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA


EPREX 40 000 UI

SOL. INJ.
40 000UI JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 4000 U.I.

SOL. INJ.
4000UI

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/0,4 ml EPREX 4000 UI

SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

4000ui/0.4ml

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 50000UI/ml 10000UI/1,0ml 10000UI/1,0ml 10000UI/1,0ml 1000UI/0,5ml 1000UI/0,5ml 1000UI/0,5ml 2000UI/1,0ml 2000UI/1,0ml 2000UI/1,0ml 3000UI/0,3ml 3000UI/0,3ml 3000UI/0,3ml 4000UI/0,4ml 4000UI/0,4ml 4000UI/0,4ml 5000UI/0,5ml 5000UI/0,5ml 5000UI/0,5ml 6000UI/0,6ml 6000UI/0,6ml 6000UI/0,6ml 8000UI/0,8ml 8000UI/0,8ml 8000UI/0,8ml RENAMED FARMA S.R.L.

4000UI/1ml 50000UI/ml 10000UI/1,0ml

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

B03XA01 EPOETINUM ALFA


ABSEAMED 10000UI/1,0ml BINOCRIT 10000UI/1,0ml EPOETIN ALFA HEXAL 10000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA


ABSEAMED 1000UI/0,5ml BINOCRIT 1000UI/0,5ml EPOETIN ALFA HEXAL 1000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

1000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 2000UI/1,0ml BINOCRIT 2000UI/1,0ml EPOETIN ALFA HEXAL 2000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

2000UI/1,0ml

B03XA01 EPOETINUM ALFA


ABSEAMED 3000UI/0,3ml BINOCRIT 3000UI/0,3ml EPOETIN ALFA HEXAL 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

3000UI/0,3ml

B03XA01 EPOETINUM ALFA


ABSEAMED 4000UI/0,4ml BINOCRIT 4000UI/0,4ml EPOETIN ALFA HEXAL 4000UI/0,4ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

4000UI/0,4ml

B03XA01 EPOETINUM ALFA


ABSEAMED 5000UI/0,5ml BINOCRIT 5000UI/0,5ml EPOETIN ALFA HEXAL 5000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

5000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 6000UI/0,6ml BINOCRIT 6000UI/0,6ml EPOETIN ALFA HEXAL 6000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

6000UI/0,6ml

B03XA01 EPOETINUM ALFA


ABSEAMED 8000UI/0,8ml BINOCRIT 8000UI/0,8ml EPOETIN ALFA HEXAL 8000UI/0,8ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

8000UI/0,8ml

427

B03XA01

EPOETINUM BETA ***


LIOF. + SOLV. PT. SOL. INJ.
1000UI/ml 20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml ROCHE REGISTRATION LTD.

Protocol: L022B
1000UI/ml 20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 500UI

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ. SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 1000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 2000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 30000UI/0,6ml

B03XA01 EPOETINUM BETA

90 / 233

DCI/DENUMIRE COMERCIALA
NEORECORMON 3000UI/0,3ml

CONCENTRATIE
3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

FORMA FARM.
ROCHE REGISTRATION LTD.

FIRMA

PROTOCOL

B03XA01 EPOETINUM BETA


NEORECORMON 4000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD.

4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 5000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON 500UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA


NEORECORMON 60000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 6000UI/0,3ml

428
ARANESP 10g/0.4ml

B03XA02

DARBEPOETINUM ALFA ***


SOL. INJ. IN STILOU INJECTOR PREUMPLUT
10g/0.4ml 100g/0.5ml 100g/ml 100g/ml 100g/ml 130g/0.65ml 15g/0.375ml 15g/ml 15g/ml 150g/0.3ml 20g/0.5ml 200g/ml 200g/ml 200g/ml 200g/ml 25g/ml 25g/ml 25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40g/ml 40g/ml 40g/ml 50g/0.5ml 500g/ml 500g/ml 500g/ml 500g/ml 60g/0.3ml 60g/ml 60g/ml 80g/0.4ml 10g/0.4ml 100g/0.5ml 100g/ml 100g/ml 100g/ml 130g/0.65ml 15g/0.375ml 150g/0.3ml AMGEN EUROPE BV

Protocol: L022B
10g/0.4ml 100g/0.5ml 100g/ml

B03XA02 DARBEPOETINUM ALFA B03XA02 DARBEPOETINUM ALFA


ARANESP 100g/0.5ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


NESPO 30g NESPO 40g NESPO 50g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

B03XA02 DARBEPOETINUM ALFA


ARANESP 130g/0.65ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

130g/0.65ml 15g/0.375ml 15g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/0.375ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/ml NESPO 15g

SOL. INJ. IN FLACON

B03XA02 DARBEPOETINUM ALFA


ARANESP 150g/0.3ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

150g/0.3ml 20g/0.5ml 200g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 20g/0.5ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE DOMPE DOMPE DOMPE BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


NESPO 100g NESPO 130g NESPO 60g NESPO 80g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

B03XA02 DARBEPOETINUM ALFA


ARANESP 25g/ml NESPO 25g

SOL. INJ. IN FLACON


AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

25g/ml

B03XA02 DARBEPOETINUM ALFA


NESPO 10g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


DOMPE BIOTEC S.P.A.

25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 30g/0.3ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 300g/0.6ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT SOL. INJ. IN STILOU INJECTOR PREUMPLUT SOL. INJ. IN FLACON

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/0.4ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/ml NESPO 40g

B03XA02 DARBEPOETINUM ALFA


NESPO 15g NESPO 20g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

40g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 50g/0.5ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

50g/0.5ml 500g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 500g/ml NESPO 150g NESPO 300g NESPO 500g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 60g/0.3ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

60g/0.3ml 60g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 60g/ml NESPO 60g

SOL. INJ. IN FLACON


AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 80g/0.4ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

80g/0.4ml 10g/0.4ml 100g/0.5ml 100g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 10g/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 100g/0.5ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA02 DARBEPOETINUM ALFA


NESPO 30g NESPO 40g NESPO 50g

B03XA02 DARBEPOETINUM ALFA


ARANESP 130g/0.65ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

130g/0.65ml 15g/0.375ml 150g/0.3ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/0.375ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV AMGEN EUROPE BV

B03XA02 DARBEPOETINUM ALFA


ARANESP 150g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA

91 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
20g/0.5ml 200g/ml 200g/ml 200g/ml 200g/ml 25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40gml 50g/0.5ml 500g 500g/ml 500g/ml 500g/ml 60g/0.3ml 80g/0.4ml

FORMA FARM.
AMGEN EUROPE BV

FIRMA

PROTOCOL

B03XA02 DARBEPOETINUM ALFA


ARANESP 20g/0.5ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA


DOMPE DOMPE DOMPE DOMPE BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A.

20g/0.5ml 200g/ml

B03XA02 DARBEPOETINUM ALFA


NESPO 100g NESPO 130g NESPO 60g NESPO 80g

B03XA02 DARBEPOETINUM ALFA


NESPO 10g

SOL. INJ. IN SERINGA PREUMPLUTA


DOMPE BIOTEC S.P.A.

25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40gml 50g/0.5ml 500g 500g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 30g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 300g/0.6ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/0.4ml

B03XA02 DARBEPOETINUM ALFA


NESPO 15g

B03XA02 DARBEPOETINUM ALFA


NESPO 20g

B03XA02 DARBEPOETINUM ALFA


ARANESP 50g/0.5ml

B03XA02 DARBEPOETINUM ALFA


NESPO 150g

B03XA02 DARBEPOETINUM ALFA


ARANESP 500g/ml NESPO 300g NESPO 500g

B03XA02 DARBEPOETINUM ALFA


ARANESP 60g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

60g/0.3ml 80g/0.4ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 80g/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

429
ANDROCUR

G03HA01
Cod restrictie 1014:

CYPROTERONUM **
COMPR.
50mg SCHERING AG

G03HA01 CYPROTERONUM
Cancer de prostata in stadiu avansat;
50mg

50mg

G03HA01 CYPROTERONUM
ANDROCUR SCHERING AG

430

H02AB02

DEXAMETHASONUM
SOL. INJ.
8mg E.I.P.I.CO. MED S.R.L.

H02AB02 DEXAMETHASONUM
DEXAMETHASONE SODIUM PHOSPHATE

8mg 8mg/2ml
MEDOCHEMIE LTD. VIANEX SA

H02AB02 DEXAMETHASONUM
DEXAMED DEXATON 8 mg/2 ml

SOL. INJ.
8mg/2ml 8mg/2ml

431

J02AC02

ITRACONAZOLUM
CAPS.
100mg 100mg 100mg 100mg ARENA GROUP S.A. MEDICO UNO PHARMACEUTICAL S.R.L. JANSSEN PHARMACEUTICA NV GEDEON RICHTER ROMANIA S.A.

J02AC02 ITRACONAZOLUM
ITRACONAZOL 100 mg OMICRAL 100 mg ORUNGAL SPORILIN 100 mg

100mg

432
VFEND 200mg

J02AC03

VORICONAZOLUM **
COMPR. FILM.
200mg 200mg 40mg/ml 50mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg

J02AC03 VORICONAZOLUM J02AC03 VORICONAZOLUM


VFEND 200mg

PULB. PT. SOL. PERF.


PFIZER LTD. PFIZER LTD. PFIZER LTD.

J02AC03 VORICONAZOLUM
VFEND 40 mg/ml

PULB. PT. SUSP. ORALA COMPR. FILM.

J02AC03 VORICONAZOLUM
VFEND 50mg

433

J02AC04

POSACONAZOLUM **
SUSP. ORALA
40mg/ml 40mg/ml SP EUROPE SP EUROPE

J02AC04 POSACONAZOLUM
NOXAFIL SP 40mg/ml POSACONAZOLE SP 40mg/ml

40mg/ml

NOTA: Profilaxia infectiilor fungice invazive la pacientii: (1) aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care prezinta risc inalt de a dezvolta infectii fungice masive; (2) Pacienti in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de a dezvolta infectii fungice masive..

434
J02AX04 J02AX04 J02AX04
CANCIDAS 50 mg

J02AX04
CASPOFUNGINUM

CASPOFUNGINUM **
PULB. PT. CONC. PT. SOL. PERF.
50mg 50mg 70mg MERCK SHARP & DOHME LTD

Protocol: J010D
50mg 50mg 70mg

CASPOFUNGINUM CASPOFUNGINUM

PULB. PT. SOL. PERF.


MERCK SHARP & DOHME LTD

CANCIDAS 50 mg CANCIDAS 70 mg

PULB. PT. CONC. PT. SOL. PERF.


MERCK SHARP & DOHME LTD

435
THROMBOREDUCTIN

L01XX35

ANAGRELIDUM ***
CAPS.
0.5mg ORPHA-DEVEL HANDELS UND VERTRIEBS GMBH

Protocol: L015D
0.5mg

L01XX35 ANAGRELIDUM

436

L04AA01

CICLOSPORINUM *
CAPS. MOI
100mg 100mg 100mg HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 100 mg EQUORAL 100 mg IMUSPORIN 100 mg

100mg

92 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

FIRMA

PROTOCOL

L04AA01 CICLOSPORINUM
CICLORAL HEXAL EQUORAL SANDIMMUN NEORAL

SOL. ORALA
100mg/ml 100mg/ml 100mg/ml

100mg/ml

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 25 mg EQUORAL 25 mg IMUSPORIN 25 mg SANDIMMUN NEORAL 25mg 25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

25mg

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 50 mg EQUORAL 50 mg IMUSPORIN 50 mg SANDIMMUN NEORAL 50mg 50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

50mg

437

N02AA01

MORPHYNUM
SOL. INJ.
10 mg MUNDIPHARMA GMBH

N02AA01 MORPHYNUM
MSI 10 mg MUNDIPHARMA

10 mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA01 MORPHYNUM
MST CONTINUS 100 mg

COMPR. FILM. ELIB. MODIF.


100mg MUNDIPHARMA GMBH

100mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA01 MORPHYNUM
VENDAL RETARD 100 mg

COMPR. FILM. ELIB. PREL.


100mg LANNACHER HEILMITTEL GMBH

100mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA01 MORPHYNUM
MSI 100 mg MUNDIPHARMA

SOL. INJ.
100mg MUNDIPHARMA GMBH

100mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:


SEVREDOL 10 mg

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AA01 MORPHYNUM
10mg

COMPR. FILM.
MUNDIPHARMA GMBH

10mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA01 MORPHYNUM
MST CONTINUS 10 mg 10mg

COMPR. FILM. ELIB. MODIF.


MUNDIPHARMA GMBH

10mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA01 MORPHYNUM
VENDAL RETARD 10 mg 10mg

COMPR. FILM. ELIB. PREL.


LANNACHER HEILMITTEL GMBH

10mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA01 MORPHYNUM
MST CONTINUS 200 mg

COMPR. FILM. ELIB. MODIF.


200mg MUNDIPHARMA GMBH

200mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA01 MORPHYNUM
MSI 200 mg MUNDIPHARMA

SOL. INJ.
200mg MUNDIPHARMA GMBH

200mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:


SEVREDOL 20 mg

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AA01 MORPHYNUM
20mg

COMPR. FILM.
MUNDIPHARMA GMBH

20mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA01 MORPHYNUM
MSI 20 mg MUNDIPHARMA 20mg

SOL. INJ.
MUNDIPHARMA GMBH

20mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:


MORFINA 20 mg/ml

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AA01 MORPHYNUM
Prescriere limitata:

SOL. INJ.
20mg/ml ZENTIVA S.A.

20mg/ml

Durere severa, invalidanta, asociata cu diagnosticul de cancer

93 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata: Prescriere limitata:


MST CONTINUS 30 mg

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AA01 MORPHYNUM
30mg

COMPR. FILM. ELIB. MODIF.


MUNDIPHARMA GMBH

30mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA01 MORPHYNUM
VENDAL RETARD 30 mg 30mg

COMPR. FILM. ELIB. PREL.


LANNACHER HEILMITTEL GMBH

30mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA01 MORPHYNUM
MST CONTINUS 60 mg 60mg

COMPR. FILM. ELIB. MODIF.


MUNDIPHARMA GMBH

60mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA01 MORPHYNUM
VENDAL RETARD 60 mg 60mg

COMPR. FILM. ELIB. PREL.


LANNACHER HEILMITTEL GMBH

60mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

438
OXYCONTIN 10 mg

N02AA05

OXYCODONUM
COMPR. FILM. ELIB. MODIF.
10 mg MUNDIPHARMA GMBH

N02AA05 OXYCODONUM

10 mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA05 OXYCODONUM
OXYCONTIN 20 mg 20 mg

COMPR. FILM. ELIB. MODIF.


MUNDIPHARMA GMBH

20 mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA05 OXYCODONUM
OXYCONTIN 40 mg 40 mg

COMPR. FILM. ELIB. MODIF.


MUNDIPHARMA GMBH

40 mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

N02AA05 OXYCODONUM
OXYCONTIN 80 mg 80mg

COMPR. FILM. ELIB. MODIF.


MUNDIPHARMA GMBH

80mg

Prescriere limitata: Durere severa, invalidanta, asociata cu diagnosticul de cancer Prescriere limitata: Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Prescriere limitata: Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni Risc inalt de aparitie a dependentei

439

N02AA08

DIHYDROCODEINUM
COMPR. ELIB. PREL.
120mg 60mg 90mg MUNDIPHARMA GMBH

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 120 mg

120mg 60mg 90mg

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 60 mg

COMPR. ELIB. PREL.


MUNDIPHARMA GMBH

N02AA08 DIHYDROCODEINUM
DHC CONTINUS 90 mg

COMPR. ELIB. PREL.


MUNDIPHARMA GMBH

440
MIALGIN 100 mg/2 ml

N02AB02

PETHIDINUM
SOL. INJ.
50mg/ml ZENTIVA SA

N02AB02 PETHIDINUM

50mg/ml

441
EFFENTORA 100g

N02AB03
Prescriere limitata: Prescriere limitata: Prescriere limitata:

FENTANYLUM **
COMPR.
100g CEPHALON EUROPE

N02AB03 FENTANYLUM

100g

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
FENTANYL SANDOZ 100 g/h

PLASTURE TRANSDERMIC
100g/h SANDOZ S.R.L.

100g/h

Prescriere limitata: Prescriere limitata: Prescriere limitata:


DOLFORIN 100 g/ORA

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:

PLASTURE TRANSDERMIC
100g/ora GEDEON RICHTER PLC

100g/ora

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM

PLASTURE TRANSDERMIC

11.56mg/21.00cm p

94 / 233

DCI/DENUMIRE COMERCIALA
FENTANYL SANDOZ MATRIX 50g/h

CONCENTRATIE
11.56mg/21.00cm p

FORMA FARM.
SANDOZ S.R.L.

FIRMA

PROTOCOL

Prescriere limitata: Prescriere limitata: Prescriere limitata:


DUROGESIC 100 g/h

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:

PLASTURE TRANSDERM.
16.8mg/42.0cmp JANSSEN PHARMACEUTICA NV

16.8mg/42.0cmp

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
FENTANYL SANDOZ MATRIX 75g/h

PLASTURE TRANSDERM.
17.34mg/31.50cm p SANDOZ S.R.L.

17.34mg/31.50cm p

Prescriere limitata: Prescriere limitata: Prescriere limitata:


EFFENTORA 200g

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
200g

COMPR.
CEPHALON EUROPE

200g

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
FENTANYL SANDOZ MATRIX 100g/h

PLASTURE TRANSDERM.
23.12mg/42.00cm p SANDOZ S.R.L.

23.12mg/42.00cm p

Prescriere limitata: Prescriere limitata: Prescriere limitata:


FENTANYL SANDOZ 25 g/h

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
DOLFORIN 25 g/ORA

PLASTURE TRANSDERMIC
25g/h SANDOZ S.R.L.

25g/h

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
DUROGESIC 25 g/h

PLASTURE TRANSDERMIC
25g/ora GEDEON RICHTER PLC

25g/ora

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
IONSYS 40g/ doza

PLASTURE TRANSDERM.
4.2mg/10.5cmp JANSSEN PHARMACEUTICA NV

4.2mg/10.5cmp

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
EFFENTORA 400g

SIST. TRANSDERMIC IONTOFORETIC


40g/ doza JANSSEN-CILAG INTERNATIONAL NV

40g/ doza

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
400g

COMPR.
CEPHALON EUROPE

400g

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
FENTANYL SANDOZ MATRIX 25g/h

PLASTURE TRANSDERMIC
5.78mg/10.5cmp SANDOZ S.R.L.

5.78mg/10.5cmp

Prescriere limitata: Prescriere limitata: Prescriere limitata:


FENTANYL SANDOZ 50 g/h

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
DOLFORIN 50 g/ORA

PLASTURE TRANSDERMIC
50g/h SANDOZ S.R.L.

50g/h

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
EFFENTORA 600g

PLASTURE TRANSDERMIC
50g/ora GEDEON RICHTER PLC

50g/ora

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
600g

COMPR.
CEPHALON EUROPE

600g

Prescriere limitata: Prescriere limitata: Prescriere limitata:


FENTANYL SANDOZ 75 g/h

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:

PLASTURE TRANSDERMIC
75g/h SANDOZ S.R.L.

75g/h

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM

PLASTURE TRANSDERMIC

75g/ora

95 / 233

DCI/DENUMIRE COMERCIALA
DOLFORIN 75 g/ORA

CONCENTRATIE
75g/ora

FORMA FARM.
GEDEON RICHTER PLC

FIRMA

PROTOCOL

Prescriere limitata: Prescriere limitata: Prescriere limitata:


DUROGESIC 50 g/h

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
EFFENTORA 800g

PLASTURE TRANSDERM.
8.4mg/21.0cmp JANSSEN PHARMACEUTICA NV

8.4mg/21.0cmp

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

N02AB03 FENTANYLUM
800g

COMPR.
CEPHALON EUROPE

800g

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Durere severa, invalidanta, asociata cu diagnosticul de cancer Durere severa, invalidanta, indusa de cancer, care nu raspunde la analgezice non-opioide Durere cronica severa, invalidanta, care nu raspunde la analgezice non-opioide, unde durata totala a tratamentului opioid este mai scurta de 12 luni

442

N02AX02
Prescriere limitata: Prescriere limitata:

TRAMADOLUM
COMPR. ELIB. MODIF.
100mg HEXAL AG

N02AX02 TRAMADOLUM
TRAMADOLOR 100 ID

100mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
NOAX UNO 100 mg TRALGIT SR 100 TRAMADOL RETARD

COMPR. ELIB. PREL.


100mg 100mg 100mg LABOPHARM EUROPE LIMITED ZENTIVA AS KRKA D.D.

100mg

Prescriere limitata: Prescriere limitata:


TRAMAL RETARD 100 mg TRAMUNDIN RETARD 100 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.


100mg 100mg GRUNENTHAL GMBH MUNDIPHARMA GES.M.B.H

100mg

Prescriere limitata: Prescriere limitata:


MABRON TRADOLAN

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

SOL. INJ.
100mg 100mg MEDOCHEMIE LTD. LANNACHER HEILMITTEL GMBH

100mg

Prescriere limitata:
TRADOLAN TRAMADOL TRAMAG 100 TRAMAL

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM

SUPOZ.
100mg 100mg 100mg 100mg LANNACHER HEILMITTEL GMBH KRKA D.D. MAGISTRA C & C GRUNENTHAL GMBH

100mg

N02AX02 TRAMADOLUM
TRALGIT 100

SOL. INJ.
100mg/2ml ZENTIVA A.S.

100mg/2ml

Prescriere limitata:
TRALGIT

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
TRADOLAN

PIC. ORALE, SOL.


100mg/ml ZENTIVA A.S.

100mg/ml

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
TRALGIT SR 150

SOL. ORALA
100mg/ml LANNACHER HEILMITTEL GMBH

100mg/ml

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
TRAMADOL RETARD 150 mg TRAMAL RETARD 150 mg

COMPR. ELIB. PREL.


150mg ZENTIVA AS

150mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.


150mg 150mg KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

150mg

Prescriere limitata: Prescriere limitata:


NOAX UNO 200 mg TRALGIT SR 200

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. ELIB. PREL.


200mg 200mg LABOPHARM EUROPE LIMITED ZENTIVA AS

200mg

Prescriere limitata: Prescriere limitata:


TRAMADOL RETARD 200 mg TRAMAL RETARD 200 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.


200mg 200mg KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

200mg

Prescriere limitata: Prescriere limitata:


NOAX UNO 300 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
K-ALMA MABRON 50 mg TRALGIT 50 TRAMACALM TRAMADOL TRAMADOL LPH 50 mg TRAMADOL AL 50 TRAMADOL ARENA

COMPR. ELIB. PREL.


300mg LABOPHARM EUROPE LIMITED

300mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
ANTIBIOTICE SA MEDOCHEMIE LTD. ZENTIVA A.S. AC HELCOR SRL KRKA D.D. LABORMED PHARMA SA ALIUD PHARMA GMBH & CO.KG ARENA GROUP S.A.

50mg

96 / 233

DCI/DENUMIRE COMERCIALA
TRAMADOLOR 50 mg TRAMAL URGENDOL

CONCENTRATIE
50mg 50mg 50mg

FORMA FARM.
HEXAL AG GRUNENTHAL GMBH MEDICAROM GROUP SRL

FIRMA

PROTOCOL

Prescriere limitata:
TRAMADOL 50 mg TRAMADOL EEL TRAMAG 50

Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg 50mg 50mg

COMPR.
OZONE LABORATORIES LTD. BIO EEL SRL MAGISTRA C & C

50mg

Prescriere limitata: Prescriere limitata:


TRADOLAN 50 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg

COMPR. FILM.
LANNACHER HEILMITTEL GMBH

50mg

Prescriere limitata: Prescriere limitata:


TRADOLAN 50 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg

SOL. INJ.
LANNACHER HEILMITTEL GMBH

50mg

Prescriere limitata:
TRALGIT 50 TRAMADOL TRAMADOL AL 100 Fiole TRAMAL 100 TRAMAL 50 URGENDOL

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM

SOL. INJ.
50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml ZENTIVA A.S. KRKA D.D. ALIUD PHARMA GMBH & CO.KG GRUNENTHAL GMBH GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg/ml

Prescriere limitata:
TRAMADOL AL PICATURI

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM N02AX02 TRAMADOLUM


TRAMAL

PIC. ORALE, SOL.


ALIUD PHARMA GMBH & CO.KG

PICATURI ORALE-SOL.
100mg/ml GRUNENTHAL GMBH

100mg/ml

443
SINTALGON 2,5 mg

N07BC02
Risc inalt de aparitie a dependentei

METHADONUM
COMPR.
2.5mg ZENTIVA S.A.

N07BC02 METHADONUM

2.5mg

N07BC02 METHADONUM
SUBSTIDON 20 mg 20mg

COMPR.
BIO EEL SRL

20mg

Risc inalt de aparitie a dependentei

N07BC02 METHADONUM
SUBSTIDON 5 mg 5mg

COMPR.
BIO EEL SRL

5mg

Risc inalt de aparitie a dependentei

444

R05DA04

CODEINUM
COMPR.
15mg 15mg 15mg 15mg 15mg 15mg 15mg SLAVIA PHARM SRL OZONE LABORATORIES LTD. LABORMED PHARMA SA BIO EEL SRL MAGISTRA C & C FARMACOM SA SINTOFARM SA

R05DA04 CODEINUM
CODEINA FOSFAT CODEINA FOSFAT 15 mg CODEINA FOSFAT LPH 15 mg CODEINA FOSFORICA CODEINA FOSFORICA 15 mg FARMACOD FOSFAT DE CODEINA 15 mg

15mg

R05DA04 CODEINUM
TUSOCALM 7,5mg/120mg

COMPR.
7.5mg/120mg ARENA GROUP SA

7.5mg/120mg

445
DESFERAL

V03AC01

DEFEROXAMINUM **(3)
LIOF. PT. SOL. INJ./PERF.
500mg NOVARTIS PHARMA GMBH

Protocol: V001D
500mg

V03AC01 DEFEROXAMINUM

446
EXJADE 125mg

V03AC03

DEFERASIROXUM ***
COMPR. DISP.
125mg 250mg 500mg NOVARTIS EUROPHARM LTD.

Protocol: V002D
125mg 250mg 500mg

V03AC03 DEFERASIROXUM V03AC03 DEFERASIROXUM


EXJADE 250mg

COMPR. DISP.
NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

V03AC03 DEFERASIROXUM
EXJADE 500mg

COMPR. DISP.

97 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G11 EPILEPSIE. 447 N03AA02


N03AA02 PHENOBARBITALUM
FENOBARBITAL 100 mg

Protocol: NG01G
PHENOBARBITALUM
COMPR.
100 mg ZENTIVA SA

100 mg

Prescriere limitata:
FENOBARBITAL 100 mg

Epilepsie

N03AA02 PHENOBARBITALUM
Prescriere limitata:
FENOBARBITAL 200 mg/ 2 ml

COMPR.
100mg SC ARENA GROUP SA

100mg

Epilepsie

N03AA02 PHENOBARBITALUM
10%

SOL. INJ.
ZENTIVA S.A

10%

448
FENITOIN 100 mg

N03AB02

PHENYTOINUM
COMPR.
100mg GEDEON RICHTER ROMANIA SA

N03AB02 PHENYTOINUM N03AB02 PHENYTOINUM


PHENHYDANSOLUTIE INJECTABILA

100mg 50mg/ml
DESITIN

SOL. INJ.
50mg/ml

449
RIVOTRIL

N03AE01

CLONAZEPAMUM
COMPR.
0.5mg ROCHE ROMANIA S.R.L.

N03AE01 CLONAZEPAMUM N03AE01 CLONAZEPAMUM


RIVOTRIL 2mg

0.5mg 2mg
ROCHE ROMANIA S.R.L.

COMPR.

450
TIMONIL SIROP

N03AF01

CARBAMAZEPINUM
SUSP. ORALA
100mg/5ml 150mg DESITIN ARZNEIMITTEL GMBH

N03AF01 CARBAMAZEPINUM N03AF01 CARBAMAZEPINUM


TIMONIL 150 RETARD

100mg/5ml 150mg 200mg

COMPR. RET.
DESITIN SLAVIA PHARM SRL BIO EEL SRL OZONE LABORATORIES LTD. LAROPHARM SRL ARENA GROUP SA LABORMED PHARMA SA TEVA PHARMACEUTICALS S.R.L. VIM SPECTRUM SRL AC HELCOR SRL AWD PHARMA GMBH & CO.KG GEROT PHARMAZEUTIKA GMBH MEDOCHEMIE LTD. NOVARTIS PHARMA GMBH

N03AF01 CARBAMAZEPINUM
CARBAMAZEPIN CARBAMAZEPIN EEL CARBAMAZEPINA CARBAMAZEPINA 200 mg CARBAMAZEPINA ARENA 200 mg CARBAMAZEPINA LPH 200 mg CARBAMAZEPINE TEVA 200 CARBAVIM CARBEPSIL 200 FINLEPSIN NEUROTOP TAVER TEGRETOL 200

COMPR.
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 300mg 300mg 300mg

N03AF01 CARBAMAZEPINUM
TEGRETOL CR 200

COMPR. FILM. ELIB. PREL.


NOVARTIS PHARMA GMBH

200mg 300mg

N03AF01 CARBAMAZEPINUM
CARBAMAZEPIN SANDOZ 300 mg NEUROTOP RETARD 300 mg

COMPR. ELIB. PREL.


HEXAL AG GEROT PHARMAZEUTIKA GMBH

N03AF01 CARBAMAZEPINUM
TIMONIL 300 RETARD

COMPR. RET.
DESITIN

300mg 400mg

N03AF01 CARBAMAZEPINUM
CARBEPSIL 400 TEGRETOL 400

COMPR.
400mg 400mg 400mg 400mg 400mg 600mg 600mg 600mg 200mg AC HELCOR SRL NOVARTIS PHARMA GMBH

N03AF01 CARBAMAZEPINUM
CARBAMAZEPIN SANDOZ 400 mg

COMPR. ELIB. PREL.


HEXAL AG

400mg 400mg 400mg 600mg

N03AF01 CARBAMAZEPINUM
TEGRETOL CR 400

COMPR. FILM. ELIB. PREL.


NOVARTIS PHARMA GMBH AWD PHARMA GMBH & CO.KG HEXAL AG GEROT PHARMAZEUTIKA GMBH

N03AF01 CARBAMAZEPINUM
FINLEPSIN 400 RETARD

COMPR. RET. COMPR. ELIB. PREL.

N03AF01 CARBAMAZEPINUM
CARBAMAZEPIN SANDOZ 600 mg NEUROTOP RETARD 600 mg

N03AF01 CARBAMAZEPINUM
TIMONIL 600 RETARD

COMPR. RET.
DESITIN

600mg 200mg

N03AF01 CARBAMAZEPINUM
FINLEPSIN 200 RETARD

COMPR.FILM.ELIB.PREL
AWD PHARMA GMBH & CO.KG

451
TRILEPTAL 150 mg

N03AF02
Cod restrictie 1587:

OXCARBAZEPINUM
COMPR. FILM.
150mg NOVARTIS PHARMA GMBH

N03AF02 OXCARBAZEPINUM

150mg

Tratamentul crizelor epileptice partiale si al crizelor primare cu contractii tonico-clonice generalizate, care nu pot fi suficient controlate cu alte medicamente anti-epileptice

N03AF02 OXCARBAZEPINUM
TRILEPTAL 300 mg

COMPR. FILM.
300mg NOVARTIS PHARMA GMBH

300mg

Cod restrictie 1587:

Tratamentul crizelor epileptice partiale si al crizelor primare cu contractii tonico-clonice generalizate, care nu pot fi suficient controlate cu alte medicamente anti-epileptice

N03AF02 OXCARBAZEPINUM
TRILEPTAL 600 mg

COMPR. FILM.
600mg NOVARTIS PHARMA GMBH

600mg

Cod restrictie 1587:

Tratamentul crizelor epileptice partiale si al crizelor primare cu contractii tonico-clonice generalizate, care nu pot fi suficient controlate cu alte medicamente anti-epileptice

N03AF02 OXCARBAZEPINUM
TRILEPTAL 60mg/ml

SUSP. ORALA
60mg/ml NOVARTIS PHARMA GMBH

60mg/ml

Cod restrictie 1587:

Tratamentul crizelor epileptice partiale si al crizelor primare cu contractii tonico-clonice generalizate, care nu pot fi suficient controlate cu alte medicamente anti-epileptice

452

N03AG01

ACIDUM VALPROICUM + SARURI

98 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
1000mg

FORMA FARM.
SANOFI-AVENTIS FRANCE

FIRMA

PROTOCOL

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONOSPHERE 1000 mg

GRAN. ELIB. PREL.

1000mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL LONG 1000 mg

MINICOMPR. ELIB. PREL.


1000mg DESITIN ARZNEIMITTEL GMBH

1000mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONOSPHERE 100 mg

GRAN. ELIB. PREL.


100mg SANOFI-AVENTIS FRANCE

100mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL LONG 150 mg

CAPS. ELIB. PREL.


150mg DESITIN ARZNEIMITTEL GMBH

150mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


CONVULEX 150 mg

CAPS. MOI GASTROREZ.


150mg GEROT PHARMAZEUTIKA GMBH

150mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL 150

COMPR. FILM. GASTROREZ.


150mg DESITIN ARZNEIMITTEL GMBH

150mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


PETILIN

COMPR. FILM.
200mg REMEDICA LTD.

200mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE 200 mg

COMPR. FILM. GASTROREZ.


200mg SANOFI-AVENTIS FRANCE

200mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


VALEPIL

SIROP
200mg/5ml ARENA GROUP S.A.

200mg/5ml

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONOSPHERE 250 mg

GRAN. ELIB. PREL.


250mg SANOFI-AVENTIS FRANCE

250mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL LONG 300 mg

CAPS. ELIB. PREL.


300mg DESITIN ARZNEIMITTEL GMBH

300mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


CONVULEX 300 mg

CAPS. MOI GASTROREZ.


300mg GEROT PHARMAZEUTIKA GMBH

300mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL 300

COMPR. FILM. GASTROREZ.


300mg DESITIN ARZNEIMITTEL GMBH

300mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL SIROP

SIROP
300mg/5ml DESITIN ARZNEIMITTEL GMBH

300mg/5ml

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE 400 mg/4 ml LIOFILIZAT SI SOLVENT PENTRU SOLUTIE INJECTABILA i.v.

LIOF. + SOLV. PT. SOL.


400mg/4ml SANOFI-AVENTIS FRANCE

400mg/4ml

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


CONVULEX 500 mg

CAPS. MOI GASTROREZ.


500mg GEROT PHARMAZEUTIKA GMBH

500mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONOSPHERE 500 mg

GRAN. ELIB. PREL.


500mg SANOFI-AVENTIS FRANCE

500mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL LONG 500 mg

MINICOMPR. ELIB. PREL.


500mg DESITIN ARZNEIMITTEL GMBH

500mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


CONVULEX

SIROP
50mg/ml GEROT PHARMAZEUTIKA GMBH

50mg/ml

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE

SIROP
57.64mg/ml SANOFI - AVENTIS FRANCE

57.64mg/ml

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL 600

COMPR. FILM. GASTROREZ.


600mg DESITIN ARZNEIMITTEL GMBH

600mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONOSPHERE 750 mg

GRAN. ELIB. PREL.


750mg SANOFI-AVENTIS FRANCE

750mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONO 300 mg

COMPR. FILM. ELIB. PREL. DIVIZ.


300mg 500mg SANOFI-AVENTIS FRANCE

300mg 500mg

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONO 500 mg

COMPR. FILM. ELIB. PREL. DIVIZ.


SANOFI-AVENTIS FRANCE

453
EPIMIL 100 mg EPIRAL 100 EPIZOL 100 mg LAMEPTIL 100 mg LAMICTAL 100 mg LAMOLEP 100 mg LAMOTIRAN 100 mg

N03AX09

LAMOTRIGINUM **
COMPR.
100mg 100mg 100mg 100mg 100mg 100mg 100mg IVAX PHARMCEUTICALS S.R.O. ZENTIVA AS KRKA D.D. NOVO MESTO SANDOZ S.R.L. THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD.

Protocol: N012F
100mg

N03AX09 LAMOTRIGINUM

99 / 233

DCI/DENUMIRE COMERCIALA
LAMOTRIGINE FARMAL 100 mg LAMOTRIX 100 mg PLEXXO 100 mg XEBARIN 100 mg

CONCENTRATIE
100mg 100mg 100mg 100mg

FORMA FARM.
FARMAL INTERNATIONAL S.R.L. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH DR. REDDY'S LABORATORIES

FIRMA

PROTOCOL

N03AX09 LAMOTRIGINUM
EPIZOL 100 mg LAMOTRIGIN STADA 100 mg LAMOTRIGINE SANDOZ 100 mg LAMOTRIN 100 mg

PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB. PRELUNG.


100mg 100mg 100mg 100mg 100mg 100mg KRKA D.D. NOVO MESTO STADA ARZNEIMITTEL AG SANDOZ S.R.L. ACTAVIS GROUP HF.

10mg

N03AX09 LAMOTRIGINUM
LAMICTAL 100 mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

100mg 100mg 200mg

N03AX09 LAMOTRIGINUM
LAMOTIRAN CD 100 mg

COMPR. ORODISP./MAST.
RANBAXY UK LIMITED KRKA D.D. NOVO MESTO SANDOZ S.R.L. RANBAXY UK LTD. FARMAL INTERNATIONAL S.R.L. MEDOCHEMIE LTD. DR. REDDY'S LABORATORIES

N03AX09 LAMOTRIGINUM
EPIZOL 200 mg LAMEPTIL 200 mg LAMOTIRAN 200 mg LAMOTRIGINE FARMAL 200 mg LAMOTRIX 200 mg XEBARIN 200 mg

COMPR.
200mg 200mg 200mg 200mg 200mg 200mg

Cod restrictie 1426:


EPIZOL 200 mg LAMOTRIGINE SANDOZ 200 mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM

COMPR. DISP.
200mg 200mg KRKA D.D. NOVO MESTO SANDOZ S.R.L.

200mg

Cod restrictie 1426:


LAMOTIRAN CD 200 mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
Cod restrictie 1426:
EPIMIL 25mg EPIRAL 25 EPIZOL 25 mg LAMEPTIL 25 mg LAMICTAL 25 mg LAMOLEP 25 mg LAMOTIRAN 25 mg LAMOTRIGINE FARMAL 25 mg LAMOTRIX 25 mg PLEXXO 25 mg XEBARIN 25 mg

COMPR. ORODISP./MAST.
200mg RANBAXY UK LIMITED

200mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg

COMPR.
IVAX PHARMCEUTICALS S.R.O. ZENTIVA AS KRKA D.D. NOVO MESTO SANDOZ S.R.L. THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD. FARMAL INTERNATIONAL S.R.L. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH DR. REDDY'S LABORATORIES

25mg

Cod restrictie 1426:


EPIZOL 25 mg LAMOTRIGIN STADA 25 mg LAMOTRIGINE SANDOZ 25 mg LAMOTRIN 25 mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
25mg 25mg 25mg 25mg

COMPR. DISP.
KRKA D.D. NOVO MESTO STADA ARZNEIMITTEL AG SANDOZ S.R.L. ACTAVIS GROUP HF.

25mg

Cod restrictie 1426:


LAMICTAL 25 mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
25mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

25mg

Cod restrictie 1426:


LAMOTIRAN CD 25 mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
25mg

COMPR. ORODISP./MAST.
RANBAXY UK LIMITED

25mg

Cod restrictie 1426:


EPIZOL 2 mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
2mg

COMPR. DISP.
KRKA D.D. NOVO MESTO

2mg

Cod restrictie 1426:


LAMICTAL 2 mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
2mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

2mg

Cod restrictie 1426:


LAMOTIRAN CD 50 mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
50 mg

COMPR. ORODISP./MAST.
RANBAXY UK LIMITED

50 mg

Cod restrictie 1426:


EPIMIL 50 mg EPIRAL 50 EPIZOL 50 mg LAMEPTIL 50 mg LAMICTAL 50 mg LAMOLEP 50 mg LAMOTIRAN 50 mg LAMOTRIGINE FARMAL 50 mg LAMOTRIX 50 mg PLEXXO 50 mg XEBARIN 50 mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

COMPR.
IVAX PHARMCEUTICALS S.R.O. ZENTIVA AS KRKA D.D. NOVO MESTO SANDOZ S.R.L. THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD. FARMAL INTERNATIONAL S.R.L. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH DR. REDDY'S LABORATORIES

50mg

Cod restrictie 1426:


EPIZOL 50 mg LAMOTRIGIN STADA 50 mg LAMOTRIGINE SANDOZ 50 mg LAMOTRIN 50 mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
50mg 50mg 50mg 50mg

COMPR. DISP.
KRKA D.D. NOVO MESTO STADA ARZNEIMITTEL AG SANDOZ S.R.L. ACTAVIS GROUP HF.

50mg

Cod restrictie 1426:


EPIZOL 5 mg

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
5mg

COMPR. DISP.
KRKA D.D. NOVO MESTO

5mg

100 / 233

DCI/DENUMIRE COMERCIALA Cod restrictie 1426:


LAMICTAL 5 mg

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

N03AX09 LAMOTRIGINUM
5mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

5mg

Cod restrictie 1426:

Tratamentul crizelor epileptice insuficient controlate prin administrarea altor medicamente antiepileptice

454
TOPAMAX 100 mg TOPRAN 100 mg

N03AX11

TOPIRAMATUM **
COMPR. FILM.
100mg 100mg JOHNSON & JOHNSON D.O.O. TERAPIA S.A.

N03AX11 TOPIRAMATUM

100mg

Cod restrictie 2797:

Tratamentul crizelor epileptice partiale, crizelor primare cu contractii tonico-clonice generalizate, crizelor din sindromul Lennox-Gastaut, insuficient controlate prin administrarea altor merdicamente antiepileptice.

N03AX11 TOPIRAMATUM
TOPAMAX 15mg

CAPS. CU MICROSFERE
CILAG AG

15mg

Cod restrictie 2798:

Tratamentul crizelor epileptice partiale, crizelor primare cu contractii tonico-clonice generalizate, crizelor din sindromul Lennox-Gastaut, insuficient controlate prin administrarea altor merdicamente antiepileptice, la pacientii care nu pot fi tratati cu forma solida a topiramatului.

N03AX11 TOPIRAMATUM
TOPAMAX 200 mg TOPRAN 200 mg

COMPR. FILM.
200mg 200mg JOHNSON & JOHNSON D.O.O. TERAPIA S.A.

200mg

Cod restrictie 2797:

Tratamentul crizelor epileptice partiale, crizelor primare cu contractii tonico-clonice generalizate, crizelor din sindromul Lennox-Gastaut, insuficient controlate prin administrarea altor merdicamente antiepileptice.

N03AX11 TOPIRAMATUM
TOPAMAX 25 mg TOPRAN 25 mg 25mg 25mg

COMPR. FILM.
JOHNSON & JOHNSON D.O.O. TERAPIA S.A.

25mg

Cod restrictie 2797:

Tratamentul crizelor epileptice partiale, crizelor primare cu contractii tonico-clonice generalizate, crizelor din sindromul Lennox-Gastaut, insuficient controlate prin administrarea altor merdicamente antiepileptice.

N03AX11 TOPIRAMATUM
TOPAMAX 50 mg TOPRAN 50 mg 50mg 50mg

COMPR. FILM.
JOHNSON & JOHNSON D.O.O. TERAPIA S.A.

50mg

Cod restrictie 2797:

Tratamentul crizelor epileptice partiale, crizelor primare cu contractii tonico-clonice generalizate, crizelor din sindromul Lennox-Gastaut, insuficient controlate prin administrarea altor merdicamente antiepileptice.

455

N03AX12

GABAPENTINUM ***
CAPS.
100mg 100mg 100mg 100mg 100mg WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O. STADA ARZNEIMITTEL AG RANBAXY UK LTD. GEDEON RICHTER LTD.

N03AX12 GABAPENTINUM
GABAGAMMA 100 mg GABALEPT 100 mg GABAPENTIN STADA 100 mg GABARAN 100 mg GORDIUS 100 mg

100mg

Cod restrictie 2664:


GABAGAMMA 300 mg GABALEPT 300 mg GABAPENTIN STADA 300 mg GABARAN 300 mg GABOTON 300 GORDIUS 300 mg

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.

N03AX12 GABAPENTINUM

CAPS.
300mg 300mg 300mg 300mg 300mg 300mg WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O. STADA ARZNEIMITTEL AG RANBAXY UK LTD. HEXAL AG GEDEON RICHTER LTD.

300mg

Cod restrictie 2664:


GABAGAMMA 400 mg GABALEPT 400 mg GABAPENTIN STADA 400 mg GABARAN 400 mg GABOTON 400 GORDIUS 400 mg

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.

N03AX12 GABAPENTINUM

CAPS.
400mg 400mg 400mg 400mg 400mg 400mg WORWAG PHARMA GMBH & CO. KG PLIVA LJUBLJANA D.O.O. STADA ARZNEIMITTEL AG RANBAXY UK LTD. HEXAL AG GEDEON RICHTER LTD.

400mg

Cod restrictie 2664:


GABARAN 600 mg

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.

N03AX12 GABAPENTINUM
Cod restrictie 2664:
GABARAN 800 mg

COMPR. FILM.
600mg RANBAXY UK LTD.

600mg

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.

N03AX12 GABAPENTINUM
Cod restrictie 2664:

COMPR. FILM.
800mg RANBAXY UK LTD.

800mg

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.

456
KEPPRA 1000 mg

N03AX14
Prescriere limitata:

LEVETIRACETAMUM **
COMPR. FILM.
1000mg UCB PHARMA SA

N03AX14 LEVETIRACETAMUM

1000mg

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.

N03AX14 LEVETIRACETAMUM
KEPPRA 100 mg/ml

SOL. ORALA
100mg/ml 250mg UCB PHARMA SA

100mg/ml 250mg

N03AX14 LEVETIRACETAMUM
KEPPRA 250 mg

COMPR. FILM.
UCB PHARMA SA

Prescriere limitata:
KEPPRA 500 mg

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.

N03AX14 LEVETIRACETAMUM
Prescriere limitata:
KEPPRA 750 mg

COMPR. FILM.
500mg UCB PHARMA LTD

500mg

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice.

N03AX14 LEVETIRACETAMUM N03AX14 LEVETIRACETAMUM


KEPPRA 1000 mg

COMPR. FILM.
750mg 1000mg UCB PHARMA SA

750mg 1000mg

COMPR. FILM.
UCB PHARMA SA

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat reactii adverse in antecedente la alte antiepileptice. Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat interactiuni medicamentoase cu alte medicamente compensate adecvate. Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde sunt de asteptat interactiuni medicamentoase cu alte medicamente compensate adecvate.

101 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde transferul la alt medicament compensat adecvat este posibil sa genereze consecinte clinice adverse.

N03AX14 LEVETIRACETAMUM
KEPPRA 250 mg

COMPR. FILM.
250mg UCB PHARMA SA

250mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat reactii adverse in antecedente la alte antiepileptice. Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat interactiuni medicamentoase cu alte medicamente compensate adecvate. Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde sunt de asteptat interactiuni medicamentoase cu alte medicamente compensate adecvate. Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde transferul la alt medicament compensat adecvat este posibil sa genereze consecinte clinice adverse.

N03AX14 LEVETIRACETAMUM
KEPPRA 500 mg

COMPR. FILM.
500mg UCB PHARMA LTD

500mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat reactii adverse in antecedente la alte antiepileptice. Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde au existat interactiuni medicamentoase cu alte medicamente compensate adecvate. Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde sunt de asteptat interactiuni medicamentoase cu alte medicamente compensate adecvate. Tratamentul crizelor epileptice partiale insuficient controlate prin administrarea altor medicamente antiepileptice si unde transferul la alt medicament compensat adecvat este posibil sa genereze consecinte clinice adverse.

N03AX14 LEVETIRACETAMUM
KEPPRA 100 mg/ml

CONC. PT. SOL. PERF.


100mg/ml UCB PHARMA SA

100mg/ml

457
LYRICA 100 mg

N03AX16

PREGABALINUM ***
CAPS.
100mg PFIZER LTD.

N03AX16 PREGABALINUM N03AX16 PREGABALINUM


LYRICA 150 mg

100mg 150mg
PFIZER LTD.

CAPS.
150mg

N03AX16 PREGABALINUM
LYRICA 200 mg

CAPS.
200mg PFIZER LTD.

200mg 225mg
PFIZER LTD.

N03AX16 PREGABALINUM
LYRICA 225 mg

CAPS.
225mg

N03AX16 PREGABALINUM
LYRICA 25 mg 25mg

CAPS.
PFIZER LTD.

25mg 300mg
PFIZER LTD.

N03AX16 PREGABALINUM
LYRICA 300 mg

CAPS.
300mg

N03AX16 PREGABALINUM
LYRICA 50 mg 50mg

CAPS.
PFIZER LTD.

50mg 75mg
PFIZER LTD.

N03AX16 PREGABALINUM
LYRICA 75 mg 75mg

CAPS.

102 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G12 BOALA PARKINSON. 458 N04AA01 TRIHEXYPHENIDYLUM


N04AA01 TRIHEXYPHENIDYLUM
ROMPARKIN 2 mg 2mg

COMPR.
TERAPIA SA

2mg

459
AKINETON

N04AA02

BIPERIDENUM
COMPR.
2mg DESMA GMBH

N04AA02 BIPERIDENUM

2mg

460

N04BA02

COMBINATII (LEVODOPUM + CARBIDOPUM) **


COMPR. ELIB. PREL.
100mg + 25mg MERCK SHARP & DOHME ROMANIA S.R.L.

N04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM)


SINEMET CR 25/100 mg

100mg + 25mg

N04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM)


MADOPAR HBS

CAPS. ELIB. MODIF.


100mg+25mg ROCHE ROMANIA S.R.L.

100mg+25mg

N04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM)


CARBIDOPA / LEVODOPA TEVA 25/100

COMPR.
100mg+25mg TEVA PHARMACEUTICALS SRL

100mg+25mg

N04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM)


SINEMET CR 50/200 mg

COMPR. ELIB. PREL.


200mg + 50mg MERCK SHARP & DOHME ROMANIA S.R.L.

200mg + 50mg

Cod restrictie 1257:

Boala Parkinson in care tulburarile functiei motorii nu sunt suficient controlate cu administrari frecvente ale formulelor conventionale de levodopa combinat cu inhibitor al decarboxylazei

N04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM)


MADOPAR 250 MADOPAR 250

COMPR.
200mg+50mg 200mg+50mg ROCHE ROMANIA SRL TERAPIA SA

200mg+50mg

Cod restrictie 1257:

Boala Parkinson in care tulburarile functiei motorii nu sunt suficient controlate cu administrari frecvente ale formulelor conventionale de levodopa combinat cu inhibitor al decarboxylazei

N04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM)


ISICOM 250 mg/25 mg

COMPR.
250mg/25mg DESITIN ARZNEIMITTEL GMBH

250mg/25mg

N04BA02 COMBINATII (LEVODOPUM + CARBIDOPUM)


CARBIDOPA / LEVODOPA TEVA 25/250 CREDANIL 25/250 NAKOM ZIMOX

COMPR.
250mg+25mg 250mg+25mg 250mg+25mg 250mg+25mg TEVA PHARMACEUTICALS SRL REMEDICA LTD. LEK PHARMACEUTICALS D.D. FARAN LABORATORIES S.A.

250mg+25mg

461

N04BA02

COMBINATII (LEVODOPUM + BENSERAZIDUM) **


COMPR. ELIB. PREL.
100mg + 25mg MERCK SHARP & DOHME ROMANIA S.R.L.

N04BA02 COMBINATII (LEVODOPUM + BENSERAZIDUM)


SINEMET CR 25/100 mg

100mg + 25mg

N04BA02 COMBINATII (LEVODOPUM + BENSERAZIDUM)


MADOPAR HBS

CAPS. ELIB. MODIF.


100mg+25mg ROCHE ROMANIA S.R.L.

100mg+25mg

N04BA02 COMBINATII (LEVODOPUM + BENSERAZIDUM)


CARBIDOPA / LEVODOPA TEVA 25/100

COMPR.
100mg+25mg TEVA PHARMACEUTICALS SRL

100mg+25mg

N04BA02 COMBINATII (LEVODOPUM + BENSERAZIDUM)


SINEMET CR 50/200 mg

COMPR. ELIB. PREL.


200mg + 50mg MERCK SHARP & DOHME ROMANIA S.R.L.

200mg + 50mg

Cod restrictie 1257:

Boala Parkinson in care tulburarile functiei motorii nu sunt suficient controlate cu administrari frecvente ale formulelor conventionale de levodopa combinat cu inhibitor al decarboxylazei

N04BA02 COMBINATII (LEVODOPUM + BENSERAZIDUM)


MADOPAR 250 MADOPAR 250

COMPR.
200mg+50mg 200mg+50mg ROCHE ROMANIA SRL TERAPIA SA

200mg+50mg

Cod restrictie 1257:

Boala Parkinson in care tulburarile functiei motorii nu sunt suficient controlate cu administrari frecvente ale formulelor conventionale de levodopa combinat cu inhibitor al decarboxylazei

N04BA02 COMBINATII (LEVODOPUM + BENSERAZIDUM)


ISICOM 250 mg/25 mg

COMPR.
250mg/25mg DESITIN ARZNEIMITTEL GMBH

250mg/25mg

N04BA02 COMBINATII (LEVODOPUM + BENSERAZIDUM)


CARBIDOPA / LEVODOPA TEVA 25/250 CREDANIL 25/250 NAKOM ZIMOX

COMPR.
250mg+25mg 250mg+25mg 250mg+25mg 250mg+25mg TEVA PHARMACEUTICALS SRL REMEDICA LTD. LEK PHARMACEUTICALS D.D. FARAN LABORATORIES S.A.

250mg+25mg

462

N04BA03

COMBINATII (LEVODOPUM+CARBIDOPUM+ENTACAPONUM) ***


COMPR. FILM. 100mg/25mg/200 mg

N04BA03 COMBINATII (LEVODOPUM+CARBIDOPUM+ENTACAPO NUM)


STALEVO 100 mg/25 mg/200 mg

100mg/25mg/200 mg

ORION CORPORATION

Cod restrictie 2059: Cod restrictie 2060:

Boala Parkinson la pacienti tratati cu combinatii de inhibitor de decarboxylase-levodopa, care prezinta tulburari ale functiilor motorii induse la sfarsitul perioadei de actiune a unei doze Boala Parkinson la pacienti stabilizati sub tratamentul cu inhibitor de decarboxylase-levodopa in asociere cu entacapone

N04BA03 COMBINATII (LEVODOPUM+CARBIDOPUM+ENTACAPO NUM)

COMPR. FILM.

150mg/37.5mg/20 0mg

103 / 233

DCI/DENUMIRE COMERCIALA
STALEVO 150 mg/37,5 mg/200 mg

CONCENTRATIE
150mg/37.5mg/20 0mg

FORMA FARM.
ORION CORPORATION

FIRMA

PROTOCOL

Cod restrictie 2059: Cod restrictie 2060:

Boala Parkinson la pacienti tratati cu combinatii de inhibitor de decarboxylase-levodopa, care prezinta tulburari ale functiilor motorii induse la sfarsitul perioadei de actiune a unei doze Boala Parkinson la pacienti stabilizati sub tratamentul cu inhibitor de decarboxylase-levodopa in asociere cu entacapone

N04BA03 COMBINATII (LEVODOPUM+CARBIDOPUM+ENTACAPO NUM)


STALEVO 50 mg/12,5 mg/200 mg

COMPR. FILM.

50mg/12.5mg/200 mg

50mg/12.5mg/200 mg

ORION CORPORATION

Cod restrictie 2059: Cod restrictie 2060:

Boala Parkinson la pacienti tratati cu combinatii de inhibitor de decarboxylase-levodopa, care prezinta tulburari ale functiilor motorii induse la sfarsitul perioadei de actiune a unei doze Boala Parkinson la pacienti stabilizati sub tratamentul cu inhibitor de decarboxylase-levodopa in asociere cu entacapone

463
VIREGYT- K

N04BB01

AMANTADINUM **
CAPS.
100mg EGIS PHARMACEUTICALS LTD.

N04BB01 AMANTADINUM

100mg

464
BROCRIPTIN

N04BC01
Prescriere limitata: Boala Parkinson

BROMOCRIPTINUM
DRAJ.
2.5mg BIOFARM SA

N04BC01 BROMOCRIPTINUM

2.5mg

465
REQUIP 0,25 mg REQUIP 1 mg REQUIP 2 mg REQUIP 5 mg

N04BC04

ROPINIROLUM **
COMPR. FILM.
SMITHKLINE BEECHAM PLC T/A SMITHKLINE BEECHAM PLC T/A SMITHKLINE BEECHAM PLC T/A SMITHKLINE BEECHAM PLC T/A

N04BC04 ROPINIROLUM

466
SIFROL 0,088mg

N04BC05

PRAMIPEXOLUM **
COMPR.
0,088mg BOEHRINGER INGELHEIM INT. GMBH

N04BC05 PRAMIPEXOLUM

0,088mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
SIFROL 0,18mg

COMPR.
0,18mg BOEHRINGER INGELHEIM INT. GMBH

0,18mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
SIFROL 0,70mg

COMPR.
0,70mg BOEHRINGER INGELHEIM INT. GMBH

0,70mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 0,088 mg

COMPR.
0.088mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH

0.088mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 0,18 mg

COMPR.
0.18mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH

0.18mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 0,35 mg SIFROL 0.35mg

COMPR.
0.35mg 0.35mg BOEHRINGER INGELHEIM INT. GMBH BOEHRINGER INGELHEIM INT. GMBH

0.35mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 0,7 mg 0.7mg

COMPR.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

0.7mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

N04BC05 PRAMIPEXOLUM
MIRAPEXIN 1,1mg SIFROL 1,1mg 1,1mg 1,1mg

COMPR.
BOEHRINGER INGELHEIM INT. GMBH BOEHRINGER INGELHEIM INT. GMBH

1,1mg

La acest medicament au fost raportate episoade de instalare brusca a somnului fara avertizare in timpul activitatii.

467
NEUPRO 2mg/24h

N04BC09

ROTIGOTINUM ***
PLASTURE TRANSDERMIC
2mg/24h 4mg/24h 6mg/24h 8mg/24h SCHWARZ PHARMA LTD

N04BC09 ROTIGOTINUM N04BC09 ROTIGOTINUM


NEUPRO 4mg/24h

2mg/24h 4mg/24h 6mg/24h 8mg/24h

PLASTURE TRANSDERMIC
SCHWARZ PHARMA LTD SCHWARZ PHARMA LTD SCHWARZ PHARMA LTD SCHWARZ PHARMA LTD

N04BC09 ROTIGOTINUM
NEUPRO 6mg/24h

PLASTURE TRANSDERMIC PLASTURE TRANSDERMIC PLASTURE TRANSDERMIC

N04BC09 ROTIGOTINUM
NEUPRO 8mg/24h

N04BC09 ROTIGOTINUM
NEUPRO

468
JUMEX 10 mg

N04BD01

SELEGILINUM
COMPR.
10mg CHINOIN PRIVATE CO. LTD.

N04BD01 SELEGILINUM N04BD01 SELEGILINUM


ALS-SELEGILINA 5 mg JUMEX 5 mg SELEGILIN AL 5 SELEGILINE TEVA SELEGOS 5mg 5mg 5mg 5mg 5mg

10mg 5mg
ALSIFCOM INTERMED SRL CHINOIN PRIVATE CO. LTD. ALIUD PHARMA GMBH & CO.KG TEVA PHARM. IND. LTD. MEDOCHEMIE LTD.

COMPR.

Prescriere limitata:

Stadiu tardiv al bolii Parkinson ca tratament complementar la pacientii tratati cu levodopa combinat cu inhibitor al decarboxylazei .

469
AZILECT 1mg

N04BD02

RASAGILINUM ***
COMPR.
1mg TEVA PHARMA GMBH

N04BD02 RASAGILINUM

1mg

470
COMTAN 200mg

N04BX02

ENTACAPONUM ***
COMPR. FILM.
200mg NOVARTIS EUROPHARM LTD.

N04BX02 ENTACAPONUM

200mg

104 / 233

DCI/DENUMIRE COMERCIALA
COMTESS 200mg

CONCENTRATIE
200mg

FORMA FARM.
ORION CORPORATION

FIRMA

PROTOCOL

Cod restrictie 2067:

Boala Parkinson la pacienti tratati cu combinatii de inhibitor de decarboxylase-levodopa, care prezinta tulburari ale functiilor motorii induse la sfarsitul perioadei de actiune a unei doze

471

N05AH02

CLOZAPINUM **
COMPR.
100mg 100mg HEXAL AG NOVARTIS PHARMA GMBH

N05AH02 CLOZAPINUM
CLOZAPIN SANDOZ 100 mg LEPONEX 100 mg

100mg

N05AH02 CLOZAPINUM
CLOZAPIN SANDOZ 25 mg LEPONEX 25 mg 25mg 25mg

COMPR.
HEXAL AG NOVARTIS PHARMA GMBH

25mg

N05AH02 CLOZAPINUM
CLOZAPIN SANDOZ 50 mg 50mg

COMPR.
HEXAL AG

50mg

SUBLISTA C1-G13 MIASTENIA GRAVIS. 472 H02AB07 PREDNISONUM


H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg 5mg 5mg 5mg 5mg 5mg

COMPR.
MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

5mg

474
IMURAN

L04AX01

AZATHIOPRINUM
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

L04AX01 AZATHIOPRINUM

50mg

475
MIOSTIN 0,5 mg/ml

N07AA01

NEOSTIGMINI BROMIDUM
SOL. INJ.
0.5mg/ml ZENTIVA S.A.

N07AA01 NEOSTIGMINI BROMIDUM N07AA01 NEOSTIGMINI BROMIDUM


NEOSTIGMINA LPH 15 mg 15mg

0.5mg/ml 15mg
LABORMED PHARMA SA

COMPR.

476
MESTINON 60 mg

N07AA02

PYRIDOSTIGMINI BROMIDUM
DRAJ.
60mg ICN POLFA RZESZOW S.A.

N07AA02 PYRIDOSTIGMINI BROMIDUM

60mg

105 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G14 SCLEROZA MULTIPLA. 477 H02AB04 METHYLPREDNISOLONUM


H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 125 mg

LIOF. PT. SOL. INJ.


125mg 125mg/2ml HEMOFARM S.R.L.

125mg 125mg/2ml 16mg

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL A 16 16mg 20mg

COMPR. LIOF. PT. SOL. INJ.


HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 20 mg

20mg 250mg/4ml 32mg

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
250mg/4ml PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 32 32mg 40mg

COMPR. LIOF. PT. SOL. INJ.


HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 40 mg

40mg 40mg/1ml 4mg

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
40mg/1ml PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg 4mg

COMPR. LIOF. PT. SOL. INJ.


500mg 500mg/7.8ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 500 mg

500mg 500mg/7.8ml

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL 500 mg/7,8 ml

LIOF. + SOLV. PT. SOL. INJ.


PFIZER EUROPE MA EEIG

478

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

5mg

479

L01BA01

METHOTREXATUM (4)
CONC. PT. SOL. INJ./PERF.
100mg/ml 100mg/ml 100mg/ml 10mg/ml 10mg/ml EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG

L01BA01 METHOTREXATUM
METHOTREXAT "EBEWE" 1000 mg METHOTREXAT "EBEWE" 500 mg METHOTREXAT "EBEWE" 5000 mg

100mg/ml

L01BA01 METHOTREXATUM
METHOTREXAT "EBEWE" 10 mg METHOTREXAT "EBEWE" 50 mg

SOL. INJ./PERF.
EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG

10mg/ml

L01BA01 METHOTREXATUM
METHOTREXATE TEVA 25mg/ml

SOL. INJ.
25mg/ml 50mg TEVA PHARMACEUTICALS S.R.L.

25mg/ml 50mg 5mg/ml


EBEWE PHARMA GMBH NFG. KG

L01BA01 METHOTREXATUM
ANTIFOLAN 50 mg

PULB. PT. SOL. INJ./PERF.


SINDAN SRL

L01BA01 METHOTREXATUM
METHOTREXAT "EBEWE" 5 mg

SOL. INJ.
5mg/ml

480

L01DB07

MITOXANTRONUM ***
CONC. PT. SOL. PERF.
2 mg/ml TEVA PHARMACEUTICALS SRL

Protocol: L001G
2 mg/ml 20mg/10ml
WYETH LEDERLE PHARMA GMBH

L01DB07 MITOXANTRONUM
MITOXANTRONE TEVA 2 mg/ml

L01DB07 MITOXANTRONUM
NOVANTRONE

SOL. PERF.
20mg/10ml 2mg/ml

L01DB07 MITOXANTRONUM
ONKOTRONE

CONC. PT. SOL. INJ.


BAXTER ONCOLOGY GMBH

2mg/ml

481
IMURAN

L04AX01

AZATHIOPRINUM
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

L04AX01 AZATHIOPRINUM

50mg

106 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G15 BOLI PSIHICE (SCHIZOFRENIE, TULBURARI SCHIZOTIPALE SI DELIRANTE, TULBURARI AFECTIVE MAJORE, TULBURARI PSIHOTICE ACUTE SI BOLI PSIHICE COPII, AUTISM). 482 N03AG01 ACIDUM VALPROICUM + SARURI
N03AG01 ACIDUM VALPROICUM + SARURI
DEPAKINE CHRONOSPHERE 1000 mg

Protocol: N029F

GRAN. ELIB. PREL.


1000mg SANOFI-AVENTIS FRANCE

1000mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL LONG 1000 mg

MINICOMPR. ELIB. PREL.


1000mg DESITIN ARZNEIMITTEL GMBH

1000mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONOSPHERE 100 mg

GRAN. ELIB. PREL.


100mg SANOFI-AVENTIS FRANCE

100mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL LONG 150 mg

CAPS. ELIB. PREL.


150mg DESITIN ARZNEIMITTEL GMBH

150mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


CONVULEX 150 mg

CAPS. MOI GASTROREZ.


150mg GEROT PHARMAZEUTIKA GMBH

150mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL 150

COMPR. FILM. GASTROREZ.


150mg DESITIN ARZNEIMITTEL GMBH

150mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


PETILIN

COMPR. FILM.
200mg REMEDICA LTD.

200mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE 200 mg

COMPR. FILM. GASTROREZ.


200mg SANOFI-AVENTIS FRANCE

200mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


VALEPIL

SIROP
200mg/5ml ARENA GROUP S.A.

200mg/5ml

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONOSPHERE 250 mg

GRAN. ELIB. PREL.


250mg SANOFI-AVENTIS FRANCE

250mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL LONG 300 mg

CAPS. ELIB. PREL.


300mg DESITIN ARZNEIMITTEL GMBH

300mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


CONVULEX 300 mg

CAPS. MOI GASTROREZ.


300mg GEROT PHARMAZEUTIKA GMBH

300mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL 300

COMPR. FILM. GASTROREZ.


300mg DESITIN ARZNEIMITTEL GMBH

300mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL SIROP

SIROP
300mg/5ml DESITIN ARZNEIMITTEL GMBH

300mg/5ml

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE 400 mg/4 ml LIOFILIZAT SI SOLVENT PENTRU SOLUTIE INJECTABILA i.v.

LIOF. + SOLV. PT. SOL.


400mg/4ml SANOFI-AVENTIS FRANCE

400mg/4ml

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


CONVULEX 500 mg

CAPS. MOI GASTROREZ.


500mg GEROT PHARMAZEUTIKA GMBH

500mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONOSPHERE 500 mg

GRAN. ELIB. PREL.


500mg SANOFI-AVENTIS FRANCE

500mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL LONG 500 mg

MINICOMPR. ELIB. PREL.


500mg DESITIN ARZNEIMITTEL GMBH

500mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


CONVULEX

SIROP
50mg/ml GEROT PHARMAZEUTIKA GMBH

50mg/ml

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE

SIROP
57.64mg/ml SANOFI - AVENTIS FRANCE

57.64mg/ml

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


ORFIRIL 600

COMPR. FILM. GASTROREZ.


600mg DESITIN ARZNEIMITTEL GMBH

600mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONOSPHERE 750 mg

GRAN. ELIB. PREL.


750mg SANOFI-AVENTIS FRANCE

750mg

S-au raportat cazuri de hepatotoxicitate letala, in special la copii. Se inregistreaza din ce in ce mai multe dovezi cu privire la teratogenitatea legata de doza.

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONO 300 mg

COMPR. FILM. ELIB. PREL. DIVIZ.


300mg 500mg SANOFI-AVENTIS FRANCE

300mg 500mg

N03AG01 ACIDUM VALPROICUM + SARURI


DEPAKINE CHRONO 500 mg

COMPR. FILM. ELIB. PREL. DIVIZ.


SANOFI-AVENTIS FRANCE

483
EPIMIL 100 mg EPIRAL 100 EPIZOL 100 mg

N03AX09

LAMOTRIGINUM **
COMPR.
100mg 100mg 100mg IVAX PHARMCEUTICALS S.R.O. ZENTIVA AS KRKA D.D. NOVO MESTO

Protocol: N012F
100mg

N03AX09 LAMOTRIGINUM

107 / 233

DCI/DENUMIRE COMERCIALA
LAMEPTIL 100 mg LAMICTAL 100 mg LAMOLEP 100 mg LAMOTIRAN 100 mg LAMOTRIGINE FARMAL 100 mg LAMOTRIX 100 mg PLEXXO 100 mg XEBARIN 100 mg

CONCENTRATIE
100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg 100mg

FORMA FARM.

FIRMA

PROTOCOL

SANDOZ S.R.L. THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD. FARMAL INTERNATIONAL S.R.L. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH DR. REDDY'S LABORATORIES

N03AX09 LAMOTRIGINUM
EPIZOL 100 mg LAMOTRIGIN STADA 100 mg LAMOTRIGINE SANDOZ 100 mg LAMOTRIN 100 mg

COMPR. DISP.
KRKA D.D. NOVO MESTO STADA ARZNEIMITTEL AG SANDOZ S.R.L. ACTAVIS GROUP HF.

100mg

N03AX09 LAMOTRIGINUM
LAMICTAL 100 mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

100mg 100mg 200mg

N03AX09 LAMOTRIGINUM
LAMOTIRAN CD 100 mg

COMPR. ORODISP./MAST.
RANBAXY UK LIMITED KRKA D.D. NOVO MESTO SANDOZ S.R.L. RANBAXY UK LTD. FARMAL INTERNATIONAL S.R.L. MEDOCHEMIE LTD. DR. REDDY'S LABORATORIES

N03AX09 LAMOTRIGINUM
EPIZOL 200 mg LAMEPTIL 200 mg LAMOTIRAN 200 mg LAMOTRIGINE FARMAL 200 mg LAMOTRIX 200 mg XEBARIN 200 mg

COMPR.
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg

N03AX09 LAMOTRIGINUM
EPIZOL 200 mg LAMOTRIGINE SANDOZ 200 mg

COMPR. DISP.
KRKA D.D. NOVO MESTO SANDOZ S.R.L.

200mg

N03AX09 LAMOTRIGINUM
LAMOTIRAN CD 200 mg

COMPR. ORODISP./MAST.
RANBAXY UK LIMITED

200mg 25mg

N03AX09 LAMOTRIGINUM
EPIMIL 25mg EPIRAL 25 EPIZOL 25 mg LAMEPTIL 25 mg LAMICTAL 25 mg LAMOLEP 25 mg LAMOTIRAN 25 mg LAMOTRIGINE FARMAL 25 mg LAMOTRIX 25 mg PLEXXO 25 mg XEBARIN 25 mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 2mg 2mg 50 mg

COMPR.
IVAX PHARMCEUTICALS S.R.O. ZENTIVA AS KRKA D.D. NOVO MESTO SANDOZ S.R.L. THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD. FARMAL INTERNATIONAL S.R.L. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH DR. REDDY'S LABORATORIES

N03AX09 LAMOTRIGINUM
EPIZOL 25 mg LAMOTRIGIN STADA 25 mg LAMOTRIGINE SANDOZ 25 mg LAMOTRIN 25 mg

COMPR. DISP.
KRKA D.D. NOVO MESTO STADA ARZNEIMITTEL AG SANDOZ S.R.L. ACTAVIS GROUP HF.

25mg

N03AX09 LAMOTRIGINUM
LAMICTAL 25 mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

25mg 25mg 2mg 2mg 50 mg 50mg

N03AX09 LAMOTRIGINUM
LAMOTIRAN CD 25 mg

COMPR. ORODISP./MAST.
RANBAXY UK LIMITED

N03AX09 LAMOTRIGINUM
EPIZOL 2 mg

COMPR. DISP.
KRKA D.D. NOVO MESTO

N03AX09 LAMOTRIGINUM
LAMICTAL 2 mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

N03AX09 LAMOTRIGINUM
LAMOTIRAN CD 50 mg

COMPR. ORODISP./MAST.
RANBAXY UK LIMITED

N03AX09 LAMOTRIGINUM
EPIMIL 50 mg EPIRAL 50 EPIZOL 50 mg LAMEPTIL 50 mg LAMICTAL 50 mg LAMOLEP 50 mg LAMOTIRAN 50 mg LAMOTRIGINE FARMAL 50 mg LAMOTRIX 50 mg PLEXXO 50 mg XEBARIN 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 5mg 5mg

COMPR.
IVAX PHARMCEUTICALS S.R.O. ZENTIVA AS KRKA D.D. NOVO MESTO SANDOZ S.R.L. THE WELLCOME FOUNDATION LTD. GEDEON RICHTER LTD. RANBAXY UK LTD. FARMAL INTERNATIONAL S.R.L. MEDOCHEMIE LTD. DESITIN ARZNEIMITTEL GMBH DR. REDDY'S LABORATORIES

N03AX09 LAMOTRIGINUM
EPIZOL 50 mg LAMOTRIGIN STADA 50 mg LAMOTRIGINE SANDOZ 50 mg LAMOTRIN 50 mg

COMPR. DISP.
KRKA D.D. NOVO MESTO STADA ARZNEIMITTEL AG SANDOZ S.R.L. ACTAVIS GROUP HF.

50mg

N03AX09 LAMOTRIGINUM
EPIZOL 5 mg

COMPR. DISP.
KRKA D.D. NOVO MESTO

5mg 5mg

N03AX09 LAMOTRIGINUM
LAMICTAL 5 mg

COMPR. DISP./MAST.
THE WELLCOME FOUNDATION LTD.

484
ROMPARKIN 2 mg

N04AA01

TRIHEXYPHENIDYLUM
COMPR.
2mg TERAPIA SA

N04AA01 TRIHEXYPHENIDYLUM

2mg

485

N05AD01

HALOPERIDOLUM
COMPR.
0.5mg LAROPHARM S.R.L.

N05AD01 HALOPERIDOLUM
HALOPERIDOL LAROPHARM 0,5 mg

0.5mg 1mg

N05AD01 HALOPERIDOLUM

COMPR.

108 / 233

DCI/DENUMIRE COMERCIALA
HALOPERIDOL 1 mg

CONCENTRATIE
1mg

FORMA FARM.
ARENA GROUP SA

FIRMA

PROTOCOL

N05AD01 HALOPERIDOLUM
HALOPERIDOL 2 mg 2mg

COMPR.
ARENA GROUP SA

2mg 2mg/ml 50mg/ml


GEDEON RICHTER LTD.

N05AD01 HALOPERIDOLUM
HALOPERIDOL RANBAXY 2mg/ml

PIC. ORALE, SOL.


2mg/ml RANBAXY U.K. LIMITED

N05AD01 HALOPERIDOLUM
HALOPERIDOL DECANOAT

SOL. INJ.
50mg/ml

N05AD01 HALOPERIDOLUM
HALDOL 5mg

COMPR.
JANSSEN PHARMACEUTICA NV

5mg 5mg/ml
GEDEON RICHTER LTD.

N05AD01 HALOPERIDOLUM
HALOPERIDOL 5 mg/ml

SOL. INJ.
5mg/ml 2mg/ml 2mg/ml

N05AD01 HALOPERIDOLUM
HALOPERIDOL 2 mg/ml

PIC. ORALE-SOL.
GEDEON RICHTER ROMANIA SA

2mg/ml 2mg/ml

N05AD01 HALOPERIDOLUM
HALOPERIDOL

PICATURI ORALE-SOL.
TERAPIA SA

486
SERDOLECT 12 mg

N05AE03

SERTINDOL **
COMPR. FILM.
12mg 16mg 20mg 4mg H. LUNDBECK A/S

Protocol: N017F
12mg 16mg 20mg 4mg

N05AE03 SERTINDOL N05AE03 SERTINDOL


SERDOLECT 16 mg

COMPR. FILM.
H. LUNDBECK A/S

N05AE03 SERTINDOL
SERDOLECT 20 mg

COMPR. FILM.
H. LUNDBECK A/S

N05AE03 SERTINDOL
SERDOLECT 4 mg

COMPR. FILM.
H. LUNDBECK A/S

487
ZELDOX 10 mg/ml

N05AE04

ZIPRASIDONUM **
SUSP. ORALA
10mg/ml PFIZER EUROPE MA EEIG

Protocol: N018F
10mg/ml 20mg
PFIZER EUROPE MA EEIG

N05AE04 ZIPRASIDONUM N05AE04 ZIPRASIDONUM


ZELDOX 20 mg 20mg

CAPS.
Schizofrenie

Cod restrictie 1589:

N05AE04 ZIPRASIDONUM
ZELDOX 20 mg/ml

LIOF. PT. SOL. INJ. + SOLV.


20mg/ml PFIZER EUROPE MA EEIG

20mg/ml 40mg

N05AE04 ZIPRASIDONUM
ZELDOX 40 mg 40mg

CAPS.
PFIZER EUROPE MA EEIG

Cod restrictie 1589:

Schizofrenie

N05AE04 ZIPRASIDONUM
ZELDOX 60 mg 60mg

CAPS.
PFIZER EUROPE MA EEIG

60mg

Cod restrictie 1589:

Schizofrenie

N05AE04 ZIPRASIDONUM
ZELDOX 80 mg 80mg

CAPS.
PFIZER EUROPE MA EEIG

80mg

Cod restrictie 1589:

Schizofrenie

488
FLUANXOL DEPOT

N05AF01

FLUPENTIXOLUM **
SOL. INJ.
20mg/ml H. LUNDBECK A/S

Protocol: N015F
20mg/ml

N05AF01 FLUPENTIXOLUM

489
CLOPIXOL 10 mg

N05AF05

ZUCLOPENTHIXOLUM **
COMPR. FILM.
10mg H. LUNDBECK A/S

Protocol: N019F
10mg 200mg/ml

N05AF05 ZUCLOPENTHIXOLUM N05AF05 ZUCLOPENTHIXOLUM


CLOPIXOL DEPOT

SOL. INJ.
200mg/ml 25mg H. LUNDBECK A/S

N05AF05 ZUCLOPENTHIXOLUM
CLOPIXOL 25 mg

COMPR. FILM.
H. LUNDBECK A/S

25mg 50mg/ml

N05AF05 ZUCLOPENTHIXOLUM
CLOPIXOL ACUPHASE

SOL. INJ.
50mg/ml 20mg/ml H. LUNDBECK A/S

N05AF05 ZUCLOPENTHIXOLUM
CLOPIXOL 20 mg/ml

PIC. ORALE-SOL.
H. LUNDBECK A/S

20mg/ml

490

N05AH02

CLOZAPINUM **
COMPR.
100mg 100mg HEXAL AG NOVARTIS PHARMA GMBH

Protocol: N016F
100mg

N05AH02 CLOZAPINUM
CLOZAPIN SANDOZ 100 mg LEPONEX 100 mg

N05AH02 CLOZAPINUM
CLOZAPIN SANDOZ 25 mg LEPONEX 25 mg 25mg 25mg

COMPR.
HEXAL AG NOVARTIS PHARMA GMBH

25mg

N05AH02 CLOZAPINUM
CLOZAPIN SANDOZ 50 mg 50mg

COMPR.
HEXAL AG

50mg

491
ZALASTA 10mg

N05AH03
Cod restrictie 1589: Cod restrictie 2044:

OLANZAPINUM **
COMPR.
10mg KRKA D.D. NOVO MESTO

Protocol: N003F
10mg

N05AH03 OLANZAPINUM

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
OLANZAPINE NEOPHARMA 10mg OLANZAPINE NIOLIB 10 mg OLANZAPINE NYZOL 10 mg OLANZAPINE TEVA 10mg ZYPREXA 10 mg 10mg 10mg 10mg 10mg 10mg

COMPR. FILM.
NEOPHARMA LIMITED LABORATORIOS LESVI, S.L. LABORATORIOS LESVI, S.L. TEVA PHARMA BV ELI LILLY NEDERLAND BV

10mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
OLANZAPINE TEVA 10mg 10mg

COMPR. ORODISPERSABILE
TEVA PHARMA BV

10mg

109 / 233

DCI/DENUMIRE COMERCIALA
ZALASTA 10mg ZYPREXA VELOTAB 10 mg

CONCENTRATIE
10mg 10mg

FORMA FARM.
KRKA D.D. NOVO MESTO ELI LILLY NEDERLAND BV

FIRMA

PROTOCOL

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
ZYPREXA 10 mg 10mg

PULB. PT. SOL. INJ.


ELI LILLY NEDERLAND BV

10mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
ZALASTA 15mg 15mg 15mg 15mg 15mg 15mg 15mg 15mg

COMPR.
KRKA D.D. NOVO MESTO

15mg 15mg

N05AH03 OLANZAPINUM
OLANZAPINE NEOPHARMA 15mg OLANZAPINE TEVA 15mg ZYPREXA 15mg

COMPR. FILM.
NEOPHARMA LIMITED TEVA PHARMA BV ELI LILLY NEDERLAND BV

N05AH03 OLANZAPINUM
OLANZAPINE TEVA 15mg ZALASTA 15mg ZYPREXA VELOTAB 15 mg

COMPR. ORODISPERSABILE
TEVA PHARMA BV KRKA D.D. NOVO MESTO ELI LILLY NEDERLAND BV

15mg

N05AH03 OLANZAPINUM
ZALASTA 2,5mg 2,5mg

COMPR.
KRKA D.D. NOVO MESTO

2,5mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
OLANZAPINE NEOPHARMA 2,5mg OLANZAPINE NIOLIB 2,5 mg OLANZAPINE NYZOL 2,5 mg OLANZAPINE TEVA 2,5mg 2,5mg 2,5mg 2,5mg 2,5mg

COMPR. FILM.
NEOPHARMA LIMITED LABORATORIOS LESVI, S.L. LABORATORIOS LESVI, S.L. TEVA PHARMA BV

2,5mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
ZYPREXA 2,5 mg 2.5mg

COMPR. FILM.
ELI LILLY NEDERLAND BV

2.5mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
ZALASTA 20mg 20mg 20mg 20mg 20mg 20mg 20mg

COMPR.
KRKA D.D. NOVO MESTO

20mg 20mg

N05AH03 OLANZAPINUM
OLANZAPINE TEVA 20mg ZYPREXA 20mg

COMPR. FILM.
TEVA PHARMA BV ELI LILLY NEDERLAND BV

N05AH03 OLANZAPINUM
OLANZAPINE TEVA 20mg ZALASTA 20mg ZYPREXA VELOTAB 20 mg

COMPR. ORODISPERSABILE
TEVA PHARMA BV KRKA D.D. NOVO MESTO ELI LILLY NEDERLAND BV

20mg

N05AH03 OLANZAPINUM
ZALASTA 5mg 5mg

COMPR.
KRKA D.D. NOVO MESTO

5mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
OLANZAPINE NEOPHARMA 5 mg OLANZAPINE NIOLIB 5 mg OLANZAPINE NYZOL 5 mg OLANZAPINE TEVA 5mg ZYPREXA 5 mg 5mg 5mg 5mg 5mg 5mg

COMPR. FILM.
NEOPHARMA LIMITED LABORATORIOS LESVI, S.L. LABORATORIOS LESVI, S.L. TEVA PHARMA BV ELI LILLY NEDERLAND BV

5mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
OLANZAPINE TEVA 5mg ZALASTA 5mg ZYPREXA VELOTAB 5 mg 5mg 5mg 5mg

COMPR. ORODISPERSABILE
TEVA PHARMA BV KRKA D.D. NOVO MESTO ELI LILLY NEDERLAND BV

5mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
ZALASTA 7,5mg 7,5mg

COMPR.
KRKA D.D. NOVO MESTO

7,5mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
OLANZAPINE NEOPHARMA 7,5mg OLANZAPINE NIOLIB 7,5 mg OLANZAPINE NYZOL 7,5 mg OLANZAPINE TEVA 7,5mg 7,5mg 7,5mg 7,5mg 7,5mg

COMPR. FILM.
NEOPHARMA LIMITED LABORATORIOS LESVI, S.L. LABORATORIOS LESVI, S.L. TEVA PHARMA BV

7,5mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
ZALASTA 7,5mg 7,5mg

COMPR. ORODISPERSABILE
KRKA D.D. NOVO MESTO

7,5mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

N05AH03 OLANZAPINUM
ZYPREXA 7,5mg 7.5mg

COMPR. FILM.
ELI LILLY NEDERLAND BV

7.5mg

Cod restrictie 1589: Cod restrictie 2044:

Schizofrenie Tratamentul de intretinere a tulburarilor bipolare tip I

492
SEROQUEL 100mg

N05AH04

QUETIAPINUM **
COMPR. FILM.
100mg ASTRAZENECA UK LTD.

Protocol: N005F
100mg

N05AH04 QUETIAPINUM

110 / 233

DCI/DENUMIRE COMERCIALA Cod restrictie 1589: Cod restrictie 2765:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Schizofrenie Monoterapia,pentru maximum 6 luni, pentru episodul acut de manie asociat cu tulburari bipolare tip I

N05AH04 QUETIAPINUM
SEROQUEL 200 mg

COMPR. FILM.
200mg ASTRAZENECA UK LTD.

200mg

Cod restrictie 1589: Cod restrictie 2765:

Schizofrenie Monoterapia,pentru maximum 6 luni, pentru episodul acut de manie asociat cu tulburari bipolare tip I

N05AH04 QUETIAPINUM
SEROQUEL XR 200 mg

COMPR. FILM. ELIB. PREL.


200mg ASTRAZENECA UK LTD.

200mg

Cod restrictie 1589: Cod restrictie 2765:

Schizofrenie Monoterapia,pentru maximum 6 luni, pentru episodul acut de manie asociat cu tulburari bipolare tip I

N05AH04 QUETIAPINUM
SEROQUEL 300 mg

COMPR. FILM.
300mg ASTRAZENECA UK LTD.

300mg

Cod restrictie 1589: Cod restrictie 2765:

Schizofrenie Monoterapia,pentru maximum 6 luni, pentru episodul acut de manie asociat cu tulburari bipolare tip I

N05AH04 QUETIAPINUM
SEROQUEL XR 300 mg

COMPR. FILM. ELIB. PREL.


300mg ASTRAZENECA UK LTD.

300mg

Cod restrictie 1589: Cod restrictie 2765:

Schizofrenie Monoterapia,pentru maximum 6 luni, pentru episodul acut de manie asociat cu tulburari bipolare tip I

N05AH04 QUETIAPINUM
SEROQUEL XR 50 mg 50mg

COMPR. FILM. ELIB. PREL.


ASTRAZENECA UK LTD.

50mg

493
EGLONYL 200 mg

N05AL01

SULPIRIDUM
COMPR.
200mg SANOFI-SYNTHELABO FRANCE

N05AL01 SULPIRIDUM N05AL01 SULPIRIDUM


EGLONYL 50 mg 50mg

200mg 50mg
SANOFI-SYNTHELABO FRANCE

CAPS. SOL. INJ.


50mg/ml SANOFI-AVENTIS FRANCE

N05AL01 SULPIRIDUM
EGLONYL 100 mg/2 ml

50mg/ml

494
SOLIAN 100 mg

N05AL05
Cod restrictie 1589: Schizofrenie

AMISULPRIDUM **
COMPR.
100mg SANOFI-SYNTHELABO FRANCE

Protocol: N006F
100mg

N05AL05 AMISULPRIDUM

N05AL05 AMISULPRIDUM
SOLIAN 200 mg

COMPR. DIVIZ.
200mg SANOFI-AVENTIS FRANCE

200mg

Cod restrictie 1589:

Schizofrenie

N05AL05 AMISULPRIDUM
SOLIAN 400 mg

COMPR. FILM.
400mg SANOFI-AVENTIS FRANCE

400mg

Cod restrictie 1589:

Schizofrenie

495

N05AX08
Cod restrictie 1589: Schizofrenie

RISPERIDONUM **
COMPR. FILM.
0.5mg MEDOCHEMIE LTD.

Protocol: N004F
0.5mg

N05AX08 RISPERIDONUM
RISPERIDONA MEDOCHEMIE 0,5 mg

N05AX08 RISPERIDONUM
TORENDO Q-TAB 0,5 mg 0.5mg

COMPR. ORODISPERSABILE
KRKA D.D. NOVO MESTO

0.5mg

Cod restrictie 1589:


RISSET 1 mg

Schizofrenie

N05AX08 RISPERIDONUM
1 mg

COMPR. FILM.
PLIVA LJUBLJANA D.O.O.

1 mg

Cod restrictie 1589:


ESSENS 1 mg RILEPTID 1 mg RISPEN 1 RISPERIDONA 1 mg RISPERIDONA ACCORD 1 mg RISPERIDONA MEDOCHEMIE 1 mg RISPERIDONE TEVA 1 mg RISPOLEPT 1 mg SPRING 1 mg TORENDO 1 mg XENOMA 1 mg

Schizofrenie

N05AX08 RISPERIDONUM
1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg

COMPR. FILM.
RANBAXY UK LTD. EGIS PHARMACEUTICALS P.L.C. ZENTIVA AS ARENA GROUP S.A. ACCORD HEALTHCARE LIMITED MEDOCHEMIE LTD. TEVA PHARMACEUTICAL S.R.L. JANSSEN PHARMACEUTICA NV ANTIBIOTICE S.A. KRKA D.D. NOVO MESTO DR. REDDY'S LABORATORIES

1mg

Cod restrictie 1589:


RISPOLEPT QUICKLET TORENDO Q-TAB 1 mg

Schizofrenie

N05AX08 RISPERIDONUM
1mg 1mg

COMPR. ORODISPERSABILE
JANSSEN PHARMACEUTICA NV KRKA D.D. NOVO MESTO

1mg

Cod restrictie 1589:


RISPOLEPT

Schizofrenie

N05AX08 RISPERIDONUM
Cod restrictie 1589:
RISPEN 2 RISSET 2 mg

SOL. ORALA
1mg/ml JANSSEN PHARMACEUTICA NV

1mg/ml

Schizofrenie

N05AX08 RISPERIDONUM
2 mg 2 mg

COMPR. FILM.
ZENTIVA AS PLIVA LJUBLJANA D.O.O.

2 mg

Cod restrictie 1589:


RISPOLEPT CONSTA 25 mg

Schizofrenie

N05AX08 RISPERIDONUM
25mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg

PULB. + SOLV. PT. SOL. INJ.


JANSSEN PHARMACEUTICA NV

25mg 2mg

N05AX08 RISPERIDONUM
ESSENS 2 mg RILEPTID 2 mg RISON 2 mg RISPERIDONA 2 mg RISPERIDONA ACCORD 2 mg RISPERIDONA MEDOCHEMIE 2 mg RISPERIDONE 2 mg

COMPR. FILM.
RANBAXY UK LTD. EGIS PHARMACEUTICALS P.L.C. ACTAVIS GROUP HF. ARENA GROUP S.A. ACCORD HEALTHCARE LIMITED MEDOCHEMIE LTD. OZONE LABORATORIES LTD.

111 / 233

DCI/DENUMIRE COMERCIALA
RISPERIDONE TEVA 2 mg RISPOLEPT 2 mg SPRING 2 mg TORENDO 2 mg XENOMA 2 mg

CONCENTRATIE
2mg 2mg 2mg 2mg 2mg

FORMA FARM.
TEVA PHARMACEUTICALS SRL JANSSEN PHARMACEUTICA NV ANTIBIOTICE S.A. KRKA D.D. NOVO MESTO DR. REDDY'S LABORATORIES

FIRMA

PROTOCOL

Cod restrictie 1589:


RISPOLEPT QUICKLET TORENDO Q-TAB 2 mg

Schizofrenie

N05AX08 RISPERIDONUM
2mg 2mg

COMPR. ORODISPERSABILE
JANSSEN PHARMACEUTICA NV KRKA D.D. NOVO MESTO

2mg

Cod restrictie 1589:


RISPOLEPT CONSTA 37,5 mg

Schizofrenie

N05AX08 RISPERIDONUM
Cod restrictie 1589:
ESSENS 3 mg RILEPTID 3 mg RISON 3 mg RISPEN 3 RISPERIDONA 3 mg RISPERIDONA ACCORD 3 mg RISPERIDONA MEDOCHEMIE 3 mg RISPERIDONE TEVA 3 mg RISPOLEPT 3 mg RISSET 3 mg SPRING 3 mg TORENDO 3 mg XENOMA 3 mg

PULB. + SOLV. PT. SOL. INJ.


37.5mg JANSSEN PHARMACEUTICA NV

37.5mg

Schizofrenie

N05AX08 RISPERIDONUM
3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg

COMPR. FILM.
RANBAXY UK LTD. EGIS PHARMACEUTICALS P.L.C. ACTAVIS GROUP HF. ZENTIVA AS ARENA GROUP S.A. ACCORD HEALTHCARE LIMITED MEDOCHEMIE LTD. TEVA PHARMACEUTICALS SRL JANSSEN PHARMACEUTICA NV PLIVA LJUBLJANA D.O.O. ANTIBIOTICE S.A. KRKA D.D. NOVO MESTO DR. REDDY'S LABORATORIES

3mg

Cod restrictie 1589:


RISPEN 4

Schizofrenie

N05AX08 RISPERIDONUM
4 mg

COMPR. FILM.
ZENTIVA AS

4 mg

Cod restrictie 1589:


ESSENS 4 mg RILEPTID 4 mg RISON 4 mg RISPERIDONA 4 mg RISPERIDONA MEDOCHEMIE 4 mg RISPERIDONE TEVA 4 mg RISPOLEPT 4 mg RISSET 4 mg SPRING 4 mg TORENDO 4 mg XENOMA 4 mg

Schizofrenie

N05AX08 RISPERIDONUM
4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg

COMPR. FILM.
TERAPIA S.A. EGIS PHARMACEUTICALS P.L.C. ACTAVIS GROUP HF. ARENA GROUP S.A. MEDOCHEMIE LTD. TEVA PHARMACEUTICALS SRL JANSSEN PHARMACEUTICA NV PLIVA LJUBLJANA D.O.O. ANTIBIOTICE S.A. KRKA D.D. NOVO MESTO DR. REDDY'S LABORATORIES

4mg

Cod restrictie 1589:


RISPOLEPT CONSTA 50 mg

Schizofrenie

N05AX08 RISPERIDONUM
50mg

PULB. + SOLV. PT. SOL. INJ.


JANSSEN PHARMACEUTICA NV

50mg

Cod restrictie 1589:


ESSENS 6 mg RISPERIDONA MEDOCHEMIE 6 mg

Schizofrenie

N05AX08 RISPERIDONUM
6mg 6mg 8mg

COMPR. FILM.
TERAPIA S.A. MEDOCHEMIE LTD.

6mg

N05AX08 RISPERIDONUM
RISPERIDONA MEDOCHEMIE 8 mg

COMPR. FILM.
MEDOCHEMIE LTD.

8mg

496
ABILIFY 10mg

N05AX12
Cod restrictie 1589: Schizofrenie

ARIPIPRAZOLUM **
COMPR.
10mg OTSUKA PHARMACEUTICAL EUROPE LTD.

Protocol: N007F
10mg

N05AX12 ARIPIPRAZOLUM

N05AX12 ARIPIPRAZOLUM
ABILIFY 10mg 10mg

COMPR. ORODISPERSABILE
OTSUKA PHARMACEUTICAL EUROPE LTD.

10mg 15mg

N05AX12 ARIPIPRAZOLUM
ABILIFY 15mg 15mg

COMPR.
OTSUKA PHARMACEUTICAL EUROPE LTD.

Cod restrictie 1589:


ABILIFY 15mg

Schizofrenie

N05AX12 ARIPIPRAZOLUM
15mg

COMPR. ORODISPERSABILE
OTSUKA PHARMACEUTICAL EUROPE LTD.

15mg 1mg/ml 30mg

N05AX12 ARIPIPRAZOLUM
ABILIFY 1mg/ml

SOL. ORALA
1mg/ml OTSUKA PHARMACEUTICAL EUROPE LTD. OTSUKA PHARMACEUTICAL EUROPE LTD.

N05AX12 ARIPIPRAZOLUM
ABILIFY 30mg 30mg

COMPR.

Cod restrictie 1589:


ABILIFY 30mg

Schizofrenie

N05AX12 ARIPIPRAZOLUM
30mg

COMPR. ORODISPERSABILE
OTSUKA PHARMACEUTICAL EUROPE LTD.

30mg 5mg

N05AX12 ARIPIPRAZOLUM
ABILIFY 5mg 5mg 5mg

COMPR.
OTSUKA PHARMACEUTICAL EUROPE LTD.

N05AX12 ARIPIPRAZOLUM
ABILIFY 5mg

COMPR. ORODISPERSABILE
OTSUKA PHARMACEUTICAL EUROPE LTD.

5mg 7,5mg/ml

N05AX12 ARIPIPRAZOLUM
ABILIFY 7,5mg/ml

SOL. INJ.
7,5mg/ml OTSUKA PHARMACEUTICAL EUROPE LTD.

498
CITALEC 10

N06AB04
Prescriere limitata:

CITALOPRAMUM **
COMPR. FILM.
10 mg ZENTIVA A.S.

Protocol: N008F
10 mg

N06AB04 CITALOPRAMUM
Tulburari depresive majore

N06AB04 CITALOPRAMUM
CITALOMERCK 10 mg CITALOPRAM SANDOZ 10 mg 10mg 10mg

COMPR. FILM.
GENERICS LTD. HEXAL AG

10mg

112 / 233

DCI/DENUMIRE COMERCIALA
CITALOPRAM STADA 10 mg CITALORAN 10 mg DALSAN 10 mg LINISAN 10 mg

CONCENTRATIE
10mg 10mg 10mg 10mg

FORMA FARM.
STADA ARZNEIMITTEL AG RANBAXY UK LIMITED EGIS PHARMACEUTICALS P.L.C. GEDEON RICHTER ROMANIA S.A.

FIRMA

PROTOCOL

Prescriere limitata:
CITALEC 20

Tulburari depresive majore

N06AB04 CITALOPRAMUM
20 mg

COMPR. FILM.
ZENTIVA A.S.

20 mg

Prescriere limitata:
CITALOMERCK 20 mg CITALOPRAM SANDOZ 20 mg CITALOPRAM STADA 20 mg CITALORAN 20mg DALSAN 20 mg LINISAN 20 mg

Tulburari depresive majore

N06AB04 CITALOPRAMUM
20mg 20mg 20mg 20mg 20mg 20mg

COMPR. FILM.
GENERICS LTD. HEXAL AG STADA ARZNEIMITTEL AG RANBAXY UK LIMITED EGIS PHARMACEUTICALS P.L.C. GEDEON RICHTER ROMANIA S.A.

20mg

Prescriere limitata:
CITALOPRAM SANDOZ 30 mg

Tulburari depresive majore

N06AB04 CITALOPRAMUM
30mg 40 mg

COMPR. FILM.
HEXAL AG

30mg 40 mg

N06AB04 CITALOPRAMUM
CITALEC 40

COMPR. FILM.
ZENTIVA A.S.

Prescriere limitata:
CITALOPRAM SANDOZ 40 mg CITALOPRAM STADA 40 mg CITALORAN 40 mg DALSAN 40 mg LINISAN 40 mg

Tulburari depresive majore

N06AB04 CITALOPRAMUM
40mg 40mg 40mg 40mg 40mg

COMPR. FILM.
HEXAL AG STADA ARZNEIMITTEL AG RANBAXY UK LIMITED EGIS PHARMACEUTICALS P.L.C. GEDEON RICHTER ROMANIA S.A.

40mg

Prescriere limitata:
CITALOPRAM SANDOZ 60 mg

Tulburari depresive majore

N06AB04 CITALOPRAMUM
60mg

COMPR. FILM.
HEXAL AG

60mg

499
CIPRALEX 10 mg

N06AB10
Prescriere limitata:

ESCITALOPRAMUM **
COMPR. FILM.
10mg H. LUNDBECK A/S

Protocol: N009F
10mg

N06AB10 ESCITALOPRAMUM
Tulburari depresive majore

N06AB10 ESCITALOPRAMUM
CIPRALEX 15 mg 15mg 20mg

COMPR. FILM.
H. LUNDBECK A/S

15mg 20mg

N06AB10 ESCITALOPRAMUM
CIPRALEX 20 mg

COMPR. FILM.
H. LUNDBECK A/S

Prescriere limitata:
CIPRALEX 5 mg

Tulburari depresive majore

N06AB10 ESCITALOPRAMUM
5mg

COMPR. FILM.
H. LUNDBECK A/S

5mg

500
TRITTICO AC 150 mg

N06AX05

TRAZODONUM **
COMPR. ELIB. PREL.
150mg 75mg ANGELINI FRANCESCO SPA

Protocol: N010F
150mg 75mg

N06AX05 TRAZODONUM N06AX05 TRAZODONUM


TRITTICO AC 75 mg

COMPR. ELIB. PREL.


ANGELINI FRANCESCO SPA

501
COAXIL

N06AX14

TIANEPTINUM **
DRAJ.
12.5mg LES LAB. SERVIER IND.

Protocol: N011F
12.5mg

N06AX14 TIANEPTINUM

502
ALVENTA 150mg EFECTIN ER 150 mg VELAXIN 150 mg

N06AX16

VENLAFAXINUM **
CAPS. ELIB. PREL.
150mg 150mg 150mg KRKA D.D. NOVO MESTO WYETH LEDERLE PHARMA GMBH EGIS PHARMACEUTICALS P.L.C.

Protocol: N013F
150mg

N06AX16 VENLAFAXINUM

Prescriere limitata:
ARGOFAN 150 SR

Tulburari depresive majore

N06AX16 VENLAFAXINUM N06AX16 VENLAFAXINUM


VELAXIN 25 mg VENLAFAXINA TERAPIA 25 mg 25mg 25mg

COMPR. ELIB. PREL.


150mg ZENTIVA A.S.

150mg 25mg

COMPR.
EGIS PHARMACEUTICALS P.L.C. TERAPIA S.A.

N06AX16 VENLAFAXINUM
EFECTIN ER 37,5 mg VELAXIN 37,5 mg

CAPS. ELIB. PREL.


37,5mg 37,5mg WYETH LEDERLE PHARMA GMBH EGIS PHARMACEUTICALS P.L.C.

37,5mg

Prescriere limitata:
ALVENTA 37,5 mg

Tulburari depresive majore

N06AX16 VENLAFAXINUM
Prescriere limitata:
VELAXIN 37,5 mg VENLAFAXINA LPH 37,5 mg VENLAFAXINA TERAPIA 37,5 mg

CAPS. ELIB. PREL.


37.5mg KRKA D.D. NOVO MESTO

37.5mg

Tulburari depresive majore

N06AX16 VENLAFAXINUM

COMPR.
37.5mg 37.5mg 37.5mg EGIS PHARMACEUTICALS PLC LABORMED PHARMA SA TERAPIA S.A.

37.5mg

N06AX16 VENLAFAXINUM
VELAXIN 50 mg VENLAFAXINA TERAPIA 50 mg 50mg 50mg 75mg 75mg 75mg

COMPR.
EGIS PHARMACEUTICALS PLC TERAPIA S.A.

50mg

N06AX16 VENLAFAXINUM
ALVENTA 75 mg EFECTIN ER 75 mg VELAXIN 75 mg

CAPS. ELIB. PREL.


KRKA D.D. NOVO MESTO WYETH LEDERLE PHARMA GMBH EGIS PHARMACEUTICALS P.L.C.

75mg

Prescriere limitata:
VELAXIN 75 mg VENLAFAXINA LPH 75 mg

Tulburari depresive majore

N06AX16 VENLAFAXINUM
75mg 75mg

COMPR.
EGIS PHARMACEUTICALS PLC LABORMED PHARMA SA

75mg

113 / 233

DCI/DENUMIRE COMERCIALA
VENLAFAXINA TERAPIA 75 mg

CONCENTRATIE
75mg 75mg

FORMA FARM.
TERAPIA S.A.

FIRMA

PROTOCOL

N06AX16 VENLAFAXINUM
ARGOFAN 75 SR

COMPR. ELIB. PREL.


ZENTIVA A.S.

75mg

503
IXEL

N06AX17

MILNACIPRANUM **
CAPS.
25mg PIERRE FABRE MEDICAMENT

Protocol: N002F
25mg 50mg
PIERRE FABRE MEDICAMENT

N06AX17 MILNACIPRANUM N06AX17 MILNACIPRANUM


IXEL 50mg

CAPS.

504
YENTREVE 20mg

N06AX21

DULOXETINUM **
CAPS. GASTROREZ.
20 mg 20mg 30mg 30mg 30mg ELI LILLY NEDERLAND BV

Protocol: N014F
20 mg 20mg 30mg

N06AX21 DULOXETINUM N06AX21 DULOXETINUM


ARICLAIM 20mg

CAPS. GASTROREZ.
ELI LILLY NEDERLAND BV

N06AX21 DULOXETINUM
ARICLAIM 30mg CYMBALTA 30mg XERISTAR 30mg

CAPS. GASTROREZ.
ELI LILLY NEDERLAND BV ELI LILLY NEDERLAND BV BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Prescriere limitata:
YENTREVE 40mg

Tulburari depresive majore

N06AX21 DULOXETINUM
40 mg 40mg 60mg 60mg 60mg

CAPS. GASTROREZ.
ELI LILLY NEDERLAND BV

40 mg 40mg 60mg

N06AX21 DULOXETINUM
ARICLAIM 40mg

CAPS. GASTROREZ.
ELI LILLY NEDERLAND BV

N06AX21 DULOXETINUM
ARICLAIM 60mg CYMBALTA 60mg XERISTAR 60mg

CAPS. GASTROREZ.
ELI LILLY NEDERLAND BV ELI LILLY NEDERLAND BV BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Prescriere limitata:

Tulburari depresive majore

114 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G16 DEMENTE (DEGENERATIVE, VASCULARE, MIXTE). 505 N06DA02 DONEPEZILUM ***
N06DA02 DONEPEZILUM
ARICEPT 10 mg DONEPEZIL SYNTHON 10 mg DONESYN 10 mg YASNAL 10 mg 10mg 10mg 10mg 10mg 10mg 5mg 5mg 5mg 5mg 5mg

Protocol: N020G
10mg

COMPR. FILM.
PFIZER EUROPE MA EEIG SYNTHON B.V. SYNTHON B.V. KRKA D.D. NOVO MESTO

N06DA02 DONEPEZILUM
ARICEPT EVESS

COMPR. ORODISPERSABILE
PFIZER EUROPE MA EEIG

10mg 5mg

N06DA02 DONEPEZILUM
ARICEPT 5 mg DONEPEZIL SYNTHON 5mg DONESYN 5 mg YASNAL 5 mg

COMPR. FILM.
PFIZER EUROPE MA EEIG SYNTHON B.V. SYNTHON B.V. KRKA D.D. NOVO MESTO

N06DA02 DONEPEZILUM
ARICEPT EVESS

COMPR. ORODISPERSABILE
PFIZER EUROPE MA EEIG

5mg

506
PROMETAX 1,5mg

N06DA03

RIVASTIGMINUM ***
CAPS.
1,5mg NOVARTIS EUROPHARM LTD.

Protocol: N021G
1,5mg 1.5mg
NOVARTIS EUROPHARM LTD.

N06DA03 RIVASTIGMINUM N06DA03 RIVASTIGMINUM


EXELON 1.5mg 1.5mg

CAPS. SOL. ORALA


2mg/ml 2mg/ml 2mg/ml 2mg/ml NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

N06DA03 RIVASTIGMINUM
EXELON 2mg/ml PROMETAX 2mg/ml

2mg/ml

N06DA03 RIVASTIGMINUM
EXELON 2mg/ml PROMETAX 2mg/ml

SOL. ORALA
NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

2mg/ml

N06DA03 RIVASTIGMINUM
EXELON 3mg PROMETAX 3mg 3mg 3mg

CAPS.
NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

3mg

N06DA03 RIVASTIGMINUM
PROMETAX 4,5mg 4,5mg

CAPS.
NOVARTIS EUROPHARM LTD.

4,5mg 4,6mg/24ore 4.5mg


NOVARTIS EUROPHARM LTD.

N06DA03 RIVASTIGMINUM
PROMETAX 4,6mg/24ore

PLASTURE TRANSDERMIC
4,6mg/24ore NOVARTIS EUROPHARM LTD.

N06DA03 RIVASTIGMINUM
EXELON 4.5mg 4.5mg

CAPS. PLASTURE TRANSDERMIC


4.6mg/24h NOVARTIS EUROPHARM LTD.

N06DA03 RIVASTIGMINUM
EXELON 4.6mg/24h

4.6mg/24h 6mg

N06DA03 RIVASTIGMINUM
EXELON 6mg PROMETAX 6mg 6mg 6mg

CAPS.
NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

N06DA03 RIVASTIGMINUM
PROMETAX 9,5mg/24ore

PLASTURE TRANSDERMIC
9,5mg/24ore 9.5mg/24h NOVARTIS EUROPHARM LTD.

9,5mg/24ore 9.5mg/24h

N06DA03 RIVASTIGMINUM
EXELON 9.5mg/24h

PLASTURE TRANSDERMIC
NOVARTIS EUROPHARM LTD.

507
REMINYL 12 mg

N06DA04

GALANTAMINUM ***
COMPR. FILM.
12mg 16mg 24mg 4mg 4mg/ml 8 + 16mg 8mg 8mg JANSSEN-PHARMACEUTICA NV

Protocol: N022G
12mg 16mg 24mg 4mg 4mg/ml 8 + 16mg 8mg 8mg

N06DA04 GALANTAMINUM N06DA04 GALANTAMINUM


REMINYL 16 mg

CAPS. ELIB. PREL.


JANSSEN PHARMACEUTICA NV

N06DA04 GALANTAMINUM
REMINYL 24 mg

CAPS. ELIB. PREL.


JANSSEN PHARMACEUTICA NV

N06DA04 GALANTAMINUM
REMINYL 4 mg

COMPR. FILM.
JANSSEN-PHARMACEUTICA NV

N06DA04 GALANTAMINUM
REMINYL 4 mg/ml

SOL. ORALA
JANSSEN-PHARMACEUTICA NV JANSSEN PHARMACEUTICA NV JANSSEN PHARMACEUTICA NV

N06DA04 GALANTAMINUM
REMINYL 8+16 mg

CAPS. ELIB. PREL. CAPS. ELIB. PREL. COMPR. FILM.


JANSSEN-PHARMACEUTICA NV

N06DA04 GALANTAMINUM
REMINYL 8 mg

N06DA04 GALANTAMINUM
REMINYL 8 mg

508
AXURA 10mg EBIXA 10 mg

N06DX01

MEMANTINUM ***
COMPR. FILM.
10mg 10mg 10mg/g 10mg/g MERZ PHARMACEUTICALS GMBH H. LUNDBECK A/S

Protocol: N001F
10mg

N06DX01 MEMANTINUM

N06DX01 MEMANTINUM
EBIXA 10 mg/g

PIC. ORALE, SOL.


H. LUNDBECK A/S

10mg/g 10mg/g

N06DX01 MEMANTINUM
AXURA 10mg/g

SOL. ORALA IN PICATURI


MERZ PHARMACEUTICALS GMBH

115 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G17 COLAGENOZE MAJORE (LUPUS ERITEMATOS SISTEMIC, SCLERODERMIE, POLI/DERMATOMIOZITA, VASCULITE SISTEMICE). 509 H02AB04 METHYLPREDNISOLONUM (5)
H02AB04 METHYLPREDNISOLONUM
MEDROL A 16 16mg

COMPR.
PFIZER EUROPE MA EEIG

16mg 32mg
PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 32 32mg

COMPR. COMPR.
4mg PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg

4mg

510
ENDOXAN 1 g

L01AA01

CYCLOPHOSPHAMIDUM *
PULB. PT. SOL. INJ./PERF.
1g 1g 200mg 200mg 500mg 500mg BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM L01AA01 CYCLOPHOSPHAMIDUM


ENDOXAN 1 g

1g 1g 200mg 200mg 500mg 500mg 50mg

PULB. PT. SOL. PERF./INJ. I.V.


ACTAVIS S.R.L.

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 200 mg

PULB. PT. SOL. INJ./PERF.


BAXTER ONCOLOGY GMBH ACTAVIS S.R.L. BAXTER ONCOLOGY GMBH ACTAVIS S.R.L. BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 200 mg

PULB. PT. SOL. PERF./INJ. I.V. PULB. PT. SOL. INJ./PERF. PULB. PT. SOL. PERF./INJ. I.V. DRAJ.
50mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 50 mg

511
IMURAN

L04AX01

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

L04AX01 AZATHIOPRINUM

50mg

512
PLAQUENIL

P01BA02

HYDROXYCHLOROQUINUM
COMPR. FILM.
200mg SANOFI-SYNTHELABO LTD.

P01BA02 HYDROXYCHLOROQUINUM

200mg

116 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G18 POLIARTRITA REUMATOIDA, ARTROPATIA PSORIAZICA, SI ARTRITA JUVENILA. 513 A07EC01 SULFASALAZINUM
A07EC01 SULFASALAZINUM
SALAZIDIN

COMPR. FILM.
500mg 500mg 500mg AC HELCOR SRL

500mg 500mg

A07EC01 SULFASALAZINUM
SALAZOPYRIN EN SULFASALAZIN EN

COMPR. FILM. GASTROREZ.


PFIZER EUROPE MA EEIG KRKA D.D. NOVO MESTO

514
DIPROPHOS

H02AB01

BETAMETHASONUM
SUSP. INJ. I.M.
7mg/ml SCHERING PLOUGH EUROPE

H02AB01 BETAMETHASONUM

7mg/ml

515
MEDROL A 16

H02AB04

METHYLPREDNISOLONUM (5)
COMPR.
16mg PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM H02AB04 METHYLPREDNISOLONUM


MEDROL 32 32mg

16mg 32mg
PFIZER EUROPE MA EEIG

COMPR. COMPR.
4mg PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg

4mg

517

L04AA01

CICLOSPORINUM *
CAPS. MOI
100mg 100mg 100mg HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 100 mg EQUORAL 100 mg IMUSPORIN 100 mg

100mg

Prescriere limitata:

Terapie de mentinere ulterioara initierii si stabilizarii tratamentului cu ciclosporina, la pacientii cu poliartrita reumatoida severa pentru care agentii antireumatici clasici cu actiune lenta (inclusiv methotrexat) sunt ineficienti sau inadecvati. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL EQUORAL SANDIMMUN NEORAL

SOL. ORALA
100mg/ml 100mg/ml 100mg/ml HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

100mg/ml

Prescriere limitata:

Terapie de mentinere ulterioara initierii si stabilizarii tratamentului cu ciclosporina, la pacientii cu poliartrita reumatoida severa pentru care agentii antireumatici clasici cu actiune lenta (inclusiv methotrexat) sunt ineficienti sau inadecvati. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 25 mg EQUORAL 25 mg IMUSPORIN 25 mg SANDIMMUN NEORAL 25mg 25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

25mg

Prescriere limitata:

Terapie de mentinere ulterioara initierii si stabilizarii tratamentului cu ciclosporina, la pacientii cu poliartrita reumatoida severa pentru care agentii antireumatici clasici cu actiune lenta (inclusiv methotrexat) sunt ineficienti sau inadecvati. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 50 mg EQUORAL 50 mg IMUSPORIN 50 mg SANDIMMUN NEORAL 50mg 50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

50mg

Prescriere limitata:

Terapie de mentinere ulterioara initierii si stabilizarii tratamentului cu ciclosporina, la pacientii cu poliartrita reumatoida severa pentru care agentii antireumatici clasici cu actiune lenta (inclusiv methotrexat) sunt ineficienti sau inadecvati. Monitorizarea atent a pacienilor este obligatorie

518
ARAVA 100mg

L04AA13
Cod restrictie 2643:

LEFLUNOMIDUM **
COMPR. FILM.
100mg SANOFI- AVENTIS DEUTSCHLAND GMBH

L04AA13 LEFLUNOMIDUM

100mg

Tratamentul iniial al poliartritei reumatoide active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente i/sau inadecvate. Cod restrictie 2681: Tratamentul iniial al artritei psoriazice active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente i/sau inadecvate. Leflunomide este un medicament care nu trebuie administrat la gravide. Sarcina trebuie evitat timp de doi ani dup ntreruperea tratamentului.

L04AA13 LEFLUNOMIDUM
ARAVA 10mg 10mg

COMPR. FILM.
SANOFI- AVENTIS DEUTSCHLAND GMBH

10mg

Cod restrictie 2644:

Tratamentul iniial al poliartritei reumatoide active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente i/sau inadecvate. Cod restrictie 2682: Tratamentul iniial al artritei psoriazice active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente i/sau inadecvate. Leflunomide este un medicament care nu trebuie administrat la gravide. Sarcina trebuie evitat timp de doi ani dup ntreruperea tratamentului.

L04AA13 LEFLUNOMIDUM
ARAVA 20mg 20mg

COMPR. FILM.
SANOFI- AVENTIS DEUTSCHLAND GMBH

20mg

Cod restrictie 2644:

Tratamentul iniial al poliartritei reumatoide active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente i/sau inadecvate. Cod restrictie 2682: Tratamentul iniial al artritei psoriazice active severe in conditiile in care alte medicamente remisive standard (inclusiv methotrexat) sunt ineficiente i/sau inadecvate. Leflunomide este un medicament care nu trebuie administrat la gravide. Sarcina trebuie evitat timp de doi ani dup ntreruperea tratamentului.

519
IMURAN

L04AX01

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

L04AX01 AZATHIOPRINUM

50mg

520
DICLOTARD 100 mg REFEN RETARD VOLTAREN RETARD

M01AB05

DICLOFENACUM
COMPR. FILM. ELIB. PREL.
100mg 100mg 100mg TERAPIA SA HEMOFARM S.R.L. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM

100mg

M01AB05 DICLOFENACUM
CLAFEN 100 mg

SUPOZ.
100mg ANTIBIOTICE SA

100mg

117 / 233

DCI/DENUMIRE COMERCIALA
DICLOFENAC 100 mg DICLOFENAC SODIC 100 mg DICLOGESIC 100 SUPOZITOARE EPIFENAC VOLTAREN

CONCENTRATIE
100mg 100mg 100mg 100mg 100mg 12.5mg

FORMA FARM.
SINTOFARM SA MAGISTRA C & C DAR AL DAWA PHARMA SRL E.I.P.I.CO. MED S.R.L. NOVARTIS PHARMA GMBH

FIRMA

PROTOCOL

M01AB05 DICLOFENACUM
VOLTAREN DOLO

COMPR. FILM.
NOVARTIS CONSUMER HEALTH GMBH

12.5mg 12.5mg

M01AB05 DICLOFENACUM
DICLOGESIC 12,5 SUPOZITOARE

SUPOZ.
12.5mg DAR AL DAWA PHARMA S.R.L

M01AB05 DICLOFENACUM
TRATUL 120

SUPOZ.
120mg 150mg 25mg 25mg GEROT PHARMAZEUTIKA GMBH

120mg 150mg 25mg

M01AB05 DICLOFENACUM
DICLOREUM 150 mg

CAPS. ELIB. PREL.


ALFA WASSERMANN SPA FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
RHEUMAVEK VOLTAREN 25

COMPR. FILM. GASTROREZ.

Prescriere limitata: Prescriere limitata:


EPIFENAC

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
25mg

COMPR. GASTROREZ.
E.I.P.I.CO. MED S.R.L.

25mg

Prescriere limitata: Prescriere limitata:


DICLOFENAC 25 mg

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
25mg

DRAJ. GASTROREZ.
ARENA GROUP SA

25mg

Prescriere limitata: Prescriere limitata:


REFEN RHEUMAVEK VOLTAREN

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM

SOL. INJ.
25mg/ml 25mg/ml 25mg/ml HEMOFARM S.R.L. FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

25mg/ml

M01AB05 DICLOFENACUM
TRATUL

SOL. INJ.
30mg/ml 50mg GEROT PHARMAZEUTIKA GMBH

30mg/ml 50mg

M01AB05 DICLOFENACUM
TRATUL 50

CAPS. GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

Prescriere limitata: Prescriere limitata:


CLAFEN 50 mg DICLOFENAC 50 mg

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
50mg 50mg 50mg 50mg

COMPR. FILM. GASTROREZ.


ANTIBIOTICE SA AC HELCOR PHARMA SRL DAR AL DAWA PHARMA S.R.L NOVARTIS PHARMA GMBH

50mg

DICLOGESIC 50 COMPRIMATE FILMATE GASTROREZISTENTE VOLTAREN 50

Prescriere limitata: Prescriere limitata:


VOLTAREN RAPID

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
50mg

DRAJ.
NOVARTIS PHARMA GMBH

50mg

Prescriere limitata: Prescriere limitata:


DICLOFENAC 50 mg N - DICLOFENAC

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
50mg 50mg

DRAJ. GASTROREZ.
ARENA GROUP SA MEDUMAN SA

50mg

Prescriere limitata: Prescriere limitata:


VOLTAREN

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
50mg

SUPOZ.
NOVARTIS PHARMA GMBH

50mg 60mg
GEROT PHARMAZEUTIKA GMBH

M01AB05 DICLOFENACUM
TRATUL 60 60mg 75mg 75mg

SUPOZ. CAPS. ELIB. PREL.


BRISTOL-MYERS SQUIBB KFT.

M01AB05 DICLOFENACUM
DICLOFENAC DUO BMS 75 mg

75mg 75mg 75mg

M01AB05 DICLOFENACUM
DICLAC 75 ID

COMPR. ELIB. MODIF.


HEXAL AG

M01AB05 DICLOFENACUM
DICLAC VURDON 75mg 75mg

SOL. INJ.
HEXAL AG HELP S.A. PHARMACEUTICALS

M01AB05 DICLOFENACUM
ALMIRAL DICLOFENAC 75 mg DICLOFENAC AL I.M.

SOL. INJ.
75mg/3ml 75mg/3ml 75mg/3ml MEDOCHEMIE LTD. TERAPIA SA ALIUD PHARMA GMBH & CO.KG

75mg/3ml

521
PLAQUENIL

P01BA02

HYDROXYCHLOROQUINUM
COMPR. FILM.
200mg SANOFI-SYNTHELABO LTD.

P01BA02 HYDROXYCHLOROQUINUM

200mg

118 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G19 SPONDILITA ANKILOZANTA. 522 A07EC01 SULFASALAZINUM


A07EC01 SULFASALAZINUM
SALAZIDIN

COMPR. FILM.
500mg 500mg 500mg AC HELCOR SRL

500mg 500mg

A07EC01 SULFASALAZINUM
SALAZOPYRIN EN SULFASALAZIN EN

COMPR. FILM. GASTROREZ.


PFIZER EUROPE MA EEIG KRKA D.D. NOVO MESTO

523
DIPROPHOS

H02AB01

BETAMETHASONUM
SUSP. INJ. I.M.
7mg/ml SCHERING PLOUGH EUROPE

H02AB01 BETAMETHASONUM

7mg/ml

524
DICLOTARD 100 mg REFEN RETARD VOLTAREN RETARD

M01AB05

DICLOFENACUM
COMPR. FILM. ELIB. PREL.
100mg 100mg 100mg TERAPIA SA HEMOFARM S.R.L. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM

100mg

M01AB05 DICLOFENACUM
CLAFEN 100 mg DICLOFENAC 100 mg DICLOFENAC SODIC 100 mg DICLOGESIC 100 SUPOZITOARE EPIFENAC VOLTAREN

SUPOZ.
100mg 100mg 100mg 100mg 100mg 100mg 12.5mg ANTIBIOTICE SA SINTOFARM SA MAGISTRA C & C DAR AL DAWA PHARMA SRL E.I.P.I.CO. MED S.R.L. NOVARTIS PHARMA GMBH

100mg

M01AB05 DICLOFENACUM
VOLTAREN DOLO

COMPR. FILM.
NOVARTIS CONSUMER HEALTH GMBH

12.5mg 12.5mg

M01AB05 DICLOFENACUM
DICLOGESIC 12,5 SUPOZITOARE

SUPOZ.
12.5mg DAR AL DAWA PHARMA S.R.L

M01AB05 DICLOFENACUM
TRATUL 120

SUPOZ.
120mg 150mg 25mg 25mg GEROT PHARMAZEUTIKA GMBH

120mg 150mg 25mg

M01AB05 DICLOFENACUM
DICLOREUM 150 mg

CAPS. ELIB. PREL.


ALFA WASSERMANN SPA FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

M01AB05 DICLOFENACUM
RHEUMAVEK VOLTAREN 25

COMPR. FILM. GASTROREZ.

Prescriere limitata: Prescriere limitata:


EPIFENAC

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
25mg

COMPR. GASTROREZ.
E.I.P.I.CO. MED S.R.L.

25mg

Prescriere limitata: Prescriere limitata:


DICLOFENAC 25 mg

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
25mg

DRAJ. GASTROREZ.
ARENA GROUP SA

25mg

Prescriere limitata: Prescriere limitata:


REFEN RHEUMAVEK VOLTAREN

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM

SOL. INJ.
25mg/ml 25mg/ml 25mg/ml HEMOFARM S.R.L. FARAN LABORATORIES S.A. NOVARTIS PHARMA GMBH

25mg/ml

M01AB05 DICLOFENACUM
TRATUL

SOL. INJ.
30mg/ml 50mg GEROT PHARMAZEUTIKA GMBH

30mg/ml 50mg

M01AB05 DICLOFENACUM
TRATUL 50

CAPS. GASTROREZ.
GEROT PHARMAZEUTIKA GMBH

Prescriere limitata: Prescriere limitata:


CLAFEN 50 mg DICLOFENAC 50 mg

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
50mg 50mg 50mg 50mg

COMPR. FILM. GASTROREZ.


ANTIBIOTICE SA TERAPIA SA DAR AL DAWA PHARMA S.R.L NOVARTIS PHARMA GMBH

50mg

DICLOGESIC 50 COMPRIMATE FILMATE GASTROREZISTENTE VOLTAREN 50

Prescriere limitata: Prescriere limitata:


VOLTAREN RAPID

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
50mg

DRAJ.
NOVARTIS PHARMA GMBH

50mg

Prescriere limitata: Prescriere limitata:


DICLOFENAC 50 mg N - DICLOFENAC

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
50mg 50mg

DRAJ. GASTROREZ.
ARENA GROUP SA MEDUMAN SA

50mg

Prescriere limitata: Prescriere limitata:


VOLTAREN

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AB05 DICLOFENACUM
50mg

SUPOZ.
NOVARTIS PHARMA GMBH

50mg 60mg
GEROT PHARMAZEUTIKA GMBH

M01AB05 DICLOFENACUM
TRATUL 60 60mg 75mg 75mg

SUPOZ. CAPS. ELIB. PREL.


BRISTOL-MYERS SQUIBB KFT.

M01AB05 DICLOFENACUM
DICLOFENAC DUO BMS 75 mg

75mg 75mg 75mg

M01AB05 DICLOFENACUM
DICLAC 75 ID

COMPR. ELIB. MODIF.


HEXAL AG

M01AB05 DICLOFENACUM
DICLAC VURDON 75mg 75mg

SOL. INJ.
HEXAL AG HELP S.A. PHARMACEUTICALS

119 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
MEDOCHEMIE LTD. TERAPIA SA ALIUD PHARMA GMBH & CO.KG

FIRMA

PROTOCOL

M01AB05 DICLOFENACUM
ALMIRAL DICLOFENAC 75 mg DICLOFENAC AL I.M.

SOL. INJ.
75mg/3ml 75mg/3ml 75mg/3ml

75mg/3ml

120 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G22 BOLI ENDOCRINE (GUSA ENDEMICA, INSUFICIENTA SUPRARENALA CRONICA, DIABETUL INSIPID, MIXEDEMUL ADULTULUI, TUMORI HIPOFIZARE CU EXPANSIUNE SUPRASELARA SI TUMORI NEUROENDOCRINE). 525 G02CB03 CABERGOLINUM **
G02CB03 CABERGOLINUM
DOSTINEX 0.5mg

Protocol: G001C

COMPR.
PFIZER EUROPE MA EEG

0.5mg 0.5mg
PFIZER EUROPE MA EEG

G02CB03 CABERGOLINUM
DOSTINEX 0.5mg

COMPR.

Prescriere limitata: Prevenirea aparitiei lactatiei in lauzie din motive medicale Cod restrictie 2659: Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicala Cod restrictie 2660: Hiperprolactinemia patologica pentru care a fost utilizat tratament chirurgical dar cu rezultate incomplete Cod restrictie 2661: Hiperprolactinemia patologica pentru care radioterapia este contraindicata Cod restrictie 2662: Hiperprolactinemia patologica pentru care a fost utilizata radioterapia, dar cu rezultate incomplete

526
SOMAVERT 10 mg

H01AX01

PEGVISOMANTUM ****
LIOF. + SOLV. PT. SOL. INJ.
10mg 15mg 20mg PFIZER LTD.

H01AX01 PEGVISOMANTUM H01AX01 PEGVISOMANTUM


SOMAVERT 15 mg

10mg 15mg 20mg

LIOF. + SOLV. PT. SOL. INJ.


PFIZER LTD.

H01AX01 PEGVISOMANTUM
SOMAVERT 20 mg

LIOF. + SOLV. PT. SOL. INJ.


PFIZER LTD.

527

H01BA02
Cod restrictie 1678: Diabet insipid.

DESMOPRESSINUM
SPRAY NAZAL - SOL.
0,1mg/ml FERRING AB

H01BA02 DESMOPRESSINUM
MINIRIN SPRAY NAZAL

0,1mg/ml

H01BA02 DESMOPRESSINUM
MINIRIN 0,1 mg 0.1mg

COMPR.
FERRING AB

0.1mg 0.2mg
FERRING AB

H01BA02 DESMOPRESSINUM
MINIRIN 0,2 mg 0.2mg

COMPR.

Cod restrictie 1678:


MINIRIN MELT 120 g

Diabet insipid.

H01BA02 DESMOPRESSINUM
120g

LIOF. ORAL
ALTANA PHARMA S.R.L.

120g 240g
ALTANA PHARMA SRL

H01BA02 DESMOPRESSINUM
MINIRIN MELT 240 g 240g

LIOF. ORAL LIOF. ORAL


60g 0,1mg/ml 0.2mg ALTANA PHARMA S.R.L. FERRING AB FERRING AB

H01BA02 DESMOPRESSINUM
MINIRIN MELT 60 g

60g

H01BA02 DESMOPRESSINUM
MINIRIN SPRAY NAZAL

H01BA02 DESMOPRESSINUM
MINIRIN 0,2 mg

528
SANDOSTATIN

H01CB02

OCTREOTIDUM ****
COMPR.
0.1mg/ml NOVARTIS PHARMA GMBH

Protocol: H008E
100mg 10mg

H01CB02 OCTREOTIDUM H01CB02 OCTREOTIDUM


SANDOSTATIN LAR 10 mg 10mg

PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB. PRELUNG.


NOVARTIS PHARMA GMBH

H01CB02 OCTREOTIDUM
SANDOSTATIN LAR 20 mg 20mg

PULB. + SOLV. PT. SUSP. INJ. (I.M.) CU ELIB. PRELU


NOVARTIS PHARMA GMBH

20mg

H01CB02 OCTREOTIDUM
SANDOSTATIN LAR 30 mg 30mg

PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB. PRELUNG.


NOVARTIS PHARMA GMBH

30mg

529

H01CB03

LANREOTIDUM ****
SOL. INJ. CU ELIB. PREL.
120mg 30mg 60mg 90mg BEAUFOUR IPSEN PHARMA

Protocol: H005E;H006C
120mg 30mg 60mg 90mg

H01CB03 LANREOTIDUM
SOMATULINE AUTOGEL 120 mg

H01CB03 LANREOTIDUM
SOMATULINE PR 30 mg

LIOF. PT. SOL. INJ. + SOLV.


BEAUFOUR IPSEN PHARMA

H01CB03 LANREOTIDUM
SOMATULINE AUTOGEL 60 mg

SOL. INJ. CU ELIB. PREL.


BEAUFOUR IPSEN PHARMA

H01CB03 LANREOTIDUM
SOMATULINE AUTOGEL 90 mg

SOL. INJ. CU ELIB. PREL.


BEAUFOUR IPSEN PHARMA

530
ASTONIN H

H02AA02

FLUDROCORTISONUM
COMPR.
0.1mg MERCK KGAA

H02AA02 FLUDROCORTISONUM

0.1mg

531
DECORTIN H 20 mg

H02AB06

PREDNISOLONUM
COMPR.
20 mg 250mg MERCK KGAA

H02AB06 PREDNISOLONUM H02AB06 PREDNISOLONUM


SOLU - DECORTIN H 250

20 mg 250mg 5 mg
MERCK KGAA

LIOF. + SOLV. PT. SOL. INJ.


MERCK KGAA

H02AB06 PREDNISOLONUM
DECORTIN H 5 mg 5 mg 50mg

COMPR. LIOF. + SOLV. PT. SOL. INJ.


MERCK KGAA

H02AB06 PREDNISOLONUM
SOLU - DECORTIN H 50

50mg

532

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

5mg

121 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

533

H02AB09

HYDROCORTISONUM
LIOF. + SOLV. PT. SOL. INJ.
100mg 100mg 25mg/5ml 500mg HEMOFARM S.R.L. E.I.P.I.CO. MED S.R.L.

H02AB09 HYDROCORTISONUM
HYDROCORTISONE 100 mg HYDROCORTISONE SUCCINAT SODIC

100mg

H02AB09 HYDROCORTISONUM
HIDROCORTIZON HEMISUCCINAT

SOL. INJ. I.V.


ZENTIVA S.A.

25mg/5ml 500mg

H02AB09 HYDROCORTISONUM
HYDROCORTISONE 500 mg

LIOF. PT. SOL. INJ. + SOLV.


HEMOFARM S.R.L.

534
THYRO - 4 0,1 mg

H03AA01

LEVOTHYROXINUM
COMPR.
0.1mg FARAN LABORATORIES S.A.

H03AA01 LEVOTHYROXINUM H03AA01 LEVOTHYROXINUM


THYRO - 4 0,2 mg 0.2mg

0.1mg 0.2mg
FARAN LABORATORIES S.A.

COMPR. COMPR.
100g 100g MERCK KGAA BERLIN CHEMIE AG MENARINI GROUP

H03AA01 LEVOTHYROXINUM
EUTHYROX 100 L-THYROXIN 100 BERLIN - CHEMIE

100g

H03AA01 LEVOTHYROXINUM
EUTHYROX 150 150g

COMPR.
MERCK KGAA

150g 200g
MERCK KGAA

H03AA01 LEVOTHYROXINUM
EUTHYROX 200 200g

COMPR. COMPR.
25g MERCK KGAA

H03AA01 LEVOTHYROXINUM
EUTHYROX 25

25g 50g
MERCK KGAA BERLIN CHEMIE AG MENARINI GROUP

H03AA01 LEVOTHYROXINUM
EUTHYROX 50 L-THYROXIN 50 50g 50g

COMPR.

535
JODID 100

H03CA01

KALII IODIDUM
COMPR.
100g MERCK KGAA

H03CA01 KALII IODIDUM H03CA01 KALII IODIDUM


JODID 200 200g

100g 200g
MERCK KGAA

COMPR.

536
BROCRIPTIN

G02CB01
Prescriere limitata: Boala Parkinson

BROMOCRIPTINUM
DRAJ.
2.5mg BIOFARM SA

G02CB01 BROMOCRIPTINUM

2.5mg

G02CB01 BROMOCRIPTINUM
BROCRIPTIN 2.5mg

DRAJ.
BIOFARM SA

2.5mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Hiperprolactinemia patologica pentru care nu este indicata interventia chirurgicala Hiperprolactinemia patologica pentru care tratamentul chirurgical utilizat a dus la rezultate incomplete; Hiperprolactinemia patologica pentru care radioterapia este contraindicata; Hiperprolactinemia patologica pentru care radioterapia a fost utilizata, dar cu rezultate incomplete.

122 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G25 BOALA CRONICA DE RINICHI FAZA PREDIALIZA. 538 A11CC07 PARICALCITOLUM **
A11CC07 PARICALCITOLUM
ZEMPLAR 1g 1g

Protocol: A005E
1g

CAPS. MOI
ABBOTT LABORATORIES S.A.

A11CC07 PARICALCITOLUM
ZEMPLAR 2g 2g

CAPS. MOI
ABBOTT LABORATORIES S.A.

2g 4g
ABBOTT LABORATORIES S.A.

A11CC07 PARICALCITOLUM
ZEMPLAR 4g 4g

CAPS. MOI SOL. INJ.


5 g/ml ABBOTT LABORATORIES S.A.

A11CC07 PARICALCITOLUM
ZEMPLAR

5 g/ml

539

B03AC02

COMPLEX DE HIDROXID DE FER (III) SUCROZA **


SOL. INJ./PERF.
20mg/ml VIFOR FRANCE S.A.

Protocol: A010N
20mg/ml

B03AC02 COMPLEX DE HIDROXID DE FER (III) SUCROZA


VENOFER

Cod restrictie 2070:

Anemie feripriv, la pacieni hemodializai cronic care au prezenta o reacie de hipersensibilitate documentat la fier polimaltozat i la care este indicat administrarea continu intravenoas.

540
EPREX 10000 UI

B03XA01

EPOETINUM ALFA **
SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

Protocol: B010N
10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA


EPOKINE 1000 UI/0,5 ml EPREX 1000 UI

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml 1000UI/ml 20000UI/ml

B03XA01 EPOETINUM ALFA


NEORECORMON 500UI

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD.

1000UI/ml 20000UI/ml 2000UI

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 2000 U.I.

SOL. INJ.
2000UI

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/0,5 ml EPREX 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

2000ui/0.5ml

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA


EPREX 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA


EPREX 40 000 UI

SOL. INJ.
40 000UI JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 4000 U.I.

SOL. INJ.
4000UI

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/0,4 ml EPREX 4000 UI

SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

4000ui/0.4ml

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 50000UI/ml 10000UI/1,0ml 10000UI/1,0ml 10000UI/1,0ml 1000UI/0,5ml 1000UI/0,5ml 1000UI/0,5ml 2000UI/1,0ml 2000UI/1,0ml 2000UI/1,0ml 3000UI/0,3ml 3000UI/0,3ml 3000UI/0,3ml 4000UI/0,4ml 4000UI/0,4ml 4000UI/0,4ml 5000UI/0,5ml 5000UI/0,5ml 5000UI/0,5ml 6000UI/0,6ml 6000UI/0,6ml 6000UI/0,6ml 8000UI/0,8ml 8000UI/0,8ml 8000UI/0,8ml RENAMED FARMA S.R.L.

4000UI/1ml 50000UI/ml 10000UI/1,0ml

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

B03XA01 EPOETINUM ALFA


ABSEAMED 10000UI/1,0ml BINOCRIT 10000UI/1,0ml EPOETIN ALFA HEXAL 10000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA


ABSEAMED 1000UI/0,5ml BINOCRIT 1000UI/0,5ml EPOETIN ALFA HEXAL 1000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

1000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 2000UI/1,0ml BINOCRIT 2000UI/1,0ml EPOETIN ALFA HEXAL 2000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

2000UI/1,0ml

B03XA01 EPOETINUM ALFA


ABSEAMED 3000UI/0,3ml BINOCRIT 3000UI/0,3ml EPOETIN ALFA HEXAL 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

3000UI/0,3ml

B03XA01 EPOETINUM ALFA


ABSEAMED 4000UI/0,4ml BINOCRIT 4000UI/0,4ml EPOETIN ALFA HEXAL 4000UI/0,4ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

4000UI/0,4ml

B03XA01 EPOETINUM ALFA


ABSEAMED 5000UI/0,5ml BINOCRIT 5000UI/0,5ml EPOETIN ALFA HEXAL 5000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

5000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 6000UI/0,6ml BINOCRIT 6000UI/0,6ml EPOETIN ALFA HEXAL 6000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

6000UI/0,6ml

B03XA01 EPOETINUM ALFA


ABSEAMED 8000UI/0,8ml BINOCRIT 8000UI/0,8ml EPOETIN ALFA HEXAL 8000UI/0,8ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

8000UI/0,8ml

541

B03XA01

EPOETINUM BETA **
LIOF. + SOLV. PT. SOL. INJ.
1000UI/ml ROCHE REGISTRATION LTD.

Protocol: B009N
1000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 500UI

123 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

FORMA FARM.
ROCHE REGISTRATION LTD.

FIRMA

PROTOCOL

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ. LIOF. + SOLV. PT. SOL. INJ.
ROCHE REGISTRATION LTD.

20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 50 000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/ml

LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA


NEORECORMON 1000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 2000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 30000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 3000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 4000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 5000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 500UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 60000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 6000UI/0,3ml

542
ARANESP 10g/0.4ml

B03XA02

DARBEPOETINUM ALFA **
SOL. INJ. IN STILOU INJECTOR PREUMPLUT
10g/0.4ml 100g/0.5ml 100g/ml 100g/ml 100g/ml 130g/0.65ml 15g/0.375ml 15g/ml 15g/ml 150g/0.3ml 20g/0.5ml 200g/ml 200g/ml 200g/ml 200g/ml 25g/ml 25g/ml 25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40g/ml 40g/ml 40g/ml 50g/0.5ml 500g/ml 500g/ml 500g/ml 500g/ml AMGEN EUROPE BV

Protocol: B011N
10g/0.4ml 100g/0.5ml 100g/ml

B03XA02 DARBEPOETINUM ALFA B03XA02 DARBEPOETINUM ALFA


ARANESP 100g/0.5ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


NESPO 30g NESPO 40g NESPO 50g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

B03XA02 DARBEPOETINUM ALFA


ARANESP 130g/0.65ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

130g/0.65ml 15g/0.375ml 15g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/0.375ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/ml NESPO 15g

SOL. INJ. IN FLACON

B03XA02 DARBEPOETINUM ALFA


ARANESP 150g/0.3ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

150g/0.3ml 20g/0.5ml 200g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 20g/0.5ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE DOMPE DOMPE DOMPE BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


NESPO 100g NESPO 130g NESPO 60g NESPO 80g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

B03XA02 DARBEPOETINUM ALFA


ARANESP 25g/ml NESPO 25g

SOL. INJ. IN FLACON


AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

25g/ml

B03XA02 DARBEPOETINUM ALFA


NESPO 10g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


DOMPE BIOTEC S.P.A.

25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 30g/0.3ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 300g/0.6ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT SOL. INJ. IN STILOU INJECTOR PREUMPLUT SOL. INJ. IN FLACON

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/0.4ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/ml NESPO 40g

B03XA02 DARBEPOETINUM ALFA


NESPO 15g NESPO 20g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

40g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 50g/0.5ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

50g/0.5ml 500g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 500g/ml NESPO 150g NESPO 300g NESPO 500g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

60g/0.3ml

124 / 233

DCI/DENUMIRE COMERCIALA
ARANESP 60g/0.3ml

CONCENTRATIE
60g/0.3ml 60g/ml 60g/ml 80g/0.4ml 10g/0.4ml 100g/0.5ml 100g/ml 100g/ml 100g/ml 130g/0.65ml 15g/0.375ml 150g/0.3ml 20g/0.5ml 200g/ml 200g/ml 200g/ml 200g/ml 25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40gml 50g/0.5ml 500g 500g/ml 500g/ml 500g/ml 60g/0.3ml 80g/0.4ml

FORMA FARM.
AMGEN EUROPE BV

FIRMA

PROTOCOL

B03XA02 DARBEPOETINUM ALFA


ARANESP 60g/ml NESPO 60g

SOL. INJ. IN FLACON


AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

60g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 80g/0.4ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

80g/0.4ml 10g/0.4ml 100g/0.5ml 100g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 10g/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 100g/0.5ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA02 DARBEPOETINUM ALFA


NESPO 30g NESPO 40g NESPO 50g

B03XA02 DARBEPOETINUM ALFA


ARANESP 130g/0.65ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

130g/0.65ml 15g/0.375ml 150g/0.3ml 20g/0.5ml 200g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/0.375ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV DOMPE DOMPE DOMPE DOMPE BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 150g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA02 DARBEPOETINUM ALFA


ARANESP 20g/0.5ml

B03XA02 DARBEPOETINUM ALFA


NESPO 100g NESPO 130g NESPO 60g NESPO 80g

B03XA02 DARBEPOETINUM ALFA


NESPO 10g

SOL. INJ. IN SERINGA PREUMPLUTA


DOMPE BIOTEC S.P.A.

25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40gml 50g/0.5ml 500g 500g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 30g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 300g/0.6ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/0.4ml

B03XA02 DARBEPOETINUM ALFA


NESPO 15g

B03XA02 DARBEPOETINUM ALFA


NESPO 20g

B03XA02 DARBEPOETINUM ALFA


ARANESP 50g/0.5ml

B03XA02 DARBEPOETINUM ALFA


NESPO 150g

B03XA02 DARBEPOETINUM ALFA


ARANESP 500g/ml NESPO 300g NESPO 500g

B03XA02 DARBEPOETINUM ALFA


ARANESP 60g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

60g/0.3ml 80g/0.4ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 80g/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

544

C09CA04

IRBESARTANUM **
COMPR.
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

Protocol: C008N
150mg

C09CA04 IRBESARTANUM
APROVEL 150mg IRBESARTAN BMS 150mg IRBESARTAN WINTHROP 150mg KARVEA 150 mg

C09CA04 IRBESARTANUM
APROVEL 150mg IRBESARTAN BMS 150mg IRBESARTAN WINTHROP 150mg KARVEA 150 mg

COMPR. FILM.
SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

150mg

C09CA04 IRBESARTANUM
APROVEL 300mg IRBESARTAN BMS 300mg IRBESARTAN WINTHROP 300mg KARVEA 300 mg

COMPR.
300mg 300mg 300mg 300mg 300mg 300mg 300mg 300mg SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

300mg

C09CA04 IRBESARTANUM
APROVEL 300mg IRBESARTAN BMS 300mg IRBESARTAN WINTHROP 300mg KARVEA 300 mg

COMPR. FILM.
SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

300mg

C09CA04 IRBESARTANUM
APROVEL 75mg IRBESARTAN BMS 75mg IRBESARTAN WINTHROP 75mg KARVEA 75 mg 75mg 75mg 75mg 75mg 75mg 75mg 75mg 75mg

COMPR.
SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

75mg

C09CA04 IRBESARTANUM
APROVEL 75mg IRBESARTAN BMS 75mg IRBESARTAN WINTHROP 75mg KARVEA 75 mg

COMPR. FILM.
SANOFI PHARMA - BRISTOL MYERS SQUIBB BRISTOL-MYERS SQUIBB PHARMA EEIG SANOFI PHARMA - BRISTOL MYERS SQUIBB SNC BRISTOL-MYERS SQUIBB PHARMA EEIG

75mg

125 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

545

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

Protocol: H002N
5mg

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

546
ENDOXAN 1 g

L01AA01

CYCLOPHOSPHAMIDUM
PULB. PT. SOL. INJ./PERF.
1g 1g 200mg 200mg 500mg 500mg BAXTER ONCOLOGY GMBH

Protocol: L027N
1g 1g 200mg 200mg 500mg 500mg 50mg

L01AA01 CYCLOPHOSPHAMIDUM L01AA01 CYCLOPHOSPHAMIDUM


ENDOXAN 1 g

PULB. PT. SOL. PERF./INJ. I.V.


ACTAVIS S.R.L.

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 200 mg

PULB. PT. SOL. INJ./PERF.


BAXTER ONCOLOGY GMBH ACTAVIS S.R.L. BAXTER ONCOLOGY GMBH ACTAVIS S.R.L. BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 200 mg

PULB. PT. SOL. PERF./INJ. I.V. PULB. PT. SOL. INJ./PERF. PULB. PT. SOL. PERF./INJ. I.V. DRAJ.
50mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 50 mg

547

L04AA01

CICLOSPORINUM *
CAPS. MOI
100mg 100mg 100mg HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED

Protocol: L028N
100mg

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 100 mg EQUORAL 100 mg IMUSPORIN 100 mg

Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL EQUORAL SANDIMMUN NEORAL

SOL. ORALA
100mg/ml 100mg/ml 100mg/ml HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

100mg/ml

Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 25 mg EQUORAL 25 mg IMUSPORIN 25 mg SANDIMMUN NEORAL 25mg 25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

25mg

Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 50 mg EQUORAL 50 mg IMUSPORIN 50 mg SANDIMMUN NEORAL 50mg 50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

50mg

Monitorizarea atent a pacienilor este obligatorie

548
IMURAN

L04AX01

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

Protocol: L029N
50mg

L04AX01 AZATHIOPRINUM

549

V06DDN1

AMINOACIZI INCLUSIV COMBINATII CU POLIPEPTIDE **


COMPR. FILM.
FRESENIUS KABI DEUTSCHLAND GMBH

Protocol: V004N

V06DDN1 AMINOACIZI INCLUSIV COMBINATII CU POLIPEPTIDE


KETOSTERIL

126 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G26 GLAUCOM. 550 S01EC03


S01EC03 DORZOLAMIDUM
TRUSOPT

DORZOLAMIDUM
SOL. OFT.
20mg/ml MERCK SHARP & DOHME S.R.L.

20mg/ml

551
AZOPT 10mg/ml

S01EC04

BRINZOLAMIDUM
PICATURI OFT.-SUSP.
10mg/ml ALCON LABORATORIES LTD.

S01EC04 BRINZOLAMIDUM

10mg/ml

552
TIMO-COMOD TIMOLOL 0,25%

S01ED01

TIMOLOLUM
PICATURI OFT.-SOL.
0.25% 0.25% 0.5% 0.5% 0.5% 0.5% URSAPHARM ARZNEIMITTEL GMBH&CO.KG E.I.P.I.CO. MED S.R.L.

S01ED01 TIMOLOLUM

0.25%

S01ED01 TIMOLOLUM
TIMO-COMOD TIMO-GAL TIMOLOL 0,5% UNITIMOLOL

PICATURI OFT.-SOL.
URSAPHARM ARZNEIMITTEL GMBH&CO.KG TERAPIA SA E.I.P.I.CO. MED S.R.L. UNIMED PHARMA LTD.

0.5%

S01ED01 TIMOLOLUM
NYOLOL GEL 1mg/g

GEL OFT.
NOVARTIS PHARMA GMBH

1mg/g 2.5mg/ml 2.5mg/ml 5mg/ml 5mg/ml 2.5mg/ml 2.5mg/ml 5mg/ml

S01ED01 TIMOLOLUM
TIMOPTIC

PIC. OFT.-SOL.
2.5mg/ml 2.5mg/ml 5mg/ml 5mg/ml 2.5mg/ml 2.5mg/ml 5mg/ml 5mg/ml MERCK SHARP & DOHME ROMANIA S.R.L. CHAUVIN ANKERPHARM GMBH MERCK SHARP & DOHME ROMANIA S.R.L. CHAUVIN ANKERPHARM GMBH ROMPHARM COMPANY SRL LABORATOIRES THEA LABORATORIES THEA ROMPHARM COMPANY SRL

S01ED01 TIMOLOLUM
ARUTIMOL 0,25%

PICATURI OFT.-SOL. PIC. OFT.-SOL. PICATURI OFT.-SOL. PIC. OFT., SOL. PIC. OFT.,SOL. PIC. OFT.,SOL.

S01ED01 TIMOLOLUM
TIMOPTIC

S01ED01 TIMOLOLUM
ARUTIMOL 0,5%

S01ED01 TIMOLOLUM
TIMOLOL RPH 0,25%

S01ED01 TIMOLOLUM
TIMABAK 2,5 mg/ml

S01ED01 TIMOLOLUM
TIMABAK 5 mg/ml TIMOLOL RPH 0,5%

553
BETOPTIC - S

S01ED02

BETAXOLOLUM
PICATURI OFT.-SUSP.
0.25% 0.5% 5mg/ml 5mg/ml 5mg/ml ALCON COUVREUR NV

S01ED02 BETAXOLOLUM S01ED02 BETAXOLOLUM


OPTIPRES

0.25% 0.5% 5mg/ml 5mg/ml 5mg/ml

PICATURI OFT.-SOL.
CIPLA LTD.

S01ED02 BETAXOLOLUM
BETAX

PIC. OFT.-SOL.
ROMPHARM SRL ALCON COUVREUR NV TERAPIA SA

S01ED02 BETAXOLOLUM
BETOPTIC

PIC.OFTALMICE,SOL. PIC. OFT., SOL.

S01ED02 BETAXOLOLUM
BETAXOLOL

554
FORTINOL EP 1%

S01ED05

CARTEOLOLUM
PIC. OFTALMICE CU ELIB. PREL.
10mg/ml 20mg/ml 20mg/ml 2% DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

S01ED05 CARTEOLOLUM S01ED05 CARTEOLOLUM


CARTEOL 2%

10mg/ml 20mg/ml 20mg/ml 2%

PICATURI OFT.-SOL.
S.I.F.I. SPA DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH S.I.F.I. SPA

S01ED05 CARTEOLOLUM
FORTINOL EP 2%

PIC. OFTALMICE CU ELIB. PREL. PICATURI OFT.-SOL.

S01ED05 CARTEOLOLUM
CARTEOL 2%

555

S01ED51

COMBINATII (BIMATOPROSTUM + TIMOLOLUM)


PIC. OFT.-SOL.
40g/ml + 5mg/ml ALCON LABORATORIES (UK) LTD.

S01ED51 COMBINATII (BIMATOPROSTUM + TIMOLOLUM)


DUOTRAV 40g/ml + 5mg/ml

40g/ml + 5mg/ml

S01ED51 COMBINATII (BIMATOPROSTUM + TIMOLOLUM)


GANFORT

PIC. OFT.,SOL.
300g/ml+5mg/ml ALLERGAN PHARMACEUTICALS IRELAND

300g/ml+5mg/ml

556

S01ED51

COMBINATII (DORZOLAMIDUM + TIMOLOLUM)


PIC. OFT.-SOL.
40g/ml + 5mg/ml ALCON LABORATORIES (UK) LTD.

S01ED51 COMBINATII (DORZOLAMIDUM + TIMOLOLUM)


DUOTRAV 40g/ml + 5mg/ml

40g/ml + 5mg/ml

557

S01ED51

COMBINATII (LATANOPROSTUM + TIMOLOLUM)


PIC. OFT.-SOL.
40g/ml + 5mg/ml ALCON LABORATORIES (UK) LTD.

S01ED51 COMBINATII (LATANOPROSTUM + TIMOLOLUM)


DUOTRAV 40g/ml + 5mg/ml

40g/ml + 5mg/ml

558
XALATAN

S01EE01

LATANOPROSTUM
PICATURI OFT.-SOL.
0.005% PFIZER EUROPE MA EEIG

S01EE01 LATANOPROSTUM

5,00%

559
LUMIGAN 0,3mg/ml

S01EE03

BIMATOPROSTUM
PIC. OFT.,SOL.
0,3mg/ml ALLERGAN PHARMACEUTICALS IRELAND

S01EE03 BIMATOPROSTUM

0,3mg/ml

560

S01ED51

COMBINATII (TRAVOPROSTUM + TIMOLOLUM)


PIC. OFT.-SOL.
40g/ml + 5mg/ml ALCON LABORATORIES (UK) LTD.

S01ED51 COMBINATII (TRAVOPROSTUM + TIMOLOLUM)


DUOTRAV 40g/ml + 5mg/ml

40g/ml + 5mg/ml

127 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

561
TRAVATAN 40g/ml

S01EE04

TRAVOPROSTUM
PICATURI OFT.SOL.
40g/ml ALCON LABORATORIES LTD.

S01EE04 TRAVOPROSTUM

40g/ml

SUBLISTA C1-G27 PEMFIGUS. 562 H02AB02


H02AB02 DEXAMETHASONUM
DEXAMETHASONE SODIUM PHOSPHATE

DEXAMETHASONUM
SOL. INJ.
8mg E.I.P.I.CO. MED S.R.L.

8mg 8mg/2ml
MEDOCHEMIE LTD. VIANEX SA

H02AB02 DEXAMETHASONUM
DEXAMED DEXATON 8 mg/2 ml

SOL. INJ.
8mg/2ml 8mg/2ml

564

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

5mg

566
ENDOXAN 1 g

L01AA01

CYCLOPHOSPHAMIDUM
PULB. PT. SOL. INJ./PERF.
1g 1g 200mg 200mg 500mg 500mg BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM L01AA01 CYCLOPHOSPHAMIDUM


ENDOXAN 1 g

1g 1g 200mg 200mg 500mg 500mg 50mg

PULB. PT. SOL. PERF./INJ. I.V.


ACTAVIS S.R.L.

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 200 mg

PULB. PT. SOL. INJ./PERF.


BAXTER ONCOLOGY GMBH ACTAVIS S.R.L. BAXTER ONCOLOGY GMBH ACTAVIS S.R.L. BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 200 mg

PULB. PT. SOL. PERF./INJ. I.V. PULB. PT. SOL. INJ./PERF. PULB. PT. SOL. PERF./INJ. I.V. DRAJ.
50mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 50 mg

567

L01BA01

METHOTREXATUM (4)
CONC. PT. SOL. INJ./PERF.
100mg/ml 100mg/ml 100mg/ml 10mg/ml 10mg/ml EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG

L01BA01 METHOTREXATUM
METHOTREXAT "EBEWE" 1000 mg METHOTREXAT "EBEWE" 500 mg METHOTREXAT "EBEWE" 5000 mg

100mg/ml

L01BA01 METHOTREXATUM
METHOTREXAT "EBEWE" 10 mg METHOTREXAT "EBEWE" 50 mg

SOL. INJ./PERF.
EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG

10mg/ml

L01BA01 METHOTREXATUM
METHOTREXATE TEVA 25mg/ml

SOL. INJ.
25mg/ml 50mg TEVA PHARMACEUTICALS S.R.L.

25mg/ml 50mg 5mg/ml


EBEWE PHARMA GMBH NFG. KG

L01BA01 METHOTREXATUM
ANTIFOLAN 50 mg

PULB. PT. SOL. INJ./PERF.


SINDAN SRL

L01BA01 METHOTREXATUM
METHOTREXAT "EBEWE" 5 mg

SOL. INJ.
5mg/ml

568

L04AA01

CICLOSPORINUM *
CAPS. MOI
100mg 100mg 100mg HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 100 mg EQUORAL 100 mg IMUSPORIN 100 mg

100mg

Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL EQUORAL SANDIMMUN NEORAL

SOL. ORALA
100mg/ml 100mg/ml 100mg/ml HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

100mg/ml

Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 25 mg EQUORAL 25 mg IMUSPORIN 25 mg SANDIMMUN NEORAL 25mg 25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

25mg

Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 50 mg EQUORAL 50 mg IMUSPORIN 50 mg SANDIMMUN NEORAL 50mg 50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

50mg

Monitorizarea atent a pacienilor este obligatorie

569
IMURAN

L04AX01

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

L04AX01 AZATHIOPRINUM

50mg

128 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G29 BOALA GAUCHER. 570 A16AB02 IMIGLUCERASUM ****


A16AB02 IMIGLUCERASUM
CEREZYME 200U 200U 400U

Protocol: A008E
200U 400U
GENZYME EUROPE BV

PULB. PT.CONC. PT.SOL. PERF. PULB. PT.CONC. PT.SOL. PERF.


GENZYME EUROPE BV

A16AB02 IMIGLUCERASUM
CEREZYME 400U

571
ZAVESCA

A16AX06

MIGLUSTATUM ****
CAPS.
100mg ACTELION REGISTRATION LTD.

A16AX06 MIGLUSTATUM

100mg

129 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G30 BOLI VENERICE (SIFILIS, GONOREE, INFECTIA CU CHLAMIDIA). 572 J01AA02 DOXYCYCLINUM
J01AA02 DOXYCYCLINUM CAPS.
100mg 100mg 100mg 100mg 100mg ARENA GROUP SA ANTIBIOTICE SA SANDOZ SRL

100mg

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02

DOXYCYCLINUM

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V. PFIZER EUROPE MA EEIG

100mg

UNIDOX SOLUTAB VIBRAMYCIN D

J01AA02

DOXYCYCLINUM

CAPS.
100mg 100mg 100mg 100mg 100mg ARENA GROUP SA ANTIBIOTICE SA SANDOZ SRL

100mg

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02

DOXYCYCLINUM

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V. PFIZER EUROPE MA EEIG

100mg

UNIDOX SOLUTAB VIBRAMYCIN D

J01AA02

DOXYCYCLINUM

CAPS.
100mg 100mg 100mg 100mg 100mg ARENA GROUP SA ANTIBIOTICE SA SANDOZ SRL

100mg

DOXICICLINA DOXICICLINA 100 mg DOXICICLINA SANDOZ 100 mg

J01AA02

DOXYCYCLINUM

COMPR. DISP.
ASTELLAS PHARMA EUROPE B.V. PFIZER EUROPE MA EEIG

100mg

UNIDOX SOLUTAB VIBRAMYCIN D

573
J01AA07

J01AA07
TETRACYCLINUM

TETRACYCLINUM
CAPS.
250mg 250mg 250mg ARENA GROUP SA ANTIBIOTICE SA SANDOZ SRL

250mg

TETRACICLINA TETRACICLINA 250 mg TETRACICLINA SANDOZ 250 mg

574

J01CE02

PHENOXYMETHYLPENICILLINUM
COMPR.
1000000ui 1000000ui 1500000ui EUROPHARM SA

J01CE02 PHENOXYMETHYLPENICILLINUM
PENICILINA V 1 000 000 U.I.

1000000ui 1000000ui 1500000ui 400000ui/5ml


SANDOZ GMBH

J01CE02 PHENOXYMETHYLPENICILLINUM
OSPEN 1000

COMPR. FILM.
SANDOZ GMBH SANDOZ GMBH

J01CE02 PHENOXYMETHYLPENICILLINUM
OSPEN 1500

COMPR. FILM. SIROP


400000ui/5ml 500000ui

J01CE02 PHENOXYMETHYLPENICILLINUM
OSPEN 400

J01CE02 PHENOXYMETHYLPENICILLINUM
OSPEN 500

COMPR. FILM.
SANDOZ GMBH

500000ui

575

J01CE01

BENZYLPENICILLINUM
PULB. PT. SOL. INJ.
1 000 000ui 1000000ui 400 000ui 400000ui 5000000ui ANTIBIOTICE SA

J01CE01 BENZYLPENICILLINUM
PENICILINA G SODICA

1 000 000ui 1000000ui 400 000ui 400000ui 5000000ui

J01CE01 BENZYLPENICILLINUM
PENICILINA G POTASICA

PULB. PT. SOL. INJ.


ANTIBIOTICE SA ANTIBIOTICE SA ANTIBIOTICE SA ANTIBIOTICE SA

J01CE01 BENZYLPENICILLINUM
PENICILINA G SODICA

PULB. PT. SOL. INJ. PULB. PT. SOL. INJ. PULB. PT. SOL. INJ.

J01CE01 BENZYLPENICILLINUM
PENICILINA G POTASICA

J01CE01 BENZYLPENICILLINUM
PENICILINA G SODICA

576
MOLDAMIN

J01CE08

BENZATHINI BENZYLPENICILLINUM
PULB. PT. SUSP. INJ.
1200000ui 2400000ui 600000ui ANTIBIOTICE SA

J01CE08 BENZATHINI BENZYLPENICILLINUM J01CE08 BENZATHINI BENZYLPENICILLINUM


MOLDAMIN

1200000ui 2400000ui 600000ui

PULB. PT. SUSP. INJ.


ANTIBIOTICE SA ANTIBIOTICE SA

J01CE08 BENZATHINI BENZYLPENICILLINUM


MOLDAMIN

PULB. PT. SUSP. INJ.

577
SUPRAX

J01DD08

CEFIXIMUM
GRAN. PT. SUSP. ORALA
100mg/5ml GEDEON RICHTER LTD.

J01DD08 CEFIXIMUM J01DD08 CEFIXIMUM


EFICEF 200 mg

100mg/5ml 200mg

CAPS.
200mg 200mg ANTIBIOTICE SA

J01DD08 CEFIXIMUM
SUPRAX

COMPR. FILM.
GEDEON RICHTER LTD.

200mg

578
J01FA01

J01FA01
ERYTHROMYCINUM

ERYTHROMYCINUM
COMPR.
200mg 200mg 200mg 200mg 200mg/5ml ARENA GROUP SA ANTIBIOTICE SA EUROPHARM SA SANDOZ S.R.L.

200mg

ERITROMAGIS 200 mg ERITROMICINA 200 mg ERITROMICINA EUROPHARM 200 mg ERITROMICINA SANDOZ 200 mg COMPRIMATE

J01FA01
ERITRO 200

ERYTHROMYCINUM

PULB. PT. SUSP. ORALA


LEK PHARMATECH SRL

200mg/5ml

579
J01FA10

J01FA10
AZITHROMYCINUM

AZITHROMYCINUM
PULB. PT. SUSP. ORALA
100mg/5ml 100mg/5ml 125mg 125mg SANDOZ SRL PLIVA LJUBLIJANA D.O.O.

100mg/5ml

AZITROMICINA SANDOZ 100 mg/5 ml SUMAMED

J01FA10

AZITHROMYCINUM

COMPR. FILM.
GEDEON RICHTER ROMANIA S.A. PLIVA LJUBLJANA D.O.O.

125mg

ORIGEN 125 mg SUMAMED 125 mg

J01FA10

AZITHROMYCINUM

PULB. PT. SUSP. ORALA

200 mg/5 ml

130 / 233

DCI/DENUMIRE COMERCIALA
AZITROMICINA SANDOZ 200 mg/5 ml

CONCENTRATIE
200 mg/5 ml 200mg/5ml 200mg/5ml

FORMA FARM.
SANDOZ SRL

FIRMA

PROTOCOL

J01FA10 J01FA10 J01FA10

AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM

PULB. + SOLV. SUSP. ORALA


ECZACIBASI PHARMACEUTICALS S.R.L.

200mg/5ml 200mg/5ml 250mg

AZITROX 200 mg/5 ml SUMAMED FORTE AZATRIL 250 mg SUMAMED

PULB. PT. SUSP. ORALA


PLIVA LJUBLIJANA D.O.O. BALKANPHARMA RAZGRAD AD PLIVA LJUBLIJANA D.O.O.

CAPS.
250mg 250mg 250mg 250mg 250mg 500mg

J01FA10

AZITHROMYCINUM

COMPR. FILM.
SANDOZ S.R.L. TERAPIA S.A. ZENTIVA AS

250mg

AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE AZITROMICINA TERAPIA 250 mg AZITROX 250

J01FA10
SUMAMED

AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM

LIOF. PT. SOL. PERF.


PLIVA LJUBLJANA D.O.O.

500mg 600mg 500mg

J01FA10 J01FA10

COMPR. FILM.
600mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg TERAPIA S.A. KRKA D.D. NOVO MESTO HEXAL AG SANDOZ S.R.L. TERAPIA S.A. ZENTIVA AS ECZACIBASI PHARMACEUTICALS S.R.L. GEDEON RICHTER ROMANIA S.A. PLIVA LJUBLJANA D.O.O. OZONE LABORATORIES LTD.

AZITROMICINA TERAPIA 600 mg AZIBIOT 500 mg AZITROMICIN HEXAL 500 mg AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE AZITROMICINA TERAPIA 500 mg AZITROX 500 AZRO 500 mg ORIGEN 500 mg SUMAMED 500 mg ZITROCIN 500 mg

COMPR. FILM.

Prescriere limitata: Prescriere limitata:

Uretrita necomplicata cu Chlamydia trachomatis Cervicita necomplicata cu Chlamydia trachomatis

J01FA10 J01FA10
ZMAX 2 g

AZITHROMYCINUM AZITHROMYCINUM
2g

COMPR.FILM
250mg HEXAL AG

250mg 2g

AZITROMICIN HEXAL 250 mg

GRAN. ELIB. PREL. PT. SUSP. ORALA


PFIZER EUROPE MA EEIG

580
LOXACIL 250 mg

J01MA02
Prescriere limitata: Gonoreea

CIPROFLOXACINUM
COMPR.
250mg TERAPIA SA

J01MA02 CIPROFLOXACINUM

250mg

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 250 CIPRINOL 250 mg CIPROCIN 250 mg CIPROFLOXACIN 250 mg CIPROFLOXACINA ALKALOID 250 mg CIPROLEN 250 mg CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg SERVIFLOX 250 mg

COMPR. FILM.
250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO E.I.P.I.CO. MED S.R.L. LAROPHARM SRL ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SANDOZ GMBH

250mg

Prescriere limitata:
CIPROBAY XR 1000 mg

Gonoreea

J01MA02 CIPROFLOXACINUM
Prescriere limitata:
CIPRINOL CIPROFLOXACINA 100 mg/10 ml

COMPR. FILM. ELIB. PREL.


1000 mg BAYER HEALTHCARE AG

1000 mg

Gonoreea

J01MA02 CIPROFLOXACINUM

CONC. PT. SOL. PERF.


100mg/10ml 100mg/10ml KRKA D.D. SICOMED SA

100mg/10ml

Prescriere limitata:
CIPHIN 100mg/50ml CIPRINOL

Gonoreea

J01MA02 CIPROFLOXACINUM

SOL. PERF.
100mg/50ml 100mg/50ml ZENTIVA A.S. KRKA D.D. NOVO MESTO

100mg/50ml

Prescriere limitata:
CIPHIN 200mg/100ml CIPRINOL CIPROBAY 200

Gonoreea

J01MA02 CIPROFLOXACINUM

SOL. PERF.
200mg/100ml 200mg/100ml 200mg/100ml ZENTIVA A.S. KRKA D.D. NOVO MESTO BAYER HEALTHCARE AG

200mg/100ml

Prescriere limitata:
EUCIPRIN

Gonoreea

J01MA02 CIPROFLOXACINUM
Prescriere limitata:
LOXACIL 250 mg

CAPS.
250mg EUROPHARM SA

250mg

Gonoreea

J01MA02 CIPROFLOXACINUM
Prescriere limitata: Gonoreea

COMPR.
250mg TERAPIA SA

250mg

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 250 CIPRINOL 250 mg CIPROCIN 250 mg CIPROFLOXACIN 250 mg CIPROFLOXACINA ALKALOID 250 mg CIPROLEN 250 mg CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg SERVIFLOX 250 mg

COMPR. FILM.
250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO E.I.P.I.CO. MED S.R.L. LAROPHARM SRL ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SANDOZ GMBH

250mg

131 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata:


CIPROBAY 400 UFEXIL

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Gonoreea

J01MA02 CIPROFLOXACINUM

SOL. PERF.
2mg/ml 2mg/ml BAYER HEALTHCARE AG DEMO SA

2mg/ml

Prescriere limitata:
CIPRINOL

Gonoreea

J01MA02 CIPROFLOXACINUM
Prescriere limitata:
CIPROBAY XR 500 mg

SOL. PERF.
400mg/200ml KRKA D.D.

400mg/200ml

Gonoreea

J01MA02 CIPROFLOXACINUM
Prescriere limitata:
LOXACIL 500 mg

COMPR. FILM. ELIB. PREL.


500 mg BAYER HEALTHCARE AG

500 mg

Gonoreea

J01MA02 CIPROFLOXACINUM
Prescriere limitata: Gonoreea

COMPR.
500mg TERAPIA S.A.

500mg

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 500 CIPRINOL 500 mg CIPRO QUIN CIPROBAY 500 CIPROCIN 500 mg CIPRODAR CIPROFLOXACINA ALKALOID 500 mg CIPROLEN 500 mg CIPROLET 500 mg CIPROZONE FORTE 500 mg CUMINOL 500 mg SERVIFLOX 500 mg SIFLOKS

COMPR. FILM.
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO ANTIBIOTICE SA BAYER HEALTHCARE AG E.I.P.I.CO. MED S.R.L. DAR AL DAWA PHARMA S.R.L ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SANDOZ GMBH ECZACIBASI ILAC SANAYI VE TICARET AS

500mg

Prescriere limitata:
CIPROXIN 10% CIPROXIN 5%

Gonoreea

J01MA02 CIPROFLOXACINUM

MICROCAPS. + DIL.
50mg/ml 50mg/ml BAYER AG PHARMA DEUTSCHLAND BAYER AG PHARMA DEUTSCHLAND

50mg/ml

Prescriere limitata:
CIPRINOL 750 mg

Gonoreea

J01MA02 CIPROFLOXACINUM
Prescriere limitata: Gonoreea

COMPR. FILM.
750mg KRKA D.D. NOVO MESTO

750mg

SUBLISTA C1-G31A BOALA CRONICA INFLAMATORIE INTESTINALA. 582 L04AA12 INFLIXIMABUM ****
L04AA12 INFLIXIMABUM
REMICADE 100 mg

Protocol: L034K
100mg

PULB. PT. CONC. PT. SOL. PERF.


100mg CENTOCOR B.V.

583
HUMIRA 40 mg

L04AA17

ADALIMUMABUM ****
SOL. INJ.
40mg 40mg 40mg ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM L04AA17 ADALIMUMABUM


HUMIRA 40 mg

40mg 40mg 40mg 40mg

SOL. INJ. IN PEN PRE-UMPLUTA


ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM
HUMIRA 40 mg

SOL. INJ. IN SERINGA PREUMPLUTA


ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM
HUMIRA 40 mg 40mg

SOL. INJ. IN SERINGA PREUMPLUTA CU APARATOR PT AC


ABBOTT LABORATORIES LTD.

132 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G31B POLIARTRITA REUMATOIDA. 584 L01XC02 RITUXIMABUM ****


L01XC02 RITUXIMABUM
MABTHERA 100 mg MABTHERA 500 mg

Protocol: L043M
10mg/ml

CONC. PT. SOL. PERF.


10mg/ml 10mg/ml ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

585

L04AA11

ETANERCEPTUM ****
PULB. + SOLV. PT. SOL. INJ.
25mg 25mg 25mg 50mg 50mg 25mg 25mg 25mg 50mg 50mg 25mg 50mg WYETH EUROPA LIMITED WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg ENBREL DE UZ PEDIATRIC

25mg

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

25mg 50mg 50mg 25mg

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg ENBREL DE UZ PEDIATRIC

PULB. + SOLV. PT. SOL. INJ.


WYETH EUROPA LIMITED WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

25mg 50mg 50mg 25mg 50mg

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

586
REMICADE 100 mg

L04AA12

INFLIXIMABUM ****
PULB. PT. CONC. PT. SOL. PERF.
100mg CENTOCOR B.V.

L04AA12 INFLIXIMABUM

100mg

587
HUMIRA 40 mg

L04AA17

ADALIMUMABUM ****
SOL. INJ.
40mg 40mg 40mg ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM L04AA17 ADALIMUMABUM


HUMIRA 40 mg

40mg 40mg 40mg 40mg

SOL. INJ. IN PEN PRE-UMPLUTA


ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM
HUMIRA 40 mg

SOL. INJ. IN SERINGA PREUMPLUTA


ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM
HUMIRA 40 mg 40mg

SOL. INJ. IN SERINGA PREUMPLUTA CU APARATOR PT AC


ABBOTT LABORATORIES LTD.

SUBLISTA C1-G31C ARTROPATIA PSORIAZICA. 589 L04AA11 ETANERCEPTUM ****


L04AA11 ETANERCEPTUM
ENBREL 25mg ENBREL DE UZ PEDIATRIC 25mg 25mg 25mg 50mg 50mg 25mg 25mg 25mg 50mg 50mg 25mg 50mg

Protocol: L040M
25mg

PULB. + SOLV. PT. SOL. INJ.


WYETH EUROPA LIMITED WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

25mg 50mg 50mg 25mg

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg ENBREL DE UZ PEDIATRIC

PULB. + SOLV. PT. SOL. INJ.


WYETH EUROPA LIMITED WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

25mg 50mg 50mg 25mg 50mg

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

590
REMICADE 100 mg

L04AA12

INFLIXIMABUM ****
PULB. PT. CONC. PT. SOL. PERF.
100mg CENTOCOR B.V.

L04AA12 INFLIXIMABUM

100mg

591
HUMIRA 40 mg

L04AA17

ADALIMUMABUM ****
SOL. INJ.
40mg 40mg 40mg ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM L04AA17 ADALIMUMABUM


HUMIRA 40 mg

40mg 40mg 40mg 40mg

SOL. INJ. IN PEN PRE-UMPLUTA


ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM
HUMIRA 40 mg

SOL. INJ. IN SERINGA PREUMPLUTA


ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM
HUMIRA 40 mg 40mg

SOL. INJ. IN SERINGA PREUMPLUTA CU APARATOR PT AC


ABBOTT LABORATORIES LTD.

133 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G31D SPONDILITA ANKILOZANTA. 592 L04AA11 ETANERCEPTUM ****


L04AA11 ETANERCEPTUM
ENBREL 25mg ENBREL DE UZ PEDIATRIC 25mg 25mg 25mg 50mg 50mg 25mg 25mg 25mg 50mg 50mg 25mg 50mg

Protocol: L041M
25mg

PULB. + SOLV. PT. SOL. INJ.


WYETH EUROPA LIMITED WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

25mg 50mg 50mg 25mg

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg ENBREL DE UZ PEDIATRIC

PULB. + SOLV. PT. SOL. INJ.


WYETH EUROPA LIMITED WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

25mg 50mg 50mg 25mg 50mg

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

593
REMICADE 100 mg

L04AA12

INFLIXIMABUM ****
PULB. PT. CONC. PT. SOL. PERF.
100mg CENTOCOR B.V.

L04AA12 INFLIXIMABUM

100mg

594
HUMIRA 40 mg

L04AA17

ADALIMUMABUM ****
SOL. INJ.
40mg 40mg 40mg ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM L04AA17 ADALIMUMABUM


HUMIRA 40 mg

40mg 40mg 40mg 40mg

SOL. INJ. IN PEN PRE-UMPLUTA


ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM
HUMIRA 40 mg

SOL. INJ. IN SERINGA PREUMPLUTA


ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM
HUMIRA 40 mg 40mg

SOL. INJ. IN SERINGA PREUMPLUTA CU APARATOR PT AC


ABBOTT LABORATORIES LTD.

SUBLISTA C1-G31E ARTRITA JUVENILA. 595 L04AA11 ETANERCEPTUM ****


L04AA11 ETANERCEPTUM
ENBREL 25mg ENBREL DE UZ PEDIATRIC 25mg 25mg 25mg 50mg 50mg 25mg 25mg 25mg 50mg 50mg 25mg 50mg

Protocol: L039M
25mg

PULB. + SOLV. PT. SOL. INJ.


WYETH EUROPA LIMITED WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

25mg 50mg 50mg 25mg

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg ENBREL DE UZ PEDIATRIC

PULB. + SOLV. PT. SOL. INJ.


WYETH EUROPA LIMITED WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

25mg 50mg 50mg 25mg 50mg

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

134 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C1-G31F PSORIAZIS CRONIC SEVER (PLACI). 596 L04AA11 ETANERCEPTUM ****
L04AA11 ETANERCEPTUM
ENBREL 25mg ENBREL DE UZ PEDIATRIC 25mg 25mg 25mg 50mg 50mg 25mg 25mg 25mg 50mg 50mg 25mg 50mg

Protocol: L044L
25mg

PULB. + SOLV. PT. SOL. INJ.


WYETH EUROPA LIMITED WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

25mg 50mg 50mg 25mg

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg ENBREL DE UZ PEDIATRIC

PULB. + SOLV. PT. SOL. INJ.


WYETH EUROPA LIMITED WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

25mg 50mg 50mg 25mg 50mg

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

597
REMICADE 100 mg

L04AA12

INFLIXIMABUM ****
PULB. PT. CONC. PT. SOL. PERF.
100mg CENTOCOR B.V.

L04AA12 INFLIXIMABUM

100mg

598
RAPTIVA 100mg/ml

L04AA21

EFALIZUMABUM ****
PULB+SOLV.PT.SOL.INJ
100mg/ml SERONO EUROPE LTD.

L04AA21 EFALIZUMABUM

100mg/ml

599
HUMIRA 40 mg

L04AA17

ADALIMUMABUM ****
SOL. INJ.
40mg 40mg 40mg ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM L04AA17 ADALIMUMABUM


HUMIRA 40 mg

40mg 40mg 40mg 40mg

SOL. INJ. IN PEN PRE-UMPLUTA


ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM
HUMIRA 40 mg

SOL. INJ. IN SERINGA PREUMPLUTA


ABBOTT LABORATORIES LTD.

L04AA17 ADALIMUMABUM
HUMIRA 40 mg 40mg

SOL. INJ. IN SERINGA PREUMPLUTA CU APARATOR PT AC


ABBOTT LABORATORIES LTD.

135 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-I P1: PROGRAMUL NATIONAL DE BOLI TRANSMISIBILE. A ) SUBPROGRAMUL DE TRATAMENT SI MONITORIZARE A PERSOANELOR CU INFECTIE HIV /SIDA SI TRATAMENTUL POSTEXPUNERE 600 J05AE01 SAQUINAVIRUM
J05AE01 SAQUINAVIRUM CAPS.
200mg ROCHE REGISTRATION LTD.

200mg

INVIRASE 200mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE01

SAQUINAVIRUM

COMPR. FILM.
500mg ROCHE REGISTRATION LTD.

500mg

INVIRASE 500 mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

601
J05AE02
CRIXIVAN 100mg

J05AE02
INDINAVIRUM
Prescriere limitata:

INDINAVIRUM
CAPS.
100mg MERCK SHARP & DOHME LTD.

100mg

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE02

INDINAVIRUM

CAPS.
200mg MERCK SHARP & DOHME LTD.

200mg

CRIXIVAN 200mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE02

INDINAVIRUM

CAPS.
333mg MERCK SHARP & DOHME LTD.

333mg

CRIXIVAN 333mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE02

INDINAVIRUM

CAPS.
400mg MERCK SHARP & DOHME LTD.

400mg

CRIXIVAN 400mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

602
J05AE03
NORVIR 100 mg

J05AE03
RITONAVIRUM
Prescriere limitata:

RITONAVIRUM **
CAPS. MOI
100mg ABBOTT LABORATORIES LTD.

100mg

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE03

RITONAVIRUM

SOL. ORALA
80mg/ml ABBOTT LABORATORIES LTD.

80mg/ml

NORVIR 80mg/ml

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

603
J05AE04
VIRACEPT 250 mg

J05AE04
NELFINAVIRUM
Prescriere limitata:

NELFINAVIRUM
COMPR.
250mg ROCHE REGISTRATION LTD.

250mg

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE04

NELFINAVIRUM

COMPR. FILM.
250mg ROCHE REGISTRATION LTD.

250mg

VIRACEPT 250 mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE04

NELFINAVIRUM

PULB. PT. SOL. ORALA


50mg/g ROCHE REGISTRATION LTD.

50mg/g

VIRACEPT 50 mg/g

604
J05AE05 J05AE05 J05AE05
AGENERASE 150mg

J05AE05
AMPRENAVIRUM AMPRENAVIRUM

AMPRENAVIRUM
CAPS. MOI
150mg GLAXO GROUP LTD.

150mg 50mg
GLAXO GROUP LTD.

CAPS. MOI
50mg 15mg/ml

AGENERASE 50mg

AMPRENAVIRUM

SOL. ORALA
GLAXO GROUP LTD.

15mg/ml

AGENERASE 15mg/ml

605
J05AE06

J05AE06
LOPINAVIRUM+RITONAVIRUM
Prescriere limitata:

LOPINAVIRUM+RITONAVIRUM **
CAPS. MOI
133.3mg/33.3mg ABBOTT LABORATORIES LTD.

133.3mg/33.3mg

KALETRA 133,3mg/33,3mg

Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE06

LOPINAVIRUM+RITONAVIRUM

COMPR. FILM.
200mg/50mg ABBOTT LABORATORIES LTD.

200mg/50mg

KALETRA 200mg/50mg

Prescriere limitata:

Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE06

LOPINAVIRUM+RITONAVIRUM

SOL. ORALA
80mg/ml+20mg/ml ABBOTT LABORATORIES LTD.

80mg/ml+20mg/ml

KALETRA 80mg/ml+20mg/ml

Prescriere limitata:

Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

606
J05AE07
TELZIR 50mg/ml

J05AE07
FOSAMPRENAVIRUM
Prescriere limitata:

FOSAMPRENAVIRUM **
SUSP. ORALA
50mg/ml GLAXO GROUP LTD.

50mg/ml

Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE07
TELZIR 700mg

FOSAMPRENAVIRUM

COMPR. FILM.
700mg GLAXO GROUP LTD.

700mg

Prescriere limitata:

Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

607
J05AE08
REYATAZ 100 mg

J05AE08
ATAZANAVIRUM
Prescriere limitata:

ATAZANAVIRUM
CAPS.
100mg BRISTOL-MYERS SQUIBB PHARMA EEIG

100mg

Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE08

ATAZANAVIRUM

CAPS.
150mg BRISTOL-MYERS SQUIBB PHARMA EEIG

150mg

REYATAZ 150 mg

Prescriere limitata:

Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE08

ATAZANAVIRUM

CAPS.
200mg BRISTOL-MYERS SQUIBB PHARMA EEIG

200mg

REYATAZ 200 mg

Prescriere limitata:

Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AE08

ATAZANAVIRUM

PULB. PT. SOL. ORALA


50mg/1.5g BRISTOL-MYERS SQUIBB PHARMA EEIG

50mg/1.5g

REYATAZ 50mg/1.5g

Prescriere limitata:

Tratamentul combinat al infectiei HIV cu doua sau mai multe antiretrovirale la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

608
J05AE09
APTIVUS 250mg

J05AE09
TIPRANAVIRUM

TIPRANAVIRUM **
CAPS. MOI
250mg BOEHRINGER INGELHEIM INTERNATIONAL GMBH

250mg

136 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratmentul combinat al infectiei HIV concomitent cu 200 mg ritonavir de doua ori pe zi la adulti experimentati cu evidenta replicarii virale (incarcare virala > 10.000 copii per mL) si/ sau celule CD4 < 500 pe mm cub. Pacientii au avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1 inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza

609
J05AE10
PREZISTA 300mg

J05AE10
DARUNAVIRUM
Prescriere limitata:

DARUNAVIRUM **
COMPR. FILM.
300mg JANSSEN-CILAG INTERNATIONAL NV

300mg

Tratmentul combinat al infectiei HIV concomitent cu 200 mg ritonavir de doua ori pe zi la adulti experimentati cu evidenta replicarii virale (incarcare virala > 10.000 copii per mL) si/ sau celule CD4 < 500 pe mm cub. Pacientii au avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1 inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza

610
J05AF01
RETROVIR

J05AF01
ZIDOVUDINUM
Prescriere limitata:

ZIDOVUDINUM
CAPS.
100mg THE WELLCOME FOUNDATION LTD.

100mg

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF01
RETROVIR

ZIDOVUDINUM
1%

SOL. ORALA
THE WELLCOME FOUNDATION LTD.

1%

611
J05AF02
VIDEX 100 mg

J05AF02
DIDANOSINUM
Prescriere limitata:

DIDANOSINUM
COMPR. DISP./MAST.
100mg BRISTOL-MYERS SQUIBB

100mg

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF02

DIDANOSINUM

CAPS. GASTROREZ.
125mg BRISTOL MYERS SQUIBB KFT

125mg

VIDEX EC 125 mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF02

DIDANOSINUM

COMPR. DISP./MAST.
150mg BRISTOL-MYERS SQUIBB

150mg

VIDEX 150 mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF02

DIDANOSINUM

CAPS. GASTROREZ.
200mg BRISTOL MYERS SQUIBB KFT

200mg

VIDEX EC 200 mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF02

DIDANOSINUM

CAPS. GASTROREZ.
250mg BRISTOL MYERS SQUIBB KFT

250mg

VIDEX EC 250 mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF02

DIDANOSINUM

CAPS. GASTROREZ.
400mg BRISTOL MYERS SQUIBB KFT

400mg

VIDEX EC 400 mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

612
J05AF04
ZERIT 15 mg

J05AF04
STAVUDINUM
Prescriere limitata:

STAVUDINUM
CAPS.
15mg BRISTOL-MYERS SQUIBB PHARMA EEIG

15mg

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF04
ZERIT 200 mg

STAVUDINUM

PULB. PT. SOL. ORALA


200mg BRISTOL-MYERS SQUIBB PHARMA EEIG

200mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF04
ZERIT 20 mg

STAVUDINUM
20mg

CAPS.
BRISTOL-MYERS SQUIBB PHARMA EEIG

20mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF04
ZERIT 30 mg

STAVUDINUM
30mg

CAPS.
BRISTOL-MYERS SQUIBB PHARMA EEIG

30mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF04
ZERIT 40 mg

STAVUDINUM
40mg

CAPS.
BRISTOL-MYERS SQUIBB PHARMA EEIG

40mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

613
J05AF05 J05AF05 J05AF05
EPIVIR 150mg ZEFFIX 100 mg

J05AF05
LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM

LAMIVUDINUM
COMPR. FILM.
100mg 10mg/ml 150mg 300mg 5mg/ml GLAXO GROUP LTD.

100mg 10mg/ml 150mg 300mg 5mg/ml

SOL. ORALA
GLAXO GROUP LTD. GLAXO GROUP LTD. GLAXO GROUP LTD. GLAXO GROUP LTD.

EPIVIR 10mg/ml

COMPR. FILM. COMPR. FILM. SOL. ORALA

J05AF05
EPIVIR 300mg

J05AF05

ZEFFIX 5 mg/ml

614
J05AF06
ZIAGEN 20 mg/ml

J05AF06
ABACAVIRUM
Prescriere limitata:

ABACAVIRUM
SOL. ORALA
20mg/ml GLAXO GROUP LTD.

20mg/ml

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF06

ABACAVIRUM

COMPR. FILM.
300mg GLAXO GROUP LTD.

300mg

ZIAGEN 300 mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

615
J05AF07
VIREAD 245mg

J05AF07
Prescriere limitata:

TENOFOVIRUM DISOPROXIL FUMARATE


COMPR. FILM.
245mg GILEAD SCIENCE INTERNATIONAL LIMITED

TENOFOVIRUM DISOPROXIL FUMARATE

245mg

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

616
J05AF09
EMTRIVA 10mg/ml

J05AF09
EMTRICITABINUM
Prescriere limitata:

EMTRICITABINUM
SOL. ORALA
10mg/ml GILEAD SCIENCE INTERNATIONAL LIMITED

10mg/ml

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AF09

EMTRICITABINUM

CAPS.
200mg GILEAD SCIENCE INTERNATIONAL LIMITED

200mg

EMTRIVA 200mg

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

137 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

617
VIRAMUNE 200mg

J05AG01
Prescriere limitata:

NEVIRAPINUM
COMPR.
200mg BOEHRINGER INGELHEIM INT. GMBH

J05AG01 NEVIRAPINUM

200mg

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

J05AG01 NEVIRAPINUM
VIRAMUNE 50mg/ml

SUSP. ORALA
50mg/5ml BOEHRINGER INGELHEIM INT. GMBH

50mg/5ml

Prescriere limitata:

Tratamentul infectiei HIV la pacientii cu: celule CD4 < 500 pe mm cub sau incarcare virala > 10.000 copii per mL

618
STOCRIN 100 mg SUSTIVA 100mg

J05AG03

EFAVIRENZUM
CAPS.
100mg 100mg MERCK SHARP & DOHME LTD. BRISTOL-MYERS SQUIBB PHARMA EEIG

J05AG03 EFAVIRENZUM

100mg

J05AG03 EFAVIRENZUM
STOCRIN 200 mg SUSTIVA 200mg

CAPS.
200mg 200mg 200mg 300mg 300mg 30mg/ml 30mg/ml MERCK SHARP & DOHME LTD. BRISTOL-MYERS SQUIBB PHARMA EEIG

200mg

J05AG03 EFAVIRENZUM
STOCRIN 200 mg

COMPR. FILM.
MERCK SHARP & DOHME LTD.

200mg 300mg

J05AG03 EFAVIRENZUM
STOCRIN 300 mg SUSTIVA 300mg

COMPR. FILM.
MERCK SHARP & DOHME LTD. BRISTOL-MYERS SQUIBB PHARMA EEIG

J05AG03 EFAVIRENZUM
STOCRIN 30 mg/ml SUSTIVA 30mg/ml

SOL. ORALA
MERCK SHARP & DOHME LTD. BRISTOL-MYERS SQUIBB PHARMA EEIG

30mg/ml

J05AG03 EFAVIRENZUM
STOCRIN 50 mg SUSTIVA 50mg 50mg 50mg 50mg

CAPS.
MERCK SHARP & DOHME LTD. BRISTOL-MYERS SQUIBB PHARMA EEIG

50mg

J05AG03 EFAVIRENZUM
STOCRIN 50 mg

COMPR. FILM.
MERCK SHARP & DOHME LTD.

50mg 600mg

J05AG03 EFAVIRENZUM
STOCRIN 600 mg SUSTIVA 600mg

COMPR. FILM.
600mg 600mg MERCK SHARP & DOHME LTD. BRISTOL-MYERS SQUIBB PHARMA EEIG

619

J05AR01

ZIDOVUDINUM+LAMIVUDINUM **
COMPR. FILM.
150mg/300mg GLAXO GROUP LTD.

J05AR01 ZIDOVUDINUM+LAMIVUDINUM
COMBIVIR 150mg/300mg

150mg/300mg

620

J05AR02

ABACAVIRUM+LAMIVUDINUM **
COMPR. FILM.
600mg/300mg GLAXO GROUP LTD.

J05AR02 ABACAVIRUM+LAMIVUDINUM
KIVEXA 600mg/300mg

600mg/300mg

621

J05AR04

ABACAVIRUM+LAMIVUDINUM+ZIDOVUDINUM **
COMPR. FILM.
300mg/150mg/300 mg GLAXO GROUP LTD.

J05AR04 ABACAVIRUM+LAMIVUDINUM+ZIDOVUDIN UM
TRIZIVIR 300mg/150mg/300mg

300mg/150mg/300 mg

622
J05AX07
FUZEON 90mg/ml

J05AX07
ENFUVIRTIDUM
Prescriere limitata:

ENFUVIRTIDUM **
PULB. + SOLV. PT. SOL. INJ.
90mg/ml ROCHE REGISTRATION LTD.

90mg/ml

Tratmentul combinat al infectiei HIV concomitent cu 200 mg ritonavir de doua ori pe zi la adulti experimentati cu evidenta replicarii virale (incarcare virala > 10.000 copii per mL) si/ sau celule CD4 < 500 pe mm cub. Pacientii au avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1 inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza

J05AX07

ENFUVIRTIDUM

PULB. PT. SOL. INJ.


90mg/ml ROCHE REGISTRATION LTD.

90mg/ml

FUZEON 90mg/ml

Prescriere limitata:

Tratmentul combinat al infectiei HIV concomitent cu 200 mg ritonavir de doua ori pe zi la adulti experimentati cu evidenta replicarii virale (incarcare virala > 10.000 copii per mL) si/ sau celule CD4 < 500 pe mm cub. Pacientii au avut esec terapeutic sau rezistenta la 3 regimuri ARV diferite care au inclus: cel putin 1 inhibitor de non-nucleozid revers trasncriptaza si cel putin 1 inhibitor de nucleozid revers trasncriptaza si cel putin 2 inhibitori de proteaza

623
NORMIX 100mg/5ml

A07AA11

RIFAXIMINUM
GRAN. PT. SUSP. ORALA
100mg/5ml 200mg 400mg ALFA WASSERMANN SPA

A07AA11 RIFAXIMINUM A07AA11 RIFAXIMINUM


NORMIX 200 mg

100mg/5ml 200mg 400mg

COMPR. FILM.
ALFA WASSERMANN SPA BAMA-GEVE S.L.

A07AA11 RIFAXIMINUM
NORMIX 400 mg

COMPR. FILM.

624
MICONAL ECOBI

D01AC02

MICONAZOLUM
CREMA
20mg/g FARMACEUTICI ECOBI S.A.S

D01AC02 MICONAZOLUM D01AC02 MICONAZOLUM


MEDACTER MICONAZOL NITRAT 2% 2% 2%

20mg/g 2%
FARAN LABORATORIES S.A. SLAVIA PHARM SRL

CREMA

D01AC02 MICONAZOLUM
DERMOZOL 2%

GEL
PHARCO IMPEX 93 S.R.L.

2%

625

D06BB03

ACICLOVIRUM
CREMA
50mg/g 50mg/g 50mg/g HYPERION S.A. TIS FARMACEUTIC SA A & G MED TRADING S.R.L.

D06BB03 ACICLOVIRUM
ACICLOVIR HYPERION ACICLOVIR TIS 50mg/g ACIKLOVIR CREMA

50mg/g

D06BB03 ACICLOVIRUM
ACICLOVIR ACICLOVIR 5% ACICLOVIR MK CLOVIRAL 5% LOVIR ZOVIRAX 5% 5% 5% 5% 5% 5%

CREMA
OZONE LABORATORIES LTD. EGIS PHARMACEUTICALS PLC FITERMAN PHARMA S.R.L. ANTIBIOTICE SA RANBAXY U.K. LIMITED THE WELLCOME FOUNDATION LTD.

5%

626

G01AF04

MICONAZOLUM

138 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
1.2g 200mg 200mg 20mg/g 2mg/ml 400mg

FORMA FARM.
FARMACEUTICI ECOBI S.A.S

FIRMA

PROTOCOL

G01AF04 MICONAZOLUM
MICONAL ECOBI

CAPS. MOI VAG. CAPS. VAG.


PHARCO IMPEX 93 S.R.L.

1.2g 200mg 200mg 20mg/g 2mg/ml 400mg 50mg

G01AF04 MICONAZOLUM
GYNOZOL 200

G01AF04 MICONAZOLUM
MYCOHEAL 200

SUPOZ. VAG.
DAR AL DAWA PHARMA S.R.L FARMACEUTICI ECOBI S.A.S FARMACEUTICI ECOBI S.A.S PHARCO IMPEX 93 S.R.L. FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM
MICONAL ECOBI

CREMA VAG. SOL. VAGINALA CAPS. VAG. OVULE


50mg 2% 2%

G01AF04 MICONAZOLUM
MICONAL ECOBI

G01AF04 MICONAZOLUM
GYNOZOL 400

G01AF04 MICONAZOLUM
MICONAL ECOBI

G01AF04 MICONAZOLUM
MEDACTER MYCOHEAL

CREMA VAG.
FARAN LABORATORIES S.A. DAR AL DAWA PHARMA S.R.L.

2%

627
J01CF04

J01CF04
OXACILLINUM

OXACILLINUM
CAPS.
250mg 250mg 250mg 250mg 250mg FARMACOM SA OZONE LABORATORIES LTD. ARENA GROUP SA FARMEX COMPANY SRL SANDOZ SRL

250mg

OXACILINA OXACILINA 250 mg OXACILINA ARENA 250 mg OXACILINA FARMEX 250 mg OXACILINA SANDOZ 250 mg

J01CF04

OXACILLINUM

CAPS.
500mg 500mg 500mg 500mg 500mg 500mg 500mg 1g 250mg ANTIBIOTICE SA ARENA GROUP SA OZONE LABORATORIES LTD. MARK PHARMACEUTICS SRL SANDOZ SRL EUROPHARM SA

500mg

OXACILINA 500 mg OXACILINA ARENA 500 mg OXACILINA FORTE 500 mg OXACILINA MARK 500 mg OXACILINA SANDOZ 500 mg OXALIN 500 mg

J01CF04 J01CF04 J01CF04

OXACILLINUM OXACILLINUM OXACILLINUM

PULB. PT. SOL. INJ./PERF. I.M./I.V.


ANTIBIOTICE SA

500mg 1g 250mg

OXACILINA ANTIBIOTICE 500 mg OXACILINA ANTIBIOTICE 1 g OXACILINA ANTIBIOTICE 250 mg

PULB. PT. SOL. INJ./PERF.I.M./I.V.


ANTIBIOTICE SA

PULB. PT. SOL. INJ./PERF.I.M./I.V.


ANTIBIOTICE SA

628
UNASYN im/iv

J01CR01

AMPICILLINUM + SULBACTAM
PULB. PT. SOL. INJ. IM/IV
1g + 500mg 1g+500mg PFIZER EUROPE MA EEIG

J01CR01 AMPICILLINUM + SULBACTAM J01CR01 AMPICILLINUM + SULBACTAM


AMPIPLUS 1,5 g

1g + 500mg 1g+500mg

PULB. PT. SOL. INJ.


ANTIBIOTICE SA

629

J01CR02

AMOXICILLINUM + ACIDUM CLAVULANICUM


PULB. PT. SOL. INJ.
1.2g KRKA D.D. NOVO MESTO

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


BETAKLAV 1,2 g

1.2g

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOXIPLUS 1,2 g 1.2g

PULB. PT. SOL. INJ./PERF.


ANTIBIOTICE SA

1.2g

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


BETAKLAV DUO 1000 mg

COMPR.
1000mg KRKA D.D. NOVO MESTO

1000mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 2 x 1000 mg MEDOCLAV 1000 mg

COMPR. FILM.
1000mg 1000mg LEK PHARMACEUTICALS D.D. MEDOCHEMIE LTD.

1000mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 1,2 g AUGMENTIN INTRAVENOS 1.2g

PULB. PT. SOL. INJ./PERF.


1000mg+200mg 1000mg+200mg LEK PHARMACEUTICALS D.D. BEECHAM GROUP PLC

1000mg+200mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AUGMENTIN SR

COMPR. FILM. ELIB. PREL.


1062.5mg BEECHAM GROUP PLC

1062.5mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


FORCID SOLUTAB 125/31,25

COMPR. DISP.
125/31,25mg ASTELLAS PHARMA EUROPE BV

125/31,25mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


MEDOCLAV 156,25 mg/5 ml

PULB. PT. SUSP. ORALA


125mg+31.25/5ml MEDOCHEMIE LTD.

125mg+31.25/5ml

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 156,25mg/5ml BIOCLAVID 156.25mg/5ml

PULB. PT. SUSP. ORALA


156.25mg/5ml 156.25mg/5ml LEK PHARMACEUTICALS D.D. SANDOZ GMBH

156.25mg/5ml

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


BETAKLAV 2,2 g 2.2g

PULB. PT. SOL. INJ.


KRKA D.D. NOVO MESTO

2.2g

139 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AUGMENTIN INTRAVENOS 2,2g

PULB. PT. SOL. PERF.


2000mg+200mg BEECHAM GROUP PLC

2000mg+200mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


FORCID SOLUTAB 250/62,5

COMPR. DISP.
250/62,5mg ASTELLAS PHARMA EUROPE BV

250/62,5mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


MEDOCLAV 375 mg

COMPR. FILM.
250mg+125mg MEDOCHEMIE LTD.

250mg+125mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


MEDOCLAV FORTE 312,5mg/5ml

PULB. PT. SUSP. ORALA


250mg+62.5mg/5 ml MEDOCHEMIE LTD.

250mg+62.5mg/5 ml 312.5mg/5ml

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


BIOCLAVID 312.5mg/5ml

PULB. PT. SUSP. ORALA


312.5mg/5ml SANDOZ GMBH

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 312.5mg/5ml ENHANCIN 312,5 mg/5 ml

PULB. PT.SUSP. ORALA


312.5mg/5ml 312.5mg/5ml LEK PHARMACEUTICALS D.D. RANBAXY UK LIMITED

312.5mg/5ml

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


FORCID SOLUTAB 375/93,75

COMPR. DISP.
375/93,75mg ASTELLAS PHARMA EUROPE BV

375/93,75mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 2x AUGMENTIN BIS CLAVUMOX DUO

PULB. PT. SUSP. ORALA


400mg+57mg/5ml 400mg+57mg/5ml 400mg+57mg/5ml LEK PHARMACEUTICALS D.D. SMITHKLINE BEECHAM PLC GLAXOSMITHKLINE SRL

400mg+57mg/5ml

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


FORCID SOLUTAB 500/125

COMPR. DISP.
500/125mg ASTELLAS PHARMA EUROPE BV

500/125mg

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 600mg

PULB. PT. SOL. INJ./PERF.


500mg+100mg LEK PHARMACEUTICALS D.D.

500mg+100mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AUGMENTIN 625 mg CLAVUMOX DUO 625 mg MEDOCLAV 625 mg

COMPR. FILM.
500mg+125mg 500mg+125mg 500mg+125mg BEECHAM GROUP PLC GLAXOSMITHKLINE SRL MEDOCHEMIE LTD.

500mg+125mg

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOXIPLUS 600 mg

PULB. PT. SOL. INJ./PERF.


600mg ANTIBIOTICE SA

600mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


BETAKLAV 625 mg

COMPR.
625mg KRKA D.D. NOVO MESTO

625mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV 2 x 625 mg AMOKSIKLAV 625 mg BIOCLAVID 625 mg ENHANCIN 625 mg

COMPR. FILM.
625mg 625mg 625mg 625mg LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. SANDOZ GMBH RANBAXY UK LIMITED

625mg

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AUGMENTIN ES

PULB. PT. SUSP. ORALA


642.90mg/5ml SMITHKLINE BEECHAM PLC

642.90mg/5ml

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


FORCID SOLUTAB 875/125

COMPR. DISP.
875mg+125mg ASTELLAS PHARMA EUROPE BV

875mg+125mg

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AUGMENTIN 1 g BIOCLAVID 1000 mg CLAVUMOX DUO 1 g

COMPR. FILM.
875mg+125mg 875mg+125mg 875mg+125mg BEECHAM GROUP PLC SANDOZ GMBH GLAXOSMITHKLINE SRL

875mg+125mg

Prescriere limitata: Infectii la care este suspectata rezistenta la amoxicilina Prescriere limitata: Infectii la care este dovedita rezistenta la amoxicilina. A fost raportat hepatotoxicitate la acest medicament.

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV QUICKTAB 1000 mg

COMPR. PT. DISPERSIE ORALA/ORODISPERSABILE


1000mg BIOMEDIAL PHARMA S.R.L.

1000mg

140 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

J01CR02 AMOXICILLINUM + ACIDUM CLAVULANICUM


AMOKSIKLAV QUICKTAB 625 mg

COMPR. PT. DISPERSIE ORALA/ORODISPERSABILE


625mg BIOMEDIAL PHARMA S.R.L.

625mg

630
TAZOCIN 2,25 TAZOCIN 4,5

J01CR05

PIPERACILLINUM + TAZOBACTAMUM
LIOF. PT. SOL. INJ.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

J01CR05 PIPERACILLINUM + TAZOBACTAMUM

631

J01CR50

COMBINATII (CEFOPERAZONUM+SULBACTAM)
PULB. PT. SOL. INJ.
1g+1g PFIZER EUROPE MA EEIG

J01CR50 COMBINATII (CEFOPERAZONUM+SULBACTAM)


SULPERAZON 2 g

1g+1g

J01CR50 COMBINATII (CEFOPERAZONUM+SULBACTAM)


AMPICLOX

CAPS.
250mg+250 mg EUROPHARM SA

250mg+250 mg

632
NOVOSEF 0,5 g i.v.

J01DD04
Prescriere limitata: Prescriere limitata: Prescriere limitata:

CEFTRIAXONUM
PULB. PT. SOL. INJ.
0.5g ECZACIBASI PHARMACEUTICALS S.R.L.

J01DD04 CEFTRIAXONUM

0.5g

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01DD04 CEFTRIAXONUM
LENDACIN 1 g NOVOSEF 1 g i.m. NOVOSEF 1 g i.v. 1g 1g 1g

PULB. PT. SOL. INJ.


LEK PHARMACEUTICALS D.D. ECZACIBASI PHARMACEUTICALS S.R.L. ECZACIBASI PHARMACEUTICALS S.R.L.

1g

Prescriere limitata: Prescriere limitata: Prescriere limitata:


OFRAMAX 1 g

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01DD04 CEFTRIAXONUM
1g

PULB. PT. SOL. INJ. i.m./i.v.


TERAPIA S.A.

1g

Prescriere limitata: Prescriere limitata: Prescriere limitata:


CEFORT 1 g CEFTRIAXON 1 g CEFTRIAXONE SANDOZ 1 g MEDAXONE 1 g

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01DD04 CEFTRIAXONUM
1g 1g 1g 1g

PULB. PT. SOL. INJ./PERF.


ANTIBIOTICE SA OZONE LABORATORIES LTD. SANDOZ GMBH MEDOCHEMIE LTD.

1g

Prescriere limitata: Prescriere limitata: Prescriere limitata:


LENDACIN 250 mg MEGION 250 mg

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01DD04 CEFTRIAXONUM

PULB. PT. SOL. INJ.


250mg 250mg 250mg 250mg 2g 2g LEK PHARMACEUTICALS D.D. SANDOZ S.R.L.

250mg

J01DD04 CEFTRIAXONUM
OFRAMAX 250 mg

PULB. PT. SOL. INJ. i.m./i.v.


TERAPIA S.A.

250mg 250mg 2g

J01DD04 CEFTRIAXONUM
CEFORT 250 mg

PULB. PT. SOL. INJ./PERF.


ANTIBIOTICE SA ANTIBIOTICE SA MEDOCHEMIE LTD.

J01DD04 CEFTRIAXONUM
CEFORT 2 g MEDAXONE 2 g

PULB. PT. SOL. INJ./PERF.

Prescriere limitata: Prescriere limitata: Prescriere limitata:


MEGION 2 g ROCEPHIN

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01DD04 CEFTRIAXONUM
2g 2g

PULB. PT. SOL. PERF.


SANDOZ S.R.L. ROCHE ROMANIA S.R.L.

2g

Prescriere limitata: Prescriere limitata: Prescriere limitata:


CEFORT 500 mg CEFTRIAXONE SANDOZ 500 mg MEDAXONE 500 mg

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01DD04 CEFTRIAXONUM

PULB. PT. SOL. INJ./PERF.


500mg 500mg 500mg ANTIBIOTICE SA SANDOZ GMBH MEDOCHEMIE LTD

500mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:


NOVOSEF 0,5 g i.v.

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01DD04 CEFTRIAXONUM
0.5g

PULB. PT. SOL. INJ.


ECZACIBASI PHARMACEUTICALS S.R.L.

0.5g 500mg

J01DD04 CEFTRIAXONUM
CEFORT 500 mg CEFTRIAXONE SANDOZ 500 mg MEDAXONE 500 mg

PULB. PT. SOL. INJ./PERF.


500mg 500mg 500mg 0.5g ANTIBIOTICE SA SANDOZ GMBH MEDOCHEMIE LTD

J01DD04 CEFTRIAXONUM
NOVOSEF 0,5 g i.m.

PULB. + SOLV. PT. SOL. INJ./PERF.


ECZACIBASI PHARMACEUTICALS S.R.L.

0.5g

633
SUPRAX

J01DD08

CEFIXIMUM
GRAN. PT. SUSP. ORALA
100mg/5ml GEDEON RICHTER LTD.

J01DD08 CEFIXIMUM J01DD08 CEFIXIMUM


EFICEF 200 mg

100mg/5ml 200mg

CAPS.
200mg ANTIBIOTICE SA

J01DD08 CEFIXIMUM

COMPR. FILM.

200mg

141 / 233

DCI/DENUMIRE COMERCIALA
SUPRAX

CONCENTRATIE
200mg

FORMA FARM.
GEDEON RICHTER LTD.

FIRMA

PROTOCOL

634
LYZONE 1 g MEDOCEF 1 g

J01DD12

CEFOPERAZONUM
PULB. PT. SOL. INJ.
1g 1g 2g 2g 2g 500mg 1g MEDICAROM GROUP S.R.L. MEDOCHEMIE LTD.

J01DD12 CEFOPERAZONUM

1g

J01DD12 CEFOPERAZONUM
LYZONE 2 g MEDOCEF 2 g

PULB. PT. SOL. INJ.


MEDICAROM GROUP S.R.L. MEDOCHEMIE LTD.

2g

J01DD12 CEFOPERAZONUM
CEFOZON 2 g

PULB. PT. SOL. INJ./PERF. I.M./I.V.


E.I.P.I.CO. MED S.R.L.

2g 500mg 1g

J01DD12 CEFOPERAZONUM
CEFOZON 500 mg

PULB. PT. SOL. INJ.


E.I.P.I.CO. MED S.R.L. E.I.P.I.CO. MED S.R.L.

J01DD12 CEFOPERAZONUM
CEFOZON 1 g

PULB. PT. SOL. INJ./PERF.I.M./I.V.

635
CEFROM 1 g

J01DE02

CEFPIROMUM
PULB. PT. SOL. INJ./PERF.
1g 2g LAB. AVENTIS

J01DE02 CEFPIROMUM J01DE02 CEFPIROMUM


CEFROM 2 g

1g 2g

PULB. PT. SOL. INJ./PERF.


LAB. AVENTIS

636
MERONEM IV 1 g

J01DH02

MEROPENEMUM
PULB. PT. SOL. INJ. I.V./PERF.
1g 500mg ASTRAZENECA UK LTD.

J01DH02 MEROPENEMUM J01DH02 MEROPENEMUM


MERONEM IV 500 mg

1g 500mg

PULB. PT. SOL. INJ. I.V./PERF.


ASTRAZENECA UK LTD.

637
TIENAM I.V.

J01DH51

IMIPENEMUM + CILASTATINUM
PULB. PT. SOL. PERF.
MERCK SHARP & DOHME ROMANIA S.R.L.

J01DH51 IMIPENEMUM + CILASTATINUM

638
J01EE01
EPITRIM

J01EE01
SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM
SUSP. ORALA
200mg/40mg /5ml E.I.P.I.CO. MED S.R.L.

200mg/40mg /5ml

Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.

J01EE01
SUMETROLIM

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SIROP
25mg/5mg/ml EGIS PHARMACEUTICALS P.L.C.

25mg/5mg/ml

J01EE01
BISEPTRIM CO - TRIM ELL SUMETROLIM TAGREMIN

COMPR.
400mg/80mg 400mg/80mg 400mg/80mg 400mg/80mg EUROPHARM SA BIO EEL SRL EGIS PHARMACEUTICALS P.L.C. ZENTIVA S.A.

400mg/80mg

Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.

J01EE01
SEPTRIN

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SOL. PERF.
400mg/80mg THE WELLCOME FOUNDATION LTD.

400mg/80mg

639
J01FA02 J01FA02

J01FA02
SPIRAMYCINUM SPIRAMYCINUM

SPIRAMYCINUM
COMPR. FILM.
1.5 M ui 3M ui LAB. AVENTIS

1.5 M ui 3M ui

ROVAMYCINE 1,5 Mil. UI ROVAMYCINE 3 Mil. UI

COMPR. FILM.
LAB. AVENTIS

640
J01FA06

J01FA06
ROXITHROMYCINUM

ROXITHROMYCINUM
COMPR. FILM.
150mg 150mg 150mg 300mg ECZACIBASI ILAC SANAYI VE TICARET AS DAR AL DAWA PHARMA S.R.L ALIUD PHARMA GMBH & CO.KG

150mg

ROKSOLIT ROXAMED 150 ROXITHROMYCIN AL 150

J01FA06

ROXITHROMYCINUM

COMPR. FILM.
ALIUD PHARMA GMBH & CO.KG

300mg

ROXITHROMYCIN AL 300

641
J01FA09

J01FA09
CLARITHROMYCINUM

CLARITHROMYCINUM
GRAN. PT. SUSP. ORALA
125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg/5ml 250mg/5ml 500mg 500mg 500mg 500mg 500mg KRKA D.D. TERAPIA S.A. ABBOTT SPA SANDOZ S.R.L.

125mg/5ml

FROMILID 125 mg/5 ml KLABAX 125 mg/5 ml KLACID LEKOKLAR 125 mg/5 ml

J01FA09

CLARITHROMYCINUM

COMPR. FILM.
MEDICAROM GROUP S.R.L. HEXAL AG OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT SPA MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

250mg

CLAR 250 CLARITROMICIN HEXAL 250 CLARITROMICINA 250 mg FROMILID 250 KLABAX 250 mg KLACID KLERIMED 250 LEKOKLAR 250 mg

J01FA09

CLARITHROMYCINUM

GRAN. PT. SUSP. ORALA


TERAPIA S.A. SANDOZ SRL

250mg/5ml

KLABAX 250 mg/5 ml LEKOKLAR 250 mg/5 ml

J01FA09

CLARITHROMYCINUM

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT LABORATORIES LTD.

500mg

CLAR 500 CLARITROMICINA 500 mg FROMILID 500 KLABAX 500 mg KLACID 500 mg

142 / 233

DCI/DENUMIRE COMERCIALA
KLERIMED 500 LEKOKLAR 500 mg

CONCENTRATIE
500mg 500mg 500mg 500mg 500mg 500mg 500mg

FORMA FARM.
MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

FIRMA

PROTOCOL

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. MODIF.


TERAPIA S.A. LEK PHARMACEUTICALS D.D.

500mg

KLABAX MR 500 mg LEKOKLAR XL 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. PREL.


KRKA D.D. ABBOTT LABORATORIES LTD.

500mg

FROMILID UNO KLACID SR

J01FA09
KLACID I.V.

CLARITHROMYCINUM

LIOF. PT. SOL. PERF.


ABBOTT LABORATORIES LTD.

500mg

642
J01FA10

J01FA10
AZITHROMYCINUM

AZITHROMYCINUM
PULB. PT. SUSP. ORALA
100mg/5ml 100mg/5ml 125mg 125mg 200 mg/5 ml 200mg/5ml 200mg/5ml SANDOZ SRL PLIVA LJUBLIJANA D.O.O.

100mg/5ml

AZITROMICINA SANDOZ 100 mg/5 ml SUMAMED

J01FA10

AZITHROMYCINUM

COMPR. FILM.
GEDEON RICHTER ROMANIA S.A. PLIVA LJUBLJANA D.O.O.

125mg

ORIGEN 125 mg SUMAMED 125 mg

J01FA10 J01FA10 J01FA10 J01FA10

AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM

PULB. PT. SUSP. ORALA


SANDOZ SRL

200 mg/5 ml 200mg/5ml 200mg/5ml 250mg

AZITROMICINA SANDOZ 200 mg/5 ml AZITROX 200 mg/5 ml SUMAMED FORTE AZATRIL 250 mg SUMAMED

PULB. + SOLV. SUSP. ORALA


ECZACIBASI PHARMACEUTICALS S.R.L. PLIVA LJUBLIJANA D.O.O. BALKANPHARMA RAZGRAD AD PLIVA LJUBLIJANA D.O.O.

PULB. PT. SUSP. ORALA CAPS.


250mg 250mg 250mg 250mg 250mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg

J01FA10

AZITHROMYCINUM

COMPR. FILM.
SANDOZ S.R.L. TERAPIA S.A. ZENTIVA AS

250mg

AZITROMICINA SANDOZ 250 mg COMPRIMATE FILMATE AZITROMICINA TERAPIA 250 mg AZITROX 250

J01FA10

AZITHROMYCINUM

COMPR. FILM.
KRKA D.D. NOVO MESTO HEXAL AG SANDOZ S.R.L. TERAPIA S.A. ZENTIVA AS ECZACIBASI PHARMACEUTICALS S.R.L. GEDEON RICHTER ROMANIA S.A. PLIVA LJUBLJANA D.O.O. OZONE LABORATORIES LTD.

500mg

AZIBIOT 500 mg AZITROMICIN HEXAL 500 mg AZITROMICINA SANDOZ 500 mg COMPRIMATE FILMATE AZITROMICINA TERAPIA 500 mg AZITROX 500 AZRO 500 mg ORIGEN 500 mg SUMAMED 500 mg ZITROCIN 500 mg

J01FA10
SUMAMED

AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM AZITHROMYCINUM


2g

LIOF. PT. SOL. PERF.


PLIVA LJUBLJANA D.O.O.

500mg 600mg 250mg 2g

J01FA10 J01FA10 J01FA10


ZMAX 2 g

COMPR. FILM.
600mg 250mg TERAPIA S.A. HEXAL AG PFIZER EUROPE MA EEIG

AZITROMICINA TERAPIA 600 mg AZITROMICIN HEXAL 250 mg

COMPR.FILM GRAN. ELIB. PREL. PT. SUSP. ORALA

643

J01GB03

GENTAMICINUM
SOL. INJ.
40mg/ml 40mg/ml KRKA D.D. NOVO MESTO SANDOZ GMBH

J01GB03 GENTAMICINUM
GENTAMICIN KRKA GENTAMICINA SANDOZ 40 mg/ml

40mg/ml

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01GB03 GENTAMICINUM
GENTAMICIN KRKA GENTAMICINA SANDOZ 40 mg/ml

SOL. INJ.
40mg/ml 40mg/ml KRKA D.D. NOVO MESTO SANDOZ GMBH

40mg/ml

Prescriere limitata: Prescriere limitata: Prescriere limitata:


LYRAMYCIN

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01GB03 GENTAMICINUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
GENTAMICIN KRKA

SOL. PARENT.
40mg/ml MEDICAROM GROUP S.R.L.

40mg/ml

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01GB03 GENTAMICINUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
PAN - GENTAMICINE

SOL. INJ.
80mg/2ml KRKA D.D. NOVO MESTO

80mg/2ml

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01GB03 GENTAMICINUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:

SOL.INJ.
80mg/2ml LAB. PANPHARMA

80mg/2ml

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

644

J01GB06

AMIKACINUM
SOL. INJ.
100mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

J01GB06 AMIKACINUM
AMIKOZIT 100 mg/2 ml

100mg/2ml 250mg/ml
BRISTOL MYERS SQUIBB KFT

J01GB06 AMIKACINUM
AMIKIN

SOL. INJ.
250mg/ml

143 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

J01GB06 AMIKACINUM
AMIKOZIT 500 mg/2 ml

SOL. INJ.
500mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

500mg/2ml

645
NETROMYCINE

J01GB07

NETILMICINUM
SOL. INJ.
150mg/1.5ml SCHERING PLOUGH EUROPE

J01GB07 NETILMICINUM J01GB07 NETILMICINUM


NETROMYCINE

150mg/1.5ml 200mg/2ml
SCHERING PLOUGH EUROPE

SOL. INJ.
200mg/2ml

J01GB07 NETILMICINUM
NETROMYCINE

SOL. INJ.
50mg/2ml SCHERING PLOUGH EUROPE

50mg/2ml

646
OFLOXACIN 200 mg OFLOXIN 200 ZANOCIN

J01MA01

OFLOXACINUM
COMPR. FILM.
200mg 200mg 200mg ANTIBIOTICE SA ZENTIVA AS RANBAXY UK LIMITED

J01MA01 OFLOXACINUM

200mg

J01MA01 OFLOXACINUM
OFLOXIN INF

SOL. PERF.
200mg/100ml 400mg ZENTIVA AS

200mg/100ml 400mg

J01MA01 OFLOXACINUM
ZANOCIN OD 400

COMPR. FILM. ELIB. PREL.


RANBAXY U.K. LIMITED

647

J01MA02

CIPROFLOXACINUM
COMPR. FILM. ELIB. PREL.
1000 mg 100mg/10ml 100mg/10ml BAYER HEALTHCARE AG

J01MA02 CIPROFLOXACINUM
CIPROBAY XR 1000 mg

1000 mg 100mg/10ml

J01MA02 CIPROFLOXACINUM
CIPRINOL CIPROFLOXACINA 100 mg/10 ml

CONC. PT. SOL. PERF.


KRKA D.D. SICOMED SA

J01MA02 CIPROFLOXACINUM
CIPHIN 100mg/50ml CIPRINOL

SOL. PERF.
100mg/50ml 100mg/50ml ZENTIVA A.S. KRKA D.D. NOVO MESTO

100mg/50ml

J01MA02 CIPROFLOXACINUM
CIPHIN 200mg/100ml CIPRINOL CIPROBAY 200

SOL. PERF.
200mg/100ml 200mg/100ml 200mg/100ml ZENTIVA A.S. KRKA D.D. NOVO MESTO BAYER HEALTHCARE AG

200mg/100ml

J01MA02 CIPROFLOXACINUM
EUCIPRIN

CAPS.
250mg EUROPHARM SA

250mg 250mg
TERAPIA SA

J01MA02 CIPROFLOXACINUM
LOXACIL 250 mg

COMPR.
250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 250 CIPRINOL 250 mg CIPROCIN 250 mg CIPROFLOXACIN 250 mg CIPROFLOXACINA ALKALOID 250 mg CIPROLEN 250 mg CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg SERVIFLOX 250 mg

COMPR. FILM.
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO E.I.P.I.CO. MED S.R.L. LAROPHARM SRL ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SANDOZ GMBH

250mg

J01MA02 CIPROFLOXACINUM
CIPROBAY 400 UFEXIL

SOL. PERF.
2mg/ml 2mg/ml BAYER HEALTHCARE AG DEMO SA

2mg/ml

J01MA02 CIPROFLOXACINUM
CIPRINOL

SOL. PERF.
400mg/200ml 500 mg KRKA D.D.

400mg/200ml 500 mg 500mg


TERAPIA S.A.

J01MA02 CIPROFLOXACINUM
CIPROBAY XR 500 mg

COMPR. FILM. ELIB. PREL.


BAYER HEALTHCARE AG

J01MA02 CIPROFLOXACINUM
LOXACIL 500 mg

COMPR.
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 50mg/ml 50mg/ml 750mg

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 500 CIPRINOL 500 mg CIPRO QUIN CIPROBAY 500 CIPROCIN 500 mg CIPRODAR CIPROFLOXACINA ALKALOID 500 mg CIPROLEN 500 mg CIPROLET 500 mg CIPROZONE FORTE 500 mg CUMINOL 500 mg SERVIFLOX 500 mg SIFLOKS

COMPR. FILM.
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO ANTIBIOTICE SA BAYER HEALTHCARE AG E.I.P.I.CO. MED S.R.L. DAR AL DAWA PHARMA S.R.L ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SANDOZ GMBH ECZACIBASI ILAC SANAYI VE TICARET AS

500mg

J01MA02 CIPROFLOXACINUM
CIPROXIN 10% CIPROXIN 5%

MICROCAPS. + DIL.
BAYER AG PHARMA DEUTSCHLAND BAYER AG PHARMA DEUTSCHLAND

50mg/ml

J01MA02 CIPROFLOXACINUM
CIPRINOL 750 mg

COMPR. FILM.
KRKA D.D. NOVO MESTO

750mg 250mg

J01MA02 CIPROFLOXACINUM
LOXACIL 250 mg

COMPR.
250mg TERAPIA SA

Prescriere limitata:
CIFRAN CIPHIN 250 CIPRINOL 250 mg

Gonoreea

J01MA02 CIPROFLOXACINUM

COMPR. FILM.
250mg 250mg 250mg RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO

250mg

144 / 233

DCI/DENUMIRE COMERCIALA
CIPROCIN 250 mg CIPROFLOXACIN 250 mg CIPROFLOXACINA ALKALOID 250 mg CIPROLEN 250 mg CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg SERVIFLOX 250 mg

CONCENTRATIE
250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg

FORMA FARM.
E.I.P.I.CO. MED S.R.L. LAROPHARM SRL ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SANDOZ GMBH

FIRMA

PROTOCOL

Prescriere limitata:

Gonoreea

648

J01MA03

PEFLOXACINUM
COMPR. FILM.
400mg 400mg 400mg/5ml LEK PHARMACEUTICALS D.D. LAROPHARM S.R.L.

J01MA03 PEFLOXACINUM
ABAKTAL PEFLOXACIN LAROPHARM

400mg

J01MA03 PEFLOXACINUM
ABAKTAL 400mg/5ml

CONC. PT. SOL. PERF.


LEK PHARMACEUTICALS D.D.

400mg/5ml

649
NORFLOXACINA - 400

J01MA06
Prescriere limitata: Prescriere limitata:

NORFLOXACINUM
CAPS.
400mg ARENA GROUP SA

J01MA06 NORFLOXACINUM
Enterocolita bacteriana acuta Infectii de tract urinar.

400mg

J01MA06 NORFLOXACINUM
EPINOR H - NORFLOXACIN 400 mg NOLICIN 400 mg NORFLOX - 400 NORFLOXACIN 400 mg NORFLOXACIN OZONE 400 mg NORFLOXACINA LPH 400 mg NORFLOXACINA TERAPIA 400 mg

COMPR. FILM.
400mg 400mg 400mg 400mg 400mg 400mg 400mg 400mg E.I.P.I.CO. MED S.R.L. AC HELCOR SRL KRKA D.D. NOVO MESTO LEK PHARMATECH SRL OZONE LABORATORIES LTD. OZONE LABORATORIES LTD. LABORMED PHARMA SA TERAPIA S.A.

400mg

Prescriere limitata: Prescriere limitata:

Enterocolita bacteriana acuta Infectii de tract urinar.

650

J01MA12

LEVOFLOXACINUM
COMPR. FILM.
250mg 250mg 500mg 500mg ACTAVIS GROUP PTC EHF. AVENTIS PHARMA DEUTSCHLAND GMBH

J01MA12 LEVOFLOXACINUM
LEVOFLOXACINA ACTAVIS 250 mg TAVANIC

250mg

J01MA12 LEVOFLOXACINUM
LEVOFLOXACINA ACTAVIS 500 mg TAVANIC

COMPR. FILM.
ACTAVIS GROUP PTC EHF. AVENTIS PHARMA DEUTSCHLAND GMBH

500mg

J01MA12 LEVOFLOXACINUM
TAVANIC I.V. 250 mg TAVANIC I.V. 500 mg

SOL. PERF.
5mg/ml 5mg/ml AVENTIS PHARMA DEUTSCHLAND GMBH AVENTIS PHARMA DEUTSCHLAND GMBH

5mg/ml

651
AVELOX 400 mg

J01MA14

MOXIFLOXACINUM
COMPR. FILM.
400mg BAYER HEALTHCARE AG

J01MA14 MOXIFLOXACINUM J01MA14 MOXIFLOXACINUM


AVELOX 400 mg/250 ml

400mg 400mg/250ml

SOL. PERF.
400mg/250ml BAYER HEALTHCARE AG

652
J01XA01 J01XA01
EDICIN VANCOMYCIN TEVA

J01XA01
VANCOMYCINUM

VANCOMYCINUM
LIOF. PT. SOL. PERF.
1g 1g TEVA PHARM. WORKS PRIVATE LTD. COMPANY

1g 1g 500mg 1g

VANCOMYCINUM VANCOMYCINUM VANCOMYCINUM


1g

PULB.LIOF.PT.SOL.PERF./INJ
LEK PHARMACEUTICALS D.D.

J01XA01 J01XA01

LIOF. PT. SOL. PERF.


500mg TEVA PHARM. WORKS PRIVATE LTD. COMPANY TEVA PHARM. WORKS PRIVATE LTD. COMPANY

VANCOMYCIN TEVA VANCOMYCIN TEVA

LIOF. PT. SOL. PERF.

Prescriere limitata:

Tratamentul este initiat in spital pentru infectiile cu germeni sensibili la vancomicina

J01XA01
EDICIN

VANCOMYCINUM
1g

PULB.LIOF.PT.SOL.PERF./INJ
LEK PHARMACEUTICALS D.D.

1g

Prescriere limitata:

Tratamentul este initiat in spital pentru infectiile cu germeni sensibili la vancomicina

J01XA01

VANCOMYCINUM

LIOF. PT. SOL. PERF.


500mg TEVA PHARM. WORKS PRIVATE LTD. COMPANY

500mg

VANCOMYCIN TEVA

Prescriere limitata:

Tratamentul este initiat in spital pentru infectiile cu germeni sensibili la vancomicina

J01XA01
EDICIN

VANCOMYCINUM

LIOF. PT. SOL. PERF./INJ.


500mg LEK PHARMACEUTICALS D.D.

500mg

653
J01XA02 J01XA02
TARGOCID 200 mg

J01XA02
TEICOPLANINUM TEICOPLANINUM

TEICOPLANINUM
LIOF. + SOLV. PT. SOL. INJ.
200mg 400mg AVENTIS PHARMA LTD.

200mg 400mg

LIOF. + SOLV. PT. SOL. INJ.


AVENTIS PHARMA LTD.

TARGOCID 400 mg

654
J01XB01

J01XB01
COLISTINUM

COLISTINUM
PULB. PT. SOL. PERF.
1000000ui ANTIBIOTICE SA

1000000ui

COLISTINA ANTIBIOTICE 1000000 UI

655

J01XD01

METRONIDAZOLUM
COMPR.
250mg 250mg 250mg ARENA GROUP SA ARENA GROUP SA

J01XD01 METRONIDAZOLUM
METRONIDAZOL 250 mg (J01XD01) METRONIDAZOL 250 mg (P01AB1)

250mg

J01XD01 METRONIDAZOLUM
FLAGYL

COMPR. FILM.
LABORATOIRE AVENTIS

250mg 5g/l

J01XD01 METRONIDAZOLUM
METRONIDAZOL A 5 g/l METRONIDAZOL B 5 g/l 5g/l 5g/l

SOL. PERF.
INFOMED FLUIDS SRL INFOMED FLUIDS SRL

145 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata: Prescriere limitata:


METRONIDAZOL BRAUN 5mg/ml

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul infectiilor cu germeni anaerobi Tratament in spital al tratamentul acut al infectiilor cu germeni anaerobi

J01XD01 METRONIDAZOLUM
Prescriere limitata: Prescriere limitata:

SOL. PERF.
5mg/ml B. BRAUN MELSUNGEN AG

5mg/ml

Tratamentul infectiilor cu germeni anaerobi Tratament in spital al tratamentul acut al infectiilor cu germeni anaerobi

J01XD01 METRONIDAZOLUM
METRONIDAZOL 250 mg (J01XD01) METRONIDAZOL 250 mg (P01AB1)

COMPR.
250mg 250mg 250mg ARENA GROUP SA ARENA GROUP SA

250mg

J01XD01 METRONIDAZOLUM
FLAGYL

COMPR. FILM.
LABORATOIRE AVENTIS

250mg

Prescriere limitata:
FLAGYL 4 % (J01XD01) FLAGYL 4% (P01AB01)

Tratamentul infectiilor cu anaerobi

J01XD01 METRONIDAZOLUM
4% 4%

SUSP. ORALA
LABORATOIRE AVENTIS LABORATOIRE AVENTIS

4%

656
J01XX08
ZYVOXID

J01XX08
LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID

SOL. PERF.
2mg/ml 400mg 600mg PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

400mg 600mg

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

657
J02AB02

J02AB02
KETOCONAZOLUM

KETOCONAZOLUM
COMPR.
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg ANTIBIOTICE SA SLAVIA PHARM SRL FABIOL S.A. FARMEX COMPANY SRL OZONE LABORATORIES LTD. AC HELCOR SRL MEDUMAN S.A. JANSSEN PHARMACEUTICA NV TERAPIA SA

200mg

KEFUNGIN KETOCONAZOL 200 mg KETOCONAZOL FABIOL 200 mg KETOCONAZOL FARMEX 200 mg KETOCONAZOL OZONE 200 mg KETOSTIN 200 mg N - KETOCONAZOL 200 mg NIZORAL NIZORAL 200 mg

Prescriere limitata: Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade. A fost raportat hepatotoxicitate la ketoconazol.

J02AB02

KETOCONAZOLUM

COMPR.
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg ANTIBIOTICE SA SLAVIA PHARM SRL FABIOL S.A. FARMEX COMPANY SRL OZONE LABORATORIES LTD. AC HELCOR SRL MEDUMAN S.A. JANSSEN PHARMACEUTICA NV TERAPIA SA

200mg

KEFUNGIN KETOCONAZOL 200 mg KETOCONAZOL FABIOL 200 mg KETOCONAZOL FARMEX 200 mg KETOCONAZOL OZONE 200 mg KETOSTIN 200 mg N - KETOCONAZOL 200 mg NIZORAL NIZORAL 200 mg

Prescriere limitata: Candidoza orala la persoanele imunocompromise sever la care tratamentul local nu a avut rezultate Prescriere limitata: Micoze sistemice la care alte forme de terapie antifungica nu au avut efect. A fost raportat hepatotoxicitate la ketoconazol.

658

J02AC01

FLUCONAZOLUM
CAPS.
100mg 100mg 100mg 100mg 100mg 100mg 100mg KRKA D.D. OZONE LABORATORIES LTD. LINCOSA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

J02AC01 FLUCONAZOLUM
DIFLAZON 100 mg FLUCONAZOL 100 mg FLUCONAZOLE LINCOSA 100mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

100mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM
DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL BIOGALENICA 150 mg FLUCONAZOL LAROPHARM 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCONIMED 150 mg FLUCORIC 150 mg FLUCOVIM 150 MEDOFLUCON 150 mg MYCOMAX 150

CAPS.
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. LAROPHARM S.R.L. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL MEDOCHEMIE LTD. ZENTIVA AS

150mg

J02AC01 FLUCONAZOLUM
DIFLAZON 200 mg FLUCONAZOLE LINCOSA 200 mg

CAPS.
200mg 200mg KRKA D.D. LICONSA S.A.

200mg

146 / 233

DCI/DENUMIRE COMERCIALA
FLUCONAZOLE TEVA 200 mg

CONCENTRATIE
200mg

FORMA FARM.
TEVA PHARMACEUTICALS SRL

FIRMA

PROTOCOL

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM
DIFLAZON DIFLUCAN FLUCONAZOL BIOGALENICA 2mg/ml MYCOMAX INF

SOL. PERF.
2mg/ml 2mg/ml 2mg/ml 2mg/ml KRKA D.D. PFIZER EUROPE MA EEIG LABORATOARELE PROF.DR.MORAIT S.R.L. ZENTIVA AS

2mg/ml

J02AC01 FLUCONAZOLUM
DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL BIOGALENICA 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCONIMED 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg MEDOFLUCON 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD MEDOCHEMIE LTD

50mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:
DIFLUCAN 50 mg/5 ml

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM

PULB. PT. SUSP. ORALA


50mg/5ml PFIZER EUROPE MA EEIG

50mg/5ml

659

J02AC02

ITRACONAZOLUM
CAPS.
100mg 100mg 100mg 100mg TERAPIA S.A. MEDICO UNO PHARMACEUTICAL S.R.L. JANSSEN PHARMACEUTICA NV GEDEON RICHTER ROMANIA S.A.

J02AC02 ITRACONAZOLUM
ITRACONAZOL 100 mg OMICRAL 100 mg ORUNGAL SPORILIN 100 mg

100mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Aspergiloza sistemica Histoplasmoza sistemica Tratament si terapia de intretinere la pacienti cu SIDA si histoplasmoza pulmonara diseminata Tratament si terapia de intretinere la pacienti cu SIDA si histoplasmoza pulmonara cronica;

660
VFEND 200mg

J02AC03

VORICONAZOLUM **
COMPR. FILM.
200mg 200mg 40mg/ml 50mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg

J02AC03 VORICONAZOLUM J02AC03 VORICONAZOLUM


VFEND 200mg

PULB. PT. SOL. PERF.


PFIZER LTD. PFIZER LTD. PFIZER LTD.

J02AC03 VORICONAZOLUM
VFEND 40 mg/ml

PULB. PT. SUSP. ORALA COMPR. FILM.

J02AC03 VORICONAZOLUM
VFEND 50mg

661

J02AC04

POSACONAZOLUM **
SUSP. ORALA
40mg/ml 40mg/ml SP EUROPE SP EUROPE

J02AC04 POSACONAZOLUM
NOXAFIL SP 40mg/ml POSACONAZOLE SP 40mg/ml

40mg/ml

662
J02AX04 J02AX04 J02AX04
CANCIDAS 50 mg

J02AX04
CASPOFUNGINUM

CASPOFUNGINUM **
PULB. PT. CONC. PT. SOL. PERF.
50mg 50mg 70mg MERCK SHARP & DOHME LTD

Protocol: J010D
50mg 50mg 70mg

CASPOFUNGINUM CASPOFUNGINUM

PULB. PT. SOL. PERF.


MERCK SHARP & DOHME LTD

CANCIDAS 50 mg CANCIDAS 70 mg

PULB. PT. CONC. PT. SOL. PERF.


MERCK SHARP & DOHME LTD

664
J04AB04
MYCOBUTIN 150 mg

J04AB04
RIFABUTINUM
Prescriere limitata: Prescriere limitata:

RIFABUTINUM
CAPS.
150mg PFIZER EUROPE MA EEIG

150mg

Tratamentul contra infectiilor complexe cu Mycobacterium avium la pacientii HIV-pozitivi Profilaxia contra infectiilor complexe cu Mycobacterium avium la pacientii HIV-pozitivi cu celule CD4 mai putin de 75 pe milimetru cub

665
ISONIAZIDA 100 mg

J04AC01

ISONIAZIDUM
COMPR.
100mg ANTIBIOTICE SA

J04AC01 ISONIAZIDUM J04AC01 ISONIAZIDUM


ISONIAZIDA

100mg 300mg
ANTIBIOTICE SA

COMPR.
300mg

J04AC01 ISONIAZIDUM
IZONIAZIDA 500 mg

SOL. INJ.
500mg/10ml TERAPIA SA

500mg/10ml

666
J04AK01

J04AK01
PYRAZINAMIDUM

PYRAZINAMIDUM
COMPR.
500mg ANTIBIOTICE S.A.

500mg

PIRAZINAMIDA ANTIBIOTICE 500 mg

667
J04AK02

J04AK02
ETHAMBUTOLUM

ETHAMBUTOLUM
CAPS. 250mg

147 / 233

DCI/DENUMIRE COMERCIALA
ETAMBUTOL 250 mg

CONCENTRATIE
250mg 250mg

FORMA FARM.
ARENA GROUP SA

FIRMA

PROTOCOL

J04AK02 J04AK02 J04AK02

ETHAMBUTOLUM ETHAMBUTOLUM ETHAMBUTOLUM

COMPR. FILM.
ANTIBIOTICE SA

250mg 400mg

ETAMBUTOL 250 mg ETAMBUTOL 400 mg ETAMBUTOL 400 mg

CAPS.
400mg 400mg ARENA GROUP SA

COMPR. FILM.
ANTIBIOTICE SA

400mg

668

J04AM02

COMBINATII (RIFAMPICINUM+IZONIAZIDUM)
DRAJ.
150mg+100mg AVENTIS PHARMA LTD.

J04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)


RIFINAH 150mg/100mg

150mg+100mg

J04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)


SINERDOL ISO

CAPS.
300mg+150mg ANTIBIOTICE SA

300mg+150mg

J04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)


RIFINAH 300 mg/150mg

DRAJ.
300mg+150mg AVENTIS PHARMA LTD.

300mg+150mg

669
J05AB01
ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01
ACICLOVIRUM

ACICLOVIRUM
CAPS.
200mg 200mg ARENA GROUP SA EUROPHARM SA

200mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR.
200mg 200mg 200mg 200mg GEDEON RICHTER ROMANIA SA ALSIFCOM INTERMED SRL ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

200mg

ACICLOVIR 200 mg ALS-ACICLOVIR CLOVIRAL 200 mg ZOVIRAX

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR. DISP.
200mg 200mg OZONE LABORATORIES LTD. RANBAXY UK LIMITED

200mg

ACICLOVIR 200 mg LOVIR 200 mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01
VIROLEX

ACICLOVIRUM ACICLOVIRUM

PULB. PT. SOL. INJ./PERF.


250mg KRKA D.D. NOVO MESTO

250mg 400mg

J05AB01

CAPS.
400mg ARENA GROUP S.A.

ACICLOVIR 400 mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

J05AB01

ACICLOVIRUM

COMPR.
400mg EGIS PHARMACEUTICALS P.L.C.

400mg

ACICLOVIR 400 mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

J05AB01
ACIKLOVIR

ACICLOVIRUM

COMPR. FILM.
400mg A & G MED TRADING S.R.L.

400mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

670
J05AB04 J05AB04
COPEGUS REBETOL 200 mg

J05AB04
RIBAVIRINUM RIBAVIRINUM RIBAVIRINUM

RIBAVIRINUM
CAPS.
200mg 200mg 40mg/ml SP EUROPE

200mg 200mg 40mg/ml

COMPR. FILM.
ROCHE ROMANIA SRL SP EUROPE

J05AB04

SOL. ORALA

REBETOL 40 mg/ml

671
J05AB06
CYMEVENE

J05AB06
GANCICLOVIRUM

GANCICLOVIRUM
LIOF. PT. SOL. INJ.
500mg ROCHE ROMANIA S.R.L.

500mg

672
J05AB11
VALTREX 500 mg

J05AB11
VALACYCLOVIRUM
Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

VALACYCLOVIRUM
COMPR. FILM.
500mg THE WELLCOME FOUNDATION LTD.

500mg

Tratamentul pacientilor cu herpes zoster in decurs de 72 de ore de la debutul rash-ului Herpes zoster oftalmic. Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe).

673
J05AB14
VALCYTE 450 mg

J05AB14
VALGANCICLOVIRUM

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

450mg

674
BRIVAL

J05ABN1

BRIVUDINUM
COMPR.
125mg BERLIN CHEMIE AG MENARINI GROUP

J05ABN1 BRIVUDINUM

125mg

675

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA **

148 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA

SOL. PERF.
100mg/ml BAXTER AG

100mg/ml

KIOVIG 100mg/ml

J06BA02

SOL. PERF.
10g/200ml KEDRION SPA

10g/200ml

IG VENA 10g/200ml

J06BA02

SOL. PERF.
1g/20ml KEDRION SPA

1g/20ml

IG VENA 1g/20ml

J06BA02

SOL. PERF.
2.5mg/50ml KEDRION SPA

2.5mg/50ml

IG VENA 2,5g/50ml

J06BA02

SOL. PERF.
50mg/ml 50mg/ml 50mg/ml INSTITUTO GRIFOLS S.A. OCTAPHARMA (IP) LTD. BIOTEST PHARMA GMBH

50mg/ml

FLEBOGAMMADIF 50mg/ml OCTAGAM PENTAGLOBIN

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA
5%

SOL. PERF.
5g/100ml KEDRION SPA

5g/100ml

IG VENA 5g/100ml

J06BA02
HUMAGLOBIN

PULB.+SOLV. PT. SOL. PERF.


TEVA PHARM. WORKS PRIVATE LTD. COMPANY

5%

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA


5%

SOL. PERF.
INSTITUTO GRIFOLS S.A.

5%

FLEBOGAMMA 5%

676
J06BB16
SYNAGIS 100 mg

J06BB16
PALIVIZUMABUM
Prescriere limitata:

PALIVIZUMABUM **
PULB. + SOLV. PT. SOL. INJ.
100mg ABBOTT LABORATORIES LTD.

100mg

Tratamentul combinat al astmului bronsic la pacientii cu simptomatologie necontrolata corespunzator cu corticoizi inhalatori si beta-2-agonisti de scurta durata.

J06BB16

PALIVIZUMABUM
50mg

PULB. + SOLV. PT. SOL. INJ.


ABBOTT LABORATORIES LTD.

50mg

SYNAGIS 50 mg

Prescriere limitata:

Tratamentul combinat al astmului bronsic la pacientii cu simptomatologie necontrolata corespunzator cu corticoizi inhalatori si beta-2-agonisti de scurta durata.

681
NEUPOGEN

L03AA02

FILGRASTIMUM (G-CSF) **
SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

L03AA02 FILGRASTIMUM (G-CSF) L03AA02 FILGRASTIMUM (G-CSF)


NEUPOGEN

30MU/0.5ml 48MU/0.5ml
AMGEN EUROPE B.V.

SOL. INJ.
48MU/0.5ml

682
NETTACIN

S01AA23

NETILMICINUM
PICATURI OFT.-SOL.
0.3% S.I.F.I. SPA

S01AA23 NETILMICINUM S01AA23 NETILMICINUM


NETTAVISC 3mg/g 3mg/g 0.3%

0.3% 3mg/g

UNG. OFT.
S.I.F.I. SPA

S01AA23 NETILMICINUM
NETTACIN

PIC. OFT., SOL


S.I.F.I. SPA

0.3%

683
OKACIN

S01AX17

LOMEFLOXACINUM
PICATURI OFT.-SOL.
3mg/ml NOVARTIS PHARMA GMBH

S01AX17 LOMEFLOXACINUM

3mg/ml

684
NORFLOX

S03AAN2

NORFLOXACINUM
PICATURI OFT./AURIC.-SOL.
0.3% CIPLA (UK) LIMITED

S03AAN2 NORFLOXACINUM

0.3%

685
MAXIDEX

S01BA01

DEXAMETHASONUM
PICATURI OFT.-SUSP.
0.1% ALCON COUVREUR NV

S01BA01 DEXAMETHASONUM S01BA01 DEXAMETHASONUM


MAXIDEX 0.1%

0.1% 0.1%

UNG. OFT.
ALCON COUVREUR NV

S01BA01 DEXAMETHASONUM
DEXAGEL

GEL OFT.
0.985mg/g 1mg/ml DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

0.985mg/g 1mg/ml

S01BA01 DEXAMETHASONUM
DEXAMETAZONA RPH 1mg/ml

PIC. OFT. SUSP.


ROMPHARM COMPANY SRL

149 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-II P1: PROGRAMUL NATIONAL DE BOLI TRANSMISIBILE. B) SUBPROGRAMUL DE TRATAMENT AL BOLNAVILOR CU TUBERCULOZA 686 A11HA02 PYRIDOXINUM
A11HA02 PYRIDOXINUM
VITAMINA B6 250 mg

COMPR.
250 mg ARENA GROUP SA

250 mg 250mg
ZENTIVA SA

A11HA02 PYRIDOXINUM
SICOVIT B6 250 mg

COMPR.
250mg

A11HA02 PYRIDOXINUM
SICOVIT B6 250 mg/5 ml

SOL. INJ.
250mg/5ml ZENTIVA SA

250mg/5ml 50mg/2ml
ZENTIVA SA

A11HA02 PYRIDOXINUM
SICOVIT B6 50 mg/2ml

SOL. INJ.
50mg/2ml

687

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

5mg

688
J01FA09

J01FA09
CLARITHROMYCINUM

CLARITHROMYCINUM
GRAN. PT. SUSP. ORALA
125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg/5ml 250mg/5ml 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg KRKA D.D. TERAPIA S.A. ABBOTT SPA SANDOZ S.R.L.

125mg/5ml

FROMILID 125 mg/5 ml KLABAX 125 mg/5 ml KLACID LEKOKLAR 125 mg/5 ml

J01FA09

CLARITHROMYCINUM

COMPR. FILM.
MEDICAROM GROUP S.R.L. HEXAL AG OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT SPA MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

250mg

CLAR 250 CLARITROMICIN HEXAL 250 CLARITROMICINA 250 mg FROMILID 250 KLABAX 250 mg KLACID KLERIMED 250 LEKOKLAR 250 mg

J01FA09

CLARITHROMYCINUM

GRAN. PT. SUSP. ORALA


TERAPIA S.A. SANDOZ SRL

250mg/5ml

KLABAX 250 mg/5 ml LEKOKLAR 250 mg/5 ml

J01FA09

CLARITHROMYCINUM

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT LABORATORIES LTD. MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

500mg

CLAR 500 CLARITROMICINA 500 mg FROMILID 500 KLABAX 500 mg KLACID 500 mg KLERIMED 500 LEKOKLAR 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. MODIF.


TERAPIA S.A. LEK PHARMACEUTICALS D.D.

500mg

KLABAX MR 500 mg LEKOKLAR XL 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. PREL.


KRKA D.D. ABBOTT LABORATORIES LTD.

500mg

FROMILID UNO KLACID SR

J01FA09
KLACID I.V.

CLARITHROMYCINUM

LIOF. PT. SOL. PERF.


ABBOTT LABORATORIES LTD.

500mg

689
STREVITAL 1 g

J01GA01

STREPTOMYCINUM
PULB. PT. SOL. INJ.
1g 5g ANTIBIOTICE SA

J01GA01 STREPTOMYCINUM J01GA01 STREPTOMYCINUM


STREVITAL 5 g

1g 5g

PULB. PT. SOL. INJ.


ANTIBIOTICE SA

690
PAN - KANAMYCINE

J01GB04

KANAMYCINUM
PULB. PT. SOL. INJ.
1g LAB. PANPHARMA

J01GB04 KANAMYCINUM

1g

691

J01GB06

AMIKACINUM
SOL. INJ.
100mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

J01GB06 AMIKACINUM
AMIKOZIT 100 mg/2 ml

100mg/2ml 250mg/ml
BRISTOL MYERS SQUIBB KFT

J01GB06 AMIKACINUM
AMIKIN

SOL. INJ.
250mg/ml

J01GB06 AMIKACINUM
AMIKOZIT 500 mg/2 ml

SOL. INJ.
500mg/2ml ECZACIBASI PHARMACEUTICALS S.R.L.

500mg/2ml

692
OFLOXACIN 200 mg OFLOXIN 200 ZANOCIN

J01MA01

OFLOXACINUM
COMPR. FILM.
200mg 200mg 200mg ANTIBIOTICE SA ZENTIVA AS RANBAXY UK LIMITED

J01MA01 OFLOXACINUM

200mg

J01MA01 OFLOXACINUM
OFLOXIN INF

SOL. PERF.
200mg/100ml 400mg ZENTIVA AS

200mg/100ml 400mg

J01MA01 OFLOXACINUM
ZANOCIN OD 400

COMPR. FILM. ELIB. PREL.


RANBAXY U.K. LIMITED

693

J01MA02

CIPROFLOXACINUM
COMPR. FILM. ELIB. PREL.
1000 mg 100mg/10ml BAYER HEALTHCARE AG

J01MA02 CIPROFLOXACINUM
CIPROBAY XR 1000 mg

1000 mg 100mg/10ml

J01MA02 CIPROFLOXACINUM
CIPRINOL

CONC. PT. SOL. PERF.


KRKA D.D.

150 / 233

DCI/DENUMIRE COMERCIALA
CIPROFLOXACINA 100 mg/10 ml

CONCENTRATIE
100mg/10ml

FORMA FARM.
SICOMED SA

FIRMA

PROTOCOL

J01MA02 CIPROFLOXACINUM
CIPHIN 100mg/50ml CIPRINOL

SOL. PERF.
100mg/50ml 100mg/50ml ZENTIVA A.S. KRKA D.D. NOVO MESTO

100mg/50ml

J01MA02 CIPROFLOXACINUM
CIPHIN 200mg/100ml CIPRINOL CIPROBAY 200

SOL. PERF.
200mg/100ml 200mg/100ml 200mg/100ml ZENTIVA A.S. KRKA D.D. NOVO MESTO BAYER HEALTHCARE AG

200mg/100ml

J01MA02 CIPROFLOXACINUM
EUCIPRIN

CAPS.
250mg EUROPHARM SA

250mg 250mg
TERAPIA SA

J01MA02 CIPROFLOXACINUM
LOXACIL 250 mg

COMPR.
250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 250 CIPRINOL 250 mg CIPROCIN 250 mg CIPROFLOXACIN 250 mg CIPROFLOXACINA ALKALOID 250 mg CIPROLEN 250 mg CIPROLET 250 mg CIPROZONE 250 mg CUMINOL 250 mg SERVIFLOX 250 mg

COMPR. FILM.
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO E.I.P.I.CO. MED S.R.L. LAROPHARM SRL ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SANDOZ GMBH

250mg

J01MA02 CIPROFLOXACINUM
CIPROBAY 400 UFEXIL

SOL. PERF.
2mg/ml 2mg/ml BAYER HEALTHCARE AG DEMO SA

2mg/ml

J01MA02 CIPROFLOXACINUM
CIPRINOL

SOL. PERF.
400mg/200ml 500 mg KRKA D.D.

400mg/200ml 500 mg 500mg


TERAPIA S.A.

J01MA02 CIPROFLOXACINUM
CIPROBAY XR 500 mg

COMPR. FILM. ELIB. PREL.


BAYER HEALTHCARE AG

J01MA02 CIPROFLOXACINUM
LOXACIL 500 mg

COMPR.
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 50mg/ml 50mg/ml 750mg

J01MA02 CIPROFLOXACINUM
CIFRAN CIPHIN 500 CIPRINOL 500 mg CIPRO QUIN CIPROBAY 500 CIPROCIN 500 mg CIPRODAR CIPROFLOXACINA ALKALOID 500 mg CIPROLEN 500 mg CIPROLET 500 mg CIPROZONE FORTE 500 mg CUMINOL 500 mg SERVIFLOX 500 mg SIFLOKS

COMPR. FILM.
RANBAXY UK LIMITED ZENTIVA A.S. KRKA D.D. NOVO MESTO ANTIBIOTICE SA BAYER HEALTHCARE AG E.I.P.I.CO. MED S.R.L. DAR AL DAWA PHARMA S.R.L ALKALOID D.O.O. AC HELCOR SRL DR. REDDY'S LABORATORIES OZONE LABORATORIES LTD. GEDEON RICHTER ROMANIA SANDOZ GMBH ECZACIBASI ILAC SANAYI VE TICARET AS

500mg

J01MA02 CIPROFLOXACINUM
CIPROXIN 10% CIPROXIN 5%

MICROCAPS. + DIL.
BAYER AG PHARMA DEUTSCHLAND BAYER AG PHARMA DEUTSCHLAND

50mg/ml

J01MA02 CIPROFLOXACINUM
CIPRINOL 750 mg

COMPR. FILM.
KRKA D.D. NOVO MESTO

750mg

694
AVELOX 400 mg

J01MA14

MOXIFLOXACINUM
COMPR. FILM.
400mg BAYER HEALTHCARE AG

J01MA14 MOXIFLOXACINUM J01MA14 MOXIFLOXACINUM


AVELOX 400 mg/250 ml

400mg 400mg/250ml

SOL. PERF.
400mg/250ml BAYER HEALTHCARE AG

696
J04AB01

J04AB01
CICLOSERINUM

CICLOSERINUM
CAPS.
250mg 250mg ANTIBIOTICE S.A. HELP PHARMACEUTICALS LTD.

250mg

CICLOSERINA ANTIBIOTICE 250 mg HELPOCERIN

697
J04AB02
RIFAMPICINA 150 mg SINERDOL 150 mg

J04AB02
RIFAMPICINUM

RIFAMPICINUM
CAPS.
150mg 150mg EUROPHARM SA ANTIBIOTICE SA

150mg

J04AB02

RIFAMPICINUM

CAPS.
300mg ANTIBIOTICE SA

300mg

SINERDOL 300 mg

698
J04AB04
MYCOBUTIN 150 mg

J04AB04
RIFABUTINUM

RIFABUTINUM
CAPS.
150mg PFIZER EUROPE MA EEIG

150mg

700
ISONIAZIDA 100 mg

J04AC01

ISONIAZIDUM
COMPR.
100mg ANTIBIOTICE SA

J04AC01 ISONIAZIDUM J04AC01 ISONIAZIDUM


ISONIAZIDA

100mg 300mg
ANTIBIOTICE SA

COMPR.
300mg

J04AC01 ISONIAZIDUM
IZONIAZIDA 500 mg

SOL. INJ.
500mg/10ml TERAPIA SA

500mg/10ml

701

J04AD01

PROTIONAMIDUM
COMPR. FILM.
250mg ANTIBIOTICE SA

J04AD01 PROTIONAMIDUM
PROTIONAMIDA 250 mg

250mg

702

J04AK01

PYRAZINAMIDUM

151 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
ANTIBIOTICE S.A.

FIRMA

PROTOCOL

J04AK01

PYRAZINAMIDUM

COMPR.
500mg

500mg

PIRAZINAMIDA ANTIBIOTICE 500 mg

703
J04AK02 J04AK02 J04AK02 J04AK02
ETAMBUTOL 250 mg

J04AK02
ETHAMBUTOLUM ETHAMBUTOLUM ETHAMBUTOLUM ETHAMBUTOLUM

ETHAMBUTOLUM
CAPS.
250mg 250mg ARENA GROUP SA

250mg 250mg 400mg


ARENA GROUP SA

COMPR. FILM.
ANTIBIOTICE SA

ETAMBUTOL 250 mg ETAMBUTOL 400 mg ETAMBUTOL 400 mg

CAPS.
400mg 400mg

COMPR. FILM.
ANTIBIOTICE SA

400mg

704

J04AM02

COMBINATII (RIFAMPICINUM+IZONIAZIDUM)
DRAJ.
150mg+100mg AVENTIS PHARMA LTD.

J04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)


RIFINAH 150mg/100mg

150mg+100mg

J04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)


SINERDOL ISO

CAPS.
300mg+150mg ANTIBIOTICE SA

300mg+150mg

J04AM02 COMBINATII (RIFAMPICINUM+IZONIAZIDUM)


RIFINAH 300 mg/150mg

DRAJ.
300mg+150mg AVENTIS PHARMA LTD.

300mg+150mg

152 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-III P3: PROGRAMUL NATIONAL DE ONCOLOGIE. 705 G03HA01 CYPROTERONUM


G03HA01 CYPROTERONUM
ANDROCUR 50mg

Protocol: L025C
50mg
SCHERING AG

COMPR.

Cod restrictie 1014:

Cancer de prostata in stadiu avansat;

706
ENDOXAN 1 g

L01AA01

CYCLOPHOSPHAMIDUM
PULB. PT. SOL. INJ./PERF.
1g 1g 200mg 200mg 500mg 500mg BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM L01AA01 CYCLOPHOSPHAMIDUM


ENDOXAN 1 g

1g 1g 200mg 200mg 500mg 500mg 50mg

PULB. PT. SOL. PERF./INJ. I.V.


ACTAVIS S.R.L.

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 200 mg

PULB. PT. SOL. INJ./PERF.


BAXTER ONCOLOGY GMBH ACTAVIS S.R.L. BAXTER ONCOLOGY GMBH ACTAVIS S.R.L. BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 200 mg

PULB. PT. SOL. PERF./INJ. I.V. PULB. PT. SOL. INJ./PERF. PULB. PT. SOL. PERF./INJ. I.V. DRAJ.
50mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 50 mg

707
LEUKERAN

L01AA02
Prescriere limitata:

CHLORAMBUCILUM
COMPR. FILM.
2mg THE WELLCOME FOUNDATION LTD.

L01AA02 CHLORAMBUCILUM

2mg

Tratamentul limfomului Hodgking, anumite forme de limfoame non-Hodgking, LLC si macroglobulinemia Waldenstrom

708
ALKERAN 2 mg

L01AA03
Prescriere limitata:

MELPHALANUM
COMPR. FILM.
2mg THE WELLCOME FOUNDATION LTD.

L01AA03 MELPHALANUM

2mg

Tratamentul mielomului multiplu, adenocancerului ovarian, cancerului de san avansat, policitemia vera

709
HOLOXAN 1 g

L01AA06
Prescriere limitata: Prescriere limitata:

IFOSFAMIDUM
PULB. PT. SOL. PERF.
1g BAXTER ONCOLOGY GMBH

L01AA06 IFOSFAMIDUM

1g

Tumori refractare/recaderi ale celulelor germinale dup primul ciclu chimioterapeutic Sarcoame refractare/recadere dupa administrarea tratamentului de prima linie.

L01AA06 IFOSFAMIDUM
HOLOXAN 2 g 2g

PULB. PT. SOL. PERF.


BAXTER ONCOLOGY GMBH

2g

Prescriere limitata: Prescriere limitata:


HOLOXAN 500 mg

Tumori refractare/recaderi ale celulelor germinale dup primul ciclu chimioterapeutic Sarcoame refractare/recadere dupa administrarea tratamentului de prima linie.

L01AA06 IFOSFAMIDUM

PULB. PT. SOL. PERF.


500mg BAXTER ONCOLOGY GMBH

500mg

710
MYLERAN

L01AB01
Prescriere limitata:

BUSULFANUM
COMPR. FILM.
2mg THE WELLCOME FOUNDATION LTD.

L01AB01 BUSULFANUM

2mg

Tratament de pregatire a procedurii de transplant atunci cand asocierea unor doze crescute de busulfan si ciclofosfamida reprezinta tratamentul de electie; Tratamentul paliativ al fazei cronice in LGC; Tratamentul polcitemiei vera; Tratamentul mielofibrozei si trombocitemiei

L01AB01 BUSULFANUM
BUSILVEX 6mg/ml

CONC. PT. SOL. PERF.


6mg/ml PIERRE FABRE MEDICAMENT

6mg/ml

Prescriere limitata:

Tratament de pregatire a procedurii de transplant atunci cand asocierea unor doze crescute de busulfan si ciclofosfamida reprezinta tratamentul de electie; Tratamentul paliativ al fazei cronice in LGC; Tratamentul polcitemiei vera; Tratamentul mielofibrozei si trombocitemiei

712
TEMODAL 100 mg

L01AX03
Prescriere limitata:

TEMOZOLOMIDUM **
CAPS.
100mg SP EUROPE

L01AX03 TEMOZOLOMIDUM

100mg

Tratamentul glioblastomului multiform concomitent cu radioterapie. Recadere a astrocitomului anaplastic dupa terapie standard. Recadere a glioblastomului multiform dupa terapie standard. Tratamentul glioblastomului multiform dupa radioterapie NOTA: Astrocitom anaplastic recurent dup terapia standard. Glioblastom multiform recurent dup terapia standard.

L01AX03 TEMOZOLOMIDUM
TEMODAL 140mg

CAPS.
140mg SP EUROPE

140mg

Prescriere limitata:

Tratamentul glioblastomului multiform concomitent cu radioterapie. Recadere a astrocitomului anaplastic dupa terapie standard. Recadere a glioblastomului multiform dupa terapie standard. Tratamentul glioblastomului multiform dupa radioterapie

L01AX03 TEMOZOLOMIDUM
TEMODAL 180 mg

CAPS.
180mg SP EUROPE

180mg

Prescriere limitata:

Tratamentul glioblastomului multiform concomitent cu radioterapie. Recadere a astrocitomului anaplastic dupa terapie standard. Recadere a glioblastomului multiform dupa terapie standard. Tratamentul glioblastomului multiform dupa radioterapie

L01AX03 TEMOZOLOMIDUM
TEMODAL 20 mg 20mg

CAPS.
SP EUROPE

20mg

Prescriere limitata:

Tratamentul glioblastomului multiform concomitent cu radioterapie. Recadere a astrocitomului anaplastic dupa terapie standard. Recadere a glioblastomului multiform dupa terapie standard. Tratamentul glioblastomului multiform dupa radioterapie NOTA: Astrocitom anaplastic recurent dup terapia standard. Glioblastom multiform recurent dup terapia standard.

L01AX03 TEMOZOLOMIDUM
TEMODAL 250 mg

CAPS.
250mg SP EUROPE

250mg

Prescriere limitata:

Tratamentul glioblastomului multiform concomitent cu radioterapie. Recadere a astrocitomului anaplastic dupa terapie standard. Recadere a glioblastomului multiform dupa terapie standard. Tratamentul glioblastomului multiform dupa radioterapie NOTA: Astrocitom anaplastic recurent dup terapia standard. Glioblastom multiform recurent dup terapia standard.

L01AX03 TEMOZOLOMIDUM
TEMODAL 5 mg 5mg

CAPS.
SP EUROPE

5mg

Prescriere limitata:

Tratamentul glioblastomului multiform concomitent cu radioterapie. Recadere a astrocitomului anaplastic dupa terapie standard. Recadere a glioblastomului multiform dupa terapie standard. Tratamentul glioblastomului multiform dupa radioterapie NOTA: Astrocitom anaplastic recurent dup terapia standard. Glioblastom multiform recurent dup terapia standard.

L01AX03 TEMOZOLOMIDUM

153 / 233

DCI/DENUMIRE COMERCIALA
TEMODAL 100 mg

CONCENTRATIE
100mg 20mg 5mg

FORMA FARM.
SP EUROPE SP EUROPE SP EUROPE

FIRMA

PROTOCOL

L01AX03 TEMOZOLOMIDUM
TEMODAL 20 mg

L01AX03 TEMOZOLOMIDUM
TEMODAL 5 mg

713
DALTRIZEN 200 mg

L01AX04

DACARBAZINUM
LIOF. PT. SOL. PERF.
200mg ACTAVIS S.R.L.

L01AX04 DACARBAZINUM

200mg

714

L01BA01

METHOTREXATUM
CONC. PT. SOL. INJ./PERF.
100mg/ml 100mg/ml 100mg/ml 10mg/ml 10mg/ml EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG

L01BA01 METHOTREXATUM
METHOTREXAT "EBEWE" 1000 mg METHOTREXAT "EBEWE" 500 mg METHOTREXAT "EBEWE" 5000 mg

100mg/ml

L01BA01 METHOTREXATUM
METHOTREXAT "EBEWE" 10 mg METHOTREXAT "EBEWE" 50 mg

SOL. INJ./PERF.
EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG

10mg/ml

L01BA01 METHOTREXATUM
METHOTREXATE TEVA 25mg/ml

SOL. INJ.
25mg/ml 50mg TEVA PHARMACEUTICALS S.R.L.

25mg/ml 50mg 5mg/ml


EBEWE PHARMA GMBH NFG. KG

L01BA01 METHOTREXATUM
ANTIFOLAN 50 mg

PULB. PT. SOL. INJ./PERF.


SINDAN SRL

L01BA01 METHOTREXATUM
METHOTREXAT "EBEWE" 5 mg

SOL. INJ.
5mg/ml

715
ALIMTA 100mg

L01BA04
Prescriere limitata:

PEMETREXEDUM ****
PULB. PT. CONC. PT. SOL. PERF.
100mg ELI LILLY NEDERLAND BV

L01BA04 PEMETREXEDUM

100mg

Cancer pulmonar cu celule non-mici avansat local sau metastatic, dupa chimioterapie anterioara cu derivati de platinum. Doze > 500 mg/metru patrat suprafata corporala nu vor fi aprobate pentru compensare. Suprafata corporala a pacientului va trebui declarata in dosarul de aprobare. Prescriere limitata: Tratamentul mesoteliomului in combinatie cu cisplatin. Doze > 500 mg/metru patrat suprafata corporala nu vor fi aprobate pentru compensare. Suprafata corporala a pacientului va trebui declarata in dosarul de aprobare. NOTA: Doze mai mari de 500 mg pe metru ptrat de suprafa corporal nu se vor aproba pentru compensare..

L01BA04 PEMETREXEDUM
ALIMTA 500mg

PULB. PT. CONC. PT. SOL. PERF.


500mg ELI LILLY NEDERLAND BV

500mg

Prescriere limitata:

Cancer pulmonar cu celule non-mici avansat local sau metastatic, dupa chimioterapie anterioara cu derivati de platinum. Doze > 500 mg/metru patrat suprafata corporala nu vor fi aprobate pentru compensare. Suprafata corporala a pacientului va trebui declarata in dosarul de aprobare. Prescriere limitata: Tratamentul mesoteliomului in combinatie cu cisplatin. Doze > 500 mg/metru patrat suprafata corporala nu vor fi aprobate pentru compensare. Suprafata corporala a pacientului va trebui declarata in dosarul de aprobare. NOTA: Doze mai mari de 500 mg pe metru ptrat de suprafa corporal nu se vor aproba pentru compensare..

716
PURI - NETHOL

L01BB02

MERCAPTOPURINUM
COMPR.
50mg THE WELLCOME FOUNDATION LTD.

L01BB02 MERCAPTOPURINUM

50mg

717
LANVIS

L01BB03

TIOGUANINUM
COMPR.
40mg THE WELLCOME FOUNDATION LTD.

L01BB03 TIOGUANINUM

40mg

718
LITAK 2 mg/ml

L01BB04
Prescriere limitata:

CLADRIBINUM
SOL. INJ.
2mg/ml LIPOMED GMBH

L01BB04 CLADRIBINUM
Leucemia cu celule paroase

2mg/ml

719
FLUDARA ORAL

L01BB05

FLUDARABINUM ****
COMPR. FILM.
10mg 50mg SCHERING AG

L01BB05 FLUDARABINUM L01BB05 FLUDARABINUM


FLUDARA

10mg 50mg

LIOF. PT. SOL. INJ./PERF.


SCHERING AG

720
CYTOSAR 100 mg

L01BC01

CYTARABINUM
PULB. + SOLV. PT. SOL. INJ.
100mg PFIZER EUROPE MA EEIG

L01BC01 CYTARABINUM L01BC01 CYTARABINUM


ALEXAN 20mg/ml

100mg 20mg/ml

SOL. INJ.
20mg/ml EBEWE PHARMA GMBH NFG. KG

L01BC01 CYTARABINUM
DEPOCYTE 50mg 50mg

SUSP. INJ.
SKYEPHARMKA PLC

50mg 50mg/ml
EBEWE PHARMA GMBH NFG. KG

L01BC01 CYTARABINUM
ALEXAN 50mg/ml

SOL. INJ.
50mg/ml

721

L01BC02

FLUOROURACILUM
SOL. PERF./INJ.
250mg/5ml ACTAVIS S.R.L.

L01BC02 FLUOROURACILUM
FLUOROSINDAN 250mg/5ml

250mg/5ml 50 mg/g

L01BC02 FLUOROURACILUM
EFUDIX

UNGUENT
50 mg/g 50mg/ml ICN HUNGARY CO. LTD.

L01BC02 FLUOROURACILUM
5 - FLUOROURACIL EBEWE 50mg/ml

CONC. PT. SOL. INJ./PERF.


EBEWE PHARMA GMBH NFG. KG

50mg/ml

722

L01BC05

GEMCITABINUM **
PULB. PT. SOL. PERF.
1g 1g ACTAVIS S.R.L. LILLY FRANCE SAS

L01BC05 GEMCITABINUM
GEMCITABINA SINDAN 1 g GEMZAR 1 g

1g

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:
GEMCITABINA SINDAN 200 mg

Terapia asociata a cancerului mamar avansat cu paclitaxelum dupa esecul terapiei anterioare cu un derivat de antraciclina Terapia asociata a cancerului ovarian epitelial avansat cu carboplatinum la pacientele cu recadere la mai mult de 6 luni dupa chimioterpia cu derivati de platinum Cancer pulmonar cu celule non-mici avansat local sau metastatic Adenocarcinom pancreatic avansat local sau metastatic Tratamentul asociat al cancerului vezical avansat local sau metastatic in combinatie cu cisplatin

L01BC05 GEMCITABINUM

PULB. PT. SOL. PERF.


200mg ACTAVIS S.R.L.

200mg

154 / 233

DCI/DENUMIRE COMERCIALA
GEMZAR 200 mg

CONCENTRATIE
200mg

FORMA FARM.
LILLY FRANCE SAS

FIRMA

PROTOCOL

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Terapia asociata a cancerului mamar avansat cu paclitaxelum dupa esecul terapiei anterioare cu un derivat de antraciclina Terapia asociata a cancerului ovarian epitelial avansat cu carboplatinum la pacientele cu recadere la mai mult de 6 luni dupa chimioterpia cu derivati de platinum Cancer pulmonar cu celule non-mici avansat local sau metastatic Adenocarcinom pancreatic avansat local sau metastatic Tratamentul asociat al cancerului vezical avansat local sau metastatic in combinatie cu cisplatin

723
XELODA 150 mg

L01BC06

CAPECITABINUM
COMPR. FILM.
150mg ROCHE REGISTRATION LTD.

L01BC06 CAPECITABINUM

150mg

Prescriere limitata: Cancer mamar avansat dupa esecul terapiei anterioare cu un taxan si un derivat de antraciclina Prescriere limitata: Cancer mamar avansat in care terapia cu un taxan si/sau un derivat de antraciclina este contraindicata Prescriere limitata: Terapia asociata a cancerului mamar avansat cu docetaxelum dupa esecul terapiei anterioare cu un derivat de antraciclina Prescriere limitata: Tratamentul cancerului colorectal metastatic avansat Prescriere limitata: Tratamentul adjuvant al cancerului de colon stadiul III (Dukes C), dupa rezectia completa a tumorii primare NOTA: Durata recomandata a tratamentului adjuvant este de 24 de saptamani; nu se compenseaza tratamentul cu Capecitabinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal..

L01BC06 CAPECITABINUM
XELODA 500 mg

COMPR. FILM.
500mg ROCHE REGISTRATION LTD.

500mg

Prescriere limitata: Cancer mamar avansat dupa esecul terapiei anterioare cu un taxan si un derivat de antraciclina Prescriere limitata: Cancer mamar avansat in care terapia cu un taxan si/sau un derivat de antraciclina este contraindicata Prescriere limitata: Terapia asociata a cancerului mamar avansat cu docetaxelum dupa esecul terapiei anterioare cu un derivat de antraciclina Prescriere limitata: Tratamentul cancerului colorectal metastatic avansat Prescriere limitata: Tratamentul adjuvant al cancerului de colon stadiul III (Dukes C), dupa rezectia completa a tumorii primare NOTA: Durata recomandata a tratamentului adjuvant este de 24 de saptamani; nu se compenseaza tratamentul cu Capecitabinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal..

724
UFT

L01BC53

COMBINATII (TEGAFUR+URACIL)
CAPS.
100mg+224mg MERCK KGAA

L01BC53 COMBINATII (TEGAFUR+URACIL)

100mg+224mg

726
SINDOVIN 1 mg

L01CA02
Prescriere limitata: Prescriere limitata:

VINCRISTINUM
LIOF. PT. SOL. INJ./PERF. I.V.
1mg ACTAVIS S.R.L.

L01CA02 VINCRISTINUM

1mg

Avansat local sau metastatic cancer pulmonar cu celule non-mici Cancer de sn avansat dup eec prealabil la tratament care include un anthracycline;

727

L01CA04
Prescriere limitata: Prescriere limitata:

VINORELBINUM
CONC. PT. SOL. INJ./PERF.
10mg/ml EBEWE PHARMA GES.M.B.H. NFG KG

L01CA04 VINORELBINUM
VINORELBIN EBEWE 10 mg/ ml

10mg/ml

Cancer mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina Cancer pulmonar cu celule non-mici avansat local sau metastatic

L01CA04 VINORELBINUM
VINORELBIN ACTAVIS 10 mg/ml VINORELBIN TEVA 10 mg/ml

CONC. PT. SOL. PERF.


10mg/ml 10mg/ml ACTAVIS S.R.L. TEVA PHARMACEUTICALS SRL

10mg/ml

Prescriere limitata: Prescriere limitata:


NAVELBINE

Cancer mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina Cancer pulmonar cu celule non-mici avansat local sau metastatic

L01CA04 VINORELBINUM
Prescriere limitata: Prescriere limitata:
NAVELBINE 20 mg

SOL. INJ.
10mg/ml LAB. PIERRE FABRE

10mg/ml

Cancer mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina Cancer pulmonar cu celule non-mici avansat local sau metastatic

L01CA04 VINORELBINUM
20mg

CAPS. MOI
PIERRE FABRE MEDICAMENT

20mg

Prescriere limitata: Prescriere limitata:


NAVELBINE 30 mg

Cancer mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina Cancer pulmonar cu celule non-mici avansat local sau metastatic

L01CA04 VINORELBINUM
30mg

CAPS. MOI
PIERRE FABRE MEDICAMENT

30mg

Prescriere limitata: Prescriere limitata:

Cancer mamar avansat dupa esecul terapiei anterioare cu un derivat de antraciclina Cancer pulmonar cu celule non-mici avansat local sau metastatic

728
LASTET 100 mg VEPESID

L01CB01

ETOPOSIDUM
CAPS. MOI
100mg 100mg 100mg/5ml 100mg/5ml 200mg/10ml 20mg/ml ACTAVIS S.R.L. BRISTOL MYERS SQUIBB KFT

L01CB01 ETOPOSIDUM

100mg

L01CB01 ETOPOSIDUM
ETOPOSID "EBEWE" 100 mg/5 ml SINTOPOZID 100 mg/5 ml

CONC. PT. SOL. PERF.


EBEWE PHARMA GMBH NFG. KG ACTAVIS S.R.L.

100mg/5ml

L01CB01 ETOPOSIDUM
ETOPOSID "EBEWE" 200 mg/10 ml

CONC. PT. SOL. PERF.


EBEWE PHARMA GMBH NFG. KG

200mg/10ml 20mg/ml 25mg

L01CB01 ETOPOSIDUM
ETOPOSIDE - TEVA

CONC. PT. SOL. PERF.


TEVA PHARMACEUTICALS S.R.L. ACTAVIS S.R.L.

L01CB01 ETOPOSIDUM
LASTET 25 mg 25mg

CAPS. MOI CAPS. MOI


50mg 50mg 50mg/2.5ml ACTAVIS S.R.L. BRISTOL MYERS SQUIBB KFT

L01CB01 ETOPOSIDUM
LASTET 50 mg VEPESID

50mg

L01CB01 ETOPOSIDUM
ETOPOSID "EBEWE" 50 mg/2,5 ml

CONC. PT. SOL. PERF.


EBEWE PHARMA GMBH NFG. KG

50mg/2.5ml

729
ABRAXANE 5mg/ml

L01CD01
Prescriere limitata: Prescriere limitata: Prescriere limitata:

PACLITAXELUM **
PULB. PT. SUSP. PERF.
5mg/ml ABRAXIS BIOSCIENCE LIMITED

L01CD01 PACLITAXELUM

5mg/ml

Tratamentul adjuvant al cancerului mamar cu ganglioni pozitivi administrat secvential cu un derivat de antraciclina si ciclofosfamida Cancer mamar avansat dupa esecul terapiei anterioare cu un taxan si un derivat de antraciclina Terapia cancerului ovarian avansat la pacientele cu esec anterior la chimioterapia cu derivati de platinum

155 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata: Prescriere limitata: Prescriere limitata:


ONXOL 6mg/ml PACLITAXEL 6 mg/ml PACLITAXEL EBEWE 6mg/ml PAXENE 6mg/ml SINDAXEL

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Terapia primara a cancerului ovarian in combinatie cu derivati de platinum Cancer pulmonar cu celule non-mici avansat local sau metastatic Terapia asociata a cancerului de san in stadiu precoce (HER2 pozitiv) cu trastuzumab

L01CD01 PACLITAXELUM

CONC. PT. SOL. PERF.


6mg/ml 6mg/ml 6mg/ml 6mg/ml 6mg/ml IVAX - PHARMACEUTICALS S.R.O. PHARMEXPRESS S.R.L. EBEWE PHARMA GES.M.B.H. NFG KG NORTON HEATHCARE LTD ACTAVIS S.R.L.

6mg/ml

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratamentul adjuvant al cancerului mamar cu ganglioni pozitivi administrat secvential cu un derivat de antraciclina si ciclofosfamida Cancer mamar avansat dupa esecul terapiei anterioare cu un taxan si un derivat de antraciclina Terapia cancerului ovarian avansat la pacientele cu esec anterior la chimioterapia cu derivati de platinum Terapia primara a cancerului ovarian in combinatie cu derivati de platinum Cancer pulmonar cu celule non-mici avansat local sau metastatic Terapia asociata a cancerului de san in stadiu precoce (HER2 pozitiv) cu trastuzumab

730

L01CD02

DOCETAXELUM **
CONC. + SOLV. PT. SOL. PERF.
20mg 20mg AVENTIS PHARMA SA AVENTIS PHARMA SA

L01CD02 DOCETAXELUM
DOCETAXEL WINTHROP 20mg TAXOTERE 20 mg

20mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratamentul adjuvant al cancerului mamar cu ganglioni pozitivi in combinatie cu un derivat de antraciclina si ciclofosfamida Cancer mamar avansat dupa esecul terapiei anterioare cu un taxan si un derivat de antraciclina Terapia cancerului ovarian avansat la pacientele cu esec anterior la chimioterapia cu derivati de platinum Cancer pulmonar cu celule non-mici avansat local sau metastatic Terapia asociata a cancerului de san in stadiu precoce (HER2 pozitiv) cu trastuzumab

Tratamentul carcinomului de prostata metastazat (refractar hormonal)androgen independent la un pacient cu scorul Karnofsky de minimum 60%. Chimioterapia cu docetaxel este prima linie de tratament si se va efectua in trei cicluri saptamanale. Un numar de maximum 10 cicluri de tratament cu Docetaxelum va fi autorizat pentru aceasta indicatie NOTA: Maxim 10 cicluri de tratament cu docetaxel vor fi aprobate sub aceast restricie.

L01CD02 DOCETAXELUM
DOCETAXEL WINTHROP 80mg TAXOTERE 80 mg 80mg 80mg

CONC. + SOLV. PT. SOL. PERF.


AVENTIS PHARMA SA AVENTIS PHARMA SA

80mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratamentul adjuvant al cancerului mamar cu ganglioni pozitivi in combinatie cu un derivat de antraciclina si ciclofosfamida Cancer mamar avansat dupa esecul terapiei anterioare cu un taxan si un derivat de antraciclina Terapia cancerului ovarian avansat la pacientele cu esec anterior la chimioterapia cu derivati de platinum Cancer pulmonar cu celule non-mici avansat local sau metastatic Terapia asociata a cancerului de san in stadiu precoce (HER2 pozitiv) cu trastuzumab

Tratamentul carcinomului de prostata metastazat (refractar hormonal)androgen independent la un pacient cu scorul Karnofsky de minimum 60%. Chimioterapia cu docetaxel este prima linie de tratament si se va efectua in trei cicluri saptamanale. Un numar de maximum 10 cicluri de tratament cu Docetaxelum va fi autorizat pentru aceasta indicatie NOTA: Maxim 10 cicluri de tratament cu docetaxel vor fi aprobate sub aceast restricie.

732

L01DB01

DOXORUBICINUM
LIOF. PT. SOL. INJ.
10mg 10mg 2mg/ml 2mg/ml ACTAVIS S.R.L.

L01DB01 DOXORUBICINUM
ADRIBLASTINA RD 10 mg

10mg 10mg 2mg/ml

L01DB01 DOXORUBICINUM
ADRIBLASTINA RD 10 mg

LIOF/SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

L01DB01 DOXORUBICINUM
CAELYX 2 mg/ml DOXORUBICIN "EBEWE" 2mg/ml

CONC. PT. SOL. PERF.


SP EUROPE EBEWE PHARMA GMBH NFG. KG

Prescriere limitata: Prescriere limitata: Prescriere limitata:


SINDROXOCIN 2mg/ml

Cancer ovarian avansat metastatic dup eec prealabil la terapie care include un derivat de platina. Cancer de sn avansat dup eec prealabil la tratament care include un taxan i o capecitabinum Cancer de san metastatic, in monoterapie, unde tratamentul cu capecitabinum si/sau un taxan este contraindicat.

L01DB01 DOXORUBICINUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
DOXORUBICIN TEVA 2 mg/ml

PULB. PT. SOL. PERF.


2mg/ml ACTAVIS S.R.L

2mg/ml

Cancer ovarian avansat metastatic dup eec prealabil la terapie care include un derivat de platina. Cancer de sn avansat dup eec prealabil la tratament care include un taxan i o capecitabinum Cancer de san metastatic, in monoterapie, unde tratamentul cu capecitabinum si/sau un taxan este contraindicat.

L01DB01 DOXORUBICINUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
ADRIBLASTINA RD 50 mg

SOL. INJ.
2mg/ml TEVA PHARMACEUTICALS S.R.L

2mg/ml

Cancer ovarian avansat metastatic dup eec prealabil la terapie care include un derivat de platina. Cancer de sn avansat dup eec prealabil la tratament care include un taxan i o capecitabinum Cancer de san metastatic, in monoterapie, unde tratamentul cu capecitabinum si/sau un taxan este contraindicat.

L01DB01 DOXORUBICINUM
50mg

LIOF. PT. SOL. INJ.


PFIZER EUROPE MA EEIG

50mg 50mg

L01DB01 DOXORUBICINUM
MYOCET 50mg 50mg

PULB. + AMESTC. PT. CONC. PT.DISP.LIPOZOM.PT.PERF


CEPHALON EUROPE

733

L01DB03

EPIRUBICINUM
LIOF. PT. SOL. INJ.
10mg 10mg 10mg ACTAVIS S.R.L. PFIZER EUROPE MA EEIG ACTAVIS S.R.L.

L01DB03 EPIRUBICINUM
EPISINDAN 10 mg FARMORUBICIN RD FARMORUBICIN RD 10 mg

10mg

L01DB03 EPIRUBICINUM
FARMORUBICIN C.S. 10mg/5ml FARMORUBICIN PFS 10 mg/5 ml

SOL. INJ.
10mg/5ml 10mg/5ml 2mg/ml 50mg 50mg 50mg PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

10mg/5ml

L01DB03 EPIRUBICINUM
EPIRUBICIN "EBEWE" 2 mg/ml

CONC. PT. SOL. INJ.


EBEWE PHARMA GMBH NFG. KG

2mg/ml 50mg

L01DB03 EPIRUBICINUM
EPISINDAN 50 mg FARMORUBICIN RD FARMORUBICIN RD 50 mg

LIOF. PT. SOL. INJ.


ACTAVIS S.R.L. PFIZER EUROPE MA EEIG ACTAVIS S.R.L.

L01DB03 EPIRUBICINUM

SOL. INJ.

50mg/25ml

156 / 233

DCI/DENUMIRE COMERCIALA
FARMARUBICIN C.S. 50mg/25ml FARMORUBICIN PFS 50 mg/25 ml

CONCENTRATIE
50mg/25ml 50mg/25ml

FORMA FARM.
PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

FIRMA

PROTOCOL

734
ZAVEDOS

L01DB06
Prescriere limitata:

IDARUBICINUM
CAPS.
10mg PFIZER EUROPE MA EEIG

L01DB06 IDARUBICINUM
Leucemie mieloida acuta

10mg

L01DB06 IDARUBICINUM
ZAVEDOS 5 mg 5mg

LIOF. PT. SOL. INJ.


PFIZER EUROPE MA EEIG

5mg

Prescriere limitata:

Leucemie mieloida acuta

735

L01DB07

MITOXANTRONUM **
CONC. PT. SOL. PERF.
2 mg/ml TEVA PHARMACEUTICALS SRL

L01DB07 MITOXANTRONUM
MITOXANTRONE TEVA 2 mg/ml

2 mg/ml 20mg/10ml

L01DB07 MITOXANTRONUM
NOVANTRONE

SOL. PERF.
20mg/10ml 2mg/ml WYETH LEDERLE PHARMA GMBH

L01DB07 MITOXANTRONUM
ONKOTRONE

CONC. PT. SOL. INJ.


BAXTER ONCOLOGY GMBH

2mg/ml

736
BLEOCIN

L01DC01
Prescriere limitata: Prescriere limitata:

BLEOMYCINUM SULFAS
LIOF. PT. SOL. INJ.
15mg EURO NIPPON KAYAKU GMBH

L01DC01 BLEOMYCINUM SULFAS


Cancer al celulelor germinative limfoame

15mg

738
SINPLATIN 10 mg

L01XA01

CISPLATINUM
LIOF. PT. SOL. PERF.
10mg 10mg/20ml 10mg/20ml ACTAVIS S.R.L.

L01XA01 CISPLATINUM L01XA01 CISPLATINUM


CISPLATIN "EBEWE" 10 mg/20 ml CISPLATIN TEVA 10 mg/20 ml

10mg 10mg/20ml

CONC. PT. SOL. PERF.


EBEWE PHARMA GMBH NFG. KG TEVA PHARMACEUTICALS S.R.L.

L01XA01 CISPLATINUM
CISPLATIN 10 HEXAL PI

SOL. PERF.
10mg/20ml 1mg/1ml 1mg/ml 25mg/50ml 50mg 50mg/100ml 50mg/100ml HEXAL AG

10mg/20ml 1mg/1ml 1mg/ml 25mg/50ml 50mg 50mg/100ml

L01XA01 CISPLATINUM
SINPLATIN 1 mg/1 ml

CONC. PT. SOL. PERF.


ACTAVIS S.R.L. TEVA PHARMACEUTICALS S.R.L. EBEWE PHARMA GMBH NFG. KG ACTAVIS S.R.L.

L01XA01 CISPLATINUM
CISPLATIN TEVA 1 mg/ml

CONC. PT. SOL. PERF. CONC. PT. SOL. PERF. LIOF. PT. SOL. PERF. CONC. PT. SOL. PERF.
EBEWE PHARMA GMBH NFG. KG TEVA PHARMACEUTICALS S.R.L.

L01XA01 CISPLATINUM
CISPLATIN "EBEWE" 25 mg/50 ml

L01XA01 CISPLATINUM
SINPLATIN 50 mg

L01XA01 CISPLATINUM
CISPLATIN "EBEWE" 50 mg/100 ml CISPLATIN TEVA 50 mg/100 ml

L01XA01 CISPLATINUM
CISPLATIN 50 HEXAL PI

SOL. PERF.
50mg/100ml HEXAL AG

50mg/100ml

739

L01XA02

CARBOPLATINUM
CONC. PT. SOL. PERF.
10mg/ml 10mg/ml 10mg/ml 150mg/15ml 450mg/45ml 50mg/5ml EBEWE PHARMA GES.M.B.H. NFG KG ACTAVIS S.R.L. TEVA PHARMACEUTICALS S.R.L.

L01XA02 CARBOPLATINUM
CARBOPLATIN "EBEWE" 10 mg/ml CARBOPLATIN ACTAVIS 10mg/ml CARBOPLATIN TEVA 10mg/ml

10mg/ml

L01XA02 CARBOPLATINUM
CYCLOPLATIN 150

CONC. PT. SOL. PERF.


PLIVA-LACHEMA A.S.

150mg/15ml 450mg/45ml 50mg/5ml

L01XA02 CARBOPLATINUM
CYCLOPLATIN 450

CONC. PT. SOL. PERF.


PLIVA-LACHEMA A.S. PLIVA-LACHEMA A.S.

L01XA02 CARBOPLATINUM
CYCLOPLATIN 50

CONC. PT. SOL. PERF.

740
ELOXATIN 5mg/ml

L01XA03

OXALIPLATINUM
CONC. PT. SOL. PERF.
5mg/ml SANOFI-AVENTIS FRANCE

L01XA03 OXALIPLATINUM

5mg/ml

Prescriere limitata: Cancer colorectal metastazat la un pacient cu status de performanta WHO mai mic sau egal cu 2, in combinatie cu 5-FU si acid folic Prescriere limitata: tratament adjuvant al cancerului de colon stadiul III (Dukes C) in combinatie cu 5-FU si acid folic dupa rezectia completa a tumorii primare NOTA: Nu se compenseaza tratamentul cu Oxaliplatinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal..

L01XA03 OXALIPLATINUM
ELOXATIN 5 mg/ml OXALIPLATIN ACTAVIS 5 mg/ml

LIOF. PT. SOL. PERF.


5mg/ml 5mg/ml SANOFI-AVENTIS FRANCE ACTAVIS S.R.L.

5mg/ml

Prescriere limitata: Cancer colorectal metastazat la un pacient cu status de performanta WHO mai mic sau egal cu 2, in combinatie cu 5-FU si acid folic Prescriere limitata: tratament adjuvant al cancerului de colon stadiul III (Dukes C) in combinatie cu 5-FU si acid folic dupa rezectia completa a tumorii primare NOTA: Nu se compenseaza tratamentul cu Oxaliplatinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal..

L01XA03 OXALIPLATINUM
OXALIPLATIN EBEWE 5mg/ml OXALIPLATIN STADA 5 mg/ml

PULB. PT. SOL. PERF.


5mg/ml 5mg/ml EBEWE PHARMA GES.M.B.H. NFG KG STADA ARZNEIMITTEL AG

5mg/ml

Prescriere limitata: Cancer colorectal metastazat la un pacient cu status de performanta WHO mai mic sau egal cu 2, in combinatie cu 5-FU si acid folic Prescriere limitata: tratament adjuvant al cancerului de colon stadiul III (Dukes C) in combinatie cu 5-FU si acid folic dupa rezectia completa a tumorii primare NOTA: Nu se compenseaza tratamentul cu Oxaliplatinum pentru cancerul de colon stadiul II (Dukes B) si tratamentul adjuvant al pacientilor cu cancer rectal..

742

L01XC04

ALEMTUZUMABUM ****
CONC. PT. SOL. PERF.
10mg/ml 30mg/ml GENZYME EUROPE BV

Protocol: L024C
10mg/ml 30mg/ml

L01XC04 ALEMTUZUMABUM
MABCAMPATH 10 mg/ml

L01XC04 ALEMTUZUMABUM
MABCAMPATH 30 mg/ml

CONC. PT. SOL. PERF.


GENZYME EUROPE BV

743
MABTHERA 100 mg

L01XC02

RITUXIMABUM ****
CONC. PT. SOL. PERF.
10mg/ml ROCHE REGISTRATION LTD.

Protocol: L014C
10mg/ml

L01XC02 RITUXIMABUM

157 / 233

DCI/DENUMIRE COMERCIALA
MABTHERA 500 mg

CONCENTRATIE
10mg/ml

FORMA FARM.
ROCHE REGISTRATION LTD.

FIRMA

PROTOCOL

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:


MABTHERA 100 mg MABTHERA 500 mg

Limfom non Hodgkin's cu celule B (low grade) refractar la tratament sau recadere Limfom non Hodgkin's cu celule B de tip folicular refractar la tratament sau recadere Tratamentul limfomului non Hodgkin's cu celule B de tip (diffuse large), pozitive CD20 asociat chimioterapiei pentru pacientii netratati anterior Tratamentul simptomatic al pacientilor anterior netratati cu limfom non Hodgkin's cu celule B de tip folicular, pozitive CD20, stadiile III sau IV asociat chimioterapiei

L01XC02 RITUXIMABUM

CONC. PT. SOL. PERF.


10mg/ml 10mg/ml ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

10mg/ml

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Limfom non Hodgkin's cu celule B (low grade) refractar la tratament sau recadere Limfom non Hodgkin's cu celule B de tip folicular refractar la tratament sau recadere Tratamentul limfomului non Hodgkin's cu celule B de tip (diffuse large), pozitive CD20 asociat chimioterapiei pentru pacientii netratati anterior Tratamentul simptomatic al pacientilor anterior netratati cu limfom non Hodgkin's cu celule B de tip folicular, pozitive CD20, stadiile III sau IV asociat chimioterapiei

744
HERCEPTIN 150mg

L01XC03
Prescriere limitata:

TRASTUZUMABUM ****
PULB. PT. CONC. PT. SOL. PERF.
150mg ROCHE REGISTRATION LTD.

Protocol: L026C;L033C
150mg

L01XC03 TRASTUZUMABUM

Prescriere limitata:

Tratament initial pentru cancer de san precoce HER2 pozitiv inceput concomitent cu chimioterapie adjuvanta dupa chirurgie. Durata totala a tratamentului rambursat (initial plus de continuare) ce va fi autorizat este de 52 saptamani. Pozitivitatea HER2 trebuie demonstrata prin hibridizare in situ (ISH). Trastuzumab nu trebuie utilizat la pacienti cu o fractie de ejectie ventriculara a ventriculului stang mai mica de 45% si/sau cu insuficienta cardiaca simptomatica. Functia cardiaca trebuie testata printr-o metda adecvata inclusiv, de exemplu, ECHO sau MUGA, inainte de solicitarea aprobarii, si ulterior la intervale de 3 in timpul tratamentului. Solicitarile pentru tratamentul initial trebuie facute in scris si trebuie sa cuprinda: (a) un formular de prescriere completat; si (b) un formular completat cu informatii de sustinere care include: (i) o copie a raportului patologic de la o autoritate patologica acreditatacare confima prezenta amplificarii genei HER2 prin hibridizare in situ (ISH); si (ii) o copie a consimtamantului pacientului. Prescriptorul trebuie sa solicite o cantitate suficienta pe baza greutatii pacientului pentru a acoperi o perioada maxima de 3 saptamani de tratament (echivalentul dozei de incarcare pentru schema de 3 saptamani, si doza de incarcare si 2 doze saptamanale pentru schema cu o doza saptamanala). Tratament de continuare pentru cancer de san precoce HER2 pozitiv unde pacientul a primit anterior tratament rambursat cu trastuzumab. Pacientul poate primi suficient trastuzumab pentru a completa 52 saptamani de tratament combinat compensat si necompensat.Trastuzumab nu trebuie utilizat la pacienti cu o fractie de ejectie ventriculara a ventriculului stang mai mica de 45% si/sau cu insuficienta cardiaca simptomatica. Functia cardiaca trebuie testata printr-o metda adecvata inclusiv, de exemplu, ECHO sau MUGA, inainte de solicitarea aprobarii, si ulterior la intervale de 3 in timpul tratamentului. Prescriptorul trebuie sa solicite o cantitate suficienta pe baza greutatii pacientului pentru a acoperi o perioada maxima de 3 saptamani de tratament (echivalentul a 1 doza pentru schema de 3, sau 3 doze pentru schema cu o doza saptamanala). Pot fi autorizate pana la 3 repetari. Pauze in terapie. Daca un aacient are o pauza in tratamentul cu trastuzumab de mai mult de o saptamanadar mai putin de 6 saptamani de cand trebuia luata ultima doza, se va aproba o noua doza de incarcare.

745
ERBITUX 2mg/ml

L01XC06
Prescriere limitata: Prescriere limitata: Prescriere limitata:

CETUXIMABUM ****
SOL. PERF.
2mg/ml MERCK KGAA

Protocol: L037C
2mg/ml

L01XC06 CETUXIMABUM

Tratamentul initial al cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb pentru saptamana anterioara radioterapiei atunci cand tratamentul cu cisplatin este contraindicat Tratamentul initial al cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb asociat radioterapiei atunci cand tratamentul cu cisplatin nu este tolerat Continuarea tratamentului cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb asociat radioterapiei atunci cand tratamentul cu cisplatin este contraindicata sau nu este tolerata. Doza in cazul acestei indicatii este limitata la un numar de maximum 8 serii de tratament per site sau 10 serii de tratament per site la pacientii la care se intrerupe radioterapia.

L01XC06 CETUXIMABUM
ERBITUX 5mg/ml

SOL. PERF.
5mg/ml MERCK KGAA

5mg/ml

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratamentul initial al cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb pentru saptamana anterioara radioterapiei atunci cand tratamentul cu cisplatin este contraindicat Tratamentul initial al cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb asociat radioterapiei atunci cand tratamentul cu cisplatin nu este tolerat Continuarea tratamentului cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb asociat radioterapiei atunci cand tratamentul cu cisplatin este contraindicata sau nu este tolerata. Doza in cazul acestei indicatii este limitata la un numar de maximum 8 serii de tratament per site sau 10 serii de tratament per site la pacientii la care se intrerupe radioterapia.

L01XC06 CETUXIMABUM
ERBITUX 2mg/ml

SOL. PERF.
2mg/ml MERCK KGAA

2mg/ml

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratamentul initial al cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb pentru saptamana anterioara radioterapiei atunci cand tratamentul cu cisplatin este contraindicat Tratamentul initial al cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb asociat radioterapiei atunci cand tratamentul cu cisplatin nu este tolerat Continuarea tratamentului cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb asociat radioterapiei atunci cand tratamentul cu cisplatin este contraindicata sau nu este tolerata. Doza in cazul acestei indicatii este limitata la un numar de maximum 8 serii de tratament per site sau 10 serii de tratament per site la pacientii la care se intrerupe radioterapia.

L01XC06 CETUXIMABUM
ERBITUX 5mg/ml

SOL. PERF.
5mg/ml MERCK KGAA

5mg/ml

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratamentul initial al cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb pentru saptamana anterioara radioterapiei atunci cand tratamentul cu cisplatin este contraindicat Tratamentul initial al cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb asociat radioterapiei atunci cand tratamentul cu cisplatin nu este tolerat Continuarea tratamentului cancerului de laringe, orofarinx sau hipofarinx cu celule squamoase in stadiile III, IVa sau Ivb asociat radioterapiei atunci cand tratamentul cu cisplatin este contraindicata sau nu este tolerata. Doza in cazul acestei indicatii este limitata la un numar de maximum 8 serii de tratament per site sau 10 serii de tratament per site la pacientii la care se intrerupe radioterapia.

746
AVASTIN 25mg/ml

L01XC07

BEVACIZUMABUM ****
CONC. PT. SOL. PERF.
25mg/ml ROCHE REGISTRATION LTD.

Protocol: L004C
25mg/ml

L01XC07 BEVACIZUMABUM

747
GLIVEC 100 mg

L01XE01

IMATINIBUM ****
CAPS.
100mg 100mg 400mg NOVARTIS EUROPHARM LTD.

Protocol: L008C;L036C;L011
100mg 100mg 400mg 50mg
NOVARTIS EUROPHARM LTD.

L01XE01 IMATINIBUM L01XE01 IMATINIBUM


GLIVEC 100 mg

COMPR. FILM.
NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

L01XE01 IMATINIBUM
GLIVEC 400 mg

COMPR. FILM. CAPS.


50mg

L01XE01 IMATINIBUM
GLIVEC 50 mg

158 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
NOVARTIS EUROPHARM LTD.

FIRMA

PROTOCOL

L01XE01 IMATINIBUM
GLIVEC 100 mg

CAPS.
100mg 100mg 400mg

100mg 100mg 400mg 100mg


NOVARTIS EUROPHARM LTD.

L01XE01 IMATINIBUM
GLIVEC 100 mg

COMPR. FILM.
NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

L01XE01 IMATINIBUM
GLIVEC 400 mg

COMPR. FILM. CAPS.


100mg 100mg 400mg

L01XE01 IMATINIBUM
GLIVEC 100 mg

L01XE01 IMATINIBUM
GLIVEC 100 mg

COMPR. FILM.
NOVARTIS EUROPHARM LTD.

100mg 400mg

L01XE01 IMATINIBUM
GLIVEC 400 mg

COMPR. FILM.
NOVARTIS EUROPHARM LTD.

748
TARCEVA 100 mg

L01XE03

ERLOTINIBUM ****
COMPR. FILM.
100mg 150mg 25mg ROCHE REGISTRATION LTD.

Protocol: L031C
100mg 150mg 25mg

L01XE03 ERLOTINIBUM L01XE03 ERLOTINIBUM


TARCEVA 150 mg

COMPR. FILM.
ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

L01XE03 ERLOTINIBUM
TARCEVA 25 mg

COMPR. FILM.

749
SUTENT 12,5 mg

L01XE04

SUNITINIBUM ****
CAPS.
12,5mg PFIZER LIMITED

Protocol: L042C
12,5mg 25mg
PFIZER LIMITED

L01XE04 SUNITINIBUM L01XE04 SUNITINIBUM


SUTENT 25mg 25mg

CAPS. CAPS.
50mg PFIZER LIMITED

L01XE04 SUNITINIBUM
SUTENT 50 mg

50mg

750
NEXAVAR 200 mg

L01XE05

SORAFENIBUM ****
COMPR. FILM.
200mg BAYER HEALTHCARE AG

Protocol: L038C
200mg

L01XE05 SORAFENIBUM

751
SPRYCEL 20mg

L01XE06

DASATINIBUM ****
COMPR. FILM.
20 mg 50 mg 70 mg 20 mg 50 mg 70 mg BRISTOL-MYERS SQUIBB PHARMA EEIG

Protocol: L035C
20 mg 50 mg 70 mg 20 mg 50 mg 70 mg

L01XE06 DASATINIBUM L01XE06 DASATINIBUM


SPRYCEL 50mg

COMPR. FILM.
BRISTOL-MYERS SQUIBB PHARMA EEIG

L01XE06 DASATINIBUM
SPRYCEL 70mg

COMPR. FILM.
BRISTOL-MYERS SQUIBB PHARMA EEIG

L01XE06 DASATINIBUM
SPRYCEL 20mg

COMPR. FILM.
BRISTOL-MYERS SQUIBB PHARMA EEIG

L01XE06 DASATINIBUM
SPRYCEL 50mg

COMPR. FILM.
BRISTOL-MYERS SQUIBB PHARMA EEIG

L01XE06 DASATINIBUM
SPRYCEL 70mg

COMPR. FILM.
BRISTOL-MYERS SQUIBB PHARMA EEIG

753

L01XX02

ASPARAGINAZUM
LIOF. PT. SOL. INJ./PERF.
10000ui 5000ui

L01XX02 ASPARAGINAZUM
ASPARAGINASE 10000 MEDAC

10000ui 5000ui

MEDAC GESELLSCAFT FUR KLINISCHE SPEZIALPRPARATE MEDAC GESELLSCAFT FUR KLINISCHE SPEZIALPRPARATE

L01XX02 ASPARAGINAZUM
ASPARAGINASE 5000 MEDAC

LIOF. PT. SOL. INJ./PERF.

754
SIKLOS 1000mg

L01XX05

HYDROXYCARBAMIDUM
COMPR. FILM.
1000 mg ADDMEDICA

L01XX05 HYDROXYCARBAMIDUM L01XX05 HYDROXYCARBAMIDUM


HYDREA

1000 mg 500mg

CAPS.
500mg BRISTOL MYERS SQUIBB KFT

755
ESTRACYT

L01XX11

ESTRAMUSTINUM
CAPS.
140mg PFIZER EUROPE MA EEIG

L01XX11 ESTRAMUSTINUM

140mg

757
HYCAMTIN 1 mg/1ml

L01XX17

TOPOTECAMUM
PULB.CONC.SOL.PERF.
1mg/1ml 4mg SMITHKLINE BEECHAM PLC

L01XX17 TOPOTECAMUM L01XX17 TOPOTECAMUM


HYCAMTIN 4 mg

1mg/1ml 4mg

PULB.CONC.SOL.PERF.
SMITHKLINE BEECHAM PLC

Prescriere limitata:

Cancer ovarian avansat metastatic dup eec prealabil la tratament care include un derivat de platina.

758
CAMPTO 100 mg/5 ml IRINOTESIN 20mg/ml

L01XX19

IRINOTECANUM
CONC. PT. SOL. PERF.
20mg/ml 20mg/ml PFIZER EUROPE MA EEIG ACTAVIS S.R.L.

L01XX19 IRINOTECANUM

20mg/ml

Prescriere limitata: Cancer colorectal metastatic la pacienti cu un status de performanta OMS de 2 sau mai putin NOTA: La utilizarea de prim linie, eficiena i tolerana pot fi mbuntite cnd irinotecan este combinat cu administrarea parenteral a unei scheme cu 5-fluorouracil..

L01XX19 IRINOTECANUM
CAMPTO 100 mg/5 ml IRINOTESIN 20mg/ml

CONC. PT. SOL. PERF.


20mg/ml 20mg/ml PFIZER EUROPE MA EEIG ACTAVIS S.R.L.

20mg/ml

Prescriere limitata: Cancer colorectal metastatic la pacienti cu un status de performanta OMS de 2 sau mai putin NOTA: La utilizarea de prim linie, eficiena i tolerana pot fi mbuntite cnd irinotecan este combinat cu administrarea parenteral a unei scheme cu 5-fluorouracil..

759
VELCADE 3,5 mg

L01XX32

BORTEZOMIBUM ****
PULB. PT. SOL. INJ.
3.5mg JANSSEN-CILAG INTERNATIONAL NV

Protocol: L012C
3.5mg

L01XX32 BORTEZOMIBUM

760
MEGESIN 160 mg

L02AB01

MEGESTROLUM
COMPR.
160mg ACTAVIS S.R.L.

L02AB01 MEGESTROLUM

160mg

159 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata:


MEGACE

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Cancer de sn hormonodependent avansat.

L02AB01 MEGESTROLUM

SUSP. ORALA
40mg/ml BRISTOL MYERS SQUIBB KFT

40mg/ml

761

L02AE02
Prescriere limitata:

LEUPRORELINUM **
LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.
11.25mg ABBOTT LABORATORIES S.A.

L02AE02 LEUPRORELINUM
LUCRIN DEPOT 11,25mg

11.25mg

Carcinom al prostatei avansat local (echivalent stadiului C) sau metastatic (echivalent stadiului D).

L02AE02 LEUPRORELINUM
ELIGARD 22,5 mg

LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.


22.5mg ASTELLAS PHARMA EUROPE B.V.

11.25mg

Prescriere limitata:
ELIGARD 22,5 mg

Carcinom al prostatei avansat local (echivalent stadiului C) sau metastatic (echivalent stadiului D).

L02AE02 LEUPRORELINUM
Prescriere limitata:
ELIGARD 45 mg

LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.


22.5mg ASTELLAS PHARMA EUROPE B.V.

11.25mg

Carcinom al prostatei avansat local (echivalent stadiului C) sau metastatic (echivalent stadiului D).

L02AE02 LEUPRORELINUM
45mg

LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.


ASTELLAS PHARMA EUROPE B.V.

11.25mg

Prescriere limitata:
ELIGARD 7,5 mg

Carcinom al prostatei avansat local (echivalent stadiului C) sau metastatic (echivalent stadiului D).

L02AE02 LEUPRORELINUM
7.5mg

LIOF.+ SOLV. PT. SUSP. INJ. ELIB. PREL.


ASTELLAS PHARMA EUROPE B.V.

11.25mg

Prescriere limitata:

Carcinom al prostatei avansat local (echivalent stadiului C) sau metastatic (echivalent stadiului D).

762
ZOLADEX LA

L02AE03
Prescriere limitata:

GOSERELINUM **
IMPLANT
10,8mg ASTRAZENECA UK LTD.

L02AE03 GOSERELINUM

10,8mg

Carcinom al prostatei avansat local (echivalent stadiului C) sau metastatic (echivalent stadiului D).

L02AE03 GOSERELINUM
ZOLADEX 3.6mg

IMPLANT
ASTRAZENECA UK LTD.

3.6mg

Prescriere limitata: Prescriere limitata:

Carcinom al prostatei avansat local (echivalent stadiului C) sau metastatic (echivalent stadiului D). Cancer de sn hormonodependent avansat local (echivalent cu stadiul III) sau metastatic (echivalent cu stadiul IV) la femei n premenopauz;

763
DIPHERELINE 0,1 mg

L02AE04
Prescriere limitata:

TRIPTORELINUM **
LIOF. + SOLV. PT. SOL. INJ.
0.1mg BEAUFOUR IPSEN PHARMA

L02AE04 TRIPTORELINUM

0.1mg

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

L02AE04 TRIPTORELINUM
DIPHERELINE 11,25 mg

LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.


11.25mg BEAUFOUR IPSEN PHARMA

11.25mg

Prescriere limitata:
DIPHERELINE 3,75 mg

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

L02AE04 TRIPTORELINUM
Prescriere limitata:

LIOF.+ SOLV. PT. SUSP. INJ. I.M. ELIB. PREL.


3.75mg BEAUFOUR IPSEN PHARMA

3.75mg

Tratamentul de scurta durata (pana la 6 luni) al endometriozei confirmate histologic

764
TAMONEPRIN 10 mg TAMOXIFEN 10 TEVA

L02BA01

TAMOXIFENUM
COMPR.
10mg 10mg ACTAVIS S.R.L. PHARMACHEMIE BV

L02BA01 TAMOXIFENUM

10mg

Prescriere limitata:
TAMOXIFEN 10 HEXAL

Cancer de sn hormonodependent

L02BA01 TAMOXIFENUM
10mg

COMPR. FILM.
HEXAL AG

10mg

Prescriere limitata:
TAMOXIFEN 20 TEVA

Cancer de sn hormonodependent

L02BA01 TAMOXIFENUM
20mg

COMPR.
PHARMACHEMIE BV

20mg

Prescriere limitata:
TAMOXIFEN 30 TEVA

Cancer de sn hormonodependent

L02BA01 TAMOXIFENUM
30mg

COMPR.
PHARMACHEMIE BV

30mg 40mg
PHARMACHEMIE BV

L02BA01 TAMOXIFENUM
TAMOXIFEN 40 TEVA 40mg

COMPR.

765
FASLODEX 250mg/5ml

L02BA03

FULVESTRANTUM **
SOL. INJ.
250mg/5ml ASTRAZENECA UK LTD.

Protocol: L003C
250mg/5ml

L02BA03 FULVESTRANTUM

766
FLUTAN FLUTASIN 250 mg

L02BB01

FLUTAMIDUM
COMPR.
250mg 250mg MEDOCHEMIE LTD. ACTAVIS S.R.L.

L02BB01 FLUTAMIDUM

250mg

Prescriere limitata:

Carcinom prostatic metastatic (echivalent cu stadiul D) n combinaie cu Tratament cu agoniti GnRH (LH-RH).

L02BB01 FLUTAMIDUM
FLUTAMIDE CSC 250 mg

COMPR. FILM.
250mg CSC PHARMACEUTICALS HANDELS GMBH

250mg

Prescriere limitata:

Carcinom prostatic metastatic (echivalent cu stadiul D) n combinaie cu Tratament cu agoniti GnRH (LH-RH).

767
CASODEX 150 mg

L02BB03

BICALUTAMIDUM
COMPR. FILM.
150mg 50mg 50mg 50mg ASTRAZENECA UK LTD.

L02BB03 BICALUTAMIDUM L02BB03 BICALUTAMIDUM


BICALUTAMID STADA 50 mg CALUMID CASODEX 50 mg

150mg 50mg

COMPR. FILM.
STADA ARZNEIMITTEL AG GEDEON RICHTER PLC. ASTRAZENECA UK LTD.

Prescriere limitata:

Carcinom prostatic metastatic (echivalent cu stadiul D) n combinaie cu Tratament cu agoniti GnRH (LH-RH).

768
ROGLUTEN 250 mg

L02BG01

AMINOGLUTETHIMIDUM
COMPR.
250mg ACTAVIS S.R.L.

L02BG01 AMINOGLUTETHIMIDUM

250mg

769
ARIMIDEX ARIMIDEX 1 mg

L02BG03

ANASTROZOLUM
COMPR. FILM.
1mg 1mg ACTAVIS S.R.L. ASTRAZENECA UK LTD.

L02BG03 ANASTROZOLUM

1mg

Prescriere limitata:

Tratamentul hormonodependent cancer de sn la femei n post-menopauz.

160 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

770
FEMARA 2,5 mg

L02BG04
Prescriere limitata: Prescriere limitata: Prescriere limitata:

LETROZOLUM
COMPR. FILM.
2.5mg NOVARTIS PHARMA GMBH

L02BG04 LETROZOLUM

2.5mg

Tratamentul hormonodependent cancer de sn la femei n post-menopauz Tratamentul hormonodependent cancer de sn la femei n post-menopauz Adjuvant extins n tratamentul tratamentul hormonodependent al cancerului de sn depistat precoce la femei n post-menopauz nceput n primele 6 luni de la ntreruperea tratamentului cu tamoxifen citrate.

771
AROMASIN 25 mg

L02BG06
Prescriere limitata: Prescriere limitata:

EXEMESTANUM
DRAJ.
25mg PFIZER EUROPE MA EEIG

L02BG06 EXEMESTANUM

25mg

Adjuvant extins n tratamentul tratamentul hormonodependent al cancerului de sn depistat precoce la femei n post-menopauz nceput n primele 6 luni de la ntreruperea tratamentului cu tamoxifen citrate. Tratamentul hormonodependent al cancerului de sn avansat la femei n post-menopauz dup minim 2 ani de tratament cu tamoxifen citrate.

772
NEUPOGEN

L03AA02

FILGRASTIMUM (G-CSF) **
SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

L03AA02 FILGRASTIMUM (G-CSF) L03AA02 FILGRASTIMUM (G-CSF)


NEUPOGEN

30MU/0.5ml 48MU/0.5ml
AMGEN EUROPE B.V.

SOL. INJ.
48MU/0.5ml

773
NEULASTA 6mg NEUPOPEG 6mg

L03AA13

PEGFILGRASTIMUM ***
SOL. INJ.
6mg 6mg 6mg 6mg/l AMGEN EUROPE B.V. DOMPE BIOTEC S.P.A.

L03AA13 PEGFILGRASTIMUM

6mg

L03AA13 PEGFILGRASTIMUM
NEULASTA 6mg

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE B.V.

6mg 6mg/l

L03AA13 PEGFILGRASTIMUM
NEUPOPEG 6mg

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


DOMPE BIOTEC S.P.A.

774
ROFERON A

L03AB04

INTERFERONUM ALFA 2a ***


SOL. INJ.
18Mui/0.6ml ROCHE ROMANIA S.R.L.

L03AB04 INTERFERONUM ALFA 2a

18Mui/0.6ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
3Mui/0.5ml ROCHE ROMANIA S.R.L.

3Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
4.5Mui/0.5ml ROCHE ROMANIA S.R.L.

4.5Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
6Mui/0.5ml ROCHE ROMANIA S.R.L.

6Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB04 INTERFERONUM ALFA 2a


ROFERON A

SOL. INJ.
9Mui/0.5ml ROCHE ROMANIA S.R.L.

9Mui/0.5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

775

L03AB05

INTERFERONUM ALFA 2b ***


SOL. INJ./PERF.
10 milioane U.I./ml SP EUROPE

Protocol: L016C
10 milioane U.I./ml

L03AB05 INTERFERONUM ALFA 2b


INTRON A 10 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 10milioane UI/ml

PULB. + SOLV. PT. SOL. INJ.


10milioane UI/ml SCHERING PLOUGH EUROPE

10milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 10milioane UI/ml

SOL. INJ.
10milioane UI/ml SCHERING PLOUGH EUROPE

10milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 18 milioane U.I./0,3ml

SOL. INJ./PERF.
18 milioane U.I./0,3 ml SP EUROPE

18 milioane U.I./0,3 ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 18 milioane UI/3ml

SOL. INJ.
18 milioane UI/3ml SCHERING PLOUGH EUROPE

18 milioane UI/3ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 1milionUI/ml

PULB. + SOLV. PT. SOL. INJ.


1milionUI/ml SCHERING PLOUGH EUROPE

1milionUI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 25 milioane U.I./2,5ml

SOL. INJ./PERF.
25 milioane U.I./2,5 ml SP EUROPE

25 milioane U.I./2,5 ml

161 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 25milioane UI/2,5ml

SOL. INJ.
25milioane UI/2,5ml SCHERING PLOUGH EUROPE

25milioane UI/2,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 3 milioane U.I./0,5ml

SOL. INJ./PERF.
3 milioane U.I./0,5ml SP EUROPE

3 milioane U.I./0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 3milioane UI/0,5ml

SOL. INJ.
3milioane UI/0,5ml SCHERING PLOUGH EUROPE

3milioane UI/0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 3milioane UI/ml

PULB. + SOLV. PT. SOL. INJ.


3milioane UI/ml SCHERING PLOUGH EUROPE

3milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 5 milioane U.I./0,5ml

SOL. INJ./PERF.
5 milioane U.I./0,5ml SP EUROPE

5 milioane U.I./0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 5milioane UI/0,5ml

SOL. INJ.
5milioane UI/0,5ml SCHERING PLOUGH EUROPE

5milioane UI/0,5ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 5milioane UI/ml

PULB. + SOLV. PT. SOL. INJ.


5milioane UI/ml SCHERING PLOUGH EUROPE

5milioane UI/ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 1 milion U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


1 milion U.I./ml SP EUROPE

1 milion U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 10 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


10 milioane U.I./ml SP EUROPE

10 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 18 milioane U.I.

SOL. INJ. PEN MULTIDOZA


18 milioane U.I. SP EUROPE

18 milioane U.I.

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 18 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


18 milioane U.I./ml SP EUROPE

18 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 18milioane UI

SOL. INJ. PEN MULTIDOZA


18milioane UI SCHERING PLOUGH EUROPE

18milioane UI

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 3 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


3 milioane U.I./ml SP EUROPE

3 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

SOL. INJ. PEN MULTIDOZA


30 milioane U.I. 60 milioane U.I. SP EUROPE SP EUROPE

30 milioane U.I.

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 30 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


30 milioane U.I./ml SP EUROPE

30 milioane U.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 30milioane UI

SOL. INJ. PEN MULTIDOZA


30milioane UI SCHERING PLOUGH EUROPE

30milioane UI

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 5 milioane U.I./ml

PULB+SOLV. PT. SOL. INJ./PERF.


5 milioaneU.I./ml SP EUROPE

5 milioaneU.I./ml

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


INTRON A 30 milioane U.I. INTRON A 60 milioane U.I.

SOL. INJ. PEN MULTIDOZA


30 milioane U.I. 60 milioane U.I. SP EUROPE SP EUROPE

60 milioane U.I.

162 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

L03AB05 INTERFERONUM ALFA 2b


VIRAFERON 60milioane UI

SOL. INJ. PEN MULTIDOZA


60milioane UI SCHERING PLOUGH EUROPE

60milioane UI

Tratamentul cu interferon alfa a fost asociat cu depresie i suicid la unii pacieni. Pacienii cu istoric de ideaie suicidar sau boal depresiv trebuie avertizai de riscuri. Trebuie monitorizat statusul psihiatric n timpul tratamentului

777

M05BA02

ACIDUM CLODRONICUM **
CONC. PT. SOL. PERF.
300mg/5ml ACTAVIS S.R.L.

M05BA02 ACIDUM CLODRONICUM


SINDRONAT 300 mg/5 ml

300mg/5ml 400mg

M05BA02 ACIDUM CLODRONICUM


BONEFOS 400 mg CLODROBON 400 mg SINDRONAT 400 mg

CAPS.
400mg 400mg 400mg SCHERING OY (SCHERING AG) SCHERING OY (SCHERING AG) ACTAVIS S.R.L.

Prescriere limitata: Prescriere limitata: Prescriere limitata:


BONEFOS 60 mg/ml

Metastaze osoase consecutive cancerului de san. Tratament de ntreinere in hipercalcemia din cancerele refractare la terapia antineoplazica Mielomul multiplu

M05BA02 ACIDUM CLODRONICUM M05BA02 ACIDUM CLODRONICUM


BONEFOS 800 mg

CONC. PT. SOL. PERF.


60mg/ml 800mg SCHERING OY

60mg/ml 800mg

COMPR. FILM.
SCHERING OY

778
AREDIA 15 mg

M05BA03

ACIDUM PAMIDRONICUM **
LIOF.+ SOLV. PT. SOL. PERF.
15mg 15mg/ml 30mg 60mg NOVARTIS PHARMA GMBH

M05BA03 ACIDUM PAMIDRONICUM M05BA03 ACIDUM PAMIDRONICUM


PAMIDRONAT TORREX

15mg 15mg/ml 30mg 60mg

CONC. PT. SOL. PERF.


TORREX CHIESI PHARMA GMBH DR. REDDY'S LABORATORIES

M05BA03 ACIDUM PAMIDRONICUM


PAMIRED 30

LIOF. PT. SOL. PERF. I.V. LIOF. PT. SOL. PERF. I.V.
DR. REDDY'S LABORATORIES

M05BA03 ACIDUM PAMIDRONICUM


PAMIRED 60

779
BONDEZA 150mg BONVIVA 150mg

M05BA06

ACIDUM IBANDRONICUM **
COMPR. FILM.
150mg 150mg 2.5mg 2.5mg 2mg/2ml 50mg 6mg/6ml 3mg/3ml 3mg/3ml ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

M05BA06 ACIDUM IBANDRONICUM

150mg

M05BA06 ACIDUM IBANDRONICUM


BONDEZA 2.5mg BONVIVA 2.5mg

COMPR. FILM.
ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

2.5mg

M05BA06 ACIDUM IBANDRONICUM


BONDRONAT 2mg/2ml

CONC. PT. SOL. PERF.


ROCHE REGISTRATION LTD.

2mg/2ml 50mg 6mg/6ml 3mg/3ml

M05BA06 ACIDUM IBANDRONICUM


BONDRONAT 50mg

COMPR. FILM.
ROCHE REGISTRATION LTD.

M05BA06 ACIDUM IBANDRONICUM


BONDRONAT 6mg/6ml

CONC. PT. SOL. PERF.


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD

M05BA06 ACIDUM IBANDRONICUM


BONDEZA 3mg/3ml BONVIVA 3mg/3ml

SOL. INJ. IN SERINGA PREUMPLUTA

780
ZOMETA 4 mg

M05BA08

ACIDUM ZOLEDRONICUM **
PULB. + SOLV. SOL. PERF.
4mg 4mg/5ml NOVARTIS EUROPHARM LTD.

M05BA08 ACIDUM ZOLEDRONICUM M05BA08 ACIDUM ZOLEDRONICUM


ZOMETA 4 mg/5 ml

4mg 4mg/5ml 5mg/100ml

CONC. PT. SOL. PERF.


NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

M05BA08 ACIDUM ZOLEDRONICUM


ACLASTA 5mg/100ml

SOL. PERF.
5mg/100ml

781

V03AF01
Prescriere limitata:

MESNUM
SOL. INJ.
400mg/4ml BAXTER ONCOLOGY GMBH

V03AF01 MESNUM
UROMITEXAN 400 mg

400mg/4ml

Terapie adjuvanta in regimurile chimioterapice cu ifosfamida sau doze ridicate de ciclofosfamida

782

V03AF03

CALCII FOLINAS
SOL. INJ.
10mg/ml 10mg/ml 10mg/ml 10mg/ml ACTAVIS S.R.L. ACTAVIS S.R.L. TEVA PHARM. IND. LTD. TEVA PHARMACEUTICALS S.R.L.

V03AF03 CALCII FOLINAS


FOLCASIN 10 mg/ml FOLCASIN 100 mg/10 ml LEUCOVORIN-TEVA 100 mg/10 ml LEUCOVORIN-TEVA 50 mg/5 ml

10mg/ml

V03AF03 CALCII FOLINAS


FOLCASIN 10 mg/ml FOLCASIN 100 mg/10 ml LEUCOVORIN-TEVA 100 mg/10 ml LEUCOVORIN-TEVA 50 mg/5 ml

SOL. INJ.
10mg/ml 10mg/ml 10mg/ml 10mg/ml 10mg/ml ACTAVIS S.R.L. ACTAVIS S.R.L. TEVA PHARM. IND. LTD. TEVA PHARMACEUTICALS S.R.L.

10mg/ml

V03AF03 CALCII FOLINAS


CALCIUMFOLINAT "EBEWE" 10 mg/ml

SOL. INJ./PERF.
EBEWE PHARMA GMBH NFG. KG

10mg/ml 15mg

V03AF03 CALCII FOLINAS


CALCIUM FOLINAT "EBEWE" 15 mg 15mg

CAPS.
EBEWE PHARMA GES.M.B.H. NFG KG

Prescriere limitata:
FOLCASIN 30 mg/10 ml

Antidot pentru antagonisti de acid folic

V03AF03 CALCII FOLINAS

SOL. INJ.
3mg/ml ACTAVIS S.R.L.

3mg/ml

783
ETHYOL

V03AF05

AMIFOSTINUM **
LIOF. PT. SOL. PERF.
375mg 500mg SCHERING PLOUGH EUROPE

V03AF05 AMIFOSTINUM V03AF05 AMIFOSTINUM


ETHYOL

375mg 500mg

LIOF. PT. SOL. PERF.


SCHERING PLOUGH EUROPE

163 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-IV P4: PROGRAMUL NATIONAL DE BOLI NEUROLOGICE. SUBPROGRAMUL DE TRATAMENT AL SCLEROZEI MULTIPLE 784 L03AB07 INTERFERONUM BETA 1a ****
L03AB07 INTERFERONUM BETA 1a
REBIF 22 micrograme

Protocol: L002G

SOL. INJ.
22g/0,5ml 30g (6 mil. UI) SERONO EUROPE LTD.

22g/0,5ml 30g (6 mil. UI)

L03AB07 INTERFERONUM BETA 1a


AVONEX 30 g BIO-SET

PULB. + SOLV. PT. SOL. INJ.


BIOGEN IDEC LIMITED

Prescriere limitata:

Prescriere limitata:

Tratamentul iniial al sclerozei multiple cu recderi-remiteri evidente clinic la pacienii n ambulator (fr asisten sau suport) care au suferit cel puin 2 atacuri documentate de disfuncie neurologic, considerat a se datora sclerozei multiple, n ultimii 2 ani. Diagnosticul trebuie confirmat de RMN cerebral i/sau vertebral i data analizei inclus n solicitarea de aprobare, dac solicitarea de aprobare nu este nsoit de certificare scris furnizat de un radiolog c un examen RMN este contraindicat din cauza riscului de afectare fizic (nu psihic) a pacientului. Aprobarea se va limita la cantitatea maxim i numrul de repetri indicat n tabel;Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel. Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel.

L03AB07 INTERFERONUM BETA 1a


AVONEX 30g/0.5ml

SOL. INJ.
30g/0.5ml BIOGEN IDEC LIMITED

30g/0.5ml

Prescriere limitata:

Prescriere limitata:

Tratamentul iniial al sclerozei multiple cu recderi-remiteri evidente clinic la pacienii n ambulator (fr asisten sau suport) care au suferit cel puin 2 atacuri documentate de disfuncie neurologic, considerat a se datora sclerozei multiple, n ultimii 2 ani. Diagnosticul trebuie confirmat de RMN cerebral i/sau vertebral i data analizei inclus n solicitarea de aprobare, dac solicitarea de aprobare nu este nsoit de certificare scris furnizat de un radiolog c un examen RMN este contraindicat din cauza riscului de afectare fizic (nu psihic) a pacientului. Aprobarea se va limita la cantitatea maxim i numrul de repetri indicat n tabel;Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel. Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel.

L03AB07 INTERFERONUM BETA 1a


REBIF 44 micrograme 44g

SOL. INJ.
SERONO EUROPE LTD.

44g

Prescriere limitata:

Prescriere limitata:

Tratamentul iniial al sclerozei multiple cu recderi-remiteri evidente clinic la pacienii n ambulator (fr asisten sau suport) care au suferit cel puin 2 atacuri documentate de disfuncie neurologic, considerat a se datora sclerozei multiple, n ultimii 2 ani. Diagnosticul trebuie confirmat de RMN cerebral i/sau vertebral i data analizei inclus n solicitarea de aprobare, dac solicitarea de aprobare nu este nsoit de certificare scris furnizat de un radiolog c un examen RMN este contraindicat din cauza riscului de afectare fizic (nu psihic) a pacientului. Aprobarea se va limita la cantitatea maxim i numrul de repetri indicat n tabel;Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel. Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel.

L03AB07 INTERFERONUM BETA 1a


REBIF 8,8 micrograme +22 micrograme

SOL. INJ.
SERONO EUROPE LTD.

785
BETAFERON 250g/ml

L03AB08
Prescriere limitata:

INTERFERONUM BETA 1B ****


PULB. + SOLV. PT. SOL. INJ.
250g/ml BAYER SCHERING AG

L03AB08 INTERFERONUM BETA 1B

250g/ml

Prescriere limitata:

Tratamentul iniial al sclerozei multiple cu recderi-remiteri evidente clinic la pacienii n ambulator (fr asisten sau suport) care au suferit cel puin 2 atacuri documentate de disfuncie neurologic, considerat a se datora sclerozei multiple, n ultimii 2 ani. Diagnosticul trebuie confirmat de RMN cerebral i/sau vertebral i data analizei inclus n solicitarea de aprobare, dac solicitarea de aprobare nu este nsoit de certificare scris furnizat de un radiolog c un examen RMN este contraindicat din cauza riscului de afectare fizic (nu psihic) a pacientului. Aprobarea se va limita la cantitatea maxim i numrul de repetri indicat n tabel;Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel. Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel.

786
COPAXONE

L03AX13
Prescriere limitata:

GLATIRAMER ACETAT ****


LIOF. + SOLV. PT. SOL. INJ.
20mg TEVA PHARMACEUTICALS S.R.L.

L03AX13 GLATIRAMER ACETAT

20mg

Prescriere limitata:

Tratamentul iniial al sclerozei multiple cu recderi-remiteri evidente clinic la pacienii n ambulator (fr asisten sau suport) care au suferit cel puin 2 atacuri documentate de disfuncie neurologic, considerat a se datora sclerozei multiple, n ultimii 2 ani. Diagnosticul trebuie confirmat de RMN cerebral i/sau vertebral i data analizei inclus n solicitarea de aprobare, dac solicitarea de aprobare nu este nsoit de certificare scris furnizat de un radiolog c un examen RMN este contraindicat din cauza riscului de afectare fizic (nu psihic) a pacientului. Aprobarea se va limita la cantitatea maxim i numrul de repetri indicat n tabel;Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel. Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel.

L03AX13 GLATIRAMER ACETAT


COPAXONE

SOL. INJ.
20mg/ml TEVA PHARMACEUTICALS S.R.L.

20mg/ml

Prescriere limitata:

Tratamentul iniial al sclerozei multiple cu recderi-remiteri evidente clinic la pacienii n ambulator (fr asisten sau suport) care au suferit cel puin 2 atacuri documentate de disfuncie neurologic, considerat a se datora sclerozei multiple, n ultimii 2 ani. Diagnosticul trebuie confirmat de RMN cerebral i/sau vertebral i data analizei inclus n solicitarea de aprobare, dac solicitarea de aprobare nu este nsoit de certificare scris furnizat de un radiolog c un examen RMN este contraindicat din cauza riscului de afectare fizic (nu psihic) a pacientului. Aprobarea se va limita la cantitatea maxim i numrul de repetri indicat n tabel;Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel.

164 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Autorizarea se va limita la cantitatea maxim i la numrul de repetri indica n tabel.

787
TYSABRI 300mg

L04AA23
Prescriere limitata:

NATALIZUMABUM ****
CONC. PT. SOL. PERF.
20mg/ml ELAN PHARMA INTERNATIONAL LTD

L04AA23 NATALIZUMABUM

20mg/ml

Tratamentul iniial al sclerozei multiple cu recderi-remiteri evidente clinic la pacienii n ambulator (fr asisten sau suport) care au suferit cel puin 2 atacuri documentate de disfuncie neurologic, considerat a se datora sclerozei multiple, n ultimii 2 ani. Diagnosticul trebuie confirmat de RMN cerebral i/sau vertebral i data analizei inclus n solicitarea de aprobare, dac solicitarea de aprobare nu este nsoit de certificare scris furnizat de un radiolog c un examen RMN este contraindicat din cauza riscului de afectare fizic (nu psihic) a pacientului. Se va aproba iniial o cantitate maxima de 6 perfuzii. Prescriere limitata: Tratamentul de continuare al sclerozei multiple cu recderi-remiteri evidente clinic la pacieni care au primit anterior aprobare de prescriere pentru acest medicament care nu prezint progresia continu a dizabilitii sub tratament cu acest medicament i care au demonstrat complian cu, i abilitatea de a tolera acest tratament. Se va aproba iniial o cantitate maxima de 3 perfuzii. A fost raportat la acest medicament leucoencefalopatie multifocala progresiva.

788
IMURAN

L04AX01

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

L04AX01 AZATHIOPRINUM

50mg

165 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-V P5: PROGRAMUL NATIONAL DE DIABET ZAHARAT. 789 A10AB01 INSULINE UMANE
A10AB01 INSULINE UMANE
HUMULIN R INSULIN HUMAN WINTHROP INFUSAT 100UI/ml INSULIN HUMAN WINTHROP RAPID 100UI/ml INSULIN HUMAN WINTHROP RAPID 100UI/ml OptiClik INSULIN HUMAN WINTHROP RAPID 100UI/ml OptiSet

Protocol: AE01E
100UI/ml

SOL. INJ.
100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml LILLY FRANCE SAS SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AB01 INSULINE UMANE


HUMULIN R INSULIN HUMAN WINTHROP INFUSAT 100UI/ml INSULIN HUMAN WINTHROP RAPID 100UI/ml INSULIN HUMAN WINTHROP RAPID 100UI/ml OptiClik INSULIN HUMAN WINTHROP RAPID 100UI/ml OptiSet

SOL. INJ.
100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml LILLY FRANCE SAS SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml

A10AB01 INSULINE UMANE


ACTRAPID FLEXPEN 100 UI/ml ACTRAPID INNOLET 100 UI/ml ACTRAPID PENFILL 100 UI/ml INSUMAN INFUSAT 100UI/ml INSUMAN RAPID 100UI/ml INSUMAN RAPID 100UI/ml OPTICLIK

SOL. INJ. IN CARTUS


NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml

A10AB01 INSULINE UMANE


ACTRAPID 100 UI/ml INSUMAN RAPID 100UI/ml

SOL. INJ. IN FLACON


NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml

A10AB01 INSULINE UMANE


ACTRAPID 100 UI/ml INSUMAN RAPID 100UI/ml

SOL. INJ. IN FLACON


NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml

A10AB01 INSULINE UMANE


VELOSULIN 100UI/ml

SOL. INJ./PERF.
NOVO NORDISK A/S

100UI/ml 100UI/ml

A10AB01 INSULINE UMANE


ACTRAPID NOVOLET 100 UI/ml INSUMAN RAPID 100 UI/ml OPTISET

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AB01 INSULINE UMANE


INSUMAN INFUSAT 100UI/ml

SUSP. INJ. IN FLACON


SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml 40UI/ml

A10AB01 INSULINE UMANE


INSULIN HUMAN WINTHROP RAPID 40 UI/ml

SOL. INJ.
40UI/ml 40UI/ml 40UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AB01 INSULINE UMANE


ACTRAPID 40 UI/ml INSUMAN RAPID 40UI/ml

SOL. INJ. IN FLACON


NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH

40UI/ml

790

A10AB04

INSULINUM LISPRO **
SOL. INJ.
100U/ml 100U/ml 100U/ml 100U/ml ELI LILLY NEDERLAND BV ELI LILLY NEDERLAND BV

A10AB04 INSULINUM LISPRO


HUMALOG 100 U/ml HUMALOG-Pen 100 U/ml

100U/ml

A10AB04 INSULINUM LISPRO


LIPROLOG 100U/ml

SOL. INJ. IN CARTUS


ELI LILLY NEDERLAND BV

100U/ml 100U/ml 100U/ml

A10AB04 INSULINUM LISPRO


LIPROLOG 100U/ml

SOL. INJ. IN FLACON


ELI LILLY NEDERLAND BV ELI LILLY NEDERLAND BV

A10AB04 INSULINUM LISPRO


HUMALOG HUMAJECT 100U/ml

SUSP. INJ.
100U/ml 100U/ml

A10AB04 INSULINUM LISPRO


LIPROLOG PEN 100U/ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


ELI LILLY NEDERLAND BV

100U/ml

791
NOVORAPID 100U/ml

A10AB05

INSULINUM ASPART **
SOL. INJ. IN FLACON
100U/ml 100U/ml 100U/ml 100U/ml 100Uml NOVO NORDISK A/S

Protocol: A016E
100U/ml 100U/ml

A10AB05 INSULINUM ASPART A10AB05 INSULINUM ASPART


NOVORAPID FLEXPEN 100U/ml NOVORAPID FNOVOLET 100U/ml NOVORAPID INNOLET100U/ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S

A10AB05 INSULINUM ASPART


NOVORAPID PENFILL 100 U/ml

SOL. INJ. IN CARTUS


NOVO NORDISK A/S

100Uml

792
APIDRA 100U/ml

A10AB06

INSULINUM GLULIZINA **
SOL. INJ. IN CARTUS
100U/ml 100U/ml 100U/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AB06 INSULINUM GLULIZINA A10AB06 INSULINUM GLULIZINA


APIDRA 100U/ml

100U/ml 100U/ml 100U/ml

SOL. INJ. IN FLACON


SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AB06 INSULINUM GLULIZINA


APIDRA 100U/ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

793

A10AC01

INSULINE UMANE
SUSP. INJ.
100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml LILLY FRANCE SAS SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AC01 INSULINE UMANE


HUMULIN N INSULIN HUMAN WINTHROP BASAL 100UI/ml INSULIN HUMAN WINTHROP BASAL 100UI/ml OptiSet INSULIN HUMAN WINTHROP BASAL 100UI/ml OptiClik

100UI/ml

A10AC01 INSULINE UMANE


INSULATARD FLEXPEN 100 UI/ml INSULATARD INNOLET 100 UI/ml INSULATARD NOVOLET 100 UI/ml INSUMAN BASAL 100UI/ml OPTISET PROTAPHANE FLEXPEN 100UI/ml PROTAPHANE INNOLET 100UI/ml PROTAPHANE NOVOLET 100UI/ml

SUSP. INJ. IN STILOU INJECTOR PREUMPLUT


NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S

100UI/ml

166 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml

FORMA FARM.

FIRMA

PROTOCOL

A10AC01 INSULINE UMANE


INSULATARD PENFILL 100 UI/ml INSUMAN BASAL 100 UI/ml OPTICLIK INSUMAN BASAL 100UI/ml PROTAPHANE PENFILL 100UI/ml

SUSP. INJ. IN CARTUS


NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S

100UI/ml

A10AC01 INSULINE UMANE


INSULATARD 100 UI/ml INSUMAN BASAL 100UI/ml PROTAPHANE 100UI/ml

SUSP. INJ. IN FLACON


NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S

100UI/ml

A10AC01 INSULINE UMANE


INSULATARD 100 UI/ml INSUMAN BASAL 100UI/ml PROTAPHANE 100UI/ml

SUSP. INJ. IN FLACON


NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S

100UI/ml

A10AC01 INSULINE UMANE


INSULIN HUMAN WINTHROP BASAL 40UI/ml

SUSP. INJ.
40UI/ml 40UI/ml 40UI/ml 40UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

40UI/ml 40UI/ml

A10AC01 INSULINE UMANE


INSULATARD 40 UI/ml INSUMAN BASAL 40UI/ml PROTAPHANE 40UI/ml

SUSP. INJ. IN FLACON


NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S

794

A10AC04

INSULINUM LISPRO **
SOL. INJ.
100U/ml ELI LILLY NEDERLAND BV

Protocol: A029E
100U/ml 100U/ml

A10AC04 INSULINUM LISPRO


HUMALOG NPL 100 U/ml

A10AC04 INSULINUM LISPRO


HUMALOG NPL 100 U/ml Pen

SUSP. INJ.
100U/ml ELI LILLY NEDERLAND BV

795

A10AD01

INSULINE UMANE
SUSP. INJ.
100ui/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml LILLY FRANCE SAS SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AD01 INSULINE UMANE


HUMULIN M3 (30/70) INSULIN HUMAN WINTHROP COMB 15 100UI/ml INSULIN HUMAN WINTHROP COMB 15 OptiClik INSULIN HUMAN WINTHROP COMB 15 OptiSet INSULIN HUMAN WINTHROP COMB 25 100UI/ml INSULIN HUMAN WINTHROP COMB 25 OptiClik INSULIN HUMAN WINTHROP COMB 25 OptiSet INSULIN HUMAN WINTHROP COMB 50 100UI/ml INSULIN HUMAN WINTHROP COMB 50 OptiClik INSULIN HUMAN WINTHROP COMB 50 OptiSet

100UI/ml

A10AD01 INSULINE UMANE


HUMULIN M3 (30/70) INSULIN HUMAN WINTHROP COMB 15 100UI/ml INSULIN HUMAN WINTHROP COMB 15 OptiClik INSULIN HUMAN WINTHROP COMB 15 OptiSet INSULIN HUMAN WINTHROP COMB 25 100UI/ml INSULIN HUMAN WINTHROP COMB 25 OptiClik INSULIN HUMAN WINTHROP COMB 25 OptiSet INSULIN HUMAN WINTHROP COMB 50 100UI/ml INSULIN HUMAN WINTHROP COMB 50 OptiClik INSULIN HUMAN WINTHROP COMB 50 OptiSet

SUSP. INJ.
100ui/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml LILLY FRANCE SAS SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

100ui/ml

A10AD01 INSULINE UMANE


ACTRAPHANE 10 NOVOLET ACTRAPHANE 20 NOVOLET ACTRAPHANE 30 FLEXPEN ACTRAPHANE 30 INNOLET ACTRAPHANE 30 NOVOLET ACTRAPHANE 40 NOVOLET ACTRAPHANE 50 NOVOLET INSUMAN COMB 15 100UI/ml OPTISET INSUMAN COMB 25 100UI/ml OPTISET INSUMAN COMB 50 100UI/ml OPTISET MIXTARD 10 NOVOLET 100 UI/ml MIXTARD 20 NOVOLET 100 UI/ml MIXTARD 30 FLEXPEN100 UI/ml MIXTARD 30 INNOLET 100 UI/ml MIXTARD 30 NOVOLET 100 UI/ml MIXTARD 40 NOVOLET 100 UI/ml MIXTARD 50 NOVOLET 100 UI/ml

SUSP. INJ. IN STILOU INJECTOR PREUMPLUT


NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S

100UI/ml

A10AD01 INSULINE UMANE


ACTRAPHANE 10 PENFIILL ACTRAPHANE 20 PENFIILL ACTRAPHANE 30 PENFIILL ACTRAPHANE 40 PENFIILL ACTRAPHANE 50 PENFIILL INSUMAN COMB 15 100UI/ml OPTICLIK INSUMAN COMB 15 100UI/ml INSUMAN COMB 25 100UI/ml OPTICLIK INSUMAN COMB 25 100UI/ml INSUMAN COMB 50 100UI/ml OPTICLIK INSUMAN COMB 50 100UI/ml MIXTARD 10 PENFILL 100 UI/ml MIXTARD 20 PENFILL 100 UI/ml MIXTARD 30 PENFILL 100 UI/ml MIXTARD 40 PENFILL 100 UI/ml MIXTARD 50 PENFILL 100 UI/ml

SUSP. INJ. IN CARTUS


NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S

100UI/ml

A10AD01 INSULINE UMANE


ACTRAPHANE 30 INSUMAN COMB 15 100UI/ml INSUMAN COMB 25 100UI/ml

SUSP. INJ. IN FLACON


NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml

167 / 233

DCI/DENUMIRE COMERCIALA
INSUMAN COMB 50 100UI/ml MIXTARD 30 100UI/ml

CONCENTRATIE
100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml

FORMA FARM.

FIRMA

PROTOCOL

SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S

A10AD01 INSULINE UMANE


ACTRAPHANE 30 INSUMAN COMB 15 100UI/ml INSUMAN COMB 25 100UI/ml INSUMAN COMB 50 100UI/ml MIXTARD 30 100UI/ml

SUSP. INJ. IN FLACON


NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S

100UI/ml

A10AD01 INSULINE UMANE


INSULIN HUMAN WINTHROP COMB 15 40UI/ml INSULIN HUMAN WINTHROP COMB 25 40UI/ml INSULIN HUMAN WINTHROP COMB 50 40UI/ml

SUSP. INJ.
40UI/ml 40UI/ml 40UI/ml 40UI/ml 40UI/ml 40UI/ml 40UI/ml 40UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

40UI/ml

A10AD01 INSULINE UMANE


ACTRAPHANE 30 INSUMAN COMB 15 40UI/ml INSUMAN COMB 25 40UI/ml INSUMAN COMB 50 40UI/ml MIXTARD 30 40UI/ml

SUSP. INJ. IN FLACON


NOVO NORDISK A/S SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH NOVO NORDISK A/S

40UI/ml

796

A10AD04

INSULINUM LISPRO **
SUSP. INJ.
100U/ml 100U/ml 100U/ml 100U/ml 100U/ml 100U/ml 100U/ml 100U/ml ELI LILLY ELI LILLY ELI LILLY ELI LILLY NEDERLAND BV NEDERLAND BV NEDERLAND BV NEDERLAND BV

Protocol: A015E
100U/ml

A10AD04 INSULINUM LISPRO


HUMALOG MIX 50 Pen HUMALOG MIX 25 Pen HUMALOG MIX25 HUMALOG MIX50

A10AD04 INSULINUM LISPRO


LIPROLOG MIX25 100U/ml PEN LIPROLOG MIX50 100U/ml PEN

SUSP. INJ. IN STILOU INJECTOR PREUMPLUT


ELI LILLY NEDERLAND BV ELI LILLY NEDERLAND BV

100U/ml

A10AD04 INSULINUM LISPRO


LIPROLOG MIX25 100U/ml LIPROLOG MIX50 100U/ml

SUSP. INJ. IN CARTUS


ELI LILLY NEDERLAND BV ELI LILLY NEDERLAND BV

100U/ml

797

A10AD05

INSULINUM ASPART **
SUSP. INJ.
100U/ml 100U/ml 100U/ml 100u/ml 100U/ml 100UIml NOVO NORDISK A/S

Protocol: A018E
100U/ml 100U/ml 100U/ml

A10AD05 INSULINUM ASPART


NOVOMIX 70 FLEXPEN 100 U/ml

A10AD05 INSULINUM ASPART


NOVOMIX 50 FLEXPEN 100 U/ml

SUSP. INJ. IN STILOU INJECTOR PREUMPLUT


NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S NOVO NORDISK A/S

A10AD05 INSULINUM ASPART


NOVOMIX 30 PENFILL 100 U/ml NOVOMIX 50 PENFILL 100 U/ml NOVOMIX 70 PENFILL 100 U/ml

SUSP. INJ. IN CARTUS

A10AD05 INSULINUM ASPART


NOVOMIX 30 FLEXPEN

SUSP. INJ. IN STILOU INJECTOR PREUMPLUT


NOVO NORDISK A/S

100UIml

798
OPTISULIN 100U/ml

A10AE04

INSULINUM GLARGINE **
SOL. INJ. IN CARTUS
100U/ml 100U/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml 100UI/ml SANOFI - AVENTIS DEUTSCHLAND GMBH

Protocol: A024E
100U/ml 100U/ml 100UI/ml

A10AE04 INSULINUM GLARGINE A10AE04 INSULINUM GLARGINE


OPTISULIN 100U/ml

SOL. INJ. IN FLACON


SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

A10AE04 INSULINUM GLARGINE


LANTUS 100UI/ml LANTUS OptiClik

SOL. INJ. IN CARTUS

A10AE04 INSULINUM GLARGINE


LANTUS 100UI/ml

SOL. INJ. IN FLACON


SANOFI - AVENTIS DEUTSCHLAND GMBH

100UI/ml 100UI/ml

A10AE04 INSULINUM GLARGINE


LANTUS OptiSet LANTUS SoloStar

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


SANOFI - AVENTIS DEUTSCHLAND GMBH SANOFI - AVENTIS DEUTSCHLAND GMBH

799

A10AE05

INSULINUM DETEMIR **
SOL. INJ.
100U/ml 100U/ml 100U/ml NOVO NORDISK A/S

Protocol: A023E
100U/ml 100U/ml 100U/ml

A10AE05 INSULINUM DETEMIR


LEVEMIR INNOLET100 U/ml

A10AE05 INSULINUM DETEMIR


LEVEMIR PENFILL 100 U/ml

SOL. INJ. IN CARTUS


NOVO NORDISK A/S NOVO NORDISK A/S

A10AE05 INSULINUM DETEMIR


LEVEMIR FLEXPEN 100 U/ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

800
METFORMIN 1000 mg

A10BA02

METFORMINUM
COMPR.
1000mg 1000mg 1000mg 1000mg 1000mg 1000mg ARENA GROUP S.A.

A10BA02 METFORMINUM A10BA02 METFORMINUM


GLUCOPHAGE 1000 mg METFOGAMMA 1000mg METFORMIN TEVA 1000 mg SIOFOR 1000

1000mg 1000mg

COMPR. FILM.
MERCK SANTE WORWAG PHARMA GMBH & CO. KG TEVA PHARMACEUTICAL S.R.L. BERLIN CHEMIE AG MENARINI GROUP

A10BA02 METFORMINUM
FORMIRAN 1000 mg

COMPR. PT. SOL. ORALA


TERAPIA S.A.

1000mg 500mg

A10BA02 METFORMINUM
DIGUAN 500 mg METFORMIN 500 mg

COMPR.
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg ZENTIVA S.A. ARENA GROUP SA

A10BA02 METFORMINUM
GLUCOPHAGE XR

COMPR. ELIB. PREL.


MERCK SANTE S.A.S.

500mg 500mg

A10BA02 METFORMINUM
DIPIMET 500 mg GLUCOPHAGE 500 MEGUAN 500 mg METFOGAMMA 500 METFORMIN AL 500

COMPR. FILM.
ANTIBIOTICE SA MERCK SANTE GEDEON RICHTER ROMANIA SA WORWAG PHARMA GMBH & CO. KG ALIUD PHARMA GMBH & CO.KG

168 / 233

DCI/DENUMIRE COMERCIALA
METFORMIN LPH 500 mg METFORMIN SANDOZ 500 mg METFORMIN-TEVA 500 mg SIOFOR 500

CONCENTRATIE
500mg 500mg 500mg 500mg 500mg

FORMA FARM.

FIRMA

PROTOCOL

LABORMED PHARMA SA HEXAL AG TEVA PHARMACEUTICAL S.R.L. BERLIN CHEMIE AG MENARINI GROUP

A10BA02 METFORMINUM
FORMIRAN 500 mg

COMPR. PT. SOL. ORALA


TERAPIA S.A.

500mg 850mg

A10BA02 METFORMINUM
DIAFORMIN 850 mg METFORMIN 850 mg

COMPR.
850mg 850mg 850mg 850mg 850mg 850mg 850mg 850mg 850mg 850mg 850mg 850mg 850mg TERAPIA SA ARENA GROUP SA

A10BA02 METFORMINUM
ALTROIN GLUCOPHAGE 850 mg MEDIFOR 850 MEGUAN 850 mg METFOGAMMA 850 METFORMIN AL 850 METFORMIN LPH 850 mg METFORMIN SANDOZ 850 mg METFORMIN-TEVA 850 mg SIOFOR 850

COMPR. FILM.
PLIVA LJUBLJANA D.O.O. MERCK SANTE STD CHEMICALS LTD. GEDEON RICHTER ROMANIA SA WORWAG PHARMA GMBH & CO. KG ALIUD PHARMA GMBH & CO.KG LABORMED PHARMA SA HEXAL AG TEVA PHARMACEUTICAL S.R.L. BERLIN CHEMIE AG MENARINI GROUP

850mg

A10BA02 METFORMINUM
FORMIRAN 850 mg

COMPR. PT. SOL. ORALA


TERAPIA S.A.

850mg

801
SILUBIN RETARD

A10BA03

BUFORMINUM
DRAJ. RET.
100mg DITA IMPORT EXPORT SRL

A10BA03 BUFORMINUM

100mg

802

A10BB01

GLIBENCLAMIDUM
COMPR.
1,75 mg ANTIBIOTICE S.A.

A10BB01 GLIBENCLAMIDUM
GLIBENCLAMID ANTIBIOTICE 1,75 mg

1,75 mg 1.75mg
LABORMED PHARMA SA ARENA GROUP SA BERLIN CHEMIE AG MENARINI GROUP

A10BB01 GLIBENCLAMIDUM
GLIBENCLAMID LPH 1,75 mg GLIBENCLAMID ARENA 1,75 mg MANINIL 1,75 mg

COMPR.
1.75mg 1.75mg 1.75mg

A10BB01 GLIBENCLAMIDUM
GLIBENCLAMID ANTIBIOTICE 3,5 mg 3,5mg

COMPR.
ANTIBIOTICE S.A.

3,5mg 3.5mg
ARENA GROUP SA LABORMED PHARMA SA BERLIN CHEMIE AG MENARINI GROUP

A10BB01 GLIBENCLAMIDUM
GLIBENCLAMID ARENA 3,5 mg GLIBENCLAMID LPH 3,5 mg MANINIL 3,5 mg 3.5mg 3.5mg 3.5mg

COMPR.

A10BB01 GLIBENCLAMIDUM
GLIBENCLAMID GLIBENCLAMID 5 mg 5mg 5mg

COMPR.
LAROPHARM SRL ARENA GROUP SA

5mg

803
TOLBUTAMID

A10BB03

TOLBUTAMIDUM
COMPR.
500mg SINTOFARM SA

A10BB03 TOLBUTAMIDUM

500mg

804

A10BB07

GLIPIZIDUM
COMPR. FILM. ELIB. MODIF.
10mg PFIZER EUROPE MA EEIG

A10BB07 GLIPIZIDUM
GLUCOTROL XL 10 mg

10mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

A10BB07 GLIPIZIDUM
GLIPIZID LPH 5 mg 5mg

COMPR.
LABORMED PHARMA SA

5mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

A10BB07 GLIPIZIDUM
GLUCOTROL XL 5mg 5mg

COMPR. FILM. ELIB. MODIF.


PFIZER EUROPE MA EEIG

5mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

805
GLURENORM

A10BB08

GLIQUIDONUM
COMPR.
30mg BOEHRINGER INGELHEIM INT. GMBH

A10BB08 GLIQUIDONUM

30mg

806
DIAPREL MR

A10BB09

GLICLAZIDUM
COMPR. ELIB. MODIF.
30mg LES LABORATOIRES SERVIER

A10BB09 GLICLAZIDUM

30mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

A10BB09 GLICLAZIDUM
GLICLAZID MR LPH 30 mg GLICLAZIDA EP ANTIBIOTICE 30 mg GLITOPP MR 30 mg 30mg 30mg 30mg

COMPR. ELIB. PREL.


LABORMED PHARMA SA ANTIBIOTICE S.A. TERAPIA S.A.

30mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

A10BB09 GLICLAZIDUM
DIABREZIDE DICLAZID 80 mg ESQUEL 80 mg GLICLAZID LPH GLIDIET GLUCTAM 80mg 80mg 80mg 80mg 80mg 80mg

COMPR.
L. MOLTENI TERAPIA S.A. GEDEON RICHTER ROMANIA SA LABORMED PHARMA SA MEDICAROM GROUP S.R.L. EGIS PHARMACEUTICALS LTD.

80mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

A10BB09 GLICLAZIDUM
DIAPREL 80mg

COMPR. DIVIZ.
LES LABORATOIRES SERVIER

80mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

807
AMYX 1

A10BB12

GLIMEPIRIDUM
COMPR.
1 mg ZENTIVA A.S.

A10BB12 GLIMEPIRIDUM

1 mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

169 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

A10BB12 GLIMEPIRIDUM
AMARYL 1mg DIBIGLIM 1 mg GLEMPID 1 mg GLIBEPOL 1 mg GLIME TAD 1 mg GLIMEGAMMA AAA-PHARMA 1 mg GLIMEPIRID 1 mg GLIMEPIRID LPH 1 mg GLIMERAN 1 mg GLIPREX 1 mg MEGLIMID 1 mg OLTAR 1 mg TINERIL 1 mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg 1mg

COMPR.
AVENTIS PHARMA DEUTSCHLAND SANDOZ S.R.L. EGIS PHARMACEUTICALS P.L.C. MEDANA PHARMA TERPOL GROUP S.A. TAD PHARMA GMBH AAA-PHARMA GMBH TERAPIA S.A. LABORMED PHARMA SA RANBAXY UK LIMITED MEDICO UNO PHARMACEUTICAL SRL KRKA D.D. BERLIN CHEMIE AG (MENARINI GROUP) GEDEON RICHTER ROMANIA S.A.

1mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

A10BB12 GLIMEPIRIDUM
OLTAR 2 mg 2 mg

COMPR.
BERLIN CHEMIE AG (MENARINI GROUP)

2 mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

A10BB12 GLIMEPIRIDUM
AMARYL 2 mg AMYX 2 DIBIGLIM 2 mg GLEMPID 2 mg GLIBEPOL 2 mg GLIME TAD 2 mg GLIMEGAMMA AAA-PHARMA 2 mg GLIMEPIRID 2 mg GLIMEPIRID LPH 2 mg GLIMEPIRIDE 2 mg GLIMERAN 2 mg GLIPREX 2 mg MEGLIMID 2 mg TINERIL 2 mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg

COMPR.
AVENTIS PHARMA DEUTSCHLAND ZENTIVA A.S. SANDOZ SRL EGIS PHARMACEUTICALS P.L.C. MEDANA PHARMA TERPOL GROUP S.A. TAD PHARMA GMBH AAA-PHARMA GMBH SPECIFAR SA LABORMED PHARMA SA ACTAVIS GROUP HF. RANBAXY UK LIMITED MEDICO UNO PHARMACEUTICAL SRL KRKA D.D. GEDEON RICHTER ROMANIA S.A.

2mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

A10BB12 GLIMEPIRIDUM
AMARYL 3 mg AMYX 3 DIBIGLIM 3 mg GLEMPID 3 mg GLIBEPOL 3 mg GLIME TAD 3 mg GLIMEGAMMA AAA-PHARMA 3 mg GLIMEPIRID 3 mg GLIMEPIRID LPH 3 mg GLIMEPIRIDE 3 mg GLIMERAN 3 mg GLIPREX 3 mg MEGLIMID 3 mg OLTAR 3 mg TINERIL 3 mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg 3mg

COMPR.
AVENTIS PHARMA DEUTSCHLAND ZENTIVA A.S. SANDOZ SRL EGIS PHARMACEUTICALS P.L.C. MEDANA PHARMA TERPOL GROUP S.A. TAD PHARMA GMBH AAA-PHARMA GMBH TERAPIA S.A. LABORMED PHARMA SA ACTAVIS GROUP HF. RANBAXY UK LIMITED MEDICO UNO PHARMACEUTICAL SRL KRKA D.D. BERLIN CHEMIE AG (MENARINI GROUP) GEDEON RICHTER ROMANIA S.A.

3mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

A10BB12 GLIMEPIRIDUM
AMARYL 4 mg AMYX 4 DIBIGLIM 4 mg GLEMPID 4 mg GLIBEPOL 4 mg GLIMEGAMMA AAA-PHARMA 4 mg GLIMEPIRID 4 mg GLIMERAN 4 mg GLIPREX 4 mg MEGLIMID 4 mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg 4mg

COMPR.
AVENTIS PHARMA DEUTSCHLAND GMBH ZENTIVA A.S. SANDOZ S.R.L. EGIS PHARMACEUTICALS P.L.C. MEDANA PHARMA TERPOL GROUP S.A. AAA-PHARMA GMBH TERAPIA S.A. RANBAXY UK LIMITED MEDICO UNO PHARMACEUTICAL SRL KRKA D.D.

4mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

A10BB12 GLIMEPIRIDUM
GLEMPID 6 mg GLIMEPIRID 6 mg MEGLIMID 6 mg 6mg 6mg 6mg

COMPR.
EGIS PHARMACEUTICALS P.L.C. TERAPIA S.A. KRKA D.D.

6mg

A10BB12 GLIMEPIRIDUM
TINERIL 4 mg 4mg

COMPR
GEDEON RICHTER ROMANIA S.A.

4mg

808

A10BD02

COMBINATII(GLIBENCLAMIDUM+METFORMINUM)
COMPR. FILM.
2,5mg/400mg LAB. GUIDOTTI SPA

Protocol: A027E
2,5mg/400mg

A10BD02 COMBINATII(GLIBENCLAMIDUM+METFOR MINUM)


GLIBOMET

A10BD02 COMBINATII(GLIBENCLAMIDUM+METFOR MINUM)


GLIFORMIN

COMPR. FILM.
400mg + 2.5mg LABORMED PHARMA SA

400mg + 2.5mg

A10BD02 COMBINATII(GLIBENCLAMIDUM+METFOR MINUM)


BIDIAB

CAPS.
400mg+2.5mg ARENA GROUP SA

400mg+2.5mg

A10BD02 COMBINATII(GLIBENCLAMIDUM+METFOR MINUM)


GLUCOVANCE 500 mg/2,5 mg

COMPR. FILM.
500mg/2.5mg MERCK SANTE

500mg/2.5mg

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

A10BD02 COMBINATII(GLIBENCLAMIDUM+METFOR MINUM)

COMPR. FILM.

500mg/5mg

170 / 233

DCI/DENUMIRE COMERCIALA
GLUCOVANCE 500 mg/5 mg

CONCENTRATIE
500mg/5mg

FORMA FARM.
MERCK SANTE

FIRMA

PROTOCOL

Sulfonilurea poate cauza hipoglicemie, in mod particular la vrstnici

809

A10BD03

COMBINATII(ROSIGLITAZONUM+METFORMINUM) ***
COMPR. FILM.
1mg/500mg SMITHKLINE BEECHAM PLC

Protocol: A026E
1mg/500mg

A10BD03 COMBINATII(ROSIGLITAZONUM+METFOR MINUM)


AVANDAMET 1mg/500mg

A10BD03 COMBINATII(ROSIGLITAZONUM+METFOR MINUM)


AVANDAMET 2mg/1000mg

COMPR. FILM.
2mg/1000mg SMITHKLINE BEECHAM PLC

2mg/1000mg

A10BD03 COMBINATII(ROSIGLITAZONUM+METFOR MINUM)


AVANDAMET 2mg/500mg

COMPR. FILM.
2mg/500mg SMITHKLINE BEECHAM PLC

2mg/500mg

A10BD03 COMBINATII(ROSIGLITAZONUM+METFOR MINUM)


AVANDAMET 4mg/1000mg

COMPR. FILM.
4mg/1000mg SMITHKLINE BEECHAM PLC

4mg/1000mg

810

A10BD04

COMBINATII (ROSIGLITAZONUM + GLIMEPIRIDUM) ***


COMPR. FILM.
4mg/4mg SMITHKLINE BEECHAM PLC

Protocol: A027E

A10BD04 COMBINATII (ROSIGLITAZONUM + GLIMEPIRIDUM)


AVAGLIM 4mg/4mg

4mg/4mg

A10BD04 COMBINATII (ROSIGLITAZONUM + GLIMEPIRIDUM)


AVAGLIM 8mg/4mg

COMPR. FILM.
8mg/4mg SMITHKLINE BEECHAM PLC

8mg/4mg

811

A10BD05

COMBINATII (PIOGLITAZONUM + METFORMINUM) ***


COMPR. FILM.
15mg/850mg 15mg/850mg

Protocol: A025E
15mg/850mg

A10BD05 COMBINATII (PIOGLITAZONUM + METFORMINUM)


COMPETACT PIOGLITAZONE/METFORMIN HYDROCHLORIDE TAKEDA 15mg/850mg

TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

812
GLUCOBAY 100

A10BF01

ACARBOSUM
COMPR.
100mg BAYER HEALTHCARE AG

A10BF01 ACARBOSUM A10BF01 ACARBOSUM


GLUCOBAY 50 50mg

100mg 50mg
BAYER HEALTHCARE AG

COMPR.

813
AVANDIA 2mg

A10BG02

ROSIGLITAZONUM ***
COMPR. FILM.
2mg 4mg 8mg SMITHKLINE BEECHAM PLC

Protocol: A020E
2mg 4mg 8mg

A10BG02 ROSIGLITAZONUM A10BG02 ROSIGLITAZONUM


AVANDIA 4mg

COMPR. FILM.
SMITHKLINE BEECHAM PLC

A10BG02 ROSIGLITAZONUM
AVANDIA 8mg

COMPR. FILM.
SMITHKLINE BEECHAM PLC

814
ACTOS 15mg GLUSTIN 15mg

A10BG03

PIOGLITAZONUM ***
COMPR.
15mg 15mg

Protocol: A020E
15mg
TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

A10BG03 PIOGLITAZONUM

A10BG03 PIOGLITAZONUM
ACTOS 30mg GLUSTIN 30mg 30mg 30mg

COMPR.

30mg
TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

A10BG03 PIOGLITAZONUM
ACTOS 45mg GLUSTIN 45mg 45mg 45mg

COMPR.

45mg
TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE LTD

815
JANUVIA 100mg TESAVEL 100mg TESAVEL 50mg XELEVIA 100mg

A10BH01

SITAGLIPTINUM ***
COMPR. FILM.
100mg 100mg 50mg 100mg 25mg 25mg 25mg 50mg 100mg 50mg 50mg MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD.

Protocol: A022E
100mg

A10BH01 SITAGLIPTINUM

A10BH01 SITAGLIPTINUM
JANUVIA 25mg TESAVEL 25mg XELEVIA 25mg

COMPR. FILM.
MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD.

25mg

A10BH01 SITAGLIPTINUM
JANUVIA 50mg TESAVEL 100mg TESAVEL 50mg XELEVIA 50mg

COMPR. FILM.
MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD.

50mg

816
PRANDIN 0,5mg

A10BX02

REPAGLINIDUM
COMPR.
0,5mg NOVO NORDISK A/S

A10BX02 REPAGLINIDUM A10BX02 REPAGLINIDUM


NOVONORM 0,5 mg 0.5mg

0,5mg 0.5mg
NOVO NORDISK A/S

COMPR. COMPR.
1mg 1mg NOVO NORDISK A/S NOVO NORDISK A/S

A10BX02 REPAGLINIDUM
NOVONORM 1 mg PRANDIN 1mg

1mg

A10BX02 REPAGLINIDUM
NOVONORM 2 mg PRANDIN 2mg 2mg 2mg

COMPR.
NOVO NORDISK A/S NOVO NORDISK A/S

2mg

817
BYETTA 10g/doza

A10BX04

EXENATIDUM ***
SOL. INJ. IN STILOU INJECTOR PREUMPLUT
10g/doza ELI LILLY NEDERLAND BV

Protocol: A028E
10g/doza 5g/doza

A10BX04 EXENATIDUM A10BX04 EXENATIDUM

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

171 / 233

DCI/DENUMIRE COMERCIALA
BYETTA 5g/doza

CONCENTRATIE
5g/doza

FORMA FARM.
ELI LILLY NEDERLAND BV

FIRMA

PROTOCOL

818
BENFOGAMMA

A11DA03

BENFOTIAMINUM
DRAJ.
50mg WORWAG PHARMA GMBH & CO. KG

A11DA03 BENFOTIAMINUM

50mg

819
MILGAMMA N

A11DBN1

COMBINATII **
CAPS. MOI
WORWAG PHARMA GMBH & CO. KG

A11DBN1 COMBINATII A11DBN1 COMBINATII


MILGAMMA 100

DRAJ.
WORWAG PHARMA GMBH & CO. KG

A11DBN1 COMBINATII
MILGAMMA N MILGAMMA NA

SOL. INJ.
WORWAG PHARMA GMBH & CO. KG WORWAG PHARMA GMBH & CO. KG

820

H04AA01

GLUCAGONUM
PULB. + SOLV. PT. SOL. INJ.
1mg NOVO NORDISK A/S

H04AA01 GLUCAGONUM
GLUCAGEN HYPOKIT 1 mg

1mg

172 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-VI P6: PROGRAMUL NATIONAL DE HEMOFILIE, TALASEMIE SI ALTE BOLI RARE. P6.1: HEMOFILIE SI TALASEMIE 821 B02BD02 MOROCTOCOG ALFA **
B02BD02 MOROCTOCOG ALFA
OCTANATE 1000

PULB. + SOLV. PT. SOL. INJ.


1000 UI 1000UI 1000ui 1000UI 1000UI 100UI 1500UI 2000UI 250 U.I. 250 UI 250UI 250ui 250UI 250UI 500 UI 500 UI 500 UI 500ui 500UI 500UI 50UI 1000 UI 2000 UI 250 UI 500 UI OCTAPHARMA (IP) LIMITED

1000 UI 1000UI

B02BD02 MOROCTOCOG ALFA


ADVATE 1000UI FANHDI 100ui/ml HELIXATE NEXGEN 1000 UI KOGENATE BAYER 1000UI

PULB+SOLV.PT.SOL.INJ
BAXTER AG INSTITUTO GRIFOLS S.A. BAYER HEALTHCARE AG BAYER HEALTHCARE AG

B02BD02 MOROCTOCOG ALFA


HAEMOCTIN SDH 1000

LIOF. + SOLV. PT. SOL. INJ.


BIOTEST PHARMA GMBH

100UI 1500UI 2000UI 250 U.I. 250 UI 250UI 250UI

B02BD02 MOROCTOCOG ALFA


ADVATE 1500UI

PULB+SOLV.PT.SOL.INJ
BAXTER AG BAYER HEALTHCARE AG OCTAPHARMA (IP) LIMITED KEDRION SPA

B02BD02 MOROCTOCOG ALFA


KOGENATE BAYER 2000UI

PULB+SOLV.PT.SOL.INJ PULB. + SOLV. PT. SOL. INJ. PULB. + SOLV. SOL. PERF. LIOF. + SOLV. PT. SOL. INJ.
BIOTEST PHARMA GMBH

B02BD02 MOROCTOCOG ALFA


OCTANATE 250

B02BD02 MOROCTOCOG ALFA


EMOCLOT 250 U. I.

B02BD02 MOROCTOCOG ALFA


HAEMOCTIN SDH 250

B02BD02 MOROCTOCOG ALFA


FANHDI 25 ui/ml HELIXATE NEXGEN 250 UI KOGENATE BAYER 250UI

PULB+SOLV.PT.SOL.INJ
INSTITUTO GRIFOLS S.A. BAYER HEALTHCARE AG BAYER HEALTHCARE AG

B02BD02 MOROCTOCOG ALFA


ADVATE 500UI

PULB+SOLV.PT.SOL.INJ
BAXTER AG

500 UI 500 UI 500 UI 500UI

B02BD02 MOROCTOCOG ALFA


OCTANATE 500

PULB. + SOLV. PT. SOL. INJ.


OCTAPHARMA (IP) LIMITED

B02BD02 MOROCTOCOG ALFA


EMOCLOT 500 UI

PULB.+SOLV. SOL. PERF.


KEDRION SPA

B02BD02 MOROCTOCOG ALFA


FANHDI 50 ui/ml HELIXATE NEXGEN 500 UI KOGENATE BAYER 500UI

PULB+SOLV.PT.SOL.INJ
INSTITUTO GRIFOLS S.A. BAYER HEALTHCARE AG BAYER HEALTHCARE AG

B02BD02 MOROCTOCOG ALFA


HAEMOCTIN SDH 500

LIOF. + SOLV. PT. SOL. INJ.


BIOTEST PHARMA GMBH

50UI 1000 UI 2000 UI 250 UI 500 UI

B02BD02 MOROCTOCOG ALFA


REFACTO 1000UI

PULB. + SOL. PT. SOL. INJ.


WYETH EUROPA LTD WYETH EUROPA LTD WYETH EUROPA LTD

B02BD02 MOROCTOCOG ALFA


REFACTO 2000UI

PULB. + SOL. PT. SOL. INJ. PULB. + SOL. PT. SOL. INJ. PULB. + SOL. PT. SOL. INJ.
WYETH EUROPA LTD

B02BD02 MOROCTOCOG ALFA


REFACTO 250UI

B02BD02 MOROCTOCOG ALFA


REFACTO 500UI

822
OCTANATE 1000

B02BD02

OCTOCOG ALFA **
PULB. + SOLV. PT. SOL. INJ.
1000 UI 1000UI 1000ui 1000UI 1000UI 100UI 1500UI 2000UI 250 U.I. 250 UI 250UI 250ui 250UI 250UI 500 UI 500 UI 500 UI 500ui 500UI 500UI OCTAPHARMA (IP) LIMITED

B02BD02 OCTOCOG ALFA B02BD02 OCTOCOG ALFA


ADVATE 1000UI FANHDI 100ui/ml HELIXATE NEXGEN 1000 UI KOGENATE BAYER 1000UI

1000 UI 1000UI

PULB+SOLV.PT.SOL.INJ
BAXTER AG INSTITUTO GRIFOLS S.A. BAYER HEALTHCARE AG BAYER HEALTHCARE AG

B02BD02 OCTOCOG ALFA


HAEMOCTIN SDH 1000

LIOF. + SOLV. PT. SOL. INJ.


BIOTEST PHARMA GMBH

100UI 1500UI 2000UI 250 U.I. 250 UI 250UI 250UI

B02BD02 OCTOCOG ALFA


ADVATE 1500UI

PULB+SOLV.PT.SOL.INJ
BAXTER AG BAYER HEALTHCARE AG OCTAPHARMA (IP) LIMITED KEDRION SPA

B02BD02 OCTOCOG ALFA


KOGENATE BAYER 2000UI

PULB+SOLV.PT.SOL.INJ PULB. + SOLV. PT. SOL. INJ. PULB. + SOLV. SOL. PERF. LIOF. + SOLV. PT. SOL. INJ.
BIOTEST PHARMA GMBH

B02BD02 OCTOCOG ALFA


OCTANATE 250

B02BD02 OCTOCOG ALFA


EMOCLOT 250 U. I.

B02BD02 OCTOCOG ALFA


HAEMOCTIN SDH 250

B02BD02 OCTOCOG ALFA


FANHDI 25 ui/ml HELIXATE NEXGEN 250 UI KOGENATE BAYER 250UI

PULB+SOLV.PT.SOL.INJ
INSTITUTO GRIFOLS S.A. BAYER HEALTHCARE AG BAYER HEALTHCARE AG

B02BD02 OCTOCOG ALFA


ADVATE 500UI

PULB+SOLV.PT.SOL.INJ
BAXTER AG

500 UI 500 UI 500 UI 500UI

B02BD02 OCTOCOG ALFA


OCTANATE 500

PULB. + SOLV. PT. SOL. INJ.


OCTAPHARMA (IP) LIMITED

B02BD02 OCTOCOG ALFA


EMOCLOT 500 UI

PULB.+SOLV. SOL. PERF.


KEDRION SPA

B02BD02 OCTOCOG ALFA


FANHDI 50 ui/ml HELIXATE NEXGEN 500 UI KOGENATE BAYER 500UI

PULB+SOLV.PT.SOL.INJ
INSTITUTO GRIFOLS S.A. BAYER HEALTHCARE AG BAYER HEALTHCARE AG

173 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
50UI 1000UI/10ml 250 UI 250UI/10ml 500 UI/10ml

FORMA FARM.
BIOTEST PHARMA GMBH

FIRMA

PROTOCOL

B02BD02 OCTOCOG ALFA


HAEMOCTIN SDH 500

LIOF. + SOLV. PT. SOL. INJ. LIOF. + SOLV. PT. SOL. INJ./PERF.
BAXTER SA

50UI 1000UI/10ml 250 UI 250UI/10ml 500 UI/10ml

B02BD02 OCTOCOG ALFA


RECOMBINATE 1000 UI/10 ml

B02BD02 OCTOCOG ALFA


ADVATE 250UI

PULB+SOLV.PT.SOL.INJ.
BAXTER AG

B02BD02 OCTOCOG ALFA


RECOMBINATE 250 UI/10 ml

LIOF. + SOLV. PT. SOL. INJ./PERF.


BAXTER SA BAXTER SA

B02BD02 OCTOCOG ALFA


RECOMBINATE 500 UI/10 ml

LIOF. + SOLV. PT. SOL. INJ./PERF.

823

B02BD03

COMPLEX DE ANTIINHIBITORI AI COAGULARII **


LIOF. + SOLV. PT. SOL. INJ./PERF.
1000 U/20 ml BAXTER AG

B02BD03 COMPLEX DE ANTIINHIBITORI AI COAGULARII


FEIBA NF 1000 U FEIBA

1000 U/20 ml

B02BD03 COMPLEX DE ANTIINHIBITORI AI COAGULARII


FEIBA NF 500 U FEIBA

LIOF. + SOLV. PT. SOL. INJ./PERF.


500 U/20ml BAXTER AG

500 U/20ml

824
OCTANINE F 1000

B02BD04

FACTOR IX DE COAGULARE **
PULB. LIOF. + SOLV.
1000 UI 1000UI 100UI/ml 2000UI 200UI 250 UI 250UI 500 UI 500UI 600 U.I. 1200UI 600UI OCTAPHARMA (IP) LIMITED

B02BD04 FACTOR IX DE COAGULARE B02BD04 FACTOR IX DE COAGULARE


BENEFIX 1000UI

1000 UI 1000UI 100UI/ml 2000UI 200UI 250 UI 250UI 500 UI 500UI 600 U.I. 1200UI 600UI

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LTD SANQUIN WYETH EUROPA LTD BAXTER AG

B02BD04 FACTOR IX DE COAGULARE


NONAFACT

LIOF. + SOLV. PT. SOL. PULB+SOLV.PT.SOL.INJ PULB.+SOLV. PT. SOL. PERF. LIOF. + SOLV. PT. SOL. PERF.
OCTAPHARMA (IP) LIMITED

B02BD04 FACTOR IX DE COAGULARE


BENEFIX 2000UI

B02BD04 FACTOR IX DE COAGULARE


IMMUNINE 200 UI

B02BD04 FACTOR IX DE COAGULARE


OCTANINE F 250

B02BD04 FACTOR IX DE COAGULARE


BENEFIX 250UI

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LTD

B02BD04 FACTOR IX DE COAGULARE


OCTANINE F 500

LIOF. + SOLV. PT. SOL. PERF.


OCTAPHARMA (IP) LIMITED

B02BD04 FACTOR IX DE COAGULARE


BENEFIX 500UI

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LTD

B02BD04 FACTOR IX DE COAGULARE


BERININ P 600 U.I.

LIOF. + SOLV.
AVENTIS BEHRING GMBH BAXTER AG BAXTER AG

B02BD04 FACTOR IX DE COAGULARE


IMMUNINE 1200 UI

PULB.+SOLV. PT. SOL. INJ./PERF. PULB.+SOLV. PT. SOL. INJ./PERF.

B02BD04 FACTOR IX DE COAGULARE


IMMUNINE 600 UI

825

B02BD06

FACTOR VIII DE COAGULARE SI FACTOR VON WILLEBRAND **


LIOF. SI SOLV. PT. SOL. INJ./PERF.
CSL BEHRING GMBH

B02BD06 FACTOR VIII DE COAGULARE SI FACTOR VON WILLEBRAND


HAEMATE P 1000 UI

1000 UI

B02BD06 FACTOR VIII DE COAGULARE SI FACTOR VON WILLEBRAND


HAEMATE P 250 UI

LIOF. SI SOLV. PT. SOL. INJ./PERF.


CSL BEHRING GMBH

250 UI

B02BD06 FACTOR VIII DE COAGULARE SI FACTOR VON WILLEBRAND


HAEMATE P 500 UI

LIOF. SI SOLV. PT. SOL. INJ./PERF.


CSL BEHRING GMBH

500 UI

826

B02BD08

EPTACOG ALFA ACTIVATUM **


PULB. + SOLV. PT. SOL. INJ.
60 KIU 120KUI 240 KUI NOVO NORDISK A/S

Protocol: B015D
60 KIU 120KUI 240 KUI

B02BD08 EPTACOG ALFA ACTIVATUM


NOVOSEVEN 1,2 mg (60 KUI)

B02BD08 EPTACOG ALFA ACTIVATUM


NOVOSEVEN 2,4 mg (120 KUI)

PULB. + SOL. PT. SOL. INJ.


NOVO NORDISK A/S NOVO NORDISK A/S

B02BD08 EPTACOG ALFA ACTIVATUM


NOVOSEVEN 4,8 mg (240 KUI)

PULB. + SOL. PT. SOL. INJ.

827
DESFERAL

V03AC01

DEFEROXAMINUM **(3)
LIOF. PT. SOL. INJ./PERF.
500mg NOVARTIS PHARMA GMBH

Protocol: V001D
500mg

V03AC01 DEFEROXAMINUM

828
EXJADE 125mg

V03AC03

DEFERASIROXUM ****
COMPR. DISP.
125mg 250mg 500mg NOVARTIS EUROPHARM LTD.

Protocol: V002D
125mg 250mg 500mg

V03AC03 DEFERASIROXUM V03AC03 DEFERASIROXUM


EXJADE 250mg

COMPR. DISP.
NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

V03AC03 DEFERASIROXUM
EXJADE 500mg

COMPR. DISP.

829
NEOTIGASON

D05BB02

ACITRETINUM
CAPS.
10mg ACTAVIS GROUP PTC EHF

D05BB02 ACITRETINUM

10mg

Acest medicament are un mare potential teratogen - sarcina trebuie evitata pentru o perioada de cel puin doi ani dupa intreruperea tratamentului

830

D06AA04

TETRACYCLINUM
UNGUENT
3% ANTIBIOTICE SA

D06AA04 TETRACYCLINUM
TETRACICLINA CLORHIDRAT

3,00%

831

D06AX01

ACIDUM FUSIDICUM
CREMA 2,00%

D06AX01 ACIDUM FUSIDICUM

174 / 233

DCI/DENUMIRE COMERCIALA
FUCIDIN

CONCENTRATIE
2%

FORMA FARM.

FIRMA

PROTOCOL

LEO PHARMACEUTICAL PRODUCTS

D06AX01 ACIDUM FUSIDICUM


FUCIDIN 2%

UNGUENT
LEO PHARMACEUTICAL PRODUCTS

2,00%

832
DERMAZIN 1%

D06BA01

SULFADIAZINUM
CREMA
1% LEK PHARMACEUTICALS D.D.

D06BA01 SULFADIAZINUM

1,00%

833

D07CA01

COMBINATII (ACIDUM FUSIDICUM + HYDROCORTISONUM)


CREMA
LEO PHARMACEUTICAL PRODUCTS ASTELLAS PHARMA EUROPE B.V.

Protocol: D001L

D07CA01 COMBINATII (ACIDUM FUSIDICUM + HYDROCORTISONUM)


FUCIDIN H PIMAFUCORT

D07CA01 COMBINATII (ACIDUM FUSIDICUM + HYDROCORTISONUM)


OXIMED

SPRAY CUT. - SUSP.


MEBRA SRL

D07CA01 COMBINATII (ACIDUM FUSIDICUM + HYDROCORTISONUM)


PIMAFUCORT

UNGUENT
ASTELLAS PHARMA EUROPE B.V.

834
BELOGENT DIPROGENTA FUCICORT TRIDERM

D07CC01

COMBINATII
CREMA
A & G MED TRADING S.R.L. SCHERING PLOUGH EUROPE LEO PHARMACEUTICAL PRODUCTS SCHERING PLOUGH EUROPE

Protocol: D001L

D07CC01 COMBINATII

D07CC01 COMBINATII
BELOGENT DIPROGENTA TRIDERM

UNGUENT
A & G MED TRADING S.R.L. SCHERING PLOUGH EUROPE SCHERING PLOUGH EUROPE

836
J01AA07

J01AA07
TETRACYCLINUM

TETRACYCLINUM
CAPS.
250mg 250mg 250mg ARENA GROUP SA ANTIBIOTICE SA SANDOZ SRL

250mg

TETRACICLINA TETRACICLINA 250 mg TETRACICLINA SANDOZ 250 mg

837
FUCIDIN

J01XC01

ACIDUM FUSIDICUM
COMPR. FILM.
250mg LEO PHARMACEUTICAL PRODUCTS

J01XC01 ACIDUM FUSIDICUM

250mg

838
FENITOIN 100 mg

N03AB02

PHENYTOINUM
COMPR.
100mg GEDEON RICHTER ROMANIA SA

N03AB02 PHENYTOINUM N03AB02 PHENYTOINUM


PHENHYDANSOLUTIE INJECTABILA

100mg 50mg/ml
DESITIN

SOL. INJ.
50mg/ml

839
TRACLEER 125 mg

C02KX01

BOSENTANUM **
COMPR. FILM.
125mg ACTELION REGISTRATION LTD.

Protocol: CI01I
125mg

C02KX01 BOSENTANUM

Bosentanum este un medicament care nu trebuie administrat la gravide. Sarcina trebuie evitat timp de trei luni dup ntreruperea tratamentului.

C02KX01 BOSENTANUM
TRACLEER 62,5 mg

COMPR. FILM.
62.5mg ACTELION REGISTRATION LTD.

62.5mg

Bosentanum este un medicament care nu trebuie administrat la gravide. Sarcina trebuie evitat timp de trei luni dup ntreruperea tratamentului.

840
REVATIO 20 mg

G04BE03

SILDENAFILUM **
COMPR. FILM.
20mg PFIZER LTD.

Protocol: CI01I
20mg

G04BE03 SILDENAFILUM

841
J01FA09

J01FA09
CLARITHROMYCINUM

CLARITHROMYCINUM
GRAN. PT. SUSP. ORALA
125mg/5ml 125mg/5ml 125mg/5ml 125mg/5ml 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg 250mg/5ml 250mg/5ml 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg KRKA D.D. TERAPIA S.A. ABBOTT SPA SANDOZ S.R.L.

125mg/5ml

FROMILID 125 mg/5 ml KLABAX 125 mg/5 ml KLACID LEKOKLAR 125 mg/5 ml

J01FA09

CLARITHROMYCINUM

COMPR. FILM.
MEDICAROM GROUP S.R.L. HEXAL AG OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT SPA MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

250mg

CLAR 250 CLARITROMICIN HEXAL 250 CLARITROMICINA 250 mg FROMILID 250 KLABAX 250 mg KLACID KLERIMED 250 LEKOKLAR 250 mg

J01FA09

CLARITHROMYCINUM

GRAN. PT. SUSP. ORALA


TERAPIA S.A. SANDOZ SRL

250mg/5ml

KLABAX 250 mg/5 ml LEKOKLAR 250 mg/5 ml

J01FA09

CLARITHROMYCINUM

COMPR. FILM.
MEDICAROM GROUP S.R.L. OZONE LABORATORIES LTD. KRKA D.D. NOVO MESTO TERAPIA S.A. ABBOTT LABORATORIES LTD. MEDOCHEMIE LTD. LEK PHARMACEUTICALS D.D.

500mg

CLAR 500 CLARITROMICINA 500 mg FROMILID 500 KLABAX 500 mg KLACID 500 mg KLERIMED 500 LEKOKLAR 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. MODIF.


TERAPIA S.A. LEK PHARMACEUTICALS D.D.

500mg

KLABAX MR 500 mg LEKOKLAR XL 500 mg

J01FA09

CLARITHROMYCINUM

COMPR. FILM. ELIB. PREL.


KRKA D.D.

500mg

FROMILID UNO

175 / 233

DCI/DENUMIRE COMERCIALA
KLACID SR

CONCENTRATIE
500mg

FORMA FARM.
ABBOTT LABORATORIES LTD.

FIRMA

PROTOCOL

J01FA09
KLACID I.V.

CLARITHROMYCINUM

LIOF. PT. SOL. PERF.


500mg ABBOTT LABORATORIES LTD.

500mg

842
TOBI

J01GB01
Prescriere limitata:

TOBRAMYCINUM **
SOL. INHAL.
300mg/5ml NOVARTIS PHARMA GMBH

J01GB01 TOBRAMYCINUM

300mg/5ml

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic.

843
PULMOZYME

R05CB13

DORNAZA ALFA **
SOL. INHAL.
1mg/ml ROCHE ROMANIA S.R.L.

R05CB13 DORNAZA ALFA

1mg/ml

844
RILUTEK 50 mg

N07XX02

RILUZOLUM **
COMPR. FILM.
50mg AVENTIS PHARMA SA

Protocol: N024G
50mg

N07XX02 RILUZOLUM

845
J06BA02

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA **


SOL. PERF.
100mg/ml BAXTER AG

Protocol: J001G

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA

100mg/ml

KIOVIG 100mg/ml

J06BA02

SOL. PERF.
10g/200ml KEDRION SPA

10g/200ml

IG VENA 10g/200ml

J06BA02

SOL. PERF.
1g/20ml KEDRION SPA

1g/20ml

IG VENA 1g/20ml

J06BA02

SOL. PERF.
2.5mg/50ml KEDRION SPA

2.5mg/50ml

IG VENA 2,5g/50ml

J06BA02

SOL. PERF.
50mg/ml 50mg/ml 50mg/ml INSTITUTO GRIFOLS S.A. OCTAPHARMA (IP) LTD. BIOTEST PHARMA GMBH

50mg/ml

FLEBOGAMMADIF 50mg/ml OCTAGAM PENTAGLOBIN

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA
5%

SOL. PERF.
5g/100ml KEDRION SPA

5g/100ml

IG VENA 5g/100ml

J06BA02
HUMAGLOBIN

PULB.+SOLV. PT. SOL. PERF.


TEVA PHARM. WORKS PRIVATE LTD. COMPANY

5%

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA


5%

SOL. PERF.
INSTITUTO GRIFOLS S.A.

5%

FLEBOGAMMA 5%

846
AREDIA 15 mg

M05BA03

ACIDUM PAMIDRONICUM
LIOF.+ SOLV. PT. SOL. PERF.
15mg 15mg/ml 30mg 60mg NOVARTIS PHARMA GMBH

Protocol: M002Q
15mg 15mg/ml 30mg 60mg

M05BA03 ACIDUM PAMIDRONICUM M05BA03 ACIDUM PAMIDRONICUM


PAMIDRONAT TORREX

CONC. PT. SOL. PERF.


TORREX CHIESI PHARMA GMBH DR. REDDY'S LABORATORIES

M05BA03 ACIDUM PAMIDRONICUM


PAMIRED 30

LIOF. PT. SOL. PERF. I.V. LIOF. PT. SOL. PERF. I.V.
DR. REDDY'S LABORATORIES

M05BA03 ACIDUM PAMIDRONICUM


PAMIRED 60

847
OMNITROPE 1,3mg/ml

H01AC01

SOMATROPINUM **
PULB+SOLV.PT.SOL.INJ
1,3mg/ml SANDOZ GMBH

Protocol: H011Q
1,3mg/ml 10mg/1.5ml
NOVO NORDISK A/S

H01AC01 SOMATROPINUM H01AC01 SOMATROPINUM


NORDITROPIN SIMPLEX x 10mg/1,5ml

SOL. INJ.
10mg/1.5ml

H01AC01 SOMATROPINUM
NUTROPINAq 10 mg/2 ml

SOL. INJ.
10mg/2ml IPSEN LIMITED

10mg/2ml 3,3mg/ml
SANDOZ GMBH

H01AC01 SOMATROPINUM
OMNITROPE 3,3mg/ml

SOL. INJ.
3,3mg/ml 4mg (12ui) 5.3mg/ml (16ui) 5mg/1,5ml

H01AC01 SOMATROPINUM
ZOMACTON

LIOF. + SOLV. PT. SOL. INJ.


FERING GMBH

4mg (12ui) 5.3mg/ml (16ui) 5mg/1,5ml 5mg/1.5ml

H01AC01 SOMATROPINUM
GENOTROPIN 16 ui (5,3 mg)

PULB. + SOLV. PT. SOL. INJ.


PFIZER EUROPE MA EEIG BIOPARTNERS GMBH NOVO NORDISK A/S

H01AC01 SOMATROPINUM
VALTROPIN

PULB. + SOLV. PT. SOL. INJ. SOL. INJ.


5mg/1.5ml 5mg/ml

H01AC01 SOMATROPINUM
NORDITROPIN SIMPLEXx 5 mg/1,5 ml

H01AC01 SOMATROPINUM
OMNITROPE 5mg/ml

PULB+SOLV.PT.SOL.INJ
SANDOZ GMBH

5mg/ml 6,7mg/ml

H01AC01 SOMATROPINUM
OMNITROPE 6,7mg/ml

SOL. INJ.
6,7mg/ml SANDOZ GMBH

848
FABRAZYME 35 mg

A16AB04

AGALSIDASUM BETA **
PULB. PT. CONC. PT. SOL. PERF.
35mg 5mg GENZYME EUROPE BV

Protocol: A014E
35mg 5mg

A16AB04 AGALSIDASUM BETA A16AB04 AGALSIDASUM BETA


FABRAZYME 5 mg

PULB. PT. CONC. PT. SOL. PERF.


GENZYME EUROPE BV

849
MYOZYME 50mg

A16AB07

ALGLUCOSIDASUM ALPHA **
PULB. PT. CONC. PT. SOL. PERF.
50mg GENZYME EUROPE B.V.

Protocol: A030Q
50mg

A16AB07 ALGLUCOSIDASUM ALPHA

176 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-VII P7: PROGRAMUL NATIONAL DE BOLI ENDOCRINE. TRATAMENTUL MEDICAMENTOS AL BOLNAVILOR CU OSTEOPOROZA, GUSA DATORATA CARENTEI DE IOD SI PROLIFERARII MALIGNE 850 A11CC02 DIHYDROTACHYSTEROLUM
A11CC02 DIHYDROTACHYSTEROLUM
TACHYSTIN

PICATURI ORALE-SOL.
0.1mg/ml 1mg/ml CHAUVIN ANKERPHARM GMBH

0.1mg/ml 1mg/ml

A11CC02 DIHYDROTACHYSTEROLUM
A.T. 10

PICATURI ORALE-SOL.
MERCK KGAA

851
ALPHA D3 0,25 g

A11CC03

ALFACALCIDOLUM
CAPS. MOI
0.25g TEVA PHARMACEUTICALS SRL

A11CC03 ALFACALCIDOLUM A11CC03 ALFACALCIDOLUM


ALPHA D3 0.50 g

0.25g 0.50g
TEVA PHARMACEUTICALS S.R.L.

CAPS. MOI
0.50g

A11CC03 ALFACALCIDOLUM
ALPHA D3 1 g 1g

CAPS. MOI
TEVA PHARMACEUTICALS SRL

1g

852
OSTEO D 0,25 g ROCALTROL

A11CC04

CALCITRIOLUM
CAPS. MOI
0.25g 0.25g TEVA PHARMACEUTICALS S.R.L. ROCHE ROMANIA S.R.L.

A11CC04 CALCITRIOLUM

0.25g

A11CC04 CALCITRIOLUM
OSTEO D 0,50 g ROCALTROL

CAPS. MOI
0.50g 0.50g TEVA PHARMACEUTICALS S.R.L. F. HOFFMANN LA ROCHE LTD.

0.50g

853
OESTROGEL

G03CA03

ESTRADIOLUM
GEL
0.06% LAB. BESINS INTERNATIONAL

G03CA03 ESTRADIOLUM G03CA03 ESTRADIOLUM


ESTREVA 0.1%

0.06% 0.1%
LAB. THERAMEX

GEL SIST. TERAP. TRANSDERM.


100g/24 ore NOVARTIS PHARMA GMBH

G03CA03 ESTRADIOLUM
ESTRADOT 100

100g/24 ore

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. NOTA: Estradiol trebuie folosit mpreuna cu un progestativ oral la femeile nehisterectomizate..

G03CA03 ESTRADIOLUM
ESTROFEM 1 mg 1mg 25g

COMPR. FILM.
NOVO NORDISK A/S

1mg 25g 25mg

G03CA03 ESTRADIOLUM
VAGIFEM

COMPR. VAG.
NOVO NORDISK A/S

G03CA03 ESTRADIOLUM
RISELLE 25 mg 25mg

IMPLANT
ORGANON NV

G03CA03 ESTRADIOLUM
ESTRADOT 37,5

SIST. TERAP. TRANSDERM.


37.5g/24 ore NOVARTIS PHARMA GMBH

37.5g/24 ore

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. NOTA: Estradiol trebuie folosit mpreuna cu un progestativ oral la femeile nehisterectomizate..

G03CA03 ESTRADIOLUM
ESTRADOT 50

SIST. TERAP. TRANSDERM.


50g/24 ore NOVARTIS PHARMA GMBH

50g/24 ore

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. NOTA: Estradiol trebuie folosit mpreuna cu un progestativ oral la femeile nehisterectomizate..

G03CA03 ESTRADIOLUM
CLIMARA

PLASTURE TRANSDERM.
50g/24ore SCHERING AG

50g/24ore

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. NOTA: Estradiol trebuie folosit mpreuna cu un progestativ oral la femeile nehisterectomizate..

G03CA03 ESTRADIOLUM
ESTRADOT 75

SIST. TERAP. TRANSDERM.


75g/24 ore NOVARTIS PHARMA GMBH

75g/24 ore

Prescriere limitata: Utilizat in simptomele caracteristice post-menopauzei, in cazul in care terapia estrogenica in doze reduse a demonstrat intoleranta la administrarea orala cu estrogeni. NOTA: Estradiol trebuie folosit mpreuna cu un progestativ oral la femeile nehisterectomizate..

854
LADYBON

G03DC05

TIBOLONUM
COMPR.
2,5mg ZENTIVA A.S.

Protocol: G007N
2,5mg 2.5mg
ORGANON NV

G03DC05 TIBOLONUM G03DC05 TIBOLONUM


LIVIAL 2,5 mg 2.5mg

COMPR.

855
KLIMODIEN

G03FA15

ESTRADIOLUMVALERAT+DIENOGEST
DRAJ.
SCHERING AG

Protocol: G002N

G03FA15 ESTRADIOLUMVALERAT+DIENOGEST

856
EVISTA 60mg OPTRUMA 60mg

G03XC01

RALOXIFENUM
COMPR. FILM.
60mg 60mg ELI LILLY NEDERLAND BV ELI LILLY NEDERLAND BV

G03XC01 RALOXIFENUM

60mg

Cod restrictie 2647:

Monoterapia cu medicamente anti-resorbtive pentru tratamentul osteoporozei post-menopauza la pacientele cu fracturi consecutive unor traume minore. Ofractura vertebrala se definiste ca fiind o reducere de cel putin 20% a inaltimii pertiunii anterioare raportata la inaltimea zonei posterioare sau o reducere cu cel putin 20% a inaltimii oricarei zone a acorpului vertebral prin compararea cu inltimea corpuirilor vertrbreleor vecine, afectate. NOTA: Agentii anti-resorbtivi utilizati in tratamentul osteoporozei instalate sunt: alendronate sodium, risedronate sodium, disodium etidronate, raloxifene hydrochloride si strontium ranelate..

857
THYROGEN 0,9 mg

H01AB01
Prescriere limitata:

TIREOTROPINUM ALFA
PULB. PT. SOL. INJ.
0.9mg GENZYME EUROPE BV

H01AB01 TIREOTROPINUM ALFA

0.9mg

Ablaia esutului tiroidian remanent in combinaie cu iod radioactiv la un adult de minimum 18 ani dupa tiroidectomie fara metastaze prezente.

858
LEMOD SOLU 125 mg

H02AB04

METHYLPREDNISOLONUM
LIOF. PT. SOL. INJ.
125mg 125mg/2ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM H02AB04 METHYLPREDNISOLONUM


SOLU - MEDROL ACT-O-VIAL

125mg 125mg/2ml

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG

177 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
PFIZER EUROPE MA EEIG

FIRMA

PROTOCOL

H02AB04 METHYLPREDNISOLONUM
MEDROL A 16 16mg 20mg

COMPR. LIOF. PT. SOL. INJ.


HEMOFARM S.R.L.

16mg 20mg 250mg/4ml 32mg


PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 20 mg

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
250mg/4ml PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 32 32mg 40mg

COMPR. LIOF. PT. SOL. INJ.


HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 40 mg

40mg 40mg/1ml 4mg

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
40mg/1ml PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg 4mg

COMPR. LIOF. PT. SOL. INJ.


500mg 500mg/7.8ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 500 mg

500mg 500mg/7.8ml

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL 500 mg/7,8 ml

LIOF. + SOLV. PT. SOL. INJ.


PFIZER EUROPE MA EEIG

859
THYRO - 4 0,1 mg

H03AA01

LEVOTHYROXINUM
COMPR.
0.1mg FARAN LABORATORIES S.A.

H03AA01 LEVOTHYROXINUM H03AA01 LEVOTHYROXINUM


THYRO - 4 0,2 mg 0.2mg

0.1mg 0.2mg
FARAN LABORATORIES S.A.

COMPR. COMPR.
100g 100g MERCK KGAA BERLIN CHEMIE AG MENARINI GROUP

H03AA01 LEVOTHYROXINUM
EUTHYROX 100 L-THYROXIN 100 BERLIN - CHEMIE

100g

H03AA01 LEVOTHYROXINUM
EUTHYROX 150 150g

COMPR.
MERCK KGAA

150g 200g
MERCK KGAA

H03AA01 LEVOTHYROXINUM
EUTHYROX 200 200g

COMPR. COMPR.
25g MERCK KGAA

H03AA01 LEVOTHYROXINUM
EUTHYROX 25

25g 50g
MERCK KGAA BERLIN CHEMIE AG MENARINI GROUP

H03AA01 LEVOTHYROXINUM
EUTHYROX 50 L-THYROXIN 50 50g 50g

COMPR.

860

H03AAN1

LEVOTHYROXINUM+KALII IODIDUM
COMPR.
MERCK KGAA

H03AAN1 LEVOTHYROXINUM+KALII IODIDUM


JODTHYROX 100/130,8

861
THYROZOL 10 mg

H03BB02

THIAMAZOLUM
COMPR. FILM.
10mg 20mg 5mg MERCK KGAA

H03BB02 THIAMAZOLUM H03BB02 THIAMAZOLUM


THYROZOL 20 mg

10mg 20mg 5mg

COMPR. FILM.
MERCK KGAA

H03BB02 THIAMAZOLUM
THYROZOL 5 mg

COMPR. FILM.
MERCK KGAA

862
JODID 100

H03CA01

KALII IODIDUM
COMPR.
100g MERCK KGAA

H03CA01 KALII IODIDUM H03CA01 KALII IODIDUM


JODID 200 200g

100g 200g
MERCK KGAA

COMPR.

863
FORSTEO 20g/80g

H05AA02

TERIPARATIDUM **
SOL. INJ.
20g/80g ELI LILLY NEDERLAND BV

Protocol: M003M
20g/80g

H05AA02 TERIPARATIDUM

864
FORCALTONIN

H05BA01

CALCITONINUM (SOMON)
SOL. INJ.
100 UI UNIGENE UK LIMITED

H05BA01 CALCITONINUM (SOMON) H05BA01 CALCITONINUM (SOMON)


TONOCALCIN 100 UI 100UI

100 UI 100UI
ALFA WASSERMANN SPA

SOL. INJ. SPRAY NAZ.,SOL.


100UI/doza 100ui/doza PHARMACEUTICAL IND. PROEL EPAM. G.CORONIS SA ALFA WASSERMANN SPA

H05BA01 CALCITONINUM (SOMON)


NYLEX 100 UI/doza TONOCALCIN

100ui/doza

H05BA01 CALCITONINUM (SOMON)


NYLEX

SOL. INJ.
100UI/ml 200ui/doza 200UI/doza PROEL E.P. CORONIS SA

100UI/ml 200UI/doza

H05BA01 CALCITONINUM (SOMON)


MIACALCIC NASAL 200 NYLEX

SPRAY NAZAL - SOL.


NOVARTIS PHARMA GMBH PROEL E.P. CORONIS SA

H05BA01 CALCITONINUM (SOMON)


TONOCALCIN 50 UI 50UI

SOL. INJ.
ALFA WASSERMANN SPA

50UI 50ui/ml
NOVARTIS PHARMA GMBH

H05BA01 CALCITONINUM (SOMON)


MIACALCIC

SOL. INJ.
50ui/ml

865
FOSAMAX 10 mg TEVA NAT 10 mg

M05BA04

ACIDUM ALENDRONICUM **
COMPR.
10mg 10mg MERCK SHARP & DOHME S.R.L. TEVA PHARMACEUTICALS S.R.L.

Protocol: M003M
10mg

M05BA04 ACIDUM ALENDRONICUM

M05BA04 ACIDUM ALENDRONICUM


FOSAMAX 5mg

COMPR.
MERCK SHARP & DOHME ROMANIA S.R.L.

5mg 70 mg
TEVA PHARMACEUTICALS SRL

M05BA04 ACIDUM ALENDRONICUM


TEVA NAT 70 mg

COMPR. COMPR.

M05BA04 ACIDUM ALENDRONICUM

70mg

178 / 233

DCI/DENUMIRE COMERCIALA
FOSAMAX 70 mg

CONCENTRATIE
70mg 70mg

FORMA FARM.
MERCK SHARP & DOHME S.R.L.

FIRMA

PROTOCOL

M05BA04 ACIDUM ALENDRONICUM


ALENDRONAT SANDOZ 70 mg

COMPR. FILM.
SANDOZ S.R.L.

70mg

866
BONDEZA 150mg BONVIVA 150mg

M05BA06

ACIDUM IBANDRONICUM **
COMPR. FILM.
150mg 150mg 2.5mg 2.5mg 3mg/3ml 3mg/3ml ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

Protocol: M003M
150mg

M05BA06 ACIDUM IBANDRONICUM

M05BA06 ACIDUM IBANDRONICUM


BONDEZA 2.5mg BONVIVA 2.5mg

COMPR. FILM.
ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

2.5mg

M05BA06 ACIDUM IBANDRONICUM


BONDEZA 3mg/3ml BONVIVA 3mg/3ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD

3mg/3ml

867

M05BA07

ACIDUM RISEDRONICUM **
COMPR. FILM.
35mg 35mg 5mg AVENTIS PHARMA AB ZENTIVA A.S.

Protocol: M003M
35mg

M05BA07 ACIDUM RISEDRONICUM


ACTONEL SAPTAMANAL RISENDROS 35 mg

M05BA07 ACIDUM RISEDRONICUM


ACTONEL 5 mg

COMPR. FILM.
AVENTIS PHARMA AB

5mg

868

M05BB03

COMBINATII (ACIDUM ALENDRONICUM+COLECALCIFEROLUM) **


COMPR.
70mg/2800UI 70mg/2800UI MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD.

Protocol: M003M

M05BB03 COMBINATII (ACIDUM ALENDRONICUM+COLECALCIFEROLUM)


ADROVANCE 70mg/2800UI FOSAVANCE 70mg/2800UI

70mg/2800UI

M05BB03 COMBINATII (ACIDUM ALENDRONICUM+COLECALCIFEROLUM)


ADROVANCE 70mg/5600UI FOSAVANCE 70mg/5600UI

COMPR.
70mg/5600UI 70mg/5600UI MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD.

70mg/5600UI

869
OSSEOR 2 g PROTELOS 2 g

M05BX03

STRONTIUM RANELATUM
GRAN. PT. SUSP. ORALA
2g 2g LES LAB. SERVIER LES LAB. SERVIER IND.

M05BX03 STRONTIUM RANELATUM

2g

870

V09FX03

NATRII IODIDUM (131I)


SOL. ORALA
0,37-3,7GBq INCDFIN "HORIA HULUBEI"

V09FX03 NATRII IODIDUM (131I)


RADIOIODURA (131I) DE SODIU, SOL. ORALA (0,37-3,7GBq/cm)

0,37-3,7GBq

V09FX03 NATRII IODIDUM (131I)


IODURA DE SODIU (131I) CAPSULE PENTRU DIAGNOSTIC

CAPS.
3.7MBq GE HEALTHCARE LTD

3.7MBq 3.7MBq,1.85MBq, 0.925MBq


INCDFIN "HORIA HULUBEI"

V09FX03 NATRII IODIDUM (131I)


RADIOIODURA (131I) DE SODIU, CAPSULE CU ACTIVITATE DE 3,7MBq, 1,85MBq, 0,925MBq

CAPS.
3.7MBq,1.85MBq, 0.925MBq

871
THERACAP 131

V10XA01

NATRII IODIDUM (131I)


CAPS.
37MBq-5.55GBq GE HEALTHCARE LTD

V10XA01 NATRII IODIDUM (131I)

37MBq-5.55GBq

872
ACLASTA 5mg/100ml

M05BA08

ACIDUM ZOLEDRONICUM **
SOL. PERF.
5mg/100ml NOVARTIS EUROPHARM LTD.

Protocol: M001M
5mg/100ml

M05BA08 ACIDUM ZOLEDRONICUM

1218
CARBIMAZOLE 5

H03BB01

CARBIMAZOLUM
COMPR. FILM.
5mg REMEDICA LTD.

H03BB01 CARBIMAZOLUM

5mg

179 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-VIII P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.1: TRANSPLANT MEDULAR 873 A04AA01 ONDANSETRONUM **
A04AA01 ONDANSETRONUM
OSETRON 8 mg

SOL. INJ.
2mg/ml 2mg/ml 2mg/ml 4mg 4mg 4mg 4mg 4mg 4mg DR. REDDY'S LABORATORIES

2mg/ml 2mg/ml

A04AA01 ONDANSETRONUM
EMESET 4 mg/2 ml EMESET 8 mg/4 ml

SOL. INJ./PERF.
CIPLA (UK) LIMITED CIPLA (UK) LIMITED

A04AA01 ONDANSETRONUM
ONDANSETRON TEVA 4mg ONDANTOR 4 mg OSETRON 4 mg SETRONON 4 mg ZOFRAN 4 mg

COMPR. FILM.
TEVA PHARMACEUTICALS SRL SANDOZ SRL DR. REDDY'S LABORATORIES PLIVA LJUBLJANA D.O.O. GLAXO WELLCOME UK LTD.

4mg

A04AA01 ONDANSETRONUM
ONDARAN MD 4mg

COMPR. ORODISPERSABILE
RANBAXY UK LTD.

4mg 4mg/2ml

A04AA01 ONDANSETRONUM
ZOFRAN 4mg/2ml

SOL. INJ.
4mg/2ml 4mg/2ml 8mg 8mg 8mg 8mg 8mg 8mg GLAXO WELLCOME UK LIMITED

A04AA01 ONDANSETRONUM
SETRONON 4 mg/2 ml

SOL. INJ./PERF.
PLIVA LJUBLJANA D.O.O.

4mg/2ml 8mg

A04AA01 ONDANSETRONUM
ONDANSETRON TEVA 8 mg ONDANTOR 8 mg OSETRON 8 mg SETRONON 8 mg ZOFRAN 8 mg

COMPR. FILM.
TEVA PHARMACEUTICALS SRL SANDOZ SRL DR. REDDY'S LABORATORIES (UK) LTD PLIVA LJUBLJANA D.O.O. GLAXO WELLCOME UK LTD.

A04AA01 ONDANSETRONUM
ONDARAN MD 8 mg

COMPR. ORODISPERSABILE
RANBAXY UK LIMITED

8mg 8mg/4ml

A04AA01 ONDANSETRONUM
ZOFRAN 8mg/4ml

SOL. INJ.
8mg/4ml 8mg/4 ml GLAXO WELLCOME UK LIMITED

A04AA01 ONDANSETRONUM
SETRONON 8 mg/4 ml

SOL. INJ./PERF.
PLIVA LJUBLJANA D.O.O.

8mg/4 ml

874
URSOCHOL 150 mg

A05AA02

ACIDUM URSODEOXYCHOLICUM
COMPR.
150mg ZAMBON S.P.A.

A05AA02 ACIDUM URSODEOXYCHOLICUM


NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

150mg

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOFALK URSOSAN

CAPS.
250mg 250mg DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

250mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOCHOL 300 mg

COMPR.
300mg ZAMBON S.P.A.

300mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

875

B01AB08

REVIPARINUM
SOL. INJ.
1432ui/0.25ml 1432ui/0.25ml ABBOTT GMBH&CO.KG ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN 1432UI/0,25 ml CLIVARIN -PEN

1432ui/0.25ml

B01AB08 REVIPARINUM
CLIVARIN 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml ABBOTT GMBH&CO.KG

3436ui/0.6ml 5726ui/ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN - multi

SOL. INJ.
5726ui/ml

877

B02BD08

EPTACOG ALFA ACTIVATUM **


PULB. + SOLV. PT. SOL. INJ.
60 KIU 120KUI 240 KUI NOVO NORDISK A/S

B02BD08 EPTACOG ALFA ACTIVATUM


NOVOSEVEN 1,2 mg (60 KUI)

60 KIU 120KUI 240 KUI

B02BD08 EPTACOG ALFA ACTIVATUM


NOVOSEVEN 2,4 mg (120 KUI)

PULB. + SOL. PT. SOL. INJ.


NOVO NORDISK A/S NOVO NORDISK A/S

B02BD08 EPTACOG ALFA ACTIVATUM


NOVOSEVEN 4,8 mg (240 KUI)

PULB. + SOL. PT. SOL. INJ.

878
EPREX 10000 UI

B03XA01

EPOETINUM ALFA
SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA


EPOKINE 1000 UI/0,5 ml EPREX 1000 UI

10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml 1000UI/ml 20000UI/ml

B03XA01 EPOETINUM ALFA


NEORECORMON 500UI

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD.

1000UI/ml 20000UI/ml 2000UI

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 2000 U.I.

SOL. INJ.
2000UI

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/0,5 ml EPREX 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

2000ui/0.5ml

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA


EPREX 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA


EPREX 40 000 UI

SOL. INJ.
40 000UI JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI

B03XA01 EPOETINUM ALFA

SOL. INJ.

180 / 233

DCI/DENUMIRE COMERCIALA
EPOPHAR 4000 U.I.

CONCENTRATIE
4000UI

FORMA FARM.

FIRMA

PROTOCOL

GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/0,4 ml EPREX 4000 UI

SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

4000ui/0.4ml

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 50000UI/ml 10000UI/1,0ml 10000UI/1,0ml 10000UI/1,0ml 1000UI/0,5ml 1000UI/0,5ml 1000UI/0,5ml 2000UI/1,0ml 2000UI/1,0ml 2000UI/1,0ml 3000UI/0,3ml 3000UI/0,3ml 3000UI/0,3ml 4000UI/0,4ml 4000UI/0,4ml 4000UI/0,4ml 5000UI/0,5ml 5000UI/0,5ml 5000UI/0,5ml 6000UI/0,6ml 6000UI/0,6ml 6000UI/0,6ml 8000UI/0,8ml 8000UI/0,8ml 8000UI/0,8ml RENAMED FARMA S.R.L.

4000UI/1ml 50000UI/ml 10000UI/1,0ml

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

B03XA01 EPOETINUM ALFA


ABSEAMED 10000UI/1,0ml BINOCRIT 10000UI/1,0ml EPOETIN ALFA HEXAL 10000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA


ABSEAMED 1000UI/0,5ml BINOCRIT 1000UI/0,5ml EPOETIN ALFA HEXAL 1000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

1000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 2000UI/1,0ml BINOCRIT 2000UI/1,0ml EPOETIN ALFA HEXAL 2000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

2000UI/1,0ml

B03XA01 EPOETINUM ALFA


ABSEAMED 3000UI/0,3ml BINOCRIT 3000UI/0,3ml EPOETIN ALFA HEXAL 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

3000UI/0,3ml

B03XA01 EPOETINUM ALFA


ABSEAMED 4000UI/0,4ml BINOCRIT 4000UI/0,4ml EPOETIN ALFA HEXAL 4000UI/0,4ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

4000UI/0,4ml

B03XA01 EPOETINUM ALFA


ABSEAMED 5000UI/0,5ml BINOCRIT 5000UI/0,5ml EPOETIN ALFA HEXAL 5000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

5000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 6000UI/0,6ml BINOCRIT 6000UI/0,6ml EPOETIN ALFA HEXAL 6000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

6000UI/0,6ml

B03XA01 EPOETINUM ALFA


ABSEAMED 8000UI/0,8ml BINOCRIT 8000UI/0,8ml EPOETIN ALFA HEXAL 8000UI/0,8ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

8000UI/0,8ml

879

B03XA01

EPOETINUM BETA
LIOF. + SOLV. PT. SOL. INJ.
1000UI/ml 20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON 500UI

1000UI/ml 20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ. SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 1000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 2000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 30000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 3000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 4000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 5000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 500UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 60000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 6000UI/0,3ml

880

J01CR03

TICARCILLINUM + ACIDUM CLAVULANICUM


PULB. PT. SOL. INJ./PERF.
1.6g BEECHAM GROUP PLC

J01CR03 TICARCILLINUM + ACIDUM CLAVULANICUM


TIMENTIN 1,6 g

1.6g

J01CR03 TICARCILLINUM + ACIDUM CLAVULANICUM


TIMENTIN 3,2 g 3.2g

PULB. PT. SOL. INJ./PERF.


BEECHAM GROUP PLC

3.2g

881

J01CR05

PIPERACILLINUM + TAZOBACTAMUM

181 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

FIRMA

PROTOCOL

J01CR05 PIPERACILLINUM + TAZOBACTAMUM


TAZOCIN 2,25 TAZOCIN 4,5

LIOF. PT. SOL. INJ.

882
MERONEM IV 1 g

J01DH02

MEROPENEMUM
PULB. PT. SOL. INJ. I.V./PERF.
1g 500mg ASTRAZENECA UK LTD.

J01DH02 MEROPENEMUM J01DH02 MEROPENEMUM


MERONEM IV 500 mg

1g 500mg

PULB. PT. SOL. INJ. I.V./PERF.


ASTRAZENECA UK LTD.

883
TIENAM I.V.

J01DH51

IMIPENEMUM + CILASTATINUM
PULB. PT. SOL. PERF.
MERCK SHARP & DOHME ROMANIA S.R.L.

J01DH51 IMIPENEMUM + CILASTATINUM

884
J01XA01 J01XA01
EDICIN VANCOMYCIN TEVA

J01XA01
VANCOMYCINUM

VANCOMYCINUM
LIOF. PT. SOL. PERF.
1g 1g TEVA PHARM. WORKS PRIVATE LTD. COMPANY

1g 1g 500mg 500mg

VANCOMYCINUM VANCOMYCINUM VANCOMYCINUM

PULB.LIOF.PT.SOL.PERF./INJ
LEK PHARMACEUTICALS D.D.

J01XA01 J01XA01
EDICIN

LIOF. PT. SOL. PERF.


500mg 500mg TEVA PHARM. WORKS PRIVATE LTD. COMPANY LEK PHARMACEUTICALS D.D.

VANCOMYCIN TEVA

LIOF. PT. SOL. PERF./INJ.

885
J01XA02 J01XA02
TARGOCID 200 mg

J01XA02
TEICOPLANINUM TEICOPLANINUM

TEICOPLANINUM
LIOF. + SOLV. PT. SOL. INJ.
200mg 400mg AVENTIS PHARMA LTD.

200mg 400mg

LIOF. + SOLV. PT. SOL. INJ.


AVENTIS PHARMA LTD.

TARGOCID 400 mg

886
FUCIDIN

J01XC01
Prescriere limitata:

ACIDUM FUSIDICUM
COMPR. FILM.
250mg LEO PHARMACEUTICAL PRODUCTS

J01XC01 ACIDUM FUSIDICUM

250mg

Se utilizeaza in combinatie cu alt antibiotic pentru tratamentul infectiilor stafilococice severe

887
J01XX08
ZYVOXID

J01XX08
LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID

SOL. PERF.
2mg/ml 400mg 600mg PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

400mg 600mg

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

888

J02AC01

FLUCONAZOLUM
CAPS.
100mg 100mg 100mg 100mg 100mg 100mg 100mg KRKA D.D. OZONE LABORATORIES LTD. LINCOSA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

J02AC01 FLUCONAZOLUM
DIFLAZON 100 mg FLUCONAZOL 100 mg FLUCONAZOLE LINCOSA 100mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

100mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM
DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL BIOGALENICA 150 mg FLUCONAZOL LAROPHARM 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCONIMED 150 mg FLUCORIC 150 mg FLUCOVIM 150 MEDOFLUCON 150 mg MYCOMAX 150

CAPS.
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. LAROPHARM S.R.L. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL MEDOCHEMIE LTD. ZENTIVA AS

150mg

J02AC01 FLUCONAZOLUM
DIFLAZON 200 mg FLUCONAZOLE LINCOSA 200 mg FLUCONAZOLE TEVA 200 mg

CAPS.
200mg 200mg 200mg KRKA D.D. LICONSA S.A. TEVA PHARMACEUTICALS SRL

200mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:
DIFLAZON

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM

SOL. PERF.
2mg/ml KRKA D.D.

2mg/ml

182 / 233

DCI/DENUMIRE COMERCIALA
DIFLUCAN FLUCONAZOL BIOGALENICA 2mg/ml MYCOMAX INF

CONCENTRATIE
2mg/ml 2mg/ml 2mg/ml

FORMA FARM.

FIRMA

PROTOCOL

PFIZER EUROPE MA EEIG LABORATOARELE PROF.DR.MORAIT S.R.L. ZENTIVA AS

J02AC01 FLUCONAZOLUM
DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL BIOGALENICA 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCONIMED 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg MEDOFLUCON 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD MEDOCHEMIE LTD

50mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:
DIFLUCAN 50 mg/5 ml

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM

PULB. PT. SUSP. ORALA


50mg/5ml PFIZER EUROPE MA EEIG

50mg/5ml

889
VFEND 200mg

J02AC03

VORICONAZOLUM **
COMPR. FILM.
200mg 200mg 40mg/ml 50mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg

J02AC03 VORICONAZOLUM J02AC03 VORICONAZOLUM


VFEND 200mg

PULB. PT. SOL. PERF.


PFIZER LTD. PFIZER LTD. PFIZER LTD.

J02AC03 VORICONAZOLUM
VFEND 40 mg/ml

PULB. PT. SUSP. ORALA COMPR. FILM.

J02AC03 VORICONAZOLUM
VFEND 50mg

890

J02AC04

POSACONAZOLUM **
SUSP. ORALA
40mg/ml 40mg/ml SP EUROPE SP EUROPE

J02AC04 POSACONAZOLUM
NOXAFIL SP 40mg/ml POSACONAZOLE SP 40mg/ml

40mg/ml

NOTA: Profilaxia infectiilor fungice invazive la pacientii: (1) aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care prezinta risc inalt de a dezvolta infectii fungice masive; (2) Pacienti in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de a dezvolta infectii fungice masive..

891
J02AX04 J02AX04 J02AX04
CANCIDAS 50 mg

J02AX04
CASPOFUNGINUM

CASPOFUNGINUM **
PULB. PT. CONC. PT. SOL. PERF.
50mg 50mg 70mg MERCK SHARP & DOHME LTD

Protocol: J010D
50mg 50mg 70mg

CASPOFUNGINUM CASPOFUNGINUM

PULB. PT. SOL. PERF.


MERCK SHARP & DOHME LTD

CANCIDAS 50 mg CANCIDAS 70 mg

PULB. PT. CONC. PT. SOL. PERF.


MERCK SHARP & DOHME LTD

893
J05AB01
ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01
ACICLOVIRUM

ACICLOVIRUM
CAPS.
200mg 200mg ARENA GROUP SA EUROPHARM SA

200mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR.
200mg 200mg 200mg 200mg GEDEON RICHTER ROMANIA SA ALSIFCOM INTERMED SRL ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

200mg

ACICLOVIR 200 mg ALS-ACICLOVIR CLOVIRAL 200 mg ZOVIRAX

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR. DISP.
200mg 200mg OZONE LABORATORIES LTD. RANBAXY UK LIMITED

200mg

ACICLOVIR 200 mg LOVIR 200 mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01
VIROLEX

ACICLOVIRUM ACICLOVIRUM

PULB. PT. SOL. INJ./PERF.


250mg KRKA D.D. NOVO MESTO

250mg 400mg

J05AB01

CAPS.
400mg ARENA GROUP S.A.

ACICLOVIR 400 mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

J05AB01

ACICLOVIRUM

COMPR.
400mg EGIS PHARMACEUTICALS P.L.C.

400mg

ACICLOVIR 400 mg

Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului.

183 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata: Herpes zoster oftalmic.

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

J05AB01
ACIKLOVIR

ACICLOVIRUM

COMPR. FILM.
400mg A & G MED TRADING S.R.L.

400mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

894
J05AB11
VALTREX 500 mg

J05AB11
VALACYCLOVIRUM
Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

VALACYCLOVIRUM
COMPR. FILM.
500mg THE WELLCOME FOUNDATION LTD.

500mg

Tratamentul pacientilor cu herpes zoster in decurs de 72 de ore de la debutul rash-ului Herpes zoster oftalmic. Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe).

895
J05AB14
VALCYTE 450 mg

J05AB14
VALGANCICLOVIRUM

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

450mg

896
J06BA02

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA **


SOL. PERF.
100mg/ml BAXTER AG

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA

100mg/ml

KIOVIG 100mg/ml

J06BA02

SOL. PERF.
10g/200ml KEDRION SPA

10g/200ml

IG VENA 10g/200ml

J06BA02

SOL. PERF.
1g/20ml KEDRION SPA

1g/20ml

IG VENA 1g/20ml

J06BA02

SOL. PERF.
2.5mg/50ml KEDRION SPA

2.5mg/50ml

IG VENA 2,5g/50ml

J06BA02

SOL. PERF.
50mg/ml 50mg/ml 50mg/ml INSTITUTO GRIFOLS S.A. OCTAPHARMA (IP) LTD. BIOTEST PHARMA GMBH

50mg/ml

FLEBOGAMMADIF 50mg/ml OCTAGAM PENTAGLOBIN

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA
5%

SOL. PERF.
5g/100ml KEDRION SPA

5g/100ml

IG VENA 5g/100ml

J06BA02
HUMAGLOBIN

PULB.+SOLV. PT. SOL. PERF.


TEVA PHARM. WORKS PRIVATE LTD. COMPANY

5%

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA


5%

SOL. PERF.
INSTITUTO GRIFOLS S.A.

5%

FLEBOGAMMA 5%

897
ENDOXAN 1 g

L01AA01

CYCLOPHOSPHAMIDUM
PULB. PT. SOL. INJ./PERF.
1g 1g 200mg 200mg 500mg 500mg BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM L01AA01 CYCLOPHOSPHAMIDUM


ENDOXAN 1 g

1g 1g 200mg 200mg 500mg 500mg 50mg

PULB. PT. SOL. PERF./INJ. I.V.


ACTAVIS S.R.L.

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 200 mg

PULB. PT. SOL. INJ./PERF.


BAXTER ONCOLOGY GMBH ACTAVIS S.R.L. BAXTER ONCOLOGY GMBH ACTAVIS S.R.L. BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 200 mg

PULB. PT. SOL. PERF./INJ. I.V. PULB. PT. SOL. INJ./PERF. PULB. PT. SOL. PERF./INJ. I.V. DRAJ.
50mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 50 mg

898
ALKERAN 2 mg

L01AA03

MELPHALANUM
COMPR. FILM.
2mg THE WELLCOME FOUNDATION LTD.

L01AA03 MELPHALANUM

2mg

899
HOLOXAN 1 g

L01AA06

IFOSFAMIDUM
PULB. PT. SOL. PERF.
1g 2g 500mg BAXTER ONCOLOGY GMBH

L01AA06 IFOSFAMIDUM L01AA06 IFOSFAMIDUM


HOLOXAN 2 g

1g 2g 500mg

PULB. PT. SOL. PERF.


BAXTER ONCOLOGY GMBH

L01AA06 IFOSFAMIDUM
HOLOXAN 500 mg

PULB. PT. SOL. PERF.


BAXTER ONCOLOGY GMBH

900
MYLERAN

L01AB01
Prescriere limitata:

BUSULFANUM
COMPR. FILM.
2mg THE WELLCOME FOUNDATION LTD.

L01AB01 BUSULFANUM

2mg

Tratament de pregatire a procedurii de transplant atunci cand asocierea unor doze crescute de busulfan si ciclofosfamida reprezinta tratamentul de electie; Tratamentul paliativ al fazei cronice in LGC; Tratamentul polcitemiei vera; Tratamentul mielofibrozei si trombocitemiei

L01AB01 BUSULFANUM
BUSILVEX 6mg/ml

CONC. PT. SOL. PERF.


6mg/ml PIERRE FABRE MEDICAMENT

6mg/ml

Prescriere limitata:

Tratament de pregatire a procedurii de transplant atunci cand asocierea unor doze crescute de busulfan si ciclofosfamida reprezinta tratamentul de electie; Tratamentul paliativ al fazei cronice in LGC; Tratamentul polcitemiei vera; Tratamentul mielofibrozei si trombocitemiei

901

L01BA01

METHOTREXATUM
CONC. PT. SOL. INJ./PERF. 100mg/ml

L01BA01 METHOTREXATUM

184 / 233

DCI/DENUMIRE COMERCIALA
METHOTREXAT "EBEWE" 1000 mg METHOTREXAT "EBEWE" 500 mg METHOTREXAT "EBEWE" 5000 mg

CONCENTRATIE
100mg/ml 100mg/ml 100mg/ml 10mg/ml 10mg/ml

FORMA FARM.
EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG

FIRMA

PROTOCOL

L01BA01 METHOTREXATUM
METHOTREXAT "EBEWE" 10 mg METHOTREXAT "EBEWE" 50 mg

SOL. INJ./PERF.
EBEWE PHARMA GMBH NFG. KG EBEWE PHARMA GMBH NFG. KG

10mg/ml

L01BA01 METHOTREXATUM
METHOTREXATE TEVA 25mg/ml

SOL. INJ.
25mg/ml 50mg TEVA PHARMACEUTICALS S.R.L.

25mg/ml 50mg 5mg/ml


EBEWE PHARMA GMBH NFG. KG

L01BA01 METHOTREXATUM
ANTIFOLAN 50 mg

PULB. PT. SOL. INJ./PERF.


SINDAN SRL

L01BA01 METHOTREXATUM
METHOTREXAT "EBEWE" 5 mg

SOL. INJ.
5mg/ml

902
FLUDARA ORAL

L01BB05

FLUDARABINUM
COMPR. FILM.
10mg 50mg SCHERING AG

L01BB05 FLUDARABINUM L01BB05 FLUDARABINUM


FLUDARA

10mg 50mg

LIOF. PT. SOL. INJ./PERF.


SCHERING AG

903
LASTET 100 mg VEPESID

L01CB01

ETOPOSIDUM
CAPS. MOI
100mg 100mg 100mg/5ml 100mg/5ml 200mg/10ml 20mg/ml ACTAVIS S.R.L. BRISTOL MYERS SQUIBB KFT

L01CB01 ETOPOSIDUM

100mg

L01CB01 ETOPOSIDUM
ETOPOSID "EBEWE" 100 mg/5 ml SINTOPOZID 100 mg/5 ml

CONC. PT. SOL. PERF.


EBEWE PHARMA GMBH NFG. KG ACTAVIS S.R.L.

100mg/5ml

L01CB01 ETOPOSIDUM
ETOPOSID "EBEWE" 200 mg/10 ml

CONC. PT. SOL. PERF.


EBEWE PHARMA GMBH NFG. KG

200mg/10ml 20mg/ml 25mg

L01CB01 ETOPOSIDUM
ETOPOSIDE - TEVA

CONC. PT. SOL. PERF.


TEVA PHARMACEUTICALS S.R.L. ACTAVIS S.R.L.

L01CB01 ETOPOSIDUM
LASTET 25 mg 25mg

CAPS. MOI CAPS. MOI


50mg 50mg 50mg/2.5ml ACTAVIS S.R.L. BRISTOL MYERS SQUIBB KFT

L01CB01 ETOPOSIDUM
LASTET 50 mg VEPESID

50mg

L01CB01 ETOPOSIDUM
ETOPOSID "EBEWE" 50 mg/2,5 ml

CONC. PT. SOL. PERF.


EBEWE PHARMA GMBH NFG. KG

50mg/2.5ml

904
ZAVEDOS

L01DB06

IDARUBICINUM
CAPS.
10mg 5mg PFIZER EUROPE MA EEIG

L01DB06 IDARUBICINUM L01DB06 IDARUBICINUM


ZAVEDOS 5 mg

10mg 5mg

LIOF. PT. SOL. INJ.


PFIZER EUROPE MA EEIG

905

L01DB07

MITOXANTRONUM **
CONC. PT. SOL. PERF.
2 mg/ml TEVA PHARMACEUTICALS SRL

L01DB07 MITOXANTRONUM
MITOXANTRONE TEVA 2 mg/ml

2 mg/ml 20mg/10ml

L01DB07 MITOXANTRONUM
NOVANTRONE

SOL. PERF.
20mg/10ml 2mg/ml WYETH LEDERLE PHARMA GMBH

L01DB07 MITOXANTRONUM
ONKOTRONE

CONC. PT. SOL. INJ.


BAXTER ONCOLOGY GMBH

2mg/ml

906
SINPLATIN 10 mg

L01XA01

CISPLATINUM
LIOF. PT. SOL. PERF.
10mg 10mg/20ml 10mg/20ml ACTAVIS S.R.L.

L01XA01 CISPLATINUM L01XA01 CISPLATINUM


CISPLATIN "EBEWE" 10 mg/20 ml CISPLATIN TEVA 10 mg/20 ml

10mg 10mg/20ml

CONC. PT. SOL. PERF.


EBEWE PHARMA GMBH NFG. KG TEVA PHARMACEUTICALS S.R.L.

L01XA01 CISPLATINUM
CISPLATIN 10 HEXAL PI

SOL. PERF.
10mg/20ml 1mg/1ml 1mg/ml 25mg/50ml 50mg 50mg/100ml 50mg/100ml HEXAL AG

10mg/20ml 1mg/1ml 1mg/ml 25mg/50ml 50mg 50mg/100ml

L01XA01 CISPLATINUM
SINPLATIN 1 mg/1 ml

CONC. PT. SOL. PERF.


ACTAVIS S.R.L. TEVA PHARMACEUTICALS S.R.L. EBEWE PHARMA GMBH NFG. KG ACTAVIS S.R.L.

L01XA01 CISPLATINUM
CISPLATIN TEVA 1 mg/ml

CONC. PT. SOL. PERF. CONC. PT. SOL. PERF. LIOF. PT. SOL. PERF. CONC. PT. SOL. PERF.
EBEWE PHARMA GMBH NFG. KG TEVA PHARMACEUTICALS S.R.L.

L01XA01 CISPLATINUM
CISPLATIN "EBEWE" 25 mg/50 ml

L01XA01 CISPLATINUM
SINPLATIN 50 mg

L01XA01 CISPLATINUM
CISPLATIN "EBEWE" 50 mg/100 ml CISPLATIN TEVA 50 mg/100 ml

L01XA01 CISPLATINUM
CISPLATIN 50 HEXAL PI

SOL. PERF.
50mg/100ml HEXAL AG

50mg/100ml

907

L01XA02

CARBOPLATINUM
CONC. PT. SOL. PERF.
10mg/ml 10mg/ml 10mg/ml 150mg/15ml 450mg/45ml 50mg/5ml EBEWE PHARMA GES.M.B.H. NFG KG ACTAVIS S.R.L. TEVA PHARMACEUTICALS S.R.L.

L01XA02 CARBOPLATINUM
CARBOPLATIN "EBEWE" 10 mg/ml CARBOPLATIN ACTAVIS 10mg/ml CARBOPLATIN TEVA 10mg/ml

10mg/ml

L01XA02 CARBOPLATINUM
CYCLOPLATIN 150

CONC. PT. SOL. PERF.


PLIVA-LACHEMA A.S.

150mg/15ml 450mg/45ml 50mg/5ml

L01XA02 CARBOPLATINUM
CYCLOPLATIN 450

CONC. PT. SOL. PERF.


PLIVA-LACHEMA A.S. PLIVA-LACHEMA A.S.

L01XA02 CARBOPLATINUM
CYCLOPLATIN 50

CONC. PT. SOL. PERF.

185 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

908

L01XC04

ALEMTUZUMABUM **
CONC. PT. SOL. PERF.
10mg/ml 30mg/ml GENZYME EUROPE BV

L01XC04 ALEMTUZUMABUM
MABCAMPATH 10 mg/ml

10mg/ml 30mg/ml

L01XC04 ALEMTUZUMABUM
MABCAMPATH 30 mg/ml

CONC. PT. SOL. PERF.


GENZYME EUROPE BV

909
MABTHERA 100 mg MABTHERA 500 mg

L01XC02

RITUXIMABUM **
CONC. PT. SOL. PERF.
10mg/ml 10mg/ml ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

L01XC02 RITUXIMABUM

10mg/ml

910
NEUPOGEN

L03AA02

FILGRASTIMUM (G-CSF) **
SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

L03AA02 FILGRASTIMUM (G-CSF) L03AA02 FILGRASTIMUM (G-CSF)


NEUPOGEN

30MU/0.5ml 48MU/0.5ml
AMGEN EUROPE B.V.

SOL. INJ.
48MU/0.5ml

911

L04AA01

CICLOSPORINUM
CAPS. MOI
100mg 100mg 100mg HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 100 mg EQUORAL 100 mg IMUSPORIN 100 mg

100mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL EQUORAL SANDIMMUN NEORAL

SOL. ORALA
100mg/ml 100mg/ml 100mg/ml HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

100mg/ml

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 25 mg EQUORAL 25 mg IMUSPORIN 25 mg SANDIMMUN NEORAL 25mg 25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

25mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 50 mg EQUORAL 50 mg IMUSPORIN 50 mg SANDIMMUN NEORAL 50mg 50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

50mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

912

L04AA04

IMUNOGLOBULINA ANTI-LIMFOCITE UMANE **


CONC. PT. SOL. INJ.
20mg/ml FRESENIUS BIOTECH GMBH

L04AA04 IMUNOGLOBULINA ANTI-LIMFOCITE UMANE


ATG-FRESENIUS

20mg/ml

L04AA04 IMUNOGLOBULINA ANTI-LIMFOCITE UMANE


THYMOGLOBULINE

PULB. PT. SOL. PERF.


5mg/ml GENZYME EUROPE B.V.

5mg/ml

913
ADVAGRAF 0,5mg

L04AA05

TACROLIMUSUM **
CAPS. ELIB. PREL.
0,5mg ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM L04AA05 TACROLIMUSUM


PROGRAF 0,5 mg 0.5mg

0,5mg 0.5mg

CAPS.
ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM
PROGRAF 1 mg 1mg 1mg

CAPS.
ASTELLAS IRELAND CO. LTD.

1mg 1mg 5mg


ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM
ADVAGRAF 1mg

CAPS. ELIB. PREL.


ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM
PROGRAF 5 mg 5mg 5mg

CAPS. CAPS. ELIB. PREL.


ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM
ADVAGRAF 5mg

5mg 5mg/ml

L04AA05 TACROLIMUSUM
PROGRAF 5 mg/ml

CONC. PT. SOL. PERF.


5mg/ml ASTELLAS PHARMA GMBH

914
MYFORTIC 180 mg

L04AA06

MYCOPHENOLATUM **
COMPR. FILM. GASTROREZ.
180mg 1g/5ml NOVARTIS PHARMA GMBH

L04AA06 MYCOPHENOLATUM L04AA06 MYCOPHENOLATUM


CELLCEPT 1mg/5ml

180mg 1g/5ml 250mg

PULB. PT. SUSP. ORALA


ROCHE REGISTRATION LTD.

L04AA06 MYCOPHENOLATUM
CELLCEPT 250mg MICOFENOLAT MOFETIL TEVA MYFENAX 250mg

CAPS.
250mg 250mg 250mg 360mg ROCHE REGISTRATION LTD. TEVA PHARMA BV TEVA PHARMA BV

L04AA06 MYCOPHENOLATUM
MYFORTIC 360 mg

COMPR. FILM. GASTROREZ.


NOVARTIS PHARMA GMBH

360mg 500mg

L04AA06 MYCOPHENOLATUM
MICOFENOLAT MOFETIL TEVA MYFENAX 500mg

CAPS.
500mg 500mg 500mg TEVA PHARMA BV TEVA PHARMA BV

L04AA06 MYCOPHENOLATUM
CELLCEPT 500mg

COMPR. FILM.
ROCHE REGISTRATION LTD.

500mg 500mg

L04AA06 MYCOPHENOLATUM

PULB. PT. CONC. PT. SOL. PERF.

186 / 233

DCI/DENUMIRE COMERCIALA
CELLCEPT 500mg

CONCENTRATIE
500mg

FORMA FARM.
ROCHE REGISTRATION LTD.

FIRMA

PROTOCOL

915
ZENAPAX 5 mg/ml

L04AA08
Prescriere limitata:

DACLIZUMABUM **
CONC. PT. SOL. PERF.
5mg/ml ROCHE REGISTRATION LTD.

L04AA08 DACLIZUMABUM

5mg/ml

Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu daclizumabum. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant.

916
RAPAMUNE 1mg

L04AA10

SIROLIMUS **
COMPR. FILM.
1mg WYETH EUROPA LTD.

L04AA10 SIROLIMUS

1mg

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 1mg/ml

SOL. ORALA
1mg/ml WYETH EUROPA LTD.

1mg/ml

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 2mg 2mg

COMPR. FILM.
WYETH EUROPA LTD.

2mg

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 5mg 5mg

COMPR. FILM.
WYETH EUROPA LTD.

5mg

917

L04AA11

ETANERCEPTUM **
PULB. + SOLV. PT. SOL. INJ.
25mg 50mg 25mg 50mg 25mg 25mg 50mg 50mg 25mg 50mg WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL DE UZ PEDIATRIC

25mg 50mg 25mg 50mg 25mg 25mg 50mg 50mg 25mg 50mg

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL DE UZ PEDIATRIC

PULB. + SOLV. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. + SOLV. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB+SOLV.PT.SOL.INJ
WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50 mg

PULB. PT. SOL. INJ.


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 25mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

L04AA11 ETANERCEPTUM
ENBREL 50mg

SOL. INJ. IN SERINGA PREUMPLUTA


WYETH EUROPA LIMITED

918

N02AX02
Prescriere limitata: Prescriere limitata:

TRAMADOLUM
COMPR. ELIB. MODIF.
100mg HEXAL AG

N02AX02 TRAMADOLUM
TRAMADOLOR 100 ID

100mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
NOAX UNO 100 mg TRALGIT SR 100 TRAMADOL RETARD

COMPR. ELIB. PREL.


100mg 100mg 100mg LABOPHARM EUROPE LIMITED ZENTIVA AS KRKA D.D.

100mg

Prescriere limitata: Prescriere limitata:


TRAMAL RETARD 100 mg TRAMUNDIN RETARD 100 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.


100mg 100mg GRUNENTHAL GMBH MUNDIPHARMA GES.M.B.H

100mg

Prescriere limitata: Prescriere limitata:


MABRON TRADOLAN

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

SOL. INJ.
100mg 100mg MEDOCHEMIE LTD. LANNACHER HEILMITTEL GMBH

100mg

Prescriere limitata:
TRADOLAN TRAMADOL TRAMAG 100 TRAMAL

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM

SUPOZ.
100mg 100mg 100mg 100mg LANNACHER HEILMITTEL GMBH KRKA D.D. MAGISTRA C & C GRUNENTHAL GMBH

100mg

N02AX02 TRAMADOLUM
TRALGIT 100

SOL. INJ.
100mg/2ml ZENTIVA A.S.

100mg/2ml

Prescriere limitata:
TRALGIT

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
TRADOLAN

PIC. ORALE, SOL.


100mg/ml ZENTIVA A.S.

100mg/ml

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
TRALGIT SR 150

SOL. ORALA
100mg/ml LANNACHER HEILMITTEL GMBH

100mg/ml

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata:

COMPR. ELIB. PREL.


150mg ZENTIVA AS

150mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide

187 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata:


TRAMADOL RETARD 150 mg TRAMAL RETARD 150 mg

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.


150mg 150mg KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

150mg

Prescriere limitata: Prescriere limitata:


NOAX UNO 200 mg TRALGIT SR 200

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. ELIB. PREL.


200mg 200mg LABOPHARM EUROPE LIMITED ZENTIVA AS

200mg

Prescriere limitata: Prescriere limitata:


TRAMADOL RETARD 200 mg TRAMAL RETARD 200 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.


200mg 200mg KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

200mg

Prescriere limitata: Prescriere limitata:


NOAX UNO 300 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
K-ALMA MABRON 50 mg TRALGIT 50 TRAMACALM TRAMADOL TRAMADOL LPH 50 mg TRAMADOL AL 50 TRAMADOL ARENA TRAMADOLOR 50 mg TRAMAL URGENDOL

COMPR. ELIB. PREL.


300mg LABOPHARM EUROPE LIMITED

300mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
ANTIBIOTICE SA MEDOCHEMIE LTD. ZENTIVA A.S. AC HELCOR SRL KRKA D.D. LABORMED PHARMA SA ALIUD PHARMA GMBH & CO.KG ARENA GROUP S.A. HEXAL AG GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg

Prescriere limitata:
TRAMADOL 50 mg TRAMADOL EEL TRAMAG 50

Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg 50mg 50mg

COMPR.
OZONE LABORATORIES LTD. BIO EEL SRL MAGISTRA C & C

50mg

Prescriere limitata: Prescriere limitata:


TRADOLAN 50 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg

COMPR. FILM.
LANNACHER HEILMITTEL GMBH

50mg

Prescriere limitata: Prescriere limitata:


TRADOLAN 50 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg

SOL. INJ.
LANNACHER HEILMITTEL GMBH

50mg

Prescriere limitata:
TRALGIT 50 TRAMADOL TRAMADOL AL 100 Fiole TRAMAL 100 TRAMAL 50 URGENDOL

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM

SOL. INJ.
50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml 50mg/ml ZENTIVA A.S. KRKA D.D. ALIUD PHARMA GMBH & CO.KG GRUNENTHAL GMBH GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg/ml

Prescriere limitata:
TRAMADOL AL PICATURI

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM N02AX02 TRAMADOLUM


TRAMAL

PIC. ORALE, SOL.


ALIUD PHARMA GMBH & CO.KG

PICATURI ORALE-SOL.
100mg/ml GRUNENTHAL GMBH

100mg/ml

919
PULMOZYME

R05CB13

DORNAZA ALFA **
SOL. INHAL.
1mg/ml ROCHE ROMANIA S.R.L.

R05CB13 DORNAZA ALFA

1mg/ml

920
EXJADE 125mg

V03AC03
Prescriere limitata:

DEFERASIROXUM **
COMPR. DISP.
125mg NOVARTIS EUROPHARM LTD.

V03AC03 DEFERASIROXUM

125mg

Terapie adjuvanta in regimurile chimioterapice cu ifosfamida sau doze ridicate de ciclofosfamida

V03AC03 DEFERASIROXUM
EXJADE 250mg

COMPR. DISP.
250mg NOVARTIS EUROPHARM LTD.

250mg

Prescriere limitata:
EXJADE 500mg

Terapie adjuvanta in regimurile chimioterapice cu ifosfamida sau doze ridicate de ciclofosfamida

V03AC03 DEFERASIROXUM
Prescriere limitata:

COMPR. DISP.
500mg NOVARTIS EUROPHARM LTD.

500mg

Terapie adjuvanta in regimurile chimioterapice cu ifosfamida sau doze ridicate de ciclofosfamida

921

V03AF01
Prescriere limitata:

MESNUM
SOL. INJ.
400mg/4ml BAXTER ONCOLOGY GMBH

V03AF01 MESNUM
UROMITEXAN 400 mg

400mg/4ml

Terapie adjuvanta in regimurile chimioterapice cu ifosfamida sau doze ridicate de ciclofosfamida

188 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-IX P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.2: TRANSPLANT DE CORD 922 B01AB08 REVIPARINUM
B01AB08 REVIPARINUM
CLIVARIN 1432UI/0,25 ml CLIVARIN -PEN

SOL. INJ.
1432ui/0.25ml 1432ui/0.25ml ABBOTT GMBH&CO.KG ABBOTT GMBH&CO.KG

1432ui/0.25ml

B01AB08 REVIPARINUM
CLIVARIN 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml ABBOTT GMBH&CO.KG

3436ui/0.6ml 5726ui/ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN - multi

SOL. INJ.
5726ui/ml

923
HAEMACCEL

B05AA06

POLYGELINUM
SOL. PERF.
3.5% THERASELECT GMBH

B05AA06 POLYGELINUM

3.5%

924

C01CA24

EPINEPHRINUM
SOL. INJ.
150g/0.3ml LINCOLN MEDICAL LTD.

C01CA24 EPINEPHRINUM
ANAPEN JUNIOR 150 g/0,3 ml

150g/0.3ml 1mg/ml
TERAPIA SA

C01CA24 EPINEPHRINUM
ADRENALINA 1 mg

SOL. INJ.
1mg/ml

C01CA24 EPINEPHRINUM
ANAPEN 300 g/0,3 ml

SOL. INJ.
300g/0.3ml LINCOLN MEDICAL LTD.

300g/0.3ml

925
TAZOCIN 2,25 TAZOCIN 4,5

J01CR05

PIPERACILLINUM + TAZOBACTAMUM
LIOF. PT. SOL. INJ.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

J01CR05 PIPERACILLINUM + TAZOBACTAMUM

926
LYZONE 1 g MEDOCEF 1 g

J01DD12

CEFOPERAZONUM
PULB. PT. SOL. INJ.
1g 1g 2g 2g 2g 500mg 1g MEDICAROM GROUP S.R.L. MEDOCHEMIE LTD.

J01DD12 CEFOPERAZONUM

1g

J01DD12 CEFOPERAZONUM
LYZONE 2 g MEDOCEF 2 g

PULB. PT. SOL. INJ.


MEDICAROM GROUP S.R.L. MEDOCHEMIE LTD.

2g

J01DD12 CEFOPERAZONUM
CEFOZON 2 g

PULB. PT. SOL. INJ./PERF. I.M./I.V.


E.I.P.I.CO. MED S.R.L.

2g 500mg 1g

J01DD12 CEFOPERAZONUM
CEFOZON 500 mg

PULB. PT. SOL. INJ.


E.I.P.I.CO. MED S.R.L. E.I.P.I.CO. MED S.R.L.

J01DD12 CEFOPERAZONUM
CEFOZON 1 g

PULB. PT. SOL. INJ./PERF.I.M./I.V.

927
TIENAM I.V.

J01DH51

IMIPENEMUM + CILASTATINUM
PULB. PT. SOL. PERF.
MERCK SHARP & DOHME ROMANIA S.R.L.

J01DH51 IMIPENEMUM + CILASTATINUM

928
J01XX08
ZYVOXID

J01XX08
LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID

SOL. PERF.
2mg/ml 400mg 600mg PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

400mg 600mg

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

929

J02AC01

FLUCONAZOLUM
CAPS.
100mg 100mg 100mg 100mg 100mg 100mg 100mg KRKA D.D. OZONE LABORATORIES LTD. LINCOSA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

J02AC01 FLUCONAZOLUM
DIFLAZON 100 mg FLUCONAZOL 100 mg FLUCONAZOLE LINCOSA 100mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

100mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM
DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL BIOGALENICA 150 mg FLUCONAZOL LAROPHARM 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCONIMED 150 mg FLUCORIC 150 mg FLUCOVIM 150 MEDOFLUCON 150 mg MYCOMAX 150

CAPS.
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. LAROPHARM S.R.L. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL MEDOCHEMIE LTD. ZENTIVA AS

150mg

J02AC01 FLUCONAZOLUM

CAPS.

200mg

189 / 233

DCI/DENUMIRE COMERCIALA
DIFLAZON 200 mg FLUCONAZOLE LINCOSA 200 mg FLUCONAZOLE TEVA 200 mg

CONCENTRATIE
200mg 200mg 200mg

FORMA FARM.
KRKA D.D. LICONSA S.A. TEVA PHARMACEUTICALS SRL

FIRMA

PROTOCOL

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM
DIFLAZON DIFLUCAN FLUCONAZOL BIOGALENICA 2mg/ml MYCOMAX INF

SOL. PERF.
2mg/ml 2mg/ml 2mg/ml 2mg/ml KRKA D.D. PFIZER EUROPE MA EEIG LABORATOARELE PROF.DR.MORAIT S.R.L. ZENTIVA AS

2mg/ml

J02AC01 FLUCONAZOLUM
DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL BIOGALENICA 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCONIMED 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg MEDOFLUCON 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD MEDOCHEMIE LTD

50mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:
DIFLUCAN 50 mg/5 ml

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM

PULB. PT. SUSP. ORALA


50mg/5ml PFIZER EUROPE MA EEIG

50mg/5ml

930
VFEND 200mg

J02AC03

VORICONAZOLUM **
COMPR. FILM.
200mg 200mg 40mg/ml 50mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg

J02AC03 VORICONAZOLUM J02AC03 VORICONAZOLUM


VFEND 200mg

PULB. PT. SOL. PERF.


PFIZER LTD. PFIZER LTD. PFIZER LTD.

J02AC03 VORICONAZOLUM
VFEND 40 mg/ml

PULB. PT. SUSP. ORALA COMPR. FILM.

J02AC03 VORICONAZOLUM
VFEND 50mg

932
J05AB14
VALCYTE 450 mg

J05AB14
VALGANCICLOVIRUM

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

450mg

933

L04AA01

CICLOSPORINUM
CAPS. MOI
100mg 100mg 100mg HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 100 mg EQUORAL 100 mg IMUSPORIN 100 mg

100mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL EQUORAL SANDIMMUN NEORAL

SOL. ORALA
100mg/ml 100mg/ml 100mg/ml HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

100mg/ml

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 25 mg EQUORAL 25 mg IMUSPORIN 25 mg SANDIMMUN NEORAL 25mg 25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

25mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 50 mg EQUORAL 50 mg IMUSPORIN 50 mg SANDIMMUN NEORAL 50mg 50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

50mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

934

L04AA04

IMUNOGLOBULINA ANTI-LIMFOCITE UMANE **


CONC. PT. SOL. INJ.
20mg/ml FRESENIUS BIOTECH GMBH

L04AA04 IMUNOGLOBULINA ANTI-LIMFOCITE UMANE


ATG-FRESENIUS

20mg/ml

L04AA04 IMUNOGLOBULINA ANTI-LIMFOCITE UMANE


THYMOGLOBULINE

PULB. PT. SOL. PERF.


5mg/ml GENZYME EUROPE B.V.

5mg/ml

190 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

935
ADVAGRAF 0,5mg

L04AA05
Prescriere limitata:

TACROLIMUSUM **
CAPS. ELIB. PREL.
0,5mg ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM

0,5mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac.

L04AA05 TACROLIMUSUM
PROGRAF 0,5 mg 0.5mg

CAPS.
ASTELLAS PHARMA GMBH

0.5mg

Prescriere limitata:
PROGRAF 1 mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac.

L04AA05 TACROLIMUSUM
1mg

CAPS.
ASTELLAS IRELAND CO. LTD.

1mg

Prescriere limitata:
ADVAGRAF 1mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac.

L04AA05 TACROLIMUSUM
1mg

CAPS. ELIB. PREL.


ASTELLAS PHARMA GMBH

1mg

Prescriere limitata:
PROGRAF 5 mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac.

L04AA05 TACROLIMUSUM
5mg

CAPS.
ASTELLAS PHARMA GMBH

5mg

Prescriere limitata:
ADVAGRAF 5mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac.

L04AA05 TACROLIMUSUM
5mg

CAPS. ELIB. PREL.


ASTELLAS PHARMA GMBH

5mg

Prescriere limitata:
PROGRAF 5 mg/ml

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac.

L04AA05 TACROLIMUSUM
Prescriere limitata:

CONC. PT. SOL. PERF.


5mg/ml ASTELLAS PHARMA GMBH

5mg/ml

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac.

936
MYFORTIC 180 mg

L04AA06
Prescriere limitata:

MYCOPHENOLATUM **
COMPR. FILM. GASTROREZ.
180mg NOVARTIS PHARMA GMBH

L04AA06 MYCOPHENOLATUM

180mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac.

L04AA06 MYCOPHENOLATUM
CELLCEPT 1mg/5ml 1g/5ml

PULB. PT. SUSP. ORALA


ROCHE REGISTRATION LTD.

1g/5ml

Prescriere limitata:
CELLCEPT 250mg MICOFENOLAT MOFETIL TEVA MYFENAX 250mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac.

L04AA06 MYCOPHENOLATUM

CAPS.
250mg 250mg 250mg ROCHE REGISTRATION LTD. TEVA PHARMA BV TEVA PHARMA BV

250mg

Prescriere limitata:
MYFORTIC 360 mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac.

L04AA06 MYCOPHENOLATUM
Prescriere limitata:
MICOFENOLAT MOFETIL TEVA MYFENAX 500mg

COMPR. FILM. GASTROREZ.


360mg NOVARTIS PHARMA GMBH

360mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac.

L04AA06 MYCOPHENOLATUM

CAPS.
500mg 500mg TEVA PHARMA BV TEVA PHARMA BV

500mg

Prescriere limitata:
CELLCEPT 500mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac.

L04AA06 MYCOPHENOLATUM
Prescriere limitata:
CELLCEPT 500mg

COMPR. FILM.
500mg ROCHE REGISTRATION LTD.

500mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac.

L04AA06 MYCOPHENOLATUM
Prescriere limitata:

PULB. PT. CONC. PT. SOL. PERF.


500mg ROCHE REGISTRATION LTD.

500mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac.

191 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-X P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.3 TRANSPLANT HEPATIC 937 A05AA02 ACIDUM URSODEOXYCHOLICUM
A05AA02 ACIDUM URSODEOXYCHOLICUM
URSOCHOL 150 mg

COMPR.
150mg ZAMBON S.P.A.

150mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOFALK URSOSAN

CAPS.
250mg 250mg DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

250mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOCHOL 300 mg

COMPR.
300mg ZAMBON S.P.A.

300mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

938
CLEXANE

B01AB05

ENOXAPARINUM
SOL. INJ.
100mg/ml LAB. AVENTIS

B01AB05 ENOXAPARINUM B01AB05 ENOXAPARINUM


CLEXANE 2000ui anti-Xa/0.2ml

100mg/ml 2000ui anti-Xa/0.2ml


LAB. AVENTIS

SOL. INJ.
2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

B01AB05 ENOXAPARINUM
CLEXANE 8000ui anti-Xa/0.8ml

SOL. INJ.
8000ui anti-Xa/0.8ml LAB. AVENTIS

8000ui anti-Xa/0.8ml

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

939

B01AB08

REVIPARINUM
SOL. INJ.
1432ui/0.25ml 1432ui/0.25ml ABBOTT GMBH&CO.KG ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN 1432UI/0,25 ml CLIVARIN -PEN

1432ui/0.25ml

B01AB08 REVIPARINUM
CLIVARIN 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml ABBOTT GMBH&CO.KG

3436ui/0.6ml 5726ui/ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN - multi

SOL. INJ.
5726ui/ml

940
VENTAVIS 10g/ml

B01AC11

ILOPROSTUM **
SOL.NEBULIZ. DE IHHALAT
10g/ml 20g/ml BAYER SCHERING PHARMA AG

B01AC11 ILOPROSTUM B01AC11 ILOPROSTUM


ILOMEDIN 20

10g/ml 20g/ml

CONC. PT. SOL. PERF.


SCHERING AG

941
ACTILYSE

B01AD02

ALTEPLASUM **
LIOF. + SOLV. PT. SOL. INJ.
50mg BOEHRINGER INGELHEIM INT. GMBH

B01AD02 ALTEPLASUM

50mg

943

B02BD08

EPTACOG ALFA ACTIVATUM **


PULB. + SOLV. PT. SOL. INJ.
60 KIU 120KUI 240 KUI NOVO NORDISK A/S

B02BD08 EPTACOG ALFA ACTIVATUM


NOVOSEVEN 1,2 mg (60 KUI)

60 KIU 120KUI 240 KUI

B02BD08 EPTACOG ALFA ACTIVATUM


NOVOSEVEN 2,4 mg (120 KUI)

PULB. + SOL. PT. SOL. INJ.


NOVO NORDISK A/S NOVO NORDISK A/S

B02BD08 EPTACOG ALFA ACTIVATUM


NOVOSEVEN 4,8 mg (240 KUI)

PULB. + SOL. PT. SOL. INJ.

944

C03EB01

COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM)
CAPS.
TERAPIA SA

C03EB01 COMBINATII (SPIRONOLACTONUM+FUROSEMIDUM)


DIUREX 50

945

H01BA02

DESMOPRESSINUM
0,1mg/ml 0.2mg 0,1mg/ml FERRING AB FERRING AB

H01BA02 DESMOPRESSINUM
MINIRIN SPRAY NAZAL

H01BA02 DESMOPRESSINUM
MINIRIN 0,2 mg

H01BA02 DESMOPRESSINUM
MINIRIN SPRAY NAZAL

SPRAY NAZAL - SOL.


FERRING AB

0,1mg/ml

192 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
FERRING AB

FIRMA

PROTOCOL

H01BA02 DESMOPRESSINUM
MINIRIN 0,1 mg 0.1mg

COMPR. COMPR.
0.2mg FERRING AB

0.1mg 0.2mg 120g


ALTANA PHARMA S.R.L.

H01BA02 DESMOPRESSINUM
MINIRIN 0,2 mg

H01BA02 DESMOPRESSINUM
MINIRIN MELT 120 g 120g

LIOF. ORAL LIOF. ORAL


240g ALTANA PHARMA SRL

H01BA02 DESMOPRESSINUM
MINIRIN MELT 240 g

240g 60g
ALTANA PHARMA S.R.L.

H01BA02 DESMOPRESSINUM
MINIRIN MELT 60 g 60g

LIOF. ORAL

946
TAZOCIN 2,25 TAZOCIN 4,5

J01CR05

PIPERACILLINUM + TAZOBACTAMUM
LIOF. PT. SOL. INJ.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

J01CR05 PIPERACILLINUM + TAZOBACTAMUM

947
J01XX08
ZYVOXID

J01XX08
LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID

SOL. PERF.
2mg/ml 400mg 600mg PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

400mg 600mg

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

948
VFEND 200mg

J02AC03

VORICONAZOLUM **
COMPR. FILM.
200mg 200mg 40mg/ml 50mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg

J02AC03 VORICONAZOLUM J02AC03 VORICONAZOLUM


VFEND 200mg

PULB. PT. SOL. PERF.


PFIZER LTD. PFIZER LTD. PFIZER LTD.

J02AC03 VORICONAZOLUM
VFEND 40 mg/ml

PULB. PT. SUSP. ORALA COMPR. FILM.

J02AC03 VORICONAZOLUM
VFEND 50mg

949
J02AX04 J02AX04 J02AX04
CANCIDAS 50 mg

J02AX04
CASPOFUNGINUM

CASPOFUNGINUM **
PULB. PT. CONC. PT. SOL. PERF.
50mg 50mg 70mg MERCK SHARP & DOHME LTD

Protocol: J010D
50mg 50mg 70mg

CASPOFUNGINUM CASPOFUNGINUM

PULB. PT. SOL. PERF.


MERCK SHARP & DOHME LTD

CANCIDAS 50 mg CANCIDAS 70 mg

PULB. PT. CONC. PT. SOL. PERF.


MERCK SHARP & DOHME LTD

951
J05AB14
VALCYTE 450 mg

J05AB14
VALGANCICLOVIRUM

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

450mg

952
J06BB04

J06BB04

IMUNOGLOBULINA ANTI-HEPATITICA B **
PULB. + SOLV. SOL. PERF.
50UI/ml LFB - BIOMEDICAMENTS

IMUNOGLOBULINA ANTI-HEPATITICA B

50UI/ml

IVHEBEX 5000 UI/100 ml

953
NEUPOGEN

L03AA02

FILGRASTIMUM (G-CSF)
SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

Protocol: L032C
30MU/0.5ml 48MU/0.5ml

L03AA02 FILGRASTIMUM (G-CSF) L03AA02 FILGRASTIMUM (G-CSF)


NEUPOGEN

SOL. INJ.
48MU/0.5ml AMGEN EUROPE B.V.

954

L04AA01

CICLOSPORINUM
CAPS. MOI
100mg 100mg 100mg HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 100 mg EQUORAL 100 mg IMUSPORIN 100 mg

100mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL EQUORAL SANDIMMUN NEORAL

SOL. ORALA
100mg/ml 100mg/ml 100mg/ml HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

100mg/ml

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 25 mg EQUORAL 25 mg IMUSPORIN 25 mg SANDIMMUN NEORAL 25mg 25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

25mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 50 mg EQUORAL 50 mg IMUSPORIN 50 mg SANDIMMUN NEORAL 50mg 50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

50mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

955

L04AA05

TACROLIMUSUM **
CAPS. ELIB. PREL. 0,5mg

L04AA05 TACROLIMUSUM

193 / 233

DCI/DENUMIRE COMERCIALA
ADVAGRAF 0,5mg

CONCENTRATIE
0,5mg

FORMA FARM.
ASTELLAS PHARMA GMBH

FIRMA

PROTOCOL

Prescriere limitata:
PROGRAF 0,5 mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic.

L04AA05 TACROLIMUSUM
0.5mg

CAPS.
ASTELLAS PHARMA GMBH

0.5mg

Prescriere limitata:
PROGRAF 1 mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic.

L04AA05 TACROLIMUSUM
1mg

CAPS.
ASTELLAS IRELAND CO. LTD.

1mg

Prescriere limitata:
ADVAGRAF 1mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic.

L04AA05 TACROLIMUSUM
1mg

CAPS. ELIB. PREL.


ASTELLAS PHARMA GMBH

1mg

Prescriere limitata:
PROGRAF 5 mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic.

L04AA05 TACROLIMUSUM
5mg

CAPS.
ASTELLAS PHARMA GMBH

5mg

Prescriere limitata:
ADVAGRAF 5mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic.

L04AA05 TACROLIMUSUM
5mg

CAPS. ELIB. PREL.


ASTELLAS PHARMA GMBH

5mg

Prescriere limitata:
PROGRAF 5 mg/ml

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic.

L04AA05 TACROLIMUSUM
Prescriere limitata:

CONC. PT. SOL. PERF.


5mg/ml ASTELLAS PHARMA GMBH

5mg/ml

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic.

956
MYFORTIC 180 mg

L04AA06
Prescriere limitata:

MYCOPHENOLATUM **
COMPR. FILM. GASTROREZ.
180mg NOVARTIS PHARMA GMBH

L04AA06 MYCOPHENOLATUM

180mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic.

L04AA06 MYCOPHENOLATUM
CELLCEPT 1mg/5ml 1g/5ml

PULB. PT. SUSP. ORALA


ROCHE REGISTRATION LTD.

1g/5ml

Prescriere limitata:
CELLCEPT 250mg MICOFENOLAT MOFETIL TEVA MYFENAX 250mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic.

L04AA06 MYCOPHENOLATUM

CAPS.
250mg 250mg 250mg ROCHE REGISTRATION LTD. TEVA PHARMA BV TEVA PHARMA BV

250mg

Prescriere limitata:
MYFORTIC 360 mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic.

L04AA06 MYCOPHENOLATUM
Prescriere limitata:
MICOFENOLAT MOFETIL TEVA MYFENAX 500mg

COMPR. FILM. GASTROREZ.


360mg NOVARTIS PHARMA GMBH

360mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic.

L04AA06 MYCOPHENOLATUM

CAPS.
500mg 500mg TEVA PHARMA BV TEVA PHARMA BV

500mg

Prescriere limitata:
CELLCEPT 500mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic.

L04AA06 MYCOPHENOLATUM
Prescriere limitata:
CELLCEPT 500mg

COMPR. FILM.
500mg ROCHE REGISTRATION LTD.

500mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic.

L04AA06 MYCOPHENOLATUM
Prescriere limitata:

PULB. PT. CONC. PT. SOL. PERF.


500mg ROCHE REGISTRATION LTD.

500mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic.

957
RAPAMUNE 1mg

L04AA10

SIROLIMUS **
COMPR. FILM.
1mg WYETH EUROPA LTD.

L04AA10 SIROLIMUS

1mg

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 1mg/ml

SOL. ORALA
1mg/ml WYETH EUROPA LTD.

1mg/ml

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 2mg 2mg

COMPR. FILM.
WYETH EUROPA LTD.

2mg

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 5mg 5mg

COMPR. FILM.
WYETH EUROPA LTD.

5mg

194 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-XI P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.4 TRANSPLANT RENAL, TRANSPLANT COMBINAT RINICHI SI PANCREAS 958 A05AA02 ACIDUM URSODEOXYCHOLICUM
A05AA02 ACIDUM URSODEOXYCHOLICUM
URSOCHOL 150 mg

COMPR.
150mg ZAMBON S.P.A.

150mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOFALK URSOSAN

CAPS.
250mg 250mg DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

250mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOCHOL 300 mg

COMPR.
300mg ZAMBON S.P.A.

300mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

959
ALPHA D3 0,25 g

A11CC03

ALFACALCIDOLUM
CAPS. MOI
0.25g TEVA PHARMACEUTICALS SRL

A11CC03 ALFACALCIDOLUM A11CC03 ALFACALCIDOLUM


ALPHA D3 0.50 g

0.25g 0.50g
TEVA PHARMACEUTICALS S.R.L.

CAPS. MOI
0.50g

A11CC03 ALFACALCIDOLUM
ALPHA D3 1 g 1g

CAPS. MOI
TEVA PHARMACEUTICALS SRL

1g

960
CLEXANE

B01AB05

ENOXAPARINUM
SOL. INJ.
100mg/ml LAB. AVENTIS

B01AB05 ENOXAPARINUM B01AB05 ENOXAPARINUM


CLEXANE 2000ui anti-Xa/0.2ml

100mg/ml 2000ui anti-Xa/0.2ml


LAB. AVENTIS

SOL. INJ.
2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

B01AB05 ENOXAPARINUM
CLEXANE 8000ui anti-Xa/0.8ml

SOL. INJ.
8000ui anti-Xa/0.8ml LAB. AVENTIS

8000ui anti-Xa/0.8ml

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

961

B01AB04

DALTEPARINUM
SOL. INJ.
10000UI/0.4ml PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM
FRAGMIN 10000 UI/0,4 ml

10000UI/0.4ml 10000ui/ml
PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM
FRAGMIN 10000 UI/ml

SOL. INJ.
10000ui/ml

B01AB04 DALTEPARINUM
FRAGMIN 12500 UI/0,5 ml

SOL. INJ.
12500 UI/0.5ml PFIZER EUROPE MA EEIG

12500 UI/0.5ml 15000ui/0.6ml


PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM
FRAGMIN15000 UI/0,6 ml

SOL. INJ.
15000ui/0.6ml

B01AB04 DALTEPARINUM
FRAGMIN 18000 UI/0,72 ml

SOL. INJ.
18000 UI/0.72ml PFIZER EUROPE MA EEIG

18000 UI/0.72ml 25000 UI/ml


PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM
FRAGMIN 25000 UI/ml

SOL. INJ.
25000 UI/ml

B01AB04 DALTEPARINUM
FRAGMIN 2500 UI/0,2 ml

SOL. INJ.
2500ui/0.2ml PFIZER EUROPE MA EEIG

2500ui/0.2ml 5000ui/0.2ml
PFIZER EUROPE MA EEIG

B01AB04 DALTEPARINUM
FRAGMIN 5000 UI/0,2 ml

SOL. INJ.
5000ui/0.2ml

B01AB04 DALTEPARINUM
FRAGMIN 7500 UI/0,3 ml

SOL. INJ.
7500ui/0.3ml PFIZER EUROPE MA EEIG

7500ui/0.3ml

962

B01AB08

REVIPARINUM
SOL. INJ.
1432ui/0.25ml 1432ui/0.25ml ABBOTT GMBH&CO.KG ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN 1432UI/0,25 ml CLIVARIN -PEN

1432ui/0.25ml

B01AB08 REVIPARINUM
CLIVARIN 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml ABBOTT GMBH&CO.KG

3436ui/0.6ml 5726ui/ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN - multi

SOL. INJ.
5726ui/ml

963

B03XA01

EPOETINUM ALFA

195 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
JOHNSON & JOHNSON D.O.O.

FIRMA

PROTOCOL

B03XA01 EPOETINUM ALFA


EPREX 10000 UI

SOL. INJ.
10000ui/ml

10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA


EPOKINE 1000 UI/0,5 ml EPREX 1000 UI

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml 1000UI/ml 20000UI/ml

B03XA01 EPOETINUM ALFA


NEORECORMON 500UI

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD.

1000UI/ml 20000UI/ml 2000UI

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 2000 U.I.

SOL. INJ.
2000UI

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/0,5 ml EPREX 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

2000ui/0.5ml

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA


EPREX 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA


EPREX 40 000 UI

SOL. INJ.
40 000UI JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 4000 U.I.

SOL. INJ.
4000UI

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/0,4 ml EPREX 4000 UI

SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

4000ui/0.4ml

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 50000UI/ml 10000UI/1,0ml 10000UI/1,0ml 10000UI/1,0ml 1000UI/0,5ml 1000UI/0,5ml 1000UI/0,5ml 2000UI/1,0ml 2000UI/1,0ml 2000UI/1,0ml 3000UI/0,3ml 3000UI/0,3ml 3000UI/0,3ml 4000UI/0,4ml 4000UI/0,4ml 4000UI/0,4ml 5000UI/0,5ml 5000UI/0,5ml 5000UI/0,5ml 6000UI/0,6ml 6000UI/0,6ml 6000UI/0,6ml 8000UI/0,8ml 8000UI/0,8ml 8000UI/0,8ml RENAMED FARMA S.R.L.

4000UI/1ml 50000UI/ml 10000UI/1,0ml

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

B03XA01 EPOETINUM ALFA


ABSEAMED 10000UI/1,0ml BINOCRIT 10000UI/1,0ml EPOETIN ALFA HEXAL 10000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA


ABSEAMED 1000UI/0,5ml BINOCRIT 1000UI/0,5ml EPOETIN ALFA HEXAL 1000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

1000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 2000UI/1,0ml BINOCRIT 2000UI/1,0ml EPOETIN ALFA HEXAL 2000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

2000UI/1,0ml

B03XA01 EPOETINUM ALFA


ABSEAMED 3000UI/0,3ml BINOCRIT 3000UI/0,3ml EPOETIN ALFA HEXAL 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

3000UI/0,3ml

B03XA01 EPOETINUM ALFA


ABSEAMED 4000UI/0,4ml BINOCRIT 4000UI/0,4ml EPOETIN ALFA HEXAL 4000UI/0,4ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

4000UI/0,4ml

B03XA01 EPOETINUM ALFA


ABSEAMED 5000UI/0,5ml BINOCRIT 5000UI/0,5ml EPOETIN ALFA HEXAL 5000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

5000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 6000UI/0,6ml BINOCRIT 6000UI/0,6ml EPOETIN ALFA HEXAL 6000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

6000UI/0,6ml

B03XA01 EPOETINUM ALFA


ABSEAMED 8000UI/0,8ml BINOCRIT 8000UI/0,8ml EPOETIN ALFA HEXAL 8000UI/0,8ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

8000UI/0,8ml

964

B03XA01

EPOETINUM BETA
LIOF. + SOLV. PT. SOL. INJ.
1000UI/ml 20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON 500UI

1000UI/ml 20000UI/ml 50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ. SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 1000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 2000UI/0,3ml

B03XA01 EPOETINUM BETA

196 / 233

DCI/DENUMIRE COMERCIALA
NEORECORMON 30000UI/0,6ml

CONCENTRATIE
30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

FORMA FARM.
ROCHE REGISTRATION LTD.

FIRMA

PROTOCOL

B03XA01 EPOETINUM BETA


NEORECORMON 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD.

3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 4000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON 5000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA


NEORECORMON 500UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 60000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 6000UI/0,3ml

965
HAEMACCEL

B05AA06

POLYGELINUM
SOL. PERF.
3.5% THERASELECT GMBH

B05AA06 POLYGELINUM

3.5%

966
SANDOSTATIN

H01CB02

OCTREOTIDUM **
SOL. INJ.
0.1mg/ml NOVARTIS PHARMA GMBH

Protocol: H010C
0.1mg/ml 10mg

H01CB02 OCTREOTIDUM H01CB02 OCTREOTIDUM


SANDOSTATIN LAR 10 mg 10mg

PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB. PRELUNG.


NOVARTIS PHARMA GMBH

H01CB02 OCTREOTIDUM
SANDOSTATIN LAR 20 mg 20mg

PULB. + SOLV. PT. SUSP. INJ. (I.M.) CU ELIB. PRELU


NOVARTIS PHARMA GMBH

20mg

H01CB02 OCTREOTIDUM
SANDOSTATIN LAR 30 mg 30mg

PULB.+SOLV.PT.SUSP. INJ. (I.M.) CU ELIB. PRELUNG.


NOVARTIS PHARMA GMBH

30mg

967
TAZOCIN 2,25 TAZOCIN 4,5

J01CR05

PIPERACILLINUM + TAZOBACTAMUM
LIOF. PT. SOL. INJ.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

J01CR05 PIPERACILLINUM + TAZOBACTAMUM

968
J01XA02 J01XA02
TARGOCID 200 mg

J01XA02
TEICOPLANINUM TEICOPLANINUM

TEICOPLANINUM
LIOF. + SOLV. PT. SOL. INJ.
200mg 400mg AVENTIS PHARMA LTD.

200mg 400mg

LIOF. + SOLV. PT. SOL. INJ.


AVENTIS PHARMA LTD.

TARGOCID 400 mg

969
J01XX08
ZYVOXID

J01XX08
LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID

SOL. PERF.
2mg/ml 400mg 600mg PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

400mg 600mg

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

970
J02AB02

J02AB02
KETOCONAZOLUM

KETOCONAZOLUM
COMPR.
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg ANTIBIOTICE SA ARENA GROUP SA FABIOL S.A. FARMEX COMPANY SRL OZONE LABORATORIES LTD. AC HELCOR SRL MEDUMAN S.A. JANSSEN PHARMACEUTICA NV TERAPIA SA

200mg

KEFUNGIN KETOCONAZOL 200 mg KETOCONAZOL FABIOL 200 mg KETOCONAZOL FARMEX 200 mg KETOCONAZOL OZONE 200 mg KETOSTIN 200 mg N - KETOCONAZOL 200 mg NIZORAL NIZORAL 200 mg

Prescriere limitata: Candidoza genitala simptomatica recurenta dupa tratamentul local a cel putin doua episoade. A fost raportat hepatotoxicitate la ketoconazol.

J02AB02

KETOCONAZOLUM

COMPR.
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg ANTIBIOTICE SA MAGISTRA C & C FABIOL S.A. FARMEX COMPANY SRL OZONE LABORATORIES LTD. AC HELCOR SRL MEDUMAN S.A. JANSSEN PHARMACEUTICA NV TERAPIA SA

200mg

KEFUNGIN KETOCONAZOL 200 mg KETOCONAZOL FABIOL 200 mg KETOCONAZOL FARMEX 200 mg KETOCONAZOL OZONE 200 mg KETOSTIN 200 mg N - KETOCONAZOL 200 mg NIZORAL NIZORAL 200 mg

Prescriere limitata: Candidoza orala la persoanele imunocompromise sever la care tratamentul local nu a avut rezultate Prescriere limitata: Micoze sistemice la care alte forme de terapie antifungica nu au avut efect. A fost raportat hepatotoxicitate la ketoconazol.

971

J02AC01

FLUCONAZOLUM
CAPS.
100mg 100mg 100mg 100mg 100mg 100mg 100mg KRKA D.D. OZONE LABORATORIES LTD. LINCOSA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

J02AC01 FLUCONAZOLUM
DIFLAZON 100 mg FLUCONAZOL 100 mg FLUCONAZOLE LINCOSA 100mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

100mg

197 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM
DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL BIOGALENICA 150 mg FLUCONAZOL LAROPHARM 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCONIMED 150 mg FLUCORIC 150 mg FLUCOVIM 150 MEDOFLUCON 150 mg MYCOMAX 150

CAPS.
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. LAROPHARM S.R.L. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL MEDOCHEMIE LTD. ZENTIVA AS

150mg

J02AC01 FLUCONAZOLUM
DIFLAZON 200 mg FLUCONAZOLE LINCOSA 200 mg FLUCONAZOLE TEVA 200 mg

CAPS.
200mg 200mg 200mg KRKA D.D. LICONSA S.A. TEVA PHARMACEUTICALS SRL

200mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM
DIFLAZON DIFLUCAN FLUCONAZOL BIOGALENICA 2mg/ml MYCOMAX INF

SOL. PERF.
2mg/ml 2mg/ml 2mg/ml 2mg/ml KRKA D.D. PFIZER EUROPE MA EEIG LABORATOARELE PROF.DR.MORAIT S.R.L. ZENTIVA AS

2mg/ml

J02AC01 FLUCONAZOLUM
DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL BIOGALENICA 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCONIMED 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg MEDOFLUCON 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG OZONE LABORATORIES LTD. LABORATOARELE PROF.DR.MORAIT S.R.L. MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD MEDOCHEMIE LTD

50mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:
DIFLUCAN 50 mg/5 ml

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM

PULB. PT. SUSP. ORALA


50mg/5ml PFIZER EUROPE MA EEIG

50mg/5ml

972

J02AC02

ITRACONAZOLUM
CAPS.
100mg 100mg 100mg 100mg ARENA GROUP S.A. MEDICO UNO PHARMACEUTICAL S.R.L. JANSSEN PHARMACEUTICA NV GEDEON RICHTER ROMANIA S.A.

J02AC02 ITRACONAZOLUM
ITRACONAZOL 100 mg OMICRAL 100 mg ORUNGAL SPORILIN 100 mg

100mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Sporotricoza sistemica Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

973
VFEND 200mg

J02AC03

VORICONAZOLUM **
COMPR. FILM.
200mg 200mg 40mg/ml 50mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg

J02AC03 VORICONAZOLUM J02AC03 VORICONAZOLUM


VFEND 200mg

PULB. PT. SOL. PERF.


PFIZER LTD. PFIZER LTD. PFIZER LTD.

J02AC03 VORICONAZOLUM
VFEND 40 mg/ml

PULB. PT. SUSP. ORALA COMPR. FILM.

J02AC03 VORICONAZOLUM
VFEND 50mg

974
J02AX04 J02AX04 J02AX04
CANCIDAS 50 mg

J02AX04
CASPOFUNGINUM

CASPOFUNGINUM **
PULB. PT. CONC. PT. SOL. PERF.
50mg 50mg MERCK SHARP & DOHME LTD

Protocol: J010D
50mg 50mg 70mg

CASPOFUNGINUM CASPOFUNGINUM

PULB. PT. SOL. PERF.


MERCK SHARP & DOHME LTD

CANCIDAS 50 mg

PULB. PT. CONC. PT. SOL. PERF.

198 / 233

DCI/DENUMIRE COMERCIALA
CANCIDAS 70 mg

CONCENTRATIE
70mg

FORMA FARM.
MERCK SHARP & DOHME LTD

FIRMA

PROTOCOL

976
J05AB01
ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01
ACICLOVIRUM

ACICLOVIRUM
CAPS.
200mg 200mg ARENA GROUP SA EUROPHARM SA

200mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR.
200mg 200mg 200mg 200mg GEDEON RICHTER ROMANIA SA ALSIFCOM INTERMED SRL ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

200mg

ACICLOVIR 200 mg ALS-ACICLOVIR CLOVIRAL 200 mg ZOVIRAX

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR. DISP.
200mg 200mg OZONE LABORATORIES LTD. RANBAXY UK LIMITED

200mg

ACICLOVIR 200 mg LOVIR 200 mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01
VIROLEX

ACICLOVIRUM ACICLOVIRUM

PULB. PT. SOL. INJ./PERF.


250mg KRKA D.D. NOVO MESTO

250mg 400mg

J05AB01

CAPS.
400mg ARENA GROUP S.A.

ACICLOVIR 400 mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

J05AB01

ACICLOVIRUM

COMPR.
400mg EGIS PHARMACEUTICALS P.L.C.

400mg

ACICLOVIR 400 mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

J05AB01
ACIKLOVIR

ACICLOVIRUM

COMPR. FILM.
400mg A & G MED TRADING S.R.L.

400mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

977
J05AB14
VALCYTE 450 mg

J05AB14
VALGANCICLOVIRUM

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

450mg

978
J05AB11
VALTREX 500 mg

J05AB11
VALACYCLOVIRUM

VALACYCLOVIRUM
COMPR. FILM.
500mg THE WELLCOME FOUNDATION LTD.

500mg

Prescriere limitata:

Profilaxia infectiei si bolii cu citomegalovirus in urma transplantului renal la pacientii cu risc de boala cu citomegalovirus

979
J06BA02

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA **


SOL. PERF.
100mg/ml BAXTER AG

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA

100mg/ml

KIOVIG 100mg/ml

J06BA02

SOL. PERF.
10g/200ml KEDRION SPA

10g/200ml

IG VENA 10g/200ml

J06BA02

SOL. PERF.
1g/20ml KEDRION SPA

1g/20ml

IG VENA 1g/20ml

J06BA02

SOL. PERF.
2.5mg/50ml KEDRION SPA

2.5mg/50ml

IG VENA 2,5g/50ml

J06BA02

SOL. PERF.
50mg/ml 50mg/ml 50mg/ml INSTITUTO GRIFOLS S.A. OCTAPHARMA (IP) LTD. BIOTEST PHARMA GMBH

50mg/ml

FLEBOGAMMADIF 50mg/ml OCTAGAM PENTAGLOBIN

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA
5%

SOL. PERF.
5g/100ml KEDRION SPA

5g/100ml

IG VENA 5g/100ml

J06BA02
HUMAGLOBIN

PULB.+SOLV. PT. SOL. PERF.


TEVA PHARM. WORKS PRIVATE LTD. COMPANY

5%

J06BA02

IMUNOGLOBULINA NORMALA PT. ADM. INTRAVASCULARA


5%

SOL. PERF.
INSTITUTO GRIFOLS S.A.

5%

FLEBOGAMMA 5%

980
ENDOXAN 1 g

L01AA01

CYCLOPHOSPHAMIDUM
PULB. PT. SOL. INJ./PERF.
1g 1g BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM L01AA01 CYCLOPHOSPHAMIDUM


ENDOXAN 1 g

1g 1g 200mg

PULB. PT. SOL. PERF./INJ. I.V.


ACTAVIS S.R.L.

L01AA01 CYCLOPHOSPHAMIDUM

PULB. PT. SOL. INJ./PERF.

199 / 233

DCI/DENUMIRE COMERCIALA
ENDOXAN 200 mg

CONCENTRATIE
200mg 200mg 500mg 500mg

FORMA FARM.
BAXTER ONCOLOGY GMBH

FIRMA

PROTOCOL

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 200 mg

PULB. PT. SOL. PERF./INJ. I.V.


ACTAVIS S.R.L.

200mg 500mg 500mg 50mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

PULB. PT. SOL. INJ./PERF.


BAXTER ONCOLOGY GMBH ACTAVIS S.R.L. BAXTER ONCOLOGY GMBH

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 500 mg

PULB. PT. SOL. PERF./INJ. I.V. DRAJ.


50mg

L01AA01 CYCLOPHOSPHAMIDUM
ENDOXAN 50 mg

981
NEUPOGEN

L03AA02

FILGRASTIMUM (G-CSF)
SOL. INJ.
30MU/0.5ml AMGEN EUROPE B.V.

L03AA02 FILGRASTIMUM (G-CSF) L03AA02 FILGRASTIMUM (G-CSF)


NEUPOGEN

30MU/0.5ml 48MU/0.5ml
AMGEN EUROPE B.V.

SOL. INJ.
48MU/0.5ml

982

L04AA01

CICLOSPORINUM
CAPS. MOI
100mg 100mg 100mg HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 100 mg EQUORAL 100 mg IMUSPORIN 100 mg

100mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL EQUORAL SANDIMMUN NEORAL

SOL. ORALA
100mg/ml 100mg/ml 100mg/ml HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

100mg/ml

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 25 mg EQUORAL 25 mg IMUSPORIN 25 mg SANDIMMUN NEORAL 25mg 25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

25mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 50 mg EQUORAL 50 mg IMUSPORIN 50 mg SANDIMMUN NEORAL 50mg 50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

50mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

983

L04AA04

IMUNOGLOBULINA ANTI-LIMFOCITE UMANE **


CONC. PT. SOL. INJ.
20mg/ml FRESENIUS BIOTECH GMBH

L04AA04 IMUNOGLOBULINA ANTI-LIMFOCITE UMANE


ATG-FRESENIUS

20mg/ml

L04AA04 IMUNOGLOBULINA ANTI-LIMFOCITE UMANE


THYMOGLOBULINE

PULB. PT. SOL. PERF.


5mg/ml GENZYME EUROPE B.V.

5mg/ml

984
ADVAGRAF 0,5mg

L04AA05
Prescriere limitata:

TACROLIMUSUM **
CAPS. ELIB. PREL.
0,5mg ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM

0,5mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal.

L04AA05 TACROLIMUSUM
PROGRAF 0,5 mg 0.5mg

CAPS.
ASTELLAS PHARMA GMBH

0.5mg

Prescriere limitata:
PROGRAF 1 mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal.

L04AA05 TACROLIMUSUM
1mg

CAPS.
ASTELLAS IRELAND CO. LTD.

1mg

Prescriere limitata:
ADVAGRAF 1mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal.

L04AA05 TACROLIMUSUM
1mg

CAPS. ELIB. PREL.


ASTELLAS PHARMA GMBH

1mg

Prescriere limitata:
PROGRAF 5 mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal.

L04AA05 TACROLIMUSUM
5mg

CAPS.
ASTELLAS PHARMA GMBH

5mg

Prescriere limitata:
ADVAGRAF 5mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal.

L04AA05 TACROLIMUSUM
5mg

CAPS. ELIB. PREL.


ASTELLAS PHARMA GMBH

5mg

Prescriere limitata:
PROGRAF 5 mg/ml

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal.

L04AA05 TACROLIMUSUM
Prescriere limitata:

CONC. PT. SOL. PERF.


5mg/ml ASTELLAS PHARMA GMBH

5mg/ml

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal.

985
MYFORTIC 180 mg

L04AA06
Prescriere limitata:

MYCOPHENOLATUM **
COMPR. FILM. GASTROREZ.
180mg NOVARTIS PHARMA GMBH

L04AA06 MYCOPHENOLATUM

180mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal.

L04AA06 MYCOPHENOLATUM
CELLCEPT 1mg/5ml 1g/5ml

PULB. PT. SUSP. ORALA


ROCHE REGISTRATION LTD.

1g/5ml

Prescriere limitata:
CELLCEPT 250mg MICOFENOLAT MOFETIL TEVA

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal.

L04AA06 MYCOPHENOLATUM

CAPS.
250mg 250mg ROCHE REGISTRATION LTD. TEVA PHARMA BV

250mg

200 / 233

DCI/DENUMIRE COMERCIALA
MYFENAX 250mg

CONCENTRATIE
250mg

FORMA FARM.
TEVA PHARMA BV

FIRMA

PROTOCOL

Prescriere limitata:
MYFORTIC 360 mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal.

L04AA06 MYCOPHENOLATUM
Prescriere limitata:
MICOFENOLAT MOFETIL TEVA MYFENAX 500mg

COMPR. FILM. GASTROREZ.


360mg NOVARTIS PHARMA GMBH

360mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal.

L04AA06 MYCOPHENOLATUM

CAPS.
500mg 500mg TEVA PHARMA BV TEVA PHARMA BV

500mg

Prescriere limitata:
CELLCEPT 500mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal.

L04AA06 MYCOPHENOLATUM
Prescriere limitata:
CELLCEPT 500mg

COMPR. FILM.
500mg ROCHE REGISTRATION LTD.

500mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal.

L04AA06 MYCOPHENOLATUM
Prescriere limitata:

PULB. PT. CONC. PT. SOL. PERF.


500mg ROCHE REGISTRATION LTD.

500mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal.

986
ZENAPAX 5 mg/ml

L04AA08

DACLIZUMABUM **
CONC. PT. SOL. PERF.
5mg/ml ROCHE REGISTRATION LTD.

L04AA08 DACLIZUMABUM

5mg/ml

987
SIMULECT 20 mg

L04AA09

BASILIXIMABUM **
LIOF. + SOLV. PT. SOL. INJ./PERF.
20mg NOVARTIS EUROPHARM LTD.

L04AA09 BASILIXIMABUM

20mg

988
RAPAMUNE 1mg

L04AA10

SIROLIMUS **
COMPR. FILM.
1mg WYETH EUROPA LTD.

L04AA10 SIROLIMUS

1mg

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 1mg/ml

SOL. ORALA
1mg/ml WYETH EUROPA LTD.

1mg/ml

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 2mg 2mg

COMPR. FILM.
WYETH EUROPA LTD.

2mg

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 5mg 5mg

COMPR. FILM.
WYETH EUROPA LTD.

5mg

989
IMURAN

L04AX01

AZATHIOPRINUM
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

L04AX01 AZATHIOPRINUM

50mg

990
FOSAMAX 10 mg TEVA NAT 10 mg

M05BA04

ACIDUM ALENDRONICUM
COMPR.
10mg 10mg MERCK SHARP & DOHME S.R.L. TEVA PHARMACEUTICALS S.R.L.

M05BA04 ACIDUM ALENDRONICUM

10mg

M05BA04 ACIDUM ALENDRONICUM


FOSAMAX 5mg

COMPR.
MERCK SHARP & DOHME ROMANIA S.R.L.

5mg 70 mg
TEVA PHARMACEUTICALS SRL

M05BA04 ACIDUM ALENDRONICUM


TEVA NAT 70 mg

COMPR. COMPR.
70mg 70mg MERCK SHARP & DOHME S.R.L.

M05BA04 ACIDUM ALENDRONICUM


FOSAMAX 70 mg

70mg 70mg

M05BA04 ACIDUM ALENDRONICUM


ALENDRONAT SANDOZ 70 mg

COMPR. FILM.
SANDOZ S.R.L.

991
MIALGIN 100 mg/2 ml

N02AB02

PETHIDINUM
SOL. INJ.
50mg/ml ZENTIVA SA

N02AB02 PETHIDINUM

50mg/ml

201 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-XII P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.5 TRANSPLANT CELULE PANCREATICE 993 B01AB08 REVIPARINUM
B01AB08 REVIPARINUM
CLIVARIN 1432UI/0,25 ml CLIVARIN -PEN

SOL. INJ.
1432ui/0.25ml 1432ui/0.25ml ABBOTT GMBH&CO.KG ABBOTT GMBH&CO.KG

1432ui/0.25ml

B01AB08 REVIPARINUM
CLIVARIN 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml ABBOTT GMBH&CO.KG

3436ui/0.6ml 5726ui/ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN - multi

SOL. INJ.
5726ui/ml

994
HAEMACCEL

B05AA06

POLYGELINUM
SOL. PERF.
3.5% THERASELECT GMBH

B05AA06 POLYGELINUM

3.5%

995
J01XX08
ZYVOXID

J01XX08
LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID

SOL. PERF.
2mg/ml 400mg 600mg PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

400mg 600mg

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

996
VFEND 200mg

J02AC03

VORICONAZOLUM **
COMPR. FILM.
200mg 200mg 40mg/ml 50mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg

J02AC03 VORICONAZOLUM J02AC03 VORICONAZOLUM


VFEND 200mg

PULB. PT. SOL. PERF.


PFIZER LTD. PFIZER LTD. PFIZER LTD.

J02AC03 VORICONAZOLUM
VFEND 40 mg/ml

PULB. PT. SUSP. ORALA COMPR. FILM.

J02AC03 VORICONAZOLUM
VFEND 50mg

998
J05AB14
VALCYTE 450 mg

J05AB14
VALGANCICLOVIRUM

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

450mg

202 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-XIII P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.6 TRANSPLANT PULMONAR 999 B01AB05 ENOXAPARINUM
B01AB05 ENOXAPARINUM
CLEXANE

SOL. INJ.
100mg/ml LAB. AVENTIS

100mg/ml 2000ui anti-Xa/0.2ml


LAB. AVENTIS

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

B01AB05 ENOXAPARINUM
CLEXANE 8000ui anti-Xa/0.8ml

SOL. INJ.
8000ui anti-Xa/0.8ml LAB. AVENTIS

8000ui anti-Xa/0.8ml

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

1000

B01AB08

REVIPARINUM
SOL. INJ.
1432ui/0.25ml 1432ui/0.25ml ABBOTT GMBH&CO.KG ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN 1432UI/0,25 ml CLIVARIN -PEN

1432ui/0.25ml

B01AB08 REVIPARINUM
CLIVARIN 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml ABBOTT GMBH&CO.KG

3436ui/0.6ml 5726ui/ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN - multi

SOL. INJ.
5726ui/ml

1002

C01CA24

EPINEPHRINUM
SOL. INJ.
150g/0.3ml LINCOLN MEDICAL LTD.

C01CA24 EPINEPHRINUM
ANAPEN JUNIOR 150 g/0,3 ml

150g/0.3ml 1mg/ml
TERAPIA SA

C01CA24 EPINEPHRINUM
ADRENALINA 1 mg

SOL. INJ.
1mg/ml

C01CA24 EPINEPHRINUM
ANAPEN 300 g/0,3 ml

SOL. INJ.
300g/0.3ml LINCOLN MEDICAL LTD.

300g/0.3ml

1003
TAZOCIN 2,25 TAZOCIN 4,5

J01CR05

PIPERACILLINUM + TAZOBACTAMUM
LIOF. PT. SOL. INJ.
WYETH LEDERLE PHARMA GMBH WYETH LEDERLE PHARMA GMBH

J01CR05 PIPERACILLINUM + TAZOBACTAMUM

1004
J01XX08
ZYVOXID

J01XX08
LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM LINEZOLIDUM

LINEZOLIDUM
GRAN. PT. SUSP. ORALA
100mg/5ml PFIZER EUROPE MA EEIG

100mg/5ml 2mg/ml

J01XX08
ZYVOXID

SOL. PERF.
2mg/ml 400mg 600mg PFIZER EUROPE MA EEIG

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

400mg 600mg

J01XX08
ZYVOXID

COMPR. FILM.
PFIZER EUROPE MA EEIG

1005

J02AC01

FLUCONAZOLUM
CAPS.
100mg 100mg 100mg 100mg 100mg 100mg 100mg KRKA D.D. OZONE LABORATORIES LTD. LINCOSA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

J02AC01 FLUCONAZOLUM
DIFLAZON 100 mg FLUCONAZOL 100 mg FLUCONAZOLE LINCOSA 100mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

100mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:
DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM

CAPS.
150mg 150mg 150mg KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA

150mg

203 / 233

DCI/DENUMIRE COMERCIALA
FLUCONAZOL BIOGALENICA 150 mg FLUCONAZOL LAROPHARM 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCONIMED 150 mg FLUCORIC 150 mg FLUCOVIM 150 MEDOFLUCON 150 mg MYCOMAX 150

CONCENTRATIE
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg

FORMA FARM.

FIRMA

PROTOCOL

LABORATOARELE PROF.DR.MORAIT S.R.L. LAROPHARM S.R.L. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL MEDOCHEMIE LTD. ZENTIVA AS

J02AC01 FLUCONAZOLUM
DIFLAZON 200 mg FLUCONAZOLE LINCOSA 200 mg FLUCONAZOLE TEVA 200 mg

CAPS.
200mg 200mg 200mg KRKA D.D. LICONSA S.A. TEVA PHARMACEUTICALS SRL

200mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM
DIFLAZON DIFLUCAN FLUCONAZOL BIOGALENICA 2mg/ml MYCOMAX INF

SOL. PERF.
2mg/ml 2mg/ml 2mg/ml 2mg/ml KRKA D.D. PFIZER EUROPE MA EEIG LABORATOARELE PROF.DR.MORAIT S.R.L. ZENTIVA AS

2mg/ml

J02AC01 FLUCONAZOLUM
DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL BIOGALENICA 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCONIMED 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg MEDOFLUCON 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD MEDOCHEMIE LTD

50mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:
DIFLUCAN 50 mg/5 ml

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM

PULB. PT. SUSP. ORALA


50mg/5ml PFIZER EUROPE MA EEIG

50mg/5ml

1006
VFEND 200mg

J02AC03

VORICONAZOLUM **
COMPR. FILM.
200mg 200mg 40mg/ml 50mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg

J02AC03 VORICONAZOLUM J02AC03 VORICONAZOLUM


VFEND 200mg

PULB. PT. SOL. PERF.


PFIZER LTD. PFIZER LTD. PFIZER LTD.

J02AC03 VORICONAZOLUM
VFEND 40 mg/ml

PULB. PT. SUSP. ORALA COMPR. FILM.

J02AC03 VORICONAZOLUM
VFEND 50mg

1008
J05AB01
ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01
ACICLOVIRUM

ACICLOVIRUM
CAPS.
200mg 200mg ARENA GROUP SA EUROPHARM SA

200mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR.
200mg 200mg 200mg 200mg GEDEON RICHTER ROMANIA SA ALSIFCOM INTERMED SRL ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

200mg

ACICLOVIR 200 mg ALS-ACICLOVIR CLOVIRAL 200 mg ZOVIRAX

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR. DISP.
200mg 200mg OZONE LABORATORIES LTD. RANBAXY UK LIMITED

200mg

ACICLOVIR 200 mg LOVIR 200 mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

PULB. PT. SOL. INJ./PERF.

250mg

204 / 233

DCI/DENUMIRE COMERCIALA
VIROLEX

CONCENTRATIE
250mg

FORMA FARM.
KRKA D.D. NOVO MESTO

FIRMA

PROTOCOL

J05AB01

ACICLOVIRUM

CAPS.
400mg ARENA GROUP S.A.

400mg

ACICLOVIR 400 mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

J05AB01

ACICLOVIRUM

COMPR.
400mg EGIS PHARMACEUTICALS P.L.C.

400mg

ACICLOVIR 400 mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

J05AB01
ACIKLOVIR

ACICLOVIRUM

COMPR. FILM.
400mg A & G MED TRADING S.R.L.

400mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

1009
J05AB14
VALCYTE 450 mg

J05AB14
VALGANCICLOVIRUM

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

450mg

1010

L04AA01

CICLOSPORINUM
CAPS. MOI
100mg 100mg 100mg HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 100 mg EQUORAL 100 mg IMUSPORIN 100 mg

100mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL EQUORAL SANDIMMUN NEORAL

SOL. ORALA
100mg/ml 100mg/ml 100mg/ml HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

100mg/ml

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 25 mg EQUORAL 25 mg IMUSPORIN 25 mg SANDIMMUN NEORAL 25mg 25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

25mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 50 mg EQUORAL 50 mg IMUSPORIN 50 mg SANDIMMUN NEORAL 50mg 50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

50mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

1011

L04AA04

IMUNOGLOBULINA ANTI-LIMFOCITE UMANE **


CONC. PT. SOL. INJ.
20mg/ml FRESENIUS BIOTECH GMBH

L04AA04 IMUNOGLOBULINA ANTI-LIMFOCITE UMANE


ATG-FRESENIUS

20mg/ml

L04AA04 IMUNOGLOBULINA ANTI-LIMFOCITE UMANE


THYMOGLOBULINE

PULB. PT. SOL. PERF.


5mg/ml GENZYME EUROPE B.V.

5mg/ml

1012
MYFORTIC 180 mg

L04AA06

MYCOPHENOLATUM **
COMPR. FILM. GASTROREZ.
180mg 1g/5ml NOVARTIS PHARMA GMBH

L04AA06 MYCOPHENOLATUM L04AA06 MYCOPHENOLATUM


CELLCEPT 1mg/5ml

180mg 1g/5ml 250mg

PULB. PT. SUSP. ORALA


ROCHE REGISTRATION LTD.

L04AA06 MYCOPHENOLATUM
CELLCEPT 250mg MICOFENOLAT MOFETIL TEVA MYFENAX 250mg

CAPS.
250mg 250mg 250mg 360mg ROCHE REGISTRATION LTD. TEVA PHARMA BV TEVA PHARMA BV

L04AA06 MYCOPHENOLATUM
MYFORTIC 360 mg

COMPR. FILM. GASTROREZ.


NOVARTIS PHARMA GMBH

360mg 500mg

L04AA06 MYCOPHENOLATUM
MICOFENOLAT MOFETIL TEVA MYFENAX 500mg

CAPS.
500mg 500mg 500mg 500mg TEVA PHARMA BV TEVA PHARMA BV

L04AA06 MYCOPHENOLATUM
CELLCEPT 500mg

COMPR. FILM.
ROCHE REGISTRATION LTD.

500mg 500mg

L04AA06 MYCOPHENOLATUM
CELLCEPT 500mg

PULB. PT. CONC. PT. SOL. PERF.


ROCHE REGISTRATION LTD.

1013
SIMULECT 20 mg

L04AA09

BASILIXIMABUM **
LIOF. + SOLV. PT. SOL. INJ./PERF.
20mg NOVARTIS EUROPHARM LTD.

L04AA09 BASILIXIMABUM

20mg

1014
IMURAN

L04AX01

AZATHIOPRINUM
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

L04AX01 AZATHIOPRINUM

50mg

1015

N02AX02
Prescriere limitata: Prescriere limitata:

TRAMADOLUM
COMPR. ELIB. MODIF.
100mg HEXAL AG

N02AX02 TRAMADOLUM
TRAMADOLOR 100 ID

100mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. ELIB. PREL.

100mg

205 / 233

DCI/DENUMIRE COMERCIALA
NOAX UNO 100 mg TRALGIT SR 100 TRAMADOL RETARD

CONCENTRATIE
100mg 100mg 100mg

FORMA FARM.
LABOPHARM EUROPE LIMITED ZENTIVA AS KRKA D.D.

FIRMA

PROTOCOL

Prescriere limitata: Prescriere limitata:


TRAMAL RETARD 100 mg TRAMUNDIN RETARD 100 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.


100mg 100mg GRUNENTHAL GMBH MUNDIPHARMA GES.M.B.H

100mg

Prescriere limitata: Prescriere limitata:


MABRON TRADOLAN

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

SOL. INJ.
100mg 100mg MEDOCHEMIE LTD. LANNACHER HEILMITTEL GMBH

100mg

Prescriere limitata:
TRADOLAN TRAMADOL TRAMAG 100 TRAMAL

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM

SUPOZ.
100mg 100mg 100mg 100mg LANNACHER HEILMITTEL GMBH KRKA D.D. MAGISTRA C & C GRUNENTHAL GMBH

100mg

N02AX02 TRAMADOLUM
TRALGIT 100

SOL. INJ.
100mg/2ml ZENTIVA A.S.

100mg/2ml

Prescriere limitata:
TRALGIT

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
TRADOLAN

PIC. ORALE, SOL.


100mg/ml ZENTIVA A.S.

100mg/ml

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
TRALGIT SR 150

SOL. ORALA
100mg/ml LANNACHER HEILMITTEL GMBH

100mg/ml

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
TRAMADOL RETARD 150 mg TRAMAL RETARD 150 mg

COMPR. ELIB. PREL.


150mg ZENTIVA AS

150mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.


150mg 150mg KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

150mg

Prescriere limitata: Prescriere limitata:


NOAX UNO 200 mg TRALGIT SR 200

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. ELIB. PREL.


200mg 200mg LABOPHARM EUROPE LIMITED ZENTIVA AS

200mg

Prescriere limitata: Prescriere limitata:


TRAMADOL RETARD 200 mg TRAMAL RETARD 200 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM

COMPR. FILM. ELIB. PREL.


200mg 200mg KRKA D.D. NOVO MESTO GRUNENTHAL GMBH

200mg

Prescriere limitata: Prescriere limitata:


NOAX UNO 300 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
Prescriere limitata: Prescriere limitata:
K-ALMA MABRON 50 mg TRALGIT 50 TRAMACALM TRAMADOL TRAMADOL LPH 50 mg TRAMADOL AL 50 TRAMADOL ARENA TRAMADOLOR 50 mg TRAMAL URGENDOL

COMPR. ELIB. PREL.


300mg LABOPHARM EUROPE LIMITED

300mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
ANTIBIOTICE SA MEDOCHEMIE LTD. ZENTIVA A.S. AC HELCOR SRL KRKA D.D. LABORMED PHARMA SA ALIUD PHARMA GMBH & CO.KG ARENA GROUP S.A. HEXAL AG GRUNENTHAL GMBH MEDICAROM GROUP SRL

50mg

Prescriere limitata:
TRAMADOL 50 mg TRAMADOL EEL TRAMAG 50

Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg 50mg 50mg

COMPR.
OZONE LABORATORIES LTD. BIO EEL SRL MAGISTRA C & C

50mg

Prescriere limitata: Prescriere limitata:


TRADOLAN 50 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg

COMPR. FILM.
LANNACHER HEILMITTEL GMBH

50mg

Prescriere limitata: Prescriere limitata:


TRADOLAN 50 mg

Durere severa, invalidanta, care nu raspunde la analgezice non-opioide Pentru durere acuta la care tratamentul cu aspirina si /sau paracetamol este contraindicat sau nu a dat rezultate.

N02AX02 TRAMADOLUM
50mg

SOL. INJ.
LANNACHER HEILMITTEL GMBH

50mg

Prescriere limitata:
TRALGIT 50 TRAMADOL TRAMADOL AL 100 Fiole

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM

SOL. INJ.
50mg/ml 50mg/ml 50mg/ml ZENTIVA A.S. KRKA D.D. ALIUD PHARMA GMBH & CO.KG

50mg/ml

206 / 233

DCI/DENUMIRE COMERCIALA
TRAMAL 100 TRAMAL 50 URGENDOL

CONCENTRATIE
50mg/ml 50mg/ml 50mg/ml

FORMA FARM.
GRUNENTHAL GMBH GRUNENTHAL GMBH MEDICAROM GROUP SRL

FIRMA

PROTOCOL

Prescriere limitata:
TRAMADOL AL PICATURI

Tratamentul de scurta durata al durerii acute

N02AX02 TRAMADOLUM N02AX02 TRAMADOLUM


TRAMAL

PIC. ORALE, SOL.


ALIUD PHARMA GMBH & CO.KG

PICATURI ORALE-SOL.
100mg/ml GRUNENTHAL GMBH

100mg/ml

207 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-XIV P9: PROGRAM NATIONAL DE TRANSPLANT DE ORGANE, TESUTURI SI CELULE DE ORIGINE UMANA. P9.7 TRATAMENTUL STARII POSTTRANSPLANT IN AMBULATORIU A PACIENTILOR TRANSPLANTATI 1016 A05AA02 ACIDUM URSODEOXYCHOLICUM
A05AA02 ACIDUM URSODEOXYCHOLICUM
URSOCHOL 150 mg

COMPR.
150mg ZAMBON S.P.A.

150mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOFALK URSOSAN

CAPS.
250mg 250mg DR. FALK PHARMA GMBH PRO. MED. CS PRAHA AS

250mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

A05AA02 ACIDUM URSODEOXYCHOLICUM


URSOCHOL 300 mg

COMPR.
300mg ZAMBON S.P.A.

300mg

NOTA: Nu se va utiliza in tratamentul litiazei colestatice..

1017
EPREX 10000 UI

B03XA01

EPOETINUM ALFA **
SOL. INJ.
10000ui/ml JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA


EPOKINE 1000 UI/0,5 ml EPREX 1000 UI

10000ui/ml 1000UI/0.5ml
RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

SOL. INJ.
1000UI/0.5ml 1000ui/0.5ml 1000UI/ml 20000UI/ml

B03XA01 EPOETINUM ALFA


NEORECORMON 500UI

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD.

1000UI/ml 20000UI/ml 2000UI

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 2000 U.I.

SOL. INJ.
2000UI

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/0,5 ml EPREX 2000 UI

SOL. INJ.
2000UI/0.5ml 2000ui/0.5ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

2000ui/0.5ml

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/1 ml

SOL. INJ.
2000UI/1ml RENAMED FARMA S.R.L.

2000UI/1ml 3000ui/0.3ml
JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA


EPREX 3000 UI

SOL. INJ.
3000ui/0.3ml

B03XA01 EPOETINUM ALFA


EPREX 40 000 UI

SOL. INJ.
40 000UI JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 4000 U.I.

SOL. INJ.
4000UI

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/0,4 ml EPREX 4000 UI

SOL. INJ.
4000UI/0.4ml 4000ui/0.4ml RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

4000ui/0.4ml

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 50000UI/ml 10000UI/1,0ml 10000UI/1,0ml 10000UI/1,0ml 1000UI/0,5ml 1000UI/0,5ml 1000UI/0,5ml 2000UI/1,0ml 2000UI/1,0ml 2000UI/1,0ml 3000UI/0,3ml 3000UI/0,3ml 3000UI/0,3ml 4000UI/0,4ml 4000UI/0,4ml 4000UI/0,4ml 5000UI/0,5ml 5000UI/0,5ml 5000UI/0,5ml 6000UI/0,6ml 6000UI/0,6ml 6000UI/0,6ml 8000UI/0,8ml 8000UI/0,8ml 8000UI/0,8ml RENAMED FARMA S.R.L.

4000UI/1ml 50000UI/ml 10000UI/1,0ml

B03XA01 EPOETINUM ALFA


NEORECORMON MULTIDOZA 50 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD. MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

B03XA01 EPOETINUM ALFA


ABSEAMED 10000UI/1,0ml BINOCRIT 10000UI/1,0ml EPOETIN ALFA HEXAL 10000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA


ABSEAMED 1000UI/0,5ml BINOCRIT 1000UI/0,5ml EPOETIN ALFA HEXAL 1000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

1000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 2000UI/1,0ml BINOCRIT 2000UI/1,0ml EPOETIN ALFA HEXAL 2000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

2000UI/1,0ml

B03XA01 EPOETINUM ALFA


ABSEAMED 3000UI/0,3ml BINOCRIT 3000UI/0,3ml EPOETIN ALFA HEXAL 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

3000UI/0,3ml

B03XA01 EPOETINUM ALFA


ABSEAMED 4000UI/0,4ml BINOCRIT 4000UI/0,4ml EPOETIN ALFA HEXAL 4000UI/0,4ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

4000UI/0,4ml

B03XA01 EPOETINUM ALFA


ABSEAMED 5000UI/0,5ml BINOCRIT 5000UI/0,5ml EPOETIN ALFA HEXAL 5000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

5000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 6000UI/0,6ml BINOCRIT 6000UI/0,6ml EPOETIN ALFA HEXAL 6000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

6000UI/0,6ml

B03XA01 EPOETINUM ALFA


ABSEAMED 8000UI/0,8ml BINOCRIT 8000UI/0,8ml EPOETIN ALFA HEXAL 8000UI/0,8ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

8000UI/0,8ml

1018

B03XA01

EPOETINUM BETA **
LIOF. + SOLV. PT. SOL. INJ.
1000UI/ml 20000UI/ml ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON 500UI

1000UI/ml 20000UI/ml 50000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON MULTIDOZA 100 000UI/ml

LIOF. + SOLV. PT. SOL. INJ.


ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA

LIOF. + SOLV. PT. SOL. INJ.

208 / 233

DCI/DENUMIRE COMERCIALA
NEORECORMON MULTIDOZA 50 000UI/ml

CONCENTRATIE
50000UI/ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

FORMA FARM.
ROCHE REGISTRATION LTD.

FIRMA

PROTOCOL

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD.

10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/ml

LIOF. + SOLV. PT. SOL. INJ. IN CARTUS


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON 1000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 2000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 30000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 3000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 4000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 5000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 500UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 60000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 6000UI/0,3ml

1019
ARANESP 10g/0.4ml

B03XA02

DARBEPOETINUM ALFA **
SOL. INJ. IN STILOU INJECTOR PREUMPLUT
10g/0.4ml 100g/0.5ml 100g/ml 100g/ml 100g/ml 130g/0.65ml 15g/0.375ml 15g/ml 15g/ml 150g/0.3ml 20g/0.5ml 200g/ml 200g/ml 200g/ml 200g/ml 25g/ml 25g/ml 25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40g/ml 40g/ml 40g/ml 50g/0.5ml 500g/ml 500g/ml 500g/ml 500g/ml 60g/0.3ml 60g/ml 60g/ml AMGEN EUROPE BV

B03XA02 DARBEPOETINUM ALFA B03XA02 DARBEPOETINUM ALFA


ARANESP 100g/0.5ml

10g/0.4ml 100g/0.5ml 100g/ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


NESPO 30g NESPO 40g NESPO 50g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

B03XA02 DARBEPOETINUM ALFA


ARANESP 130g/0.65ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

130g/0.65ml 15g/0.375ml 15g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/0.375ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/ml NESPO 15g

SOL. INJ. IN FLACON

B03XA02 DARBEPOETINUM ALFA


ARANESP 150g/0.3ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

150g/0.3ml 20g/0.5ml 200g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 20g/0.5ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE DOMPE DOMPE DOMPE BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


NESPO 100g NESPO 130g NESPO 60g NESPO 80g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

B03XA02 DARBEPOETINUM ALFA


ARANESP 25g/ml NESPO 25g

SOL. INJ. IN FLACON


AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

25g/ml

B03XA02 DARBEPOETINUM ALFA


NESPO 10g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


DOMPE BIOTEC S.P.A.

25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 30g/0.3ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 300g/0.6ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT SOL. INJ. IN STILOU INJECTOR PREUMPLUT SOL. INJ. IN FLACON

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/0.4ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/ml NESPO 40g

B03XA02 DARBEPOETINUM ALFA


NESPO 15g NESPO 20g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

40g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 50g/0.5ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

50g/0.5ml 500g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 500g/ml NESPO 150g NESPO 300g NESPO 500g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 60g/0.3ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

60g/0.3ml 60g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 60g/ml NESPO 60g

SOL. INJ. IN FLACON


AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

209 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE
80g/0.4ml 10g/0.4ml 100g/0.5ml 100g/ml 100g/ml 100g/ml 130g/0.65ml 15g/0.375ml 150g/0.3ml 20g/0.5ml 200g/ml 200g/ml 200g/ml 200g/ml 25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40gml 50g/0.5ml 500g 500g/ml 500g/ml 500g/ml 60g/0.3ml 80g/0.4ml

FORMA FARM.
AMGEN EUROPE BV

FIRMA

PROTOCOL

B03XA02 DARBEPOETINUM ALFA


ARANESP 80g/0.4ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

80g/0.4ml 10g/0.4ml 100g/0.5ml 100g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 10g/0.4ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 100g/0.5ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


NESPO 30g NESPO 40g NESPO 50g

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA02 DARBEPOETINUM ALFA


ARANESP 130g/0.65ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

130g/0.65ml 15g/0.375ml 150g/0.3ml 20g/0.5ml 200g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/0.375ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV DOMPE DOMPE DOMPE DOMPE BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 150g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA02 DARBEPOETINUM ALFA


ARANESP 20g/0.5ml

B03XA02 DARBEPOETINUM ALFA


NESPO 100g NESPO 130g NESPO 60g NESPO 80g

B03XA02 DARBEPOETINUM ALFA


NESPO 10g

SOL. INJ. IN SERINGA PREUMPLUTA


DOMPE BIOTEC S.P.A.

25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40gml 50g/0.5ml 500g 500g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 30g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 300g/0.6ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/0.4ml

B03XA02 DARBEPOETINUM ALFA


NESPO 15g

B03XA02 DARBEPOETINUM ALFA


NESPO 20g

B03XA02 DARBEPOETINUM ALFA


ARANESP 50g/0.5ml

B03XA02 DARBEPOETINUM ALFA


NESPO 150g

B03XA02 DARBEPOETINUM ALFA


ARANESP 500g/ml NESPO 300g NESPO 500g

B03XA02 DARBEPOETINUM ALFA


ARANESP 60g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

60g/0.3ml 80g/0.4ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 80g/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

1021
LEMOD SOLU 125 mg

H02AB04

METHYLPREDNISOLONUM
LIOF. PT. SOL. INJ.
125mg 125mg/2ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM H02AB04 METHYLPREDNISOLONUM


SOLU - MEDROL ACT-O-VIAL

125mg 125mg/2ml 16mg

LIOF. SI SOLV.PT.SOL.INJ
PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL A 16 16mg 20mg

COMPR. LIOF. PT. SOL. INJ.


HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 20 mg

20mg 250mg/4ml 32mg

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
250mg/4ml PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 32 32mg 40mg

COMPR. LIOF. PT. SOL. INJ.


HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 40 mg

40mg 40mg/1ml 4mg

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL ACT-O-VIAL

LIOF. SI SOLV.PT.SOL.INJ
40mg/1ml PFIZER EUROPE MA EEIG PFIZER EUROPE MA EEIG

H02AB04 METHYLPREDNISOLONUM
MEDROL 4 mg 4mg

COMPR. LIOF. PT. SOL. INJ.


500mg 500mg/7.8ml HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM
LEMOD SOLU 500 mg

500mg 500mg/7.8ml

H02AB04 METHYLPREDNISOLONUM
SOLU - MEDROL 500 mg/7,8 ml

LIOF. + SOLV. PT. SOL. INJ.


PFIZER EUROPE MA EEIG

1022

H02AB07

PREDNISONUM
COMPR.
5mg 5mg 5mg 5mg 5mg MEDUMAN SA SINTOFARM SA ARENA GROUP SA GEDEON RICHTER ROMANIA SA MAGISTRA C & C

H02AB07 PREDNISONUM
N - PREDNISON PREDNISON 5 mg PREDNISON ARENA 5 mg PREDNISON GEDEON RICHTER 5 mg PREDNISON MAGISTRA 5 mg

5mg

1023
J01EE01

J01EE01
SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM
SUSP. ORALA 200mg/40mg /5ml

210 / 233

DCI/DENUMIRE COMERCIALA
EPITRIM

CONCENTRATIE
200mg/40mg /5ml

FORMA FARM.
E.I.P.I.CO. MED S.R.L.

FIRMA

PROTOCOL

Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.

J01EE01
SUMETROLIM

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SIROP
25mg/5mg/ml EGIS PHARMACEUTICALS P.L.C.

25mg/5mg/ml

J01EE01
BISEPTRIM CO - TRIM ELL SUMETROLIM TAGREMIN

COMPR.
400mg/80mg 400mg/80mg 400mg/80mg 400mg/80mg EUROPHARM SA ARENA GROUP S.A. EGIS PHARMACEUTICALS P.L.C. ZENTIVA S.A.

400mg/80mg

Exista un risc crescut de reactie adversa severa la administrarea acestui medicament la persoane in varsta.

J01EE01
SEPTRIN

SULFAMETHOXAZOLUM + TRIMETHOPRIMUM

SOL. PERF.
400mg/80mg THE WELLCOME FOUNDATION LTD.

400mg/80mg

1024

J02AC01

FLUCONAZOLUM
CAPS.
100mg 100mg 100mg 100mg 100mg 100mg 100mg KRKA D.D. OZONE LABORATORIES LTD. LINCOSA S.A. TEVA PHARMACEUTICALS SRL TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD

J02AC01 FLUCONAZOLUM
DIFLAZON 100 mg FLUCONAZOL 100 mg FLUCONAZOLE LINCOSA 100mg FLUCONAZOLE TEVA 100 mg FLUCORIC 100 mg FLUCOVIM 100 FUNGOLON 100 mg

100mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM
DIFLAZON 150 mg DIFLUCAN 150 mg FLUCONAZOL 150 mg FLUCONAZOL BIOGALENICA 150 mg FLUCONAZOL LAROPHARM 150 mg FLUCONAZOL MEDICO UNO 150 mg FLUCONAZOL MEDOCHEMIE 150 mg FLUCONAZOL SANDOZ 150 FLUCONAZOL TERAPIA 150 mg FLUCONAZOLE TEVA 150 mg FLUCONIMED 150 mg FLUCORIC 150 mg FLUCOVIM 150 MEDOFLUCON 150 mg MYCOMAX 150

CAPS.
150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg 150mg KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. LAROPHARM S.R.L. MEDICO UNO PHARMACEUTICAL SRL MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA SA TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL MEDOCHEMIE LTD. ZENTIVA AS

150mg

J02AC01 FLUCONAZOLUM
DIFLAZON 200 mg FLUCONAZOLE LINCOSA 200 mg FLUCONAZOLE TEVA 200 mg

CAPS.
200mg 200mg 200mg KRKA D.D. LICONSA S.A. TEVA PHARMACEUTICALS SRL

200mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM
DIFLAZON DIFLUCAN FLUCONAZOL BIOGALENICA 2mg/ml MYCOMAX INF

SOL. PERF.
2mg/ml 2mg/ml 2mg/ml 2mg/ml KRKA D.D. PFIZER EUROPE MA EEIG LABORATOARELE PROF.DR.MORAIT S.R.L. ZENTIVA AS

2mg/ml

J02AC01 FLUCONAZOLUM
DIFLAZON 50 mg DIFLUCAN 50 mg FLUCONAZOL 50 mg FLUCONAZOL BIOGALENICA 50 mg FLUCONAZOL MEDOCHEMIE 50 mg FLUCONAZOL SANDOZ 50 FLUCONAZOL TERAPIA 50 mg FLUCONAZOLE TEVA 50 mg FLUCONIMED 50 mg FLUCORIC 50 mg FLUCOVIM 50 FUNGOLON 50 mg MEDOFLUCON 50 mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg 50mg

CAPS.
KRKA D.D. PFIZER EUROPE MA EEIG ARENA GROUP SA LABORATOARELE PROF.DR.MORAIT S.R.L. MEDOCHEMIE ROMANIA SRL SANDOZ SRL TERAPIA S.A. TEVA PHARMACEUTICALS SRL STD CHEMICALS LTD. TERAPIA S.A. VIM SPECTRUM SRL BALKANPHARMA RAZGRAD AD MEDOCHEMIE LTD

50mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:
DIFLUCAN 50 mg/5 ml

Tratament de intretinere la pacienti cu meningita criptococica si imunosupresie Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul meningitei criptococice la pacientii care nu pot lua sau nu tolereaza amfotericina; Tratamentul candidozelor severe si care pun in pericol viata la pacienti care nu tolereaza amfotericina. Profilaxia secundara a candidozei orofaringiene la pacienti cu imunosupresie Tratamentul candidozei orofaringiene la pacienti cu imunosupresie

J02AC01 FLUCONAZOLUM

PULB. PT. SUSP. ORALA


50mg/5ml PFIZER EUROPE MA EEIG

50mg/5ml

1025

J02AC03

VORICONAZOLUM **

Protocol: J012B

211 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
PFIZER LTD.

FIRMA

PROTOCOL

J02AC03 VORICONAZOLUM
VFEND 200mg

COMPR. FILM.
200mg 50mg

200mg 50mg

J02AC03 VORICONAZOLUM
VFEND 50mg

COMPR. FILM.
PFIZER LTD.

1026

J02AC04

POSACONAZOLUM **
SUSP. ORALA
40mg/ml 40mg/ml SP EUROPE SP EUROPE

J02AC04 POSACONAZOLUM
NOXAFIL SP 40mg/ml POSACONAZOLE SP 40mg/ml

40mg/ml

NOTA: Profilaxia infectiilor fungice invazive la pacientii: (1) aflati sub chimioterapie de inductie-remisie pentru LAM sau pentru sindroame mielodisplazice si care prezinta risc inalt de a dezvolta infectii fungice masive; (2) Pacienti in procedura de transplant medular si aflati sub terapie imunosupresoare cu doze mari, cu risc mare de a dezvolta infectii fungice masive..

1027
J05AB01
ACICLOVIR 200 mg EUVIROX 200 mg

J05AB01
ACICLOVIRUM

ACICLOVIRUM
CAPS.
200mg 200mg ARENA GROUP SA EUROPHARM SA

200mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR.
200mg 200mg 200mg 200mg GEDEON RICHTER ROMANIA SA ALSIFCOM INTERMED SRL ANTIBIOTICE SA GLAXO WELLCOME FOUNDATION LTD.

200mg

ACICLOVIR 200 mg ALS-ACICLOVIR CLOVIRAL 200 mg ZOVIRAX

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01

ACICLOVIRUM

COMPR. DISP.
200mg 200mg OZONE LABORATORIES LTD. RANBAXY UK LIMITED

200mg

ACICLOVIR 200 mg LOVIR 200 mg

Prescriere limitata: Prescriere limitata: Prescriere limitata: Prescriere limitata:

Herpes genital initial moderat/sever. Tratamentul episodic sau supresiv al herpesului genital recurent (forme moderate/severe). Herpes labial initial moderat/sever. Tratamentul episodic sau supresiv al herpesului labial recurent (forme moderate/severe).

J05AB01
VIROLEX

ACICLOVIRUM ACICLOVIRUM

PULB. PT. SOL. INJ./PERF.


250mg KRKA D.D. NOVO MESTO

250mg 400mg

J05AB01

CAPS.
400mg ARENA GROUP S.A.

ACICLOVIR 400 mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

J05AB01

ACICLOVIRUM

COMPR.
400mg EGIS PHARMACEUTICALS P.L.C.

400mg

ACICLOVIR 400 mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

J05AB01
ACIKLOVIR

ACICLOVIRUM

COMPR. FILM.
400mg A & G MED TRADING S.R.L.

400mg

Prescriere limitata: Prescriere limitata:

Tratamentul pacientilor cu herpes zoster in primele 72 de ore de la debutul rash-ului. Herpes zoster oftalmic.

1028
J05AB14
VALCYTE 450 mg

J05AB14
VALGANCICLOVIRUM

VALGANCICLOVIRUM **
COMPR. FILM.
450mg ROCHE ROMANIA SRL

450mg

1029
J05AF05 J05AF05 J05AF05
EPIVIR 150mg ZEFFIX 100 mg

J05AF05
LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM LAMIVUDINUM

LAMIVUDINUM
COMPR. FILM.
100mg 10mg/ml 150mg 300mg 5mg/ml GLAXO GROUP LTD.

100mg 10mg/ml 150mg 300mg 5mg/ml

SOL. ORALA
GLAXO GROUP LTD. GLAXO GROUP LTD. GLAXO GROUP LTD. GLAXO GROUP LTD.

EPIVIR 10mg/ml

COMPR. FILM. COMPR. FILM. SOL. ORALA

J05AF05
EPIVIR 300mg

J05AF05

ZEFFIX 5 mg/ml

1030

L04AA01

CICLOSPORINUM
CAPS. MOI
100mg 100mg 100mg HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 100 mg EQUORAL 100 mg IMUSPORIN 100 mg

100mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL EQUORAL SANDIMMUN NEORAL

SOL. ORALA
100mg/ml 100mg/ml 100mg/ml HEXAL AG IVAX - PHARMACEUTICALS S.R.O. NOVARTIS PHARMA GMBH

100mg/ml

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 25 mg EQUORAL 25 mg IMUSPORIN 25 mg 25mg 25mg 25mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED

25mg

212 / 233

DCI/DENUMIRE COMERCIALA
SANDIMMUN NEORAL

CONCENTRATIE
25mg

FORMA FARM.
NOVARTIS PHARMA GMBH

FIRMA

PROTOCOL

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA01 CICLOSPORINUM
CICLORAL HEXAL 50 mg EQUORAL 50 mg IMUSPORIN 50 mg SANDIMMUN NEORAL 50mg 50mg 50mg 50mg

CAPS. MOI
HEXAL AG IVAX - PHARMACEUTICALS S.R.O. CIPLA (UK) LIMITED NOVARTIS PHARMA GMBH

50mg

Prescriere limitata: Managementul rejectului de grefa la pacientii supusi procedurii de transplant. Monitorizarea atent a pacienilor este obligatorie

1031
ADVAGRAF 0,5mg

L04AA05

TACROLIMUSUM **
CAPS. ELIB. PREL.
0,5mg ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM

0,5mg

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic. Monitorizarea atent a pacienilor este obligatorie

L04AA05 TACROLIMUSUM
PROGRAF 0,5 mg 0.5mg

CAPS.
ASTELLAS PHARMA GMBH

0.5mg

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic. Monitorizarea atent a pacienilor este obligatorie

L04AA05 TACROLIMUSUM
PROGRAF 1 mg 1mg

CAPS.
ASTELLAS IRELAND CO. LTD.

1mg

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic. Monitorizarea atent a pacienilor este obligatorie

L04AA05 TACROLIMUSUM
ADVAGRAF 1mg 1mg

CAPS. ELIB. PREL.


ASTELLAS PHARMA GMBH

1mg

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic. Monitorizarea atent a pacienilor este obligatorie

L04AA05 TACROLIMUSUM
PROGRAF 5 mg 5mg

CAPS.
ASTELLAS PHARMA GMBH

5mg

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic. Monitorizarea atent a pacienilor este obligatorie

L04AA05 TACROLIMUSUM
ADVAGRAF 5mg 5mg

CAPS. ELIB. PREL.


ASTELLAS PHARMA GMBH

5mg

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic. Monitorizarea atent a pacienilor este obligatorie

L04AA05 TACROLIMUSUM
PROGRAF 5 mg/ml

CONC. PT. SOL. PERF.


5mg/ml ASTELLAS PHARMA GMBH

5mg/ml

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant renal. Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant cardiac. Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu tacrolimus la pacientii cu transplant hepatic.

1032
MYFORTIC 180 mg

L04AA06
Prescriere limitata: Prescriere limitata: Prescriere limitata:

MYCOPHENOLATUM
COMPR. FILM. GASTROREZ.
180mg NOVARTIS PHARMA GMBH

L04AA06 MYCOPHENOLATUM

180mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal. Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac. Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic.

L04AA06 MYCOPHENOLATUM
CELLCEPT 1mg/5ml 1g/5ml

PULB. PT. SUSP. ORALA


ROCHE REGISTRATION LTD.

1g/5ml

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic. Monitorizarea atent a pacienilor este obligatorie

L04AA06 MYCOPHENOLATUM
CELLCEPT 250mg MICOFENOLAT MOFETIL TEVA MYFENAX 250mg

CAPS.
250mg 250mg 250mg ROCHE REGISTRATION LTD. TEVA PHARMA BV TEVA PHARMA BV

250mg

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic. Monitorizarea atent a pacienilor este obligatorie

L04AA06 MYCOPHENOLATUM
MYFORTIC 360 mg

COMPR. FILM. GASTROREZ.


360mg NOVARTIS PHARMA GMBH

360mg

Prescriere limitata: Prescriere limitata: Prescriere limitata:


MICOFENOLAT MOFETIL TEVA MYFENAX 500mg

Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal. Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac. Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic.

L04AA06 MYCOPHENOLATUM

CAPS.
500mg 500mg TEVA PHARMA BV TEVA PHARMA BV

500mg

213 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic. Monitorizarea atent a pacienilor este obligatorie

L04AA06 MYCOPHENOLATUM
CELLCEPT 500mg

COMPR. FILM.
500mg ROCHE REGISTRATION LTD.

500mg

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic. Monitorizarea atent a pacienilor este obligatorie

L04AA06 MYCOPHENOLATUM
CELLCEPT 500mg

PULB. PT. CONC. PT. SOL. PERF.


500mg ROCHE REGISTRATION LTD.

500mg

Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant renal. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant cardiac. Prescriere limitata: Terapie de mentinere consecutiva initierii si stabilizarii tratamentului cu mycophenolatum la pacientii cu transplant hepatic. Monitorizarea atent a pacienilor este obligatorie

1033
RAPAMUNE 1mg

L04AA10

SIROLIMUS **
COMPR. FILM.
1mg WYETH EUROPA LTD.

L04AA10 SIROLIMUS

1mg

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 1mg/ml

SOL. ORALA
1mg/ml WYETH EUROPA LTD.

1mg/ml

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 2mg 2mg

COMPR. FILM.
WYETH EUROPA LTD.

2mg

Prescriere limitata: Terapie de meninere, urmare a iniierii i stabilizarii tratamentului cu sirolimus. Monitorizarea si revizuirea terapiei va fi efectuata in uniti de transplant. Monitorizarea atent a pacienilor este obligatorie

L04AA10 SIROLIMUS
RAPAMUNE 5mg 5mg

COMPR. FILM.
WYETH EUROPA LTD.

5mg

1034
IMURAN

L04AX01

AZATHIOPRINUM *
COMPR. FILM.
50mg THE WELLCOME FOUNDATION LTD.

L04AX01 AZATHIOPRINUM

50mg

214 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C2-XV P10: PROGRAM NATIONAL DE SUPLEERE A FUNCTIEI RENALE LA BOLNAVII CU INSUFICIENTA RENALA CRONICA. 1035 A11CC03 ALFACALCIDOLUM
A11CC03 ALFACALCIDOLUM
ALPHA D3 0,25 g

Protocol: A007E

CAPS. MOI
0.25g TEVA PHARMACEUTICALS SRL

0.25g 0.50g
TEVA PHARMACEUTICALS S.R.L.

A11CC03 ALFACALCIDOLUM
ALPHA D3 0.50 g

CAPS. MOI
0.50g

A11CC03 ALFACALCIDOLUM
ALPHA D3 1 g 1g

CAPS. MOI
TEVA PHARMACEUTICALS SRL

1g

1036
OSTEO D 0,25 g ROCALTROL

A11CC04

CALCITRIOLUM **
CAPS. MOI
0.25g 0.25g TEVA PHARMACEUTICALS S.R.L. ROCHE ROMANIA S.R.L.

Protocol: A006E
0.25g

A11CC04 CALCITRIOLUM

A11CC04 CALCITRIOLUM
OSTEO D 0,50 g ROCALTROL

CAPS. MOI
0.50g 0.50g TEVA PHARMACEUTICALS S.R.L. F. HOFFMANN LA ROCHE LTD.

0.50g

1037
ZEMPLAR 1g

A11CC07

PARICALCITOLUM **
CAPS. MOI
1g ABBOTT LABORATORIES S.A.

Protocol: A005E
1g 2g
ABBOTT LABORATORIES S.A.

A11CC07 PARICALCITOLUM A11CC07 PARICALCITOLUM


ZEMPLAR 2g 2g

CAPS. MOI CAPS. MOI


4g ABBOTT LABORATORIES S.A.

A11CC07 PARICALCITOLUM
ZEMPLAR 4g

4g 5 g/ml
ABBOTT LABORATORIES S.A.

A11CC07 PARICALCITOLUM
ZEMPLAR

SOL. INJ.
5 g/ml

1038

B01AB01

HEPARINUM **
SOL. INJ.
5000ui/ml 5000ui/ml 5000ui/ml POLIPHARMA INDUSTRIES S.R.L. SANDOZ GMBH LAB. PANPHARMA

B01AB01 HEPARINUM
HEPARIN HEPARIN SANDOZ 25000 UI/5 ml HEPARINE SODIQUE PANPHARMA

5000ui/ml

1039
CLEXANE

B01AB05

ENOXAPARINUM **
SOL. INJ.
100mg/ml LAB. AVENTIS

B01AB05 ENOXAPARINUM B01AB05 ENOXAPARINUM


CLEXANE 2000ui anti-Xa/0.2ml

100mg/ml 2000ui anti-Xa/0.2ml


LAB. AVENTIS

SOL. INJ.
2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

B01AB05 ENOXAPARINUM
CLEXANE 8000ui anti-Xa/0.8ml

SOL. INJ.
8000ui anti-Xa/0.8ml LAB. AVENTIS

8000ui anti-Xa/0.8ml

B01AB05 ENOXAPARINUM
CLEXANE 2000ui anti-Xa/0.2ml

SOL. INJ.
2000ui anti-Xa/0.2ml LAB. AVENTIS

2000ui anti-Xa/0.2ml

B01AB05 ENOXAPARINUM
CLEXANE 4000ui anti-Xa/0.4ml

SOL. INJ.
4000ui anti-Xa/0,4ml LAB. AVENTIS

4000ui anti-Xa/0,4ml

B01AB05 ENOXAPARINUM
CLEXANE 6000ui anti-Xa/0.6ml

SOL. INJ.
6000ui anti-Xa/0.6ml LAB. AVENTIS

6000ui anti-Xa/0.6ml

1040

B01AB06

NADROPARINUM **
SOL. INJ.
11400 uiAXa/0.6ml GLAXO GROUP LTD.

B01AB06 NADROPARINUM
FRAXODI 11400 UI anti-factor Xa/0,6ml

11400 uiAXa/0.6ml 15200 uiAXa/0.8ml


GLAXO GROUP LTD.

B01AB06 NADROPARINUM
FRAXODI 15200 UI anti-factor Xa/0,8ml

SOL. INJ.
15200 uiAXa/0.8ml

B01AB06 NADROPARINUM
FRAXODI 19000 UI anti-factor Xa/1 ml

SOL. INJ.
19000 uiAXa/ml GLAXO GROUP LTD.

19000 uiAXa/ml 2850 ui AFXa/0.3ml


GLAXO GROUP LTD.

B01AB06 NADROPARINUM
FRAXIPARINE 2850 UI anti-factor Xa/0,3 ml

SOL. INJ.
2850 ui AFXa/0.3ml

B01AB06 NADROPARINUM
FRAXIPARINE 3800 UI anti-factor Xa/0,4 ml

SOL. INJ.
3800 ui AFXa/0.4ml GLAXO GROUP LTD.

3800 ui AFXa/0.4ml

215 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

B01AB06 NADROPARINUM
FRAXIPARINE 5700 UI anti-factor Xa/0,6 ml

SOL. INJ.
5700 ui AFXa/0.6ml GLAXO GROUP LTD.

5700 ui AFXa/0.6ml 7600 ui AXa/0.8ml


GLAXO GROUP LTD.

B01AB06 NADROPARINUM
FRAXIPARINE 7600 UI anti-factor Xa/0,8 ml

SOL. INJ.
7600 ui AXa/0.8ml

1041

B01AB08

REVIPARINUM **
SOL. INJ.
1432ui/0.25ml 1432ui/0.25ml ABBOTT GMBH&CO.KG ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN 1432UI/0,25 ml CLIVARIN -PEN

1432ui/0.25ml

B01AB08 REVIPARINUM
CLIVARIN 3436 UI/0,6 ml

SOL. INJ.
3436ui/0.6ml ABBOTT GMBH&CO.KG

3436ui/0.6ml 5726ui/ml
ABBOTT GMBH&CO.KG

B01AB08 REVIPARINUM
CLIVARIN - multi

SOL. INJ.
5726ui/ml

1042

B01AB10

TINZAPARINUM **
SOL. INJ.
10000u ANTIF. Xa/ml LEO PHARMACEUTICAL PRODUCTS

B01AB10 TINZAPARINUM
INNOHEP

10000u ANTIF. Xa/ml

B01AB10 TINZAPARINUM
INNOHEP

SOL. INJ.
20000u ANTIF. Xa/ml LEO PHARMACEUTICAL PRODUCTS

20000u ANTIF. Xa/ml

1043

B03AC02

COMPLEX DE HIDROXID DE FER (III) SUCROZA


SOL. INJ./PERF.
20mg/ml VIFOR FRANCE S.A.

Protocol: A010N
20mg/ml

B03AC02 COMPLEX DE HIDROXID DE FER (III) SUCROZA


VENOFER

Cod restrictie 2070:

Anemie feripriv, la pacieni hemodializai cronic care au prezenta o reacie de hipersensibilitate documentat la fier polimaltozat i la care este indicat administrarea continu intravenoas.

1044
EPREX 10000 UI

B03XA01

EPOETINUM ALFA **
SOL. INJ.
10000ui/ml 1000ui/0.5ml 1000UI/0,5ml 1000UI/0.5ml 2000UI/0.5ml JOHNSON & JOHNSON D.O.O.

Protocol: B010N
10000ui/ml 1000UI/0,3ml 1000UI/0,5ml

B03XA01 EPOETINUM ALFA B03XA01 EPOETINUM ALFA


EPREX 1000 UI

SOL. INJ. IN SERINGA PREUMPLUTA


JOHNSON & JOHNSON D.O.O. SANDOZ GMBH RENAMED FARMA S.R.L.

B03XA01 EPOETINUM ALFA


BINOCRIT 1000UI/0,5ml EPOKINE 1000 UI/0,5 ml

SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM ALFA


EPOKINE 2000 UI/0,5 ml

SOL. INJ. IN SERINGA PREUMPLUTA


RENAMED FARMA S.R.L.

20000UI/0,5ml 2000UI

B03XA01 EPOETINUM ALFA


EPOPHAR 2000 U.I. EPREX 2000 UI

SOL. INJ.
2000UI 2000ui/0.5ml 2000UI/1,0ml 2000UI/1ml 3000UI/0,3ml GULF PHARMACEUTICAL IND. S.R.L. JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA


BINOCRIT 2000UI/1,0ml EPOKINE 2000 UI/1 ml

SOL. INJ. IN SERINGA PREUMPLUTA


SANDOZ GMBH RENAMED FARMA S.R.L.

2000UI/1,0ml

B03XA01 EPOETINUM ALFA


BINOCRIT 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


SANDOZ GMBH

3000UI/0,3ml 3000ui/0.3ml

B03XA01 EPOETINUM ALFA


EPREX 3000 UI

SOL. INJ.
3000ui/0.3ml JOHNSON & JOHNSON D.O.O.

B03XA01 EPOETINUM ALFA


EPREX 40 000 UI

SOL. INJ.
40 000UI JOHNSON & JOHNSON D.O.O.

40 000UI 4000UI
GULF PHARMACEUTICAL IND. S.R.L.

B03XA01 EPOETINUM ALFA


EPOPHAR 4000 U.I.

SOL. INJ.
4000UI 4000UI/0,4ml 4000UI/0.4ml 4000ui/0.4ml

B03XA01 EPOETINUM ALFA


BINOCRIT 4000UI/0,4ml EPOKINE 4000 UI/0,4 ml EPREX 4000 UI

SOL. INJ. IN SERINGA PREUMPLUTA


SANDOZ GMBH RENAMED FARMA S.R.L. JOHNSON & JOHNSON D.O.O.

4000UI/0,4ml

B03XA01 EPOETINUM ALFA


EPOKINE 4000 UI/1 ml

SOL. INJ.
4000UI/1ml 10000UI/1,0ml 10000UI/1,0ml 10000UI/1,0ml 1000UI/0,5ml 1000UI/0,5ml 1000UI/0,5ml 2000UI/1,0ml 2000UI/1,0ml 2000UI/1,0ml 3000UI/0,3ml 3000UI/0,3ml 3000UI/0,3ml 4000UI/0,4ml 4000UI/0,4ml 4000UI/0,4ml 5000UI/0,5ml RENAMED FARMA S.R.L.

4000UI/1ml 10000UI/1,0ml

B03XA01 EPOETINUM ALFA


ABSEAMED 10000UI/1,0ml BINOCRIT 10000UI/1,0ml EPOETIN ALFA HEXAL 10000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

B03XA01 EPOETINUM ALFA


ABSEAMED 1000UI/0,5ml BINOCRIT 1000UI/0,5ml EPOETIN ALFA HEXAL 1000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

1000UI/0,5ml

B03XA01 EPOETINUM ALFA


ABSEAMED 2000UI/1,0ml BINOCRIT 2000UI/1,0ml EPOETIN ALFA HEXAL 2000UI/1,0ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

2000UI/1,0ml

B03XA01 EPOETINUM ALFA


ABSEAMED 3000UI/0,3ml BINOCRIT 3000UI/0,3ml EPOETIN ALFA HEXAL 3000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

3000UI/0,3ml

B03XA01 EPOETINUM ALFA


ABSEAMED 4000UI/0,4ml BINOCRIT 4000UI/0,4ml EPOETIN ALFA HEXAL 4000UI/0,4ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

4000UI/0,4ml

B03XA01 EPOETINUM ALFA


ABSEAMED 5000UI/0,5ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG

5000UI/0,5ml

216 / 233

DCI/DENUMIRE COMERCIALA
BINOCRIT 5000UI/0,5ml EPOETIN ALFA HEXAL 5000UI/0,5ml

CONCENTRATIE
5000UI/0,5ml 5000UI/0,5ml 6000UI/0,6ml 6000UI/0,6ml 6000UI/0,6ml 8000UI/0,8ml 8000UI/0,8ml 8000UI/0,8ml

FORMA FARM.

FIRMA

PROTOCOL

SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

B03XA01 EPOETINUM ALFA


ABSEAMED 6000UI/0,6ml BINOCRIT 6000UI/0,6ml EPOETIN ALFA HEXAL 6000UI/0,6ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

6000UI/0,6ml

B03XA01 EPOETINUM ALFA


ABSEAMED 8000UI/0,8ml BINOCRIT 8000UI/0,8ml EPOETIN ALFA HEXAL 8000UI/0,8ml

SOL. INJ. IN SERINGA PREUMPLUTA


MEDICE ARZNEIMITTEL PUTTER GMBH & CO KG SANDOZ GMBH HEXAL BIOTECH FORSCHUNGS GMBH

8000UI/0,8ml

1045

B03XA01

EPOETINUM BETA **
SOL. INJ. IN SERINGA PREUMPLUTA
10000UI/0,6ml 1000UI/0,3ml 2000UI/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml ROCHE REGISTRATION LTD.

Protocol: B009N
10000UI/0,6ml 1000UI/0,3ml 2000UI/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 10000UI/0,6ml 10000UI/ml 1000UI/0,3ml 20000UI/0,6ml 20000UI/ml 2000UI/0,3ml 30000 UI/0,6ml 3000I/0,3ml 4000UI/0,3ml 5000UI/0,3ml 500UI/0,3ml 60000UI/ml 6000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 1000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA


ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD. ROCHE REGISTRATION LTD.

B03XA01 EPOETINUM BETA


NEORECORMON 2000UI/0,3ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA LIOF. + SOLV. PT. SOL. INJ. IN CARTUS SOL. INJ. IN SERINGA PREUMPLUTA

B03XA01 EPOETINUM BETA


NEORECORMON 4000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 5000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 500UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 10000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 1000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 20000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 2000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 30000UI/0,6ml

B03XA01 EPOETINUM BETA


NEORECORMON 3000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 4000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 5000UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 500UI/0,3ml

B03XA01 EPOETINUM BETA


NEORECORMON 60000UI/ml

B03XA01 EPOETINUM BETA


NEORECORMON 6000UI/0,3ml

1046
ARANESP 10g/0.4ml

B03XA02

DARBEPOETINUM ALFA **
SOL. INJ. IN STILOU INJECTOR PREUMPLUT
10g/0.4ml 100g/0.5ml 100g/ml 100g/ml 100g/ml 130g/0.65ml 15g/0.375ml 15g/ml 15g/ml 150g/0.3ml 20g/0.5ml 200g/ml 200g/ml 200g/ml 200g/ml 25g/ml 25g/ml 25g/ml AMGEN EUROPE BV

Protocol: B011N
10g/0.4ml 100g/0.5ml 100g/ml

B03XA02 DARBEPOETINUM ALFA B03XA02 DARBEPOETINUM ALFA


ARANESP 100g/0.5ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


NESPO 30g NESPO 40g NESPO 50g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

B03XA02 DARBEPOETINUM ALFA


ARANESP 130g/0.65ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

130g/0.65ml 15g/0.375ml 15g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/0.375ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/ml NESPO 15g

SOL. INJ. IN FLACON

B03XA02 DARBEPOETINUM ALFA


ARANESP 150g/0.3ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

150g/0.3ml 20g/0.5ml 200g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 20g/0.5ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE DOMPE DOMPE DOMPE BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


NESPO 100g NESPO 130g NESPO 60g NESPO 80g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

B03XA02 DARBEPOETINUM ALFA


ARANESP 25g/ml NESPO 25g

SOL. INJ. IN FLACON


AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

25g/ml

B03XA02 DARBEPOETINUM ALFA


NESPO 10g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


DOMPE BIOTEC S.P.A.

25g/ml 30g/0.3ml

B03XA02 DARBEPOETINUM ALFA

SOL. INJ. IN STILOU INJECTOR PREUMPLUT

217 / 233

DCI/DENUMIRE COMERCIALA
ARANESP 30g/0.3ml

CONCENTRATIE
30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40g/ml 40g/ml 40g/ml 50g/0.5ml 500g/ml 500g/ml 500g/ml 500g/ml 60g/0.3ml 60g/ml 60g/ml 80g/0.4ml 10g/0.4ml 100g/0.5ml 100g/ml 100g/ml 100g/ml 130g/0.65ml 15g/0.375ml 150g/0.3ml 20g/0.5ml 200g/ml 200g/ml 200g/ml 200g/ml 25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40gml 50g/0.5ml 500g 500g/ml 500g/ml 500g/ml 60g/0.3ml 80g/0.4ml

FORMA FARM.
AMGEN EUROPE BV

FIRMA

PROTOCOL

B03XA02 DARBEPOETINUM ALFA


ARANESP 300g/0.6ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

300g/0.6ml 40g/0.4ml 40g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/0.4ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/ml NESPO 40g

SOL. INJ. IN FLACON

B03XA02 DARBEPOETINUM ALFA


NESPO 15g NESPO 20g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

40g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 50g/0.5ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

50g/0.5ml 500g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 500g/ml NESPO 150g NESPO 300g NESPO 500g

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 60g/0.3ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

60g/0.3ml 60g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 60g/ml NESPO 60g

SOL. INJ. IN FLACON


AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 80g/0.4ml

SOL. INJ. IN STILOU INJECTOR PREUMPLUT


AMGEN EUROPE BV

80g/0.4ml 10g/0.4ml 100g/0.5ml 100g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 10g/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 100g/0.5ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA02 DARBEPOETINUM ALFA


NESPO 30g NESPO 40g NESPO 50g

B03XA02 DARBEPOETINUM ALFA


ARANESP 130g/0.65ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

130g/0.65ml 15g/0.375ml 150g/0.3ml 20g/0.5ml 200g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 15g/0.375ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV DOMPE DOMPE DOMPE DOMPE BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A. BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 150g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA

B03XA02 DARBEPOETINUM ALFA


ARANESP 20g/0.5ml

B03XA02 DARBEPOETINUM ALFA


NESPO 100g NESPO 130g NESPO 60g NESPO 80g

B03XA02 DARBEPOETINUM ALFA


NESPO 10g

SOL. INJ. IN SERINGA PREUMPLUTA


DOMPE BIOTEC S.P.A.

25g/ml 30g/0.3ml 300g/0.6ml 40g/0.4ml 40g/ml 40gml 50g/0.5ml 500g 500g/ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 30g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV AMGEN EUROPE BV AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A. AMGEN EUROPE BV DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 300g/0.6ml

SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA SOL. INJ. IN SERINGA PREUMPLUTA
AMGEN EUROPE BV DOMPE BIOTEC S.P.A. DOMPE BIOTEC S.P.A.

B03XA02 DARBEPOETINUM ALFA


ARANESP 40g/0.4ml

B03XA02 DARBEPOETINUM ALFA


NESPO 15g

B03XA02 DARBEPOETINUM ALFA


NESPO 20g

B03XA02 DARBEPOETINUM ALFA


ARANESP 50g/0.5ml

B03XA02 DARBEPOETINUM ALFA


NESPO 150g

B03XA02 DARBEPOETINUM ALFA


ARANESP 500g/ml NESPO 300g NESPO 500g

B03XA02 DARBEPOETINUM ALFA


ARANESP 60g/0.3ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

60g/0.3ml 80g/0.4ml

B03XA02 DARBEPOETINUM ALFA


ARANESP 80g/0.4ml

SOL. INJ. IN SERINGA PREUMPLUTA


AMGEN EUROPE BV

1048
B05DB B05DB

B05DB
COMBINATII

COMBINATII
SOL. DIAL. PERIT.
1.5% 2.5% 2.5% PAOLO GOBBI FRATTINI

1.5% 2.5%

CAPD PERILINE 1,5% F 100

COMBINATII

SOL. DIAL. PERIT.


PAOLO GOBBI FRATTINI PAOLO GOBBI FRATTINI

CAPD PERILINE 2,5% F 200 CAPD PERILINE 4% F 400

B05DB

COMBINATII

SOL. DIAL. PERIT.


FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH

BALANCE 1,5% GLUCOZA, 1,75 mmol/l calciu BALANCE 2,3% GLUCOZA, 1,75 mmol/l calciu BALANCE 4,25% GLUCOZA, 1,75 mmol/l calciu BICAVERA 1,5% glucose

218 / 233

DCI/DENUMIRE COMERCIALA
BICAVERA 2,3% glucose BICAVERA 4,25% glucose CAPD/DPCA 2 CAPD/DPCA 2 A.N.D.Y.-PLUS CAPD/DPCA 2 SLEEP SAFE CAPD/DPCA 2 STAY SAFE CAPD/DPCA 3 CAPD/DPCA 3 A.N.D.Y.-PLUS CAPD/DPCA 3 SLEEP SAFE CAPD/DPCA 3 STAY SAFE CAPD/DPCA 4 CAPD/DPCA 4 A.N.D.Y.-PLUS CAPD/DPCA 4 SLEEP SAFE CAPD/DPCA 4 STAY SAFE DIANEAL PD4 GLUCOSE 1,36% m/v (13,6 mg/ml) DIANEAL PD4 GLUCOSE 2,27% m/v (22,7 mg/ml) DIANEAL PD4 GLUCOSE 3,86% m/v (38,6 mg/ml) NUTRINEAL PD4 CU 1,1% aminoacizi PHYSIONEAL 40 GLUCOZA 1,36% PHYSIONEAL 40 GLUCOZA 2,27% PHYSIONEAL 40 GLUCOZA 3,86%

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH BAXTER HEALTH CARE SA BAXTER HEALTH CARE SA BAXTER HEALTH CARE SA BAXTER D.O.O. BAXTER HEALTH CARE SA BAXTER HEALTH CARE SA BAXTER HEALTH CARE SA

B05DB

COMBINATII

SOL.PT.DIALIZA PERITONEALA
GAMBRO LUNDIA AB GAMBRO LUNDIA AB

GAMBROSOL TRIO 10 GAMBROSOL TRIO 40

1049
RENAGEL 400mg

V03AE02

SEVELAMER **
COMPR. FILM.
400mg GENZYME EUROPE BV

Protocol: V003D
400mg 403mg
GENZYME EUROPE BV

V03AE02 SEVELAMER V03AE02 SEVELAMER


RENAGEL 403mg

CAPS.
403mg 800mg

V03AE02 SEVELAMER
RENAGEL 800mg

COMPR. FILM.
GENZYME EUROPE BV

800mg

1050
MIMPARA 30 mg PARAREG 30mg

H05BX01

CINACALCETUM ****
COMPR. FILM.
30mg 30mg 60mg 60mg 90mg 90mg AMGEN EUROPE B.V. DOMPE BIOTEC SPA

Protocol: H003N
30mg

H05BX01 CINACALCETUM

H05BX01 CINACALCETUM
MIMPARA 60 mg PARAREG 60mg

COMPR. FILM.
AMGEN EUROPE B.V. DOMPE BIOTEC SPA

60mg

H05BX01 CINACALCETUM
MIMPARA 90 mg PARAREG 90mg

COMPR. FILM.
AMGEN EUROPE B.V. DOMPE BIOTEC SPA

90mg

SUBLISTA C2-XVI P11: PROGRAM NATIONAL DE SANATATE MINTALA. SUBPROGRAMUL TRATAMENTUL TOXICODEPENDENTELOR 1051 N07BB04 NALTREXONUM
N07BB04 NALTREXONUM
REVIA 50mg

COMPR. FILM.
TORREX CHIESI PHARMA GMBH

50mg

Naltrexone hydrochloride este contraindicata la pacientii tratati cu medicamente opioide

1052
SINTALGON 2,5 mg

N07BC02
Risc inalt de aparitie a dependentei

METHADONUM
COMPR.
2.5mg ZENTIVA S.A.

N07BC02 METHADONUM

2.5mg

N07BC02 METHADONUM
SUBSTIDON 20 mg 20mg

COMPR.
BIO EEL SRL

20mg

Risc inalt de aparitie a dependentei

N07BC02 METHADONUM
SUBSTIDON 5 mg 5mg

COMPR.
BIO EEL SRL

5mg

Risc inalt de aparitie a dependentei

1053

N07BC51

COMBINATII ( BUPRENORPHINUM + NALAXONE)


COMPR. SUBLING.
2mg/0,5mg SP EUROPE

N07BC51 COMBINATII ( BUPRENORPHINUM + NALAXONE)


SUBOXONE 2mg/0,5mg

2mg/0,5mg

Prescriere limitata:

Tratamentul dependentei de opioide in cadrul terapiei medicale, sociale si psihologice

N07BC51 COMBINATII ( BUPRENORPHINUM + NALAXONE)


SUBOXONE 8mg/2mg

COMPR. SUBLING.
8mg/2mg SP EUROPE

8mg/2mg

Prescriere limitata:

Tratamentul dependentei de opioide in cadrul terapiei medicale, sociale si psihologice

219 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

SUBLISTA C3 - DCI-URI CORESPUNZTOARE MEDICAMENTELOR DE CARE BENEFICIAZ COPIII PAN LA 18 ANI, TINERII DE LA 18 LA 26 ANI DACA SUNT ELEVI, UCENICI SAU STUDENTI DAC NU REALIZEAZ VENITURI PRECUM SI GRAVIDE SI LEHUZE, IN TRATAMENTUL AMBULATORIU IN REGIM DE COMPENSARE 100% DIN PRETUL DE REFERINT. 1054 A01AA01 NATRII FLUORIDUM
A01AA01 NATRII FLUORIDUM
ZYMAFLUOR 1/4 mg

COMPR.
0.25mg NOVARTIS CONSUMER HEALTH GMBH

0.25mg 1mg
NOVARTIS CONSUMER HEALTH GMBH

A01AA01 NATRII FLUORIDUM


ZYMAFLUOR 1 mg 1mg

COMPR.

1055
METROGENE 4,5 mg

A01AB17

METRONIDAZOLUM
BURETE DENTAR
4.5mg LAB. SEPTODONT

A01AB17 METRONIDAZOLUM A01AB17 METRONIDAZOLUM


GRINAZOLE

4.5mg

PASTA
LAB. SEPTODONT

1056
NO - SPA 40 mg SPASMOCALM

A03AD02

DROTAVERINUM
COMPR.
40mg 40mg

A03AD02 DROTAVERINUM

40mg
CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS CO. LTD MAGISTRA C & C

A03AD02 DROTAVERINUM
NO - SPA 40 mg/2 ml

SOL. INJ.
40mg/2ml CHINOIN PRIVATE CO. LTD.

40mg/2ml 80mg
CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS CO. LTD

A03AD02 DROTAVERINUM
NO - SPA FORTE 80 mg 80mg

COMPR.

1057

A03BA01

ATROPINUM
SOL. INJ.
1mg/ml ZENTIVA S.A.

A03BA01 ATROPINUM
SULFAT DE ATROPINA

1mg/ml

1058
BUSCOREM 10 mg BUSCOTIL 10 mg SCOBUNORD 10 mg SCOBUTIL 10 mg SCOPANTIL 10 mg

A03BB01

BUTYLSCOPOLAMMONII BROMIDUM
COMPR.
10mg 10mg 10mg 10mg 10mg REMEDIA SRL ARENA GROUP SA MEDUMAN SA ZENTIVA SA ANTIBIOTICE SA

A03BB01 BUTYLSCOPOLAMMONII BROMIDUM

10mg

A03BB01 BUTYLSCOPOLAMMONII BROMIDUM


BUSCOPAN 10mg

DRAJ.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

10mg 10mg
ANTIBIOTICE SA SINTOFARM SA

A03BB01 BUTYLSCOPOLAMMONII BROMIDUM


SCOPANTIL 10 mg USCOSIN 10 mg 10mg 10mg

SUPOZ.

A03BB01 BUTYLSCOPOLAMMONII BROMIDUM


SCOBUTIL 10 mg/ml

SOL. INJ.
10mg/ml ZENTIVA SA

10mg/ml 20mg/ml
BOEHRINGER INGELHEIM INT. GMBH PHARCO IMPEX 93 S.R.L.

A03BB01 BUTYLSCOPOLAMMONII BROMIDUM


BUSCOPAN 20 mg/ml FARCORELAXIN

SOL. INJ.
20mg/ml 20mg/ml

1059

A03DA02

COMBINATII
COMPR.
ZENTIVA SA ANTIBIOTICE SA

A03DA02 COMBINATII
ALGIFEN COMPRIMATE PIAFEN

A03DA02 COMBINATII
ALGIFEN SOLUTIE INJECTABILA

SOL. INJ.
ZENTIVA SA

A03DA02 COMBINATII
PIAFEN

SUPOZ.
ANTIBIOTICE SA

1060
ASPATOFORT

A05BAN3

COMBINATII
SOL. INJ.
TERAPIA SA

A05BAN3 COMBINATII

1061
ENDOFALK

A06AD65

COMBINATII
PULB. PT. SOL. ORALA
DR. FALK PHARMA GMBH

A06AD65 COMBINATII

1062
ERCEFURYL 200 mg

A07AX03

NIFUROXAZIDUM
CAPS.
200mg SANOFI-SYNTHELABO OTC

A07AX03 NIFUROXAZIDUM

200mg

1063
VITAMINA A

A11CA01

RETINOLUM
PIC. ORALE, SOL.
1500000ui/g BIOFARM SA

A11CA01 RETINOLUM A11CA01 RETINOLUM


VITAMIN A 50000 ui

1500000ui/g 50000ui

CAPS.
50000ui PHARCO IMPEX 93 S.R.L.

A11CA01 RETINOLUM
VITAMINA A FORTE

CAPS. MOI
50000ui BIOFARM SA

50000ui

1064
TACHYSTIN

A11CC02

DIHYDROTACHYSTEROLUM
PICATURI ORALE-SOL.
0.1mg/ml 1mg/ml CHAUVIN ANKERPHARM GMBH

A11CC02 DIHYDROTACHYSTEROLUM A11CC02 DIHYDROTACHYSTEROLUM


A.T. 10

0.1mg/ml 1mg/ml

PICATURI ORALE-SOL.
MERCK KGAA

1065
OSTEO D 0,25 g ROCALTROL

A11CC04

CALCITRIOLUM
CAPS. MOI
0.25g 0.25g TEVA PHARMACEUTICALS S.R.L. ROCHE ROMANIA S.R.L.

A11CC04 CALCITRIOLUM

0.25g

Cod restrictie 1166: Cod restrictie 1167: Cod restrictie 1467:

Hipoparatiroidism Rahitism hipofosfatemic Rahitism rezistent la vitamina D

A11CC04 CALCITRIOLUM

CAPS. MOI

0.50g

220 / 233

DCI/DENUMIRE COMERCIALA
OSTEO D 0,50 g ROCALTROL

CONCENTRATIE
0.50g 0.50g

FORMA FARM.
TEVA PHARMACEUTICALS S.R.L. F. HOFFMANN LA ROCHE LTD.

FIRMA

PROTOCOL

Cod restrictie 1166: Cod restrictie 1167: Cod restrictie 1467:

Hipoparatiroidism Rahitism hipofosfatemic Rahitism rezistent la vitamina D

1066
VITAMINA D3

A11CC05

COLECALCIFEROLUM
PIC. ORALE, SOL.
0,45mg/ml 0.5mg/ml BIOFARM S.A.

A11CC05 COLECALCIFEROLUM A11CC05 COLECALCIFEROLUM


VIGANTOL OIL

0,45mg/ml 0.5mg/ml 1000UI

PIC. ORALE, SOL.


MERCK KGAA MERCK KGAA

A11CC05 COLECALCIFEROLUM
VIGANTOLETTEN 1000

COMPR.
1000UI

A11CC05 COLECALCIFEROLUM
VIGANTOLETTEN 500 500UI

COMPR.
MERCK KGAA

500UI

1067

A11CC20

COMBINATII
COMPR.
MERCK KGAA MERCK KGAA

A11CC20 COMBINATII
FLUOR VIGANTOLETTEN 1000 FLUOR VIGANTOLETTEN 500

1068

A11DA01

THIAMINUM
SOL. INJ.
100mg/2ml ZENTIVA SA

A11DA01 THIAMINUM
SICOVIT B1 100 mg/2 ml

100mg/2ml 10mg
ZENTIVA SA

A11DA01 THIAMINUM
SICOVIT B1 10 mg 10mg

COMPR.

1069
BENFOGAMMA

A11DA03

BENFOTIAMINUM
DRAJ.
50mg WORWAG PHARMA GMBH & CO. KG

A11DA03 BENFOTIAMINUM

50mg

1070
MILGAMMA N

A11DBN1

COMBINATII
CAPS. MOI
WORWAG PHARMA GMBH & CO. KG

A11DBN1 COMBINATII A11DBN1 COMBINATII


MILGAMMA 100

DRAJ.
WORWAG PHARMA GMBH & CO. KG

A11DBN1 COMBINATII
MILGAMMA N MILGAMMA NA

SOL. INJ.
WORWAG PHARMA GMBH & CO. KG WORWAG PHARMA GMBH & CO. KG

1071
NEUROMULTIVIT

A11DBN2

COMBINATII
COMPR. FILM.
LANNACHER HEILMITTEL GMBH

A11DBN2 COMBINATII

1072

A11GA01

ACIDUM ASCORBICUM
COMPR. EFF.
1000mg 1000mg 1000mg 1000mg 1g DR.B.SCHEFELER GMBH & CO KG MERCK SELBSTMEDICATION GMBH MERCK SELBSTMEDICATION GMBH BAYER S.R.L.

A11GA01 ACIDUM ASCORBICUM


ADDITIVA VITAMIN C CEBION 1g BLUTORANGE CEBION 1g CITRUS REDOXON

1000mg

A11GA01 ACIDUM ASCORBICUM


UPSAVIT VITAMIN C

COMPR. EFF.
BRISTOL MYERS SQUIBB KFT

1g 1g/plic

A11GA01 ACIDUM ASCORBICUM


VITAMIN C EFF. INSTANT 1g/plic

PULB. EFF.
SEDICO IMPEX S.R.L.

A11GA01 ACIDUM ASCORBICUM


VITAMINA C 250 mg

COMPR. MAST.
250mg 500mg 500mg 500mg 500mg 500mg PHARMEX ROM IND.

250mg 500mg

A11GA01 ACIDUM ASCORBICUM


CEBION RETARD 500 CETEBE

CAPS. ELIB. PREL.


MERCK SELBSTMEDICATION GMBH GLAXOSMITHKLINE CONSUMER HEALTHCARE

A11GA01 ACIDUM ASCORBICUM


SICOVIT C 500 mg MANDARINE SICOVIT C 500 mg PORTOCALE ROSII

COMPR. EFF.
ZENTIVA A.S. ZENTIVA A.S.

500mg

A11GA01 ACIDUM ASCORBICUM


VITAMINA C 500 mg

COMPR. MAST.
PHARMEX ROM IND.

500mg 750mg

A11GA01 ACIDUM ASCORBICUM


VITAMINA C ARENA 750 mg

SOL. INJ.
750mg ARENA GROUP S.A.

1073
VITAMINA B6 250 mg

A11HA02

PYRIDOXINUM
COMPR.
250 mg ARENA GROUP SA

A11HA02 PYRIDOXINUM A11HA02 PYRIDOXINUM


SICOVIT B6 250 mg

250 mg 250mg
ZENTIVA SA

COMPR.
250mg

A11HA02 PYRIDOXINUM
SICOVIT B6 250 mg/5 ml

SOL. INJ.
250mg/5ml ZENTIVA SA

250mg/5ml 50mg/2ml
ZENTIVA SA

A11HA02 PYRIDOXINUM
SICOVIT B6 50 mg/2ml

SOL. INJ.
50mg/2ml

1074
EUROVITA E VITAMIN E 100 VITAMINA E VITAMINA E 100 mg

A11HA03

TOCOFEROLUM
CAPS. MOI
100mg 100mg 100mg 100mg GLAXOSMITHKLINE PHARMACEUTICALS SA ZENTIVA AS BIOFARM SA PHARCO IMPEX 93 S.R.L.

A11HA03 TOCOFEROLUM

100mg

A11HA03 TOCOFEROLUM
VITAMIN E 200

CAPS. MOI
200mg ZENTIVA AS

200mg 400mg
GLAXOSMITHKLINE PHARMACEUTICALS SA ZENTIVA AS PHARCO IMPEX 93 S.R.L.

A11HA03 TOCOFEROLUM
EUROVITA E FORTE VITAMIN E 400 VITAMINA E 400 mg

CAPS. MOI
400mg 400mg 400mg

221 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

1075
SICOVIT B2 10mg/2ml

A11HA04

RIBOFLAVINUM
SOL. INJ.
10mg/2ml ZENTIVA S.A.

A11HA04 RIBOFLAVINUM

10mg/2ml

1076

A12AA03

CALCII GLUCONAS
SOL. INJ.
10% ZENTIVA SA B. BRAUN MELSUNGEN AG

A12AA03 CALCII GLUCONAS


GLUCONAT DE CALCIU GLUCONAT DE CALCIU 10%

A12AA03 CALCII GLUCONAS


GLUCONAT DE CALCIU GLUCONAT DE CALCIU 10% 10%

SOL. INJ.
ZENTIVA SA B. BRAUN MELSUNGEN AG

10,00%

1077
NAPOSIM 5 mg

A14AA03

METANDIENONUM
COMPR.
5mg TERAPIA SA

A14AA03 METANDIENONUM

5mg

1078
CARNIL

A16AA01

LEVOCARNITINUM
SOL. ORALA
100mg/ml 10% ANFARM HELLAS S.A. PHARMACEUTICALS

A16AA01 LEVOCARNITINUM A16AA01 LEVOCARNITINUM


MIOCOR

100mg/ml 10%

SOL. ORALA
ECOBI PHARMACEUTICI

1079
ACTOVEGIN

A16AXN1

DIVERSE
DRAJ.
200mg NYCOMED AUSTRIA GMBH

A16AXN1 DIVERSE A16AXN1 DIVERSE


ACTOVEGIN

200mg 200mg/5ml
NYCOMED AUSTRIA GMBH

SOL. INJ.
200mg/5ml

A16AXN1 DIVERSE
ACTOVEGIN

SOL. INJ.
80mg/2ml NYCOMED AUSTRIA GMBH

80mg/2ml

1080
DICYNONE 250 mg

B02BX01

ETAMSYLATUM
SOL. INJ.
125mg/ml OM PORTUGUESA S.A.

B02BX01 ETAMSYLATUM B02BX01 ETAMSYLATUM


DICYNONE 250 mg

125mg/ml 250mg
OM PORTUGUESA S.A.

COMPR.
250mg

B02BX01 ETAMSYLATUM
ETAMSILAT 250mg/2ml

SOL. INJ.
250mg/2ml ZENTIVA S.A

250mg/2ml

1081
ADRENOSTAZIN

B02BX02

CARBAZOCHROMI SALICYLAS
SOL. INJ.
0.3mg/ml TERAPIA SA

B02BX02 CARBAZOCHROMI SALICYLAS

0.3mg/ml

1082
FERRONAT

B03AA02

FERROSI FUMARAS
SUSP. ORALA
3% IVAX - PHARMACEUTICALS S.R.O.

B03AA02 FERROSI FUMARAS

3,00%

1083
ASCOFER

B03AA03

FERROSI GLUCONAS
COMPR.
ARENA GROUP SA

B03AA03 FERROSI GLUCONAS

1084
FER-SOL

B03ABN1

FERROCHOLINATUM
SOL. ORALA IN PICATURI
24mg Fe/ml E.I.P.I.CO. MED S.R.L.

B03ABN1 FERROCHOLINATUM

24mg Fe/ml

1085
FERRETAB

B03AD02

COMBINATII
CAPS. ELIB. PREL.
LANNACHER HEILMITTEL GMBH

B03AD02 COMBINATII

1086
FERRO SANOL GYN

B03AD03

COMBINATII
CAPS.
SCHWARZ PHARMA AG

B03AD03 COMBINATII B03AD03 COMBINATII


TARDYFERON FOL

DRAJ. ELIB. PREL.


LAB. PIERRE FABRE

1087
MALTOFER FOL

B03AD04

COMBINATII
COMPR. MAST.
VIFOR FRANCE S.A.

B03AD04 COMBINATII

1088

B03AE01

COMBINATII
CAPS. MOI
WORWAG PHARMA GMBH & CO. KG

B03AE01 COMBINATII
FERRO - FOLGAMMA

1089
TOT'HEMA

B03AE10

COMBINATII
SOL. ORALA
LAB. INNOTHERA

B03AE10 COMBINATII

1090

B03BA01

CYANOCOBALAMINUM
SOL. INJ.
1000g/ml ZENTIVA S.A.

B03BA01 CYANOCOBALAMINUM
SICOVIT B12 1000g/ml

1000g/ml 50g/ml
ZENTIVA SA

B03BA01 CYANOCOBALAMINUM
SICOVIT B12 50g/ml

SOL. INJ.
50g/ml

1091
MILGAMMA

B03BA51

COMBINATII
DRAJ.
WORWAG PHARMA GMBH & CO. KG

B03BA51 COMBINATII

1092

C01EA01

ALPROSTADILUM **
CONC. PT. SOL. PERF.
500g PINT-PHARMA GMBH

C01EA01 ALPROSTADILUM
ALPROSTADIL "PINT" 500 g

500g

1093
NEOCRYSTEPIN

C02LA51

COMBINATII
DRAJ.
ZENTIVA AS

C02LA51 COMBINATII

1094

C04AE01

CODERGOCRINUM
SOL. ORALA IN PICATURI 0.1%

C04AE01 CODERGOCRINUM

222 / 233

DCI/DENUMIRE COMERCIALA
CO-DERGOCRIN

CONCENTRATIE
0.1%

FORMA FARM.
TERAPIA SA

FIRMA

PROTOCOL

C04AE01 CODERGOCRINUM
REDERGIN

SOL. INJ.
0.3mg/ml 1mg/ml 0.1% LEK PHARMACEUTICALS D.D.

0.3mg/ml 1mg/ml 0.1%

C04AE01 CODERGOCRINUM
SECATOXIN

SOL. ORALA IN PICATURI


IVAX - PHARMACEUTICALS S.R.O. LEK PHARMACEUTICALS D.D.

C04AE01 CODERGOCRINUM
REDERGIN 1 mg/ml

PICATURI ORALE-SOL.

1095
HEMORZON

C05AA01

COMBINATII
UNGUENT
ANTIBIOTICE SA

C05AA01 COMBINATII

1096
ULTRAPROCT

C05AA08

COMBINATII
SUPOZ.
INTENDIS GmbH

C05AA08 COMBINATII C05AA08 COMBINATII


ULTRAPROCT

UNGUENT RECTAL
INTENDIS GmbH

1097
PROCTO - GLYVENOL

C05AD01

COMBINATII
CREMA RECTALA
NOVARTIS CONSUMER HEALTH GMBH

C05AD01 COMBINATII C05AD01 COMBINATII


PROCTO - GLYVENOL

SUPOZ.
NOVARTIS CONSUMER HEALTH GMBH

C05AD01 COMBINATII
DOXIPROCT DOXIPROCT PLUS

UNGUENT RECTAL
OM PORTUGUESA S.A. OM PORTUGUESA S.A.

1098
DOXILEK DOXIUM 500

C05BX01

CALCII DOBESILAS
CAPS.
500mg 500mg LEK PHARMACEUTICALS D.D. OM PORTUGUESA S.A.

C05BX01 CALCII DOBESILAS

500mg

1099
GINKOR FORT

C05CA54

TROXERUTINUM (COMBINATII)
CAPS.
BEAUFOUR IPSEN PHARMA

C05CA54 TROXERUTINUM (COMBINATII)

1100
CELIPRES

C07AB08

CELIPROLOLUM
COMPR. FILM.
100mg 200mg RANBAXY U.K. LIMITED

C07AB08 CELIPROLOLUM C07AB08 CELIPROLOLUM


CELIPRES

100mg 200mg

COMPR. FILM.
RANBAXY U.K. LIMITED

1101
CALMOGEN

C07NAN1

COMBINATII
CAPS.
EUROPHARM SA

C07NAN1 COMBINATII C07NAN1 COMBINATII


DISTONOVAL

COMPR.
FABIOL S.A.

C07NAN1 COMBINATII
DISTONOCALM

COMPR. FILM.
ZENTIVA S.A.

1102
DILCEREN NIMOTOP

C08CA06

NIMODIPINUM
SOL. PERF.
10mg/50ml 10mg/50ml SLOVAKOFARMA BAYER HEALTHCARE AG

C08CA06 NIMODIPINUM

10mg/50ml

C08CA06 NIMODIPINUM
NIMODIPIN 30mg 30mg

COMPR.
LAROPHARM SRL

30mg 30mg

C08CA06 NIMODIPINUM
NIMOTOP

COMPR. FILM.
BAYER HEALTHCARE AG

1103
NIASPAN 1000 mg

C10AD02

ACIDUM NICOTINICUM
COMPR. ELIB. PREL.
1000mg 375mg 500mg 750mg MERCK KGAA

C10AD02 ACIDUM NICOTINICUM C10AD02 ACIDUM NICOTINICUM


NIASPAN 375 mg

1000mg 375mg 500mg 750mg

COMPR. ELIB. PREL.


MERCK KGAA MERCK KGAA MERCK KGAA

C10AD02 ACIDUM NICOTINICUM


NIASPAN 500 mg

COMPR. ELIB. PREL. COMPR. ELIB. PREL.

C10AD02 ACIDUM NICOTINICUM


NIASPAN 750 mg

1104
TRAVOGEN

D01AC05

ISOCONAZOLUM
CREMA
10mg/1g INTENDIS GmbH

D01AC05 ISOCONAZOLUM D01AC05 ISOCONAZOLUM


IZOCON 1 1%

10mg/1g 1%
ROMINKO S.A.

CREMA

1105
KETO - TIS

D01AC08

KETOCONAZOLUM
GEL CAPILAR
1g/20g TIS FARMACEUTIC S.A.

D01AC08 KETOCONAZOLUM D01AC08 KETOCONAZOLUM


KETOCONAZOL CREMA

1g/20g 20mg/g

CREMA
20mg/g SC HYPERION SA

D01AC08 KETOCONAZOLUM
KEFUNGIN 2mg/100mg

CREMA
2mg/100mg ANTIBIOTICE S.A.

2mg/100mg 2%
TIS FARMACEUTIC SA FITERMAN PHARMA S.R.L. JANSSEN PHARMACEUTICA NV

D01AC08 KETOCONAZOLUM
KETOCONAZOL KETOCONAZOL MK NIZORAL 2% 2% 2%

CREMA

D01AC08 KETOCONAZOLUM
NIZORAL SAMPON 2%

SAMPON
JANSSEN PHARMACEUTICA NV

2%

1106

D01AC52

COMBINATII

223 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
DAR AL DAWA PHARMA S.R.L

FIRMA

PROTOCOL

D01AC52 COMBINATII
MYCOHEAL HC

CREMA

1107
PANTHENOL

D03AX03

DEXPANTHENOLUM
SPUMA CUT.
46.30mg/g CHAUVIN ANKERPHARM GMBH

D03AX03 DEXPANTHENOLUM D03AX03 DEXPANTHENOLUM


BEPANTHEN

46.30mg/g 50mg/g

CREMA
50mg/g BAYER S.R.L.

D03AX03 DEXPANTHENOLUM
BEPANTHEN 5mg/g

UNGUENT
BAYER S.R.L.

5mg/g

1108
PSORIANOL 0,5%

D05AC01

DITHRANOLUM
UNGUENT
0.5% HYPERION SA

D05AC01 DITHRANOLUM D05AC01 DITHRANOLUM


PSORIANOL 1% 1%

0.5% 1%
HYPERION SA

UNGUENT

1109
ASORIAN

D05AXN1

COMBINATII
SOL. CUT.
BIOFARM SA

D05AXN1 COMBINATII

1110
AFLODERM

D07AB10

ALCLOMETAZONUM
CREMA
0.5mg/g A & G MED TRADING S.R.L.

Protocol: D001L
0.5mg/g 0.5mg/g
A & G MED TRADING S.R.L.

D07AB10 ALCLOMETAZONUM D07AB10 ALCLOMETAZONUM


AFLODERM

UNGUENT
0.5mg/g

1111

D07AC04

FLUOCINOLONI ACETONIDUM
UNGUENT
0.025% LAROPHARM SRL

Protocol: D001L
25,00%

D07AC04 FLUOCINOLONI ACETONIDUM


FLUOCINOLON ACETONID 0,025%

1112
ULTRALAN CREMA

D07AC05

FLUOCORTOLONUM
CREMA
0.25% INTENDIS GMBH

Protocol: D001L
0.25% 0.25%
SCHERING AG

D07AC05 FLUOCORTOLONUM D07AC05 FLUOCORTOLONUM


ULTRALAN UNGUENT 0.25%

UNGUENT

1113
NIDOFLOR

D07CB01

COMBINATII
CREMA
ANTIBIOTICE SA

Protocol: D001L

D07CB01 COMBINATII D07CB01 COMBINATII


PANDERM

UNGUENT
GULF PHARMACEUTICAL INDUSTRIES S.R.L.

1114
FLUOCINOLON G FLUOCINOLON G MK

D07CC02

COMBINATII
CREMA
OZONE LABORATORIES LTD. FITERMAN PHARMA S.R.L.

Protocol: D001L

D07CC02 COMBINATII

D07CC02 COMBINATII
FLUOCINOLON N

UNGUENT
ANTIBIOTICE SA

1115
TRIAMCINOLON S

D07XB02

COMBINATII
CREMA
ANTIBIOTICE SA

Protocol: D001L

D07XB02 COMBINATII

1116
BELOSALIC DIPROSALIC

D07XC01

COMBINATII
SOL. CUT.
A & G MED TRADING S.R.L. SCHERING-PLOUGH EUROPE

Protocol: D001L

D07XC01 COMBINATII

D07XC01 COMBINATII
BELOSALIC DIPROSALIC

UNGUENT
A & G MED TRADING S.R.L. SCHERING-PLOUGH EUROPE

1117
TRAVOCORT

D07XC04

COMBINATII
CREMA
INTENDIS GmbH

Protocol: D001L

D07XC04 COMBINATII

1118
FLUOCINOLON D MK

D07XDN1

COMBINATII
CREMA
FITERMAN PHARMA S.R.L.

Protocol: D001L

D07XDN1 COMBINATII

1119
RETIN - A SMOODERM

D10AD01

TRETINOINUM
CREMA
0.05% 0.05% JOHNSON & JOHNSON D.O.O. DAR AL DAWA PHARMA S.R.L

D10AD01 TRETINOINUM

0.05%

1120
BREVOXYL

D10AE01

BENZOYLIS PEROXIDUM
CREMA
4% STIEFEL LABORATORIES LTD.

D10AE01 BENZOYLIS PEROXIDUM

4,00%

1121
ERYFLUID

D10AF02

ERYTHROMYCINUM
SOL. CUT.
4g PIERRE FABRE DERMATOLOGIE

D10AF02 ERYTHROMYCINUM

4g

1122
ZINERYT

D10AF52

COMBINATII
PULB. + SOLV. SOL. CUT.
40mg/12mg/ml ASTELLAS PHARMA EUROPE B.V.

D10AF52 COMBINATII

40mg/12mg/ml

1123
ELIDEL 1%

D11AX15

PIMECROLIMUS
CREMA
1% NOVARTIS PHARMA GMBH

D11AX15 PIMECROLIMUS

1,00%

1124
FLAGYL

G01AF01

METRONIDAZOLUM
OVULE
500mg LAB. AVENTIS

G01AF01 METRONIDAZOLUM

500mg

1125

G01AX12

CICLOPIROXUM

224 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
POLICHEM SA

FIRMA

PROTOCOL

G01AX12 CICLOPIROXUM
DAFNEGIN 0.2%

SOL. VAGINALA OVULE


100mg 1% POLICHEM SA

0.2% 100mg 1%

G01AX12 CICLOPIROXUM
DAFNEGIN

G01AX12 CICLOPIROXUM
DAFNEGIN

CREMA VAG.
POLICHEM SA

1126
COLPOSEPTINE

G01AXN1

COMBINATII
COMPR. VAG.
LAB. THERAMEX

G01AXN1 COMBINATII G01AXN1 COMBINATII


CERVIRON - OVULE

OVULE
DORNAFARM SA

1127
TERGYNAN

G01BDN1

COMBINATII
COMPR. VAG.
LAB. BOUCHARA-RECORDATI

G01BDN1 COMBINATII

1128
DEPO-PROVERA MEGESTRON

G03AC06

MEDROXYPROGESTERONUM
SUSP. INJ.
150mg 150mg PFIZER EUROPE MA EEIG N. V. ORGANON

G03AC06 MEDROXYPROGESTERONUM

150mg

1129
LUTENYL

G03DB04

NOMEGESTROLUM
COMPR.
5mg LAB. THERAMEX

G03DB04 NOMEGESTROLUM

5mg

1130
PREGNYL 5000

G03GA01

GONADOTROPHINUM CHORIONICUM
LIOF. + SOLV. PT. SOL. INJ.
5000ui/ml 500ui/ml NV ORGANON

G03GA01 GONADOTROPHINUM CHORIONICUM G03GA01 GONADOTROPHINUM CHORIONICUM


PREGNYL 500

5000ui/ml 500ui/ml

LIOF. + SOLV. PT. SOL. INJ.


ORGANON NV

Prescriere limitata: Infertilitate anovulatorie Prescriere limitata: Pentru tratamentul infertilitatii masculine ca urmare a hipogonadismului hipogonadotrop; Prescriere limitata: Pentru tratamentul infertilitatii masculine asociata cu deficit de LH; Prescriere limitata: Pentru tratamentul barbatilor care au insuficienta combinata de GH si gonadotropine si la care absenta caracterelor sexuale secundare indica o intarziere de maturare Prescriere limitata: Pentru tratamentul baietilor de peste 16 ani care au manifestari clinice ale hipogonadismului sau ale pubertatii intarziate. Tratamentul nu trebuie sa depaseasca 6 luni NOTA: Cu excepia cazurilor de hipopituitarism sau amenoree primara, pacienta trebuie sa fi fost tratata anterior cu citrat de clomifen si/sau gonadorelin, iar tratamentul sa fi ramas fr efect (sarcina nu a fost obinuta). Femeile care au urmat tratament pentru inducerea ovulaiei cu alte clase de medicamente si nu au obinut o sarcina necesita evaluare laparoscopic pentru a exclude alte cauze care mpiedica apariia unei sarcini. Oligomenoreea trebuie sa fie prezenta de cel puin dousprezece luni sau amenoreea sa fie prezenta de cel puin sase luni naintea tratamentului. naintea acestui tratament pacientele cu hiperprolactinemie trebuie sa fi urmat tratament specific medical sau chirurgical..

1131

G03GA02

MENOTROPINUM
LIOF. SI SOLV.PT.SOL.INJ
75ui FSH / 75ui LH FERING GMBH FERRING LAEGEMIDLER A/S

G03GA02 MENOTROPINUM
MENOGON

75ui FSH / 75ui LH

G03GA02 MENOTROPINUM
MENOPUR

LIOF. + SOLV. PT. SOL. INJ.

1132
URALYT-U

G04BCN1

COMBINATII
GRAN. ORALE
MADAUS GMBH

G04BCN1 COMBINATII

1133
NOVOTHYRAL 100

H03AA03

COMBINATII
COMPR.
100g+20g MERCK KGAA

H03AA03 COMBINATII

100g+20g

1134
SULPERAZON 2 g

J01CR50

COMBINATII
PULB. PT. SOL. INJ.
1g+1g PFIZER EUROPE MA EEIG

J01CR50 COMBINATII J01CR50 COMBINATII


AMPICLOX

1g+1g 250mg+250 mg

CAPS.
250mg+250 mg EUROPHARM SA

1135
LYZOLIN

J01DB04
Prescriere limitata:

CEFAZOLINUM
PULB. PT. SOL. INJ.
1g MEDICAROM GROUP S.R.L.

J01DB04 CEFAZOLINUM

1g

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic.

J01DB04 CEFAZOLINUM
CEFAZOLIN SANDOZ 1 g 1g

PULB. PT. SOL. INJ. IM/IV


SANDOZ GMBH

1g

Prescriere limitata:

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic.

1136
CEFROM 1 g

J01DE02

CEFPIROMUM
PULB. PT. SOL. INJ./PERF.
1g 2g LAB. AVENTIS

J01DE02 CEFPIROMUM J01DE02 CEFPIROMUM


CEFROM 2 g

1g 2g

PULB. PT. SOL. INJ./PERF.


LAB. AVENTIS

1137
J01EB05
NEOXAZOL 500 mg SULFAFURAZOL

J01EB05
SULFAFURAZOLUM

SULFAFURAZOLUM
COMPR.
500mg 500mg ZENTIVA S.A. ARENA GROUP SA

500mg

1138
J01FA06

J01FA06
ROXITHROMYCINUM

ROXITHROMYCINUM
COMPR. FILM.
150mg 150mg 150mg 300mg ECZACIBASI ILAC SANAYI VE TICARET AS DAR AL DAWA PHARMA S.R.L ALIUD PHARMA GMBH & CO.KG

150mg

ROKSOLIT ROXAMED 150 ROXITHROMYCIN AL 150

J01FA06

ROXITHROMYCINUM

COMPR. FILM.
ALIUD PHARMA GMBH & CO.KG

300mg

ROXITHROMYCIN AL 300

1139
GENTAMICIN KRKA

J01GB03

GENTAMICINUM
SOL. INJ.
40mg/ml KRKA D.D. NOVO MESTO

J01GB03 GENTAMICINUM

40mg/ml

225 / 233

DCI/DENUMIRE COMERCIALA
GENTAMICINA SANDOZ 40 mg/ml

CONCENTRATIE
40mg/ml

FORMA FARM.
SANDOZ GMBH

FIRMA

PROTOCOL

Prescriere limitata: Prescriere limitata: Prescriere limitata:

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01GB03 GENTAMICINUM
GENTAMICIN KRKA GENTAMICINA SANDOZ 40 mg/ml

SOL. INJ.
40mg/ml 40mg/ml KRKA D.D. NOVO MESTO SANDOZ GMBH

40mg/ml

Prescriere limitata: Prescriere limitata: Prescriere limitata:


LYRAMYCIN

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01GB03 GENTAMICINUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
GENTAMICIN KRKA

SOL. PARENT.
40mg/ml MEDICAROM GROUP S.R.L.

40mg/ml

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01GB03 GENTAMICINUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:
PAN - GENTAMICINE

SOL. INJ.
80mg/2ml KRKA D.D. NOVO MESTO

80mg/2ml

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

J01GB03 GENTAMICINUM
Prescriere limitata: Prescriere limitata: Prescriere limitata:

SOL.INJ.
80mg/2ml LAB. PANPHARMA

80mg/2ml

Infectii cu agent patogen sensibil confirmat pentru acest tip de antibiotic. Suspiciune de septicemie Septicemie dovedita

1140
NETROMYCINE

J01GB07

NETILMICINUM
SOL. INJ.
150mg/1.5ml SCHERING PLOUGH EUROPE

J01GB07 NETILMICINUM J01GB07 NETILMICINUM


NETROMYCINE

150mg/1.5ml 200mg/2ml
SCHERING PLOUGH EUROPE

SOL. INJ.
200mg/2ml

J01GB07 NETILMICINUM
NETROMYCINE

SOL. INJ.
50mg/2ml SCHERING PLOUGH EUROPE

50mg/2ml

1141
J01XB01

J01XB01
COLISTINUM

COLISTINUM
PULB. PT. SOL. PERF.
1000000ui ANTIBIOTICE SA

1000000ui

COLISTINA ANTIBIOTICE 1000000 UI

1142
FUCIDIN

J01XC01
Prescriere limitata:

ACIDUM FUSIDICUM
COMPR. FILM.
250mg LEO PHARMACEUTICAL PRODUCTS

J01XC01 ACIDUM FUSIDICUM

250mg

Se utilizeaza in combinatie cu alt antibiotic pentru tratamentul infectiilor stafilococice severe

1143
VFEND 200mg

J02AC03

VORICONAZOLUM **
COMPR. FILM.
200mg 200mg 40mg/ml 50mg PFIZER LTD.

Protocol: J012B
200mg 200mg 40mg/ml 50mg

J02AC03 VORICONAZOLUM J02AC03 VORICONAZOLUM


VFEND 200mg

PULB. PT. SOL. PERF.


PFIZER LTD. PFIZER LTD. PFIZER LTD.

J02AC03 VORICONAZOLUM
VFEND 40 mg/ml

PULB. PT. SUSP. ORALA COMPR. FILM.

J02AC03 VORICONAZOLUM
VFEND 50mg

1144
ARTHROTEC 75

M01AB55

COMBINATII
COMPR. GASTROREZ.
PFIZER EUROPE MA EEIG

M01AB55 COMBINATII M01AB55 COMBINATII


NEODOLPASSE

SOL. PERF.
FRESENIUS KABI AUSTRIA GMBH

M01AB55 COMBINATII
ACECLOFEN

SUPOZ.
ANTIBIOTICE SA

1145

M01AE01

IBUPROFENUM
COMPR. ORODISPERSABILE
100mg 100mg/5ml 100mg/5ml 100mg/5ml 100mg/5ml 100mg/5ml RECKITT BENCKISER HEALTHCARE INT. LTD.

M01AE01 IBUPROFENUM
NUROFEN PENTRU COPII

100mg 100mg/5ml

M01AE01 IBUPROFENUM
IBALGIN BABY IBUGESIC MARCOFEN NUROFEN PENTRU COPII, cu aroma de capsuni NUROFEN PENTRU COPII, cu aroma de portocala

SUSP. ORALA

ZENTIVA AS DAR AL DAWA PHARMA S.R.L. GLAXOSMITHKLINE (GSK) SRL RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED

M01AE01 IBUPROFENUM
NUROFEN PENTRU COPII 125 mg

SUPOZ.
125mg

125mg
RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED

M01AE01 IBUPROFENUM
IBUPROFEN ARENA 200 mg PADUDEN 200 mg

CAPS.
200mg 200mg ARENA GROUP SA TERAPIA SA

200mg

M01AE01 IBUPROFENUM
ADVIL ULTRA NUROFEN 200 mg VOLINI 200 mg

CAPS. MOI
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg

200mg
WYETH WHITEHALL EXPORT GMBH CONSUMER HEALTHCARE RECKITT BENCKISER HEALTHCARE INTERNATIONAL LTD. RANBAXY UK LIMITED

M01AE01 IBUPROFENUM
IBALGIN IBUFEN 200 mg IBUPROFEN 200 IBUPROFEN LAROPHARM 200 mg REUPROFEN 200 mg RUPAN 200 mg

COMPR. FILM.
ZENTIVA AS ANTIBIOTICE SA CIPLA (UK) LIMITED LAROPHARM S.R.L. AC HELCOR SRL MEDOCHEMIE LTD.

200mg

226 / 233

DCI/DENUMIRE COMERCIALA
SARIDON N 200

CONCENTRATIE
200mg 200mg

FORMA FARM.
BAYER S.R.L.

FIRMA

PROTOCOL

M01AE01 IBUPROFENUM
NUROFEN NON-AQUA

COMPR. ORODISPERSABILE
RECKITT BENCKISER HEALTHCARE INT. LTD.

200mg 200mg

M01AE01 IBUPROFENUM
ADVIL IBUPROFEN IBUPROM NUROFEN 200 mg PROFINAL

DRAJ.
200mg 200mg 200mg 200mg 200mg 300mg

WYETH WHITEHALL EXPORT GMBH PABIANICKIE ZAKLADY FARMACEUTYCZNE POLFA US PHARMACIA SP RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED GULF PHARMACEUTICAL INDUSTRIES S.R.L.

M01AE01 IBUPROFENUM
PADUDEN SR 300 mg

CAPS. ELIB. PREL.


TERAPIA SA

300mg 400mg

M01AE01 IBUPROFENUM
MARCOFEN

CAPS.
400mg EUROPHARM SA

M01AE01 IBUPROFENUM
IBUTOP

CAPS. MOI
400mg 400mg 400mg 400mg 400mg 400mg 400mg 400mg 400mg 400mg DOLORGIET GMBH & CO. KG

400mg 400mg

M01AE01 IBUPROFENUM
FASPIC 400 mg IBALGIN FORTE IBUPROFEN 400 IMET MIG-400 PROFINAL REUPROFEN 400 mg RUPAN 400 mg SARIDON N 400

COMPR. FILM.
ZAMBON S.P.A. ZENTIVA AS CIPLA (UK) LIMITED BERLIN CHEMIE AG (MENARINI GROUP) BERLIN-CHEMIE AG (MENARINI GROUP) GULF PHARMACEUTICAL INDUSTRIES S.R.L. AC HELCOR SRL MEDOCHEMIE LTD. BAYER S.R.L.

M01AE01 IBUPROFENUM
NUROFEN FORTE

DRAJ.
400mg 400mg 600mg 600mg 600mg RECKITT BENCKISER HEALTHCARE INT. LTD.

400mg 400mg 600mg

M01AE01 IBUPROFENUM
FASPIC 400

GRAN. PT. SOL. ORALA


ZAMBON S.P.A. CIPLA (UK) LIMITED GULF PHARMACEUTICAL INDUSTRIES S.R.L.

M01AE01 IBUPROFENUM
IBUPROFEN 600 PROFINAL

COMPR. FILM.

M01AE01 IBUPROFENUM
FASPIC 600

GRAN. PT. SOL. ORALA


ZAMBON S.P.A.

600mg 200mg

M01AE01 IBUPROFENUM
IBUPROFEN ARENA 200 mg PADUDEN 200 mg

CAPS.
200mg 200mg ARENA GROUP SA TERAPIA SA

M01AE01 IBUPROFENUM
ADVIL ULTRA NUROFEN 200 mg VOLINI 200 mg

CAPS. MOI
200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg

200mg
WYETH WHITEHALL EXPORT GMBH CONSUMER HEALTHCARE RECKITT BENCKISER HEALTHCARE INTERNATIONAL LTD. RANBAXY UK LIMITED

M01AE01 IBUPROFENUM
IBALGIN IBUFEN 200 mg IBUPROFEN 200 IBUPROFEN LAROPHARM 200 mg REUPROFEN 200 mg RUPAN 200 mg SARIDON N 200

COMPR. FILM.
ZENTIVA AS ANTIBIOTICE SA CIPLA (UK) LIMITED LAROPHARM S.R.L. AC HELCOR SRL MEDOCHEMIE LTD. BAYER S.R.L.

200mg

M01AE01 IBUPROFENUM
NUROFEN NON-AQUA

COMPR. ORODISPERSABILE
RECKITT BENCKISER HEALTHCARE INT. LTD.

200mg 200mg

M01AE01 IBUPROFENUM
ADVIL IBUPROFEN IBUPROM NUROFEN 200 mg PROFINAL

DRAJ.
200mg 200mg 200mg 200mg 200mg

WYETH WHITEHALL EXPORT GMBH PABIANICKIE ZAKLADY FARMACEUTYCZNE POLFA US PHARMACIA SP RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED GULF PHARMACEUTICAL INDUSTRIES S.R.L.

M01AE01 IBUPROFENUM
MARCOFEN

CAPS.
400mg EUROPHARM SA

400mg 400mg
DOLORGIET GMBH & CO. KG

M01AE01 IBUPROFENUM
IBUTOP

CAPS. MOI
400mg 400mg 400mg 400mg 400mg 400mg 400mg 400mg 400mg 400mg

M01AE01 IBUPROFENUM
FASPIC 400 mg IBALGIN FORTE IBUPROFEN 400 IMET MIG-400 PROFINAL REUPROFEN 400 mg RUPAN 400 mg SARIDON N 400

COMPR. FILM.
ZAMBON S.P.A. ZENTIVA AS CIPLA (UK) LIMITED BERLIN CHEMIE AG (MENARINI GROUP) BERLIN-CHEMIE AG (MENARINI GROUP) GULF PHARMACEUTICAL INDUSTRIES S.R.L. AC HELCOR SRL MEDOCHEMIE LTD. BAYER S.R.L.

400mg

M01AE01 IBUPROFENUM
NUROFEN FORTE

DRAJ.
400mg RECKITT BENCKISER HEALTHCARE INT. LTD.

400mg

1146
MOMENDOL

M01AE02

NAPROXENUM
COMPR. FILM.
200mg 220mg AZIENDE CHIMICHE RIUNITE A.F.-ACRAF SPA

M01AE02 NAPROXENUM M01AE02 NAPROXENUM


ALEVE

200mg 220mg 250mg

COMPR. FILM.
BAYER S.R.L. AC HELCOR PHARMA SRL

M01AE02 NAPROXENUM
REUXEN 250 mg

COMPR.
250mg

Prescriere limitata: Prescriere limitata:

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

M01AE02 NAPROXENUM

COMPR.

500mg

227 / 233

DCI/DENUMIRE COMERCIALA
REUXEN 500 mg

CONCENTRATIE
500mg

FORMA FARM.
AC HELCOR PHARMA SRL

FIRMA

PROTOCOL

Prescriere limitata: Prescriere limitata:

Dureri osoase/musculare cauzate de afectiuni acute. Artropatii cronice (inclusiv osteoartrite) cu componenta inflamatorie

1147
VIDAN

M01AG01

ACIDUM MEFENAMICUM
COMPR. FILM.
500mg VIANEX SA

M01AG01 ACIDUM MEFENAMICUM

500mg

1148
DYNASTAT 20mg

M01AH04

PARECOXIBUM
PULB. + SOLV. PT. SOL. INJ.
20mg 20mg 40mg 40mg PFIZER LIMITED

M01AH04 PARECOXIBUM M01AH04 PARECOXIBUM


DYNASTAT 20mg

20mg 20mg 40mg 40mg

PULB. PT. SOL. INJ.


PFIZER LIMITED

M01AH04 PARECOXIBUM
DYNASTAT 40mg

PULB. + SOLV. PT. SOL. INJ.


PFIZER LIMITED

M01AH04 PARECOXIBUM
DYNASTAT 40mg

PULB. PT. SOL. INJ.


PFIZER LIMITED

1149
NIFLURIL

M01AX02

ACIDUM NIFLUMICUM
CAPS.
250mg BRISTOL MYERS SQUIBB KFT

M01AX02 ACIDUM NIFLUMICUM

250mg

1150

M01AA01

PHENYLBUTAZONUM
SUPOZ.
250mg SINTOFARM SA

M01AA01 PHENYLBUTAZONUM
FENILBUTAZONA 250 mg

250mg

1151
FELDENE PIROXICAM 0,5%

M02AA07

PIROXICAMUM
GEL
0.5% 0.5% PFIZER H.C.P. CORPORATION ANTIBIOTICE SA

M02AA07 PIROXICAMUM

0.5%

M02AA07 PIROXICAMUM
PIROXSAL GEL 0.5g% 0.5g%

GEL
SLAVIA PHARM SRL

0.5g% 5mg/g
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

M02AA07 PIROXICAMUM
FINALGEL 5mg/g

GEL GEL
1% 1% OZONE LABORATORIES LTD. FITERMAN PHARMA S.R.L.

M02AA07 PIROXICAMUM
PIROXICAM 1% PIROXICAM MK GEL

1%

M02AA07 PIROXICAMUM
PIROXICAM 3% PIROXICAM MK CREMA 3% 3%

CREMA
OZONE LABORATORIES LTD. FITERMAN PHARMA S.R.L.

3%

1152

M02AA13

IBUPROFENUM
CREMA
50mg/g OZONE LABORATORIES SRL

M02AA13 IBUPROFENUM
IBUPROFEN 50 mg/g CREMA

50mg/g 50mg/g
FITERMAN PHARMA S.R.L. DOLORGIET GMBH & CO. KG ZENTIVA A.S.

M02AA13 IBUPROFENUM
IBUPROFEN MK GEL IBUTOP GEL

GEL
50mg/g 50mg/g

M02AA13 IBUPROFENUM
IBALGIN SPORT

CREMA CREMA
5% FITERMAN PHARMA S.R.L.

M02AA13 IBUPROFENUM
IBUPROFEN MK

5% 5%
ZENTIVA AS RECKITT BENCKISER HEALTHCARE INT. LTD. GLAXOSMITHKLINE CONSUMER HEALTHCARE LAB. URGO SA

M02AA13 IBUPROFENUM
IBALGIN GEL NUROFEN GEL SOLPAFLEX GEL URGO IBUPROFEN 5% GEL 5% 5% 5% 5%

GEL

1153
NIFLUGEL 2,5%

M02AA17

ACIDUM NIFLUMICUM
GEL
2.5% BRISTOL-MYERS SQUIBB KFT.

M02AA17 ACIDUM NIFLUMICUM M02AA17 ACIDUM NIFLUMICUM


NIFLURIL

2.5% 30mg/g
BRISTOL-MYERS SQUIBB KFT

CREMA
30mg/g

1154

M02AA23

INDOMETACINUM
UNGUENT
40mg/g HYPERION SA

M02AA23 INDOMETACINUM
INDOMETACIN HYPERION

40mg/g 2%
SINTOFARM SA

M02AA23 INDOMETACINUM
INDOSIN GEL 2%

GEL CREMA
4% 4% OZONE LABORATORIES LTD. FITERMAN PHARMA S.R.L.

M02AA23 INDOMETACINUM
INDOMETACIN 4% INDOMETACIN MK

4%

1155
M02ACN 3

M02ACN3
COMBINATII

COMBINATII
GEL
LABORATOIRES CHEMINEAU

PERCUTALGINE

1156

M03BB03

CHLORZOXAZONUM
COMPR.
250mg 250mg 250mg GEDEON RICHTER ROMANIA SA SINTOFARM SA ARENA GROUP SA

M03BB03 CHLORZOXAZONUM
CLORZOXAZON 250 mg CLORZOXAZONA CLORZOXAZONA 250 mg

250mg

1157
MYDOCALM

M03BX04

TOLPERISONUM
SOL. INJ.
100mg/ml 150mg 50mg GEDEON RICHTER LTD.

M03BX04 TOLPERISONUM M03BX04 TOLPERISONUM


MYDOCALM

100mg/ml 150mg 50mg

COMPR. FILM.
GEDEON RICHTER LTD. GEDEON RICHTER LTD.

M03BX04 TOLPERISONUM
MYDOCALM

COMPR. FILM.

228 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.
TERAPIA SA

FIRMA

PROTOCOL

M03BX04 TOLPERISONUM
TOLPERISON 50 mg 50mg

DRAJ.

50mg

1158
HYALGAN

M09AX01

ACIDUM HIALURONICUM
SOL. INJ.
20mg/2ml CSC PHARMACEUTICALS HANDELS GMBH

M09AX01 ACIDUM HIALURONICUM

20mg/2ml

1159

N02AA59

COMBINATII
COMPR.
30mg+500mg 500mg+30mg ARENA GROUP S.A.

N02AA59 COMBINATII
PARADOREN 500mg/30mg

30mg+500mg 500mg+30mg 60mg+500mg


ARENA GROUP S.A.

N02AA59 COMBINATII
EFERALGAN CODEINE

COMPR. EFF.
BRISTOL MYERS SQUIBB KFT

N02AA59 COMBINATII
PARADOREN 500mg/60mg

COMPR.
60mg+500mg

1160
FASCONAL P FASCOREM

N02BA71

COMBINATII
COMPR.
GEDEON RICHTER ROMANIA SA REMEDIA SRL

N02BA71 COMBINATII

1161

N02BB02

METAMIZOLUM NATRIUM
SOL. INJ.
1g/2ml ZENTIVA S.A.

N02BB02 METAMIZOLUM NATRIUM


ALGOCALMIN 1 g/2 ml

1g/2ml 300mg
ANTIBIOTICE SA SINTOFARM SA

N02BB02 METAMIZOLUM NATRIUM


NOVOCALMIN 300 mg SINTOCALMIN 300 mg

SUPOZ.
300mg 300mg

N02BB02 METAMIZOLUM NATRIUM


ALGIOTOP ALGOCALMIN 500 mg ALGOREMIN ALGOZONE ALINDOR ANALGIN 500 mg CENTRALGIN 500 mg FABOCALM NOVALMIN NOVOCALMIN SINTOCALMIN

COMPR.
500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg 500mg/ml SANTA SA ZENTIVA S.A. REMEDIA SRL OZONE LABORATORIES LTD. LAROPHARM SRL EUROPHARM SA CENTROFARM S.A. FABIOL S.A. FARMACOM SA ANTIBIOTICE SA SINTOFARM SA

500mg

N02BB02 METAMIZOLUM NATRIUM


NEVRALGIN

PIC. ORALE, SOL.


TERAPIA S.A.

500mg/ml

1162
TRANXENE 10 mg

N05BA05

CLORAZEPAS DIKALII
CAPS.
10mg SANOFI-AVENTIS FRANCE

N05BA05 CLORAZEPAS DIKALII N05BA05 CLORAZEPAS DIKALII


TRANXENE 5 mg 5mg

10mg 5mg
SANOFI-AVENTIS FRANCE

CAPS.

1163
GRANDAXIN

N05BA23

TOFISOPAMUM
COMPR.
50mg EGIS PHARMACEUTICALS LTD.

N05BA23 TOFISOPAMUM

50mg

1164

N05CD08

MIDAZOLAMUM
SOL. INJ.
1mg/ml 1mg/ml ROCHE ROMANIA S.R.L. TORREX CHIESI PHARMA GMBH

N05CD08 MIDAZOLAMUM
DORMICUM MIDAZOLAM TORREX 1 mg/ml

1mg/ml

N05CD08 MIDAZOLAMUM
FULSED 5 mg/ml MIDAZOLAM 5 mg/ml MIDAZOLAM TORREX 5 mg/ml

SOL. INJ.
5mg/ml 5mg/ml 5mg/ml 7.5mg 7.5mg TERAPIA S.A. TERAPIA SA TORREX CHIESI PHARMA GMBH

5mg/ml

N05CD08 MIDAZOLAMUM
DORMICUM DORMICUM 7,5 mg

COMPR. FILM.
ROCHE ROMANIA S.R.L. TERAPIA SA

7.5mg

1165
GERODORM

N05CD13

CINOLAZEPAMUM
COMPR.
40mg GEROT PHARMAZEUTIKA GMBH

N05CD13 CINOLAZEPAMUM

40mg

1166
CONCERTA XL 18 mg

N06BA04
Prescriere limitata:

METHYLFENIDATUM ***
COMPR. FILM. ELIB. PREL.
18mg JANSSEN PHARMACEUTICA N.V.

N06BA04 METHYLFENIDATUM

18mg

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA04 METHYLFENIDATUM
CONCERTA XL 36 mg 36mg

COMPR. FILM. ELIB. PREL.


JANSSEN PHARMACEUTICA N.V.

36mg

Prescriere limitata:
CONCERTA XL 54 mg

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA04 METHYLFENIDATUM
54mg

COMPR. FILM. ELIB. PREL.


JANSSEN PHARMACEUTICA N.V.

54mg

Prescriere limitata:

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

1167
STRATTERA 10 mg

N06BA09
Prescriere limitata:

ATOMOXETINUM ***
CAPS.
10mg ELI LILLY AND COMPANY LIMITED

N06BA09 ATOMOXETINUM

10mg

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA09 ATOMOXETINUM
STRATTERA 18 mg 18mg

CAPS.
ELI LILLY AND COMPANY LIMITED

18mg

Prescriere limitata:
STRATTERA 25 mg

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA09 ATOMOXETINUM
25mg

CAPS.
ELI LILLY AND COMPANY LIMITED

25mg

Prescriere limitata:
STRATTERA 40 mg

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA09 ATOMOXETINUM
40mg

CAPS.
ELI LILLY AND COMPANY LIMITED

40mg

229 / 233

DCI/DENUMIRE COMERCIALA Prescriere limitata:


STRATTERA 60 mg

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

N06BA09 ATOMOXETINUM
60mg

CAPS.
ELI LILLY AND COMPANY LIMITED

60mg

Prescriere limitata:

Utilizare in tulburare cu deficit de atentie si hiperactivitate.

1168

N06BX02

PYRITINOLUM
DRAJ.
100mg 100mg MERCK KGAA ARENA GROUP S.A.

N06BX02 PYRITINOLUM
ENCEPHABOL 100 mg PIRITINOL ARENA 100 mg

100mg

N06BX02 PYRITINOLUM
ENCEPHABOL FORTE

DRAJ.
200mg 80.5mg/5ml MERCK KGAA

200mg 80.5mg/5ml

N06BX02 PYRITINOLUM
ENCEPHABOL SUSPENSIE

SUSP. ORALA
MERCK KGAA

1169

N06BX03

PIRACETAMUM
COMPR. FILM.
1200mg 1200mg EGIS PHARMACEUTICALS LTD. U.C.B. SA

N06BX03 PIRACETAMUM
LUCETAM 1200 mg NOOTROPIL 1200 mg

1200mg

N06BX03 PIRACETAMUM
NOOTROPIL 12g

SOL. PERF.
U.C.B. SA

12g 1g
U.C.B. SA

N06BX03 PIRACETAMUM
NOOTROPIL 1g

SOL. INJ. SOL. INJ.


1g/5ml 1g/5ml EGIS PHARMACEUTICALS LTD. ZENTIVA SA

N06BX03 PIRACETAMUM
LUCETAM 1 g MEMOTAL1 g/5 ml

1g/5ml

N06BX03 PIRACETAMUM
LUCETAM 3 g

SOL. INJ.
3g/15ml EGIS PHARMACEUTICALS LTD.

3g/15ml 400 mg
ANTIBIOTICE SA

N06BX03 PIRACETAMUM
PIRACETAM 400 mg

COMPR.
400 mg

N06BX03 PIRACETAMUM
PIRACETAM ARENA 400 mg

CAPS.
400mg ARENA GROUP SA

400mg 400mg
ZENTIVA S.A MEDUMAN SA MAGISTRA C & C LAROPHARM SRL FARMEX COMPANY SRL

N06BX03 PIRACETAMUM
MEMOTAL 400mg N - PIRACETAM PIRACETAM PIRACETAM 400 mg PIRACETAM FARMEX 400 mg

COMPR.
400mg 400mg 400mg 400mg 400mg 400mg 400mg 400mg 400mg 800mg 800mg 800mg 800mg 800mg 20%

N06BX03 PIRACETAMUM
LUCETAM NEUROSTIM 400 mg PIRACETAM 400 mg PIRACETAM LPH 400 mg

COMPR. FILM.
EGIS PHARMACEUTICALS PLC AC HELCOR PHARMA SRL GEDEON RICHTER ROMANIA SA LABORMED PHARMA SA

400mg

N06BX03 PIRACETAMUM
LUCETAM NEUROSTIM 800 mg NOOTROPIL 800 mg PIRACETAM 800 mg PIRACETAM LPH 800 mg

COMPR. FILM.
EGIS PHARMACEUTICALS PLC AC HELCOR PHARMA SRL U.C.B. SA GEDEON RICHTER ROMANIA SA LABORMED PHARMA SA

800mg

N06BX03 PIRACETAMUM
NOOTROPIL

SOL. ORALA
U.C.B. SA

20%

1170

N07CA02

CINNARIZINUM
CAPS.
25mg ARENA GROUP SA

N07CA02 CINNARIZINUM
CINARIZINA ARENA 25 mg

25mg 25mg
LAROPHARM SRL OZONE LABORATORIES MEDUMAN SA TERAPIA SA JANSSEN PHARMACEUTICA NV

N07CA02 CINNARIZINUM
CINARIZIN 25 mg CINARIZINA 25 mg N-CINARIZINA STUGERON 25 mg STUGERON 25mg 25mg 25mg 25mg 25mg

COMPR.

1172
ATRICAN 250 mg

P01AX08

TENONITROZOLUM
CAPS. MOI GASTROREZ.
250mg LAB. INNOTECH INT.

P01AX08 TENONITROZOLUM

250mg

1173
HELMINTOX 125 mg

P02CC01

PYRANTELUM
COMPR. FILM.
125mg 125mg/2.5ml 250mg LAB. INNOTECH INT.

P02CC01 PYRANTELUM P02CC01 PYRANTELUM


HELMINTOX

125mg 125mg/2.5ml 250mg

SUSP. ORALA
LAB. INNOTECH INT. LAB. INNOTECH INT.

P02CC01 PYRANTELUM
HELMINTOX 250 mg

COMPR. FILM.

1174

P03AAN1

SULFUR
UNGUENT
8% GEDEON RICHTER ROMANIA SA

P03AAN1 SULFUR
UNGUENT CU SULF 8%

8,00%

1175
NIX

P03AC04

PERMETHRINUM
CREMA CAPILARA
1% GLAXO WELLCOME UK LTD.

P03AC04 PERMETHRINUM

1,00%

1176

P03AX01

BENZYLUM BENZOICUM
CREMA
25% FITERMAN PHARMA S.R.L.

P03AX01 BENZYLUM BENZOICUM


BENZOAT DE BENZIL MK

25,00%

1177
PIVALONE 1%

R01AD07

TIXOCORTOLUM
SUSP. NAZALA
1% PFIZER EUROPE MA EEG

R01AD07 TIXOCORTOLUM

1,00%

1178

R01ADN1

COMBINATII

230 / 233

DCI/DENUMIRE COMERCIALA

CONCENTRATIE

FORMA FARM.

FIRMA

PROTOCOL

R01ADN1 COMBINATII
BIORINIL

SPRAY NAZ.,SUSP.
FARMILA FARMACEUTICI MILANO SPA

R01ADN1 COMBINATII
FLUORORINIL

SUSP. INHAL.
FARMILA - THEA FARMACEUTICI SPA

1179

R01BA52

COMBINATII
COMPR. FILM. ELIB. MODIF.
2,5mg/120mg 200mg/30mg 200mg/30mg SP EUROPE

R01BA52 COMBINATII
AERINAZE (R01BA52) 2,5mg/120mg

2,5mg/120mg 200mg/30mg

R01BA52 COMBINATII
LAROFEN PLUS MODAFEN

COMPR. FILM.
LAROPHARM S.R.L. ZENTIVA A.S. GLAXO WELLCOME UK LTD. EUROPHARM SA PHARMEX ROM IND. PHARMEX ROM IND.

R01BA52 COMBINATII
ACTIFED PARACETAMOL SINUS RINOALERSIN RINOALERSIN FORTE

COMPR.

R01BA52 COMBINATII
HUMEX RACEALA si GRIPA

COMPR. + CAPS.
LAB. URGO

R01BA52 COMBINATII
CLARINASE

COMPR. ELIB. MODIF.


SCHERING PLOUGH EUROPE

R01BA52 COMBINATII
COLDREX SINUS + NUROFEN RACEALA SI GRIPA

COMPR. FILM.
GLAXOSMITHKLINE CONSUMER HEALTHCARE RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIMITED

R01BA52 COMBINATII
ADVIL COLD

DRAJ.
WYETH WHITEHALL EXPORT GMBH

1180
BIOPAROX

R02AB03

FUSAFUNGINUM
SPRAY BUCOFARINGIAN SI NAZAL-SOL.
50mg/10ml LES LABORATOIRES SERVIER

R02AB03 FUSAFUNGINUM

50mg/10ml

1181
EFEDRINA 10 mg/ ml

R03CA02

EPHEDRINI HYDROCHLORIDUM
SOL. INJ.
10mg/ml ZENTIVA S.A.

R03CA02 EPHEDRINI HYDROCHLORIDUM R03CA02 EPHEDRINI HYDROCHLORIDUM


EPHEDRINE AGUETTANT 30 mg/ml

10mg/ml 30mg/ml
LAB. AGUETTANT

SOL. INJ.
30mg/ml

R03CA02 EPHEDRINI HYDROCHLORIDUM


EFEDRINA ARENA 50mg

COMPR.
ARENA GROUP SA

50mg 50mg/ml
ZENTIVA S.A.

R03CA02 EPHEDRINI HYDROCHLORIDUM


EFEDRINA 50 mg/ ml

SOL. INJ.
50mg/ml

1182
AIRONYL

R03CC03

TERBUTALINUM
SIROP
1.5mg/5ml SEDICO IMPEX S.R.L.

R03CC03 TERBUTALINUM

1.5mg/5ml

1183
ACC

R05CB01

ACETYLCYSTEINUM
GRAN. PT. SOL. ORALA
100mg/5ml 100mg/plic 100mg/plic HEXAL AG

R05CB01 ACETYLCYSTEINUM R05CB01 ACETYLCYSTEINUM


FLUIMUCIL 100

100mg/5ml 100mg/plic 100mg/plic 200mg

GRAN. PT. SOL. ORALA


ZAMBON S.P.A. HEXAL AG HEXAL AG LAROPHARM S.R.L. LABORMED PHARMA SA VIM SPECTRUM SRL

R05CB01 ACETYLCYSTEINUM
ACC 100

PULB. PT. SOL. ORALA CAPS.


200mg 200mg 200mg 200mg 200mg 200mg/plic 200mg/plic

R05CB01 ACETYLCYSTEINUM
ACC 200 ACETILCISTEINA ACETILCISTEINA LPH 200 mg MUCOVIM 200

R05CB01 ACETYLCYSTEINUM
ACC 200

COMPR. EFF.
HEXAL AG

200mg 200mg/plic 200mg/plic 300mg/3ml

R05CB01 ACETYLCYSTEINUM
FLUIMUCIL 200

GRAN. PT. SOL. ORALA


ZAMBON S.P.A. HEXAL AG HEXAL AG

R05CB01 ACETYLCYSTEINUM
ACC 200

PULB. PT. SOL. ORALA SOL. INJ.


300mg/3ml

R05CB01 ACETYLCYSTEINUM
ACC INJECT 300mg/3ml

R05CB01 ACETYLCYSTEINUM
FLUIMUCIL

SOL.INJ./INHAL.NEBULIZ./INSTILATIE ENDOTRAHEOBRON.
300mg/3ml 600mg 600mg 2% ZAMBON S.P.A.

300mg/3ml

R05CB01 ACETYLCYSTEINUM
ACC 600 FLUIMUCIL 600

COMPR. EFF.
HEXAL AG ZAMBON S.P.A.

600mg

R05CB01 ACETYLCYSTEINUM
FLUIMUCIL 2% PEDIATRIC

SOL. ORALA
ZAMBON S.P.A.

2%

1184

R05CB03

CARBOCISTEINUM
SIROP
100mg/5ml 100mg/5ml LAB. URGO

R05CB03 CARBOCISTEINUM
HUMEX EXPECTORANT PENTRU COPII SI SUGARI

100mg/5ml 100mg/5ml 20mg/ml


ECOBI PHARMACEUTICI SAS

R05CB03 CARBOCISTEINUM
FLUIDOL 100mg/5ml

SOL. ORALA
TIS FARMACEUTIC SA

R05CB03 CARBOCISTEINUM
MUCOTREIS

SIROP
20mg/ml

R05CB03 CARBOCISTEINUM
CARBOCISTEINA

SIROP
250mg/5ml 250mg/5ml TERAPIA S.A.

250mg/5ml 250mg/5ml 300mg

R05CB03 CARBOCISTEINUM
FLUIDOL 250mg/5ml

SOL. ORALA
TIS FARMACEUTIC SA

R05CB03 CARBOCISTEINUM

PULB. PT. SOL. ORALA

231 / 233

DCI/DENUMIRE COMERCIALA
MUCOTREIS

CONCENTRATIE
300mg

FORMA FARM.
ECOBI PHARMACEUTICI

FIRMA

PROTOCOL

R05CB03 CARBOCISTEINUM
MUCOTREIS

SIROP
50mg/ml ECOBI PHARMACEUTICI SAS

50mg/ml 750mg/15ml
LAB. URGO

R05CB03 CARBOCISTEINUM
HUMEX EXPECTORANT PENTRU ADULTI

SIROP
750mg/15ml

R05CB03 CARBOCISTEINUM
RHINATHIOL 2% pentru copii si sugari 2%

SIROP
SANOFI-AVENTIS OTC

2% 5%
SPECIFAR SA PHARMACEUTICALS PIERRE FABRE MEDICAMENT PIERRE FABRE MEDICAMENT SANOFI-AVENTIS OTC

R05CB03 CARBOCISTEINUM
ESTIVAL PECTODRILL EXPECTORANT FARA ZAHAR, PENTRU ADULTI PECTODRILL EXPECTORANT PENTRU ADULTI RHINATHIOL 5% pentru adulti 5% 5% 5% 5%

SIROP

1185
TAVEGYL

R06AA04

CLEMASTINUM
COMPR.
1mg NOVARTIS CONSUMER HEALTH GMBH

R06AA04 CLEMASTINUM

1mg

1186

R06AD02
Cod restrictie 9084:

PROMETHAZINUM
COMPR. FILM.
30mg ARENA GROUP S.A.

R06AD02 PROMETHAZINUM
PROMETAZINA ARENA 30 mg

30mg

Pot aparea efecte secundare semnificative

R06AD02 PROMETHAZINUM
ROMERGAN

SIROP
5mg/5ml BIOFARM S.A.

5mg/5ml

1187
PRIMALAN

R06AD07

MEQUITAZINUM
SIROP
0.05% LAB. PIERRE FABRE

R06AD07 MEQUITAZINUM R06AD07 MEQUITAZINUM


PRIMALAN 10 mg 10mg

0.05% 10mg
LAB. PIERRE FABRE

COMPR. COMPR.
5mg PIERRE FABRE MEDICAMENT

R06AD07 MEQUITAZINUM
PRIMALAN 5 mg

5mg

1188
EMETOSTOP

R06AE05

MECLOZINUM
COMPR.
30mg SPECIFAR SA

R06AE05 MECLOZINUM

30mg

1189
BIOHEPT PERITOL

R06AX02

CYPROHEPTADINUM
SIROP
2mg/5ml 2mg/5ml BIOFARM S.A. EGIS PHARMACEUTICALS LTD.

R06AX02 CYPROHEPTADINUM

2mg/5ml

R06AX02 CYPROHEPTADINUM
CIPROHEPTADINA 4 mg PERITOL 4mg 4mg

COMPR.
ARENA GROUP SA EGIS PHARMACEUTICALS LTD.

4mg

1190
PRESSING

R06AX13

LORATADINUM
COMPR. EFF.
10mg HEMOFARM S.R.L.

R06AX13 LORATADINUM R06AX13 LORATADINUM


CLARITINE SYMPHORAL 1 mg/ml

10mg 1mg/ml

SIROP
1mg/ml 1mg/ml SCHERING-PLOUGH EUROPE GEDEON RICHTER ROMANIA SA

R06AX13 LORATADINUM
LORATADINA BIOFARM 5mg/5ml

SIROP
5mg/5ml 5mg/5ml BIOFARM S.A.

5mg/5ml 5mg/5ml 0.1%


EGIS PHARMACEUTICALS LTD.

R06AX13 LORATADINUM
FLONIDAN

SUSP. ORALA
LEK PHARMACEUTICALS D.D.

R06AX13 LORATADINUM
EROLIN 0.1%

SIROP COMPR.
10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg 10mg SCHERING-PLOUGH EUROPE OZONE LABORATORIES LTD. EGIS PHARMACEUTICALS LTD. LEK PHARMACEUTICALS D.D. LEK PHARMACEUTICALS D.D. HEXAL AG AC HELCOR SRL LAROPHARM SRL ALIUD PHARMA GMBH & CO.KG LABORMED PHARMA SA DAR AL DAWA PHARMA S.R.L. STD CHEMICALS LIMITED HEMOFARM S.R.L. TERAPIA S.A. GEDEON RICHTER ROMANIA S.A.

R06AX13 LORATADINUM
CLARITINE 10 mg CLAROZONE EROLIN FLONIDAN FLONIDAN 10 mg LORANO HEXAL LORASTAMIN 10 mg LORATADIN 10 mg LORATADIN AL 10 LORATADINA LPH 10 mg LORATAN LORATIMED PRESSING 10 mg ROLETRA SYMPHORAL 10 mg

10mg

1191
SIFICETINA

S01AA01

CHLORAMPHENICOLUM
PULB. + SOLV. PT. SOL. OFT.
0.4% S.I.F.I. SPA

S01AA01 CHLORAMPHENICOLUM

0.4%

1192
FUCITHALMIC

S01AA13

ACIDUM FUSIDICUM
GEL OFT.
1% LEO PHARMACEUTICAL PRODUCTS

S01AA13 ACIDUM FUSIDICUM

1,00%

1193

S01AA24

KANAMYCINUM
UNG. OFT.
1% ANTIBIOTICE SA

S01AA24 KANAMYCINUM
KANAMICINA SULFAT 1%

1,00%

1194
ANTIBIOPTAL

S01AA30

COMBINATII
PICATURI OFT.-SOL.
FARMILA FARMACEUTICI

S01AA30 COMBINATII S01AA30 COMBINATII

PULB. + SOLV. PT. SOL. OFT.

232 / 233

DCI/DENUMIRE COMERCIALA
COLBIOCIN

CONCENTRATIE

FORMA FARM.
S.I.F.I. SPA

FIRMA

PROTOCOL

S01AA30 COMBINATII
ENBECIN

UNG. OFT.
POLIPHARMA INDUSTRIES S.R.L.

1195

S01BA07

FLUOROMETHOLONUM
UNG. OFT.
1mg/g 2mg/ml FARMILA - THEA FARMACEUTICI SPA

S01BA07 FLUOROMETHOLONUM
FLUMETOL S UNGUENT OFTALMIC

1mg/g 2mg/ml

S01BA07 FLUOROMETHOLONUM
FLUMETOL S

PICATURI OFT.SUSP.
FARMILA - THEA FARMACEUTICI SPA

1196
PRENACID

S01BA11

DESONIDUM
PICATURI OFT.-SOL.
0.25% S.I.F.I. SPA

S01BA11 DESONIDUM S01BA11 DESONIDUM


PRENACID 0.25%

0.25% 0.25%

UNG. OFT.
S.I.F.I. SPA

1197
INDOCOLLYRE 0.1%

S01BC01

INDOMETACINUM
PICATURI OFT.-SOL.
0.1% LAB. CHAUVIN

S01BC01 INDOMETACINUM

0.1%

1198
BRUXICAM 0,5%

S01BC06

PIROXICAMUM
PIC. OFT., SOL.
0.5% BRUSCHETTINI S.R.L.

S01BC06 PIROXICAMUM

0.5%

1199
DROPIL

S01EB01

PILOCARPINUM
PICATURI OFT.-SOL.
2% BRUSCHETTINI

S01EB01 PILOCARPINUM

2,00%

1200
EMADINE 0.05%

S01GX06

EMEDASTINUM
PICATURI OFT.-SOL.
0.5mg/ml 0.5mg/ml ALCON LABORATORIES LTD.

S01GX06 EMEDASTINUM S01GX06 EMEDASTINUM


EMADINE 0.05%

0.5mg/ml 0.5mg/ml

PICATURI OFT.-SOL., DOZA UNICA


ALCON LABORATORIES LTD.

1201
ZADITEN 0,25 mg/ml

S01GX08

KETOTIFENUM
PICATURI OFT.-SOL.
0.25mg/ml 0.25mg/ml NOVARTIS PHARMA GMBH

S01GX08 KETOTIFENUM S01GX08 KETOTIFENUM


ZADITEN 0,25 mg/ml

0.25mg/ml 0.25mg/ml

PIC. OFT.,SOL.
NOVARTIS PHARMA GMBH

1202
EYESTIL

S01KA01

ACIDUM HIALURONICUM
PICATURI OFT.-SOL.
0.15% S.I.F.I. SPA

S01KA01 ACIDUM HIALURONICUM

0.15%

1203
KERATYL 1%

S01XA11

NANDROLONUM
PICATURI OFT.-SOL.
1% LAB. CHAUVIN

S01XA11 NANDROLONUM

1,00%

1204
CORNEREGEL

S01XA12

DEXPANTHENOLUM
GEL OFT.
5% DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH

S01XA12 DEXPANTHENOLUM

5,00%

1205
OTIS-T

S02CA05

COMBINATII
PICATURI AURICULARE-SOL.
TIS FARMACEUTIC SA

S02CA05 COMBINATII S02CA05 COMBINATII


SOLUTIE AURICULARA CU CLORAMFENICOL SI FLUOCINOLON

SOL. AURICULARA
BIOFARM SA

1206
XOLAIR 150 mg

R03DX05

OMALIZUMABUM **
PULB+SOLV.PT.SOL.INJ.
150mg 150mg 75mg NOVARTIS EUROPHARM LTD.

R03DX05 OMALIZUMABUM R03DX05 OMALIZUMABUM


XOLAIR 150 mg XOLAIR 75 mg

150mg 75mg

PULB+SOLV.PT.SOL.INJ.
NOVARTIS EUROPHARM LTD. NOVARTIS EUROPHARM LTD.

233 / 233

S-ar putea să vă placă și